Citrus Sinensis ID: 014750
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | 2.2.26 [Sep-21-2011] | |||||||
| Q39010 | 412 | Shaggy-related protein ki | yes | no | 0.978 | 0.995 | 0.894 | 0.0 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.971 | 1.0 | 0.896 | 0.0 | |
| Q39011 | 380 | Shaggy-related protein ki | no | no | 0.906 | 1.0 | 0.902 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.880 | 0.9 | 0.832 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.937 | 0.960 | 0.777 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.949 | 0.982 | 0.757 | 0.0 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.875 | 0.897 | 0.807 | 0.0 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.904 | 0.922 | 0.787 | 0.0 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.883 | 0.900 | 0.795 | 0.0 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.887 | 0.905 | 0.785 | 0.0 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/419 (89%), Positives = 391/419 (93%), Gaps = 9/419 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAG 418
HPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEHVRRQ P AG
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/416 (89%), Positives = 387/416 (93%), Gaps = 9/416 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 416
PFF+ELREPNARLPNGRP PPLFNFKQEL GAS ELINRLIPEHVRRQ + +S
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS 407
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 733 bits (1893), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/380 (90%), Positives = 364/380 (95%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINR 399
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE+AG+SPEL+N+
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 400 LIPEHVRRQTGLSMPHSAGT 419
LIP+H++RQ GLS + +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/370 (83%), Positives = 336/370 (90%), Gaps = 1/370 (0%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCL
Sbjct: 35 IKDDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YRV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQV
Sbjct: 155 TVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQV 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL
Sbjct: 275 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDL 334
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELIN 398
SRLLQYSP+LR TA+EA HPFFDELR+PN RLPNGR PPLFNFK QEL GAS EL++
Sbjct: 335 VSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLS 394
Query: 399 RLIPEHVRRQ 408
+LIP+H R+Q
Sbjct: 395 KLIPDHARKQ 404
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/396 (77%), Positives = 343/396 (86%), Gaps = 3/396 (0%)
Query: 16 PQAQAPPSQQPHFDNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEP 73
P A S D D L DM DKEM A ++ GN TGHII TTIGG+NG+P
Sbjct: 8 PSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQP 67
Query: 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVI 133
KQTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+
Sbjct: 68 KQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVV 127
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
SLKHCFFSTT KDEL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+Y
Sbjct: 128 SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSY 187
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
IH GVCHRD+KPQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFG
Sbjct: 188 IHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
ATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+
Sbjct: 248 ATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFFDELR+PNARL
Sbjct: 308 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARL 367
Query: 374 PNGRPFPPLFNFK-QELAGASPELINRLIPEHVRRQ 408
PNGR PPLFNFK EL G E++ +L+PEH R+Q
Sbjct: 368 PNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 310/409 (75%), Positives = 346/409 (84%), Gaps = 11/409 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+ + P P P + ND+ R DKEM A V+ GN TGH
Sbjct: 1 MASVGIAPNPGARDSTGVDKLPEEM----NDMKIR------DDKEMEATVVDGNGTETGH 50
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
II TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRE
Sbjct: 51 IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 110
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET++RV+KHY+ +NQRMPLIYV
Sbjct: 111 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYV 170
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQVKLCDFGSAKVLVKGE NISYI
Sbjct: 171 KLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 230
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPT
Sbjct: 231 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 290
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR AL+ H
Sbjct: 291 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVH 350
Query: 361 PFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLIPEHVRRQ 408
PFFDELR+PNARLPNGR PPLFNFK EL G E++ +L+PEH R+Q
Sbjct: 351 PFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQ 399
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 297/368 (80%), Positives = 332/368 (90%), Gaps = 1/368 (0%)
Query: 42 SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 101
DKE+ AA++ GN TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCLET
Sbjct: 36 DDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLET 95
Query: 102 GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETM 161
GETVAIKKVLQD+RYKNRELQ MRL+DHPNV+ LKHCFFSTT KDE++LNLV+EYVPET+
Sbjct: 96 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETV 155
Query: 162 YRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221
+RV+KHY+ +NQRMPLI VKLYTYQIFR L+YIH GVCHRD+KPQNLLV+P THQVKL
Sbjct: 156 HRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKL 215
Query: 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
CDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFP
Sbjct: 216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFP 275
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
GE+ VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 276 GESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 335
Query: 342 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRL 400
RLLQYSP+LRCTALEA H FFDELR+PN RLPNGR PPLFNFK EL G S E + +L
Sbjct: 336 RLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKL 395
Query: 401 IPEHVRRQ 408
+PEH R+Q
Sbjct: 396 VPEHARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 301/382 (78%), Positives = 335/382 (87%), Gaps = 3/382 (0%)
Query: 30 NDLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGT 87
+D+L DM D+EM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 24 DDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGH 83
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDE
Sbjct: 84 GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDE 143
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
L+LNLV+EYVPET++RV+KHYS +NQRMP+IYVKLYTYQIFR L+YIH GVCHRD+KP
Sbjct: 144 LYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKP 203
Query: 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAG 267
QNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WS G
Sbjct: 204 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVG 263
Query: 268 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 327
CVLAELLLGQPLFPGE VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+
Sbjct: 264 CVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 323
Query: 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK- 386
FHKRMP EA+DL SRLLQYSP+LRC AL+ HPFFDELR+PNARLP GR PPLFNFK
Sbjct: 324 FHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKP 383
Query: 387 QELAGASPELINRLIPEHVRRQ 408
EL G E + +L+PEH R+Q
Sbjct: 384 HELKGVPVETLMKLVPEHARKQ 405
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 296/372 (79%), Positives = 332/372 (89%), Gaps = 2/372 (0%)
Query: 42 SDKEMSAA-VIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLE 100
DKEM AA ++ GN TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLE
Sbjct: 36 DDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE 95
Query: 101 TGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET 160
TGETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET
Sbjct: 96 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET 155
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
+ RV++HY+ MNQRMP+IYVKLY+YQI R LAYIH GVCHRD+KPQNLLV+P THQ+K
Sbjct: 156 VSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLK 215
Query: 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
+CDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLF
Sbjct: 216 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLF 275
Query: 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 340
PGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 276 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLV 335
Query: 341 SRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINR 399
SRLLQYSP+LR TALEA HPF+D++R+PN RLPNGR PPLFNFK EL G E++ +
Sbjct: 336 SRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVK 395
Query: 400 LIPEHVRRQTGL 411
L+P H R+Q L
Sbjct: 396 LVPPHARKQCAL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 293/373 (78%), Positives = 328/373 (87%), Gaps = 1/373 (0%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DKEM A V+ GN GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCL
Sbjct: 35 IKDDKEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCL 94
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQD+RYKNRELQ MRL+DHPNV++LKHCFFSTT KDEL+LNLV+E+VPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPE 154
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T++RV++HYS MNQRMPLIYVKLY+YQI R LAYIH GV HRD+KPQNLLV+P THQ+
Sbjct: 155 TVHRVIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQL 214
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWSAGCVL ELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPL 274
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPG + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL
Sbjct: 275 FPGASGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDL 334
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELIN 398
SRLLQYSP+LR TALEA HPFFDELR+PN RLPNGR PPLFNFK EL G E++
Sbjct: 335 VSRLLQYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLV 394
Query: 399 RLIPEHVRRQTGL 411
+L+P H R+Q L
Sbjct: 395 KLVPSHARKQCSL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| 15224593 | 412 | Shaggy-related protein kinase zeta [Arab | 0.978 | 0.995 | 0.894 | 0.0 | |
| 15221476 | 407 | Shaggy-related protein kinase iota [Arab | 0.971 | 1.0 | 0.896 | 0.0 | |
| 297826527 | 412 | hypothetical protein ARALYDRAFT_902112 [ | 0.978 | 0.995 | 0.892 | 0.0 | |
| 222423077 | 407 | AT1G06390 [Arabidopsis thaliana] | 0.971 | 1.0 | 0.894 | 0.0 | |
| 21593135 | 412 | putative shaggy-like protein kinase dzet | 0.978 | 0.995 | 0.890 | 0.0 | |
| 356543100 | 420 | PREDICTED: shaggy-related protein kinase | 0.918 | 0.916 | 0.929 | 0.0 | |
| 356517324 | 419 | PREDICTED: shaggy-related protein kinase | 1.0 | 1.0 | 0.873 | 0.0 | |
| 1225913 | 412 | shaggy-like kinase dzeta [Arabidopsis th | 0.978 | 0.995 | 0.887 | 0.0 | |
| 297843440 | 410 | hypothetical protein ARALYDRAFT_470656 [ | 0.978 | 1.0 | 0.894 | 0.0 | |
| 357452871 | 423 | Shaggy-related protein kinase [Medicago | 0.897 | 0.888 | 0.944 | 0.0 |
| >gi|15224593|ref|NP_180655.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] gi|147744570|sp|Q39010.2|KSG6_ARATH RecName: Full=Shaggy-related protein kinase zeta; AltName: Full=ASK-zeta gi|3201623|gb|AAC20732.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] gi|17381128|gb|AAL36376.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|20453108|gb|AAM19796.1| At2g30980/F7F1.19 [Arabidopsis thaliana] gi|20465727|gb|AAM20332.1| putative shaggy protein kinase dzeta [Arabidopsis thaliana] gi|330253376|gb|AEC08470.1| Shaggy-related protein kinase zeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/419 (89%), Positives = 391/419 (93%), Gaps = 9/419 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAG 418
HPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEHVRRQ P AG
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15221476|ref|NP_172127.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|42571361|ref|NP_973771.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|11133004|sp|Q39012.1|KSG9_ARATH RecName: Full=Shaggy-related protein kinase iota; AltName: Full=ASK-iota gi|8927676|gb|AAF82167.1|AC068143_9 Contains a very strong similarity to a shaggy-like kinase iota from Arabidopsis thaliana gb|X99696 and contains an eukaryotic protein kinase PF|00069 domain. EST gb|N37432 comes from this gene [Arabidopsis thaliana] gi|1480078|emb|CAA68027.1| shaggy-like protein kinase iota [Arabidopsis thaliana] gi|2444277|gb|AAB71545.1| GSK3/shaggy-like protein kinase [Arabidopsis thaliana] gi|14334750|gb|AAK59553.1| putative shaggy kinase [Arabidopsis thaliana] gi|15293239|gb|AAK93730.1| putative shaggy kinase [Arabidopsis thaliana] gi|332189859|gb|AEE27980.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] gi|332189860|gb|AEE27981.1| Shaggy-related protein kinase iota [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/416 (89%), Positives = 387/416 (93%), Gaps = 9/416 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 416
PFF+ELREPNARLPNGRP PPLFNFKQEL GAS ELINRLIPEHVRRQ + +S
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS 407
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297826527|ref|XP_002881146.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] gi|297326985|gb|EFH57405.1| hypothetical protein ARALYDRAFT_902112 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/419 (89%), Positives = 389/419 (92%), Gaps = 9/419 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLG PQPP + AP Q PH D LKR RPDMD+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLG-HPQPP----SLAP--QPPHLHGGDALKR-RPDMDTDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAG 418
HPFF+ELRE NARLPNGRP PPLFNFKQEL+GASPELINRLIPEHVRRQ P AG
Sbjct: 353 HPFFNELREANARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222423077|dbj|BAH19519.1| AT1G06390 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/416 (89%), Positives = 387/416 (93%), Gaps = 9/416 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLGPQP A APP Q D D LKR RP++DSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGPQPH------ALAPPLQL--HDGDALKR-RPELDSDKEMSAAVIEGNDAVTGH 51
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 52 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 111
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 112 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 171
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE NISYI
Sbjct: 172 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYI 231
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPG+N+VDQLVEIIKVLGTPT
Sbjct: 232 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGKNSVDQLVEIIKVLGTPT 291
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 292 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 351
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 416
PFF+ELREPNARLPNGRP PPLFNFKQEL GAS ELINRLIPEHVRRQ + +S
Sbjct: 352 PFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIPEHVRRQMSTGLQNS 407
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|21593135|gb|AAM65084.1| putative shaggy-like protein kinase dzeta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/419 (89%), Positives = 391/419 (93%), Gaps = 9/419 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRDVKPQNLLVDPLTHQ KLCDFGSAKVLVKGEANISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYR+PELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VD+LVEIIKVLGTP
Sbjct: 233 ICSRYYRSPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDRLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAG 418
HPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEHVRRQ P AG
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543100|ref|XP_003540001.1| PREDICTED: shaggy-related protein kinase zeta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/385 (92%), Positives = 372/385 (96%)
Query: 35 RHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVF 94
R DM++DK+MSA VI+GNDAVTGHIISTTIGGKNGEPK+TISYMAERVVGTGSFG+VF
Sbjct: 36 RRSSDMETDKDMSATVIEGNDAVTGHIISTTIGGKNGEPKETISYMAERVVGTGSFGVVF 95
Query: 95 QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
QAKCLETGE VAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS+DELFLNLVM
Sbjct: 96 QAKCLETGEAVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSRDELFLNLVM 155
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
EYVPE+MYRV+KHY++MNQRMPLIYVKLYTYQIFRGLAYIHT GVCHRDVKPQNLLV P
Sbjct: 156 EYVPESMYRVIKHYTTMNQRMPLIYVKLYTYQIFRGLAYIHTALGVCHRDVKPQNLLVHP 215
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
LTHQVKLCDFGSAKVLVKGE+NISYICSRYYRAPELIFGATEYT SIDIWSAGCVLAELL
Sbjct: 216 LTHQVKLCDFGSAKVLVKGESNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELL 275
Query: 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334
LGQPLFPGEN VDQLVEIIKVLGTPTREEIRCMNPNYT+FRFPQIKAHPWHKVFHKRMPP
Sbjct: 276 LGQPLFPGENQVDQLVEIIKVLGTPTREEIRCMNPNYTEFRFPQIKAHPWHKVFHKRMPP 335
Query: 335 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASP 394
EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQELAGASP
Sbjct: 336 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELAGASP 395
Query: 395 ELINRLIPEHVRRQTGLSMPHSAGT 419
ELINRLIPEH+RRQ GLS PHSAGT
Sbjct: 396 ELINRLIPEHIRRQMGLSFPHSAGT 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517324|ref|XP_003527338.1| PREDICTED: shaggy-related protein kinase zeta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/419 (87%), Positives = 380/419 (90%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLG P P + R DM++DK+MSA VI+GNDAVTGH
Sbjct: 1 MASLPLGHHHHHQPAAATIHPSQPPQCQPQPEVPRRSSDMETDKDMSATVIEGNDAVTGH 60
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCLETGE VAIKKVLQDRRYKNRE
Sbjct: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCLETGEAVAIKKVLQDRRYKNRE 120
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE+MYRV+KHY++MNQRMPLIYV
Sbjct: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPESMYRVIKHYTTMNQRMPLIYV 180
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHT VCHRDVKPQNLLV PLTHQVKLCDFGSAKVLVKGE+NISYI
Sbjct: 181 KLYTYQIFRGLAYIHTALRVCHRDVKPQNLLVHPLTHQVKLCDFGSAKVLVKGESNISYI 240
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN VDQLVEIIKVLGTPT
Sbjct: 241 CSRYYRAPELIFGATEYTPSIDIWSAGCVLAELLLGQPLFPGENQVDQLVEIIKVLGTPT 300
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAGT 419
PFFDELREPNARLPNG P PPLFNFKQELAGASPELINRLIPEH+RRQ GLS PHSAG+
Sbjct: 361 PFFDELREPNARLPNGHPLPPLFNFKQELAGASPELINRLIPEHIRRQMGLSFPHSAGS 419
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1225913|emb|CAA64408.1| shaggy-like kinase dzeta [Arabidopsis thaliana] gi|1669653|emb|CAA70483.1| serine/threonine kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/419 (88%), Positives = 389/419 (92%), Gaps = 9/419 (2%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHF-DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTG 59
M S+PLGP PQPP + AP Q PH D LKR RPD+D+DKEMSAAVI+GNDAVTG
Sbjct: 1 MTSIPLGP-PQPP----SLAP--QPPHLHGGDSLKR-RPDIDNDKEMSAAVIEGNDAVTG 52
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR 119
HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNR
Sbjct: 53 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNR 112
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
ELQLMRLMDHPNV+SLKHCFFSTT++DELFLNLVMEYVPET+YRVLKHY+S NQRMP+ Y
Sbjct: 113 ELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFY 172
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
VKLYTYQIFRGLAYIHT PGVCHRD+KPQNLLVDP THQ KLCDFGSAKVLVKGE NISY
Sbjct: 173 VKLYTYQIFRGLAYIHTAPGVCHRDIKPQNLLVDPHTHQCKLCDFGSAKVLVKGEPNISY 232
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
ICSRYYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTP
Sbjct: 233 ICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTP 292
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA
Sbjct: 293 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 352
Query: 360 HPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSAG 418
HPFF+ELREPNARLPNGRP PPLFNFKQEL+GASPELINRLIPEHVRRQ P AG
Sbjct: 353 HPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297843440|ref|XP_002889601.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] gi|297335443|gb|EFH65860.1| hypothetical protein ARALYDRAFT_470656 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/416 (89%), Positives = 386/416 (92%), Gaps = 6/416 (1%)
Query: 1 MASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGH 60
MAS+PLG QP PP Q D D LKR RP+MDSDKEMSAAVI+GNDAVTGH
Sbjct: 1 MASLPLGHQPH-----ALAPPPPQPQLHDGDALKR-RPEMDSDKEMSAAVIEGNDAVTGH 54
Query: 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE 120
IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRE
Sbjct: 55 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRE 114
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
LQLMR MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPET+YRVL+HY+S NQRMP+ YV
Sbjct: 115 LQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYV 174
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI
Sbjct: 175 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 234
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPT 294
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH
Sbjct: 295 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 354
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 416
PFF+ELREPNARLPNGRP PPLFNFKQEL GAS EL+NRLIPEHVRRQ G + +S
Sbjct: 355 PFFNELREPNARLPNGRPLPPLFNFKQELGGASVELVNRLIPEHVRRQMGTGLQNS 410
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452871|ref|XP_003596712.1| Shaggy-related protein kinase [Medicago truncatula] gi|355485760|gb|AES66963.1| Shaggy-related protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/376 (94%), Positives = 369/376 (98%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
MD+DKEMSA+V+ NDAVTGHIISTTIGGKNGEPK+TISYMAERVVGTGSFGIVFQAKCL
Sbjct: 46 MDTDKEMSASVVDSNDAVTGHIISTTIGGKNGEPKRTISYMAERVVGTGSFGIVFQAKCL 105
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGE VAIKKVLQD+RYKNRELQLMR+MDHPNVISLKHCFFSTTS+DELFLNLVMEYVPE
Sbjct: 106 ETGEAVAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 165
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
TMYRVLKHY+++NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV
Sbjct: 166 TMYRVLKHYNNINQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 225
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 226 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 285
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGEN VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 286 FPGENQVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 345
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINR 399
ASRLLQYSPSLRC+ALEACAHPFFDELREPNARLPNGRP PPLFNFKQEL+GASPELIN+
Sbjct: 346 ASRLLQYSPSLRCSALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELINK 405
Query: 400 LIPEHVRRQTGLSMPH 415
LIPEHVRRQTGL P+
Sbjct: 406 LIPEHVRRQTGLGFPY 421
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.923 | 0.939 | 0.927 | 5.3e-198 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.911 | 0.938 | 0.937 | 1.3e-196 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.906 | 1.0 | 0.902 | 2.5e-191 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.906 | 0.929 | 0.796 | 4.4e-171 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.873 | 0.892 | 0.839 | 5.6e-171 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.902 | 0.933 | 0.800 | 1.3e-169 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.880 | 0.781 | 0.770 | 3.5e-162 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.911 | 0.907 | 0.712 | 4.9e-156 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.878 | 0.840 | 0.712 | 2.7e-148 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.847 | 0.843 | 0.651 | 1.5e-129 |
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1917 (679.9 bits), Expect = 5.3e-198, P = 5.3e-198
Identities = 360/388 (92%), Positives = 374/388 (96%)
Query: 31 DLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 90
D LKR RPD+D+DKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF
Sbjct: 25 DSLKR-RPDIDNDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSF 83
Query: 91 GIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
GIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMRLMDHPNV+SLKHCFFSTT++DELFL
Sbjct: 84 GIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFL 143
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
NLVMEYVPET+YRVLKHY+S NQRMP+ YVKLYTYQIFRGLAYIHT PGVCHRDVKPQNL
Sbjct: 144 NLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNL 203
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270
LVDPLTHQ KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT+SIDIWSAGCVL
Sbjct: 204 LVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVL 263
Query: 271 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 330
AELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK
Sbjct: 264 AELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 323
Query: 331 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELA 390
RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQEL+
Sbjct: 324 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELS 383
Query: 391 GASPELINRLIPEHVRRQTGLSMPHSAG 418
GASPELINRLIPEHVRRQ P AG
Sbjct: 384 GASPELINRLIPEHVRRQMNGGFPFQAG 411
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1904 (675.3 bits), Expect = 1.3e-196, P = 1.3e-196
Identities = 361/385 (93%), Positives = 372/385 (96%)
Query: 29 DNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D D LKR RP++DSDKEMSAAVI+GNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG
Sbjct: 21 DGDALKR-RPELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 79
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS+DEL
Sbjct: 80 SFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDEL 139
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
FLNLVMEYVPET+YRVL+HY+S NQRMP+ YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ
Sbjct: 140 FLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 199
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLVDPLTHQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT SIDIWSAGC
Sbjct: 200 NLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGC 259
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 328
VLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF
Sbjct: 260 VLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 319
Query: 329 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE 388
HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRP PPLFNFKQE
Sbjct: 320 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQE 379
Query: 389 LAGASPELINRLIPEHVRRQ--TGL 411
L GAS ELINRLIPEHVRRQ TGL
Sbjct: 380 LGGASMELINRLIPEHVRRQMSTGL 404
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1854 (657.7 bits), Expect = 2.5e-191, P = 2.5e-191
Identities = 343/380 (90%), Positives = 364/380 (95%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
M DKEM AAV+ G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ETGETVAIKKVLQDRRYKNRELQLMR+MDHPNV+ LKHCFFSTTSKDELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
++YRVLKHYSS NQRMPL+YVKLY YQIFRGLAYIH V GVCHRD+KPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK LVKGEANISYICSR+YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINR 399
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQE+AG+SPEL+N+
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 400 LIPEHVRRQTGLSMPHSAGT 419
LIP+H++RQ GLS + +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1663 (590.5 bits), Expect = 4.4e-171, P = 4.4e-171
Identities = 305/383 (79%), Positives = 340/383 (88%)
Query: 29 DNDLLKRHRPDM--DSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVG 86
D D L DM DKEM A ++ GN TGHII TTIGG+NG+PKQTISYMAERVVG
Sbjct: 21 DADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVG 80
Query: 87 TGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146
GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KD
Sbjct: 81 HGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKD 140
Query: 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
EL+LNLV+EYVPET++RV+KHY+ +NQRMPL+YVKLYTYQIFR L+YIH GVCHRD+K
Sbjct: 141 ELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIK 200
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
PQNLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSA
Sbjct: 201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSA 260
Query: 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 326
GCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK
Sbjct: 261 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 320
Query: 327 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386
+FHKRMPPEA+DL SRLLQYSP+LRC AL++ HPFFDELR+PNARLPNGR PPLFNFK
Sbjct: 321 IFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFK 380
Query: 387 -QELAGASPELINRLIPEHVRRQ 408
EL G E++ +L+PEH R+Q
Sbjct: 381 PHELKGVPVEMVAKLVPEHARKQ 403
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1662 (590.1 bits), Expect = 5.6e-171, P = 5.6e-171
Identities = 308/367 (83%), Positives = 335/367 (91%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DKEM AAV+ GN TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLETG
Sbjct: 38 DKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETG 97
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
ETVAIKKVLQD+RYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 98 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVY 157
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
RV KHYS NQRMP+IYVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 158 RVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLC 217
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFPG
Sbjct: 218 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPG 277
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL SR
Sbjct: 278 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSR 337
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLI 401
LLQYSP+LR TA+EA HPFFDELR+PN RLPNGR PPLFNFK QEL GAS EL+++LI
Sbjct: 338 LLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLI 397
Query: 402 PEHVRRQ 408
P+H R+Q
Sbjct: 398 PDHARKQ 404
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1649 (585.5 bits), Expect = 1.3e-169, P = 1.3e-169
Identities = 305/381 (80%), Positives = 337/381 (88%)
Query: 31 DLLKRHRPDMD--SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTG 88
D L DM DKEM A V+ GN TGHII TTIGG+NG+PKQTISYMAERVVG G
Sbjct: 19 DKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHG 78
Query: 89 SFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148
SFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MRL+DHPNV+SLKHCFFSTT KDEL
Sbjct: 79 SFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDEL 138
Query: 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208
+LNLV+EYVPET++RV+KHY+ +NQRMPLIYVKLYTYQIFR L+YIH GVCHRD+KPQ
Sbjct: 139 YLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQ 198
Query: 209 NLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGC 268
NLLV+P THQVKLCDFGSAKVLVKGE NISYICSRYYRAPELIFGATEYTT+ID+WSAGC
Sbjct: 199 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGC 258
Query: 269 VLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 328
VLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F
Sbjct: 259 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 318
Query: 329 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-Q 387
HKRMPPEA+DL SRLLQYSP+LR AL+ HPFFDELR+PNARLPNGR PPLFNFK
Sbjct: 319 HKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPH 378
Query: 388 ELAGASPELINRLIPEHVRRQ 408
EL G E++ +L+PEH R+Q
Sbjct: 379 ELKGVPLEMVAKLVPEHARKQ 399
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1579 (560.9 bits), Expect = 3.5e-162, P = 3.5e-162
Identities = 286/371 (77%), Positives = 328/371 (88%)
Query: 43 DKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 102
DK+M V+ G+ TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLETG
Sbjct: 102 DKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETG 161
Query: 103 ETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMY 162
E VAIKKVLQD+RYKNRELQ+MRL DHPNV+ L+H FFSTT KDEL+LNLV+EYVPET+Y
Sbjct: 162 EQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVY 221
Query: 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
R KHY+ MNQ MP+I+V+LYTYQI R L Y+H V GVCHRD+KPQNLLV+P THQ+K+C
Sbjct: 222 RASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKIC 281
Query: 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
DFGSAK+LV GE NISYICSRYYRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFPG
Sbjct: 282 DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPG 341
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
E+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 342 ESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 401
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELINRLI 401
LLQYSP+LRCTALEACAHPFFD+LR+PN LPNGR PPLFNF QELAGAS EL RLI
Sbjct: 402 LLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLI 461
Query: 402 PEHVRRQTGLS 412
P H + TG S
Sbjct: 462 PAHCQG-TGSS 471
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 273/383 (71%), Positives = 324/383 (84%)
Query: 35 RHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVF 94
R + + D +++ +I G A GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VF
Sbjct: 39 RDKVETDDERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVF 98
Query: 95 QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
QAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN ++LKH FFS T +E++LNLV+
Sbjct: 99 QAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVL 158
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
E+VPET+ RV + YS NQ MPLIYVKLYTYQI R LAYIH G+CHRD+KPQNLLV+P
Sbjct: 159 EFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNP 218
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
THQ+K+CDFGSAKVLVKGE N+SYICSRYYRAPELIFGA+EYTT+IDIWS GCV+AELL
Sbjct: 219 HTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELL 278
Query: 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334
LGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PP
Sbjct: 279 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 338
Query: 335 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGAS 393
EA+DL R QYSP+LRCTALEAC HP FDELR+PN RLPNGRP PPLFNFK QEL+G
Sbjct: 339 EAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIP 398
Query: 394 PELINRLIPEHVRRQTGLSMPHS 416
PE++NRL+PEH R+Q HS
Sbjct: 399 PEIVNRLVPEHARKQNLFMALHS 421
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 263/369 (71%), Positives = 313/369 (84%)
Query: 40 MDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 99
+ DK+M +I+GN +G II+T G N + +TISY AE V+GTGSFG+VFQAKCL
Sbjct: 70 LGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCL 129
Query: 100 ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
ET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT KDEL+LNLV+EYVPE
Sbjct: 130 ETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPE 189
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219
T+YR + Y+ MNQ MPLIY++LYTYQI R + Y+H V GVCHRD+KPQNLLV+ +TH+V
Sbjct: 190 TIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEV 249
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279
K+CDFGSAK+L+ GE NISYICSRYYRAPELIFGATEYT++ID+WS GCV+AEL LG PL
Sbjct: 250 KICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPL 309
Query: 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 339
FPGE +VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DL
Sbjct: 310 FPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDL 369
Query: 340 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QELAGASPELIN 398
ASRLLQYSP+LRCTALEACAHPFFD+LR+P A LPNGR PPLF+F QELAGAS EL +
Sbjct: 370 ASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRH 429
Query: 399 RLIPEHVRR 407
RLIPEH R+
Sbjct: 430 RLIPEHARK 438
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
Identities = 234/359 (65%), Positives = 290/359 (80%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P++YVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PMVYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMP 414
EACAH FFDELREPN +LPNGR P LFNF + ++P L + LIP H R Q G S P
Sbjct: 333 EACAHSFFDELREPNVKLPNGREKPSLFNFTTQELSSNPTLASILIPAHARNQAGASTP 391
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7777 | 0.9379 | 0.9608 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7579 | 0.9498 | 0.9827 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5677 | 0.8210 | 0.8888 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8966 | 0.9713 | 1.0 | no | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6187 | 0.8042 | 0.9387 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8949 | 0.9785 | 0.9951 | yes | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9026 | 0.9069 | 1.0 | no | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7127 | 0.9116 | 0.9073 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5233 | 0.7589 | 0.8594 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6187 | 0.8042 | 0.9309 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7206 | 0.9116 | 0.9095 | no | no |
| O23145 | KSG2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7150 | 0.8687 | 0.8445 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.8070 | 0.8758 | 0.8973 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6464 | 0.8544 | 0.8523 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6205 | 0.8019 | 0.7194 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7879 | 0.9045 | 0.9221 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7855 | 0.8878 | 0.9051 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7956 | 0.8830 | 0.9002 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7391 | 0.9212 | 0.8247 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6464 | 0.8544 | 0.8523 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8324 | 0.8806 | 0.9 | no | no |
| Q91757 | GSK3B_XENLA | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6488 | 0.8400 | 0.8380 | N/A | no |
| Q5YJC2 | GSK3B_SPECI | 2, ., 7, ., 1, 1, ., 1 | 0.6436 | 0.8544 | 0.8523 | N/A | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6464 | 0.8544 | 0.8523 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | ASKdZeta | ASKdZeta (Arabidopsis SHAGGY-related protein kinase dZeta); ATP binding / kinase/ protein kinase/ protein serine/threonine kinase; Encodes a GSK3-like protein kinase. This protein can interact with the BZR1 protein involved in brassinosteroid-mediated signaling in a Y2H assay and promotes BZR1 phosphorylation in protoplasts. ; May mediate extracellular signals to regulate transcription in differentiating cells (By similarity) (412 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | PSK1 | PSK1; growth factor; Phytosulfokine 3 precursor, coding for a unique plant peptide growth facto [...] (81 aa) | • | 0.565 | |||||||
 | CAM6 | CAM6 (CALMODULIN 6); calcium ion binding; Encodes a calmodulin isoform. Expressed in leaves. ; [...] (149 aa) | • | 0.400 | |||||||
 | CAM9 | CAM9 (CALMODULIN 9); calcium ion binding; encodes a divergent member of calmodulin, which is an [...] (151 aa) | • | 0.400 | |||||||
 | CAM7 | CAM7 (CALMODULIN 7); calcium ion binding; EF hand domain protein encodes a calmodulin. Can func [...] (149 aa) | • | 0.400 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 419 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-133 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-92 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-84 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-84 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-76 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-75 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-74 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-74 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-70 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-69 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-69 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-67 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-64 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-62 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-59 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-59 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-57 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-57 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-57 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-57 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-57 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-56 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-56 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-56 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-56 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-56 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-56 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-56 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-56 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-55 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-49 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-49 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-49 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-48 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-47 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-47 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-44 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-44 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-43 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-41 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-38 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-37 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-35 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-34 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-32 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-32 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-32 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-17 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 388 bits (998), Expect = e-133
Identities = 171/333 (51%), Positives = 239/333 (71%), Gaps = 6/333 (1%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH 137
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 138 CFFSTTSKDE---LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+++ K +FLN+VME++P+T+++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H+ +CHRD+KPQNLL+DP TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
+FP +K KVF K P +AI+ S+ L+Y P R +EA A PFFD+LR+P +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 375 NG-RPFPPLFNF-KQELAGASPELINRLIPEHV 405
P LFNF E+ S ++IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 5e-92
Identities = 116/324 (35%), Positives = 181/324 (55%), Gaps = 20/324 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + +D + +V E + +++V+K Q + +++ + YQI RGL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAP 248
Y+H+ V HRD+KP N+LV+ +K+CDFG A+ + E Y+ +R+YRAP
Sbjct: 118 YLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 307
EL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++ +
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235
Query: 308 NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ ++ P+ P K+F PEAIDL ++L + P R TA EA AHP+ +
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
Query: 366 LREPNARLPNGRPFPPLFNFKQEL 389
L +P PF F EL
Sbjct: 295 LHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 6e-87
Identities = 109/293 (37%), Positives = 170/293 (58%), Gaps = 31/293 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVISLK 136
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
++ +L+L V EY LK Y + +K YQ+ RGLAY H
Sbjct: 65 DVI---HTERKLYL--VFEY----CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ + HRD+KPQN+L++ +KL DFG A+ G +Y + + +YRAPE++
Sbjct: 116 SH-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPN 310
G+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y FP+ KV R+ PE IDL S++LQY+P+ R +A EA HP+F
Sbjct: 232 YKP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 2e-84
Identities = 115/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLK 136
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+KP NLL+ +K+ DFG A++ E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 310
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y FP+ K P ++F PEA+DL LL Y PS R +A EA HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (660), Expect = 6e-84
Identities = 110/294 (37%), Positives = 166/294 (56%), Gaps = 20/294 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRLMDHPNV 132
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ G+ HRD+KP+NLL++ +KL DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 310
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 311 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F FP+ P K+F P+A+DL S++L Y P R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 4e-82
Identities = 102/291 (35%), Positives = 148/291 (50%), Gaps = 43/291 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +DE L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H+ G+ HRD+KP+N+L+D VKL DFG A+ L GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PEA DL +LL P R TA EA HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 2e-79
Identities = 100/289 (34%), Positives = 145/289 (50%), Gaps = 39/289 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F KD L+L VMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGA 254
+ G+ HRD+KP+N+L+D VK+ DFG AK L+K + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + EA DL + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 3e-76
Identities = 110/296 (37%), Positives = 169/296 (57%), Gaps = 32/296 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRLMDHPNVIS 134
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L +L +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
LK F DEL+ V EY+ +Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHI 115
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H G HRD+KP+NLLV VK+ DFG A+ + Y+ +R+YRAPE++ +
Sbjct: 116 HKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 307
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FRFPQ H++ PEAIDL +L++ P R TA +A HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 7e-75
Identities = 93/293 (31%), Positives = 159/293 (54%), Gaps = 26/293 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
TSK + + +V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 ---VTSKGKGSIYMVFEYMDHDLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFG 253
G+ HRD+K N+L++ + +KL DFG A+ K + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARPYTK-RNSADYTNRVITLWYRPPELLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 310
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + + + + F + P A+DL +LL P R +A +A H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 234 bits (599), Expect = 1e-74
Identities = 104/297 (35%), Positives = 162/297 (54%), Gaps = 25/297 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDH 129
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN+I L F K +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRYYRAP 248
GL Y+H + HRD+KP NLL+ +KL DFG A+ +++ + +R+YRAP
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAP 171
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
EL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E +
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 309 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P+Y +F+ P ++F +A+DL RLL +P+ R TA +A HP+F
Sbjct: 232 SLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 3e-74
Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 21/291 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F K L+L V EYV T+ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + +KLCDFG A+ L A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 313
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 314 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ + + ++ A+D L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 3e-70
Identities = 111/329 (33%), Positives = 177/329 (53%), Gaps = 32/329 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + + + +V E + +Y+++K Q + +++ + YQI RGL
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ +K+CDFG A++ + Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 308 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF-- 362
+ ++ P PW+K+F P+A+DL ++L ++P R T EA AHP+
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296
Query: 363 --FDELREPNARLPNGRPFPPLFNFKQEL 389
D EP A PFP F +L
Sbjct: 297 QYHDPSDEPVAE----EPFPFDFELFDDL 321
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 6e-70
Identities = 109/306 (35%), Positives = 169/306 (55%), Gaps = 28/306 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F +S ++ + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 248
GL YIH+ G+ HRD+KP N+ V+ ++K+ DFG A+ + ++ Y+ +R+YRAP
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLAR---HTDDEMTGYVATRWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E ++ ++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 309 P----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
NY PQ+ + +VF P AIDL ++L P R TA EA AHP+
Sbjct: 245 SESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302
Query: 365 ELREPN 370
E +P
Sbjct: 303 EYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 1e-69
Identities = 106/309 (34%), Positives = 171/309 (55%), Gaps = 31/309 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQ-LMRLMDH 129
Y + +G G++GIV++A T E VA+KK+ D R + RE+ L L DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L + + KD + LV EY+ ++ V++ + ++ + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILED-----VHKRYIMYQLLK 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------YICSR 243
L YIH+ V HRD+KP N+L++ VKL DFG A+ L + E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 304 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
I + + P P ++ + +A+DL +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 361 PFFDELREP 369
P+ + P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 6e-69
Identities = 118/333 (35%), Positives = 188/333 (56%), Gaps = 21/333 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I++K + + +V E + ++++++ +Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLK 122
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
YIH+ V HRD+KP NLL++ +K+CDFG A+ KG+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 310
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++ + N
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ P + ++F P AIDL ++L + PS R T EA AHP+ L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 369 PNARLPNGRPFPPLFNFKQELAGASPELINRLI 401
P+ PF F+F+++ + E I LI
Sbjct: 300 PSDEPVCQTPFS--FDFEED--ALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 1e-67
Identities = 114/344 (33%), Positives = 182/344 (52%), Gaps = 32/344 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRLMDHPN 131
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 132 VISLKHCFFSTTSKDELFLN--LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+I+++ F + +VM+ + ++ ++ +S +Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDLMESDLHHII--HS--DQPLTEEHIRYFLYQLLR 118
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRY 244
GL YIH+ V HRD+KP NLLV+ +++ DFG A+ L Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 305 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ Y P+ + PW K+F K PEA+DL S++LQ+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEH 404
PF + +P+ + PP F+F E S E + I +
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 2e-64
Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 26/291 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL+D +KL DFG A+ V + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ KV + + +DL S++L Y P+ R +A A HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 4e-62
Identities = 100/289 (34%), Positives = 151/289 (52%), Gaps = 25/289 (8%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMR-LMDHPNVISLKH 137
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R L HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRGLAYIH 195
F + L LV E + +Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+N+L+ +KL DFGS + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 314
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP K K+ E +DL +LL Y P R TA +A HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 7e-62
Identities = 110/291 (37%), Positives = 172/291 (59%), Gaps = 23/291 (7%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKH 137
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F K L+L V E+V T+ L+ Y + +++ V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFGAT 255
+ HRD+KP+N+LV + VKLCDFG A+ L GE Y+ +R+YRAPEL+ G T
Sbjct: 119 -HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTD 313
+Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236
Query: 314 FRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
R P++K P K F K + +DLA + L+ P R ++ + H FF
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 121/326 (37%), Positives = 182/326 (55%), Gaps = 27/326 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+RL+ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ +KH + ++ + +V E + +++V+K N + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANI---SYICSRYYRAP 248
YIHT V HRD+KP+N+L + ++K+CDFG A+V I Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 249 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 305
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 362
N + K P F ++ P P A+ L RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 363 FDELREPNARLPNGRPFPPL-FNFKQ 387
F L + R P+ +P L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 114/306 (37%), Positives = 170/306 (55%), Gaps = 29/306 (9%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLM 127
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 247
RGL Y+H+ GV HRD+KP N+L++ +K+CDFG A++ + Y+ +RYYRA
Sbjct: 118 LRGLKYVHSA-GVVHRDLKPSNILINE-NCDLKICDFGLARI--QDPQMTGYVSTRYYRA 173
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 308 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
T RF P+ + P+ + F K P AIDL ++L + P R +A EA AHP+
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
Query: 364 DELREP 369
+P
Sbjct: 292 APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-57
Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHCFFS 141
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
+ D++++ VMEYV + +++ M Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 202 HRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATE 256
HRD+K NLL L + +K+CDFG A+ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT + P +++
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239
Query: 317 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ K + K F + DL +RLL Y P+ R +A +A HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 4e-57
Identities = 97/293 (33%), Positives = 159/293 (54%), Gaps = 19/293 (6%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 139 FFSTTSKD-ELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K+ + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
GV HRD+KPQNLLVD +K+ D G + + ++ I + +YRAPE++ G+T
Sbjct: 129 H-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 316 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
FPQ K + + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 5e-57
Identities = 106/290 (36%), Positives = 164/290 (56%), Gaps = 24/290 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHT 196
T +K L LV EY M + LK Y + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL DFG A+ + + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 313
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT ++ P Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
FP+ ++F P IDL RLLQ +P LR +A +A HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 9e-57
Identities = 110/306 (35%), Positives = 169/306 (55%), Gaps = 29/306 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRLMDHP 130
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S S DE LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAP 248
GL YIH+ G+ HRD+KP NL V+ ++K+ DFG A+ +A ++ Y+ +R+YRAP
Sbjct: 129 GLKYIHSA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---HADAEMTGYVVTRWYRAP 183
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243
Query: 309 ----PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+Y P+ + +F + P+A+DL ++L+ R TA EA HP+FD
Sbjct: 244 DKAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
Query: 365 ELREPN 370
R+ +
Sbjct: 302 SFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 9e-57
Identities = 107/303 (35%), Positives = 167/303 (55%), Gaps = 29/303 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM-----NQRMPLIYVKLYTYQI 187
+ L+ S E L LV EY+ + KH S N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYR 246
RG+AY H+ V HRD+KPQNLL+D T+ +KL DFG A+ + + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 307 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+ P+Y FP+ V + P +DL S++L+ PS R TA A H +F
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 365 ELR 367
+L
Sbjct: 289 DLG 291
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 102/299 (34%), Positives = 158/299 (52%), Gaps = 26/299 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
AY H V HRD+KPQNLL+ ++KL DFG A+ K + +Y + + +YR P
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR-- 305
+++ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
NP + + FP P + P +LA + LQY P R +A EA HP+F
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 109/297 (36%), Positives = 160/297 (53%), Gaps = 32/297 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
D +FL VMEY + + +L +M VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHE-N 127
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGAT 255
+ HRD+K NLL LT + +K+ DFG A+ ++ + + +YRAPEL+ G T
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI----RCMNPNY 311
YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I + P
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGFSDL-PLV 242
Query: 312 TDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHPFFDE 365
F P+ P++ + HK P EA + L + LL Y P R TA EA +F E
Sbjct: 243 GKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 1e-56
Identities = 107/306 (34%), Positives = 167/306 (54%), Gaps = 31/306 (10%)
Query: 85 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-LMDHPNVI 133
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 134 SLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +EL+L E + ++++++ Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLK 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANIS-YICSRYYRA 247
YIH+ V HRD+KP NLLV+ ++K+CDFG A+ + ++ Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 306
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E + R
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 307 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+P ++ P I P+ +F P A+DL +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 365 ELREPN 370
+P+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 96/303 (31%), Positives = 153/303 (50%), Gaps = 46/303 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD---HPN 131
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H+ + HRD+KPQN+LV QVK+ DFG A++ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229
Query: 312 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 360
+P+ + P F + E +DL ++L ++P R +A EA H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 361 PFF 363
P+F
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 98/291 (33%), Positives = 158/291 (54%), Gaps = 25/291 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F + + L+LV EY T+ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ Q+KLCDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 315
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I N + F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235
Query: 316 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 363
I + + P A+ LQ P+ R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 3e-56
Identities = 107/300 (35%), Positives = 168/300 (56%), Gaps = 28/300 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D LVM ++ + +++KH R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
G+ HRD+KP NL V+ ++K+ DFG A+ + ++ ++ Y+ +R+YRAPE+I
Sbjct: 136 AA-GIIHRDLKPGNLAVNE-DCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----N 310
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ + N
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
Y + P+ + + + P A+++ ++L R TA EA AHP+F+E +P
Sbjct: 251 YVK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 4e-56
Identities = 106/295 (35%), Positives = 163/295 (55%), Gaps = 34/295 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISY---ICSRYYRAPELIF 252
V HRD+KPQNLL++ ++KL DFG A+ + V+ Y + + +YR P+++F
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR-----CYSAEVVTLWYRPPDVLF 172
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 309
GA Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232
Query: 310 NYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+Y + +P + V ++ DL LL +P R +A EA HP+F
Sbjct: 233 DYKPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-56
Identities = 102/293 (34%), Positives = 165/293 (56%), Gaps = 30/293 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ L LV E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHTENK-----LYLVFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT--- 312
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP + P T
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTSLP 232
Query: 313 DFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
D++ FP+ + KV + + DL S++L Y P+ R +A A AHPFF
Sbjct: 233 DYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 3e-55
Identities = 108/317 (34%), Positives = 157/317 (49%), Gaps = 46/317 (14%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYI 194
F K + L+ +Y +++++K + + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 195 HTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA-------KVLVKGEANISYICSRY 244
H+ V HRD+KP N+LV P VK+ D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 295
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 296 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 346
LGTPT ++ I+ M P Y DF+ ++ K K + DL +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 347 SPSLRCTALEACAHPFF 363
P+ R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-55
Identities = 92/290 (31%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLK 136
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ S +++ LN+ +EYV L ++P ++ YT QI GLAY+H+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRAPELIFG 253
G+ HRD+K N+LVD VKL DFG AK L GE S + Y+ APE+I G
Sbjct: 120 -NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
EY + DIWS GC + E+ G+P + + I G P
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P+I H + EA D + L+ P R TA E HPF
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-54
Identities = 92/326 (28%), Positives = 166/326 (50%), Gaps = 38/326 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRLMDHPNVIS 134
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 135 LKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI----C 241
Q+ RGL YIH+ V HRD+KP N+ ++ +K+ DFG A+++ ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 298
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 353
R E+ + P++ ++ + +P PEA+D ++L ++P R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 354 ALEACAHPFFDELREPNARLPNGRPF 379
A EA HP+ P + PF
Sbjct: 294 AEEALMHPYMSCYSCPFDEPVSLHPF 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 71/247 (28%), Positives = 121/247 (48%), Gaps = 40/247 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHCF 139
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+DE L LVMEY ++ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN- 111
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY 257
G+ HRD+KP+N+L+D +VKL DFG +K+L ++ + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 316
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 317 PQIKAHP 323
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 5e-52
Identities = 95/292 (32%), Positives = 160/292 (54%), Gaps = 27/292 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L+ E L L+ E++ + + L Q M VK Y YQI +G+ +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFG 253
H+ V HRD+KPQNLL+D +KL DFG A+ + + + +YRAPE++ G
Sbjct: 118 HS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNY 311
+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT + + P+Y
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ FP+ K + K + + +DL ++L Y P+ R +A +A HP+F
Sbjct: 236 KN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 3e-51
Identities = 97/342 (28%), Positives = 143/342 (41%), Gaps = 46/342 (13%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
I + FF +DE L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-------SYICSR 243
L Y+H+ G+ HRD+KP+N+L+D VKL DFG AK+L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 244 YYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 298
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
P A P + + A DL +LL P R ++
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 359 AHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRL 400
+H L+ + L + + L + LI+ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 103/315 (32%), Positives = 150/315 (47%), Gaps = 51/315 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRL 126
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ H N++ L + D F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVY---VEGD--FINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-----VLVKGEANISYIC 241
I GL +H HRD+ P N+ ++ K+ DFG A+ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 242 SR----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 292 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
I ++LGTP + + + + P YT+F + K K +AIDL LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301
Query: 349 SLRCTALEACAHPFF 363
R +A EA H +F
Sbjct: 302 LERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 5e-49
Identities = 93/309 (30%), Positives = 150/309 (48%), Gaps = 45/309 (14%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVISL 135
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 136 KHCFFS---TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + +V Y+ + +L S+ I K Y Q+ G+
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEGIN 129
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---------VKGEANISY---I 240
Y+H + HRD+K N+L+D +K+ DFG A+ G Y +
Sbjct: 130 YLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K+ GTPT
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPT 247
Query: 301 REEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
E P + + + + + F ++ PE +DL S+LL P R TA
Sbjct: 248 EETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTA 302
Query: 355 LEACAHPFF 363
+A HP+F
Sbjct: 303 SDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 5e-49
Identities = 107/292 (36%), Positives = 163/292 (55%), Gaps = 24/292 (8%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + +L+L V EYV + M +L+ M +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK- 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANIS-YICSRYYRAPELIFGAT 255
+ HRD+KP+NLL+ +KLCDFG A+ L +G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 313
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 314 FRFPQIKAHP--WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
RFP + HP + + + +DL LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 8e-49
Identities = 109/330 (33%), Positives = 171/330 (51%), Gaps = 51/330 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM+L++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRV----LKHYSSMNQRMPLIYVKLYTY 185
N+I L + F S +E + LVME + + +V L H +RM + Y
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH-----ERMSYL-----LY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
Q+ G+ ++H+ G+ HRD+KP N++V T +K+ DFG A+ Y+ +RY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YRAPE+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E +
Sbjct: 183 YRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241
Query: 305 RCMNP---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPS 349
+ P NY + R P+ + + ++F +K +A DL S++L P
Sbjct: 242 SRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300
Query: 350 LRCTALEACAHPF----FDELREPNARLPN 375
R + +A HP+ +D E A P
Sbjct: 301 KRISVDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 113/379 (29%), Positives = 174/379 (45%), Gaps = 59/379 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRLMDHPNVI 133
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 134 S--------LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
S F +E+++ V E M L Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSR 243
QI RGL Y+H+ G+ HRD+KP NLLV+ +K+CDFG A+V E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
YYRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 360
+R P V + EA+ L R+L + P R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 361 PFFDELR-------------EPNARL-------PNGRPFPPLFNFKQELAGASPELINRL 400
P+ DE R R+ PF + E +++
Sbjct: 289 PYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQF 348
Query: 401 IPEHVR-RQTGLS-MPHSA 417
I E + + L P SA
Sbjct: 349 ILEQQQGNRVPLCINPQSA 367
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 5e-48
Identities = 103/311 (33%), Positives = 165/311 (53%), Gaps = 21/311 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F TS + + LV + + ++K Q++ +V+ YQ+ RGL
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLRGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH+ G+ HRD+KP N+ V+ ++++ DFG A+ + Y+ +R+YRAPE++
Sbjct: 132 KYIHSA-GIIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPEIM 187
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E ++ ++ +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 312 TDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P + K+F + P AIDL ++L R +A EA AHP+F + +
Sbjct: 248 ARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306
Query: 369 PNARLPNGRPF 379
P P P+
Sbjct: 307 PEDE-PEAEPY 316
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 106/316 (33%), Positives = 167/316 (52%), Gaps = 27/316 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHPNVISLK 136
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 137 HCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S +E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 311
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++ NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
Q+ + VF P A+DL ++L R TA +A AH +F + +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 311
Query: 372 RLPNGRPFPPLFNFKQ 387
P P+ F +
Sbjct: 312 E-PVADPYDQSFESRD 326
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 97/308 (31%), Positives = 166/308 (53%), Gaps = 23/308 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + L + + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H V HRD+KPQNLL++ ++KL DFG A+ + K +N + + +YR P+
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSN--EVVTLWYRPPD 174
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307
++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
N + + +P+ +A H R+ + +L S+LLQ+ R +A EA HP+F L
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 368 EPNARLPN 375
E +LP+
Sbjct: 294 ERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 2e-45
Identities = 98/298 (32%), Positives = 164/298 (55%), Gaps = 21/298 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L + S L LV EY+ + + + + ++ M + VK++ YQI RGLA
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++KL DFG A+ V + + + + +YR P+++
Sbjct: 119 YCHRRK-VLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 310
G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 311 -YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ ++ FP+ K P + H R+ E I+L ++ LQY R +A EA H +F L
Sbjct: 237 EFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 85/287 (29%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ KDEL+ +VME+ ++ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+K N+L LT +VKL DFG + L +A + + + Y+ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIWS G EL G+P + + L +I G P R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P W F D + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 5e-45
Identities = 99/297 (33%), Positives = 162/297 (54%), Gaps = 25/297 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
++L H T E L LV EY+ + + L + ++ M + VK++ +Q+ RGL+
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGEANISYICSRYYRAPE 249
Y H + HRD+KPQNLL++ ++KL DFG A+ V K +N + + +YR P+
Sbjct: 118 YCHKRK-ILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSN--EVVTLWYRPPD 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CM 307
++ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233
Query: 308 NPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
N + + FPQ +A P + H R+ + IDL S LL Y R +A A H +F
Sbjct: 234 NEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 88/292 (30%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F + E L LV+EY P E ++ L ++ + Y +I L Y+H
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----ARFYAAEIVLALEYLH 110
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
++ G+ +RD+KP+N+L+D H +KL DFG AK L + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 363
RFP + + PEA DL S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 102/299 (34%), Positives = 159/299 (53%), Gaps = 26/299 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNV 132
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY---VKLYTYQIFR 189
+ L + + L V EY M+ L Y M Q ++ V+L+ +Q+ R
Sbjct: 66 VLLHDIIHTKET-----LTFVFEY----MHTDLAQY--MIQHPGGLHPYNVRLFMFQLLR 114
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
GLAYIH + HRD+KPQNLL+ L ++KL DFG A+ + + S + + +YR P
Sbjct: 115 GLAYIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCM 307
+++ GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + +
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232
Query: 308 N--PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PNY F K V+ + PP+A DLAS++L P R +A +A HP+F
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 6e-43
Identities = 91/303 (30%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 138 CFFSTTS-----KDELFLNLVMEYVPETMYRVLK----HYSSMNQRMPLIYVKLYTYQIF 188
KD+ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYR 246
GL Y H HRD+K N+L++ Q+KL DFG A++ E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 359
+ P+ + P K + +R +P A+DL +L PS RCTA EA
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 360 HPF 362
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 90/300 (30%), Positives = 143/300 (47%), Gaps = 30/300 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH- 137
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++L+ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 138 CFFSTT--SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISY---ICSRYYRAPEL 250
+ HRD+K N+L+ +KL DFG A+ K Y + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E + P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250
Query: 311 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ PQ K ++ P A+DL +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-41
Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 44/293 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F +++ L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPEL 250
Y+H+ + HRD+KPQN+ + VKL DFG +KVL + + + + YY +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
Y DIWS GCVL EL + F GEN + +L K+L + + +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
Y E +L S LLQ P R + + PF
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 90/320 (28%), Positives = 136/320 (42%), Gaps = 77/320 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRLMDH 129
+ +++G GSF V AK ET + AI K+L R+ Y E L RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +I L + F +DE L V+EY P + + ++ Y S++++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRY 244
L Y+H+ G+ HRD+KP+N+L+D H +K+ DFG+AKVL
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 245 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
+I+K ++ FP PP+A DL +LL
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 348 PSLRCTALEAC----AHPFF 363
P R E AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 90/290 (31%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRLMDHPNVI 133
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T ++E L + +E VP ++ ++LK Y S + P+I +LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE--PVI--RLYTRQILLGLE 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
Y+H HRD+K N+LVD VKL DFG AK +V+ S+ S Y+ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 8e-39
Identities = 100/303 (33%), Positives = 158/303 (52%), Gaps = 28/303 (9%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRLMDHPNV 132
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L + + L LV EYV + + + KH ++ VKL+ +Q+ RGL
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
+YIH + HRD+KPQNLL+ T ++KL DFG A+ V + + + +YR P++
Sbjct: 117 SYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN- 308
+ G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234
Query: 309 -PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P++ RF W+K+ + A DLAS+LLQ P R +A A +H +F
Sbjct: 235 LPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYF 291
Query: 364 DEL 366
+L
Sbjct: 292 SDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 101/314 (32%), Positives = 164/314 (52%), Gaps = 35/314 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 135 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
NY + R PQ + ++F + P +A DL S++L P R +
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310
Query: 356 EACAHPFFDELREP 369
EA HP+ +P
Sbjct: 311 EALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 87/292 (29%), Positives = 142/292 (48%), Gaps = 24/292 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLM---DHPN 131
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + HRD+KP+N+LV QVKL DFG A++ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F P V + L +L ++P R +A A HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 94/296 (31%), Positives = 142/296 (47%), Gaps = 59/296 (19%)
Query: 88 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISLKHCFF 140
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S K L+L VMEY+P + +L++ S+++ + ++Y +I L Y+H+ G
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISY--------ICSRYYRAPEL 250
+ HRD+KP N+L+D H +KL DFG +KV LV+ + N++ + + Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
I G ++ ++D WS GC+L E L+G P F GE EEI N
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 363
+P+ + EAIDL S+LL P R A E HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 101/314 (32%), Positives = 166/314 (52%), Gaps = 35/314 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F S +E + LVME + + +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 130
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 131 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
NY + R P+ + K+F + P +A DL S++L P+ R +
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 356 EACAHPFFDELREP 369
EA HP+ + +P
Sbjct: 307 EALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 101/326 (30%), Positives = 168/326 (51%), Gaps = 41/326 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+I L + F S +E + +VME + + +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYLL-----YQMLC 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 138 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 310 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 355
Y + R P+ + + K+F + P +A DL S++L S R +
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 356 EACAHPFFD------ELREPNARLPN 375
EA HP+ + E P ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 50/292 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ L+ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ ++++ + MEY T+ +L+H +++ + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHS- 117
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIF 252
G+ HRD+KP N+ +D +KL DFG A L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 253 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
G + + DIWS GCV+ E+ G+ + + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P ++ PE D R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 8e-36
Identities = 83/292 (28%), Positives = 130/292 (44%), Gaps = 54/292 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHC 138
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+ +++V+EY+ ++ +LK + + + + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIF 252
+ HRD+KP NLL++ +VK+ DFG +KVL N C+ + Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 310
G + Y+ + DIWS G L E LG+ P P +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ PE D S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 54/291 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM---------DHPNVIS 134
++G G+FG+V++ LETG+ VAIK++ K +E L +M HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI---SLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ L +++EY ++ +++K + + + V +Y YQ+ +GLAY
Sbjct: 64 YIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAY 114
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H GV HRD+K N+L VKL DFG A L + S + + Y+ APE+I
Sbjct: 115 LHE-QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+ +T+ DIWS GC + ELL G P + N + L I++ + +
Sbjct: 173 M-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP- 217
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + + PE D + Q P+LR TA + HP+
Sbjct: 218 --PLP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 97/294 (32%), Positives = 157/294 (53%), Gaps = 27/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRLMD---HPNVIS 134
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 135 L-KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 363
P+ H ++ + +L LL ++P+ R +A A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 74/291 (25%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKH 137
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F++ +++ MEY+ K + R+P + + +GL Y+H
Sbjct: 67 AFYNNGD-----ISICMEYMDGGSLD--KILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ Q+KLCDFG + LV A +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNYT 312
+ DIWS G L EL G+ +P EN + L I+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P++ + + P+ D + L P R + E HPF
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 3e-32
Identities = 104/316 (32%), Positives = 158/316 (50%), Gaps = 44/316 (13%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 300 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
E+I+ M + T DFR IK HKV + +A L +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 348 PSLRCTALEACAHPFF 363
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 83/296 (28%), Positives = 137/296 (46%), Gaps = 60/296 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +K+ DFG AK + +C + Y APE+I
Sbjct: 117 LHSL-DIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKG---RTYTLCGTPEYLAPEIIL 171
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 363
RFP P+A DL LLQ + R L+ HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 102/314 (32%), Positives = 160/314 (50%), Gaps = 40/314 (12%)
Query: 85 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQR---MPLIYVKLYTYQIFRGLAYIH 195
S + + + L+ +Y ++ ++K + S N++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 196 TVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL---VKGEANIS-YICSRYYRAP 248
V HRD+KP N+LV P +VK+ D G A++ +K A++ + + +YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 300 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 349
E+IR M P Y DFR K K ++ P++ L +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 350 LRCTALEACAHPFF 363
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 89/291 (30%), Positives = 133/291 (45%), Gaps = 58/291 (19%)
Query: 88 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLM---DHPNVISLKHCF 139
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 140 FSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S SKD L+L VMEY+ ++ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
G+ HRD+KP+NLL+D H +KL DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+ D WS GCV+ E L G P F E D + + I R +N
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363
W + + PEA+DL +RLL P+ R A E +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-30
Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 56/292 (19%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 141 STTSKDELFLNLVMEYVPETMYR------VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
DEL+ +VMEY M + +++ MN+ + YV ++ +GL Y+
Sbjct: 86 ---VGDELW--VVMEY----MDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYL 132
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELI 251
H+ V HRD+K N+L L+ VKL DFG A L K ++ S + + Y+ APE+I
Sbjct: 133 HSQ-NVIHRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+Y +DIWS G + E+ G+P + E + L I G P +
Sbjct: 189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN-------- 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
W F D ++ L P R +A E HPF
Sbjct: 239 ---------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 49/288 (17%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFS 141
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 142 TTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T L +VMEY V + M N+ + + YQ +GL Y+H+
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIM-------KITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 255
HRD+K N+L++ Q KL DFG + L A + I + ++ APE+I
Sbjct: 118 N-KKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIWS G E+ G+P + + + + I P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP------ 215
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + P ++ PE D + L P R +A++ HPF
Sbjct: 216 -PPTLSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 54/295 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHPNVISLKH 137
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 138 CFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ ++ ++MEY ++ +L+ ++ + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIACVVLAFEYLHN 111
Query: 197 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
G+ +RD+KP+NLL+D VKL DFG AK L G+ ++ + Y APE+I
Sbjct: 112 R-GIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y S+D WS G +L ELL G+P F GE+ D + +I N
Sbjct: 168 G-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE-- 214
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 364
FP + A DL +LL+ +P R L+ H +F+
Sbjct: 215 -FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 70/240 (29%), Positives = 112/240 (46%), Gaps = 22/240 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RLMDHPNVISL 135
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ L ++MEY R L + ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFGA 254
V GV HRD+K N+LV T VKLCDFG A +L + + +++ + Y+ APE+I
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 44/236 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L T ++ L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +N LV VK+ DFG ++ L + YY+
Sbjct: 116 MEYLESKN-FIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLKH 137
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH- 195
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 196 -TVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
+ PG V HRD+KP N+ +D + VKL DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 82/297 (27%), Positives = 138/297 (46%), Gaps = 51/297 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNV 132
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + T +D F NL +E++ ++ +L Y + + + + YT Q+ RGL
Sbjct: 66 IRM----LGATCEDSHF-NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYR 246
+Y+H + HRDVK NLL+D ++++ DFG+A L GE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 80/309 (25%), Positives = 130/309 (42%), Gaps = 79/309 (25%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L T ++ L+ +VMEY+ L Y ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N LV VK+ DFG ++ L + YYR
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDD---------YYRKRGGK 164
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 299
APE + ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK----- 217
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+R PQ PPE DL + P R T
Sbjct: 218 ------------NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT------ 249
Query: 360 HPFFDELRE 368
F EL E
Sbjct: 250 ---FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 94/313 (30%), Positives = 143/313 (45%), Gaps = 54/313 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +D+ +L L MEYVP +R +L + +++ + + Y ++F + +H
Sbjct: 69 AF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G HRD+KP+N L+D H +KL DFG +K +V AN S + S Y APE++ G
Sbjct: 120 L-GYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KG 174
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y ++D WS GC+L E L G P F G + + T R P Y D RF
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNA 371
+ EA DL ++L+ + + HPFF +ELRE
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKP 273
Query: 372 RLPNGRPFPPLFN 384
PF P
Sbjct: 274 ------PFVPELE 280
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 89/308 (28%), Positives = 143/308 (46%), Gaps = 67/308 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 125
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
+ H N++ S D LN+ +EYVP ++ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI------- 237
QI +GL Y+H G+ HRD+K N+LVD +K+ DFG +K K EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISK---KLEANSLSTKTNG 167
Query: 238 ---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
S S ++ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+ + P+I ++ + EAID + + + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 355 LEACAHPF 362
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 95/345 (27%), Positives = 141/345 (40%), Gaps = 88/345 (25%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LM---DHPNVISLK 136
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY----------- 244
+ G HRD+KP N+L+D H +KL DFG K + K + Y+ +
Sbjct: 119 KL-GFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 245 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
L E T +I +N RFP + PEAIDL RLL
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 346 YSPSLR-CTALEACAHPFF-----DELREPNARLPNGRPFPPLFN 384
P R + E +HPFF + LRE PF P +
Sbjct: 271 -DPEDRLGSFEEIKSHPFFKGIDWENLRETKP------PFVPELS 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRLMDHPN 131
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F + LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ + HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C +D+ L++ MEY+P ++ LK Y ++ + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L G S + Y+ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E+I G Y D+WS GC + E+L +P + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PQ+ +H + P+A + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 79/303 (26%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 124
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLY 183
+ +DH N++ E +L++ +EYVP ++ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV---LVKGEANISYI 240
T Q+ GLAY+H+ G+ HRD+K NLLVD K+ DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 241 CSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
S ++ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+ A P + P A+D + +P R TA E
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
Query: 360 HPF 362
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 46/293 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLKHC 138
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F DEL+ LVM Y+ ++ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 197 VPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKG-----EANISYICSRYYRAPEL 250
G HRD+K N+L+ VK+ DFG + L G + +++ + + APE+
Sbjct: 121 -NGQIHRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y DIWS G EL G + + L+ ++ N
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P ++ +K + K + S LQ PS R TA E H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 57/313 (18%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 122
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL 182
++ + HPN I K C+ + LVMEY + +L+ + + PL V++
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVH-----KKPLQEVEI 117
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ +GLAY+H+ HRD+K N LL +P VKL DFGSA + AN S+
Sbjct: 118 AAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SF 171
Query: 240 ICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
+ + Y+ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--- 228
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
N + P + ++ W F +D LQ P R ++ E
Sbjct: 229 ----------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEEL 264
Query: 358 CAHPFFDELREPN 370
H F R P
Sbjct: 265 LKHRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L H F T KD LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H +K+ DFG K + G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 364
+ R+P + + EA + L +P R L HPFF
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 365 EL 366
E+
Sbjct: 257 EI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 140 FSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 199 GVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+K N LLV VK+ D G +KVL K A + I + +Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 9e-25
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L T + L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N LV VK+ DFG ++ + + + YYR
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPNVISL 135
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE + LV++ + + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ G+ HRD+KP N+L+D H V + DF A + S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y+ ++D WS G E L G+ + G + R++IR
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 363
Q A + EAID ++LL+ P R + HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 89/300 (29%), Positives = 140/300 (46%), Gaps = 53/300 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVISLKHC 138
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ S DEL++ VME++ + ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGA 254
GV HRD+K ++L LT +VKL DFG A+V + S + + Y+ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y T +DIWS G ++ E++ G+P + E + + + IR P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
P++K HKV P R+L P+ R TA E HPF + P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 88/294 (29%), Positives = 135/294 (45%), Gaps = 58/294 (19%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 141 STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S +D+L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEAN-ISYICSRYYRAPELIFG 253
G HRD+K N+L LT VKL DFG + L A S+I + Y+ APE+
Sbjct: 120 T-GKIHRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
A E Y DIW+ G EL QP P + + ++ L ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219
Query: 310 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+F P++K W VFH D + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y RVVG G+FGIV + + V IK++ +R E Q+++L+ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I F + L +VMEY P T+ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++HT + HRD+K QN+L+D VK+ DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 50/230 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVIS 134
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY---------SSMNQRMPLIYVKLYTY 185
L T ++ L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
QI +G+ Y+ + V HRD+ +N LV VK+ DFG ++ + + YY
Sbjct: 113 QIAKGMEYLASKKFV-HRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 246 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 93/313 (29%), Positives = 142/313 (45%), Gaps = 57/313 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ T E AIK + +D ++ +++ L +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H F + +K+ LF VMEY+ + M+ H S + R + Y +I GL
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGDLMF----HIQS-SGRFDEARARFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H G+ +RD+K N+L+D H +K+ DFG K + GE S C + Y APE++
Sbjct: 111 FLHK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR------- 212
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPN 370
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 -----------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGID 255
Query: 371 ARLPNGRPFPPLF 383
R PP F
Sbjct: 256 WERLEKREIPPPF 268
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-23
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRLMDHPNVISLKHC 138
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F D+ LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGA 254
+ HRD+K NL +D VK+ D G AK+L + + + + YY +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELC-ED 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
Y D+W+ G VL E G+ F N +++II+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 6e-23
Identities = 74/296 (25%), Positives = 112/296 (37%), Gaps = 57/296 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++MEY L +++ Y+ ++ GL Y
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGKLDET----YIAFILREVLLGLEY 113
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YYR 246
+H G HRD+K N+L+ VKL DFG V G+ S + R ++
Sbjct: 114 LHE-EGKIHRDIKAANILLSE-EGDVKLADFG-----VSGQLT-STMSKRNTFVGTPFWM 165
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE+I + Y DIWS G EL G+P + + L I K
Sbjct: 166 APEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------ 212
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
NP P ++ + + K F D S L P R +A E H F
Sbjct: 213 NNP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 8e-23
Identities = 95/337 (28%), Positives = 151/337 (44%), Gaps = 68/337 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ GE A+K + +D + +++ L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L +C F T K+ LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+++D H +K+ DFG K V G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 370
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 371 ARLPNGRPFPPLF-----------NFKQELAGASPEL 396
R P F NF +E P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-23
Identities = 87/295 (29%), Positives = 125/295 (42%), Gaps = 52/295 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
Y+ RV+G G+FG + E V K+V L RR E+ ++ L+ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I+ + F + L + MEY T+Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT---LLIE--MEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYIC--SRYYRA 247
+YIH G+ HRD+K N+ LT +KL DFG +K+L E +++ + YY +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PEL G +Y DIW+ GCVL ELL + F N ++ +V+I +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
NYT E I L LLQ P R TA E P
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 94/336 (27%), Positives = 147/336 (43%), Gaps = 66/336 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+++G GSFG VF A+ T + AIK + +D + +++ L +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H + + +K+ LF VMEY+ + M+ H S + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMF----HIQSCH-KFDLPRATFYAAEIICGLQ 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y TS+D WS G +L E+L+GQ F G + + + IR NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 370
+ + EA D+ +L P R + HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256
Query: 371 ARLPNGR---PFPPLF-------NFKQELAGASPEL 396
+ L PF P NF +E P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 73/220 (33%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C+ E LVMEY + +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRDVK N LL +P VKL DFGSA ++ AN ++ + Y+ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSASIM--APAN-XFVGTPYWMAPEVILAM 186
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 37/296 (12%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145
G G++G+V + + + TG +A+K++ R N + Q LMD + C ++ T
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRI---RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 146 DELFLN----LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
LF + ME + ++ + K +P + I + L Y+H+ V
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVI 126
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE---YT 258
HRDVKP N+L++ QVKLCDFG + LV A + Y APE I Y
Sbjct: 127 HRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYD 185
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
D+WS G + EL G+ FP ++ ++ +V+ P+ PQ
Sbjct: 186 VKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS----------------PQ 227
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
+ A ++ PE D ++ L+ + R E HPFF+ N +
Sbjct: 228 LPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-22
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISLKH 137
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
C+ + LVMEY + +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHS- 139
Query: 198 PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+K N LL +P QVKL DFGSA AN S++ + Y+ APE+I E
Sbjct: 140 HNMIHRDIKAGNILLTEP--GQVKLADFGSASKS--SPAN-SFVGTPYWMAPEVILAMDE 194
Query: 257 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +D+WS G EL +P NA+ L I
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 8e-22
Identities = 98/326 (30%), Positives = 144/326 (44%), Gaps = 61/326 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K C+ E LVMEY + +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 196 TVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ + HRD+K N LL +P QVKL DFGSA + AN S++ + Y+ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSASIA--SPAN-SFVGTPYWMAPEVILAM 196
Query: 255 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
E Y +D+WS G EL +P NA+ L I + N +
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372
P ++++ W F + LQ P R T+ E H F LRE
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283
Query: 373 LPNGRPFPPLFNFKQELAGASPELIN 398
RP L + Q A EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 9e-22
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRLMDHPNVI 133
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ T D+ +++ ME+VP ++ +L + + P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI-------CSRYY 245
Y+H V HRD+K N+++ P +KL DFG A+ L + ++ + Y+
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 24/209 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKH 137
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T D+ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT 255
+ +RD+KP+N+L+D H +KL DFG AK L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 35/299 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +++ ME++ ++ +VLK R+P + + + RGL Y+
Sbjct: 68 FYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 312
T DIWS G L E+ +G+ P +A E+ + G P +E R ++ +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 313 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
D P I P K+ E D + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-21
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
F + + + MEY+ L + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI-----FGA 254
+ HRDVKP N+LV+ QVKLCDFG + LV A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 311
YT D+WS G + E+ LG+ +P E N QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+ +A D ++ L P+ R T + HP+ + + +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 5e-21
Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 25/212 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMR-LMDHPNVISLKHCF 139
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 140 F---STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ D+L+ LVME ++ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 196 TVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIF 252
V HRD+K QN+L LT +VKL DFG SA++ ++I + Y+ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185
Query: 253 GATE------YTTSIDIWSAGCVLAELLLGQP 278
A + Y D+WS G EL G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-21
Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 65/311 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRLMDHPNVISL 135
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
C F T L +VMEYV +LK+ ++ P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALEYL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--------------- 239
H G+ HRD+KP NLL+ + H +KL DFG +K+ + Y
Sbjct: 118 HNY-GIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+C + Y APE+I Y +D W+ G +L E L+G F G+ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 355
++I P + +P +A DL SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 356 EACAHPFFDEL 366
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 70/247 (28%), Positives = 112/247 (45%), Gaps = 51/247 (20%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNV 132
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ K L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----------VKGEANISYIC 241
Y+ + HRD+ +N+LV+ VK+ DFG AKVL GE+ I
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---- 176
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVD 287
+Y APE + + + S D+WS G L EL + L G+ V
Sbjct: 177 -FWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 288 QLVEIIK 294
+L+E++K
Sbjct: 234 RLLELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 83/302 (27%), Positives = 130/302 (43%), Gaps = 47/302 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVS----F 68
Query: 140 FSTTSKDELFLN-----LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ FLN + ME++ ++ R+ K + P+ + + GL Y
Sbjct: 69 YGA------FLNENNICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
++ V + HRD+KP N+LV+ Q+KLCDFG + L+ A+ +++ + Y +PE I G
Sbjct: 119 LYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQG 176
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+YT D+WS G + EL LG+ P D + + +L
Sbjct: 177 G-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-------------- 221
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNA 371
QI P ++ P + D L P+ R T + CA PF LR N
Sbjct: 222 ---LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
Query: 372 RL 373
L
Sbjct: 279 DL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 82 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRLMDHPNVISLK 136
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + ME VP L + + I YT QI GL Y+
Sbjct: 72 GSDSENG-----FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI-F 252
H + HRD+K N+LV+ + VK+ DFG++K L ++ + Y APE+I
Sbjct: 125 HDNQ-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF 280
G Y DIWS GC + E+ G+P F
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 96/338 (28%), Positives = 144/338 (42%), Gaps = 70/338 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRLMDHPNV 132
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L CF + D LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H G+ +RD+K N+L+D H KL DFG K + S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 363
V+ + +A+D+ + +P++R L HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 364 DELREPNARLPNGR----PFPPLFNFKQELAGASPELI 397
EL + N R PF P +++++ P+ I
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFI 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 62/322 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRLMDHP 130
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L + P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++L H F T +K L+L+++YV + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYVNGG--ELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYICSRYYRAP 248
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E S+ + Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 249 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E+I G + + ++D WS G + ELL G F + + EI + R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF- 363
K+ P F K M EA D +LL+ P R A E HPFF
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 364 ----DELREPNARLPNGRPFPP 381
D+L R+P PF P
Sbjct: 271 GIDWDDLAA--KRIP--APFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 65/293 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y ++D W G VL E+L G P F + ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 311 YT-----------------------DFRFPQIKAHP------WHKVFHKRMPP 334
+ DF +IK H W + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFL--EIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C + L++ ME++P ++ LK Y ++ + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K L + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 83/312 (26%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F +KD+L L + + + Y H ++ + P Y QI GL ++H
Sbjct: 60 YAF---ETKDDLCLVMTLMNGGDLKY----HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ +RD+KP+N+L+D + V++ D G A L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370
+ + PEA DL LLQ P R +A E HP F +L
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263
Query: 371 ARLPNGRPFPPL 382
RL G PP
Sbjct: 264 -RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 7e-20
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFF 140
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 141 STTSKDELFLNLVMEYVP----ETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+S + + MEY +++Y +V K + ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRAPELI 251
+ + HRD+KP N+L+ QVKLCDFG V GE S + + +Y APE I
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT------- 300
G Y+ + D+WS G L E+ + FP E +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 301 ----REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 333
EE + C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 89/354 (25%), Positives = 134/354 (37%), Gaps = 99/354 (27%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE +L L+MEY+P M +L + + Y+ + + I
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA----ETILAIDSI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------------VKGEANISYI 240
H + G HRD+KP NLL+D H +KL DFG L + +I
Sbjct: 118 HKL-GYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 241 CSRY-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLL 275
Y APE +F T Y D WS G ++ E+L+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 276 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 335
G P F +N + +I +N T +FP + PE
Sbjct: 235 GYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLSPE 269
Query: 336 AIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPFPP 381
A DL RL R E +HPFF + +RE A P P
Sbjct: 270 AKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISLK 136
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F S LF+ VMEY + M R+ + + ++ + QI GL +I
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHI 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIF 252
H + HRD+K QN+ + KL DFG A+ L ++Y C + YY +PE I
Sbjct: 118 HDRK-ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE-IC 174
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y DIWS GCVL EL + F G N + QLV
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 64/304 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRLMDHPNV 132
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+L HC F T KD LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H GV +RD+K N+L+D H KL DFG K + + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 362
+ D +P W + EA+ + + +P+ R C A + HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 363 FDEL 366
F E+
Sbjct: 257 FKEI 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRLMDHP 130
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI F LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAP 248
+ ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 92/319 (28%), Positives = 140/319 (43%), Gaps = 56/319 (17%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLKH 137
+G GSFG V Q + +T A+K + + E+ ++ ++ P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
FS S ++L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 --FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATE 256
V +RD+KP+N+L+D H + LCDFG K+ +K + + C + Y APEL+ G
Sbjct: 113 -NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
YT ++D W+ G +L E+L G P F EN V+++ K+L P RF
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LRF 212
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNARL 373
P +A DL LL P+ R A E HPFF +L +L
Sbjct: 213 PD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KKL 258
Query: 374 PNGRPFPPLFNFKQELAGA 392
PP FK ++ A
Sbjct: 259 LMKGIQPP---FKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 3e-19
Identities = 69/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLM 127
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
H ++ C + E L + MEY+P ++ LK Y ++ + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL----VKGEANISYICS 242
I G++Y+H+ + HRD+K N+L D VKL DFG++K L + G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y+ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 303 EI 304
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 65/236 (27%), Positives = 117/236 (49%), Gaps = 27/236 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRLMDHPNVI 133
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
C K L++ +EY+P ++ LK Y ++ + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK----VLVKGEANISYICSRYYRAP 248
Y+H+ + HRD+K N+L D VKL DFG++K + + G S + Y+ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 91/315 (28%), Positives = 148/315 (46%), Gaps = 47/315 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRY 244
+ R L+Y+H GV HRD+K ++L+ ++KL DFG A+V + S + + Y
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ APE+I Y T +DIWS G ++ E++ G+P + E P + +
Sbjct: 184 WMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQAM 227
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
R + N P++K HKV + +DL +L PS R TA E HPF
Sbjct: 228 RRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFLK 276
Query: 365 ELREPNARLPNGRPF 379
P+ +P R +
Sbjct: 277 LAGPPSCIVPLMRQY 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 90/312 (28%), Positives = 144/312 (46%), Gaps = 51/312 (16%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 125
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
H NV+ + + S DEL++ VME++ + ++ MN+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICS 242
+ + L+ +H GV HRD+K ++L LTH +VKL DFG A+V + S + +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y+ APELI Y +DIWS G ++ E++ G+P + E P +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
++ + N P++K HKV P RLL P+ R TA E HPF
Sbjct: 224 AMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 363 FDELREPNARLP 374
+ P+ +P
Sbjct: 273 LAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 26/212 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKH------- 137
+G+G+ G V++ + +TG +A+K++ RR N+E LMD +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMD-LDVVLKSHDCPYIVK 78
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIHT 196
C+ + ++F+ ME + + ++LK + +P I K+ T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFGAT 255
GV HRDVKP N+L+D + VKLCDFG + LV +A S C+ Y APE I
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPPD 190
Query: 256 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+Y D+WS G L EL GQ FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 84/312 (26%), Positives = 134/312 (42%), Gaps = 50/312 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W GC++ E++ G+ F E +K REE+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 369
++K + + ++ A + +LL P R C A E AHPFF
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269
Query: 370 NARLPNGRPFPP 381
RL G PP
Sbjct: 270 -KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 70/249 (28%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
HPN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 306 CMNPNYTDF 314
++ + DF
Sbjct: 240 KLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHC----- 138
+G G+FG V + +G +A+K++ R E + RL MD V+ C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 139 FFSTTSKD-------ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
F+ ++ EL M+ + Y+ + Y + +P + + L
Sbjct: 68 FYGALFREGDCWICMEL-----MDISLDKFYKYV--YEVLKSVIPEEILGKIAVATVKAL 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+ + HRDVKP N+L+D +KLCDFG + LV A R Y APE I
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 252 --FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 301
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 81/296 (27%), Positives = 135/296 (45%), Gaps = 45/296 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S +EL++ +ME++ + + +N+ + + + L Y+H+ G
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
V HRD+K ++L+ L +VKL DFG A++ S + + Y+ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
T +DIWS G ++ E++ G+P + ++ V + + R+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
K HK+ P D R+L P R TA E HPF + P +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 94/363 (25%), Positives = 151/363 (41%), Gaps = 108/363 (29%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-------MDHPNVISL 135
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D +L L+ME++P + M ++K Y + ++ + + Y + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDV----TRFYMAECVLAIEA 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------SAKVLVKGEANISYIC 241
+H + G HRD+KP N+L+D H +KL DFG + L++G++N + I
Sbjct: 117 VHKL-GFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 242 SRY------------------------------------YRAPELIFGATEYTTSIDIWS 265
+R Y APE IF Y D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G ++ E L+G P F EN+ + +II RE + FP H
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH--- 274
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNARLPNGRP 378
+ EA DL RL+ + + R A E +HPFF D +R+ A P
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------P 322
Query: 379 FPP 381
F P
Sbjct: 323 FIP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 1e-17
Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +PN+++ F DELF+ VMEY+ + + M++ + +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPE 239
Query: 306 CMNPNYTDF 314
++P + DF
Sbjct: 240 KLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F TT K L V+++V E + + + S P + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASAL 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K + + + ++ + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
I Y ++D W G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 25/221 (11%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
H F T + L VMEYV + MY H + + + P Y +I GL +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEP--QAVFYAAEISVGLFF 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIF 252
+H G+ +RD+K N+++D H +K+ DFG K +V G ++ + Y APE+I
Sbjct: 117 LHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T D L+ VMEYV + MY + + + + Y +I GL ++
Sbjct: 67 HSCFQTM--DRLYF--VMEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 93/342 (27%), Positives = 148/342 (43%), Gaps = 68/342 (19%)
Query: 83 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
P +++L H F T +K L+L+++YV M+ L + ++ V+ Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE----VRFYSGEI 114
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYY 245
L ++H + G+ +RD+K +N+L+D H V L DFG +K + + E S+ + Y
Sbjct: 115 ILALEHLHKL-GIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE+I G + ++D WS G ++ ELL G F E + E+ +R ++
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILK 225
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----H 360
C P F + PEA DL +LL+ P R A A H
Sbjct: 226 CDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267
Query: 361 PFFDELR-EPNARLPNGRPFPP-------LFNFKQELAGASP 394
PFF L E A PF P + NF +E P
Sbjct: 268 PFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT--------Y 185
+ K F + + L +VMEY + Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDG---------GDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVK-GEANISYICS 242
Q+ G+ +IH V HRD+K +N+ LT +VKL DFGSA++L G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
YY PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 63/299 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMDHPNV 132
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 79/317 (24%), Positives = 133/317 (41%), Gaps = 60/317 (18%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLK 136
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +D+ L LVMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY--ICSRYYRAPELI- 251
H + G HRD+KP+N+L+D H +KL DFGSA L + S + + Y APE++
Sbjct: 119 HQM-GYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 308 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
N+ F +FP+ ++ + +DL LL R C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 367 REPNAR--LPNGRPFPP 381
N R LP PF P
Sbjct: 270 DWNNIRNSLP---PFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 38/210 (18%)
Query: 85 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVIS 134
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
K +S ++ L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL--------VK--GEANISYICSR 243
+ + V HRD+ +N+LV+ VK+ DFG KVL V+ GE+ I
Sbjct: 124 LGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAEL 273
++ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 43/294 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHC 138
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ QVKLCDFG + LV A +Y+ + Y APE I G +Y
Sbjct: 116 -ILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 317
D+WS G EL LG+ +P +I K G+ ++ +C+ D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ + + F + ++ ++ P R HPF + + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYR--VLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
K C + + L L+MEYVP R + KH ++ Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE-- 249
AY+H+ + HRD+ +N+L+D VK+ DFG AK + +G YYR E
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170
Query: 250 ---LIFGATE------YTTSIDIWSAGCVLAELL 274
+ + A E ++ + D+WS G L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 83/350 (23%), Positives = 147/350 (42%), Gaps = 80/350 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF T S+ L V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR----LFFVIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII--KVLGTPTR 301
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I K + P
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-- 225
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 359
R +KA K F + P E L C
Sbjct: 226 -------------RSLSVKASSVLKGFLNKDPKE-------------RLGCHPQTGFRDI 259
Query: 360 --HPFFD----ELREPNARLPNGRPFPP-------LFNFKQELAGASPEL 396
HPFF +L E LP P+ P L NF + +L
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLP---PYKPNIESDRDLDNFDPQFTDEPVQL 306
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 47/288 (16%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +D+L++ ME+ + + H + + YV T Q GL Y+H+ G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ H VKL DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y DIW+ G EL QP + + L + K ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227
Query: 316 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P++K W FH L +P R TA + HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 84/358 (23%), Positives = 147/358 (41%), Gaps = 66/358 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRLMDHPNVIS 134
+G G+FG V+Q + +T A+K + + +E L L + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK FS + +L+L V +Y+ E + + K R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQK-----EGRFSEDRAKFYIAELVLALE 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D H + LCDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
YT +D WS G ++ E+ G F E+ T++ R N +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---------------TQQMYR--NIAF 211
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR 367
RFP+ + E LL +P R A+E HPFF ++
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI- 259
Query: 368 EPNARLPNGR----PFPPLFNFKQELAGASPELINRLIPEH--VRRQTGLSMPHSAGT 419
+ L + + PF P+ + ++++ PE N + V + +P + T
Sbjct: 260 --DWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAGIVPWEDVPGLPGANST 315
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 82/300 (27%), Positives = 131/300 (43%), Gaps = 61/300 (20%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRLMDHP 130
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L F T K L L++EY+ ++ L+ + Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT----ACFYLSEISL 111
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N+L+D H VKL DFG K + C Y AP
Sbjct: 112 ALEHLHQQ-GIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E I + + ++D WS G ++ ++L G P F EN + +I+K +
Sbjct: 170 E-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNL 219
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
P Y + PEA DL +LL+ +PS R A E +HPFF
Sbjct: 220 PPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCF 139
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+S +++ ME++ ++ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYT 258
+ HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 259 TSIDIWSAGCVLAELLLGQPLFPGENA 285
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 88/343 (25%), Positives = 142/343 (41%), Gaps = 77/343 (22%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL----------MDHPNVI 133
V+G G FG V A+ +TGE AIK + + E++ + HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+L CF ++D + VMEY + M + S + Y + GL
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H + +RD+K NLL+D VK+ DFG K + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E+R
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 363
+P + EAI + RLL+ +P R + E A PFF
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
Query: 364 ---DELREPNARLPNGRPFPP-------LFNFKQELAGASPEL 396
D+L ++ PF P + NF +E +P L
Sbjct: 263 INWDDLL--ARKIKP--PFVPTIKGPEDVSNFDEEFTSEAPVL 301
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+V+G G+FG V + + + A+K + + K E +M + ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F +D+ +L +VMEY+P + ++ +Y +P + + YT ++ L I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPE 249
H++ G HRDVKP N+L+D H +KL DFG+ +K +AN C Y +PE
Sbjct: 159 HSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213
Query: 250 LIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
++ G Y D WS G L E+L+G F ++ V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRLMDHPNV 132
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPE 249
L ++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C Y APE
Sbjct: 111 LDHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 302
++ +T S D WS G ++ E+L G F G++ + + I+K LG P +
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 303 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 334
+R + NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H +RD+KP+N+L+D H +++ D G A + +GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W GC++ E++ GQ F G E +K REE+ D
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 369
R + + +V+ + EA + LL P R C A E HPFF +
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268
Query: 370 NARLPNGRPFPPL 382
RL G PP
Sbjct: 269 FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 8e-16
Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 46/308 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 123
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 124 CLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 MAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ--- 236
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
NP +R+ D +R L+ R +A E HPF +
Sbjct: 237 --NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL-K 273
Query: 366 LREPNARL 373
L +P + L
Sbjct: 274 LAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRLMDHPNVISLK 136
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F +DE + ++E+V + H R P K Y ++ Y+H+
Sbjct: 85 CSF-----QDENRVYFLLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ +RD+KP+NLL+D H VK+ DFG AK + + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 257 YTTSIDIWSAGCVLAELLLGQPLF 280
+ ++D W+ G +L E + G P F
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-15
Identities = 68/249 (27%), Positives = 124/249 (49%), Gaps = 20/249 (8%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + DEL++ VMEY+ + + M++ + +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQ----IAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYY 245
+ L ++H+ V HRD+K N+L+ + VKL DFG A++ + + + + Y+
Sbjct: 125 CLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 183 MAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPE 240
Query: 306 CMNPNYTDF 314
++ + DF
Sbjct: 241 KLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 51/286 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L H F T K L V++YV E + + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y+H++ + +RD+KP+N+L+D H V L DFG K V+ E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 294
+ Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 334
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
+V+G GSFG V A+ + A+K + + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L H F T K L V++Y+ E Y + + + R + Y +I L
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H++ + +RD+KP+N+L+D H V L DFG K ++ S C + Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y ++D W G VL E+L G P F N + I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 79/306 (25%), Positives = 140/306 (45%), Gaps = 59/306 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----------KVLQDRRYKNRELQLMRLMD 128
+V+GTG++G VF + + ++G+ A+K K + R + + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR--Q 63
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P +++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 64 SPFLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIV 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K + E +Y C Y
Sbjct: 116 LALEHLHKL-GIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 247 APELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
AP+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--------- 224
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAH 360
+K+ P + + M A D+ RLL P R A E H
Sbjct: 225 -------------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 361 PFFDEL 366
PFF ++
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 64/229 (27%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIY----VKLYTYQIF 188
+ + F + L +VM+Y Y +N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKG-EANISYICSRYY 245
L ++H + HRD+K QN+ LT +KL DFG A+VL E + I + YY
Sbjct: 112 LALKHVHDRK-ILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 68/301 (22%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISLKHC 138
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 139 FFSTTSKDELFLNLVMEYVP--------ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+F +++L++ ++E+ + R L ++ Q+
Sbjct: 71 YFY---ENKLWI--LIEFCDGGALDSIMLELERGLTEP----------QIRYVCRQMLEA 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPE 249
L ++H+ V HRD+K N+L+ L VKL DFG SAK + ++I + Y+ APE
Sbjct: 116 LNFLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 250 LI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
++ F Y DIWS G L EL +P P + ++ + ++K+L +
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP----- 225
Query: 306 CMNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
P + W F+ D L P R TA E HPF
Sbjct: 226 -----------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
Query: 365 E 365
+
Sbjct: 267 D 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L + F +D+ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
L IH++ G HRDVKP N+L+D H +KL DFG+ + K E + + + + Y +
Sbjct: 155 LDAIHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAVGTPDYIS 211
Query: 248 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVISLKHCFF 140
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S S+++L+ + MEY + + H + + + YV T Q GLAY+H+ G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGATE--- 256
HRD+K N+L+ VKL DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 257 -YTTSIDIWSAGCVLAELLLGQP 278
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 25/228 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPN 131
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ L C F +D+ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANI-SYICSRYYRAP 248
L IH++ G+ HRDVKP N+L+D H +KL DFG+ K+ G + + + Y +P
Sbjct: 155 LDAIHSM-GLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 249 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
E++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL--------MDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF---QTESRLFF--VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 111 YLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 293
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 84/313 (26%), Positives = 134/313 (42%), Gaps = 50/313 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
YT S D W+ GC+L E++ GQ F Q + IK REE+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369
+K + + ++ P+A L LL P R A E HP F ++
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 370 NARLPNGRPFPPL 382
RL G PP
Sbjct: 269 FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 69/288 (23%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H M + Y +I GL
Sbjct: 60 VCMSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 295
Y +S D +S GC+L +LL G F ++ +D++ + V
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 296 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 337
L + C+ + + P ++ W VF ++ PP I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 83/299 (27%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRLMDHPNV 132
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+LK+ F + D L VMEY E + + + R + Y +I
Sbjct: 58 TALKYSF---QTHDRLCF--VMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISLK 136
V+G GSFG V A+ T E AIK + +D ++ +++ ++ L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
H F T + L VMEYV + MY++ R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELIFG 253
H+ G+ +RD+K N+++D H +K+ DFG K + G ++ + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDH--------PNVIS 134
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV-LVKGEANISYICSRYYRAPELI 251
++H G+ +RD+K N+L+D H +KL D+G K L G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 301
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPN 131
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ + S +D L L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRE---SWEGEDGL-LYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L Y+H + HRD+K QN+ + T+ +K+ D G A+VL + + + I + YY +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 250 LIFGATEYTTSIDIWSAGCVLAEL 273
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 29/253 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ L +++E+ P + P I ++ Q+ L Y+H++
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSMK- 130
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT--- 255
+ HRD+K N+L+ L +KL DFG SAK + + S+I + Y+ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 256 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 310
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 311 YTDFRFPQIKAHP 323
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 57/255 (22%), Positives = 115/255 (45%), Gaps = 38/255 (14%)
Query: 85 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-LMD 128
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSM---NQRMPLIYVKLYTY 185
HPN++ F D L++ VM+ + +H++S+ QR +
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
Q+ L Y+H + HRD+ P N+++ +V + DFG AK S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 304
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 305 ---------RCMNPN 310
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIH 195
+ F S T L LVM + + H ++ +R + + V Y+ QI G+ ++H
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKY--HIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+N+L+D +L D G A L G+ + Y APE I
Sbjct: 113 SM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLF 280
Y+ +D ++ GC + E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 85 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
K E + LVME P L Y + +P+ +K +Q+ G+AY+ +
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLG---PLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 197 VPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
V HRD+ +N LLV+ HQ K+ DFG ++ L G S YYR
Sbjct: 114 KHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWPL 162
Query: 247 ---APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
APE I +++ D+WS G L E G
Sbjct: 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 83 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRLMDHPNVIS 134
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F KDE +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
++ + +RD+KP+NLL+D +K+ DFG AKV+ + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLF 280
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 40/292 (13%)
Query: 9 QPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMD---SDKEMSAAV---IQGNDAVTGHII 62
+P PPP ++ R RPD+ ++ S AV + + +
Sbjct: 2 KPIQPPPGVPLPSTARH---TTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSS 58
Query: 63 STTIGGKNGEPKQTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RR 115
S++ G +++S + ERV +G+G+ G V++ TG A+K + + RR
Sbjct: 59 SSSASGSAPSAAKSLSEL-ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR 117
Query: 116 YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
RE++++R ++HPNV+ H F + ++ L E M + +
Sbjct: 118 QICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLL--------EFMDGGSLEGTHIADEQ 168
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-E 234
L V QI G+AY+H V HRD+KP NLL++ VK+ DFG +++L + +
Sbjct: 169 FLADV---ARQILSGIAYLHRRHIV-HRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223
Query: 235 ANISYICSRYYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 68/326 (20%), Positives = 108/326 (33%), Gaps = 52/326 (15%)
Query: 83 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRLMDHPNVIS 134
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVL--KHYSSMNQRMPLIYVKLYTYQIFRGLA 192
F EL++ V + L H+ + +P + + + L
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHF---PEGLPELAIAFILKDVLNALD 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELI 251
YIH+ G HR VK ++L+ +V L + ++K G+ L
Sbjct: 116 YIHSK-GFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 252 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 299
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 300 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349
+ + R N + + + LQ P
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 350 LRCTALEACAHPFFDELREPNARLPN 375
R +A + H FF + + N L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRLMDHPNVISL 135
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDF-------------------GSAKVLVKGEA 235
H + G+ +RD+KP+N+L+ H + L DF GS + V
Sbjct: 120 HLL-GIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 236 NISYICS-----------RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ ++ Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344
+ I+K + FP + A DL +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 345 QYSPSLRC----TALEACAHPFFD 364
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 46/303 (15%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG----- 129
Query: 148 LFLNLVMEYVPETMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
VL HYSS ++ +P+ + QI GL Y+H
Sbjct: 130 -----------AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR- 177
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ HRDVK +N+ ++ + QV + D G+A+ V A + + APE + +Y +
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNS 235
Query: 260 SIDIWSAGCVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEI 304
DIWSAG VL E+L P ++ L++II L P
Sbjct: 236 KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
R + + ++ + + + + F + +P + L ++L + ++R +A E +P F
Sbjct: 296 R-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354
Query: 364 DEL 366
+L
Sbjct: 355 AQL 357
|
Length = 357 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 89/344 (25%), Positives = 148/344 (43%), Gaps = 58/344 (16%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RLMDHPNVISLKH 137
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 138 C--FFSTTSKDELFLNLVM-EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+F + + +VM +Y P + ++KH + R ++ +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247
Query: 195 HTVPGVCHRDVKPQNLL-------VDPLTHQ--------VKLCDFGSAKVLVKGEANISY 239
HT + H D+KP+N+L VDP+T++ V++CD G + + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 298
+ +R+YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 299 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 346
P+ RC Y + P H ++ R E I DL LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424
Query: 347 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRPF---PPL 382
R A + HP ++ E R+ PN P+ R P+
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRPTPI 466
|
Length = 467 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RLMDHPN---VIS 134
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + + +KD L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
+ +RD+KP+N+L+D H +++ D G A + +GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLF 280
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 67/296 (22%), Positives = 131/296 (44%), Gaps = 50/296 (16%)
Query: 79 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDH 129
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI--SYICSRYYR 246
G+ Y+H + HRD+K +N+ + + +K+ DFG +++L+ G ++ ++ + YY
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 173 SPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------ 222
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
P+ + + + +L PSLR +A E +PF
Sbjct: 223 --PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPNV 132
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ + + F + D+L L + + Y + +H + M + Y +I GL
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
++H V +RD+KP N+L+D H V++ D G A K + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 89/343 (25%), Positives = 139/343 (40%), Gaps = 97/343 (28%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++S KD L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG---------SAKVLVKGE---------- 234
+H + G HRD+KP N+L+D L +KL DFG ++K KG
Sbjct: 117 VHKM-GFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174
Query: 235 ------ANI-----------------------SYICSRYYRAPELIFGATEYTTSIDIWS 265
+N S + + Y APE++ YT D WS
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWS 233
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G +L E+L+GQP F + TPT +++ +N T PQ+K
Sbjct: 234 VGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK----- 274
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDEL 366
+ PEA+DL ++L + R A + AHPFF E+
Sbjct: 275 ------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRLMDHPNV 132
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F + ++ L ++ME+ + R ++ M ++ + T Q+ L
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 192 AYIHTVPG------VCHRDVKPQNLL-------VDPLTHQV---------KLCDFGSAKV 229
AY H + V HRD+KPQN+ + +T Q K+ DFG +K
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 230 LVKGEANISYIC--SRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ G ++++ C + YY +PEL+ T+ Y D+W+ GC++ EL G+ F N
Sbjct: 192 I--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 287 DQLVEIIK 294
QL+ +K
Sbjct: 250 SQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F + D L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF---QTHDRLCF--VMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ V +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 363
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCF 139
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 140 FSTTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F S D+L+ LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH 138
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 139 -AHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 195
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQP 278
Y DIWS G E+ G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 66/249 (26%), Positives = 112/249 (44%), Gaps = 39/249 (15%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCF 139
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 140 FSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + L +++E+ V M + + + +++ Q L Y+
Sbjct: 72 YYENN-----LWILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFG 253
H + HRD+K N+L L +KL DFG SAK + S+I + Y+ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 254 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 305
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 306 CMNPNYTDF 314
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFST 142
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 143 T----SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T +DE +L LVM+Y +L S R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF---- 252
V HRD+KP N+L+D H ++L DFGS K+ G S + + Y +PE++
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LM--DHPNVISL 135
+V+G G+FG V K TG+ A+K + + K E R L+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 136 KHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ F +DE L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKG--EANIS-----YICSRYYR 246
H + G HRD+KP N+L+D H ++L DFGS ++L G ++N++ YI +
Sbjct: 119 HQL-GYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 83 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRLMDHPNVIS 134
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAY 193
L +++ ++ +VME P L+ Y +N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 194 IHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRA 247
+ + V HRD+ +N+LV P VKL DFG ++ L E Y S+ + A
Sbjct: 123 LESKRFV-HRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 248 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 284
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 83 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-------YY 245
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + E + Y + ++
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 7e-12
Identities = 59/221 (26%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRLMDHPNVISL 135
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
K+ F +KD L VMEYV E + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H+ + +RD+K +NL++D H +K+ DFG K + A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 45/225 (20%)
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYV 180
QLM+ D+PN I L + TT K + L+M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLFDLLK----KEGKLSEAEV 111
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
K Q+ L +H + H D+K +N+L D ++ LCD+G K+ +
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTP------ 163
Query: 241 CSRY-----YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI--- 292
S Y Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 164 -SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESL 219
Query: 293 ----------IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 324
IK + + ++ M N NY + +I HP+
Sbjct: 220 LKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLM-RLMDHPN 131
+ +G G+FG V +A ++ VA+K + R EL++M L +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEANISYICS 242
G+A++ + + HRD+ +N+L+ VK+CDFG A+ +VKG A +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YT D+WS G +L E+ LG +PG
Sbjct: 208 -KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 55/247 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRLM-DHPNVI 133
+G G+FG V +A+ + TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIYV 180
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ YQ+ RG+ ++ + + HRD+ +N+LV H +K+ DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASKKCI-HRDLAARNVLVTE-DHVMKIADFGLAR-------DIHHI 185
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241
Query: 288 QLVEIIK 294
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
T L ++MEY+ L ++ +K +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYT 258
+ HRD+K N+L+ VKL DFG A L + +++ + ++ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 259 TSIDIWSAGCVLAELLLGQP 278
+ DIWS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMP-LIYVKLYTYQI 187
++ L ++ S++E +V EY+ + ++ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--- 244
G+AY+ + HRD+ +N+LV K+ DFG A+++ E + +++
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYT-AREGAKFPIK 169
Query: 245 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPN--VISL 135
+V+G G+FG V K + A+K + + K E R L++ N + +L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F +DE L LVM+Y +L S R+P + Y ++ + +H
Sbjct: 67 HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA-KVLVKGEANISY-ICSRYYRAPELIF- 252
+ V HRD+KP N+L+D + ++L DFGS K++ G S + + Y +PE++
Sbjct: 120 QLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 253 ---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207
F L++ +Y Y + + + + + + R + Y+H + HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 208 QNLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYY--------RAPELIFGATEY 257
+N+ ++ H +C DFG+A V AN +YY APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 258 TTSIDIWSAGCVLAELLLGQ 277
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN--QRMPLIYVKLYTY--QIFRGLAYIH 195
T L ++MEY L S+++ + PL ++ T +I +GL Y+H
Sbjct: 72 LKDTK-----LWIIMEY--------LGGGSALDLLEPGPLDETQIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-YICSRYYRAPELIFGA 254
+ + HRD+K N+L+ +VKL DFG A L + + ++ + ++ APE+I
Sbjct: 119 SEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175
Query: 255 TEYTTSIDIWSAGCVLAELLLGQP 278
+ Y + DIWS G EL G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRLMDHPNVISLKHCFF 140
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 141 STTS----KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ D+L+ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK--GEANISYICSRYYRAPELIF-- 252
V HRD+K QN+L+ +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 253 --GATEYTTSIDIWSAGCVLAELLLGQP 278
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 83/320 (25%), Positives = 128/320 (40%), Gaps = 64/320 (20%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVISLK 136
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLI---YVKLYTYQIFRGLAY 193
+ F + T L LVM + R H ++++ P YT QI GL +
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRY--HIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D + V++ D G A L G++ Y + + APEL+
Sbjct: 113 LHQ-RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
G EY S+D ++ G L E++ + F GE KV ++ I +
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVT 219
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFF 363
Y D + P + LL P R C L HP F
Sbjct: 220 YPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLF 260
Query: 364 DELREPNARLPNGRPFPPLF 383
+L N R PP F
Sbjct: 261 RDL---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----LMDHPNVISLKHC 138
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F+S +D+L L L+ME++P M +L ++ + + Y + + IH +
Sbjct: 67 FYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE----TQFYIAETVLAIDSIHQL 120
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG------------------------ 233
G HRD+KP NLL+D H VKL DFG L K
Sbjct: 121 -GFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 234 ------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
+ S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 282 GE 283
E
Sbjct: 238 SE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRLMDHPNVISLKHCF 139
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRGLAYIH 195
T L ++MEY L S+++ P Y+ +I +GL Y+H
Sbjct: 72 LKGTK-----LWIIMEY--------LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGE-ANISYICSRYYRAPELIF 252
+ + HRD+K N+L L+ Q VKL DFG A L + +++ + ++ APE+I
Sbjct: 119 SERKI-HRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI- 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQP 278
+ Y DIWS G EL G+P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNV 132
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL---------- 182
I L + S+D L L++EY Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 183 --------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+ +QI RG+ Y+ + V HRD+ +N+LV ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 229 VLVKGEANISYICSRY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLM 127
P + ++ +G G++G VF+ + G A+K +L + E++ L L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
DHPNV+ ++ K+ L LV+E ++ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSR 243
GL ++H V HRDVK N+L LT + VKL DFG SA++ + + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 244 YYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 278
++ APE+I + Y D+WS G EL G P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 69/270 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 121
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-------SMNQ 173
+L+ H N++ T D +V EY+ + + L+ + S +
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 174 RM-PLIYVKLY--TYQIFRGLAYI---HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGS 226
M L +L QI G+ Y+ H V HRD+ +N LV L VK+ DFG
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV----HRDLATRNCLVGYDLV--VKIGDFGM 168
Query: 227 AKVLVKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL 274
++ + Y YYR PE I +TT D+WS G VL E+
Sbjct: 169 SRDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIF 218
Query: 275 L--GQPLFPGENAVDQLVEIIK---VLGTP 299
QP + N ++++E I +L P
Sbjct: 219 TYGKQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-----LMDHPNVISLKH 137
+V+G G+FG V + +TG A+K + + + ++ +R L++ +K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK- 65
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F+S K L+L +ME++P M +L ++++ + Y + + IH
Sbjct: 66 MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA----TQFYIAETVLAIDAIHQ 119
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFG------------------------------- 225
+ G HRD+KP NLL+D H VKL DFG
Sbjct: 120 L-GFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 226 ---SAKVLVKGEANISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
A+ K ++Y + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 281 PGE 283
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 75/275 (27%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 118
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ----- 173
+E +LM + HPN++ C +K++ ++ EY+ + L + N
Sbjct: 57 QEAELMSDLQHPNIV----CLLGVCTKEQP-TCMLFEYLA---HGDLHEFLVRNSPHSDV 108
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+ L QI G+ Y+ + HRD+ +N LV VK+
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKIS 166
Query: 223 DFGSAKVLVKGEANISYICSRYYR------------APELI-FGATEYTTSIDIWSAGCV 269
DFG ++ + + YYR PE I +G ++TT DIWS G V
Sbjct: 167 DFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVV 215
Query: 270 LAELL-LG-QPLFPGENAVDQLVEIIK---VLGTP 299
L E+ G QP + N +++E+I+ +L P
Sbjct: 216 LWEIFSYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + KG+A
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 294
+ + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 242 RLPL----KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDE 289
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 343
+E R P+YT Q WH +R P +L L
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 70/278 (25%), Positives = 109/278 (39%), Gaps = 46/278 (16%)
Query: 100 ETGETVAIKKVLQD-----RRYK--NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
V EYVP R L+ + + +P Q+ LA H G+ HRD+KPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 213 DP--LTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYRAPELIFGATEYTTSID 262
+ K+ DFG +L + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 263 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 321
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 322 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 356
HP +V K + P + A L + +L AL
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRLMDHPNVISLKH 137
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYI 194
F+ S E + E M + L + S Q +P+ + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-----IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 195 HTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVL-----VKGEANISYICSRYYRAP 248
HRD+ +N+LV + L K+ DFG A+++ + + I Y + AP
Sbjct: 121 EE-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY----KWTAP 173
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 291
E ++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 174 EAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 18/221 (8%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISLKHCF 139
+G G++G V++ + G A+K +L + E++ L L +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV+E ++ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 199 GVCHRDVKPQNLLVDPLTHQ--VKLCDFG-SAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ HRDVK N+L LT + VKL DFG SA++ + + + ++ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 256 EYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+Y S D+WS G EL G P + V L +I
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 44/244 (18%)
Query: 88 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS 144
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 145 KDELFLNLVMEYVPETMYRVLKH----YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
+ + + +VM K Y + +PL ++ LAY+H G+
Sbjct: 156 RWKSTVCMVM--------PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGI 206
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAPELIFGAT 255
HRDVK +N+ +D + V L DFG+A L + C + +PEL+
Sbjct: 207 IHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALD 262
Query: 256 EYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y DIWSAG VL E+ + LF + K + R IRCM +
Sbjct: 263 PYCAKTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PL 311
Query: 315 RFPQ 318
FPQ
Sbjct: 312 EFPQ 315
|
Length = 392 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 243 RY---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 298
R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 345
++ R P +I W +R +++ LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRLMDHPNVISLKH 137
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-------APE- 249
HRD+ +N LV + +K+ DFG + + E Y S + APE
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L +G YT+ D+WS G +L E LG +PG
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 55/235 (23%)
Query: 82 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKLY 183
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 184 TY--QIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISYI 240
+I G+AY+ HRD+ +N +V + LT VK+ DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAKK-FVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 241 CSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ YYR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 64/285 (22%)
Query: 83 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRLMDHPN 131
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
++ L ++ME + RV + + L+ + L
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL-- 113
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----VKLCDFGSAKVLVKGEANISYI 240
+ +G Y+ + + HRD+ +N LV + VK+ DFG A+ + K
Sbjct: 114 -DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-------- 163
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
S YYR APE L+ G +TT D+WS G ++ E+L LGQ +P N
Sbjct: 164 -SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQ 220
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+ L + R P + Q+ + W + +R
Sbjct: 221 EVLQHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 7e-09
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 20/247 (8%)
Query: 55 DAVTGHIIST---TIGGKNGEPK-QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV 110
DA+ G + T T K Q Y RV+G+G+ G V AK + GE A+K V
Sbjct: 6 DAMIGRVCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV 65
Query: 111 ------LQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE---LFLNLVMEYVPETM 161
D+ E+ + D +++ F ++ L + LV++Y
Sbjct: 66 DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGD 125
Query: 162 YRV-LKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
R +K + N+ L Q+ + ++H+ + HRD+K N+L+ VK
Sbjct: 126 LRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVK 183
Query: 221 LCDFGSAKVL---VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
L DFG +K+ V + ++ + YY APE I+ Y+ D++S G +L ELL +
Sbjct: 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 278 PLFPGEN 284
F GEN
Sbjct: 243 RPFDGEN 249
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 79 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRLMDHPNVI 133
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 134 SLKHCFFSTTSKDELFLNLVMEY-VPETMYRVLKHYSSMNQRMPL--IYVKLYTYQIFRG 190
KH F S D+L L +MEY + + +K + + +P V L YQI
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLA 181
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL---VKGEANISYICSRYYRA 247
L +H+ + HRD+K N+ + P T +KL DFG +K V + S+ + YY A
Sbjct: 182 LDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
PEL + Y+ D+WS G +L ELL F G
Sbjct: 240 PEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 8e-09
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ V HRD+ +N+LV H VK+ DFG AK+L E + + A
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRLMDHPNVI 133
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L S T + LV + +P + V +H ++ ++ L + QI +G+
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAP 248
Y+ + HRD+ +N+LV H VK+ DFG A++L E + + + A
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL--GQP 278
E I ++T D+WS G + EL+ G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L+ T S+ + + ME L + N + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------YYR 246
Y+ + V HRD+ +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 52/228 (22%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 85 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRLMDHPNVISLK 136
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ +V E P + + + + + + Y QI G+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + + HRD+ +N+L+ +VK+ DFG + L + E + Y+ + +
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166
Query: 247 -APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y++Q+ RG+ ++ + + HRD+ +N+L+ + VK+CDFG A+ + K + Y+
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLSE-NNVVKICDFGLARDIYK---DPDYVRK 232
Query: 243 RYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKV 295
R APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
+E R P Y I WH
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 26/152 (17%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAK-------VLVKG 233
++YQ+ +G++++ HRD+ +N+L LTH K+CDFG A+ +VKG
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
A + + APE IF YT D+WS G +L E+ LG +PG + ++
Sbjct: 275 NARLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 324
IK E R ++P I W
Sbjct: 330 IK-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVKGEA 235
++ Q+ +G+ ++ HRDV +N+L+ K+CDFG A+ +VKG A
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ + APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 44/217 (20%)
Query: 84 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYT--YQI 187
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ ++ V HRD+ +N LV +VK+ S L K N S YY+
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175
Query: 247 ----------APELIFGATEYTTSIDIWSAGCVLAEL 273
APE + +++T D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 47/284 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRLMDHPNVIS 134
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP----LIYVKLYTYQIFRG 190
L E + +P + L+++ P LI L Q+ +G
Sbjct: 61 L----LGICLPSE---GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
+ Y+ + V HRD+ +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLASKKFV-HRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 251 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
+ C +P Y ++ WH R P +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 54/281 (19%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 181 KLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L TYQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTE-NNVMKIADFG----LARDVNNID 191
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+++K G + C N Y R WH + R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 88 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQL------MRLMDHPNVISLKHCFF 140
G+FG V+ + + A+K V + D KN Q+ + L P ++ L ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL---YY 71
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
S S + ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H G
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ HRD+KP N+L+ H +KL DFG +KV + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
L+ T SK + +V EY+ + R KH + + +I + I
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLR--KH----DGQFTVIQLVGMLRGIAS 117
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----Y 244
G+ Y+ + G HRD+ +N+LV+ K+ DFG ++VL + + +Y
Sbjct: 118 GMKYLSDM-GYVHRDLAARNILVNS-NLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIR 174
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ APE I ++T++ D+WS G V+ E++
Sbjct: 175 WTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRLMDHPNVI 133
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L ++T + LV + +P Y L Y N+ R+ + + QI +G++
Sbjct: 73 RLLGICLTST------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPE 249
Y+ V V HRD+ +N+LV H VK+ DFG A++L E + + A E
Sbjct: 124 YLEEVRLV-HRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL 274
I +T D+WS G + EL+
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L+ +K + ++ EY+ ++ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQV-KLCDFGSAKVLVKGEANISY------ICSRYY 245
Y+ + HRD+ +N+LV+ ++ V K+ DFG ++ L ++ +Y I R+
Sbjct: 121 YLSEM-NYVHRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELL 274
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANIS-- 238
+TYQ+ RG+ ++ + V HRD+ +N+L L VK+CDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCV-HRDLAARNVL---LAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 239 -YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
++S KD L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
+H + G HRD+KP N+L+D H +KL DFG
Sbjct: 117 VHKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 69/243 (28%), Positives = 98/243 (40%), Gaps = 62/243 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 123 LMRLMDHPNVISLKH-CFFSTTSKDELFLNLVMEYV-PETMYRVLKHYSSMNQ------- 173
LM DHPN++ L C + L+ EY+ + L+H S Q
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKP------MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 174 ---------RMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222
+PL + Q+ G+AY+ V HRD+ +N LV VK+
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIA 172
Query: 223 DFGSAKVLVKGEANISYICSRYYRA------------PELIFGATEYTTSIDIWSAGCVL 270
DFG ++ NI + YY+A PE IF YTT D+W+ G VL
Sbjct: 173 DFGLSR-------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVL 222
Query: 271 AEL 273
E+
Sbjct: 223 WEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 139 FFSTTSKDE--LFLNLVMEYVPETMYRVLKHYSSMNQRMP-LIYVKLYTYQIFRGLAYIH 195
++ + +E + +M+Y ++ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIF 252
+ HRD+ +N+LV + K+ DFG A+V+ + + +++ + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 253 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 49/279 (17%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
+P P P P APP + L+R D+E + A+ +G S
Sbjct: 115 LPGDGAPDHDPAPCGPAPPGG---LTPEELER------LDREAARAISRG-----CKPPS 160
Query: 64 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL 123
G + + R + GS G VF++ + + V +K E +L
Sbjct: 161 EVAKVVAG-----LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEARL 213
Query: 124 MRLMDHPNVISL--KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 181
+R + HP V++L T LV+ +Y L + + + L V
Sbjct: 214 LRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGLAQVT 263
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
Q+ + YIH G+ HRD+K +N+LV+ + L DFG+A +G S+
Sbjct: 264 AVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWST 316
Query: 242 SRYY--------RAPELIFGATEYTTSIDIWSAGCVLAE 272
+Y APE++ G YT S+DIWSAG V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTVPG 199
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 70 VCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KN 124
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++ L+ G+ ++ +++ + APE + +
Sbjct: 125 FIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181
Query: 257 YTTSIDIWSAGCVLAEL-LLGQPLFPG 282
++ D+W+ G +L E+ G +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 79/315 (25%), Positives = 131/315 (41%), Gaps = 70/315 (22%)
Query: 85 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRLMD-HPN 131
+G G FG V +A+ + TVA+K + + K+ E++LM+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 132 VISLK---------HCFFSTTSKDEL--FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
+I+L + +K L FL P+ + + K L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-----QLSFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L +G +I
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTE-DNVMKIADFG----LARGVHDID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 334
+++ RE R P+ + WH V +R +
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 335 EAIDLASRLLQYSPS 349
E +DL+ QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 46/189 (24%), Positives = 77/189 (40%), Gaps = 40/189 (21%)
Query: 106 AIKKVLQDRRYKNRELQLMRLMDHPNVISL-------KHCFFSTTSKDELFLN-LVMEYV 157
A +D +E++++ + PN+ L + LN + ++V
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
ET L S L+Y+ QI G+ Y+ ++ V HRD+ +N LV +
Sbjct: 115 AET--SGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-Y 167
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYY----RAP--------ELIFGATEYTTSIDIWS 265
+K+ DFG ++ L Y YY RAP E + ++TT D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217
Query: 266 AGCVLAELL 274
G L E+L
Sbjct: 218 FGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 171 MNQRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
+N+ L Y+ L ++YQ+ G+ ++ + V HRD+ +N+L+ VK+CDFG A+
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLAR 287
Query: 229 VLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 284
+++ IS + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 333
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 56/291 (19%)
Query: 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ------RMPLIYVKLYTYQI 187
L + +K L + +V+ +P + L + M++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR- 246
G+ Y+ + HRD+ +N +++ V + DFG +K + G+ YYR
Sbjct: 123 ASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGD---------YYRQ 171
Query: 247 --APELIFG--ATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIK 294
A +L A E YTT D+W+ G + E++ GQ + G EN+ EI
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYN 226
Query: 295 VL--GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 343
L G ++ C+ Y ++ W R P L +L
Sbjct: 227 YLIKGNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 57/220 (25%), Positives = 84/220 (38%), Gaps = 69/220 (31%)
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY- 244
QI L +H+ G+ HRDVKPQN++ + K+ D G+A L G I+YI +
Sbjct: 263 QILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 245 ----YRAPELIFGATEYTTS----------------------IDIWSAGCVLAELLLGQP 278
Y APE +T+ T S DI+SAG L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQM 372
Query: 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---- 334
FP + L++ R+ R D+ W K+ R P
Sbjct: 373 AFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRASPDLRR 414
Query: 335 --EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 364
E +DL ++++ R +A A AHP+FD
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 81/316 (25%), Positives = 132/316 (41%), Gaps = 71/316 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVL--------KHYSSMNQRMP---LIYV 180
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 181 KLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
L + YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVTE-DNVMKIADFG----LARDVHNID 188
Query: 239 YICSRY-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 290
Y + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 333
+++K E R P I WH V +R
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 334 PEAIDLASRLLQYSPS 349
E +DL+ QYSP
Sbjct: 300 DEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 65/246 (26%)
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PN++ L H + S+D +FL V+++ L + S +P VK + ++
Sbjct: 45 PNMVCL-HKYI--VSEDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK---GEANISYICSRYYR 246
L +H VC RD+ P N+L+D H ++L F + GEA Y
Sbjct: 97 ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYC 149
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE + G +E T + D WS G +L ELL G+ L + C
Sbjct: 150 APE-VGGISEETEACDWWSLGAILFELLTGKTL------------------------VEC 184
Query: 307 MNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 358
+P+ +T P+ + EA L +LLQ++P+ R A A
Sbjct: 185 -HPSGINTHTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 359 -AHPFF 363
+HPFF
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 35/268 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVISLKHCFF 140
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N LV VK+ DFG + ++ + S +++ + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFSK 177
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
Y++ D+WS G ++ E + + P EN + E+++ + R P
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLL 344
++ H W + PE S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 58/234 (24%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRL---MDHPNVISL 135
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPL---------------IY 179
+S S + + M Y+ T+ +LK S+ Q+ L I+
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLK---SVWQKESLSKELAEKTSVGAFLSIF 119
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK-------VLVK 232
K I + Y+H+ GV HRD+KP N+L+ L +V + D+G+A L+
Sbjct: 120 HK-----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 233 GEANISYICSRY------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + IC Y APE + G + S DI++ G +L ++L
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDH 129
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ L ++ +++ +++ + EY+ ++ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYR 246
G+A+I HRD++ N+LV K+ DFG A+++ E A +
Sbjct: 113 EGMAFIE-RKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYTAREGAKFPIKWT 170
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE I T +T D+WS G +L E++ G+ +PG
Sbjct: 171 APEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L+ T K + + ME + + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ + V HRD+ +N+LV+ + K+ DFG ++VL + + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL 274
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 25/225 (11%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRLMDHPNVI 133
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ S++ +++ V EY+ + ++ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 193 YIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPE 249
YI + + HRD++ N+LV D L K+ DFG A+++ E A + APE
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 250 L-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292
++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLIY 179
+ F D L +V EY+ P+ M V + L
Sbjct: 70 VK-----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 240 ICSRYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLF 280
+ YYR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 26/197 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRLMDHPNVISLKHCFFS 141
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 72 GNP-----LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATE 256
V HRD+ +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 124 V-HRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 257 YTTSIDIWSAGCVLAEL 273
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM---DHPNVISLKHC 138
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGAT 255
HRD+ +N LV + +K+ DFG ++ G + + I ++ L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-- 169
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y++ D+WS G +L E LG +PG
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRLMDHPNVISL 135
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
++S KD L+ VM+Y+P M +L + + + Y ++ + +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGIFPEDL----ARFYIAELTCAVESV 117
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225
H + G HRD+KP N+L+D H +KL DFG
Sbjct: 118 HKM-GFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 83/331 (25%), Positives = 135/331 (40%), Gaps = 85/331 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 122
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLI 178
+M+ +V+ L SK + L +VME + ++ R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 179 YVK---LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
++ +I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 281
YYR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
N +Q+++ + M+ Y D P P DL
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 342 RLLQYSPSLRCTALEACA------HPFFDEL 366
Q++P +R T LE HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 38/126 (30%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
Y APE++ T YT D WS G +L E+L+GQP F + TP ++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQL 254
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRC---TALEA 357
+ +N W H ++ EA DL RL R A E
Sbjct: 255 KVIN---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEI 298
Query: 358 CAHPFF 363
AHPFF
Sbjct: 299 KAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRLMDHPNVI 133
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 134 SLKH-CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
L C ++ L LV + P + V +H S++ + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----ICSRYYR 246
+ Y+ + HR++ +N+L+ V++ DFG A +L + Y ++
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELL 274
++FG YT D+WS G + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 50/223 (22%)
Query: 85 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISL 135
+G G+FG VF A+C E + + K L++ R+ RE +L+ ++ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK------HYSSMNQRMPLIYVKL-----Y 183
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 243
QI G+ Y+ ++ V HRD+ +N LV VK+ DFG ++ + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 244 YYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 274
YYR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 52/230 (22%), Positives = 98/230 (42%), Gaps = 39/230 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRLMDHPNV 132
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 133 ISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L F +S ++ +V M++ + + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
G+ Y+ HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 249 ELI-----FGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 285
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 41/220 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ +L HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP----------------ETMYRVLKHYSSMNQRMPL 177
+L + +L L +EY P + + + +S L
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK---VLVKGE 234
++ + + RG+ Y+ + HRD+ +N+LV + K+ DFG ++ V VK
Sbjct: 127 LH---FAADVARGMDYLSQKQFI-HRDLAARNILVGE-NYVAKIADFGLSRGQEVYVK-- 179
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + R+ L + YTT+ D+WS G +L E++
Sbjct: 180 KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 45/195 (23%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 142 TTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI- 122
Query: 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---YRAPELIFGATEYT 258
HRD+ +N LVD VK+ DFG ++ ++ E S + S++ + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 259 TSIDIWSAGCVLAEL 273
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 64/286 (22%)
Query: 85 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRLM-DHPN 131
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ YQ+ RG+ Y+ + + HRD+ +N+LV + +K+ DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTE-DNVMKIADFGLAR-------DIH 191
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 247
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
V++L +++K G + C N Y R WH V +R
Sbjct: 248 VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 301
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 302 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 347 SPS 349
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 46/222 (20%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 70 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 111
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 112 QDRRY-KNRELQLMRL--MDHPNVISLKHC-FFSTTSKDELFLNLVMEYVPETMYRVLKH 167
+ Y ++ + +DH + C F F+ ++E + E + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI--LLEKLVENTKEIFKR 119
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227
N+ LI K + L YIH G+ H D+KP+N++VD ++ + D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 269
+ +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 56/262 (21%)
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV----MEYVPETMYRVLKHYSSMNQR 174
E M+ DHPNV+ L T + +V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+P + + I G+ Y+ + HRD+ +N +++ V + DFG +K + G+
Sbjct: 109 LPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNGD 166
Query: 235 ANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENAV 286
Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 167 ---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS- 221
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
EI L R + PP+ +D Y
Sbjct: 222 ----EIYDYLRQGNR----------------------------LKQPPDCLDGL-----Y 244
Query: 347 SPSLRCTALEACAHPFFDELRE 368
S C L P F+ LR
Sbjct: 245 SLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 23/54 (42%), Positives = 34/54 (62%), Gaps = 2/54 (3%)
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233
+K Q+ GL +H + G+ HRD+KP+NLLV + QVK+ DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCFFS 141
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S++ +++ V E++ + ++ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 201 CHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPEL-IFGATE 256
HRD++ N+LV D L K+ DFG A+++ E A + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--R 179
Query: 257 YTTSIDIWSAGCVLAELLL-GQPLFPG 282
+T D+WS G +L EL+ G+ +PG
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 49/311 (15%)
Query: 101 TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154
TGE V ++++ + + EL + +L +HPN++ + F + +EL++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI---ADNELWVVTSF 80
Query: 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
+ H+ + + Y+ + + L YIH + G HR VK ++L+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHM-GYVHRSVKASHILIS- 135
Query: 215 LTHQVKLCDFGSAKVLVK--GEANISYICSRY------YRAPELIFGATE-YTTSIDIWS 265
+ +V L S ++ + + +Y + +PE++ + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 306
G EL G F A L+E + +L T T EE+
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255
Query: 307 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
+ + R + +HP+++ F P + LQ +P R +A H FF
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
Query: 365 EL-REPNARLP 374
++ R + LP
Sbjct: 312 QIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 125
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 126 L-MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSS----------- 170
+ HPN++ C +K++ L+++ Y + + V++ S
Sbjct: 63 SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKV 229
+ P +V + T QI G+ ++ + V H+D+ +N+LV D L VK+ D G +
Sbjct: 118 KSTLEPADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFRE 173
Query: 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274
+ + S + R+ +++G +++ DIWS G VL E+
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RLMDHPNVI 133
E V+G G+FG V +A + G AIK + + D R EL+++ +L HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK------LYTYQI 187
+L ++ +L + +EY P S + + P + L + Q+
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 188 FR-------GLAYIHTVPGVCHRDVKPQNLLV-DPLTHQVKLCDFGSAKVLVKGEANISY 239
+ G+ Y+ + HRD+ +N+LV + L K+ DFG L +GE Y
Sbjct: 122 LQFASDVATGMQYLSEKQFI-HRDLAARNVLVGENLA--SKIADFG----LSRGEE--VY 172
Query: 240 ICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL 274
+ R P + + A E YTT D+WS G +L E++
Sbjct: 173 VKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNV 132
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY-------SSMNQRMPLIYVKLY- 183
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 184 -TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
QI G+ Y+ + V HRD+ +N LV VK+ DFG ++ + +
Sbjct: 125 IAQQIAAGMVYLASQHFV-HRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 243 RYYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 288
YYR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 289 LVEII---KVLGTP 299
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 85 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RLMDHPNVIS-L 135
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRM------PLIYVKLYTYQIFR 189
C S LV+E+ P LK+Y N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 190 GLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY---Y 245
GL ++H + H D+ +N L L+ VK+ D+G A + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 246 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 273
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 105 VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159
VA+K + D R E+++M + +PN+I L D+ L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL----LGVCVSDDP-LCMITEYMEN 101
Query: 160 ---TMY---RVLKHYSSMNQRMPLIYVKLYTY---QIFRGLAYIHTVPGVCHRDVKPQNL 210
+ R ++ + +P + + Y QI G+ Y+ ++ V HRD+ +N
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV-HRDLATRNC 160
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSA 266
LV + +K+ DFG ++ L G+ + + R+ ++ G ++TT+ D+W+
Sbjct: 161 LVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAF 217
Query: 267 GCVLAELL 274
G L E+
Sbjct: 218 GVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.02 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.39 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| PLN02236 | 344 | choline kinase | 97.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.05 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.64 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.61 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 96.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.93 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.4 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.99 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.86 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.68 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 93.87 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.55 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.35 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-73 Score=515.19 Aligned_cols=356 Identities=71% Similarity=1.196 Sum_probs=337.5
Q ss_pred eeeeccCCCCCCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeee
Q 014750 61 IISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFF 140 (419)
Q Consensus 61 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 140 (419)
.......+..........|...+++|.|+||.||+|....+++.||||++..+.+..++|+.+|+.++|||||++..+|.
T Consensus 8 ~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~ 87 (364)
T KOG0658|consen 8 VIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFS 87 (364)
T ss_pred EEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence 34455555666666777899999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.....+..++.+||||++.+|.+.++++...+..++...++-+..||++||.|||+ .||+||||||.|||+|++++.+|
T Consensus 88 ~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 88 SSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred ecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEE
Confidence 77766677888999999999999999998889999999999999999999999999 59999999999999999999999
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|||||.|+....++.+.++.+|+.|+|||.+.|..+|+.+.||||.||++.||+-|++.|.|.+..+++..|++++|+|+
T Consensus 167 icDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 380 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~ 380 (419)
.+++.+++++|.++.+|+++..+|..++....++++.||+.++|+++|.+|.++.|+|.||||+++++++..++++.+.+
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp 326 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLP 326 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCchHHhhcCCHHHHhhhcHHHHHhhcCCCCCCCC
Q 014750 381 PLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHSA 417 (419)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (419)
++++|.....+.+++....++|++.+++.+..+.+-+
T Consensus 327 ~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~ 363 (364)
T KOG0658|consen 327 PLFNFKRAELGISPELVNVLIPEHLREQEKDKILCES 363 (364)
T ss_pred CccCchHHHhccchHHHHhhccHhhhhhccccccccC
Confidence 9999999999999999999999999999998876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-63 Score=458.87 Aligned_cols=281 Identities=37% Similarity=0.660 Sum_probs=255.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (419)
.++|.++++||.|.||.||+|+.+.+|+.||||++++.-. ...||++.|++|+ |||||++.+++... +..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----Cce
Confidence 4579999999999999999999999999999998875532 2348999999999 99999999998432 227
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+|||||+.+|+++++++ +..|++..++.|+.||+.||+|+|+ +|+.|||||||||||. .+..|||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~-~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILIS-GNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEec-ccceeEecccccccc
Confidence 9999999999999999975 6789999999999999999999999 5999999999999999 477899999999999
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc--
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 307 (419)
.......+.++.|+||+|||+++....|+.+.||||+|||++|+.+-++.|+|.++.|++.+|+.++|+|..+.|...
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 988888899999999999999999999999999999999999999999999999999999999999999999888652
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.-...++.+|+....++...++. .+.++.+||.+||.+||.+||||+|+|+||||+.-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 12334678899988899888887 89999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-62 Score=427.44 Aligned_cols=280 Identities=36% Similarity=0.686 Sum_probs=250.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+.|+.+.++|+|+||+||+++++.||+.||||++..... ...||+++|+.++|+|+|.++++| +....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 358889999999999999999999999999999975533 346899999999999999999999 666669
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|+|||+.++++.|.++ ...++...++.++.|++.|+.|||+ +++||||||||||||+ .++.+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit-~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILIT-QNGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEe-cCCcEEeccchhhHhh
Confidence 999999999988888875 4678999999999999999999999 6999999999999999 7889999999999988
Q ss_pred c-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh--cc
Q 014750 231 V-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CM 307 (419)
Q Consensus 231 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~ 307 (419)
. .++..+.++.|+||+|||.+.|...|++.+||||+||++.||++|.+.|++.++.+++..|.+.+|........ ..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 66677789999999999999998889999999999999999999999999999999999999999987766554 45
Q ss_pred CcCCccccCCCCCC-CCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 308 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 308 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
|+-|...++|.... ++++..++. ++.-+.||+++||..||.+|++.+|+|.||||.++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 67788888887753 556666654 688999999999999999999999999999997653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-61 Score=432.30 Aligned_cols=321 Identities=38% Similarity=0.647 Sum_probs=273.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.|...+.||.|+||.|+.|.+..+|+.||||++... .+...||+++|+.++|+||+.+.+++.......-..+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 466689999999999999999999999999988622 23456899999999999999999998764444555699
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|+|+|+.+|...++. +..+++.+++.+++||++||+|+|+. ||+||||||+|+|++ .+..+||||||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLN-ADCDLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeec-cCCCEEeccccceeecc
Confidence 9999999888888875 45599999999999999999999995 999999999999999 57789999999999875
Q ss_pred c---CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 232 K---GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 232 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
. ....+.++.|+||+|||+++....|+.++||||+|||+.||++|++.|.|.+..+++..|...+|+|+.+.+..+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4 3344678899999999999998899999999999999999999999999999999999999999999999887664
Q ss_pred c-CCcc--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 P-NYTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~-~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
. +... ...|.....+|...|+ +.++++.||+.+||.+||.+|+|++|+|+||||..+.++..+......+.. +
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~ 332 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---F 332 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---c
Confidence 2 1111 2467888889999988 689999999999999999999999999999999999988777533332222 2
Q ss_pred hHHhhcCCHHHHhhhcHHHHHhhcCC
Q 014750 386 KQELAGASPELINRLIPEHVRRQTGL 411 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (419)
+.. .+.+.+++++++++......
T Consensus 333 --~~~-~~~~~~r~~i~~e~~~~~~~ 355 (359)
T KOG0660|consen 333 --EHE-LTEEELRELIYKEILDFHPD 355 (359)
T ss_pred --ccc-ccHHHHHHHHHHHHHhhCcc
Confidence 222 67899999999997766543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-61 Score=413.42 Aligned_cols=279 Identities=38% Similarity=0.712 Sum_probs=244.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+|...++||+|.||.||+|++..||+.||||+|+... ....||++.|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 46889999999999999999999999999999997442 2345899999999999999999999 444458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
.||+||++.+|...+++ ....++..+++.|+.++++||+|||+ +.|+||||||.|+||+ .++.+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis-~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLIS-SDGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEc-CCCcEEeecccchhcc
Confidence 89999999999888876 45789999999999999999999999 6999999999999999 6889999999999987
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
..... ....+.|+||+|||.+.|...|+..+||||.|||+.||+-|.+.|+|.++.+++..|.+.+|+|..+.|+.+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 54433 3345889999999999999999999999999999999999999999999999999999999999999999875
Q ss_pred -cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
++|..+. .....+....|+ ..+.++.||+.+||.+||.+|+|+.|+|+|+||+....
T Consensus 232 lpdY~~~~--~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 232 LPDYVKIQ--QFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred cccHHHHh--cCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 5666655 222333333444 46888999999999999999999999999999997543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-60 Score=422.76 Aligned_cols=287 Identities=32% Similarity=0.560 Sum_probs=251.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+.|+.+..|++|+||.||+|+++.|++.||+|+++.+.. ...||+.+|.+++|||||.+.++..... -.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MD 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cc
Confidence 44679999999999999999999999999999999975532 2359999999999999999999886543 23
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|||||||..+|..++.. ..++|...+++.++.|+++||+|||. ++|+|||||++|+|++ ..|.+||+|||+|+
T Consensus 151 ~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~-~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLS-HKGILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeec-cCCcEEecccchhh
Confidence 3899999999998888876 34789999999999999999999999 6999999999999999 68889999999999
Q ss_pred ccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.+.... ..+..+.|.||+|||+++|...|++++||||+|||+.||+++++.|++....+++.+|++.+|+|+...|+..
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 886553 3456788999999999999999999999999999999999999999999999999999999999999999875
Q ss_pred C--cCCccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 308 N--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 308 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
. +....+.++...-.+++..|+.. ++....+|+..+|.+||.+|+||+|+|.|.||.+...+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 4 33334566666666677777665 78999999999999999999999999999999985433
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-60 Score=434.46 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=214.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----------ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++.+.. ....+|+++|++|+|||||+++++|
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f---- 245 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF---- 245 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence 4557999999999999999999999999999999986432 1225899999999999999999999
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceE
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK 220 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vk 220 (419)
....+.|+||||++| .|.+.+. .++.+.+...+.++.|++.|+.|||+ +||+||||||+|||+..+ +..+|
T Consensus 246 -~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 -EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred -ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence 555558999999996 5555444 36788899999999999999999999 699999999999999732 25799
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCC--CCCCcccEeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLG 297 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~ 297 (419)
|+|||+|+.........++|||+.|.|||++.+.. .+..++||||+|||||.+++|.+||.+..... ...+|.+.
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-- 397 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-- 397 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence 99999999988888888999999999999997543 34568999999999999999999998765443 45555442
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.|.|. ......++.++.|||.+||.+||++|+|++|+|+||||+...
T Consensus 398 ---------------~y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 ---------------RYAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ---------------ccccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 11111 112245799999999999999999999999999999999744
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-59 Score=433.42 Aligned_cols=284 Identities=36% Similarity=0.611 Sum_probs=243.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
+...+.|+.+++||+|.||.||+|++..+|+.||+|++..+. ....||+.||++|+||||+++.+..+.. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~ 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence 445667999999999999999999999999999999986543 3346999999999999999999998653 3
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+|||+|||+.+|..++.. ..-.|++.+++.|+.||+.||.|||+ +||+|||||.+||||| .+|.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLid-n~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILID-NNGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEc-CCCCEEeccccc
Confidence 456999999999988887764 34579999999999999999999999 7999999999999999 788999999999
Q ss_pred ccccccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 227 AKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 227 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
|+++.... ..+..+.|.||+|||+++|...|+.++|+||.||||.||++|++.|++.++.+++.+|.+.+|.|..+.|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99765443 4567889999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hccC-cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 305 RCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 305 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+... +.+..+.-..--...+.+. ...++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 8332 2222222111112333444 3458999999999999999999999999999999954
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=449.66 Aligned_cols=332 Identities=51% Similarity=0.955 Sum_probs=288.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccC---CCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~ 151 (419)
...+|.+.+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++|+... .....+++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 345799999999999999999999999999999999877777778999999999999999999875432 12345688
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|||+|+...
T Consensus 144 lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred EEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 999999999888887766667889999999999999999999999 6999999999999999656689999999998776
Q ss_pred cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.........||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.+|.|..+.+..+++++
T Consensus 223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 302 (440)
T PTZ00036 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302 (440)
T ss_pred CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence 55555667889999999998876678999999999999999999999999999999999999999999999999889999
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCC-CCCCCCCCCchHH-h
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPFPPLFNFKQE-L 389 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~-~ 389 (419)
.++.++.+....+...++...+.++.+||.+||++||.+|+|+.|+|+||||.++.+....++. ....+.+++|... .
T Consensus 303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (440)
T PTZ00036 303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEI 382 (440)
T ss_pred hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHH
Confidence 9889998888888888888899999999999999999999999999999999998776544433 2345667888754 4
Q ss_pred hcCCHHHHhhhcHHHHHh
Q 014750 390 AGASPELINRLIPEHVRR 407 (419)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~ 407 (419)
....++..+.++|....+
T Consensus 383 ~~~~~~~~~~~~~~~~~~ 400 (440)
T PTZ00036 383 KEMSDACRRKIIPKCTYE 400 (440)
T ss_pred hhCCHHHHHHHhhHHHHH
Confidence 477888888888776554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-58 Score=437.34 Aligned_cols=248 Identities=32% Similarity=0.545 Sum_probs=222.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.+|...+.||+|||+.||.+++..+|+.||+|++.+. +....+|+++.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 6799999999999999999999999999999998653 23345799999999999999999999 88888
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|||+|+|. ++|.++++. .+.++|.+++.+++||+.||.|||+ .+|+|||||..|++++ ++.+|||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLN-ENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeec-CcCcEEecccceee
Confidence 999999999 566666553 4789999999999999999999999 5999999999999999 68889999999998
Q ss_pred ccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... +...+.||||.|.|||++... .++..+||||+|||+|.||+|++||...+..+.+.+|..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~-gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------------- 232 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKS-GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------------- 232 (592)
T ss_pred eecCcccccceecCCCcccChhHhccC-CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence 88644 777899999999999999754 589999999999999999999999999998888888876
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.+|. +|..+|.+++|||.+||..||.+|||++++|.|+||..
T Consensus 233 ----~~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----NEYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----cCcc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 2333 34568999999999999999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-58 Score=416.45 Aligned_cols=280 Identities=31% Similarity=0.499 Sum_probs=233.4
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.++||+|+||+||+++.++|++.||+|++++.. .....|..+|..++||+||+++..| ++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----cc
Confidence 34568999999999999999999999999999999886542 3345799999999999999999998 66
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+|+||+.| .|...|. ..+.+++..++.|+.+|+.||.|||+ +|||||||||||||+| ..|.|+|+|||
T Consensus 97 ~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd-~~GHi~LtDFg 170 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLD-EQGHIKLTDFG 170 (357)
T ss_pred CCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeec-CCCcEEEeccc
Confidence 6679999999996 5554444 46889999999999999999999999 6999999999999999 67889999999
Q ss_pred ccccc-ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+|+.. ..+....++|||+.|||||++.+. .|+..+|+|||||++|||++|.+||.+.+......+|.+.-.
T Consensus 171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------- 242 (357)
T KOG0598|consen 171 LCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------- 242 (357)
T ss_pred cchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-------
Confidence 99854 344556678999999999999876 499999999999999999999999999999888888876310
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC----CHHHHhcCCccccccCCCCC-CCCCCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPNAR-LPNGRPF 379 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~----t~~e~l~hp~f~~~~~~~~~-~~~~~~~ 379 (419)
...+..++.+++|||+++|+.||++|. ++.++-+||||..++|.... .....++
T Consensus 243 ---------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 243 ---------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred ---------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 112334799999999999999999996 68899999999999886532 1222233
Q ss_pred CC-------CCCchHHhhcCC
Q 014750 380 PP-------LFNFKQELAGAS 393 (419)
Q Consensus 380 ~~-------~~~~~~~~~~~~ 393 (419)
.| ..+|+.+++..+
T Consensus 302 ~P~~~~~~~~~~Fd~eft~~~ 322 (357)
T KOG0598|consen 302 KPNVTGLEDTSNFDNEFTSYT 322 (357)
T ss_pred ecCCCCccccccccHHHHhcc
Confidence 33 346666666553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-57 Score=424.89 Aligned_cols=258 Identities=33% Similarity=0.596 Sum_probs=229.0
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEecc-------CcccHHHHHHHHHhc-CCCCeeecceeeeccCC
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (419)
.....+|..++.||+|+|++|++|+++.+++.||||++.+ ...+..+|..+|..| +||.|++++..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF----- 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF----- 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence 4556789999999999999999999999999999998753 245567899999999 899999999988
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
+|+..+|+|+||++ |+|++++.++ +.|++..++.++.||+.||+|||+ +|||||||||||||+| .++++||+|
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd-~dmhikITD 217 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLD-KDGHIKITD 217 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEc-CCCcEEEee
Confidence 67777999999999 6888888875 779999999999999999999999 6999999999999999 788999999
Q ss_pred cccccccccCCc--------------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHH
Q 014750 224 FGSAKVLVKGEA--------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289 (419)
Q Consensus 224 fG~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 289 (419)
||.|+.+..... ..+++||..|.+||+|.. ...++.+|||+||||||+|+.|.+||.+.++.-.+
T Consensus 218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 999987643211 146899999999999965 45899999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
++|+++ +|. |+.++++.+.|||+++|..||.+|+|+.+|.+||||.+++|.
T Consensus 297 qkI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 297 QKIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred HHHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 999884 222 446789999999999999999999999999999999999987
Q ss_pred CC
Q 014750 370 NA 371 (419)
Q Consensus 370 ~~ 371 (419)
+-
T Consensus 348 nl 349 (604)
T KOG0592|consen 348 NL 349 (604)
T ss_pred hh
Confidence 63
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-57 Score=407.22 Aligned_cols=255 Identities=31% Similarity=0.555 Sum_probs=214.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.+.+.++.||+|+.|+||+++|+.|++.+|+|.|... .++..+|+++++..+|||||+++++|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 4677889999999999999999999999999999433 3445689999999999999999999965432 488
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+| +|...++. .+++++..+..++.+|++||.|||...+||||||||+||||+ ..|.|||||||.++.+
T Consensus 155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN-skGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN-SKGEVKICDFGVSGIL 229 (364)
T ss_pred eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec-cCCCEEeccccccHHh
Confidence 99999996 55554443 378999999999999999999999525999999999999999 5889999999999987
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCCHHHHh
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.+. ...+++||..|||||.+.+. .|+.++||||||+.++||++|++||... +..+.+..|+. .|+.
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP---- 300 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP---- 300 (364)
T ss_pred hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC----
Confidence 665 66789999999999999875 5999999999999999999999999874 34444444432 2221
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.+|+. +|+++++||..||++||.+|+|+.|+++|||+++....+
T Consensus 301 ---------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 301 ---------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ---------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 12333 799999999999999999999999999999999765443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=398.43 Aligned_cols=291 Identities=35% Similarity=0.690 Sum_probs=247.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCC-eeecceeeeccCC-CCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPN-VISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~ 148 (419)
..|..+++||+|+||+||+|+++.+|+.||+|++.-+.. ...+|+.+|+.++|+| ||.+++++.+... ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 458888899999999999999999999999999864432 3469999999999999 9999999865442 2334
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++|+||++-+|...+.........++...++.+++||+.||.|||+ +||+||||||.||||+ +++.+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~-~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLIS-SSGVLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEEC-CCCcEeeeccchHH
Confidence 689999999999888888755433567888999999999999999999 5999999999999999 58899999999998
Q ss_pred ccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... .....+..++|.||+|||+++|...|+...||||+|||++||+++++.|++..+.+++..|.+.+|+|..+.|+..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 765 3344567789999999999999988999999999999999999999999999999999999999999999999876
Q ss_pred C--cCCccccCCCCC-CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCC
Q 014750 308 N--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (419)
Q Consensus 308 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 371 (419)
. ++|.. .|+... ...+....+. .++++.||+.+||++||.+|.|++.+|+||||..+.....
T Consensus 249 ~~~~~~k~-~f~~~~~~~~l~~~~~~-~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 249 SSLPDYKA-PFPKWPGPKDLSSILPK-LDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred cccccccc-cCcCCCCccchHHhccc-cCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 4 33332 444444 4444444443 4689999999999999999999999999999998765543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=391.08 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=224.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....+|+..+.||.|+||+|.+++++.+|..+|+|++.+.. ....+|..+|+.+.||+++++.+.+ .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 45678999999999999999999999999999999886543 3345799999999999999999988 77
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..++|+||||++| .|...++ ..+++++..++.++.||+.||+|||+ ++|++|||||||||+| .+|.+||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD-~~G~iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLD-QNGHIKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeec-cCCcEEEEecc
Confidence 7789999999996 4555554 46889999999999999999999999 6999999999999999 68889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+|+..... ..+.||||.|+|||++...+ |+.++|+|||||++|||+.|.+||...+......+|+..
T Consensus 190 FAK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~---------- 256 (355)
T KOG0616|consen 190 FAKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG---------- 256 (355)
T ss_pred ceEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC----------
Confidence 99876433 67899999999999997754 999999999999999999999999999999999999873
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~ 370 (419)
++. +|..++.+++|||+++|++|-.+|. ...++.+||||+++.|..
T Consensus 257 -------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 257 -------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred -------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 222 4566899999999999999999994 567999999999988764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-55 Score=409.94 Aligned_cols=261 Identities=33% Similarity=0.525 Sum_probs=220.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|.+++.||+|+||.||+|+.+.||+.||+|++++... ....|.++|...++++||+++..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 356789999999999999999999999999999999976532 234688899999999999999999 77
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..++||||||++| ++..+|.. .+.|++..++.++.+++.|++.||++ |+|||||||+|+||| ..|++||+|||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD-~~GHiKLSDFG 286 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLID-AKGHIKLSDFG 286 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeec-CCCCEeecccc
Confidence 8889999999996 44444443 57899999999999999999999995 999999999999999 68889999999
Q ss_pred ccccccc------------------------CC-----c-------------------ceeeeeccccccchhhcCCCCC
Q 014750 226 SAKVLVK------------------------GE-----A-------------------NISYICSRYYRAPELIFGATEY 257 (419)
Q Consensus 226 ~a~~~~~------------------------~~-----~-------------------~~~~~~t~~y~aPE~~~~~~~~ 257 (419)
+|..... .. . ..+.+|||.|||||++++.. |
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y 365 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-Y 365 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-C
Confidence 9853211 00 0 02468999999999999866 9
Q ss_pred CCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHH
Q 014750 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 337 (419)
Q Consensus 258 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 337 (419)
+..+|+||||||+||||.|.+||.+.+..+...+|+..... +.+|.. ..++++++
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~----------~~~s~eA~ 420 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEE----------VDLSDEAK 420 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCc----------CcccHHHH
Confidence 99999999999999999999999999999999999874211 122211 24689999
Q ss_pred HHHhhhcccCCCCCCC---HHHHhcCCccccccCCCCC
Q 014750 338 DLASRLLQYSPSLRCT---ALEACAHPFFDELREPNAR 372 (419)
Q Consensus 338 dli~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~~ 372 (419)
|||.+||+ ||.+|.. ++||..||||+.++|..-.
T Consensus 421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 99999999 9999985 8999999999999987643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-55 Score=417.83 Aligned_cols=256 Identities=33% Similarity=0.531 Sum_probs=228.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..+-|++++.||.|+.|.|.+|++..||+..|||+|.+. ....++|+-+|+.+.|||++++++++ ++.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccC
Confidence 445699999999999999999999999999999999766 44567999999999999999999999 667
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.++|+|.||++| .|++.+. ..+++++.+++.+++||+.|+.|||.+ +|+||||||+|+|+|. .++|||+|||+
T Consensus 85 ~~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~-~~nIKIADFGM 158 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDV-KNNIKIADFGM 158 (786)
T ss_pred ceEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhc-ccCEeeeccce
Confidence 779999999995 5555554 468899999999999999999999995 9999999999999995 55599999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
|.....+....+.||++.|.|||++.|..+.+.++||||+|||||.||||+.||.+.+-...+.++.++
T Consensus 159 AsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G----------- 227 (786)
T KOG0588|consen 159 ASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG----------- 227 (786)
T ss_pred eecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-----------
Confidence 998888888888999999999999999998899999999999999999999999988888888877663
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.|. +|..++.+++|||++||.+||.+|+|.+||+.|||+.+.....
T Consensus 228 ------~f~------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 228 ------VFE------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ------ccc------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 222 3457899999999999999999999999999999998876544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=414.10 Aligned_cols=284 Identities=30% Similarity=0.514 Sum_probs=237.5
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc-------HHHHHHHHHhcC-CCCeeecceeeeccCC
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (419)
+....+|.+.++||+|.||+|++|..+.+++.||||.++++.-. ...|.+|+...+ ||++++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 45567899999999999999999999999999999998876432 235777777664 99999999999
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...++|+||||+.|+. +.+ ....+.+++..++.|+.+|+.||+|||+ +||||||||.+|||+| ..|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD-~eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLD-TEGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEc-ccCcEEeccc
Confidence 66667999999999873 332 2335789999999999999999999999 6999999999999999 5778999999
Q ss_pred ccccccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 225 GSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 225 G~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
|+++... .+....++|||+.|||||++.+. .|+.++|+|||||+|||||.|..||.+.++.+....|+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9998764 55667789999999999999764 599999999999999999999999999999999998876
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccCCCC-CCCCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPNA-RLPNGR 377 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~~-~~~~~~ 377 (419)
.+.. +|..+|.++.++++++|.+||++|..+ ++|..||||+.++|..- ......
T Consensus 583 --------d~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 583 --------DEVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred --------CCCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 2222 345689999999999999999999865 78999999999987642 222223
Q ss_pred CCCC-------CCCchHHhhcCCHHHH
Q 014750 378 PFPP-------LFNFKQELAGASPELI 397 (419)
Q Consensus 378 ~~~~-------~~~~~~~~~~~~~~~~ 397 (419)
|+.| +-||+++++...+.+-
T Consensus 643 Pf~P~i~~~~D~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 643 PFVPTIKGPEDVSNFDEEFTSEKPALT 669 (694)
T ss_pred CCCcccCChhhhcccchhhhcCCCccC
Confidence 3333 4588888888766554
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-54 Score=412.98 Aligned_cols=279 Identities=35% Similarity=0.635 Sum_probs=230.3
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHH---HHHHHHHhcC------CCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMD------HPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~e~~~l~~l~------h~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.|.+|.+..|++.||||+++....+.. .|+.+|..|+ .-|+|+++++|+. ..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----cc
Confidence 68999999999999999999999999999999987765554 5888998886 3489999999954 45
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-CCCceEEeecccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a 227 (419)
++|||+|+++.+|+++++.... ..++...++.++.||+.||.+||+ .||||+|||||||||.. ....|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 5999999999999999997654 459999999999999999999999 59999999999999862 3457999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ....+++.++.|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.++.+++..|+.++|.|+...++..
T Consensus 339 c~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 8653 3334889999999999999866 999999999999999999999999999999999999999999998877643
Q ss_pred CcCCcccc----CCCC------------------------------CCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC
Q 014750 308 NPNYTDFR----FPQI------------------------------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (419)
Q Consensus 308 ~~~~~~~~----~~~~------------------------------~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 353 (419)
......+. ++.. ....+.......-...+.|||++||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 22111110 0000 1112222222223456799999999999999999
Q ss_pred HHHHhcCCcccccc
Q 014750 354 ALEACAHPFFDELR 367 (419)
Q Consensus 354 ~~e~l~hp~f~~~~ 367 (419)
+.++|+||||....
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=394.46 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=219.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+.. .....|+.+|+.++|||||.++++. ++..
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 4467999999999999999999999999999999987653 2335799999999999999999999 6666
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--C---CceEEe
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--T---HQVKLC 222 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~---~~vkl~ 222 (419)
++|+|||||. |+|.+.++. .+.+++..++.++.||+.||++||+ ++||||||||.||||+.. + -.+||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 7999999999 566666665 4689999999999999999999999 799999999999999842 1 469999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|||+|+....+....+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|+.||...+..+.+..+.+.-.
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~----- 231 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE----- 231 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence 9999999988888888999999999999965 4599999999999999999999999999998888775543211
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
....++..++....+|+...|+.|+..|.+..+-+.|+++..
T Consensus 232 ---------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ---------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 112234456778889999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=405.44 Aligned_cols=253 Identities=33% Similarity=0.510 Sum_probs=218.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC---------cccHHHHHHHHHhcC-CCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMD-HPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 143 (419)
...+.|.+.+.||+|+||+|++|++..+|+.||+|++.+. .....+|+.+++.++ ||||+++++++.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-- 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-- 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence 3456799999999999999999999999999999976543 123347999999999 9999999999944
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
...+|+|||||.| .|++.+.. .+++.+..++.+++||+.|++|||+ +||+||||||||||++...+++||+
T Consensus 92 ---~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 92 ---PTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred ---CCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence 4449999999996 66666654 5789999999999999999999999 6999999999999999433889999
Q ss_pred eccccccc-ccCCcceeeeeccccccchhhcCCC-CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 223 DFGSAKVL-VKGEANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 223 DfG~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|||++... ..+....+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+......+|.+.
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----- 238 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----- 238 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-----
Confidence 99999987 4566777899999999999998876 5579999999999999999999999998877777776542
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCC-ChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.+. ++..+ |+++++||++||..||.+|+|+.++++||||+.
T Consensus 239 ------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 239 ------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 222 33456 999999999999999999999999999999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=379.60 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=215.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
...+|++.++||+|.||.||++.+..+|..+|.|.+.-+ +...-.|+.+|+.|+|||||++++.-+. ++..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccch
Confidence 445799999999999999999999999999999988622 2333479999999999999999884332 3344
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc--CC-CcccccccCCceeeCCCCCceEEeec
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT--VP-GVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~-~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
.++||||||+ |+|.+.++++......+++..+|.++.|+|.||..||. -+ -|+||||||.||+|+ .+|.|||+||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDf 172 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDF 172 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccc
Confidence 4889999999 79999999999999999999999999999999999998 22 289999999999999 6889999999
Q ss_pred ccccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 225 GSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 225 G~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
|+++.+..... ..+++|||+||+||++.+.+ |+.++||||+||++|||+.-++||.+.+-.+.-.+|.++--.|.
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--- 248 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--- 248 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC---
Confidence 99998765543 45789999999999998755 99999999999999999999999999988777777766411111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
| ...+|.++..||..|+..||..||+. +|++.++.
T Consensus 249 -------------p-----------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 249 -------------P-----------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred -------------c-----------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 1 13468999999999999999999986 55555443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=367.99 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=219.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEecc------CcccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+.|.+.+.||+|.|+.|+++.+..+|+.+|+|++.. +....++|+.|.+.|+|||||++++.+ ..+.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 83 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence 44679999999999999999999999999999998742 234456899999999999999999988 7777
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG 225 (419)
+.|||+|++.| .|...+-.+ ..+++..+-.+++||++||.|+|. +||||||+||+|+|+-++ +.-+||+|||
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred eeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccc
Confidence 89999999996 555554432 567899999999999999999999 799999999999999643 3469999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+|.....+..-..++|||.|||||++...+ |+..+|||+.|||||-|+.|.+||.+.+.....+.|++..-.
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd------- 230 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD------- 230 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC-------
Confidence 999887666667789999999999997654 999999999999999999999999999998899988874222
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
++. . ..+.+++++++||++||..||.+|+|+.|+|+|||+++-
T Consensus 231 ----------~~~---~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 231 ----------YPS---P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred ----------CCC---c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 211 1 124579999999999999999999999999999999863
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=383.33 Aligned_cols=277 Identities=33% Similarity=0.636 Sum_probs=232.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||.|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 456999999999999999999999999999999886332 2345799999999999999999988 445568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||++++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLIN-EKGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEECcCcceeec
Confidence 999999999888777542 3457899999999999999999999 6999999999999999 6788999999999754
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.|+...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3222 22345779999999998776668999999999999999999999999999999999999999999998887653
Q ss_pred -cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+..+.++.....++... ...++.++.|||++||++||.+|+|++|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2344444554444444332 23578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=378.48 Aligned_cols=271 Identities=27% Similarity=0.454 Sum_probs=225.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....+|++++.||.|.-|+||+|+...++..+|+|++.+.. .....|.+||+.++||.++.++..| +.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence 34457999999999999999999999999999999986542 2234699999999999999999999 77
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
+.+.|+|||||+|+-+..+++ .+.++.+++..++.|+.+++.||+|||.+ |||+||||||||||. ++|+|.|+||.+
T Consensus 149 ~~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvr-edGHIMLsDFDL 225 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVR-EDGHIMLSDFDL 225 (459)
T ss_pred cceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEe-cCCcEEeeeccc
Confidence 778999999999754445544 34578899999999999999999999995 999999999999999 688899999998
Q ss_pred cccccc---------------------------------C-C-----------------------cceeeeeccccccch
Q 014750 227 AKVLVK---------------------------------G-E-----------------------ANISYICSRYYRAPE 249 (419)
Q Consensus 227 a~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aPE 249 (419)
+..... . . ...+++||-.|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 743200 0 0 012468999999999
Q ss_pred hhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcC
Q 014750 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 329 (419)
Q Consensus 250 ~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
++.|.. .+.++|||+|||++|||++|..||.+.+..+.+.+|+.. +..||..
T Consensus 306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~---------- 357 (459)
T KOG0610|consen 306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE---------- 357 (459)
T ss_pred eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------
Confidence 998866 799999999999999999999999999999999888752 2234332
Q ss_pred CCCChhHHHHHhhhcccCCCCCCC----HHHHhcCCccccccCCCCCCCCCCCCC
Q 014750 330 KRMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPFP 380 (419)
Q Consensus 330 ~~~s~~~~dli~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~ 380 (419)
..++..++|||+++|.+||++|+. |+||.+||||++++|+.-+.......|
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 146889999999999999999998 999999999999999864433333333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=379.35 Aligned_cols=259 Identities=32% Similarity=0.547 Sum_probs=209.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..+|...+.||+|+||.||++.+..+|+.+|||.+... .....+|+.+|+.++|||||++++...... ...++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeE
Confidence 34688899999999999999999999999999988665 334579999999999999999998642221 14689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|.|||+++ +|.+.+..+. +.+++..++.+.+||++||.|||+ +|||||||||+|||++..++.+||+|||+++..
T Consensus 93 i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999995 6666666532 279999999999999999999999 699999999999999954688999999999876
Q ss_pred cc----CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHh
Q 014750 231 VK----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.. ........||+.|||||++........++|||||||++.||+||..||... ...+.+..+.. ..
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---~~------ 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---ED------ 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---cC------
Confidence 53 222446789999999999975332345999999999999999999999873 32222222221 00
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. ..++..++.++++||.+||.+||++||||+++|+|||.+....
T Consensus 240 ---------~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 ---------SL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---------CC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 01 1356678999999999999999999999999999999976443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=390.56 Aligned_cols=249 Identities=30% Similarity=0.550 Sum_probs=218.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc------HHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+. ..+|+++++.++|||||.++++| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 3688999999999999999999999999999998765433 45899999999999999999999 666669
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|.|||.|+|..++.. .+.++++.++.++.+++.||.|||+ .+|+|||+||.|||++ .++.+|+||||+|+.+
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLE-KGGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeec-CCCceeechhhhhhhc
Confidence 99999999988887765 6889999999999999999999999 6999999999999999 7889999999999988
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..+.. .+...|||.|||||++.+ ..|+..+|+||||||+|||++|++||......+....|.+- |.
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v--------- 217 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV--------- 217 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC---------
Confidence 66544 345679999999999976 45999999999999999999999999987766666666541 11
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. ++..++.++..|+..+|++||.+|+|..+++.|||+++-
T Consensus 218 -----~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 218 -----K------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred -----C------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 1 234679999999999999999999999999999999863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=334.83 Aligned_cols=276 Identities=36% Similarity=0.683 Sum_probs=236.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.|.-.++||+|.||+||+|++..+++.||+|.+.-+. ....+|+-+++.++|.|||+++++. ..+..+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4666789999999999999999999999999986443 2346899999999999999999988 4444588
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|+|||..+|...+.. .++.+..+.++.++.|+++||.|+|++ ++.||||||.|+||+ .++.+||+|||+++.+.
T Consensus 78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin-~ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLIN-RNGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEec-cCCcEEecccchhhhcC
Confidence 9999999876666554 468899999999999999999999995 999999999999999 79999999999998764
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
-.- .....+.|.||++|.++.|..-|++..|+||.|||+.|+.. |++.|++.+..+++..|.+.+|+|..+.|+.+.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 322 22345679999999999999999999999999999999997 999999999999999999999999999999875
Q ss_pred -cCCccccCCCCC-CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 -PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
++|..+ |... ...|.+..| +++...+||++++|.-+|.+|++++++++||||.+.
T Consensus 233 lpdyk~y--p~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 LPDYKPY--PIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCCccc--CCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 344433 3222 234555554 478889999999999999999999999999999863
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=380.03 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=215.4
Q ss_pred CCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------------ccHHHHHHHHHhcCCCCe
Q 014750 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRLMDHPNV 132 (419)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~e~~~l~~l~h~ni 132 (419)
..-+...+|++.+.||+|.||+|.+|++..+++.||||++.+.. ....+|+.+|+++.|+||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34456778999999999999999999999999999999985432 123479999999999999
Q ss_pred eecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
|+++++.-+ .....+|||+|||..+ .+.........+++.+++.|++.++.||+|||. +|||||||||+|+||
T Consensus 171 V~LiEvLDD---P~s~~~YlVley~s~G---~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDD---PESDKLYLVLEYCSKG---EVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecC---cccCceEEEEEeccCC---ccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEE
Confidence 999999733 3445699999999955 233322223339999999999999999999999 699999999999999
Q ss_pred CCCCCceEEeecccccccccC------CcceeeeeccccccchhhcC---CCCCCCcccEeehhHHHHHHHhCCCCCCCC
Q 014750 213 DPLTHQVKLCDFGSAKVLVKG------EANISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (419)
Q Consensus 213 ~~~~~~vkl~DfG~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (419)
+ ++++|||+|||.+.....+ ......+|||.|+|||...+ ....+.+.||||+||+||.|+.|+.||-+.
T Consensus 244 ~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 244 S-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred c-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9 6789999999999765222 12234789999999999876 234578999999999999999999999999
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...+...+|+.. ...||.. ..+.++++|||.+||++||.+|+++.++..|||.
T Consensus 323 ~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 323 FELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred hHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 999998888762 2223321 1368999999999999999999999999999999
Q ss_pred ccc
Q 014750 364 DEL 366 (419)
Q Consensus 364 ~~~ 366 (419)
..-
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=379.53 Aligned_cols=283 Identities=33% Similarity=0.563 Sum_probs=224.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence 457999999999999999999999999999999886432 2345799999999999999999998 444568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.+++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLIS-DTGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECCCCcceec
Confidence 99999999988877764 23568899999999999999999999 6999999999999999 6788999999998754
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+. +..+.+..+....+.+....|....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 22234567999999999877666899999999999999999999999875 4456777777778888776665432
Q ss_pred c--CCccccCCCCCCCCchhhcCC-CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 309 P--NYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 309 ~--~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
. .+....+.......+...+.. .++.++.|||++||+.||++|+|+.|+++||||+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 1 111111111111122222211 34678999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=384.28 Aligned_cols=319 Identities=36% Similarity=0.641 Sum_probs=245.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999999999999999886321 2245799999999999999999988655444445689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||||+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILAN-ADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCcEEEccCccccccc
Confidence 9999999888777654 3568999999999999999999999 6999999999999999 67889999999997543
Q ss_pred cCCc----ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGEA----NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....|.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1245789999999998642 4589999999999999999999999999998888888888889888776554
Q ss_pred cCcCCc-cc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 014750 307 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF 383 (419)
Q Consensus 307 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~ 383 (419)
+..... .+ .+......++...++ .+++++.+||.+||+.||++|||++++++||||+.+...... +..++... .
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~-~ 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITK-L 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCcccc-c
Confidence 321100 00 000011111222222 468899999999999999999999999999999987664322 33333322 2
Q ss_pred CchHHhhcCCHHHHhhhcHHHH
Q 014750 384 NFKQELAGASPELINRLIPEHV 405 (419)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~ 405 (419)
.|..+....+.+.+...+.+++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~ 333 (338)
T cd07859 312 EFEFERRRLTKEDVRELIYREI 333 (338)
T ss_pred cccHHHHhcCHHHHHHHHHHHH
Confidence 4444455667777777777664
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=370.69 Aligned_cols=273 Identities=27% Similarity=0.444 Sum_probs=222.0
Q ss_pred CCCCCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeecc
Q 014750 68 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 68 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (419)
.+...+...+.|++..+||.|..++||+|++..+++.||||++.-+. ....+|+..|+.++||||++++.+|...
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34455667788999999999999999999999999999999996332 3456899999999999999999999544
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
..+|+||.||. |+++++++.+.. ..+.|..++.|++++++||.|||+ +|-||||||+.||||+ .+|.|||
T Consensus 97 -----~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~-~dG~VkL 167 (516)
T KOG0582|consen 97 -----SELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILID-SDGTVKL 167 (516)
T ss_pred -----ceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEc-CCCcEEE
Confidence 44999999999 688888887654 459999999999999999999999 6999999999999999 6889999
Q ss_pred eecccccccccCC-cc----eeeeeccccccchhh-cCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 222 CDFGSAKVLVKGE-AN----ISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 222 ~DfG~a~~~~~~~-~~----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
+|||.+..+.... .. .+++||++|||||++ .....|+.|+|||||||+..||.+|..||.......++.. +.
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tL 245 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TL 245 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--Hh
Confidence 9999876653322 11 456899999999995 4445699999999999999999999999998877665543 33
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+.|+.-..... ...-...++..++++|..||+.||.+|||++++|+|+||+....
T Consensus 246 qn~pp~~~t~~~-----------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 246 QNDPPTLLTSGL-----------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cCCCCCcccccC-----------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 344442111000 00011245779999999999999999999999999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=360.58 Aligned_cols=257 Identities=31% Similarity=0.526 Sum_probs=220.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------------cccHHHHHHHHHhc-CCCCeeecceeeeccCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (419)
.|.-.+.||+|..++|.++.++.+|..+|+|++... .....+|+.+|+++ .||+|+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 477788999999999999999999999999988421 11223689999987 699999999999
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
+.+.++++|+|+|+ |.|++.|.. .-.+++...+.|++|+++|+.|||. ++||||||||+|||++ ++.+|||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILld-dn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLD-DNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeec-cccceEEec
Confidence 77788999999999 677766654 5679999999999999999999999 7999999999999999 788999999
Q ss_pred cccccccccCCcceeeeeccccccchhhcC-----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
||+|..+..++.....||||.|+|||.+.. .+.|+..+|+||+|||+|.|+.|.+||......-++..|+.+.-.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999854 345899999999999999999999999888777778877763211
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
|.-| .| .+++.+.+|||++||++||.+|+|++|+|+||||..+....
T Consensus 247 ---------------F~sp-----eW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 247 ---------------FRSP-----EW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred ---------------cCCc-----ch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 1111 22 34689999999999999999999999999999997765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-51 Score=385.82 Aligned_cols=250 Identities=29% Similarity=0.503 Sum_probs=214.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..|....+||+|+.|.||.|+...+++.||||++... +....+|+.+|+..+|+|||.+++.|... ..+++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 4588889999999999999999999999999988543 33445899999999999999999998654 33899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||++| +|.+.+.. ..++|.+++.++++++.||+|||. +||+|||||.+|||++ .++.+||+|||+|..+.
T Consensus 348 VMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~-~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLT-MDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEec-cCCcEEEeeeeeeeccc
Confidence 9999996 55555543 569999999999999999999999 7999999999999999 67889999999998776
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... ...+.+||++|||||++.. ..|++++||||||+++.||+-|.+||-..+....+..|.. -|+|...
T Consensus 421 ~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk-------- 490 (550)
T KOG0578|consen 421 EEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK-------- 490 (550)
T ss_pred cccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC--------
Confidence 554 4567899999999999965 4599999999999999999999999998777766666554 3444321
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.++.+|++++||+.+||+.|+.+|++|.|+|+||||+.
T Consensus 491 -----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 -----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 23568999999999999999999999999999999953
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=370.17 Aligned_cols=279 Identities=34% Similarity=0.586 Sum_probs=223.4
Q ss_pred ceeeeceeccCCceEEEEEEEcC-CCcEEEEEEeccCc------ccHHHHHHHHHhc---CCCCeeecceeeeccCCCCc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~ 147 (419)
+|++.+.||+|+||+||+|++.. +++.||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999854 46889999885332 1234677777665 69999999998754443445
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEc-CCCCEEEccccce
Confidence 5689999999998888776432 3458999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876544444556789999999999764 4899999999999999999999999999999999999998888877665432
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.. +....+......++.... ..+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCHHHHc-cCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11 111112222222333332 3478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=368.94 Aligned_cols=275 Identities=37% Similarity=0.716 Sum_probs=223.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 6999999999999999999999999999999886432 2345799999999999999999988 4555689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+.+++++.+.. ....+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEEeeccCccccc
Confidence 9999999887766643 24568999999999999999999999 6999999999999999 67889999999998754
Q ss_pred cCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc--
Q 014750 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307 (419)
Q Consensus 232 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 307 (419)
... ......|++.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+..+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 223457899999999997654 899999999999999999999999998888888888888887776655432
Q ss_pred CcCCccccCCCCC-CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 308 NPNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 308 ~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
++.+....++... ...+...+...++.++.|||++||++||++|+|++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 2222222222211 1122233344578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=351.40 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=210.1
Q ss_pred ccceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHh-cCCCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
+++|.+. ++||-|-.|+|..+.++.||+.||+|++. +.....+|+++--. -.|+|||.++++|.... .+..++.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence 3457664 68999999999999999999999999664 44456678887444 46999999999985433 356678899
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeeccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVL 230 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~~~ 230 (419)
||++.| .|+..+... ....+++.++..|+.||+.|+.|||++ +|.||||||||+|... .+..+||+|||+|+..
T Consensus 138 mE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999996 455554442 346799999999999999999999995 9999999999999963 3457999999999987
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHHhc
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 306 (419)
.......+.+.|++|.|||++ |...|+..+|+||+|||+|.|++|.+||...... .+..+|...
T Consensus 215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g----------- 282 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG----------- 282 (400)
T ss_pred CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc-----------
Confidence 655666678899999999998 6667999999999999999999999999876432 233333332
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.|.||+- .| +.+|++++|+|+++|..+|.+|.|+.+++.|||+.....
T Consensus 283 ------qy~FP~p---EW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 283 ------QYEFPEP---EW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ------CccCCCh---hH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 2233321 12 236999999999999999999999999999999987543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=368.55 Aligned_cols=249 Identities=26% Similarity=0.463 Sum_probs=220.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+|++.+.||.|.||+|.+|+....|+.||||.|.++.. ...+|++||..|+||||+.++++| ++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence 44589999999999999999999999999999998876532 245899999999999999999999 556
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+.|||||.. |.|++.+.. .+.+++.+++.+++||.+|+.|||+ ++++|||||.+|||+| .++++||+|||+
T Consensus 126 dKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD-~N~NiKIADFGL 199 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLD-QNNNIKIADFGL 199 (668)
T ss_pred ceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeec-CCCCeeeeccch
Confidence 66999999998 567777665 5789999999999999999999999 6999999999999999 688899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+..+.......++||++.|.+||++.|.++-++.+|-|||||+||.|++|..||.+.+...++.+|.+.
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G----------- 268 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG----------- 268 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------
Confidence 999988888899999999999999999888899999999999999999999999999988888887663
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.|.-| .-+.++.-||++||.+||.+|.|++++-.|=|.+
T Consensus 269 ------aYrEP-------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 ------AYREP-------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------cccCC-------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11111 2367899999999999999999999999996654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=356.54 Aligned_cols=286 Identities=37% Similarity=0.636 Sum_probs=229.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..|++.+.||+|.||.||+|....++. .+|||+|+.... ..-||+.+++.++|+||+.+..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 469999999999999999996555433 689999875522 235899999999999999999998642
Q ss_pred ceeEEEEeecccccHHHHHHhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC---CCceEEe
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLC 222 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~~vkl~ 222 (419)
+..+++++||.+.+|++.++.... ....++...++.|+.||+.|+.|||+ +.|+||||||.||||..+ .|.|||+
T Consensus 100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEee
Confidence 556999999999999999986543 34678999999999999999999999 799999999999999732 3899999
Q ss_pred ecccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC---------HHHHH
Q 014750 223 DFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQL 289 (419)
Q Consensus 223 DfG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---------~~~~~ 289 (419)
|||+++.+.+.-. ....+.|.||+|||.++|...|+++.||||+|||+.||+|-.+.|.+.. ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998754322 2235679999999999999999999999999999999999999997643 35789
Q ss_pred HHHHHHhCCCCHHHHhccC--cCCc----cccCCCCCCCCchhhcC--CCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 290 VEIIKVLGTPTREEIRCMN--PNYT----DFRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
..|++++|.|..+.|+.+. +.+. ++.-.......+...+. ..-++.+.+|+.+||++||.+|+|++++|+|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 9999999999999998764 2221 11100111111222221 12356699999999999999999999999999
Q ss_pred cccccc
Q 014750 362 FFDELR 367 (419)
Q Consensus 362 ~f~~~~ 367 (419)
||++-.
T Consensus 339 yF~~d~ 344 (438)
T KOG0666|consen 339 YFTEDP 344 (438)
T ss_pred ccccCC
Confidence 998743
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=372.17 Aligned_cols=283 Identities=33% Similarity=0.636 Sum_probs=233.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ..+...
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-----HTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCeE
Confidence 357999999999999999999999999999999886332 2345799999999999999999998 444568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLIN-ERGELKLADFGLARAK 154 (309)
T ss_pred EEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECccccceec
Confidence 999999999887776542 3568899999999999999999999 6999999999999999 5778999999998754
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....|+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 3222 223356789999999987766689999999999999999999999999999999999999999999888876532
Q ss_pred --CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 310 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.+.++.++......+.... ..++.++.+||.+||+.||.+|+|++|+++||||+.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred hhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 2223334433333332222 3478999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=377.86 Aligned_cols=257 Identities=32% Similarity=0.541 Sum_probs=220.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcC-CCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 146 (419)
....|.+.+.||+|.||+||+++++.+|+.+|+|.+.+... ...+|+.+|+.+. |||||.+++.| ++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence 44579999999999999999999999999999999975432 5568999999998 99999999999 55
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC---CceEEe
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLC 222 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~ 222 (419)
...+++|||+|.| .|++.+... .+++..+..++.|++.+++|||+ .||+||||||||+|+.... +.+|++
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEe
Confidence 5579999999994 666666653 39999999999999999999999 6999999999999997542 479999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|||++.....+......+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+......++.+.
T Consensus 182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~------- 253 (382)
T KOG0032|consen 182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG------- 253 (382)
T ss_pred eCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-------
Confidence 9999998877666778899999999999965 45999999999999999999999999999988888777653
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
++.| ... ..+.++..++|||++||..||.+|+|+.++|+|||++....
T Consensus 254 ----------~~~f---~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 254 ----------DFDF---TSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred ----------CCCC---CCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 1111 111 22457999999999999999999999999999999987643
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=343.20 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=222.1
Q ss_pred CCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
.....++|.+++.||+|-||.||+|+.+.++-.||+|++.+.. ....+|++|-..|+||||++++++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f----- 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF----- 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----
Confidence 3456678999999999999999999999999999999886542 3455899999999999999999999
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.+...+||++||.. |.++..|... ...++++...+.++.|++.||.|||. ++||||||||+|+|++ ..+.+||+|
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg-~~~~lkiAd 167 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLG-SAGELKIAD 167 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccC-CCCCeeccC
Confidence 55666999999998 6777777642 35678999999999999999999999 7999999999999999 678899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||.+.... .....+.|||..|.+||...+.. ++..+|+|++|++.||++.|.+||...+..+....|.+.
T Consensus 168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------- 237 (281)
T KOG0580|consen 168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------- 237 (281)
T ss_pred CCceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------
Confidence 99997654 45567889999999999997754 899999999999999999999999999888888888773
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
++. +|..++.++.|||.+||..+|.+|.+..|++.|||+..
T Consensus 238 ---------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 ---------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 222 34568999999999999999999999999999999865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-49 Score=381.39 Aligned_cols=284 Identities=33% Similarity=0.564 Sum_probs=225.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999885431 2345799999999999999999988543322223689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVN-SNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEEC-CCCCEEeccccceeecc
Confidence 9999999887776643 4679999999999999999999999 6999999999999999 67889999999997653
Q ss_pred cCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 232 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 122346789999999998766689999999999999999999999999999999999999999998876543221
Q ss_pred CCccccCCCCCC-CCch--hhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 310 NYTDFRFPQIKA-HPWH--KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 310 ~~~~~~~~~~~~-~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
............ ..+. ..+....++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 110000000000 0000 012334688999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=375.64 Aligned_cols=286 Identities=32% Similarity=0.565 Sum_probs=228.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 457999999999999999999999999999999886432 223478999999999999999998754322 2334
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||+++++.+.+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEEC-CCCcEEEEeCCCcc
Confidence 589999999998877664 247888899999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...+++..++.+..+.+....
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 76544444556789999999999764 48999999999999999999999999999999999999999998876655433
Q ss_pred cC----------CccccCCCCC---CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 309 PN----------YTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 309 ~~----------~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.. +..+.+..+. ..++........+.++++||.+||+.||.+|||+.++|+||||..+..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 22 1111111000 00111111222467899999999999999999999999999998765554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=377.95 Aligned_cols=286 Identities=32% Similarity=0.558 Sum_probs=225.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 457999999999999999999999999999999986431 223479999999999999999998854322 1223
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||+++++.+.+. ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEecCCCcc
Confidence 578999999998776653 347888999999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+.++.+....+....
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 65444444556789999999999764 48999999999999999999999999999989999999999988876543321
Q ss_pred c----------CCccccCCCCC-CC--CchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 309 P----------NYTDFRFPQIK-AH--PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 309 ~----------~~~~~~~~~~~-~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
. .+....+.... .. +.........+.++.+||.+||+.||++|||+.|+|+||||..+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 1 11111110000 00 000011123477899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=363.90 Aligned_cols=279 Identities=31% Similarity=0.553 Sum_probs=223.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhc---CCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM---DHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999886431 1234677777655 799999999988654444456
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++++|||+.+++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~-~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVT-SGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECccCccc
Confidence 689999999998877776432 2458999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............+|..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+.++....+.+....|....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76544444456789999999999764 48999999999999999999999999998888999999988887766654311
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
......+.......+.... ..++.++.+||.+||+.||.+|||+.+++.||||
T Consensus 236 -~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 -TLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -cccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0001111111122222222 3578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=370.39 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=231.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+-|.+.+.||+|-|++|.+|++.-||+.||||+|.+... ...+|+..|+.+.|||||++|++. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 34459999999999999999999999999999999976543 234799999999999999999988 3344
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|||+|+-++ +|++++.+ ....+.+..++.|++||+.|+.|||+. .+|||||||||+.+-..-|-|||+|||++
T Consensus 91 KlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred eEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeecccc
Confidence 49999999884 88887765 357799999999999999999999995 99999999999998877889999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..+..+....+.||+..|-|||+++|..+..+++||||||||||-|++|++||...++.+.+.+|+.+.
T Consensus 167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK----------- 235 (864)
T KOG4717|consen 167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK----------- 235 (864)
T ss_pred ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-----------
Confidence 999999999999999999999999999877899999999999999999999999999999999998752
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 372 (419)
|. +|..++.+++|||..||..||.+|.+.++|..|+|++.++.....
T Consensus 236 ------Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 236 ------YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred ------cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 22 345689999999999999999999999999999999988776543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=373.80 Aligned_cols=285 Identities=33% Similarity=0.577 Sum_probs=227.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 457999999999999999999999999999999886432 223468999999999999999998754332 2234
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||+++++.+.+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~-~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEC-CCCCEEEeeCcccc
Confidence 578999999998776664 247888999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+.++.+..+.+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 76544444556889999999999764 48999999999999999999999999999999999999999988776655433
Q ss_pred cC----------CccccCCCCCC---CCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 309 PN----------YTDFRFPQIKA---HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 309 ~~----------~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
+. +....++.... .+.........+.++.+||.+||+.||++|||+.|+|+||||..+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 21 11111111100 011111223346789999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=363.74 Aligned_cols=285 Identities=32% Similarity=0.613 Sum_probs=232.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCe
Confidence 3457999999999999999999999999999999886332 2345799999999999999999998 44556
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLIN-ERGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEEC-CCCcEEECcCcchhc
Confidence 8999999999887777542 3568899999999999999999999 6999999999999999 577899999999875
Q ss_pred cccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+.++.+....|+...
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 43222 22334678899999998776668899999999999999999999999999989999999999988887776532
Q ss_pred --cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 309 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 309 --~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
..+..+.++......+. .....+++++++||.+||+.||.+|||++|+++||||+.+.+.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred ccccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 12223333333222221 22345788999999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=374.99 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=199.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
....+|...+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++|+||+++++++ .+..
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 145 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG 145 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence 34467999999999999999999999999999999986432 2345799999999999999999988 4555
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||+.++.+. . .....+..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 146 ~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~~~~kL~DfG~~~ 216 (353)
T PLN00034 146 EIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLIN-SAKNVKIADFGVSR 216 (353)
T ss_pred eEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEc-CCCCEEEcccccce
Confidence 689999999975321 1 2345677888999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCC-cceeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
...... ......||..|+|||++... ..++.++|||||||++|+|++|+.||......+....+.......
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---- 292 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ---- 292 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence 654322 23346789999999987431 234578999999999999999999997443222222221110000
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
....+..++.++.+||.+||..||++|||+.|+++||||..-.
T Consensus 293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0012234688999999999999999999999999999998743
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=371.08 Aligned_cols=252 Identities=28% Similarity=0.442 Sum_probs=210.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+|.+.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence 4467999999999999999999999999999999886432 2245799999999999999999988 445
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLD-NKGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEC-CCCCEEEeeccC
Confidence 569999999985 66665553 4578999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9865332 3356789999999999764 4799999999999999999999999887766655554431
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
... ++..++..+.+||++||+.||.+|++ ++++++||||++..+.
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001 22346889999999999999999997 7999999999875443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=372.15 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=203.5
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999886432 1234688999999999999999988 45556999999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-C
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-~ 233 (419)
|+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCC
Confidence 9985 55555543 4678999999999999999999999 6999999999999999 577899999999875322 2
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 333456799999999999764 4899999999999999999999999887766555444321 0
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
. .++..+++++.+||++||+.||++|+ ++.++++||||..+.+.
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 1 12345799999999999999999999 89999999999886544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=367.28 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=209.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 6899999999999999999999999999999885321 2345799999999999999999887 555679
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.+ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLD-KEGHIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEEEecCcchh
Confidence 999999985 66666654 4578999999999999999999999 6999999999999999 678899999999976
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 5332 2346789999999999764 4899999999999999999999999988776666655431
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
. ..++..++..+++||++||+.||.+|++ ++++++||||+.+.+.
T Consensus 214 ---~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ---K------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ---C------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 0 0123456889999999999999999995 9999999999886654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=362.93 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=207.4
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
|+..+.||+|+||.||+|.+..+|+.||+|.+.+.. ....+|+.+++.++|+||+++++++ .+...++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 788999999999999999999999999999885432 1234699999999999999999988 4455689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|...+... ....+++..+..++.|++.||.|||+ +||+||||||+|||++ +++.+||+|||++...
T Consensus 77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLD-DRGHIRISDLGLAVQI 152 (285)
T ss_pred EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEEC-CCCCEEEeeCCCcEEc
Confidence 99999985 555444332 23468999999999999999999999 6999999999999999 6778999999999876
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........||..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (285)
T cd05631 153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------- 220 (285)
T ss_pred CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence 444444456789999999999764 58999999999999999999999998765543333332211110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
...++..++.++.+||++||+.||.+|++ ++++++||||.++++.
T Consensus 221 --------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 --------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred --------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01123457899999999999999999997 8999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=369.01 Aligned_cols=284 Identities=35% Similarity=0.631 Sum_probs=227.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46999999999999999999999999999999886432 223479999999999999999998743221 22345
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|++|++++++|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVN-EDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEEC-CCCCEEEcCCcccee
Confidence 78999999888776654 2569999999999999999999999 6999999999999999 678899999999986
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+.....
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 533 234567899999999997756689999999999999999999999999998889999998888887766544322
Q ss_pred CCccc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 310 NYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
..... .++......+...+ ...++.+.+||.+||+.||.+|||+.|+|+||||.....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 11110 11111122222222 24678899999999999999999999999999998866543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=364.76 Aligned_cols=278 Identities=32% Similarity=0.561 Sum_probs=213.5
Q ss_pred eceeccCCceEEEEEEEc--CCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.++||+|+||+||+|+++ .+++.||+|.+.... ....+|+.+++.++|+||+++++++.. .....+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEecc
Confidence 457999999999999965 467899999886543 235689999999999999999998854 2344589999999
Q ss_pred cccHHHHHHhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC---CCCCceEEeecccccc
Q 014750 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (419)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~DfG~a~~ 229 (419)
++++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9998887754321 22358999999999999999999999 6999999999999994 2456899999999976
Q ss_pred cccCC----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHh
Q 014750 230 LVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 296 (419)
Q Consensus 230 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~~ 296 (419)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||..... .+++..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54322 123457899999999998766689999999999999999999999975432 46778888889
Q ss_pred CCCCHHHHhccCcCCc------cc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 297 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
|.+....|........ .+ .+.......+........+.++.|||.+||++||.+|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9888877764321100 00 0000000001111112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=378.44 Aligned_cols=278 Identities=23% Similarity=0.338 Sum_probs=215.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
..+|.+.+.||+|+||.||+|++..+++.||+|.... ....+|+++++.++||||++++++|. .....++|||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEEEe
Confidence 3579999999999999999999999999999997543 34568999999999999999999883 3455899999
Q ss_pred cccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC--
Q 014750 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-- 233 (419)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-- 233 (419)
++.++|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEc-CCCCEEEEeCCcccccccccc
Confidence 999888777654 3568999999999999999999999 6999999999999999 5778999999999754222
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCCHHHHhc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||... +...++..+.+..|.++.+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222346789999999999764 5899999999999999999999887543 24456777777777765332110
Q ss_pred cCcCCcc--------ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 307 MNPNYTD--------FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
....... ..........|... ..++.++.+||.+||++||.+|||++|+|+||||+.+..+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000000 00000001112111 1357789999999999999999999999999999886543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=380.33 Aligned_cols=279 Identities=24% Similarity=0.368 Sum_probs=214.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCC------CeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~ 146 (419)
.++|++.+.||+|+||+||+|++..+++.||||++.... .....|+.+++.++|. ++++++++|.. +
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 467999999999999999999999999999999986432 2334678888777554 57888777632 2
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC---------
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--------- 217 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--------- 217 (419)
..++|+|||+++++|.+.+.. .+.+++..++.++.||+.||.|||+..|||||||||+|||++..+.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 346899999999888887764 3579999999999999999999997139999999999999984322
Q ss_pred ------ceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHH
Q 014750 218 ------QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291 (419)
Q Consensus 218 ------~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 291 (419)
.+||+|||++... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999988643 2233457899999999999775 489999999999999999999999999999999999
Q ss_pred HHHHhCCCCHHHHhccCc-C---Ccc-c--cCCCCCC---------CCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH
Q 014750 292 IIKVLGTPTREEIRCMNP-N---YTD-F--RFPQIKA---------HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~-~---~~~-~--~~~~~~~---------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~ 355 (419)
+.+.+|.++......... . +.. . ..+.... ..+... ..++.+.|||.+||++||.+|+|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV---IRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh---hchHHHHHHHHHhCCcChhhCCCHH
Confidence 999988876553321100 0 000 0 0000000 001111 1246788999999999999999999
Q ss_pred HHhcCCccccccC
Q 014750 356 EACAHPFFDELRE 368 (419)
Q Consensus 356 e~l~hp~f~~~~~ 368 (419)
|+|+||||.....
T Consensus 434 e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 434 QMTTHPYVLKYYP 446 (467)
T ss_pred HHhcCccccccCC
Confidence 9999999987543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=348.70 Aligned_cols=266 Identities=29% Similarity=0.444 Sum_probs=224.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH-------HHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|..+++||+|.||+|-+++.+.+++.+|||+++++.... ..|-++|+..+||++..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 4567999999999999999999999999999999987664333 3577899999999999998888 555
Q ss_pred eeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||..|+ |+-.| .....+++...+.+-.+|+.||.|||+ ++||+||||.+|+|+| .+|.|||+|||+
T Consensus 241 drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLD-kDGHIKitDFGL 314 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLD-KDGHIKITDFGL 314 (516)
T ss_pred ceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheec-cCCceEeeeccc
Confidence 6699999999965 33333 346789999999999999999999999 7999999999999999 688899999999
Q ss_pred cccc-ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 227 AKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 227 a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++.. ..+....++||||.|+|||++.. ..|+.++|+|.+||++|||++|+.||...+....+..|.-.
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e---------- 383 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME---------- 383 (516)
T ss_pred chhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------
Confidence 9864 34555678999999999999965 56999999999999999999999999999888777777642
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCCC-CCCCCCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA-RLPNGRPF 379 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~-~~~~~~~~ 379 (419)
+.+ ||..++++++.|+..+|.+||.+|. .+.|+.+|+||..++|... ......|+
T Consensus 384 -------d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 384 -------DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred -------hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 223 4567899999999999999999998 4789999999999988753 22333444
Q ss_pred CC
Q 014750 380 PP 381 (419)
Q Consensus 380 ~~ 381 (419)
.|
T Consensus 445 KP 446 (516)
T KOG0690|consen 445 KP 446 (516)
T ss_pred CC
Confidence 44
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=350.80 Aligned_cols=282 Identities=28% Similarity=0.521 Sum_probs=225.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCC--C----CeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDH--P----NVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~ 145 (419)
...+|.+...+|+|.||+|..+.+..++..||||+++.-.+ ...-|+++|+++.+ | -+|.+.++| .
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----d 161 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----D 161 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----h
Confidence 35689999999999999999999999999999998864433 33468999999842 1 377787888 6
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-----------
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------- 214 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----------- 214 (419)
..++.|||+|.++-++++.|.... ..+++..+++.++.||+++++|||+ .+++|.||||||||+.+
T Consensus 162 yrghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 162 YRGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ccCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCC
Confidence 677799999999989999988643 3678999999999999999999999 59999999999999841
Q ss_pred --------CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 215 --------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 215 --------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
.+..|||+|||.|... .+.....+.|..|+|||++++-+ ++.++||||+||||+||+||...|++.++.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcH
Confidence 1335899999999864 34446788999999999999865 999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhcc-CcCCc---cccCCCC-----------CCCCchhhcC--CCCChhHHHHHhhhcccCCC
Q 014750 287 DQLVEIIKVLGTPTREEIRCM-NPNYT---DFRFPQI-----------KAHPWHKVFH--KRMPPEAIDLASRLLQYSPS 349 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~-~~~~~---~~~~~~~-----------~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~ 349 (419)
+.++.+.+++|..+...+... ...|. ...+++. ...++...+. +....+++|||++||.+||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 999999999998887776654 11110 0001100 0112222221 11234689999999999999
Q ss_pred CCCCHHHHhcCCcccccc
Q 014750 350 LRCTALEACAHPFFDELR 367 (419)
Q Consensus 350 ~R~t~~e~l~hp~f~~~~ 367 (419)
+|+|+.|+|.||||+.+.
T Consensus 396 ~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 396 RRITLREALSHPFFARLT 413 (415)
T ss_pred ccccHHHHhcCHHhhcCC
Confidence 999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=367.29 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=209.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC-cEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 4557999999999999999999876655 689999885321 2234699999999999999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~-~~~~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLD-KDGFIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEEC-CCCCEEEecCC
Confidence 5569999999975 66666553 4578999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 9976532 23456889999999999764 48999999999999999999999999887766555554310
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
. .++..+++++.+||++||+.||.+|+ |++++++||||+++.+.
T Consensus 245 --------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 245 --------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred --------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0 12345688999999999999999996 89999999999987654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=370.84 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=206.3
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 6999999999999999999999999999999986432 2234689999999999999999988 555669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||+| +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~-~~~~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEEC-CCCCEEEeeccCccc
Confidence 999999985 56665543 4679999999999999999999999 6999999999999999 578899999999875
Q ss_pred cccCC------------------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHH
Q 014750 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (419)
Q Consensus 230 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (419)
..... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 42210 01235799999999999764 489999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCC---C
Q 014750 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS---L 350 (419)
Q Consensus 274 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~---~ 350 (419)
++|..||.+.+..+...++...... ..+|. ...+++++++||.+|+. +|. .
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 9999999988877776666542111 11111 01368999999999876 454 4
Q ss_pred CCCHHHHhcCCccccccCCC
Q 014750 351 RCTALEACAHPFFDELREPN 370 (419)
Q Consensus 351 R~t~~e~l~hp~f~~~~~~~ 370 (419)
||+++|+++||||+++++..
T Consensus 284 r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCHHHHhCCCCCCCCCHHH
Confidence 58999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=354.17 Aligned_cols=276 Identities=35% Similarity=0.573 Sum_probs=221.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 4889999999999999999999999999999886431 2345799999999999999999988 4455689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|+||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||+++...
T Consensus 76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLIN-KNGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEc-CCCcEEECccchhhccC
Confidence 99999999887776542 3568999999999999999999999 6999999999999999 57789999999997553
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ......++..|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....|.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 322 122346788999999987766679999999999999999998877 566677788888888888888776654332
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.-....++..............+++++.+||.+||..||.+|||+++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111222111111112234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.68 Aligned_cols=254 Identities=31% Similarity=0.509 Sum_probs=207.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 6999999999999999999999999999999986431 1234699999999999999999998 455669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEeeccccee
Confidence 999999985 55555543 4569999999999999999999999 6999999999999999 678899999999865
Q ss_pred cccCC---------------------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHH
Q 014750 230 LVKGE---------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVL 270 (419)
Q Consensus 230 ~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 270 (419)
..... .....+||+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 42211 01124689999999998654 589999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC
Q 014750 271 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350 (419)
Q Consensus 271 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 350 (419)
|+|++|..||.+.+..+....+..... ...++. ...+++++.+||++||. ||.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence 999999999998887666655543110 011111 01368999999999997 9999
Q ss_pred CCC---HHHHhcCCccccccCC
Q 014750 351 RCT---ALEACAHPFFDELREP 369 (419)
Q Consensus 351 R~t---~~e~l~hp~f~~~~~~ 369 (419)
|++ +.++++||||+...+.
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCHH
Confidence 998 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=363.99 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=210.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 6999999999999999999999999999999986432 2234689999999999999999988 455569
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLID-ASGHIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCCEEEEeCcCCcc
Confidence 999999985 66666543 4578999999999999999999999 6999999999999999 678899999999976
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 218 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------- 218 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------
Confidence 533 33456789999999999765 589999999999999999999999998887776665544211100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+.... ....++.++.+||.+||..+|.+|+++.++++||||.+..+
T Consensus 219 ------~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 219 ------RPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred ------CCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 000000 00246899999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=369.23 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=205.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|.+++.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence 5899999999999999999999999999999886432 2345799999999999999999998 445569
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||++ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~-~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILID-RDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEEeECCCCcc
Confidence 999999985 66666543 3568999999999999999999999 6999999999999999 678899999999753
Q ss_pred cccC------------------------------------------------CcceeeeeccccccchhhcCCCCCCCcc
Q 014750 230 LVKG------------------------------------------------EANISYICSRYYRAPELIFGATEYTTSI 261 (419)
Q Consensus 230 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 261 (419)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001234789999999999764 489999
Q ss_pred cEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHh
Q 014750 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (419)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 341 (419)
|||||||++|||++|+.||.+.+..+....+...... ..++. ...+++++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPP----------QAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCC----------cccCCHHHHHHHH
Confidence 9999999999999999999988776665555431110 01110 1246899999999
Q ss_pred hhcccCCCCCCC---HHHHhcCCccccccCC
Q 014750 342 RLLQYSPSLRCT---ALEACAHPFFDELREP 369 (419)
Q Consensus 342 ~~L~~dP~~R~t---~~e~l~hp~f~~~~~~ 369 (419)
+|+ .||.+|++ ++++++||||+.+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 986 59999997 9999999999887544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=368.45 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=203.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|.+++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999986432 1234799999999999999999998 445569
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||+| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~-~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILID-LDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEEC-CCCCEEEeeCcCCcc
Confidence 999999985 66666553 3568999999999999999999999 6999999999999999 578899999999753
Q ss_pred cccCC------------------------------------------------cceeeeeccccccchhhcCCCCCCCcc
Q 014750 230 LVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTSI 261 (419)
Q Consensus 230 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 261 (419)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01235789999999999764 489999
Q ss_pred cEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHh
Q 014750 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (419)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 341 (419)
|||||||++|||++|..||...+..+....+...... ..++. ...+++++.+||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999887766555544431110 01111 1246899999999
Q ss_pred hhccc--CCCCCCCHHHHhcCCccccccCC
Q 014750 342 RLLQY--SPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 342 ~~L~~--dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
+||.. ++..|++++++++||||+++.+.
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 96654 55559999999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.46 Aligned_cols=320 Identities=35% Similarity=0.624 Sum_probs=249.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+|.+.+.||+|+||+||+|++..+++.||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4699999999999999999999999999999987542 1223469999999999999999998754433333458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||++++|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLN-ANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEECcCcccccc
Confidence 99999999887776653 4679999999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+....|.+..+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 433 2233456788999999987645589999999999999999999999999888888888888888887766543221
Q ss_pred -CCccc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCch
Q 014750 310 -NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (419)
Q Consensus 310 -~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 386 (419)
....+ ..+......+.. ....+++++.+||++||+.||++|||+.++++||||..+........ . +..+.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~-~---~~~~~~~ 313 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV-C---QTPFSFD 313 (337)
T ss_pred hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc-C---CCccchh
Confidence 11100 011111111111 22357899999999999999999999999999999998876654322 2 2234555
Q ss_pred HHhhcCCHHHHhhhcHHHHHh
Q 014750 387 QELAGASPELINRLIPEHVRR 407 (419)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~ 407 (419)
-+..+.+.+++++++-.++-.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~ 334 (337)
T cd07858 314 FEEDALTEEDIKELIYNEMLA 334 (337)
T ss_pred hhhhhcCHHHHHHHHHHHHhh
Confidence 566668888999998877643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=360.48 Aligned_cols=242 Identities=31% Similarity=0.535 Sum_probs=200.5
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999886431 1234689999999999999999988 4455689999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC-Cc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA 235 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-~~ 235 (419)
.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCc
Confidence 85 56565543 4578999999999999999999999 6999999999999999 6788999999999754322 22
Q ss_pred ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcccc
Q 014750 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (419)
Q Consensus 236 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~-- 209 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------P-- 209 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------C--
Confidence 3346789999999999764 4899999999999999999999999987766655554331 0
Q ss_pred CCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC---CHHHHhcCCcccccc
Q 014750 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELR 367 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 367 (419)
..++..+++++.+||.+||..||.+|+ ++.+++.||||.+..
T Consensus 210 ----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 210 ----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 012345789999999999999999997 589999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=370.02 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=204.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|.+.+.||+|+||.||+|++..+++.||||++.+.. ....+|+++++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 6999999999999999999999999999999885432 2234689999999999999999998 455669
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+. |+|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~-~~~~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILID-RGGHIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEC-CCCCEEEeecccccc
Confidence 99999998 466666553 4678999999999999999999999 6999999999999999 678899999999863
Q ss_pred cccCC------------------------------------------------cceeeeeccccccchhhcCCCCCCCcc
Q 014750 230 LVKGE------------------------------------------------ANISYICSRYYRAPELIFGATEYTTSI 261 (419)
Q Consensus 230 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 261 (419)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 21100 00124689999999999764 489999
Q ss_pred cEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHh
Q 014750 262 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341 (419)
Q Consensus 262 DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~ 341 (419)
|||||||++|||++|..||.+.+..+.+..+..... ...++. ...++.++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence 999999999999999999998877666665553210 011111 0136889999999
Q ss_pred hhcccCCCCC---CCHHHHhcCCccccccC
Q 014750 342 RLLQYSPSLR---CTALEACAHPFFDELRE 368 (419)
Q Consensus 342 ~~L~~dP~~R---~t~~e~l~hp~f~~~~~ 368 (419)
+||. +|.+| +|+.++++||||+...+
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998 77765 59999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=363.06 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=201.2
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||.||++++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .+...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 36999999999999999999999999986432 1234688999999999999999888 45556899999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC-
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~- 233 (419)
|+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEEC-CCCcEEEecCcCCccCCCcc
Confidence 9985 55544433 4578999999999999999999999 6999999999999999 6788999999998754222
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence 222346789999999999764 4899999999999999999999999887765554443220 0
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~ 368 (419)
. .++..+++++.+||++||+.||.+|+ ++.++++||||....+
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1 12345789999999999999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=359.27 Aligned_cols=320 Identities=34% Similarity=0.639 Sum_probs=243.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++..........+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357999999999999999999999999999999885321 123469999999999999999988754443444568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.+++.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEC-CCCCEEECcccceeec
Confidence 99999999987766643 568999999999999999999999 6999999999999999 6788999999998765
Q ss_pred ccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 231 VKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 231 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..... .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33221 12346789999999986655689999999999999999999999999988888888888888887766543
Q ss_pred cCcCCcc-c--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 014750 307 MNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF 383 (419)
Q Consensus 307 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~ 383 (419)
+...... + ..+.....++.... ..++.++.+||.+||+.||.+|||+.++++||||+.+........ ...+..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~--~~~~~~~ 313 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPV--AEEPFPF 313 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHh-cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCccc--CCCCCCh
Confidence 3211100 0 01111122222222 245889999999999999999999999999999998766432211 1122234
Q ss_pred CchHHhhcCCHHHHhhhcHHHHH
Q 014750 384 NFKQELAGASPELINRLIPEHVR 406 (419)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~ 406 (419)
+|... ..+..+.+++.|.+++.
T Consensus 314 ~~~~~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 314 DFELF-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred hhccc-cccCHHHHHHHHHHHhc
Confidence 44432 34456677777776653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=369.70 Aligned_cols=275 Identities=25% Similarity=0.353 Sum_probs=206.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
...|.+.+.||+|+||.||+|.+..+++.||||... .....+|+++|+.++|+|||++++++. .....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEEEEE
Confidence 447999999999999999999999999999999643 234568999999999999999999874 3445889999
Q ss_pred cccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc
Q 014750 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (419)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~ 235 (419)
++.++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEEC-CCCCEEEcccCCceecccccc
Confidence 9999888777542 3468999999999999999999999 6999999999999999 577899999999976533221
Q ss_pred ---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCCHHH--
Q 014750 236 ---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-------AVDQLVEIIKVLGTPTREE-- 303 (419)
Q Consensus 236 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-- 303 (419)
.....||..|+|||++.+. .++.++|||||||++|||++|..++.... ...++.++++..+......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2235689999999999765 48999999999999999999875543221 1234555554433221110
Q ss_pred ------HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 304 ------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 304 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.............+......|.... .++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000011111122232221 35778999999999999999999999999999964
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.06 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=210.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....+|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 34568999999999999999999999999999999985421 2234789999999999999999988 55
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..++|+||||++| +|.+.+.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~-~~~~~kL~DfG 187 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEc-CCCCEEEEecc
Confidence 5669999999985 66665543 458899999999999999999999 6999999999999999 68889999999
Q ss_pred cccccccCC--cceeeeeccccccchhhcCCC---CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGE--ANISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
++....... .....+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+......++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---
Confidence 997654322 123467899999999986532 378999999999999999999999998887666666553211
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~ 369 (419)
...++. ...++.++.+||++||+.+|.+ |+|++++++||||+...+.
T Consensus 265 ------------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 265 ------------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred ------------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 011111 0136899999999999999998 9999999999999875543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=363.82 Aligned_cols=255 Identities=33% Similarity=0.540 Sum_probs=210.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|.+.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|++++..++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 6999999999999999999999999999999986432 2345789999999999999999988 555669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILID-ADGHIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEeecCCCCcc
Confidence 999999974 66666654 2678999999999999999999999 6999999999999999 678899999999976
Q ss_pred cccCC------------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC
Q 014750 230 LVKGE------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (419)
Q Consensus 230 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (419)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 54332 22345789999999999765 589999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-HHHHh
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEAC 358 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-~~e~l 358 (419)
|...+..+....+...... ..++. ...+++++.+||.+||. ||.+|++ +++++
T Consensus 230 f~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9988876666555441110 11111 11258999999999998 9999999 99999
Q ss_pred cCCccccccCCC
Q 014750 359 AHPFFDELREPN 370 (419)
Q Consensus 359 ~hp~f~~~~~~~ 370 (419)
+||||+.+.+..
T Consensus 284 ~hp~~~~~~~~~ 295 (350)
T cd05573 284 SHPFFKGIDWEN 295 (350)
T ss_pred cCCCcCCCCHHH
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=350.55 Aligned_cols=276 Identities=34% Similarity=0.651 Sum_probs=220.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence 4889999999999999999999999999999885331 23457999999999999999999983 445689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+.+++.+.+.... .+..+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLID-NKGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEc-CCCcEEECcccceeecC
Confidence 999999988877765432 24678999999999999999999999 6999999999999999 67889999999987543
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+....+....+.+..+.+....|.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS- 231 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-
Confidence 221 122346688999999987766678999999999999999999999999888888888888777776665543211
Q ss_pred Cccc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..++ .++......+.. ....+++++.+||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 111111111111 223478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=361.85 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=202.5
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||.||++++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 46999999999999999999999999886432 1223688999999999999999988 44556899999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC-
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~- 233 (419)
|+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEc-CCCCEEecccHHhccccCCC
Confidence 9985 55444443 4578999999999999999999999 6999999999999999 6788999999998753222
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 223346789999999999764 4899999999999999999999999887776655554321 0
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||.+..+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2345789999999999999999998 89999999999886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=355.90 Aligned_cols=245 Identities=31% Similarity=0.472 Sum_probs=200.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcE-EEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...+.+.||+|+||+||++.. .|+. ||+|++.... ..+.+|+.+|.+++|||||++++++.... ..+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cce
Confidence 455566799999999999998 5556 9999986432 35678999999999999999999984322 158
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-cccccccCCceeeCCCCC-ceEEeecccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKPQNLLVDPLTH-QVKLCDFGSA 227 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-ivH~Dlkp~NIll~~~~~-~vkl~DfG~a 227 (419)
+|||||++ |+|.+++... ....++...+..++.||++||.|||+ ++ ||||||||+|||++ .++ ++||+|||++
T Consensus 116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~-~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVD-LKGKTLKIADFGLS 191 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEc-CCCCEEEECCCccc
Confidence 99999999 5666666543 46789999999999999999999999 69 99999999999999 565 8999999999
Q ss_pred cccccC-CcceeeeeccccccchhhcC-CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 228 KVLVKG-EANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 228 ~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+..... ...+...||..|||||++.+ ...|+.++||||||+++|||+||+.||.+.........+......|
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------ 265 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------ 265 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence 876543 33344789999999999985 2459999999999999999999999999988755555544322221
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++..+++.+..||.+||..||.+||+..+++.
T Consensus 266 ---------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 ---------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 133457899999999999999999999998873
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=369.38 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=204.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+++++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 699999999999999999999999999999988532 12345799999999999999999988 455679
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||++ +|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~-~~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILID-RDGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEEC-CCCCEEEEeCCCCcc
Confidence 999999985 66666654 3568999999999999999999999 6999999999999999 678899999999743
Q ss_pred cccC--------------------------------------------CcceeeeeccccccchhhcCCCCCCCcccEee
Q 014750 230 LVKG--------------------------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWS 265 (419)
Q Consensus 230 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 265 (419)
.... ......+||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001135789999999999764 4899999999
Q ss_pred hhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcc
Q 014750 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345 (419)
Q Consensus 266 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 345 (419)
|||++|+|++|+.||.+.+..+....+...... ..++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh-
Confidence 999999999999999988776655544321100 0011 01246899999999976
Q ss_pred cCCCCCC---CHHHHhcCCccccccCC
Q 014750 346 YSPSLRC---TALEACAHPFFDELREP 369 (419)
Q Consensus 346 ~dP~~R~---t~~e~l~hp~f~~~~~~ 369 (419)
.||.+|+ |+.++++||||+.+...
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 5999999 99999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=362.60 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=208.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 446799999999999999999999999999999988532 12245799999999999999999988 455
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~-~~~~~kL~DFG~ 188 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLD-KHGHLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEC-CCCCEEEEeccc
Confidence 669999999985 66666643 358899999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc--ceeeeeccccccchhhcCCC---CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+........ ....+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+......++......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 265 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS--- 265 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc---
Confidence 986533221 23567899999999986532 3788999999999999999999999988877666666542111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~ 369 (419)
..++. ...++..+++||.+||..++.+ |+|+.++++||||+...+.
T Consensus 266 ------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 266 ------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred ------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 11111 0136889999999999866544 8899999999999875443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=358.90 Aligned_cols=246 Identities=30% Similarity=0.516 Sum_probs=201.4
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|+++.+++.||+|++.+.. ....+|..++..+ +|+||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999886432 1223577777765 799999999998 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcC
Confidence 99985 55544443 4678999999999999999999999 6999999999999999 678899999999875422
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----------------- 211 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 211 (320)
T ss_pred CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 2233456789999999999754 5899999999999999999999999988877766655431
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH------HHHhcCCccccccCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~ 369 (419)
.. .++..++.++.+||++||+.||.+|+++ +++++||||..+.+.
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 212 EV------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred CC------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 00 1233468999999999999999999998 999999999887643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=354.94 Aligned_cols=278 Identities=32% Similarity=0.571 Sum_probs=211.2
Q ss_pred eceeccCCceEEEEEEEcC--CCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
..+||+|+||.||+|++.. ++..||+|.+.... ....+|+.+++.++|+||+++++++.. .....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEeee
Confidence 3579999999999999654 56889999886543 235679999999999999999998854 2344588999999
Q ss_pred cccHHHHHHhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC---CCCCceEEeecccccc
Q 014750 158 PETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKV 229 (419)
Q Consensus 158 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~DfG~a~~ 229 (419)
++++.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 9988887753221 22358899999999999999999999 6999999999999994 2457899999999986
Q ss_pred cccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHh
Q 014750 230 LVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 296 (419)
Q Consensus 230 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~~ 296 (419)
...... .....+|+.|+|||++.+...++.++|||||||++|+|+||.+||..... ..++..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543221 23457899999999997766689999999999999999999999975432 35677788888
Q ss_pred CCCCHHHHhccCc--CCcc----ccCCCCCCCC---chhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 297 GTPTREEIRCMNP--NYTD----FRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 297 ~~~~~~~~~~~~~--~~~~----~~~~~~~~~~---~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
|.+....|..... .+.. +......... .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8877776654321 1100 0000000000 0111112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=361.50 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=201.1
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+++++.++|+||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 1224688899999999999999888 44556999999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-C
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-G 233 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-~ 233 (419)
|+.+ +|...+.. ...+++..++.++.||+.||.|||+.+||+||||||+|||++ .++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCC
Confidence 9986 45444432 457899999999999999999999624999999999999999 678899999999875322 2
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 223346789999999999764 5899999999999999999999999887765555444321 0
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
. .++..+++++.+||++||+.||++|+ ++.++++||||....+.
T Consensus 213 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 213 I------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred C------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 1 12345789999999999999999997 89999999999976443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=358.85 Aligned_cols=253 Identities=29% Similarity=0.466 Sum_probs=222.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|..++.+|+|+||.+++++++..+..|++|+|.-. ++....|+.+++++.|||||.+++.|. .++..+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 5699999999999999999999999999999998533 345568999999999999999999983 344459
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
||||+||+| ++.+.+.... +..+++..+..|+.|++.|+.|||+ ++|+|||||+.||+++ .++.|||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Niflt-k~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLT-KDKKVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhcc-ccCceeecchhhhhh
Confidence 999999995 6666666543 5779999999999999999999999 7999999999999999 566789999999999
Q ss_pred cccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
+.... ...+.+||+.||+||++.+. .|+.++|||||||++|||++-+.+|.+.+-.....+|.+....|.
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-------- 226 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-------- 226 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC--------
Confidence 87776 66788999999999999775 499999999999999999999999999999999999888654332
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+...+.+++.||+.||..+|..||++.++|.+|.+...
T Consensus 227 --------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 --------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred --------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 34568999999999999999999999999999998743
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=357.95 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=205.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCC-CeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 149 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.+.. .....|..++..++|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4889999999999999999999999999999886432 1234678888888765 577888887 44456
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-AEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEc-CCCCEEEeecCcce
Confidence 8999999985 55555543 4568999999999999999999999 6999999999999999 57789999999986
Q ss_pred ccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 532 22233456789999999999764 48999999999999999999999999888776666654310
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 369 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~ 369 (419)
..++..++.++.+||++||..||.+|++. +++++||||+.+++.
T Consensus 218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01234578999999999999999999986 899999999987553
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.20 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=210.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 6999999999999999999999999999999986432 2345788999999999999999888 445568
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||++ ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLID-RTGHIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEEC-CCCCEEeccCCCCeE
Confidence 99999997 4666666542 3579999999999999999999999 6999999999999999 678899999999976
Q ss_pred cccCCcc--eeeeeccccccchhhcC-----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 230 LVKGEAN--ISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 230 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
....... ....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+.++.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 226 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR----- 226 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 6433322 23468999999999863 34578999999999999999999999998877766665544210
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
...++. ...++.++.+||.+||. ||.+|+|++++++||||..+.+..
T Consensus 227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 001111 12468999999999998 999999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=357.03 Aligned_cols=246 Identities=30% Similarity=0.497 Sum_probs=202.0
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..+++.||+|++.+.. .....|.++++.+ +|+||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999986532 1123577777755 799999999998 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.....
T Consensus 76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEeecccceecccC
Confidence 99985 55555543 4578999999999999999999999 6999999999999999 678899999999875422
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223456789999999998654 5899999999999999999999999988877777665541
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-------CHHHHhcCCccccccCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-------t~~e~l~hp~f~~~~~~ 369 (419)
.. .++..++.++.+||++||+.||.+|+ ++.++++||||..+.+.
T Consensus 212 ~~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 212 DV------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 00 12234689999999999999999999 99999999999886544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=360.94 Aligned_cols=278 Identities=25% Similarity=0.401 Sum_probs=208.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
..+|++.+.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++|+||+++++++. .....++|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEE-----eCCeeEEEEE
Confidence 34799999999999999999999999999999975433 3457999999999999999999884 3445889999
Q ss_pred cccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc
Q 014750 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (419)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~ 235 (419)
|+.+++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEecCccccccccCcc
Confidence 999988887754 24578999999999999999999999 6999999999999999 577899999999976544444
Q ss_pred ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCC-CCCCCCC---------HHHHHHHHHHHhCCCCHHHHh
Q 014750 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGEN---------AVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 236 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.....||..|+|||++.+. .++.++|||||||++|||+++. .+|.... ....+..++..++..+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999999764 4899999999999999999854 4444321 123344455554443322110
Q ss_pred ccCcCCc-c-ccCCCCCCCCch---hhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYT-D-FRFPQIKAHPWH---KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~-~-~~~~~~~~~~~~---~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
....... . ..+......++. ..-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0000000 0 000000000000 00112467889999999999999999999999999999863
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=357.34 Aligned_cols=249 Identities=28% Similarity=0.480 Sum_probs=202.7
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHH---HhcCCCCeeecceeeeccCCCCce
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
|++.+.||+|+||.||+|.+..+|+.||||++.+.. ....+|+.++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 678999999999999999999999999999986432 1122454444 566899999999998 4455
Q ss_pred eEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|+||||+.++ |...+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~-~~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLD-TEGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEEC-CCCcEEeCcccCC
Confidence 689999999964 433332 3579999999999999999999999 6999999999999999 5778999999998
Q ss_pred ccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+.... .......+|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------- 217 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------- 217 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 75322 2223456789999999999764 58999999999999999999999999888776666554310
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
. .++..++.++.+||.+||+.||.+|+ ++.++++||||+++.+.
T Consensus 218 -------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 218 -------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred -------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 0 12345789999999999999999999 79999999999886543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.00 Aligned_cols=255 Identities=30% Similarity=0.472 Sum_probs=201.8
Q ss_pred ceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
+|++.+.||+|+||+||+|++. .+++.||+|++.+.. ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999886421 1234688999999 599999999888 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
....+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~-~~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLD-SEGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEEC-CCCCEEEeeC
Confidence 55568999999985 66665543 4568999999999999999999999 6999999999999999 5778999999
Q ss_pred ccccccccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 225 GSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 225 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|+++...... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+......
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 9997653332 2234678999999999977656789999999999999999999999754322111111111000
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~ 368 (419)
....++..+++.+.+||.+||+.||++|+ +++++++||||++..+
T Consensus 226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 00112345789999999999999999999 8899999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=349.35 Aligned_cols=286 Identities=34% Similarity=0.555 Sum_probs=228.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
...+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 3457999999999999999999999999999999886332 1234799999999999999999987432 224
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++||||+.++|.+.+... ...+++..++.++.||+.||.|||+ +|++||||||+||+++ .++.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~kL~dfg~~~ 156 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLT-DKGCLKIADFGLAR 156 (309)
T ss_pred eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECccceee
Confidence 57899999998887777653 2568999999999999999999999 6999999999999999 67789999999997
Q ss_pred ccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 664332 2223345788999999877666899999999999999999999999999999999999999998877666543
Q ss_pred Cc--CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 308 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 308 ~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.. ....+.++......+...+ ...++++.+||.+||+.||++|||+.++++||||++...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred hcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 21 1122222221111121111 2358899999999999999999999999999999875544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=355.31 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=206.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..|+..+.||+|+||.||+|.+..+++.||+|++.-+. ....+|+.+|..++++||.++++.|+.... ++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence 35888899999999999999999999999999986443 334579999999999999999999965554 89
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||.| ++.+.++. +..+.+..+..++++++.||.|||. ++.+|||||+.|||+. ..+.+||+|||.+...
T Consensus 88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s-~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLS-ESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEe-ccCcEEEEecceeeee
Confidence 99999995 55555543 4555888899999999999999999 6999999999999999 4588999999999876
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... ..+++||+.|||||++.+ ..|+.++||||||++.+||++|.+||........+..|-+
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--------------- 225 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--------------- 225 (467)
T ss_pred echhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---------------
Confidence 54433 367999999999999985 4599999999999999999999999987665322222211
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
-.- ..+...+++.+++||..||++||+.||+|.++|.|+|++.
T Consensus 226 ---------~~P----P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 ---------SAP----PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ---------CCC----CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 110 1112346899999999999999999999999999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=348.75 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=200.9
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||+|+||+||++.+..+++.||+|.+.+.. .....|+.+++.++|+||+++.+++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 799999999999999999999999886432 1234689999999999999999888 4455689999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc-
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA- 235 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~- 235 (419)
++ +|...+.........+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCcc
Confidence 85 5555554444445679999999999999999999999 6999999999999999 577899999999976543322
Q ss_pred ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcccc
Q 014750 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (419)
Q Consensus 236 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence 2345789999999999765 48999999999999999999999998654322222221110000
Q ss_pred CCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
...++..++.++.+|+.+||+.||++|+ +++++++||||+.+.+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012345789999999999999999999 88999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=356.34 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=205.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhc-CCCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 149 (419)
+|.+.+.||+|+||.||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++ .+...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48899999999999999999999999999998865321 123466676666 588999998888 44556
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+||||+++ +|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~-~~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEEC-CCCcEEEccCCCce
Confidence 8999999985 66555543 3568999999999999999999999 6999999999999999 67889999999997
Q ss_pred cccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 2223356789999999999764 48999999999999999999999999888777666655410
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~ 370 (419)
. .++..++.++.+||.+||+.||.+|++ ..++++||||+.+++..
T Consensus 218 ------~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 218 ------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred ------C------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 0 123457899999999999999999998 48999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.58 Aligned_cols=287 Identities=33% Similarity=0.592 Sum_probs=226.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
..+|++.+.||+|+||.||+|++..+|+.||+|.+.+.. ....+|+.+++.++|+||+++++++..... .+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 357999999999999999999999999999999885421 123469999999999999999998754322 2234
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..|+||||+.+++.+.+.. .+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence 5789999999988777653 28889999999999999999999 6999999999999999 57789999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+.+.++.|..+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 76444333455678999999999764 48999999999999999999999999999889999999999998876554432
Q ss_pred cCCcccc--CCCCCCCCchhhc------------CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCC
Q 014750 309 PNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (419)
Q Consensus 309 ~~~~~~~--~~~~~~~~~~~~~------------~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 371 (419)
.....+. .+......+...+ ....+.++.+||.+||+.||++|||+.|+|.||||+.+-....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 2111110 0000011111111 1234678999999999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=347.77 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=207.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|++.+.||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3889999999999999999999999999999886432 1234699999999999999999988 444569
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++ +++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLD-DYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEEC-CCCCEEEeeCCCcee
Confidence 999999985 55544443 123568999999999999999999999 6999999999999999 578899999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
...........|+..|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------- 220 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence 6444443456789999999999764 48999999999999999999999998876544443333211100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
...++..++..+.+||.+||..||.+|+ +++++++||||....+.
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 0112334688999999999999999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=361.76 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=206.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.++..++|+||+++++.+ .+...+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 6899999999999999999999999999999885321 2234688999999999999999988 555669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||+| +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~-~~~~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEEC-CCCCEEEeeccCCcc
Confidence 999999985 56665543 4678999999999999999999999 6999999999999999 678899999999864
Q ss_pred cccCC------------------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHH
Q 014750 230 LVKGE------------------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (419)
Q Consensus 230 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (419)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42110 01235789999999999764 489999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-
Q 014750 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC- 352 (419)
Q Consensus 274 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~- 352 (419)
++|..||.+.+..+...++..... ...++. ...+++++++||.+|+. ||.+|+
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 999999998887766665543110 001111 01268899999999874 999998
Q ss_pred --CHHHHhcCCccccccCCC
Q 014750 353 --TALEACAHPFFDELREPN 370 (419)
Q Consensus 353 --t~~e~l~hp~f~~~~~~~ 370 (419)
+++++++||||+.+++..
T Consensus 284 ~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCHHHHhcCCCCCCCCHHH
Confidence 489999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=346.42 Aligned_cols=285 Identities=33% Similarity=0.599 Sum_probs=224.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ |+||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6999999999999999999999999999999875432 23457999999995 6999999998865443344458
Q ss_pred EEEeecccccHHHHHHhhccC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999999999888877654332 4568999999999999999999999 69999999999999995478999999999875
Q ss_pred cccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 53221 12234568889999998765668999999999999999999999999998888888888888877766554322
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.......++......... ....++.++.+||.+||..||.+|||+.+++.||||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111111122221111111 1234789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=354.48 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=200.5
Q ss_pred ceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+.||+|+||.||+|++. .+++.||+|.+.+.. ....+|+.+++.++||||+++++++ ..+..+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence 57999999999999864 478899999886421 1234689999999999999999988 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+.. .+.+.+..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLD-AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEeeCcCCeec
Confidence 99999986 55555543 4568889999999999999999999 6999999999999999 6788999999998754
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+.+..
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------------- 216 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------------- 216 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 322 223346789999999999764 47899999999999999999999999887766665554310
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~ 368 (419)
..++..+++++.+||++||+.||++|+ +++++++||||+...+
T Consensus 217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 012345689999999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=355.27 Aligned_cols=247 Identities=25% Similarity=0.469 Sum_probs=196.7
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 1234688888888 799999999998 4555689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc-c
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-~ 232 (419)
|||++ +|...+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEECcCccccccccC
Confidence 99985 55554443 4679999999999999999999999 6999999999999999 57889999999987532 2
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCCHHHH
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 304 (419)
.......+||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... .+.+.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 3334456889999999999764 489999999999999999999999963211 1111111110
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC------HHHHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~ 369 (419)
.. ..++..++.++.+||++||+.||.+|+| ++++++||||..+.+.
T Consensus 220 -------~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 220 -------KQ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred -------CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 00 0123457899999999999999999987 7899999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=353.88 Aligned_cols=246 Identities=29% Similarity=0.490 Sum_probs=199.2
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHh-cCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..+|+.||+|.+.+.. .....|..++.. ++|+||+++++++ .+..++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986432 123356667664 5899999999988 4556799999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEeCccCCCeecccC
Confidence 99985 55555543 4678999999999999999999999 6999999999999999 577899999999875322
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~-------------- 212 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T-------------- 212 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 2223456789999999999764 4899999999999999999999999988776555544321 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-HHHhcCCccccccCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-~e~l~hp~f~~~~~~ 369 (419)
..++..++.++.+||++||+.||.+|+++ +++++||||+...+.
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 01223468999999999999999999997 589999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=330.87 Aligned_cols=284 Identities=31% Similarity=0.530 Sum_probs=233.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccC---CCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTT---SKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~ 147 (419)
+.|.-..+||+|.||.||+|+++.+|+.||+|++.-+ .....+|+++|..++|+|++.+++++-+.. ..+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3588888999999999999999999999999976432 123458999999999999999998775433 2445
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|+||.+|..+|..+|.. ...+++..++..++.++++||.|+|+ ..|+|||+|++|+||+ .++.+||+|||++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt-~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLIT-KDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEc-CCceEEeeccccc
Confidence 67999999999988888765 34679999999999999999999999 6999999999999999 6889999999999
Q ss_pred cccccCC-----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+.+.... ..+..+.|.||++||.++|...|+++.|||+.|||+.||.||.+.|.+.++..++..|...+|..+.+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 7664322 23456779999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccC--cCCccccCCCCCCCCchh---hcC-CCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 303 EIRCMN--PNYTDFRFPQIKAHPWHK---VFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~~~~~~~~---~~~-~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.|+.++ +-|..+..+.+.....+. ... -.-++++.||+.+||..||.+|++++++|+|.||..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 888664 222222222221111111 111 112568999999999999999999999999999975
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=352.35 Aligned_cols=245 Identities=31% Similarity=0.502 Sum_probs=198.2
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHh-cCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+++.||+|.+..... ....|..++.. .+|+||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999998864321 12245556554 4899999999988 4455699999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCC
Confidence 99985 55555543 4578999999999999999999999 6999999999999999 6778999999999754332
Q ss_pred -CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR---------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 223456789999999999765 48999999999999999999999999888766665543210
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-HHHhcCCccccccC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-~e~l~hp~f~~~~~ 368 (419)
..++..++.++.+||.+||..||.+|+++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01234568999999999999999999986 58889999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.55 Aligned_cols=276 Identities=42% Similarity=0.760 Sum_probs=228.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 4899999999999999999999999999999886443 2345799999999999999999998 4455689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||++++|.+.+... ...+++..++.++.||+.||.|||+ .||+|+||||+||+++ .++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLIS-ADGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEc-CCCcEEEeeeeeccccc
Confidence 99999977887776542 2568999999999999999999999 6999999999999999 57889999999997664
Q ss_pred cCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 232 KGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 232 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
.... .....++..|+|||.+.+...++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+....|+...
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4321 3345688999999998766667999999999999999999999999998888999999999988887766432
Q ss_pred -cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.++....++......+...+ ...+.++.+||.+||..||.+|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 22333333333333333333 34678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=354.81 Aligned_cols=245 Identities=29% Similarity=0.468 Sum_probs=198.4
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHH-HHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+|+.||+|++.+... ...+|. .+++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 469999999999999999999999999864321 112233 356789999999999988 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEEC-CCCcEEEeccCCCcccccC
Confidence 99985 55555543 4678999999999999999999999 6999999999999999 6788999999998754222
Q ss_pred -CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 223446789999999999764 4899999999999999999999999988776665555431 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCccccccC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f~~~~~ 368 (419)
..++..++.++.+||++||+.||.+|+++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 00123468999999999999999999997 69999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=357.51 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=207.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....+|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 34468999999999999999999999999999999885321 2234789999999999999999988 45
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..++|+|||||+| +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~-~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEEC-CCCCEEEEeCC
Confidence 5669999999985 56665543 458899999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc--ceeeeeccccccchhhcCCC---CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEA--NISYICSRYYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
++........ ....+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+......++......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-- 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--
Confidence 9976543221 23467899999999986532 3789999999999999999999999988876666665542110
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~ 369 (419)
..++. ...++.++++||.+||..++.+ |++++++++||||++..+.
T Consensus 266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 266 -------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred -------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 11111 1247899999999999844433 7899999999999875443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=353.01 Aligned_cols=245 Identities=29% Similarity=0.495 Sum_probs=200.8
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|..+++.+ +|+||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 1234677888777 699999999988 4445699999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+.| +|...+.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEEC-CCCcEEecccCCCeecCcC
Confidence 99985 55554443 4579999999999999999999999 6999999999999999 577899999999875322
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223446789999999999764 4899999999999999999999999888766655544321
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~ 368 (419)
. ..++..++.++.+||++||..||.+|+|+ .+++.||||+...+
T Consensus 212 ~------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 212 E------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred C------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 01234568999999999999999999999 99999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=351.12 Aligned_cols=311 Identities=35% Similarity=0.658 Sum_probs=241.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 57999999999999999999999999999999886432 12346899999999999999999874433 344568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVN-EDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEecccccceee
Confidence 99999999876666543 4568999999999999999999999 6999999999999999 6888999999998765
Q ss_pred ccCCc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 231 VKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
..... .....++.+|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.|+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 1234788899999998665568999999999999999999999999999888999999999988877655
Q ss_pred ccCcCCcc---ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCC
Q 014750 306 CMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPL 382 (419)
Q Consensus 306 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~ 382 (419)
........ -.++.....+|...+ ..++.++.++|++||+.||.+|||+++++.||||.+...+..... ..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~----~~~~ 312 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIF-PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT----CPPP 312 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHc-ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc----CCCC
Confidence 33211110 012222223333322 346899999999999999999999999999999998776654322 2234
Q ss_pred CCchHHhhcCCHHHHhh
Q 014750 383 FNFKQELAGASPELINR 399 (419)
Q Consensus 383 ~~~~~~~~~~~~~~~~~ 399 (419)
++++.+....+.+.+..
T Consensus 313 ~~~~~~~~~~~~~~~~~ 329 (334)
T cd07855 313 FDFDFEAIELSREQLKE 329 (334)
T ss_pred CCCChhhhhcChhhHHH
Confidence 55555544444444443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=382.13 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=222.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|.++++||+|+||.|.+++++.|++.||+|++.+- ...+..|.++|..-+.+-|+.++..| +++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 456899999999999999999999999999999988652 23456799999999999999999888 889
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.++|+||||++| +|..++..+ .++++..+++|+.+|+.||.-||++ |+|||||||+||||| ..|+|||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld-~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLD-KSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEec-ccCcEeeccchh
Confidence 999999999985 677777664 3799999999999999999999996 999999999999999 688899999999
Q ss_pred ccccccCC-c-ceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 227 AKVLVKGE-A-NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 227 a~~~~~~~-~-~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+-.+..+. . ....+|||.|.+||++.. ...|+..+|+||+||++|||++|..||+..+-.+.+.+|++--
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 87775333 2 235689999999999853 2458999999999999999999999999999889998888631
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC---HHHHhcCCccccccCCCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNA 371 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~~~ 371 (419)
..+.||+. ..+|++++|||.++|+ +|..|.+ ++++..||||.++.|.+-
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence 12334421 2379999999999986 7889998 999999999999998653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=356.05 Aligned_cols=269 Identities=28% Similarity=0.402 Sum_probs=225.8
Q ss_pred CCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
......+.|.+.+.||.|.|++|.+|++..++..||||.|.+... ...+|+++|+.++|||||+++.+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~---- 125 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE---- 125 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee----
Confidence 445566789999999999999999999999999999999976532 2458999999999999999999984
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
....+|+||||+.++ .+.+|...++++.+..++.++.|+++|++|||+ ++|||||||.+|||++ .+.++||+||
T Consensus 126 -t~~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~-~~mnikIaDf 199 (596)
T KOG0586|consen 126 -TEATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLD-ENMNIKIADF 199 (596)
T ss_pred -ecceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccc-cccceeeecc
Confidence 444599999999864 333444456888889999999999999999999 7999999999999999 6778999999
Q ss_pred ccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 225 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
|++..+..+....+++|++.|.|||++.|..+.++.+|+||+|+++|.|+.|.+||.+.+-.+.....+.
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------- 269 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------- 269 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------
Confidence 9999998888888999999999999999988889999999999999999999999998765443332222
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~ 378 (419)
..+++ +-.++.++.+||+++|..+|.+|++.+++..|.|...........+....
T Consensus 270 -------gk~rI------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~ 324 (596)
T KOG0586|consen 270 -------GKYRI------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIER 324 (596)
T ss_pred -------eeecc------------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhccccc
Confidence 12222 23468999999999999999999999999999999887665333333333
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=353.24 Aligned_cols=275 Identities=26% Similarity=0.444 Sum_probs=206.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||++++..+|..+|+|.+.... ....+|+++++.++|+||+++++++. +...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence 457999999999999999999999999999999886432 23457999999999999999999884 34458
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-CCCcEEEccCccccc
Confidence 999999995 66666543 356899999999999999999999822699999999999999 577899999999876
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc---
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC--- 306 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 306 (419)
.... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+... .++.+.......
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEPH 227 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCcc
Confidence 5332 23346789999999999764 48999999999999999999999998776544322 222211100000
Q ss_pred -cCcCC-------ccc---cCC---------CCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 307 -MNPNY-------TDF---RFP---------QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 307 -~~~~~-------~~~---~~~---------~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..+.. ... ..+ .+............+++++++||.+||++||++|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000 000 000 0000000000112468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=352.49 Aligned_cols=246 Identities=26% Similarity=0.480 Sum_probs=194.3
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 1234577777665 899999999998 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc-c
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-~ 232 (419)
||+.+ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEC-CCCCEEEeeCCccccccCC
Confidence 99995 55444432 4679999999999999999999999 6999999999999999 67789999999987532 2
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCCCHHHH
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--------AVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~ 304 (419)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 2233456789999999999764 48999999999999999999999995311 11111111100
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC------HHHHhcCCccccccC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 368 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t------~~e~l~hp~f~~~~~ 368 (419)
.. ..++..++.++.+||++||+.||.+|+| ++++++||||+.+.+
T Consensus 220 -------~~------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 -------KQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------CC------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00 1134457899999999999999999998 589999999988654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=351.08 Aligned_cols=246 Identities=30% Similarity=0.516 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHh-cCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+++.||+|++.... .....|..+++. ++||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999886532 122346667765 5999999999988 4445689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+.+ +|...+.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEEC-CCCCEEEccCCcceECCCC
Confidence 99985 66655543 3568899999999999999999999 6999999999999999 5778999999998753222
Q ss_pred -CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N-------------- 212 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 233456789999999999764 4899999999999999999999999988766555544321 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH-HHhcCCccccccCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~ 369 (419)
..++..++.++.+||.+||+.||.+|+++. ++++||||+.+.+.
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 012234688999999999999999999996 89999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.44 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=206.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+..++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 6999999999999999999999999999999986421 2234688899999999999999988 455669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.| +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLD-KNGHIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEEC-CCCCEEEEECCceee
Confidence 999999974 66666643 24568999999999999999999999 6999999999999999 678899999999876
Q ss_pred cccCCcc--eeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 230 LVKGEAN--ISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 230 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
....... ....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence 5433221 23468999999999863 24478899999999999999999999988777666655543110
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~ 370 (419)
.+.++. ....++.++++||++||+.++.+ |+++.++++||||..+++..
T Consensus 226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 001111 01236899999999999765544 78999999999998876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.29 Aligned_cols=280 Identities=24% Similarity=0.346 Sum_probs=214.4
Q ss_pred ccceeeeceeccCCceEEEEEEEc--CCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
..+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+++++.++|+||+++++++ .....+|+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence 357999999999999999999754 35678999987654 3456899999999999999999988 445568999
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||++.+++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence 99999988877742 4679999999999999999999999 6999999999999999 6778999999999765433
Q ss_pred Cc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHhcc
Q 014750 234 EA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 234 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....+..+.+.++..+.+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 2345789999999999764 48999999999999999999999997653 45667777776665443211100
Q ss_pred CcC----CccccCCCCCCCCchhhc-CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 308 NPN----YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~~----~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
... +..+.........+...+ ...++.++.+||++||.+||++|||+.++|.||||.+..+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 000 000111000000011111 1245788999999999999999999999999999987443
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=353.27 Aligned_cols=245 Identities=28% Similarity=0.473 Sum_probs=201.9
Q ss_pred ceeccCCceEEEEEEEc---CCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
+.||+|+||.||++++. .+|+.||+|++.+.. ....+|+++++.++|+||+++++++ .+...+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence 57999999999999863 578999999886432 2234689999999999999999988 445568999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLD-EEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEEC-CCCcEEEeeccCCcccCC
Confidence 999984 66555543 4568999999999999999999999 6999999999999999 677899999999976543
Q ss_pred C-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 G-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.+..
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------- 214 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------- 214 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 3 223456789999999999764 47899999999999999999999999887766665554310
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccC
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~ 368 (419)
.. ++..+++++.+||++||+.||.+|++ +.+++.||||..+.+
T Consensus 215 --~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 215 --LG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred --CC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 01 23346899999999999999999999 788999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=343.91 Aligned_cols=279 Identities=34% Similarity=0.608 Sum_probs=226.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ...+|+.+++.++|+||+++++++... +...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence 469999999999999999999999999999998863321 234799999999999999999987543 12568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~-~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLN-NRGILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEEC-CCCcEEEeecCceeec
Confidence 999999998887777642 2368999999999999999999999 6999999999999999 6788999999999866
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+.+.++....+.+....|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 443 2223456788899999987665578999999999999999999999999998899999999999888877764321
Q ss_pred --CCccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 --NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 --~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
......+.......+...++.. +++.+.+||++||+.||++|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111112222233344444 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=340.85 Aligned_cols=277 Identities=34% Similarity=0.647 Sum_probs=221.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|++|.||+|++..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999885432 2345799999999999999999988 445568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLIS-ERGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEc-CCCCEEECcccccccc
Confidence 999999999887776542 3468899999999999999999999 6999999999999999 6778999999998654
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... ......++..|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+.+.++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 2211 11223467889999998765668899999999999999999999998765 667777888888888877765443
Q ss_pred c--CCccccCCCCCCCCchhhcCCCCC--hhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 P--NYTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 ~--~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
. .+....++..........++ .++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 2 22222222222222222222 234 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=319.10 Aligned_cols=268 Identities=26% Similarity=0.417 Sum_probs=216.3
Q ss_pred cCCCCCCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH-----HHHHHHHH-hcCCCCeeecceee
Q 014750 66 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMR-LMDHPNVISLKHCF 139 (419)
Q Consensus 66 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~e~~~l~-~l~h~niv~~~~~~ 139 (419)
+++-...+....+.+.+..||.|..|.|++++.+.+|..+|||.+.+..... ...++++. ..++|+||+.+++|
T Consensus 81 i~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 81 IGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 3333334445566788889999999999999999999999999986554322 23344333 33589999999999
Q ss_pred eccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce
Q 014750 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (419)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v 219 (419)
....+ ++|.||.|..-...+++. ..++++|..+-.+...++.||.||.+..||+|||+||+|||+| ..|+|
T Consensus 161 i~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD-e~Gni 231 (391)
T KOG0983|consen 161 ITNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGNI 231 (391)
T ss_pred eeCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc-cCCCE
Confidence 66544 789999998666566654 2467999999999999999999999755999999999999999 68889
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHh
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVL 296 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~ 296 (419)
||||||++..+.+....+...|.+.|||||.+.- ...|+.++||||||++++||.||..||.+. .+.+.+.++.+.
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~- 310 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE- 310 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-
Confidence 9999999999988888888899999999999843 345899999999999999999999999984 567778777762
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.|+. ++ ...++|++..+|+..||++|+.+||...++|+|||+..+..
T Consensus 311 -ePP~--------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 311 -EPPL--------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred -CCCC--------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 1110 00 11247999999999999999999999999999999987543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=346.82 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=219.0
Q ss_pred CCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
.+.....|+.-++||+|+||.||-++...||+.||+|++.+.+ .....|..+|.+++.++||.+-..|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 3455567899999999999999999999999999999875432 2234799999999999999998888
Q ss_pred CCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
+....+|+||..|+|+ |.-.+. ...+..+++..++.++.+|+.||++||+ .+||+|||||+|||+| +.|+|+|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiy--n~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLD-d~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIY--NHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLD-DHGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEee--ccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeec-cCCCeEeec
Confidence 4444499999999975 222222 2234589999999999999999999999 7999999999999999 688899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
+|+|..+..+......+||..|||||++.+.. |+...|+|||||+||||+.|+.||...........+-+..-.
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----- 404 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----- 404 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----
Confidence 99999998888888889999999999997765 999999999999999999999999876554433333322111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~ 370 (419)
-...+++++|+++++|.+.+|+.||.+|. +++++.+||||+++++..
T Consensus 405 --------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 405 --------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred --------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 01235567899999999999999999998 467999999999998875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=347.83 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=206.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|+.++..++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 6999999999999999999999999999999885321 1245688899999999999999988 455568
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+. |+|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~-~~~~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMD-MNGHIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEC-CCCCEEEeecchhee
Confidence 99999998 5676666542 3568999999999999999999999 6999999999999999 678899999999875
Q ss_pred cccCCc--ceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 230 LVKGEA--NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 230 ~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
...... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence 433222 123578999999999863 34578999999999999999999999998877766666543110
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 369 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~ 369 (419)
.+.++. ....+++++.+||++||+.++.+ |++++++++||||..+.+.
T Consensus 226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 011111 11246899999999999765554 6899999999999987644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=341.26 Aligned_cols=275 Identities=35% Similarity=0.662 Sum_probs=221.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||.|++|.||+|++..+|+.||||.+..+. ....+|+++++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 4889999999999999999999999999999886432 2345799999999999999999988 4455689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+.+++...+... ....+++..++.++.|++.||+|||+ +|++||||+|+||+++ .++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEeeccchhhcc
Confidence 99999998877766542 24568999999999999999999999 6999999999999999 67889999999987653
Q ss_pred cCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc-
Q 014750 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 309 (419)
Q Consensus 232 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 309 (419)
.... .....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+.++.+..+.+....++....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3221 22345688899999987766578899999999999999999999999988888888888888887665543211
Q ss_pred -CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 -~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+. ..++......+... ...+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 111 12222222222222 23478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=342.27 Aligned_cols=282 Identities=36% Similarity=0.640 Sum_probs=224.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc---------HHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... ...|+++++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 488899999999999999999999999999998654322 24689999999999999999998 4455
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++||||+.++|.+.+... ...+++..++.++.||++||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~-~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIA-SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEc-CCCCEEEccceeee
Confidence 68999999977777776542 1368999999999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ......++..|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+.++...++.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 664432 2223456788999999876666899999999999999999999999988888888888888888777666432
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
...-...........+... .....+.++.+||.+||..||++|||+.+++.||||++...+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 2111111111111111111 2234688999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=338.75 Aligned_cols=275 Identities=36% Similarity=0.639 Sum_probs=220.0
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.+. |+||+++++++... ....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6788999999999999999999999999998865321 1235888888885 99999999988542 1245899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+.+++++.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 9999999888777642 3568999999999999999999999 69999999999999994 8899999999987654
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc-CC
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NY 311 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~ 311 (419)
........++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.......... ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 44444566789999999876655678999999999999999999999999998888888888888877654332211 11
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+.++......+... ...++.++.+||.+||..||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKL-LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHH-cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 2223332222222111 23568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=341.09 Aligned_cols=282 Identities=35% Similarity=0.653 Sum_probs=224.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||+|++|.||+|++..+|+.||+|.+.... ....+|+++++.++|+||+++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 46999999999999999999999999999999875432 2345799999999999999999998 444569
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+++++.+.+.... ...+++..++.++.||+.||+|||+ +||+||||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999999988877765422 2346788899999999999999999 699999999999999865678999999999754
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
.... ......+++.|+|||.+.+...++.++|||||||++|+|++|..||...+..+.+.++....+.+....|....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3221 12334678899999998765568899999999999999999999999988888888888888888766654321
Q ss_pred -cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 309 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
+++. ..++....... ......+++++.++|.+||+.||++||++.++++||||.+++.
T Consensus 234 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYK-SAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhh-hhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 1110 01111111111 1122356889999999999999999999999999999998654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.91 Aligned_cols=275 Identities=35% Similarity=0.668 Sum_probs=216.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEEE
Confidence 6999999999999999999999999999999875332 2235799999999999999999988 4445689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+++++++.+.. ....+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILIT-KQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEc-CCCcEEECccccceecC
Confidence 9999999876655543 34568999999999999999999999 6999999999999999 67789999999998764
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc-
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 309 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 309 (419)
... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+............
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 433 223456788999999987766688999999999999999999999998888777777776665544322221111
Q ss_pred -CCccccCCCCC-CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 -NYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 -~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
-+.....+... ..++...+ ..++..+.+||.+||+.||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKF-PNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHh-ccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 01111111111 11111222 3468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=353.29 Aligned_cols=244 Identities=27% Similarity=0.493 Sum_probs=196.7
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCccc-------HHHHHHHHHhc---CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRLM---DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
||+|+||+||+|++..+++.||+|++.+.... ...|..++... +||||+++++++ .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 79999999999999999999999998643211 12355555544 799999999988 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCC
Confidence 99985 55555543 4679999999999999999999999 6999999999999999 5778999999998754322
Q ss_pred -CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 -EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
......+||..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22345678999999999976666899999999999999999999999988766655544321
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC----CHHHHhcCCcccccc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR 367 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~----t~~e~l~hp~f~~~~ 367 (419)
...++ ...+++++.+||++||+.||.+|+ ++.++++||||....
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 11111 123688999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=365.07 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=214.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC---C
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 145 (419)
...+|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.++..++|+||+++++.+..... .
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4458999999999999999999999999999999886432 223468889999999999998877643322 1
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
....+++||||+. |+|.+.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~-~~~~vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLC-SNGLVKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEe-CCCCEEEEec
Confidence 2235789999998 57888777655556789999999999999999999999 6999999999999999 5788999999
Q ss_pred ccccccccC---CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 225 GSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 225 G~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~---- 262 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---- 262 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----
Confidence 999765332 122346789999999999764 489999999999999999999999998877666555443110
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..++..+++++.+||.+||+.||.+||++.++++|||++.+.
T Consensus 263 ------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 263 ------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 012345789999999999999999999999999999997643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=351.57 Aligned_cols=245 Identities=29% Similarity=0.467 Sum_probs=197.7
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHH-HHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+|+.||+|++.+... ...+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 469999999999999999999999998864321 1123333 56789999999999888 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+.+ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEEeecCCcccCCCC
Confidence 99986 5544443 34678999999999999999999999 6999999999999999 677899999999875322
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~---------------- 212 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP---------------- 212 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 2233456789999999999764 48999999999999999999999999887766655554310
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCccccccC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f~~~~~ 368 (419)
..++..++..+.++|++||+.||.+|+++ .++++||||....+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 01123468899999999999999999976 59999999987644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=348.11 Aligned_cols=250 Identities=29% Similarity=0.450 Sum_probs=203.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (419)
+|+..+.||+|+||.||+|++..+|+.||+|++.+.. .....|..+++.+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3778899999999999999999999999999886432 12335777887776 56777888887 44456
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+||||++| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~-~~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLD-SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEecccccc
Confidence 8999999985 55555543 4679999999999999999999999 6999999999999999 67889999999987
Q ss_pred ccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 54322 223345789999999999764 48999999999999999999999999887766666555410
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~ 368 (419)
. .++..++.++.+|+.+||+.||.+|++ ..++++||||+.+.+
T Consensus 218 ------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 218 ------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 0 123456899999999999999999997 579999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=349.76 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=197.8
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHH-HHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+++.||+|++.+... ...+| ..+++.++|+||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 369999999999999999999999999864321 11123 3356788999999999988 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEC-CCCCEEEccCCCCcccccC
Confidence 99996 55555543 4568899999999999999999999 6999999999999999 577899999999875422
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 2233456789999999999764 5899999999999999999999999988877666655431 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH----HHhcCCccccccC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELRE 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~----e~l~hp~f~~~~~ 368 (419)
..+...++..+.+||.+||+.||.+|+++. ++++|+||....+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 001235689999999999999999999875 8999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.05 Aligned_cols=291 Identities=37% Similarity=0.679 Sum_probs=234.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||.|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4899999999999999999999899999999886432 2345799999999999999999988554322334689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
++|||+++++.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~-~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVN-SNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEcccCceEeec
Confidence 9999999877766653 3479999999999999999999999 6999999999999999 57889999999998765
Q ss_pred cCC----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 232 KGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 232 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... ......++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2334567899999999987646899999999999999999999999999999999999999999887766532
Q ss_pred CcC-Cccc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 014750 308 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (419)
Q Consensus 308 ~~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 375 (419)
... ..++ ..+......+...+ ..++.++.+||.+||+.||.+|||+++++.||||+.+..+....+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~ 304 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC
Confidence 211 1111 01111222233322 3478999999999999999999999999999999998776555433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.48 Aligned_cols=281 Identities=36% Similarity=0.628 Sum_probs=217.7
Q ss_pred ceeeeceeccCCceEEEEEEEcC--CCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48899999999999999999988 89999999887632 2345799999999999999999998532 225
Q ss_pred eEEEEeecccccHHHHHHhhccCC-CCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC----CCceEEee
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL----THQVKLCD 223 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~~vkl~D 223 (419)
.+++||||+++++.+.+....... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ . ++.+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~-~~~~~~~~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVM-GEGPERGVVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEc-CCCCccceEEECC
Confidence 689999999998888776544333 378999999999999999999999 6999999999999999 5 67899999
Q ss_pred cccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH---------HHHH
Q 014750 224 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLV 290 (419)
Q Consensus 224 fG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~ 290 (419)
||++........ .....++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.. +.+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876533222 123467889999999877666899999999999999999999999865432 3566
Q ss_pred HHHHHhCCCCHHHHhccC--cCCccc----cCCCCCCCCchhhcC--CCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 291 EIIKVLGTPTREEIRCMN--PNYTDF----RFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+...++.+....+.... +++... .............+. ...+.++.++|.+||..||++|||+.|+++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 777777777666553221 111110 000000011111111 156889999999999999999999999999999
Q ss_pred c
Q 014750 363 F 363 (419)
Q Consensus 363 f 363 (419)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=348.58 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=197.0
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHH-HHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..+++.||+|++.+... ...+|. .+++.++|+||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 369999999999999999999999998864321 112333 467889999999999888 4455689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc-
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK- 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~- 232 (419)
||+++ +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEEC-CCCCEEEccCCCCccCCCC
Confidence 99985 55444432 4678999999999999999999999 6999999999999999 578899999999875322
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 2223446789999999999764 4899999999999999999999999988766555544321 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCccccccCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~ 369 (419)
..++...+.++.++|.+||+.||.+|+++ .++++|+||..+.+.
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 01233468899999999999999999875 599999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=347.39 Aligned_cols=247 Identities=25% Similarity=0.446 Sum_probs=196.6
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +|+||+.+++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999987532 1234677888777 699999999988 4455699999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc-c
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-K 232 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~-~ 232 (419)
||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+++... .
T Consensus 76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEe-CCCCEEEeccccceeccCC
Confidence 99985 55554443 4579999999999999999999999 6999999999999999 57789999999987532 2
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHhc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+.+.... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K-------- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence 2334456789999999999764 58999999999999999999999996422 11222221110 0
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC------HHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~ 369 (419)
. ..++..++..+.++|++||+.||.+|++ .+++++||||+.+.+.
T Consensus 219 ------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 219 ------P------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0 0123457899999999999999999998 5799999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.17 Aligned_cols=288 Identities=30% Similarity=0.537 Sum_probs=219.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCC------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK------ 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------ 145 (419)
..+|.+.+.||.|+||.||+|.+..+|+.||+|++.... ....+|+++++.++|+||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357999999999999999999999999999999885432 2345799999999999999999876432211
Q ss_pred ---CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 146 ---DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 146 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
+...+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++..++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence 1235789999999877666543 468999999999999999999999 6999999999999998667789999
Q ss_pred ecccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 223 DFGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 223 DfG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|||++........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 122357888999998866566889999999999999999999999988887777777665544
Q ss_pred CCHHHHhccCcCCccccC--CCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 299 PTREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
............+..... ......++... ...++.++.+||.+||+.||.+|||+.+++.||||+.+..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDL-LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHH-ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 433222211101000000 00111112222 235789999999999999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=336.76 Aligned_cols=276 Identities=35% Similarity=0.655 Sum_probs=224.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||.|++|.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++. +....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence 4889999999999999999999999999999886432 23347899999999999999999984 3445899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+++++.+.+.... ....+++..+..++.|++.||.|||+ .||+||||||+||+++ +++.+||+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 99999998887776532 23568999999999999999999999 6999999999999999 678899999999975433
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ......++..|++||.+.+...++.++|||||||++|+|++|..||.+.+..+....+.+..+.|....+..+. ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 21 12234568899999998776667899999999999999999999999998888899998888888877765443 11
Q ss_pred cc--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 312 TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 312 ~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.. ..++......+.. +...++.++.++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1222222222222 223468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=345.65 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=206.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|..++..++|+||+++++++ .+...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 36999999999999999999999999999999886421 1234688899999999999999988 55567
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+||||+.| +|.+.+... ...+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~-~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLD-MNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEc-CCCCEEEEecccee
Confidence 9999999985 666666542 3578999999999999999999999 6999999999999999 67789999999997
Q ss_pred ccccCCcc--eeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 229 VLVKGEAN--ISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 229 ~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
........ ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~---- 226 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER---- 226 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence 65433221 235689999999998642 34788999999999999999999999988776666555431100
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCCC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 370 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~ 370 (419)
+.++. ....+++++.+||.+||+.++++ |++++++++||||+.+.+..
T Consensus 227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 01111 01236899999999999976655 56899999999999866543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.64 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=203.7
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+.+++.+ .+...+|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence 778899999999999999999999999999885432 1234689999999999999999888 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLD-DHGHIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEEC-CCCCEEEeeccceeec
Confidence 99999985 566655432 23468999999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........|+..|+|||++.+. .++.++|||||||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------ 219 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------ 219 (285)
T ss_pred CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence 444333445789999999999764 4899999999999999999999999865432111111111000
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
....++..+++++.+||++||+.||.+|+| ++|+++||||+++...
T Consensus 220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 001123456889999999999999999999 9999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=337.85 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=197.7
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||+|+||.||++++..+|+.||+|.+.... .....|+++++.++||||+++++++ .+...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 799999999999999999999999885321 1234589999999999999999888 4555699999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
.| +|...+... ....+++..+..++.||+.||+|||+ +||+||||||+||+++ .++.+||+|||++.........
T Consensus 76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEc-CCCCEEEeeceeeeecCCCcee
Confidence 85 555555432 23458889999999999999999999 6999999999999999 6778999999999776544444
Q ss_pred eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccC
Q 014750 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (419)
Q Consensus 237 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+.+..- . ....+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----------~---~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----------E---DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----------c---ccccc
Confidence 4567899999999997655 89999999999999999999999976543221112211100 0 00000
Q ss_pred CCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCccccccCC
Q 014750 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 369 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~ 369 (419)
....++.++.+||++||+.||.+|+++ ++++.||||+.+.++
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 112468899999999999999999999 778899999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=373.75 Aligned_cols=266 Identities=27% Similarity=0.409 Sum_probs=213.9
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
+....+|.+++.||.|+||+||+|++..+++.||+|.+.... .....|+.+++.++|||||+++++|.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~ 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KA 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cC
Confidence 345568999999999999999999999999999999886432 224479999999999999999998854 23
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC------CCcccccccCCceeeCCC----
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------PGVCHRDVKPQNLLVDPL---- 215 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~ivH~Dlkp~NIll~~~---- 215 (419)
...+||||||+. ++|.+.|.........+++..++.|+.||+.||.|||+. ++||||||||+||||+..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 345899999998 578888876555567899999999999999999999983 149999999999999631
Q ss_pred ------------CCceEEeecccccccccCCcceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCC
Q 014750 216 ------------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (419)
Q Consensus 216 ------------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~ 282 (419)
...+||+|||++.............||+.|+|||++.+. ..++.++||||||||||+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 235899999999876544444456789999999998653 3478999999999999999999999987
Q ss_pred CCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 283 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+....+...+... +. ++ ....+.++.+||.+||..||.+||++.|+|.|||
T Consensus 246 ~~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 246 ANNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 66555444333210 00 00 1235889999999999999999999999999999
Q ss_pred cccccCC
Q 014750 363 FDELREP 369 (419)
Q Consensus 363 f~~~~~~ 369 (419)
|..+..+
T Consensus 298 ik~i~~p 304 (1021)
T PTZ00266 298 IKNVGPP 304 (1021)
T ss_pred HhhcCCC
Confidence 9876544
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=342.03 Aligned_cols=314 Identities=34% Similarity=0.580 Sum_probs=239.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
.+|.+.+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 46999999999999999999999999999999886431 124579999999999999999998754322 12234
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+||||+..++...+ ...+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~-~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVN-EDCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCCCCcC
Confidence 6899999987654432 2468899999999999999999999 6999999999999999 578899999999875
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+.....
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 422 223457788999999987655689999999999999999999999999888888888888888877666544321
Q ss_pred CC-cc--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCch
Q 014750 310 NY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (419)
Q Consensus 310 ~~-~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 386 (419)
.. .. ...+......+...++ ..+.++.+||.+||+.||.+||++++++.||||..+++..... . +..++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~-~----~~~~~~~ 318 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET-E----QQPYDDS 318 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC-C----CCcccch
Confidence 10 00 0112222222222222 3688999999999999999999999999999999987643221 1 2224444
Q ss_pred HHhhcCCHHHHhhhcHHHHH
Q 014750 387 QELAGASPELINRLIPEHVR 406 (419)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~ 406 (419)
.+....+.+.....+.+++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~ 338 (342)
T cd07879 319 LENEKLSVDEWKKHIYKEVK 338 (342)
T ss_pred hhhhhCCHHHHHHHhhhhhh
Confidence 44445556666666666643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.29 Aligned_cols=254 Identities=27% Similarity=0.342 Sum_probs=210.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCC-CcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ....+|+.+++.++||||+++++++ .....+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEE
Confidence 3599999999999999999998877 7889999764332 2345699999999999999999998 4445699
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|||||+. |+|.+.+.........+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~-~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLM-PTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEEC-CCCcEEEEeCcCceec
Confidence 9999998 57777776655556678999999999999999999999 6999999999999999 5778999999999865
Q ss_pred ccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------- 289 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------- 289 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 4332 13346789999999999664 5899999999999999999999999988776666655431100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.++..++.++.+||.+||..||++||++++++.|+|++..
T Consensus 290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0223468899999999999999999999999999999754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.40 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=213.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+.|.++..||.|+||+||+|.++.++-.-|.|.|.... ....-|++||..++||+||++++.|+..+. +
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----L 104 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----L 104 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----e
Confidence 3456999999999999999999999888888889875332 233458999999999999999999966544 8
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+.|||+|+-.+.+.- ..+..+++.+++.+++|+|.||.|||+ ++|||||||..|||++ -+|.|+|+|||.+...
T Consensus 105 wiliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~T-ldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLT-LDGDIRLADFGVSAKN 180 (1187)
T ss_pred EEEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEE-ecCcEeeecccccccc
Confidence 99999999875555432 346789999999999999999999999 7999999999999999 6888999999997543
Q ss_pred c-cCCcceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 231 V-KGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~-~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
. ......++.|||+|||||+... ...|+.++||||||++|.||..+.+|....+..-.+-+|.+.- |+
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--PP----- 253 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP----- 253 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--CC-----
Confidence 2 2234567999999999999754 3458999999999999999999999998888877777776521 10
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...-|...+..+.||+.+||..||..||+++++|+||||...
T Consensus 254 -------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 254 -------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 111234568899999999999999999999999999999864
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=336.10 Aligned_cols=252 Identities=35% Similarity=0.587 Sum_probs=205.9
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH------HHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++++.||+|+||+||++++..+++.||+|++....... .+|+.+++.++|+||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 889999999999999999999999999999987553222 248899999999999999999844 555889
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc-
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL- 230 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~- 230 (419)
||||+.+ +|.+.+.. ...+++..+..++.||+.||.+||+ +||+|+||||+||+++ .++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEES-TTSEEEESSGTTTEEST
T ss_pred cccccccccccccccc----ccccccccccccccccccccccccc-cccccccccccccccc-ccccccccccccccccc
Confidence 9999997 78777762 3678999999999999999999999 6999999999999999 7888999999999753
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........++..|+|||++.....++.++||||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 223334456789999999998734568999999999999999999999999885555555544433221111100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.....+.++.+||.+||+.||++|||+.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000123799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=343.63 Aligned_cols=316 Identities=35% Similarity=0.620 Sum_probs=242.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457999999999999999999999999999999875421 223469999999999999999987743322 2233
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++|+||++++|.+.+.. ..+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~-~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVN-EDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEccccccc
Confidence 5899999998888777653 569999999999999999999999 6999999999999999 57889999999997
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65332 3345678899999998765567899999999999999999999999998888888888888888776655433
Q ss_pred cCCc-cc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
.... .+ ..+......+...+ ..++.++.+||++||+.||.+|||+.++++||||.+...+... +..+.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~-----~~~~~~~~ 318 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE-----PVAPPYDQ 318 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc-----ccccccCc
Confidence 2111 00 01111112222222 2458999999999999999999999999999999987655322 22333333
Q ss_pred hHHhhcCCHHHHhhhcHHHHH
Q 014750 386 KQELAGASPELINRLIPEHVR 406 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~ 406 (419)
.-.-......+++.++..++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07851 319 SFESRDLTVDEWKELVYKEIM 339 (343)
T ss_pred chhhhhcCHHHHHHHhHHHHH
Confidence 333344566677777766654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=333.61 Aligned_cols=306 Identities=28% Similarity=0.429 Sum_probs=244.9
Q ss_pred CCCcccceeeeccCCCCCCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH---HHHHHHHHhcC--
Q 014750 54 NDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLMD-- 128 (419)
Q Consensus 54 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~e~~~l~~l~-- 128 (419)
.+...|.+..+.+|.. ...++|.+.++||-|-|++||+|.|.++.+.||+|+++....+. ..|+++|+.++
T Consensus 59 ~dY~kGGYHpV~IGD~----F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 59 EDYRKGGYHPVRIGDV----FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred hhhhcCCCceeecccc----ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3455566667777664 45589999999999999999999999999999999987665444 46999999873
Q ss_pred ------CCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 129 ------HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 129 ------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
..+||++++.|-... ....++|+|+|+++..|+..++... .+.++...++.|++||+.||.|||+-.||||
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred CCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 357999999986654 4677899999999999999998754 3669999999999999999999998679999
Q ss_pred ccccCCceeeC---------------------------------------------------------------------
Q 014750 203 RDVKPQNLLVD--------------------------------------------------------------------- 213 (419)
Q Consensus 203 ~Dlkp~NIll~--------------------------------------------------------------------- 213 (419)
.||||+|||+.
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 99999999980
Q ss_pred ---------------------------------------------CC---------------------------------
Q 014750 214 ---------------------------------------------PL--------------------------------- 215 (419)
Q Consensus 214 ---------------------------------------------~~--------------------------------- 215 (419)
..
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence 00
Q ss_pred ------------------CCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCC
Q 014750 216 ------------------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (419)
Q Consensus 216 ------------------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 277 (419)
+-++||+|||-|.... ...+..+.|+.|+|||+++|.. |+..+||||++|++|||+||.
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGD 448 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGD 448 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCc
Confidence 0137888998887652 2344567899999999999876 999999999999999999999
Q ss_pred CCCCCC------CHHHHHHHHHHHhCCCCHHHHhcc-------CcCCccccCCCCCCCCchhhcCCC------CChhHHH
Q 014750 278 PLFPGE------NAVDQLVEIIKVLGTPTREEIRCM-------NPNYTDFRFPQIKAHPWHKVFHKR------MPPEAID 338 (419)
Q Consensus 278 ~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~------~s~~~~d 338 (419)
.+|... .+++.++.|+..+|..++.....- +....-..+-.++.+++..++... ...++.|
T Consensus 449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd 528 (590)
T KOG1290|consen 449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD 528 (590)
T ss_pred eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence 999643 467899999999999888766432 222222244455666666655432 2456889
Q ss_pred HHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 339 LASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 339 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
||.-||+++|++|+||.++|+|||++....+
T Consensus 529 FL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 529 FLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 9999999999999999999999999976554
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=334.06 Aligned_cols=278 Identities=35% Similarity=0.620 Sum_probs=215.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCeE
Confidence 357999999999999999999999999999999886432 1345799999999999999999988 344568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.+++.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+|||++ .++.+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLIS-YLGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEc-CCCcEEEecccccccc
Confidence 99999999887776643 23457888899999999999999999 6999999999999999 6788999999998754
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+ ..+.+.++...++.|....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 122334568899999998765567889999999999999999999997654 456677777777777766544322
Q ss_pred --cCCccccCCCCCCCCchhhcCC-CCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 --PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 --~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+.+....++......+...... ..+.++.++|.+||+.||.+|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1221111111111111111110 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=337.66 Aligned_cols=284 Identities=30% Similarity=0.507 Sum_probs=219.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC---C
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 145 (419)
..++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999999999999999885332 122469999999999999999998754322 2
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.....++||||+.+++.+.+.. ....+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILIT-KDGILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEC-CCCcEEECcCC
Confidence 2345799999999987777654 23468999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
++........ .....++..|+|||.+.+...++.++||||||+++|+|++|..||.+.+.......+....|..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9976533221 12345678899999987765578999999999999999999999999888888888888777766
Q ss_pred HHHHhccC--cCCccccCCCCCCCCchhhc-CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 301 REEIRCMN--PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 301 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+.++... ..+....++..........+ +...+..+.+||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 55443321 00111112211111111111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=343.27 Aligned_cols=243 Identities=26% Similarity=0.363 Sum_probs=204.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC---cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
..+++++.||+|-||.||.|..+. ...||+|.++.. ...+.+|+++|+.|+|+|||++++++.. +.-+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CCceEEE
Confidence 357788899999999999999843 237999988753 3445689999999999999999999843 3358999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||. |+|++.|+. ..+..+...+...++.|||+|++||++ +++|||||-..||||+ ++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVD-EDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeec-cCceEEEcccccccccCC
Confidence 99999 789988886 346778999999999999999999999 6999999999999999 688999999999995544
Q ss_pred CCcceeeee--ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
+......-+ ...|.|||.+.-. .++.++|||||||+||||+| |+.||.+.+..+.+..+.+....|.
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------- 425 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------- 425 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence 433222222 3459999999654 59999999999999999999 9999999999999998887543332
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
|..+++++.+++..||..+|++|||.+.+.
T Consensus 426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 356899999999999999999999998654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=313.39 Aligned_cols=285 Identities=33% Similarity=0.597 Sum_probs=238.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..++|++.+++|+|-|+.||.|.+..+++.++||+++.- .+...+|+.+|+.|. |+||++++++..+..+ ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCchh
Confidence 456899999999999999999999999999999988643 345679999999997 9999999998855433 33679
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
++||+.+.-+..|- ..++...++.++.|++.||.|||+ .||+|||+||.|++||.....++|+|||+|.+...
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999976333333 457788899999999999999999 59999999999999998788899999999999888
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHh-----c
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-----C 306 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-----~ 306 (419)
+......+.+++|-.||.+..-+.|+..-|+|||||++..|+..+-|| .|.+..+++.+|.+++|+......- .
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 877777888999999999988888999999999999999999977665 6889999999999999986554332 1
Q ss_pred cCcCCccccCCCCCCCCchhhcCC----CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
+++.|.++ .......+|...++. -+++++.||+.++|.+|..+|+|+.|++.||||..+.+..
T Consensus 266 Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 266 LDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred CChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 33444332 223455667766654 2579999999999999999999999999999998766544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=337.37 Aligned_cols=275 Identities=29% Similarity=0.454 Sum_probs=225.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH-------HHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|..+.+||.|+||+|.+|..+.+.+.||||+++++.... ..|.++|... +-|.+++++.+|. .-
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----Tm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----TM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----hh
Confidence 446899999999999999999999999999999987764322 2467777766 4678999999984 44
Q ss_pred eeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+.|+ |.-.+.+ -+.+.+..+..++.+|+-||-+||+ +|||+||||.+|||+| ..+.|||+|||+
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd-~eGHiKi~DFGm 496 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLD-SEGHIKIADFGM 496 (683)
T ss_pred hheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEec-cCCceEeeeccc
Confidence 4499999999965 3333333 4678899999999999999999999 7999999999999999 577899999999
Q ss_pred cccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 227 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++...- +....+++|||.|+|||++.- ..|+.++|+||+||+||||+.|++||.+.++.+.++.|...
T Consensus 497 cKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------- 565 (683)
T KOG0696|consen 497 CKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------- 565 (683)
T ss_pred ccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence 986533 344567999999999999964 45999999999999999999999999999999999998862
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccCCC-CCCCCCCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN-ARLPNGRPF 379 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~-~~~~~~~~~ 379 (419)
...+|+.+|.++.++++.+|...|.+|... .++..||||+.++|.. +......|+
T Consensus 566 -------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPf 626 (683)
T KOG0696|consen 566 -------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPF 626 (683)
T ss_pred -------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCC
Confidence 123567889999999999999999999864 5899999999998875 334444555
Q ss_pred CCCC-------CchHHhhc
Q 014750 380 PPLF-------NFKQELAG 391 (419)
Q Consensus 380 ~~~~-------~~~~~~~~ 391 (419)
.|.. ||+..++.
T Consensus 627 kPk~k~~r~~eNFD~~Ft~ 645 (683)
T KOG0696|consen 627 KPKIKCGRDAENFDKFFTR 645 (683)
T ss_pred CCccccCCchhhhhHHHhc
Confidence 5533 66654443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=339.94 Aligned_cols=312 Identities=35% Similarity=0.603 Sum_probs=236.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCC--CcEEEEEEeccCc------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.||++++..+ +..||+|++.... ....+|+.+++.+ +|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488999999999999999999888 8999999886421 2235689999988 5999999988654322 2234
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|++|+|++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~-~~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVN-ADCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEc-CCCCEEeCcCCCce
Confidence 5789999999887777653 4678999999999999999999999 6999999999999999 57789999999997
Q ss_pred ccccCCc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
....... .....|+..|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+..++..+|.+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6533221 22356889999999987655689999999999999999999999999999999999999999988766
Q ss_pred HhccCcCCc-c--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCC
Q 014750 304 IRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 380 (419)
Q Consensus 304 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~ 380 (419)
+........ . ..........+.... ..++..+.+||.+||+.||.+|||+.+++.||||+++.++....-+.. +
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~--~ 310 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQK--P 310 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccc--c
Confidence 544321100 0 001111111222222 235889999999999999999999999999999998876544333333 3
Q ss_pred CCCCchHHhhcCCHHHHhhhcH
Q 014750 381 PLFNFKQELAGASPELINRLIP 402 (419)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~ 402 (419)
+.+.|..+. +.+.++.+|-
T Consensus 311 ~~~~~~~~~---~~~~~~~~~~ 329 (332)
T cd07857 311 FDFSFESED---SMEELRDMII 329 (332)
T ss_pred ccCCccccc---cHHHHHHHHh
Confidence 344444322 3444544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=334.43 Aligned_cols=276 Identities=36% Similarity=0.674 Sum_probs=216.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+++++.++|+||+++++++ .+....|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 6899999999999999999999899999999875432 2245799999999999999999998 4556689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+.+++++.+.. ....+++..++.++.||+.||.|||+ .||+||||+|+||+++ +++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCcEEEEeeeeeeecc
Confidence 9999999875554433 23458999999999999999999999 6999999999999999 57889999999987653
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC--
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 308 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 308 (419)
... ......++..|+|||++.+...++.++|||||||++|+|++|++||...+..+....+....+...........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 332 22345678899999998765667889999999999999999999999888777777777766654332221111
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+.......+......-.......++..+.+||.+||..||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 1111122222211111111234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.42 Aligned_cols=279 Identities=26% Similarity=0.416 Sum_probs=204.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++|+||+++++++. +...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence 357999999999999999999999999999999876442 23457999999999999999999984 34568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++ .++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-CCCCEEEeeCCcchh
Confidence 999999985 66666654 356889999999999999999999723799999999999999 577899999999875
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCCHHHHhccC
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~ 308 (419)
.... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.. ..+.+.........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 5322 22345789999999999764 489999999999999999999999987654333221110 01111100000000
Q ss_pred c-------CCccccCCC---------CCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 P-------NYTDFRFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~-------~~~~~~~~~---------~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. .+....-+. +............++.++.+||.+||++||++|||+.|++.||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0 000000000 000000000112357889999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=332.86 Aligned_cols=274 Identities=35% Similarity=0.661 Sum_probs=219.8
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++|+||+++++++ .+....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 677889999999999999999999999999886432 2345799999999999999999988 44566899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
+|||+++++.+.+.... ...+++..+..++.|++.||+|||+ +|++||||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLID-REGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEc-CCCcEEEeecccccccCC
Confidence 99999888877765422 1468999999999999999999999 6999999999999999 588899999999975432
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc--
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 309 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 309 (419)
.. ......++..|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.++.+..+.+....|.....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 21 122345688899999987655578999999999999999999999999988888888888888888776543211
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
++.. .++......... ....++.++.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKP-TFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhh-hcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1110 112111111111 234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=334.27 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=206.8
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+.+.+++ .....+|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 778889999999999999999999999999885432 1235699999999999999998888 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +||+||||||+||+++ +++.+||+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~ 152 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLD-DYGHIRISDLGLAVKI 152 (285)
T ss_pred EEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEC-CCCCEEEecCCcceec
Confidence 99999996 454444321 23469999999999999999999999 6999999999999999 5678999999999765
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+........
T Consensus 153 ~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------- 221 (285)
T cd05632 153 PEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------- 221 (285)
T ss_pred CCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------
Confidence 443333456789999999999764 489999999999999999999999987766544444433211100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
..++..++.++.+|+.+||+.||.+|++ +.+++.|+||+.....
T Consensus 222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 ---------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred ---------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0123356889999999999999999999 8999999999986443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=323.95 Aligned_cols=322 Identities=31% Similarity=0.541 Sum_probs=250.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
.+|.-++.+|.|+- .|..|.|.-+++.||+|++... .+...+|+.++..++|+||++++.+|..... .....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888999999998 7888999999999999987533 3445689999999999999999999854332 12334
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+|||+|..++.+.+. -.++-..+..++.|++.|++|||+ .||+||||||+||++. .+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~-~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVN-SDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceec-chhheeeccchhhcc
Confidence 78999999998887776 236667899999999999999999 5999999999999999 688899999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
....-..+.++.|+.|+|||++.+.. |...+||||+|||+.||++|+..|.|.+..++..++.+.+|+|....+..+.+
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 65554566789999999999999876 99999999999999999999999999999999999999999999998876653
Q ss_pred CCccc--cCCCCCCCCchhhcCC-----------CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCC
Q 014750 310 NYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376 (419)
Q Consensus 310 ~~~~~--~~~~~~~~~~~~~~~~-----------~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 376 (419)
....+ ..++.....+.+.+++ .-+..+.||+.+||..||++|.+++++|+||||+-+-...+. .
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev---~ 323 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEV---E 323 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccc---c
Confidence 21111 1111111222222222 124568999999999999999999999999999844322211 1
Q ss_pred CCCCCCCCchHHhhcCCHHHHhhhcHHHHHhhcCC
Q 014750 377 RPFPPLFNFKQELAGASPELINRLIPEHVRRQTGL 411 (419)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (419)
.+.++...-...+...+++.++..|.+++.+.-..
T Consensus 324 ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 324 APPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred CCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 22222121222344557899999999998876553
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.57 Aligned_cols=282 Identities=32% Similarity=0.578 Sum_probs=221.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC---CC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---KD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (419)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+++++.++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 568999999999999999999999999999999885321 234579999999999999999988754332 23
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+++||||+.+++...+.. ....+++..++.++.||++||.|||+ +||+||||||+||+++ +++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILID-NQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEECcCcc
Confidence 446799999999887766653 24579999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc------------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 014750 227 AKVLVKGEA------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 227 a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 294 (419)
++....... .....+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976533221 12235688899999987665689999999999999999999999999998888888888
Q ss_pred HhCCCCHHHHhccC--cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 295 VLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 295 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+.+....++... +..............+...+ ..+++++.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 88877766554321 11111000000111111111 2356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=340.68 Aligned_cols=280 Identities=35% Similarity=0.572 Sum_probs=222.0
Q ss_pred cccee-eeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------------------cHHHHHHHHHhcCCCCeeecc
Q 014750 76 TISYM-AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRLMDHPNVISLK 136 (419)
Q Consensus 76 ~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~~~ 136 (419)
..+|. +.+.||.|+||+||+|.+..+++.||+|++..... ...+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34575 45779999999999999999999999998854321 234799999999999999999
Q ss_pred eeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC
Q 014750 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
+++. .....|+||||+.+++.+.+.. ...+++..+..++.|++.||.|||+ +||+||||+|+||+++ .+
T Consensus 87 ~~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~-~~ 155 (335)
T PTZ00024 87 DVYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFIN-SK 155 (335)
T ss_pred EEEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEEC-CC
Confidence 9883 4456899999999988777754 4568999999999999999999999 6999999999999999 67
Q ss_pred CceEEeecccccccccC---------------CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCC
Q 014750 217 HQVKLCDFGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (419)
Q Consensus 217 ~~vkl~DfG~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 281 (419)
+.+||+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 78999999998765311 111223467889999999776667999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCc--CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+.+..+.+..+...++.+....|+.... .+.. +.......+... ....+.++.++|.+||..||++|||++++|.
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--cCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9999999999998888887765543211 1111 111111111111 2346889999999999999999999999999
Q ss_pred CCccccccCC
Q 014750 360 HPFFDELREP 369 (419)
Q Consensus 360 hp~f~~~~~~ 369 (419)
||||+.....
T Consensus 313 ~~~~~~~~~~ 322 (335)
T PTZ00024 313 HEYFKSDPLP 322 (335)
T ss_pred CcccCCCCCC
Confidence 9999875443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.39 Aligned_cols=276 Identities=36% Similarity=0.677 Sum_probs=223.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 699999999999999999999999999999987532 1234579999999999999999999843 44589
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||+++++.+.+.. ....+++..+..++.||+.||.|||+ +|++||||+|+||+++ +++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVS-ESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCCEEEEeeecccccC
Confidence 9999999887665543 23568999999999999999999999 6999999999999999 68889999999987765
Q ss_pred cCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC-
Q 014750 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 308 (419)
Q Consensus 232 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 308 (419)
... ......++..|+|||++.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+....+...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 23346778899999999876468999999999999999999999999888888888887777766654443322
Q ss_pred -cCCccccCCCCC-CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 309 -PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 309 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+....++... ...+...++..++.++.+||++||..||++|||+++++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 122222222221 1222333455568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.45 Aligned_cols=285 Identities=35% Similarity=0.597 Sum_probs=224.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 357999999999999999999999999999999886432 223469999999999999999998753321 2234
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..|+++++++++|.+.+.. ..+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEc-CCCCEEEecccccc
Confidence 5789999998887666543 468999999999999999999999 6999999999999999 57789999999987
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......++..|+|||++.+...++.++|||||||++|+|++|+.||...+....+..+.+..+.+.........
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 543 223345778999999998765568899999999999999999999999888888888888888887776655433
Q ss_pred cCCccc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 309 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 309 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
...... ..+......+...+ ...++++.+||.+||+.||.+|+|+.++++||||.++..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhc-CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 221100 01111111111111 13588999999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.26 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=198.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (419)
...|++++.||+||.++||++.. ...+.||+|++.... .....|+.+|.+| .|.+||+++++- -.+.
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence 44699999999999999999985 344567777664332 2235799999998 599999999987 4467
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
++|+||||-+.+|-..|..+. ..++...++.|..|++.|+.++|++ ||||.||||.|+|+- .|.+||+|||+|.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV--kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV--KGRLKLIDFGIAN 507 (677)
T ss_pred eEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE--eeeEEeeeechhc
Confidence 799999998889888888643 3344458999999999999999995 999999999999997 5779999999998
Q ss_pred ccccCCcc---eeeeeccccccchhhcCCC----------CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 229 VLVKGEAN---ISYICSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 229 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
.+..+... .+.+||+.||+||.+.... ..+.++||||||||||+|++|++||... .....++..+
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~aI 585 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLHAI 585 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHHhh
Confidence 87655443 3579999999999985321 1467899999999999999999999643 2233333332
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..|. ..+.||++.. ..++.++++.||.+||.+|||+.++|+|||+.-
T Consensus 586 -~~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 586 -TDPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred -cCCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 2221 2234444321 234999999999999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=341.99 Aligned_cols=293 Identities=34% Similarity=0.661 Sum_probs=230.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|.+.+.||+|+||.||+|.+..+|+.+|+|++... .....+|+.+++.+ +|+||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 345799999999999999999999989999999987532 12234699999999 99999999998743 233
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|+||||+.++|...+.. ..+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~-~~~~~kl~d~g~~ 154 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLN-SDCRVKLADFGLA 154 (337)
T ss_pred ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCcEEEeeccch
Confidence 45899999999887766653 267888899999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCC------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 228 KVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 228 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
....... ......++..|+|||++.+...++.++|+|||||++|+|++|+.||.+....+....+....+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 7654322 1223567899999999876666889999999999999999999999998888888888888888776
Q ss_pred HHHhccCcCCcccc---CCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCC
Q 014750 302 EEIRCMNPNYTDFR---FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378 (419)
Q Consensus 302 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~ 378 (419)
..+..+........ ++..........++ .++.++.+||.+||+.||++|||+.++++||||+.+..+........+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~ 313 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYP 313 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCC
Confidence 65554322211111 11111122222233 378999999999999999999999999999999998766555433333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=346.34 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=212.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|.-++.||.|+||.||.|+|..+.+.||||++.-..+ .+.+|+..|+.++|||++.+.+||.- +...
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-----e~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-----EHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-----cchH
Confidence 47778999999999999999999999999999864432 23479999999999999999999954 3337
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||||-|+-.+++.-. .+++.+.++..|+.+.+.||.|||++ +.||||||..|||++ +.+.|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLS-EPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEec-CCCeeeeccccchhhc
Confidence 899999999877777643 46899999999999999999999996 999999999999999 7889999999999765
Q ss_pred ccCCcceeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
....+++|||+|||||+++ ..+.|+-++|||||||+..||.-.++|+...+....+..|..-
T Consensus 177 ---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN------------- 240 (948)
T KOG0577|consen 177 ---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------------- 240 (948)
T ss_pred ---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-------------
Confidence 3446799999999999985 3456999999999999999999999999998888888877652
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.-|.+... ..|..+..||..||++-|.+|||.+++|.|+|...
T Consensus 241 ------esPtLqs~--------eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 241 ------ESPTLQSN--------EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ------CCCCCCCc--------hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 11222222 34788999999999999999999999999999865
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=332.22 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=203.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHH-HHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|++..+|+.||+|++..... ....|+. .++.++|+||+++++++. ....+|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcEE
Confidence 68999999999999999999999999999998865422 1223444 467789999999999884 344589
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||++++|.+.+.........+++..++.++.||+.||.|||+ + +++||||||+||+++ .++.+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 999999998888887655556789999999999999999999998 6 999999999999999 5778999999999866
Q ss_pred ccCCcceeeeeccccccchhhcCC---CCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHhc
Q 014750 231 VKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..........++..|+|||++.+. ..++.++|+|||||++|+|++|+.||... ...+.+..+... ..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------- 225 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PS------- 225 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CC-------
Confidence 443333345678899999988542 33688999999999999999999999653 222333322221 00
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..+ ....++.++.+||.+||..||.+||++.++++||||....
T Consensus 226 -------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 -------PQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -------CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 1123688999999999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=329.04 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=202.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 35899999999999999999999999999999875331 2345689999999999999999998 444
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+||||+|+||+++ .++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~-~~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeeccc
Confidence 579999999985 66665554 3568899999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
++........ ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------ 223 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------ 223 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence 8765332211 2345788999999997654 8999999999999999999999998765554443332210
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
....++..++.++.+||++||..||.+|||+.++++||||
T Consensus 224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0111334578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.02 Aligned_cols=275 Identities=39% Similarity=0.703 Sum_probs=223.6
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|.+.+.||+|+||.||+|++..+++.|+||.+..... ...+|+..++.++ |+||+++++++. +....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence 6788999999999999999988999999998865422 2346888999999 999999999883 4556899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+.+++.+.+.... ...+++..+..++.|++.+|.|||+ +|++|+||+|+||+++ .++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999888887776532 3578999999999999999999999 6999999999999999 678899999999987654
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc--C
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--N 310 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~ 310 (419)
........++..|+|||++.+...++.++|+||||+++|+|++|++||...+..+...++...++.+....|..... +
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44444567888999999986666689999999999999999999999999999899999999988888765543211 1
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.....++..........++. .+.++.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPN-ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHccc-CCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 11122222222222222332 37899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=330.64 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=208.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.+ +|+||+++++++..........+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 4567999999999999999999999999999999886432 2334688889888 89999999998865443344568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~-~~~~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEc-CCCCEEEeecccchh
Confidence 999999985 6666665544455678999999999999999999999 6999999999999999 577899999999876
Q ss_pred cccCCc-ceeeeeccccccchhhcCCC----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 230 LVKGEA-NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 230 ~~~~~~-~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
...... .....++..|+|||++.... .++.++|||||||++|+|++|+.||...+....+..+.+.. +.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~~---- 251 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--PP---- 251 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--CC----
Confidence 543222 22356788899999985432 26889999999999999999999998776555544433210 00
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
. ...+..++.++.+||.+||+.||++||++.++++||||+
T Consensus 252 -------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 -------------T-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------C-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 001223577899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=336.36 Aligned_cols=315 Identities=34% Similarity=0.610 Sum_probs=235.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCC-Cce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 148 (419)
.++|++.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 456999999999999999999999999999999885432 1234799999999999999999988543221 123
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++||||+++++...+.. ..+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~-~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeeccccc
Confidence 4689999998777666542 568999999999999999999999 6999999999999999 57789999999997
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... ......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+.+..+.+....+..+.
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred cccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 6532 22345678899999998765558899999999999999999999999988888888888877766655443322
Q ss_pred cCCc-c--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
.... . ...+......+. .+...++.++.++|.+||+.||.+|||+.+++.||||+......... . .++ +.-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~-~---~~~-~~~ 318 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET-E---APP-YDD 318 (343)
T ss_pred chhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc-C---CCC-ccc
Confidence 1100 0 011111111111 12345788999999999999999999999999999999876543321 1 111 222
Q ss_pred hHHhhcCCHHHHhhhcHHHH
Q 014750 386 KQELAGASPELINRLIPEHV 405 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~ 405 (419)
.-.....+.+..+++...++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~ 338 (343)
T cd07880 319 SFDEVDQSLEEWKRLTFTEI 338 (343)
T ss_pred cHHhhccchHHHHHHHHHHH
Confidence 22333445666666665554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.52 Aligned_cols=274 Identities=40% Similarity=0.737 Sum_probs=224.4
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|.+.+.||+|++|.||+|.+..+++.+++|.+..... ...+|+.+++.++|+||+++++++. +...+++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence 5678899999999999999998999999998864432 2457899999999999999999883 4456899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+++++.+.+... ...+++..+..++.||+.||.|||+ +||+|+||||+||+++ .++.+||+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEEC-CCCcEEEeeeeeeEecCC
Confidence 9999999887777652 3578999999999999999999999 6999999999999999 577899999999876644
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc--
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 309 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 309 (419)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 223356788899999997764689999999999999999999999999999999999998888888776655433
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
....+.++......... ....++.++.+||.+||..||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 22222333322222222 223578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=320.37 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=204.4
Q ss_pred ceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
-|++. +.||+|+|+.|--+....+|..||||+|.+.. ....||++++... .|+||+.++++| +++..+|
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FY 152 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFY 152 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEE
Confidence 46653 67999999999999999999999999997653 2345899998887 599999999999 7777899
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC--ceEEeeccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAK 228 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~a~ 228 (419)
||||-|.| .|+..+.+ ...+++.++.+++.+|+.||.|||. +||.||||||+|||....+. -||||||.+..
T Consensus 153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99999985 55555554 4679999999999999999999999 79999999999999874332 48999999875
Q ss_pred ccccCC--------cceeeeeccccccchhhc----CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHH---------
Q 014750 229 VLVKGE--------ANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--------- 287 (419)
Q Consensus 229 ~~~~~~--------~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------- 287 (419)
-+.... ...+.+|+..|||||+.. ....|++++|.||||+|+|.||+|.+||.+.-..+
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 432221 123568888999999862 23468999999999999999999999998753321
Q ss_pred ------HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 288 ------QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 288 ------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
.+..|.. ..|.||+. .| ..+|.+++|||+.+|..|+.+|.++.++++||
T Consensus 308 r~CQ~~LFesIQE-----------------GkYeFPdk---dW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 308 RVCQNKLFESIQE-----------------GKYEFPDK---DW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred HHHHHHHHHHHhc-----------------cCCcCChh---hh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 1222222 22344432 22 24699999999999999999999999999999
Q ss_pred ccccccCC
Q 014750 362 FFDELREP 369 (419)
Q Consensus 362 ~f~~~~~~ 369 (419)
|++.....
T Consensus 363 w~~~~~~e 370 (463)
T KOG0607|consen 363 WVQRCAPE 370 (463)
T ss_pred cccccchh
Confidence 99886554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=341.79 Aligned_cols=252 Identities=31% Similarity=0.551 Sum_probs=212.0
Q ss_pred eee--eceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 79 YMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 79 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
|++ .++||.|.||+||-|+++.+|+.||||+|.+. ......|+.||+.+.||.||.+.-.| +....+
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv 638 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV 638 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence 555 47899999999999999999999999998643 23456799999999999999987666 333448
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC--CceEEeeccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAK 228 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~ 228 (419)
++|||-+.|++++.+.. ...+++++...+.++.||+.||.|||- +||+|+||||||||+.+.+ .++||||||+|+
T Consensus 639 FVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 639 FVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999999998888765 346899999999999999999999999 7999999999999997433 379999999999
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
++.+.....+.+||+.|+|||+++... |...-||||.|||+|.-+.|.+||....+. -.+|.+
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN-------------- 778 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN-------------- 778 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccch--hHHhhc--------------
Confidence 998888888999999999999998654 899999999999999999999999755332 222221
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..|.+| ..+|. .+++++.|||..+|++.-.+|.|+++.|.|||+++.
T Consensus 779 ---AaFMyP---p~PW~-----eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 ---AAFMYP---PNPWS-----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ---cccccC---CCchh-----hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 122233 23443 469999999999999999999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=331.06 Aligned_cols=277 Identities=32% Similarity=0.612 Sum_probs=221.0
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++... .....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence 678899999999999999999999999999987542 2245799999999999999999988432 1256899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+++++.+.+... ...+++..++.++.||+.||+|||+ .|++|+||||+||+++ +++.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILIN-NDGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEc-CCCCEEEccccceeeccC
Confidence 9999998877766542 2578999999999999999999999 6999999999999999 688899999999976644
Q ss_pred CC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 233 GE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 233 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+.+..+.+....|......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 32 1233456788999998876666899999999999999999999999999988888888888888776665543211
Q ss_pred --CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.............+...+...++.++.++|++||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11111111111112222333358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=329.32 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=207.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCcee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 149 (419)
...++|++.+.||+|+||.||+|++..+++.+|+|++.... ....+|+.+++.+ +|+||+++++++..........
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 45668999999999999999999999999999999875432 2345688999998 6999999999886544445567
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ ++|+||||||+||+++ .++.+||+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~-~~~~~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLT-TEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEEC-CCCCEEEccCCcee
Confidence 8999999985 6766666544456678999999999999999999999 6999999999999999 56779999999987
Q ss_pred ccccCC-cceeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
...... ......|+..|+|||++.+. ..++.++|||||||++|+|++|..||...+....+..+... .+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~---- 246 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP---- 246 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC----
Confidence 654322 22335688999999998532 33788999999999999999999999876544333222110 00
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+ ....+..++.++.+||.+||+.||++|||+.++++|+||
T Consensus 247 -------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -------------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -------------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 001123357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=330.51 Aligned_cols=249 Identities=30% Similarity=0.503 Sum_probs=207.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+...+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCeE
Confidence 6999999999999999999999999999999885432 2244689999999999999999988 445568
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ +||+||||+|+||+++ .++.+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLD-SDGYIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEC-CCCCEEEeeCCCccc
Confidence 99999996 577666654 3678999999999999999999999 6999999999999999 578899999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+... .
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 214 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------- 214 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence 6443 3345688999999998654 4789999999999999999999999887755444444321 0
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
..++..++..++++|.+||+.||.+|+ +++++++||||+.+.+.
T Consensus 215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 012334688999999999999999999 99999999999887644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=329.56 Aligned_cols=282 Identities=30% Similarity=0.521 Sum_probs=221.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-----
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS----- 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 144 (419)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++++.....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 457999999999999999999999999999999886432 123469999999999999999998754321
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
.+...+++||||+++++...+... ...+++..++.++.||+.||.|||+ .||+||||||+||+++ +++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~-~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLN-NKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCcEEeCcc
Confidence 123368999999999877766542 3468999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 225 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|++........ .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99976543321 1223567789999998765557899999999999999999999999988888888888888887766
Q ss_pred HHhccCc--CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 303 EIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 303 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.++.... .+............+.. ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 5543321 11110000000111111 122468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.03 Aligned_cols=237 Identities=27% Similarity=0.438 Sum_probs=201.7
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeeccc-c
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-E 159 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~ 159 (419)
.++-||.|+-|.||+|+. .++.||||+++. ..+.+++-|++|+|+||+.+.+++ ...-.+|||||||. |
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeeccccc
Confidence 456799999999999986 678999998743 345789999999999999999998 56667999999999 7
Q ss_pred cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcceee
Q 014750 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239 (419)
Q Consensus 160 ~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~ 239 (419)
-|+++|+. +..++......|..+|+.|++|||.+ .|||||||.=||||. .+..|||+|||.++...+.....++
T Consensus 198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhh
Confidence 88888875 57788889999999999999999995 999999999999999 6778999999999988777777789
Q ss_pred eeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCC
Q 014750 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 319 (419)
Q Consensus 240 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
+||..|||||++...+ .+.|+|||||||+|||||||..||..-+....+ =..|
T Consensus 272 aGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVG---------------------- 324 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVG---------------------- 324 (904)
T ss_pred hhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeE----Eecc----------------------
Confidence 9999999999997654 899999999999999999999999765542111 1111
Q ss_pred CCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 320 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
...++..+|..+++.++-||++||+-.|..||+..++|.|-
T Consensus 325 -sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 325 -SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 12233445677899999999999999999999999999983
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=326.57 Aligned_cols=274 Identities=38% Similarity=0.695 Sum_probs=227.0
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++.+.||+|+||.||+|++..+++.||+|.+.... .....|+.+++.++|+||+++++++. +...+++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence 667789999999999999999999999999887542 12346899999999999999999883 3456899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||++++|.+.+.... ..+++..+..++.|++.||.|||+ +||+||||+|+||+++ +++.+||+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILIN-RDGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEc-CCCCEEEecCCcccccCC
Confidence 99999998888776532 468999999999999999999999 6999999999999999 578899999999876543
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC-
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 310 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 310 (419)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+....|......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223455778999999876656899999999999999999999999999999999999999999988877654322
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+....++..........++. ++..+.++|++||..||++||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 23334444444444444443 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.07 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=204.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++ .....+|+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence 6899999999999999999999999999999886432 2344799999999999999999988 44556899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+++ +|...+.. ......+++..+..++.||+.||.|||+..||+||||||+||+++ .++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 77 CMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-CCCCEEEeecCCccccc
Confidence 9999996 55444443 222347899999999999999999999624999999999999999 57889999999987653
Q ss_pred cCCcceeeeeccccccchhhcCCC-----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGEANISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.. ......++..|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+........
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 227 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------ 227 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence 22 223346788899999985432 258899999999999999999999977654443333332211110
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
..++..++.++.+||.+||+.||.+||++.++++||||......
T Consensus 228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01223468999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=335.15 Aligned_cols=281 Identities=32% Similarity=0.545 Sum_probs=229.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcC------CCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD------HPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~ 146 (419)
..+|.+....|+|-|++|.+|.+...|+.||||+|.... +.-.+|+++|+.|+ --|+++++..| ..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence 357999999999999999999999999999999997654 33458999999995 35789999888 44
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.+++|||+|.+.-+|.++|+.|.. +-.|....++.|+.|++.||..|.. +||+|.||||+||||+.....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcc
Confidence 556999999999999999998765 5678899999999999999999999 69999999999999998888999999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
|.....++ .+.++.+..|.|||+++|.. |+...|+||+||+||||.||+..|+|.+.-+++...+.+-|..+..++..
T Consensus 584 A~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 584 ASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 98765444 34567788999999999866 89999999999999999999999999999999999999999999887763
Q ss_pred c-------Cc--CCccccCCCCCC-------------CCchhhcCC--CCC-------hhHHHHHhhhcccCCCCCCCHH
Q 014750 307 M-------NP--NYTDFRFPQIKA-------------HPWHKVFHK--RMP-------PEAIDLASRLLQYSPSLRCTAL 355 (419)
Q Consensus 307 ~-------~~--~~~~~~~~~~~~-------------~~~~~~~~~--~~s-------~~~~dli~~~L~~dP~~R~t~~ 355 (419)
- +. +|.......+.. ..+...+-. .++ ..+.+|+.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 2 11 111111110000 011111100 122 3588999999999999999999
Q ss_pred HHhcCCcccc
Q 014750 356 EACAHPFFDE 365 (419)
Q Consensus 356 e~l~hp~f~~ 365 (419)
|+|.||||.+
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=338.68 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=193.1
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 4467999999999999999999752 345789999886432 2345799999999 89999999997742
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc----------------------------------------------------
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS---------------------------------------------------- 170 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------------------------------------------- 170 (419)
....+++||||++ |+|.+.+.....
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 2334789999998 577776654211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc---ceeeee
Q 014750 171 ------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYIC 241 (419)
Q Consensus 171 ------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~ 241 (419)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....... .....+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCC
Confidence 02357888899999999999999999 6999999999999999 578899999999976533221 112344
Q ss_pred ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCC
Q 014750 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 320 (419)
Q Consensus 242 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
+..|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...... +. ..
T Consensus 239 ~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~------ 296 (338)
T cd05102 239 PLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------RM------ 296 (338)
T ss_pred CccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------CC------
Confidence 6789999999764 48999999999999999997 99999876543333332221 00 00
Q ss_pred CCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 321 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 321 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+++++.+||.+||..||.+|||+.++++
T Consensus 297 ------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 ------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.76 Aligned_cols=248 Identities=28% Similarity=0.490 Sum_probs=205.0
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccc
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE 159 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (419)
+||+|.||+||.|+|..|...+|||.|... ..-..+|+.+-+.++|.|||++++++ .++.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 699999999999999999999999998643 23356899999999999999999997 667788999999996
Q ss_pred -cHHHHHHhhccCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc-
Q 014750 160 -TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA- 235 (419)
Q Consensus 160 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~- 235 (419)
+|..+|+. . =+++ .+..+..+..||++||+|||+ +.|||||||-+|+||+...|.+||+|||.++....-..
T Consensus 657 GSLSsLLrs-k--WGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRS-K--WGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHh-c--cCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 55555543 2 2455 788899999999999999999 79999999999999998899999999999987654333
Q ss_pred ceeeeeccccccchhhcC-CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccc
Q 014750 236 NISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (419)
Q Consensus 236 ~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 314 (419)
.-++.||..|||||++.. ...|+.++|||||||++.||.||++||......... +.++ |.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gm---------------- 793 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GM---------------- 793 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cc----------------
Confidence 446899999999999954 345999999999999999999999999865543221 2221 00
Q ss_pred cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. ..+..+|..++.+++.||.+|+..||.+||+|.++|+.||++..
T Consensus 794 ----y---KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 794 ----Y---KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----e---ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0 01223566789999999999999999999999999999999865
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=324.98 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=202.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCCC-CceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~ 150 (419)
.+.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+ +|+||+++++++...... ....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 456999999999999999999999999999999886442 2345788888888 799999999988654322 23468
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~-~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEEC-CCCCEEEccCCCcee
Confidence 899999985 666666542 23568999999999999999999999 6999999999999999 677899999999876
Q ss_pred cccCC-cceeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
..... ......|+..|+|||++.+. ..++.++|||||||++|+|++|..||...........+... +
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 53221 22345788999999998632 24788999999999999999999999765543333222110 0
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0001122457899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=355.42 Aligned_cols=283 Identities=20% Similarity=0.305 Sum_probs=199.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCC-cEEEEE------------------EeccC---cccHHHHHHHHHhcCCCCee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---RRYKNRELQLMRLMDHPNVI 133 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~e~~~l~~l~h~niv 133 (419)
..+|++++.||+|+||+||+|..+... +..+.| .+... .....+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 467999999999999999998764332 222222 11111 12235799999999999999
Q ss_pred ecceeeeccCCCCceeEEEEeecccccHHHHHHhhc-cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
++++++ ......|+|++++.+++.+.+.... ..........++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 227 ~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence 999998 3444588999999988887765422 112334567788999999999999999 699999999999999
Q ss_pred CCCCCceEEeecccccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC-CCC--CCHHH
Q 014750 213 DPLTHQVKLCDFGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPG--ENAVD 287 (419)
Q Consensus 213 ~~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~--~~~~~ 287 (419)
+ .++.+||+|||+++....... ....+||..|+|||++.+. .++.++|||||||++|||++|..+ |.. .+...
T Consensus 301 ~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 N-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred C-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9 577899999999987644322 2346789999999999764 489999999999999999998754 432 23455
Q ss_pred HHHHHHHHhCCCCHHHHhccCc--CCc-cccCCCCCCCCchhhc-CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 288 QLVEIIKVLGTPTREEIRCMNP--NYT-DFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+.+++..++....+....... ++. ...+.... ..+...+ ...++.++.++|.+||++||.+|||+.|+|.||||
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 6666666555433221000000 000 00000000 0011111 12467889999999999999999999999999999
Q ss_pred cccc
Q 014750 364 DELR 367 (419)
Q Consensus 364 ~~~~ 367 (419)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8743
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=331.08 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=210.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+++++.++|+||+++++.+ .+....
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 69999999999999999999999999999998865432 234689999999999999999988 455668
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+.+ +|.+.+... ....+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLH-ESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEc-CCCCEEEeecchhhc
Confidence 999999985 666665432 24678999999999999999999999 6999999999999999 577899999999865
Q ss_pred cccCCc------------------------------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC
Q 014750 230 LVKGEA------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 279 (419)
Q Consensus 230 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 279 (419)
...... .....|+..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 422111 1124678889999999764 479999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC----HH
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----AL 355 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----~~ 355 (419)
|.+.+....+..+... ...++. ...++.++.++|.+||+.||++||| ++
T Consensus 232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 9888776655554321 001110 0125889999999999999999999 99
Q ss_pred HHhcCCccccccCCCCCC
Q 014750 356 EACAHPFFDELREPNARL 373 (419)
Q Consensus 356 e~l~hp~f~~~~~~~~~~ 373 (419)
++|+||||+..+++.-..
T Consensus 285 ~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 285 EIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHcCchhhcCChhhccc
Confidence 999999999977665443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=354.38 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=199.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcC-CCCeeecce-eeeccCCCC-cee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKH-CFFSTTSKD-ELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~ 149 (419)
.++++.+.|.+|||+.||+|.+...|..||+|++.... ....+|+++|+.|+ |+|||.+++ ......... ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 46899999999999999999999888999999875442 33458999999997 999999999 443333333 456
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeeccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
+.|.||||. |+|.+.+..+.. .+|++.++.+|+.++++|+.+||.. . |||||||-|||||+ .++.+||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls-~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLS-ADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEc-CCCCEEeCcccc
Confidence 889999999 699999987665 4499999999999999999999994 6 99999999999999 677899999999
Q ss_pred ccccccCCc----------ceeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 014750 227 AKVLVKGEA----------NISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 227 a~~~~~~~~----------~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 294 (419)
+........ .....-|+.|+|||++. ++...+.|+|||||||+||.|++...||...... .|+.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 864322211 11234589999999862 3344799999999999999999999999765332 1111
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..|.||.. ..++..+++||+.||+.||.+||++.|++.
T Consensus 269 -----------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 269 -----------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -----------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 23344432 357899999999999999999999999884
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=336.13 Aligned_cols=275 Identities=22% Similarity=0.366 Sum_probs=198.3
Q ss_pred eeceeccC--CceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 81 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 81 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
++++||+| +|++||++++..+|+.||+|++.... ....+|+.+++.++||||+++++++. .+...|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence 46789999 78999999999999999999986432 23456899999999999999999884 3445899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+.+ ++.+.+.... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.++++|||.+....
T Consensus 77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEe-cCCcEEEcccchhhccc
Confidence 9999985 6666664322 2458999999999999999999999 6999999999999999 57789999998754332
Q ss_pred cCCc--------ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC--
Q 014750 232 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 300 (419)
Q Consensus 232 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~-- 300 (419)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||.............. +...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 230 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccc
Confidence 1111 1123457779999999653 3588999999999999999999999987654443333221 1110
Q ss_pred -------HHHHhccCcCC--ccccCCC---------CCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 301 -------REEIRCMNPNY--TDFRFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 301 -------~~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+.. .+.... .+..+.. .........+...+++++.+||.+||+.||++|||++++++|||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 231 LDTTTIPAEEL-TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred ccccchhhhhc-ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0000 000000 0000000 00000001122346789999999999999999999999999999
Q ss_pred ccccc
Q 014750 363 FDELR 367 (419)
Q Consensus 363 f~~~~ 367 (419)
|+.+.
T Consensus 310 f~~~~ 314 (327)
T cd08227 310 FKQIK 314 (327)
T ss_pred hhhcc
Confidence 98754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.66 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=198.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||+|+||.||+|++..+++.||+|.+..+. ....+|+++++.++|+||+++++++. .....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence 5888999999999999999999999999999886442 22346999999999999999999984 3445889
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||++++.+... ..+++..+..++.|++.||.|||+ .||+|+||||+|||++ .++.+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEEC-CCCCEEEeeCCcceeccc
Confidence 9999997644322 347888899999999999999999 6999999999999999 578899999999976533
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 309 (419)
. ......++..|+|||++.+. .++.++|+|||||++|+|++|..||......+. ............
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 216 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence 2 23346789999999999764 489999999999999999999999975322110 001111100000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.+ .......++++.+||.+||+.||.+||++++++.||||...+..
T Consensus 217 ------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~ 262 (279)
T cd06619 217 ------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG 262 (279)
T ss_pred ------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCc
Confidence 00 00112357899999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=323.73 Aligned_cols=263 Identities=28% Similarity=0.412 Sum_probs=208.9
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCC-CCc
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDE 147 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 147 (419)
+...++|++.+.||+|+||.||+|.+..+++.+++|++.... ....+|+.+++.+ +|+||+++++++..... ...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 345678999999999999999999999999999999886543 2345799999998 79999999999865443 335
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+.+ +|.+.+......+..+++..++.++.|++.||.|||+ +|++||||+|+||+++ .++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~-~~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLT-KNAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEc-cCCeEEECCCcc
Confidence 568999999995 6666665544345789999999999999999999999 6999999999999999 578899999999
Q ss_pred ccccccCC-cceeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGE-ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+....... ......++..|+|||++... ..++.++|||||||++|+|++|..||........+.++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----- 234 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP----- 234 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-----
Confidence 87653322 22345678899999988542 346788999999999999999999998665544444433210
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+.+ ..+..++.++.+||.+||..||++|||+.++++|||+
T Consensus 235 --------------~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 --------------PPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------CCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0000 0112357899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=327.49 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=203.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+.|++.+.||.|+||.||+|++..+++.+++|.+..... ...+|+.+++.++|+||+++++++. .+..+|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence 569999999999999999999999999999998864432 2346889999999999999999884 3446899
Q ss_pred EeecccccHHH-HHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||++++.+. .+.. ....+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEc-CCCCEEEccCccceecc
Confidence 99999975433 3332 23568999999999999999999999 6999999999999999 57889999999986543
Q ss_pred cCC-cceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
... ......++..|+|||++.+ ...++.++|+|||||++|+|++|..||...+......++... .++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~------ 233 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP------ 233 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc------
Confidence 221 2234567889999999853 233678999999999999999999999876654444333221 000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
. ...+..++.++.+||.+||..||++||+++++++||||..+...
T Consensus 234 -----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 234 -----------T-------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred -----------c-------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 0 00123467899999999999999999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=305.01 Aligned_cols=259 Identities=26% Similarity=0.361 Sum_probs=206.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...+|++.+.||+|||+.||++++..++..||+|++.... ....+|++..++++|||+++++++............
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4568999999999999999999999999999999986433 345689999999999999999998776655566678
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
||+++|.. |+|.+.+......+..+++.++..|+.+|++||++||+ .. .+||||||.|||+. +.+.++|.|||.+
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLS-DSGLPVLMDLGSA 176 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEec-CCCceEEEeccCc
Confidence 99999988 78999998887778899999999999999999999999 57 99999999999999 5788999999998
Q ss_pred cccccC---Cc-------ceeeeeccccccchhhcCCC--CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 228 KVLVKG---EA-------NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 228 ~~~~~~---~~-------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
....-. .. -....+|..|+|||.+.-.. ..+.++|||||||+||+|+.|..||...- ..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hc
Confidence 654211 10 12346788999999985332 35889999999999999999999995211 10
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
-|.-. +.-.-..+.+|.- ..+|+.+.+||+.||+.||.+||++.+++.+
T Consensus 248 GgSla------LAv~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLA------LAVQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEE------EeeeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000 0000011223321 2479999999999999999999999999865
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.01 Aligned_cols=278 Identities=34% Similarity=0.613 Sum_probs=217.1
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhc---CCCCeeecceeeeccCCCCcee
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLM---DHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 149 (419)
|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.+ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999998863321 233577776655 6999999999986544334455
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++++|||+.+++.+.+.... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.+||+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~-~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVT-SDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEc-cCCCEEEeccCccee
Confidence 89999999988877765432 2368999999999999999999999 6999999999999999 568899999999977
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
...........++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 6544444445678889999999765 48999999999999999999999999999888888888777665544332111
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
......++......+.... ..++..+.+||.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFV-PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhh-hhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0001111221122222222 2457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=326.15 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=206.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
-|.++.+||+|+||.||+|.++.+|+.+|||.+..+. ...-+|+.+|++++.+++|++++.|+-..+ ++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence 4889999999999999999999999999999986543 445589999999999999999999865443 999999
Q ss_pred ccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC-
Q 014750 156 YVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG- 233 (419)
Q Consensus 156 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~- 233 (419)
||+ |+..+.++. .++.+++.++..+++..+.||+|||.+ .-||||||..|||++ .+|..||+|||.|..+.+-
T Consensus 109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEc-ccchhhhhhccccchhhhhH
Confidence 999 677777765 357899999999999999999999996 789999999999999 5788999999999766432
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
....+..||+.|||||++..- .|..++||||||++..||..|++||....... .|.-+-..|+. .
T Consensus 184 AKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPP-----------T 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPP-----------T 248 (502)
T ss_pred HhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCC-----------C
Confidence 223467899999999999754 48999999999999999999999997654421 11111111110 0
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
|+ -|+..|.+..|||++||..+|++|.|+.++++|||.++
T Consensus 249 F~------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 249 FK------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred CC------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 00 12235888999999999999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.79 Aligned_cols=282 Identities=38% Similarity=0.726 Sum_probs=223.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||.|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++.+++... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 456799999999999999999999999999999987532 12345799999999999999999987432 23
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..|++|||++++|.+.+.. ..+++..+..++.|++.||.|||+ +||+||||+|+||+++ .++.+||+|||++.
T Consensus 84 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~-~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILIN-ENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeEC-CCCCEEeCcccccc
Confidence 4789999998887766643 467888899999999999999999 6999999999999999 67889999999987
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... ......++..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+.+.+|.++.+.+....
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5422 22345678889999998665568999999999999999999999999988888888888888888766554321
Q ss_pred cC-Cccc--cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 309 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 309 ~~-~~~~--~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.. ..++ .++.....+....+ ..++.++.++|++||+.||++|||+++++.||||.....+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 11 0000 01111111122222 34688999999999999999999999999999998766553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.11 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=202.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||.|++|.||++.+..+++.||+|.+..+. ....+|+++++.++|+|++++++.+. ..+..+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4899999999999999999999999999999885432 22456889999999999999988762 2344588
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+++ ++.+.+... ....+++..++.++.|++.||.+||+ +||+||||||+||+++ .++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~-~~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLT-RTNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEe-cCCcEEEecccceEEe
Confidence 99999985 666666542 23568999999999999999999999 6999999999999999 6788999999999766
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------ 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 4322 22345678899999998764 488999999999999999999999987776555444433110
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+ ..+..+++++.+||.+||+.||.+|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.21 Aligned_cols=245 Identities=31% Similarity=0.461 Sum_probs=202.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHh-cCCCCeeecceeeeccCCCCceeEEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
...+|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++.. -+|+||+++++.+ .+..+.|+|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 4567999999999999999999999999999999998886677778865554 4799999999998 777789999
Q ss_pred eeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||++.|+ +++.+.. ...+. ..+..|+++|+.|+.|||+ +|||||||||+|||++.+.++++|+|||.++....
T Consensus 395 ~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999975 3333322 22233 7788899999999999999 69999999999999943677899999999987644
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||...... ..+...++.+..
T Consensus 469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----------- 531 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----------- 531 (612)
T ss_pred h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-----------
Confidence 3 33456688899999997 456999999999999999999999999877655 233333333321
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...+|.+++|||++||++||.+|+++.+++.||||
T Consensus 532 ----------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ----------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 14579999999999999999999999999999999
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=325.59 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=204.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+|+++++.++|+||+++++.+. ....+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence 456999999999999999999998899999999886432 22446899999999999999999883 445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~-~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLT-LDGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEC-CCCCEEEccCccchhh
Confidence 99999996 55555443 23568999999999999999999999 6999999999999999 6788999999998654
Q ss_pred ccCC-cceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 231 VKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.... ......++..|+|||++.. ...++.++|+|||||++|+|++|+.||...+....+..+... .+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------ 225 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP------ 225 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC------
Confidence 3322 2234568899999999852 233678999999999999999999999877665544443221 00
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+.+ ..+..++.++.+||.+||+.||.+||++.++++||||.+.
T Consensus 226 -----------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 -----------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -----------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0123468899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.22 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=202.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.|++.+.||+|+||.||+|.+..++..+++|.+.... ....+|+++++.++|+||+++++++. .....++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEE
Confidence 3788999999999999999999999999999885432 22346899999999999999999884 34568999
Q ss_pred eecccccHH-HHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~~l~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||++++.+ ..+.. ....+++..+..++.|++.||.|||+ .||+||||||+|||++ .++.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEc-cCCCEEEccccccccccc
Confidence 999996543 33332 23568999999999999999999999 6999999999999999 678899999999875432
Q ss_pred CC-cceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 233 GE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.. ......++..|+|||++.. ...++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------- 227 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence 22 1234567889999999842 2346789999999999999999999998877666555544321100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...+..++.++.+||.+||..||.+|||++++++||||...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00123468899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=330.76 Aligned_cols=276 Identities=25% Similarity=0.387 Sum_probs=202.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++|+||+++++++ .+...+|+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEEE
Confidence 5999999999999999999999999999999886432 2244799999999999999999998 44556899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+..+++||||||+|||++ .++.+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe-cCCcEEEccCCCccccc
Confidence 9999985 66666553 366899999999999999999999723899999999999999 57789999999987653
Q ss_pred cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.... ..+...................
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred cc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccC
Confidence 32 23346788999999998654 488999999999999999999999987654332 2222111000000000000000
Q ss_pred ccccCC----------CCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 312 TDFRFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 312 ~~~~~~----------~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.....+ ..............++.++.+||.+||..||++|||+.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 0000000000011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.49 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=203.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++.+.. ....|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence 357999999999999999999999999999999886433 234468999999999999999998843 44589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+.. ..+++.++..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~-~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEc-CCCCEEECccccchhc
Confidence 99999985 66665542 457899999999999999999999 6999999999999999 6788999999998765
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------- 235 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------- 235 (296)
T ss_pred cccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------
Confidence 33222 2335678899999998654 4789999999999999999999999877654433322210 1000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...+..++..+.+||.+||..||.+|||+.++++||||...
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00123467899999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=327.11 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|...+.||+|+||.||++.+..+++.||+|.+.... ....+|+.++.++. |+||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcE
Confidence 35777889999999999999999999999999886432 22346888888886 9999999998843 3447
Q ss_pred EEEeecccccHHHHHHhh-ccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++|||+.+++.+..... ......+++..+..++.|++.||+|||+..||+||||||+||+++ .++.+||+|||++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc-cCCcEEEeecchhHH
Confidence 899999987665544321 123467999999999999999999999723999999999999999 577899999999976
Q ss_pred cccCCcceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...........++..|+|||++.+. ..++.++|||||||++|+|++|+.||.... .....+.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~------- 228 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP------- 228 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCC-------
Confidence 5444444445678899999999765 358999999999999999999999997654 22222222111100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
+.+ ....+..++.++.+||++||+.||.+|||+++++.||||+....
T Consensus 229 ---------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 229 ---------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred ---------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 000 00111246889999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.65 Aligned_cols=249 Identities=29% Similarity=0.494 Sum_probs=197.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence 5899999999999999999999999999999875321 124568999999999999999988743 2234
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++++|||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~-~~~~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEccCCCc
Confidence 58899999985 66666653 3468899999999999999999999 6999999999999999 5778999999998
Q ss_pred cccccC----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+... +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--- 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--- 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence 754321 111234578889999999764 4899999999999999999999999876544433332211 00
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
...++..+++.+.+|| +||..||++||+++++++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0112234688899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=319.30 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=204.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||.|+||.||+|.+..++..+|+|++.... ....+|+++++.++|+||+++++.+ ......++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEEE
Confidence 6999999999999999999999899999999886432 2345789999999999999999887 44456899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|||++.+ +|.+.+.... ....+++..++.++.|++.||.|||+ +||+||||||+||+++ +++.+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLG-EDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEc-CCCCEEEcccchHHHhc
Confidence 9999985 5655554321 13568999999999999999999999 6999999999999999 57789999999987664
Q ss_pred cCCcc-----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGEAN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..... ....++..|+|||++.....++.++|+|||||++|+|++|..||...+....+.++... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------ 225 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP------ 225 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC------
Confidence 43222 33467889999999876546899999999999999999999999877655444443321 000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.++.. .....++.++.+||.+||..||++|||+.+++.||||
T Consensus 226 --------~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 --------SLETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------CcCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00000 0012468899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.81 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=204.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||.|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. +...+|+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence 6889999999999999999999999999999886442 23457899999999999999999884 3456899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|+||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ +|++||||+|+||+++ +++.++|+|||+++...
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLS-EEGDVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEcccccceeec
Confidence 9999985 56555543 378999999999999999999999 6999999999999999 57889999999997764
Q ss_pred cC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.. .......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 214 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------- 214 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence 43 2233457788999999997654 8999999999999999999999998766544333332210
Q ss_pred CccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. ..+... ++.++.++|.+||..||++|||++++++||||.+..
T Consensus 215 -----~---------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 215 -----P---------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred -----C---------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 0 001112 688999999999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=324.45 Aligned_cols=252 Identities=28% Similarity=0.461 Sum_probs=204.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .....+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence 46999999999999999999999999999999886432 2234689999999999999999988 34456899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|+||+.+ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++ .++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccCccchhcc
Confidence 9999986 4444443 2468999999999999999999999 6999999999999999 57889999999987654
Q ss_pred cCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------- 234 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------- 234 (296)
T ss_pred cccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------
Confidence 3322 2234678899999998654 4789999999999999999999999887765554443221 1100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
...+..+++.+.+||++||..||.+|||+.+++.||||+...
T Consensus 235 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 ---------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 001234688999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=338.18 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=225.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+++.+..||-|+||.|-+++.......+|+|++++.. .....|..+|...+.++||+++..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 346778889999999999999987666669999886542 2223588999999999999999999 8888
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
++|++||-|- |.++..|++ .+.|.+..++.++..+++|+.|||+ +|||+|||||||+|++ .+|-+||.|||+|
T Consensus 494 yvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd-~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLD-NRGYLKLVDFGFA 567 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeec-cCCceEEeehhhH
Confidence 9999999987 577777775 4779999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+.+..+....++|||+.|.|||+++... .+.++|.||||+++|||++|.+||.+.+.......|++.+..
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------- 637 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------- 637 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------
Confidence 9999999999999999999999998765 799999999999999999999999999999999999885321
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~ 370 (419)
+ .+|..++..+.+||+++...+|.+|.. +.+|..|.||...+|..
T Consensus 638 ------i------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 638 ------I------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred ------h------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 1 145678999999999999999999986 88999999999988764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.95 Aligned_cols=286 Identities=33% Similarity=0.563 Sum_probs=224.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+.+-.+.||-|+||+||.+.|..+|+.||+|++..- .+..-+|+++|..++|.|++..+++.....-..-..+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3455567899999999999999999999999987532 2334589999999999999998887632221111126
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|++.|++..+|... .-....++...++.+++||++||+|||+ .||+||||||.|+|++ ++-.+||||||+++..
T Consensus 133 YV~TELmQSDLHKI----IVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVN-SNCvLKICDFGLARve 206 (449)
T KOG0664|consen 133 YVLTELMQSDLHKI----IVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVN-SNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHhhhhhe----eccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEec-cCceEEeccccccccc
Confidence 78888877654444 4456889999999999999999999999 5999999999999999 6889999999999875
Q ss_pred ccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..++. .+..+.|.+|+|||+++|...|+.++||||.|||+.||+-.+..|...+..+++..|...+|+|+.+.++..-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 44332 2335679999999999999999999999999999999999999999999999999999999999999887432
Q ss_pred cCCccc------cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 309 PNYTDF------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 309 ~~~~~~------~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.+-... +-|.... -+...-+..-.-+..+++.++|.+||.+|++.++++.|++..+.+-.
T Consensus 287 EGAk~H~LR~~~k~Ps~~v-LYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQR-LYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLR 352 (449)
T ss_pred hhhHHHhhccCCCCCCccc-eeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccccee
Confidence 221111 1111100 00000012334578999999999999999999999999999876543
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.55 Aligned_cols=252 Identities=29% Similarity=0.513 Sum_probs=201.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
+|+..+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4788899999999999999999999999999886432 2345799999999999999999998 455
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++|+||||+||+++..+..+||+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 568999999995 56665543 3568899999999999999999999 69999999999999985556799999999
Q ss_pred ccccccCC-----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+.+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 226 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--- 226 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence 87654321 11234678899999998664 5899999999999999999999999765433333322221000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.....++..+++++.++|.+||..||.+|||+.++++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000112345689999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.03 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=202.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCC-CCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
..+.|++.+.||.|+||.||+|++..+++.+|+|.+.... .....|+.+++.+ +|+||+++++++..... .....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 3457999999999999999999999999999999875442 2345688888888 79999999998854322 23457
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|++|||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~-~~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEeeCcchh
Confidence 8999999985 666666542 23558888999999999999999999 6999999999999999 67789999999987
Q ss_pred ccccC-CcceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKG-EANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
..... .......|+..|+|||++.. ...++.++|+|||||++|+|++|..||...........+... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~--- 243 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP--- 243 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC---
Confidence 54322 12234678899999999853 234788999999999999999999999766543333222110 00
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+ ......++.++.+||++||..||.+|||+.++++||||
T Consensus 244 -------------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 -------------P--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------C--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 00112468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=319.89 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=198.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+.... ....+|+++++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 488899999999999999986 578899999875332 1245689999999999999999988 445
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..++++|||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++ .++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLM-PNGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEEC-CCCeEEeccchh
Confidence 668999999985 56555543 3568899999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccC-------CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 227 AKVLVKG-------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 227 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
+...... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8754211 112234678899999998664 4789999999999999999999999876554433332221010
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
. ..++..++.++.++|++||..||.+||++.++++||||
T Consensus 227 ----------------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------M---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------C---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 11234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=316.30 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=205.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+ .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 4899999999999999999999999999999886432 2345789999999999999999987 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +||+||||||+||+++.+++.+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999985 677766542 23458999999999999999999999 699999999999999866677899999999876
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------- 218 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence 554444456788899999998764 478999999999999999999999988766555444432100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..++..++.++.++|.+||..||.+|||+.++++||||
T Consensus 219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01223468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.98 Aligned_cols=246 Identities=31% Similarity=0.531 Sum_probs=199.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 4788899999999999999999899999999885432 1234689999999999999999988
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.+....++||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||+|+||+++ +++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~-~~~~~~l~d 149 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVD-NKGGIKISD 149 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEc-CCCCEEecc
Confidence 344568899999985 66666543 3568899999999999999999999 6999999999999999 678899999
Q ss_pred cccccccccCCc-------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 014750 224 FGSAKVLVKGEA-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 224 fG~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 296 (419)
||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876642211 1234578889999998764 47899999999999999999999998765544333322200
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...++..++.++.++|++||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 011223468899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=317.13 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=207.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... .....|+++++.++|+||+++++++.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 4889999999999999999999999999999885432 123458899999999999999987753 2344588
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH-----cCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
++|||++ ++|.+.+.........+++..++.++.||+.||.||| + .+++|+||||+||+++ .++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~-~~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLD-ANNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEe-cCCCEEEeccc
Confidence 9999998 4777777765555678999999999999999999999 8 5999999999999999 57889999999
Q ss_pred cccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
++........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 225 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--------- 225 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---------
Confidence 9987654433 3345789999999998664 4889999999999999999999999887754444333221
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+ ..++..++.++.+|+.+||..||.+|||+.++++|||+
T Consensus 226 ----------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ----------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 01234568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=318.28 Aligned_cols=245 Identities=30% Similarity=0.501 Sum_probs=199.7
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||.|+||.||+|++..+++.||+|.+.+.. ....+|+.+++.++|+||+++++.+ .+...+|++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 699999999999999899999999886432 2245689999999999999999987 4445589999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
++ +|.+.+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++ .++.+||+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEc-CCCCEEEeeCCcccccCccccc
Confidence 84 66666654 3458999999999999999999999 6999999999999999 5778999999999876554334
Q ss_pred eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHhccCcCCccc
Q 014750 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (419)
Q Consensus 237 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 314 (419)
....++..|++||.+.+. .++.++|+||||+++|+|++|..||...+ ..+....+.....
T Consensus 150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 211 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------- 211 (262)
T ss_pred ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence 445778899999998654 48999999999999999999999998766 3333333321000
Q ss_pred cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccC
Q 014750 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~ 368 (419)
...++...+.++.++|.+||..||.+|++ +.|+++||||+++.+
T Consensus 212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 01123345789999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=315.32 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=203.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||+|+||.||+|.+..+++.|++|.+... .....+|+++++.++|+||+++++++ .+....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 488899999999999999999999999999987532 22334688999999999999999988 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++..
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~-~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEe-CCCCEEEcccccceec
Confidence 99999974 776666543 24578999999999999999999999 6999999999999999 5778999999998765
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+....+.+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------- 217 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 43322 2335678899999999764 48899999999999999999999998887655554443310
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
++ .++..++.++.++|.+||+.||++||++.++++|||+
T Consensus 218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 1122468899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=325.74 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=203.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ ......|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEE
Confidence 357999999999999999999999999999999886432 2234688999999999999999988 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.. ..+++..+..++.|++.||.|||+ .||+||||||+|||++ .++.+||+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEECcCccceEc
Confidence 99999985 55555432 458889999999999999999999 6999999999999999 6788999999998765
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------
Confidence 33322 223567889999999865 4578999999999999999999999977654332221111 01100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
...+..++..+.+||.+||..||.+||++.+++.||||.....
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 235 ----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 0112346888999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=316.87 Aligned_cols=248 Identities=34% Similarity=0.543 Sum_probs=202.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|+..+.||+|+||+||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 4778899999999999999998899999999875432 2345799999999999999999987 4445
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++++|||+++ +|.+.+.. ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++ .++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~-~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVD-TNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccCccc
Confidence 68999999985 66665543 3568899999999999999999999 6999999999999999 5778999999998
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.............++..|++||.+.....++.++|+|||||++|+|++|+.||......+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 220 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--------- 220 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence 77644443445678899999999865434789999999999999999999999876644444333221000
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..++..+++++.+||++||+.||.+||++.+++.|||+
T Consensus 221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01234568999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=322.39 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=191.1
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHH---hcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.||+|+||.||++.+..+++.+|+|.+.+... ...+|..+++ ..+|+||+.+++.+. .....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence 48999999999999999999999998854321 1123333333 347999999988883 34458999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+.+ +|.+.+.. .+.+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEEC-CCCCEEEccCCcceeccc
Confidence 999995 55544443 4579999999999999999999999 6999999999999999 678899999999875433
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ......|+..|+|||.+.+...++.++|+|||||++|+|++|..||......... .+......
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~-------------- 213 (279)
T cd05633 150 K-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT-------------- 213 (279)
T ss_pred c-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc--------------
Confidence 2 2233568999999999865455889999999999999999999999764322111 11110000
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~ 370 (419)
....++..++.++.++|++||..||.+|+ |+.++++||||+++.+..
T Consensus 214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 00112345789999999999999999999 699999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.13 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=199.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|.+.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.++|+||+++++.+. ....+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEE
Confidence 3479999999999999999999999999999998864422 2346899999999999999999883 445589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.. .+.+++..++.++.|++.||.|||+ .||+|+||||+||+++ .++.+||+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLT-DNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEECcceeeeEc
Confidence 99999985 66665543 4578999999999999999999999 6999999999999999 6778999999998755
Q ss_pred ccCC-cceeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGE-ANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ......|+..|+|||++. ....++.++|+|||||++|+|++|..||...........+...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------ 224 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc------------
Confidence 3222 123457899999999874 2234788999999999999999999999765543332222111
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+..+... ....++..+.+||.+||+.||++|||++++++|||
T Consensus 225 -----~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -----NFQPPKLK-------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----CCCCCccc-------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000000 01135788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=317.69 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=202.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ....+|+++++.++||||+++++++ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4899999999999999999999999999999886432 2335789999999999999999988 555669
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+.| +|.+.+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++ +++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~-~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLD-EQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEc-CCCCEEEeecccccc
Confidence 999999985 55555543 3578999999999999999999999 6999999999999999 678899999999877
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...........++..|+|||++.+. .++.++|+||||+++|+|++|..||...+. .+.+.+....
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 6544334456678899999998664 489999999999999999999999987764 2222221110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH--HHHhcCCcc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF 363 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~--~e~l~hp~f 363 (419)
....++..++.++.++|.+||..||.+|+++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0011234568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=319.83 Aligned_cols=251 Identities=28% Similarity=0.405 Sum_probs=199.6
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||+|+||+||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++.+ .....+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885321 1234689999999999999999888 4445689999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
++ +|.+.+.... ...+++..++.++.|++.||.|||+ +|++||||+|+||+++ .++.+||+|||++.........
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCcc
Confidence 85 6666665422 2468999999999999999999999 6999999999999999 6778999999998766443334
Q ss_pred eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccC
Q 014750 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (419)
Q Consensus 237 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
....++..|+|||++.+.. ++.++|+|||||++|+|++|+.||...........+......
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 212 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------ 212 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence 4456788899999987654 899999999999999999999999776542111111110000
Q ss_pred CCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCC
Q 014750 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~ 370 (419)
....++..+++++.++|++||+.||.+|| ++.++++||||..+++..
T Consensus 213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 00112345689999999999999999999 999999999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=309.78 Aligned_cols=279 Identities=25% Similarity=0.427 Sum_probs=217.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHh-cCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRL-MDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~ 145 (419)
....+|.++++||+|+|++|.+++.+.|.+.||+|+++++.. ....|..+... -+||++|.++.|| +
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----q 321 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----Q 321 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----c
Confidence 445679999999999999999999999999999999875432 22345555544 4799999999999 6
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.+..+++|.||++|+ +++.+ ......++++.++.+..+|+.||.|||+ +|||+||||.+|+|+| ..+.|||+|+|
T Consensus 322 tesrlffvieyv~gg--dlmfh-mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlld-aeghikltdyg 396 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGG--DLMFH-MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLD-AEGHIKLTDYG 396 (593)
T ss_pred ccceEEEEEEEecCc--ceeee-hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEc-cCCceeecccc
Confidence 667799999999975 23333 2335679999999999999999999999 7999999999999999 57779999999
Q ss_pred ccccc-ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCC-------CCHHHHHHHHHHHhC
Q 014750 226 SAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-------ENAVDQLVEIIKVLG 297 (419)
Q Consensus 226 ~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-------~~~~~~~~~i~~~~~ 297 (419)
.++.- ..++...+++|||.|.|||++.|. .|+..+|+|+|||+++||+.|+.||.- .+.++.+.+++-.
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-- 473 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-- 473 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--
Confidence 99764 455667789999999999999875 599999999999999999999999962 2233333333210
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC------HHHHhcCCccccccCCC-
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREPN- 370 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t------~~e~l~hp~f~~~~~~~- 370 (419)
.+ ..+|..+|-.+..+++..|++||.+|.. ..++..|+||+.++|..
T Consensus 474 ------------------------kq--iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 474 ------------------------KQ--IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred ------------------------hc--ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence 00 1134567888999999999999999974 67999999999988764
Q ss_pred CCCCCCCCCCC-------CCCchHHhhc
Q 014750 371 ARLPNGRPFPP-------LFNFKQELAG 391 (419)
Q Consensus 371 ~~~~~~~~~~~-------~~~~~~~~~~ 391 (419)
+......|+.| +-||+..++.
T Consensus 528 eqk~v~ppf~p~i~~d~~l~~fd~qft~ 555 (593)
T KOG0695|consen 528 EQKQVLPPFQPQITDDYGLDNFDTQFTS 555 (593)
T ss_pred hhcccCCCCCCccccccCcccccccccc
Confidence 22233334433 3366655544
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.16 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=198.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++. ....++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEE
Confidence 347999999999999999999999999999999886432 23457999999999999999999884 344589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||||+||+++ .++.+||+|||++...
T Consensus 83 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLT-DNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEC-CCCCEEECcCccceee
Confidence 99999995 56555543 3568999999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccCC-cceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGE-ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ......++..|+|||.+.+ ...++.++|+|||||++|+|++|..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------ 224 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence 3222 2234567889999998742 234678999999999999999999999655433222111110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+..+... ....++..+.+||++||..||++|||++++++|+|
T Consensus 225 -----~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 -----NFQPPKLK-------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----CCCCCCCc-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000000 11246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=315.57 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=202.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
++|.+.+.||+|+||.||+|.+..+++.+++|.+.... ....+|+++++.++|+||+++++++. ....+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEEEE
Confidence 46999999999999999999999889999999886443 34567999999999999999999884 345689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .||+||||+|+||+++ .++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEC-CCCcEEEcccccchhcccC
Confidence 99995 56555543 23568999999999999999999999 6999999999999999 5778999999999866443
Q ss_pred C-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 214 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----------------- 214 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-----------------
Confidence 3 22334578889999998664 5899999999999999999999999876544332221110
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+. ...+..++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 215 --~~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 --PPPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --CCCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000 00122457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=319.90 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=192.9
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccCccc-------HHHHH---HHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.||+|+||.||+|++..+++.||+|.+.+.... ...|. .+++...|+||+.+++++ .....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999999999999988643211 12232 344556899999999888 444568999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+.| +|...+. ....+++..++.++.|++.||.|||+ ++|+||||||+||+++ .++.+||+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEEC-CCCCEEEccCcCccccCc
Confidence 999986 4544443 24679999999999999999999999 6999999999999999 578899999999875533
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ......|+..|+|||++.+...++.++||||+||++|+|++|+.||..................
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 214 (278)
T cd05606 150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------------- 214 (278)
T ss_pred c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------
Confidence 2 2234578999999999976556899999999999999999999999876322111110000000
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 370 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~ 370 (419)
...++..++.++.++|.+||..||.+|+ ++.++++||||++..+..
T Consensus 215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 0112334689999999999999999999 999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=316.90 Aligned_cols=249 Identities=30% Similarity=0.487 Sum_probs=197.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence 6899999999999999999999999999999875321 123469999999999999999998732 2234
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++++|||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +||+|+||||+||+++ .++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRD-SVGNVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEec-CCCCEEECcCccc
Confidence 58899999985 66665543 3457889999999999999999999 6999999999999999 6788999999998
Q ss_pred cccccC----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
...... .......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+.......+.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence 754321 112234578899999998764 489999999999999999999999987654443332221 110
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
...++..++..+.++|++||. +|++||+++++++|||++
T Consensus 227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011234568889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=323.05 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=202.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.|.....||+|+||.||++.+..++..||||.+.... ....+|+.+++.++|+||+++++.+. .....|+|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence 4666678999999999999999999999999885432 23447899999999999999999883 34458999
Q ss_pred eeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||++++ +.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 98 MEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred EeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEc-CCCCEEEccCcchhhccc
Confidence 9999865 444332 2468899999999999999999999 6999999999999999 578899999999875432
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+.......
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 237 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------ 237 (292)
T ss_pred ccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc------------
Confidence 22 22345788999999998654 48999999999999999999999998877655544433211100
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
++ ....++..+.++|.+||..||.+|||++++++||||.....+.
T Consensus 238 ----~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 ----VK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ----cc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 00 0123588999999999999999999999999999999765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=319.20 Aligned_cols=240 Identities=17% Similarity=0.192 Sum_probs=193.0
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
..||+|++|.||+|.. +|+.||+|.+.... ....+|+.+|+.++||||+++++++.... .+...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999997 78999999886432 22348999999999999999999885411 22345889999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~ 234 (419)
|+.+ +|.+.+.. ...+++.....++.|++.||.|||+..+++||||||+|||++ .++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-
Confidence 9996 56666543 456889999999999999999999733899999999999999 6788999999999765322
Q ss_pred cceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 235 ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 235 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
.....++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 2345678899999998652 458999999999999999999999999887766665554321110
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++..+++++.+||.+||+.||++|||+.++++
T Consensus 242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 012246889999999999999999999999985
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=312.18 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=203.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||++++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 4899999999999999999999999999999885321 2345789999999999999999988 5556789
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++ .++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLT-KDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEEeeccceeec
Confidence 99999985 666666532 23457899999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------ 218 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------------
Confidence 43322 1234578889999998664 478999999999999999999999988777666555543110
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...+..++.++.++|.+||+.||.+||++.++++||||
T Consensus 219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00223468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=332.38 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=194.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (419)
...++|++.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~--- 111 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC--- 111 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe---
Confidence 3455799999999999999999986544 3579999986542 2244799999999 899999999988
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhcc---------------------------------------------------
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------------------------------------- 170 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------------------------------------- 170 (419)
.....+++|||||. |+|.+.+.....
T Consensus 112 --~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 112 --THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred --cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 44456899999998 577776643210
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc
Q 014750 171 ---------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (419)
Q Consensus 171 ---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~ 235 (419)
...++++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEe-CCCeEEEeeceeeeeccCCcc
Confidence 12357888999999999999999999 6999999999999999 678899999999976533322
Q ss_pred ce---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 236 NI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 236 ~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ...++..|+|||++.+. .++.++|||||||++|+|++ |..||........+..+.....
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-------------- 332 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-------------- 332 (374)
T ss_pred eeeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--------------
Confidence 11 12235679999998654 58999999999999999997 9999987654433333332100
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+..+++++.++|.+||+.||.+|||+.++++
T Consensus 333 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 -------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.42 Aligned_cols=248 Identities=33% Similarity=0.505 Sum_probs=205.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|+..+.||.|+||.||.+++..+++.+++|.+.... ....+|+++++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 4899999999999999999999999999999875332 2345799999999999999999998 4445689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+ .|++||||+|+||+++ .++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEe-CCCCEEECcCcceEEc
Confidence 99999984 7777665422 3568999999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 4333 22345688999999998764 4789999999999999999999999887766666555431 100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..+..++.++.++|.+||..||.+||++.++++|||+
T Consensus 220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.95 Aligned_cols=254 Identities=29% Similarity=0.482 Sum_probs=203.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+|.+.+.||+|+||.||++.+..+++.|++|.+.... ....+|+++++.++|+||+++++.+ .....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5899999999999999999999999999999886432 1233688999999999999999888 445568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||++| +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~-~~~~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEEC-CCCCEEEeeCCCccc
Confidence 999999986 56555543 3568999999999999999999999 6999999999999999 678899999999864
Q ss_pred cccCC----------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014750 230 LVKGE----------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (419)
Q Consensus 230 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 293 (419)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21100 01123567889999998764 48999999999999999999999998877665555544
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC---HHHHhcCCccccccCC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 369 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~ 369 (419)
.... ..+. ....++.++.++|.+||+.||++||+ +.++++||||...++.
T Consensus 230 ~~~~-----------------~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 230 SDDI-----------------EWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred hccc-----------------CCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 3110 0010 01236889999999999999999998 7999999999775544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=314.96 Aligned_cols=246 Identities=33% Similarity=0.509 Sum_probs=194.4
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHH-HHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||.|+||.||+|.+..+|+.||+|.+.+... ....|..+ ....+|+||+++++++ .....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 569999999999999999999999998864321 11223333 3455899999999988 4445689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++ .++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEC-CCCcEEEeecccceeccc-
Confidence 99985 66555543 3568999999999999999999999 6999999999999999 577899999999875432
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------- 210 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 23456788899999987654 89999999999999999999999988776655444432100
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC---HHHHhcCCccccccC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE 368 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---~~e~l~hp~f~~~~~ 368 (419)
.+ .......++.++.++|.+||+.||++||+ ++|++.||||++++|
T Consensus 211 -~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 211 -NW--------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -CC--------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 00 01112246899999999999999999995 579999999988765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.89 Aligned_cols=252 Identities=31% Similarity=0.532 Sum_probs=198.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------------ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 5889999999999999999999999999999875311 1234688999999999999999987
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
.....+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||+|+||+++ .++.++|+
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~-~~~~~~l~ 150 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKIS 150 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEc-CCCeEEEe
Confidence 444568999999985 66665554 2578999999999999999999999 6999999999999999 67889999
Q ss_pred ecccccccccCC---cceeeeeccccccchhhcCCC-CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 223 DFGSAKVLVKGE---ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 223 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|||++....... ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 229 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS- 229 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence 999987643221 122345788899999986543 478999999999999999999999976554433332211000
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...++ ..+...++.++.+||.+||..||.+|||++++++||||
T Consensus 230 --------------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 --------------APPIP--------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------CCcCC--------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00010 11122468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.22 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=202.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|...+.||.|++|.||+|.+..+++.+|+|.+..... ...+|+++++.++|+||+++++++.. .....+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence 68899999999999999999999999999998864322 34579999999999999999998754 23445889
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+++ +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++ .++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEe-cCCeEEEeecccccccc
Confidence 9999985 6766665544456778999999999999999999999 6999999999999999 57789999999987543
Q ss_pred cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~ 306 (419)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... .+....+.. ....
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~----- 226 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MPNP----- 226 (287)
T ss_pred ccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CCch-----
Confidence 222 223456888999999865 4589999999999999999999999986521 222111111 0000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.++... ......++.+.+||.+||..||.+|||+.|++.||||.+.
T Consensus 227 --------~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 227 --------ELKDEP------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred --------hhccCC------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 000000 0001236789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.17 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=201.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
++|++.+.||.|+||.||+|.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++ .+...+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence 57999999999999999999999999999999886442 2345799999999999999999988 34445899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++ .++.+||+|||++....
T Consensus 78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLT-EDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEEC-CCCCEEECccccchhhh
Confidence 9999996 55444433 22578999999999999999999999 6999999999999999 67789999999987654
Q ss_pred cCC-cceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||...+.......+....-.+
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 223 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--------- 223 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---------
Confidence 322 22345678899999998654 247889999999999999999999998876555444333210000
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
+.. .....++.++.+||++||..||.+|||+.+++.|+|
T Consensus 224 --------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 --------PKL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------ccc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000 011235778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.48 Aligned_cols=254 Identities=20% Similarity=0.251 Sum_probs=193.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcC----------------CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVIS 134 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~ 134 (419)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998543 34479999886532 23457999999999999999
Q ss_pred cceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhcc---------------CCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 014750 135 LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSS---------------MNQRMPLIYVKLYTYQIFRGLAYIHTVP 198 (419)
Q Consensus 135 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~ 198 (419)
+++++. +....++||||+. ++|.+.+..... ....+++..+..++.||+.||.|||+ .
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~ 157 (304)
T cd05096 84 LLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L 157 (304)
T ss_pred EEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence 999884 3345899999998 477776654211 11346788899999999999999999 6
Q ss_pred CcccccccCCceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh
Q 014750 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (419)
Q Consensus 199 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt 275 (419)
||+||||||+|||++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 999999999999999 6788999999999765333221 123446789999998764 48999999999999999987
Q ss_pred --CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC
Q 014750 276 --GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (419)
Q Consensus 276 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 353 (419)
+..||...+..+.+..+......... ......+..++..+.+||.+||..||.+|||
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGR---------------------QVYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccc---------------------cccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 66888877666555544332110000 0000112346889999999999999999999
Q ss_pred HHHHh
Q 014750 354 ALEAC 358 (419)
Q Consensus 354 ~~e~l 358 (419)
+.++.
T Consensus 295 ~~~i~ 299 (304)
T cd05096 295 FSDIH 299 (304)
T ss_pred HHHHH
Confidence 99994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=320.50 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=201.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+...+|+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEE
Confidence 4888899999999999999999999999999876432 2345799999999999999999988 44556899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++ .++.+||+|||++....
T Consensus 80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEe-CCCCEEEcccccccccc
Confidence 9999996 5554443 2568999999999999999999999 6999999999999999 57889999999997654
Q ss_pred cCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------- 216 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------- 216 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence 3322 2234678889999998764 5889999999999999999999999765543332221110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. ...+...++.++.++|.+||..||.+|||+.++++||||..+.
T Consensus 217 ----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 217 ----S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ----C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 0 0012234678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=319.96 Aligned_cols=249 Identities=30% Similarity=0.455 Sum_probs=202.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+++++.++|+||+++++++.. ...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence 45999999999999999999999999999999885332 123478999999999999999999843 345
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.|+||||+.|++.+.+... ...+++..+..++.|++.||.|||+ .||+||||+|+||+++ +++.+||+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLT-EPGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEC-CCCCEEEeecCccee
Confidence 8899999999887766532 3468999999999999999999999 6999999999999999 678899999999875
Q ss_pred cccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ....++..|+|||++.+ ...++.++||||||+++|+|++|..||...+.......+... .+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-------- 231 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-------- 231 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------
Confidence 4322 34567888999998852 345788999999999999999999999877655544333210 00
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+.. ....++.++.++|.+||..||.+||++.+++.||||..
T Consensus 232 ---------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 232 ---------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ---------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000 01235788999999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.26 Aligned_cols=249 Identities=30% Similarity=0.531 Sum_probs=200.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+|+++++.++|+||+++++.+. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence 58889999999999999999999999999998865422 2346899999999999999999884 3456899
Q ss_pred Eeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||++ ++|.+.+... ...+++..+..++.|++.||.|||+ . |++|+||||+||+++ .++.+||+|||.+...
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVN-SRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEEC-CCCCEEEeecccchhh
Confidence 999999 5676666542 2678999999999999999999999 6 999999999999999 5778999999998765
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCCHHHHh
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~ 305 (419)
...... ...++..|+|||.+.+. .++.++|||||||++|+|++|..||...+ ..+.+..+.. ...
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----- 221 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP----- 221 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-----
Confidence 332222 26778899999999765 58999999999999999999999997642 1222222211 000
Q ss_pred ccCcCCccccCCCCCCCCchhhcCC-CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+. .+. .++.++.++|.+||..||.+|||+.+++.||||+.+
T Consensus 222 -----------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -----------PR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----------CC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 111 268899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=311.78 Aligned_cols=248 Identities=28% Similarity=0.477 Sum_probs=193.8
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeec
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
....||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++ ......++||||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEec
Confidence 3457999999999999999999999999886442 2345799999999999999999988 444568999999
Q ss_pred ccc-cHHHHHHhhccCCCCC--CHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 157 VPE-TMYRVLKHYSSMNQRM--PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 157 ~~~-~l~~~l~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
+.+ +|.+.+... ...+ ++..+..++.||+.||.|||+ +||+||||||+||+++..++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 985 666666542 1234 788889999999999999999 699999999999999855778999999998765332
Q ss_pred Cc-ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 234 EA-NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 234 ~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. .....++..|+|||++.+. ..++.++|+||||+++|+|++|..||...+.............
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 228 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-------------- 228 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--------------
Confidence 22 2234578899999998543 2378899999999999999999999975432211110000000
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
....++..+++++.+||.+||..+|.+|||+.+++.||||
T Consensus 229 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 ------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011334568899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=360.05 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=204.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
-+|+-...||.|.||.||-|.+..+|+..|+|.++-. .....+|..++..++|||+|+++++-.+... +
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----H
Confidence 3677888999999999999999999999999977532 2344589999999999999999998755443 7
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|.||||.| +|.+++.+ ++..++...+.+..|++.|+.|||++ |||||||||+||+++ .+|.||++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld-~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLD-FNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeee-cCCcEEeecccceeE
Confidence 899999995 55555554 45677888889999999999999995 999999999999999 688999999999987
Q ss_pred cccCCc-----ceeeeeccccccchhhcCCC--CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 230 LVKGEA-----NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 230 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+..... .....||+.|||||++.+.. ...-++|||||||++.||+||+.||...+..-++.--+....+|
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P--- 1460 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP--- 1460 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC---
Confidence 755421 23578999999999997643 24678999999999999999999998765443322222111111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.+|.++|.+..|||.+||+.||++|.++.|+|+|-|-+..
T Consensus 1461 ------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 ------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 1455689999999999999999999999999999887653
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=325.52 Aligned_cols=277 Identities=21% Similarity=0.318 Sum_probs=197.5
Q ss_pred ceeccC--CceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
..||+| +||+||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .....+++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456666 99999999999999999999886432 2235688888999999999999998 4445589999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+.+ ++.+.+.... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+|++|||.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEe-CCCcEEEechHHHhhhhcc
Confidence 99995 6666665532 2458999999999999999999999 6999999999999999 5778999999865433211
Q ss_pred Ccc--------eeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH--
Q 014750 234 EAN--------ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 302 (419)
Q Consensus 234 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-- 302 (419)
... ....++..|+|||++.+. ..++.++|||||||++|+|++|..||...................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 012235569999998654 347899999999999999999999998876655544433211110000
Q ss_pred -------HHhccCcCCc----cccC-----CCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 303 -------EIRCMNPNYT----DFRF-----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 303 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.+......+. +... .......+.......++.++.+||++||+.||++|||++++|+||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 0000 00001111111223467889999999999999999999999999999876
Q ss_pred cC
Q 014750 367 RE 368 (419)
Q Consensus 367 ~~ 368 (419)
..
T Consensus 315 ~~ 316 (328)
T cd08226 315 KE 316 (328)
T ss_pred HH
Confidence 54
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.56 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=201.3
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....|+|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv 96 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVL 96 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEE
Confidence 3555668999999999999999999999999885322 23447889999999999999999883 44558999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+++ ++...+. ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 97 MEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISK 169 (297)
T ss_pred EecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEc-cCCcEEEeechhHhhccc
Confidence 999996 4444332 2568999999999999999999999 6999999999999999 678899999999875533
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|..||...+..+.+..+... +.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~----------- 234 (297)
T cd06659 170 DVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP----------- 234 (297)
T ss_pred ccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-----------
Confidence 22 22345788999999999764 4899999999999999999999999877665554433211 00
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
+. + .....++.++.++|++||+.||.+||++.++++||||.+...
T Consensus 235 -----~~-----~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 235 -----PK-----L--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred -----CC-----c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00 0 011245789999999999999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=327.59 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=194.0
Q ss_pred cccceeeeceeccCCceEEEEEEE-----cCCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
...+|++.+.||+|+||.||+|++ ..++..||+|++.... ....+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~---- 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC---- 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee----
Confidence 345799999999999999999974 3467789999886432 2234799999999 899999999988
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc----------------------------------------------------
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS---------------------------------------------------- 170 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------------------------------------------- 170 (419)
.+....++|||||+ |+|.+.+.....
T Consensus 109 -~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 -TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred -ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 44455899999998 577777654211
Q ss_pred -------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 171 -------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 171 -------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLT-HGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEE-CCCcEEEecCccceecc
Confidence 12357888999999999999999999 6999999999999999 57789999999997654
Q ss_pred cCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 232 KGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 232 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+.+.....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~----------- 333 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG----------- 333 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-----------
Confidence 33211 112335679999999764 48999999999999999998 899998765444433333210
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+ ....+...+.++.+||.+||+.||++|||+.++++.
T Consensus 334 ---~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 ---Y-------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ---c-------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 000122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.28 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=201.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.|+..+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+...+|+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEEEE
Confidence 5888899999999999999999999999999886432 2345789999999999999999998 44556999
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+++ +|.+.+.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++ .++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEc-CCCCEEEcccccceecc
Confidence 9999985 66655542 468899999999999999999999 6999999999999999 67789999999997654
Q ss_pred cCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... ..
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~------------ 218 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NP------------ 218 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-CC------------
Confidence 3332 2234678889999998764 4799999999999999999999999876654433322110 00
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..+...++..+.++|.+||..||.+||++.+++.|+||...
T Consensus 219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ---------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 01123457889999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=309.05 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=201.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||.|+||.||+|.+..+|..+|+|.+... .....+|+.+++.++|+||+++++.+ .....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 488999999999999999999999999999988532 22345799999999999999999988 4455689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999985 666666542 23457899999999999999999999 699999999999999955566899999998765
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....|+..|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 43322 2234578889999998654 48899999999999999999999998776555444332210
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
++ .....++.++.++|.+||..||++|||+.+++.||||
T Consensus 219 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=308.99 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=199.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++.+ .+...+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 4889999999999999999999999999999875322 2334688999999999999999988 45556999
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||+++ ++.+.+... ....+++..++.++.||+.||.|||+ +||+|+||||+||+++ .++.++|+|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEC-CCCcEEEcccCcceeec
Confidence 9999985 666665432 24568899999999999999999999 6999999999999999 57789999999997654
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 217 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------- 217 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence 322 22345688899999998664 489999999999999999999999988766555444432100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..++..++..+.+||.+||+.||.+|||+.++++-
T Consensus 218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01223468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=308.87 Aligned_cols=250 Identities=32% Similarity=0.526 Sum_probs=204.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+|++.+.||.|++|.||+|.+..+++.|++|++.... ....+|+..+..++|+||+++++++. ....+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence 5889999999999999999999999999999886553 23457899999999999999999983 4456899
Q ss_pred Eeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ . |++||||+|+||+++ .++.++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~ 150 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLIN-SKGEVKIADFGISKVL 150 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEEC-CCCCEEEccCccceec
Confidence 999999 566666654 2678999999999999999999999 7 999999999999999 5788999999999876
Q ss_pred ccCCcce-eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCHHHHhc
Q 014750 231 VKGEANI-SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 231 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+ ..+....+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~------ 220 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP------ 220 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC------
Confidence 4433332 45678899999998664 58999999999999999999999998764 2222222221 000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
+ .++.. ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus 221 ----------~---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 ----------P---------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ----------C---------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 0 01223 688999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=311.92 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=191.2
Q ss_pred ceeeecee--ccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 78 SYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 78 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.|.+.+.+ |+|+||.||++++..+++.+|+|.+...... ..|+.....+ +|+||+++++++. ....+|+||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~-----~~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVT-----TLKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEe-----cCCeeEEEE
Confidence 45665555 9999999999999999999999988654321 2234333333 7999999999984 444689999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++..++.++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9998 577666654 3478999999999999999999999 699999999999999954438999999998765322
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
....++..|+|||++.+. .++.++|||||||++|+|++|..||......+. ...+......
T Consensus 164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------- 225 (267)
T ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence 234678899999999764 489999999999999999999999986543321 1222111000
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-HHHHhcCCcccc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE 365 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-~~e~l~hp~f~~ 365 (419)
.....+.+++.+.+||.+||+.||.+|++ ++++|+||||..
T Consensus 226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112347899999999999999999996 599999999963
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.79 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=199.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+|++.+.||+|+||+||++.+..+|+.||+|++.... ....+|+++++.++|+||+++++++ .+...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence 357999999999999999999999999999999876432 2345799999999999999999998 444568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+++ +|.+.+.. .+.+++..++.++.+++.||.|||+..|++||||||+||+++ +++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC-CCCcEEEccCCcccc
Confidence 999999996 45444433 356899999999999999999999624899999999999999 678899999999865
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCHHHHh
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ----LVEIIKVLGTPTREEIR 305 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~ 305 (419)
.... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||......+. ...+..... ..+.
T Consensus 154 ~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~ 227 (284)
T cd06620 154 LINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQ 227 (284)
T ss_pred hhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH----HHhh
Confidence 4322 22345789999999998664 589999999999999999999999986544211 000000000 0000
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. ..+. .....++.++.+||.+||..||.+|||++|+++|+||..-
T Consensus 228 ~--------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 228 E--------PPPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred c--------cCCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 0000 0011257889999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=316.01 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=201.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++.+. .....|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEE
Confidence 467999999999999999999998899999999885432 22346889999999999999999884 344589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~-~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEc-CCCCEEEccCcceecc
Confidence 99999985 65555543 457888999999999999999999 6999999999999999 5778999999988655
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+.+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 33322 2234678889999998654 578999999999999999999999987655433322211 00000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
...+..++..+.++|++||..||.+||++.+++.|+||+..+
T Consensus 235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001234578899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=306.91 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=206.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||.|+||.||++.+..+++.|++|++..... ...+|+++++.++|+|++++.+.+.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 48899999999999999999998999999998864422 24478999999999999999998843 35689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+||+++ +|.+.+.........+++..+..++.+++.||.|||+ +|++|+||+|+||+++ .++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLT-SNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEc-CCCcEEECCccceeec
Confidence 99999985 7777776654445789999999999999999999999 6999999999999999 5788999999999765
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 219 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------- 219 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence 4432 22345788899999998664 48899999999999999999999998776554444433210
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.+ .++..++.++.++|.+||..||++|||+.++|+||||
T Consensus 220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 1223468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=312.59 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=200.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 45689999999999999999997652 345899998764432 234688899999999999999987
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~ 217 (419)
.+....|+||||+. |+|.+.+...... ...++...+..++.||+.||.|||+ +||+||||||+|||++ .++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~-~~~ 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVA-HDF 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEc-CCC
Confidence 33445899999998 5777777653221 1334667888999999999999999 6999999999999999 578
Q ss_pred ceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014750 218 QVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (419)
Q Consensus 218 ~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 293 (419)
.+||+|||+++........ ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8999999998755332211 122346679999998654 48999999999999999999 799998877665544433
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc------CCcccccc
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR 367 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~------hp~f~~~~ 367 (419)
.. +. . ..+..+++.+.++|.+||+.||++|||+.++++ ||||+.+.
T Consensus 236 ~~-~~------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GY------------------L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CC------------------C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 00 0 012345789999999999999999999999986 99998865
Q ss_pred C
Q 014750 368 E 368 (419)
Q Consensus 368 ~ 368 (419)
+
T Consensus 288 ~ 288 (288)
T cd05061 288 F 288 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=312.90 Aligned_cols=251 Identities=28% Similarity=0.476 Sum_probs=200.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcC---CCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 149 (419)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ |+|++++++++ .+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence 4788899999999999999999999999999885432 23457888998886 99999999987 34456
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ .||+||||+|+||+++ .++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVT-NTGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEc-CCCCEEEccCCcee
Confidence 8999999986 55554432 368999999999999999999999 6999999999999999 57889999999987
Q ss_pred ccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
....... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 6644332 234568889999999876556789999999999999999999999876543322211110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..+.+ ....++.++.++|.+||+.||++||++.+++.|+||++..
T Consensus 218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000 0112578999999999999999999999999999997744
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.98 Aligned_cols=250 Identities=31% Similarity=0.541 Sum_probs=197.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||+|.+..+++.|++|.+..... ...+|+.+++.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 58899999999999999999998999999998865433 334799999999999999999987 4445589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++ .++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEccccccccc
Confidence 99999985 55555543 3458899999999999999999999 6999999999999999 5788999999998765
Q ss_pred ccCCcce-----eeeeccccccchhhcCCC--CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 231 VKGEANI-----SYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 231 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
....... ...++..|+|||++.+.. .++.++||||||+++|+|++|..||...+........... +...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4332211 245678899999986543 2788999999999999999999999765432222211111 1000
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.++. ...++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0111 11348899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=314.17 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=198.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCC-----cEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+|+.+++.++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----TK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----cC
Confidence 46999999999999999999976655 6799998864322 235799999999999999999988 34
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~ 213 (419)
....|++|||+. ++|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence 445889999998 577777754321 11568889999999999999999999 6999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHH
Q 014750 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (419)
Q Consensus 214 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (419)
+++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+..
T Consensus 159 -~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 -EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred -CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 577899999999976533221 2234567889999998664 48999999999999999998 99999987776655
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..... ...+..++.++.+|+.+||+.||.+||++.+++++
T Consensus 237 ~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54433100 00234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=329.68 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=203.0
Q ss_pred cce-eeeceeccCCceEEEEEEEcCCCcEEEEEEec-----cC---cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QD---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
++| +...+||+|+|-+||+|.|..+|-.||-..++ +. ...+..|+.+|+.|+|+|||++++.+.+.. .
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n 115 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---N 115 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---C
Confidence 344 45678999999999999999999998865442 22 134457999999999999999999886643 3
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCcccccccCCceeeCCCCCceEEeecc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+.+|.|++. |+|..++++ .+++....++.|++||+.||.|||++ .-|||||||.+||+|+...|.|||+|+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred ceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 55889999998 666665554 56788889999999999999999984 3599999999999999888999999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 304 (419)
+|........ ...+|||.|||||++. ..|...+||||||+.+.||+|+..||..-...-+ +.++.. |..+..
T Consensus 192 LAtl~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~s-- 264 (632)
T KOG0584|consen 192 LATLLRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAA-- 264 (632)
T ss_pred HHHHhhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHH--
Confidence 9987654433 3479999999999994 5699999999999999999999999987654444 444433 221111
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+.+--.+++++||.+||.. .++|+|+.|+|.||||+.
T Consensus 265 -----------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 265 -----------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1122378999999999999 999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=310.77 Aligned_cols=245 Identities=19% Similarity=0.209 Sum_probs=193.0
Q ss_pred ccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence 356999999999999999999865 346789999886542 23347999999999999999999883 34
Q ss_pred eeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...++||||++++ |.+.+.. ....+++..++.++.||+.||+|||+ +|++||||||+|||++ .++.+|++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~-~~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVN-SDLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEc-CCCcEEECCCcc
Confidence 4589999999964 5444443 23578999999999999999999999 6999999999999999 678899999998
Q ss_pred ccccccCCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 227 AKVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 227 a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
+.......... ...++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+.+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----- 227 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----- 227 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-----
Confidence 76542221111 22345679999998664 58999999999999999875 99999888776655544321110
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++..+.+++.+||+.||.+|||++++++
T Consensus 228 -----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012346889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=314.42 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=200.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.++... +|+||+++++++ .+.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 345679999999999999999999998899999999864322 123455555555 599999999998 445
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|++|||+.+.+...+... ...+++..+..++.|++.||.|||+..||+||||+|+||+++ +++.+||+|||++
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-~~~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc-CCCCEEECccccc
Confidence 569999999988766665542 347899999999999999999999624999999999999999 6788999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCC---CCCCCcccEeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 303 (419)
.............++..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+.... .
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~--- 236 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---P--- 236 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC---C---
Confidence 765443333344577889999998653 2378899999999999999999999975432 22333222210 0
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. .++ ....++.++.+||.+||..||.+||+++++++||||....
T Consensus 237 --------~--~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 237 --------P--SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred --------C--CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 0 000 0113578999999999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=315.08 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=202.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|...+.||+|+||+||+|++..+|+.|++|++.... ....+|+.+++.++|+|++++++++. +....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence 3777788999999999999999999999999886332 12346899999999999999999984 44558
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||+.+++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||+|+||+++ .++.+||+|||++...
T Consensus 97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~-~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLT-EPGQVKLADFGSASKS 171 (313)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEEC-CCCCEEEeecCCCccc
Confidence 99999999988777654 23568999999999999999999999 6999999999999999 5778999999998643
Q ss_pred ccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
. ......++..|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~---------- 237 (313)
T cd06633 172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-S---------- 237 (313)
T ss_pred C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C----------
Confidence 2 2234578889999999842 2447889999999999999999999998877655555443210 0
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
+.. ....++..+.+||.+||+.||.+||++.+++.||||+..+
T Consensus 238 --------~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 238 --------PTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred --------CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 000 1123577899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.64 Aligned_cols=282 Identities=22% Similarity=0.278 Sum_probs=187.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCC----CcEEEEEEeccCcccHHHHHHH---HHhcCCCCeeecceeeeccCC-CC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQL---MRLMDHPNVISLKHCFFSTTS-KD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~-~~ 146 (419)
..++|.+.+.||+|+||.||+|++..+ +..||+|++..... .|..+ ++...+.+++.+...+..... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence 556899999999999999999999988 99999998764322 22222 222233344444333322111 34
Q ss_pred ceeEEEEeecccc-cHHHHHHhhcc----------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSS----------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
...+++||||+++ +|.+.+..... .........++.++.||+.||.|||+ +||+||||||+|
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N 285 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN 285 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence 5568899999985 66666653210 01112345577899999999999999 699999999999
Q ss_pred eeeCCCCCceEEeecccccccccCC--cceeeeeccccccchhhcCCC---------------------CCCCcccEeeh
Q 014750 210 LLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGAT---------------------EYTTSIDIWSA 266 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diwsl 266 (419)
||++..++.+||+|||+|+...... .....++++.|+|||.+.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9999556789999999997653322 234567899999999764321 23456799999
Q ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhccc
Q 014750 267 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346 (419)
Q Consensus 267 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 346 (419)
||++|||+++..++ .+....+..++...+... ..|....... ..+... .. ..+.+.....+.|||.+||++
T Consensus 366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~~~-~~--~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPDLR-RG--FEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc---cchhhh-hh--hhhccccchHHHHHHHHHccC
Confidence 99999999976554 334444444444333322 2222111000 000000 00 001112345677999999999
Q ss_pred CCCCCCCHHHHhcCCccccccCC
Q 014750 347 SPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 347 dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
||.+|||+.++|+||||+.....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCcc
Confidence 99999999999999999875543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.77 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=197.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..+.. ...+|+++++.++|+||+++++++ ..+..++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCcEEE
Confidence 458999999999999999999999999999998865532 245799999999999999999988 444558999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||++ ++|.+.+... ....+++..++.++.|++.||.|||+ +|++||||||+||+++ +++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEc-CCCcEEeCCCcccccccc
Confidence 99998 5666666432 23468899999999999999999999 6999999999999999 678899999999976543
Q ss_pred CCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 222 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------- 222 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 32211 12235679999998654 48899999999999999998 999998877655544433210
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+..++.++.++|.+||..||++|||+.++++
T Consensus 223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=310.29 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=202.5
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.|...+.||+|++|.||++.+..+++.+++|.+.... ....+|+.+++.++|+||+++++++. .....+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEE
Confidence 3555678999999999999999999999999875332 22457899999999999999999884 34458999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
+||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+ +||+||||+|+||+++ .++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEc-CCCcEEEcccccchhhcc
Confidence 999985 66555543 468899999999999999999999 6999999999999999 678899999998865433
Q ss_pred CCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+... ..+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~------------ 233 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP------------ 233 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC------------
Confidence 221 2235688999999998664 4899999999999999999999999877665555444321 000
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.. .....++..+.+||.+||+.||++|||+.++++||||++...+
T Consensus 234 ------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 234 ------KL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ------CC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 00 0012367899999999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=309.71 Aligned_cols=245 Identities=33% Similarity=0.551 Sum_probs=198.7
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||.|+||.||++++..+|+.+++|.+..... ...+|+++++.++|+||+++++.+ ......|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999998864432 234688999999999999999887 4555689999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC--
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-- 234 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~-- 234 (419)
.+ +|.+.+.. ...+++..+..++.||+.||.|||+ +|++||||+|+||+++ .++.+||+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEc-CCCCEEEEecccchhcccCccc
Confidence 85 66666654 2468999999999999999999999 6999999999999999 57789999999987643321
Q ss_pred -------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 235 -------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 235 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
......++..|++||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 122346788899999987654 789999999999999999999999887766555444321 0
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH---HHHhcCCccccccC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~---~e~l~hp~f~~~~~ 368 (419)
..++.. ..++..+.+||.+||+.||.+|||+ .++|+||||+++.|
T Consensus 218 ------~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 218 ------IEWPED----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ------cCCCcc----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 011100 1148899999999999999999999 99999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=302.75 Aligned_cols=270 Identities=24% Similarity=0.323 Sum_probs=211.3
Q ss_pred CCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHH-HHHhcCCCCeeecceeeeccCC
Q 014750 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~ 144 (419)
......++.+-+..||.|+||+|++-.++.+|+..|||+|..... ....|.+ +++.-+.||||++++..+....
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 344555667778899999999999999999999999999964432 2223444 4456689999999999865443
Q ss_pred CCceeEEEEeecccccHHHHHH-hhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPETMYRVLK-HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.+|.||+|+-++..+-+ -|.....++++..+-.|....+.||.||...-.|||||+||+|||++ ..|.|||||
T Consensus 138 -----cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-r~G~vKLCD 211 (361)
T KOG1006|consen 138 -----CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-RHGDVKLCD 211 (361)
T ss_pred -----eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe-cCCCEeeec
Confidence 78999999976554433 23334678999999999999999999999744899999999999999 688899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCC-CCCcccEeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTR 301 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~ 301 (419)
||++..+.+.-..+...|...|||||.+..... |+.++|+||||++|||+.||..||.+.+. .+++.++.. |.|+.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~ 289 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPI 289 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCe
Confidence 999988876666677788999999999965444 89999999999999999999999987543 344444433 33321
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
-. .+... -.++..+..+|.-||.+|-+.||...+++.+||++.+...
T Consensus 290 l~-----~~~~~----------------~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 290 LL-----FDKEC----------------VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ec-----Ccccc----------------cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 10 00000 1258899999999999999999999999999999876543
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.86 Aligned_cols=248 Identities=28% Similarity=0.483 Sum_probs=199.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence 6999999999999999999999999999999874321 133468999999999999999998743 2234
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++++|||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEc-CCCCEEECccccc
Confidence 57899999985 56555543 3458899999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccC----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+...++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--- 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence 765321 112235678899999998764 478999999999999999999999987655544443321 111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...++..++..+.++|.+||+ +|.+||++.++++|||.
T Consensus 227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112345678999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=310.98 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=200.0
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++ .+....|+|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence 778899999999999999999999999999875332 2345789999999999999999998 445568999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+++ ++.+.+. ...+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEEC-CCCCEEEeecccceeccc
Confidence 999986 5554443 2468899999999999999999999 6999999999999999 677899999999876543
Q ss_pred CCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
... .....++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...+.......+... +.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------- 218 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------- 218 (277)
T ss_pred chhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-------------
Confidence 221 2234678889999998654 4788999999999999999999999876554433332210 00
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..+...++.++.++|.+||..||.+||++.++++||||.+.
T Consensus 219 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 --------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01223468899999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=321.19 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=193.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+|+.+++.+ +|+||+++++++..
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-- 82 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-- 82 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec--
Confidence 34579999999999999999997543 457899998864321 234689999999 89999999997743
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhcc----------------------------------------------------
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS---------------------------------------------------- 170 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------------------------------------------- 170 (419)
....++++|||+++ +|.+.+.....
T Consensus 83 --~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 83 --PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred --CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 23458899999985 66666643211
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc---ceeeeec
Q 014750 171 -----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICS 242 (419)
Q Consensus 171 -----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t 242 (419)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++........ .....++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 02368899999999999999999999 6999999999999999 578899999999986533221 1123446
Q ss_pred cccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCC
Q 014750 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 321 (419)
Q Consensus 243 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+... . .
T Consensus 239 ~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--------------~-------- 294 (337)
T cd05054 239 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-T--------------R-------- 294 (337)
T ss_pred ccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-C--------------C--------
Confidence 679999998764 48999999999999999998 999998754433333322210 0 0
Q ss_pred CCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 322 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 322 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+...++++.+++.+||+.+|++||++.++++|
T Consensus 295 ----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 ----MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.63 Aligned_cols=248 Identities=31% Similarity=0.454 Sum_probs=203.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.|...+.||+|+||.||+|++..++..+|+|.+..... ...+|+++++.++|+|++++++++. +....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeE
Confidence 38889999999999999999999999999998864321 2346899999999999999999884 34458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||+.|++.+.+... ...+++..+..++.|++.||.|||+ +||+||||+|+||+++ .++.+||+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLT-EPGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEEC-CCCCEEEecCCCcccc
Confidence 899999999887766532 3568999999999999999999999 6999999999999999 5778999999998654
Q ss_pred ccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.. .....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...+.......+......+
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 243 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------- 243 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence 32 234567889999999742 2447889999999999999999999998876665555554321100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.....++..+.+||.+||+.||.+||++.++++|+|+..
T Consensus 244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 011235788999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=315.35 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=193.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcE--EEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|++.+.||+|+||.||+|.+..++.. +|+|.+.... ....+|++++..+ +|+||+++++++ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 35799999999999999999998877764 5777665322 1234689999999 899999999988 445
Q ss_pred eeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
..+|+||||++ ++|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~- 158 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG- 158 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec-
Confidence 56899999998 577777654321 12368899999999999999999999 6999999999999999
Q ss_pred CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 293 (419)
.++.+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |..||.+.+..+....+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 5778999999998643211111122335679999998654 48999999999999999998 999998776655444332
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
... . ...+..++.++.+||.+||+.||++||++++++++
T Consensus 238 ~~~------------------~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGY------------------R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCC------------------c----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 0 00112357899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=326.03 Aligned_cols=254 Identities=29% Similarity=0.486 Sum_probs=203.8
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
|..++.||-|+||.|.+++...|...||+|.+.+... ....|.+||..-+++-||+++..| ++...+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY 705 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY 705 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence 8888999999999999999999999999998865432 234689999999999999999988 6777799
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||+|++| ++..+|.+ .+-|+|..+++|+.++..|+++.|.+ |+|||||||+||||| .+|.|||+|||++.-+
T Consensus 706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILID-rdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILID-RDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEc-cCCceeeeeccccccc
Confidence 99999995 66666554 47799999999999999999999996 999999999999999 7888999999998432
Q ss_pred ---------ccCCc----------------------------------ceeeeeccccccchhhcCCCCCCCcccEeehh
Q 014750 231 ---------VKGEA----------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAG 267 (419)
Q Consensus 231 ---------~~~~~----------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 267 (419)
..+.- ..+.+||+.|+|||++... .|+..+|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhh
Confidence 11100 0146899999999999764 489999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccC
Q 014750 268 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347 (419)
Q Consensus 268 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 347 (419)
||||||+.|++||......+.-.+++++ + ++ ++..+-.++|+++.+||.++. .+
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw---------~----~~------------l~~~~~~~ls~e~~~li~kLc-~s 912 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINW---------R----NF------------LHIPYQGNLSKEALDLIQKLC-CS 912 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeeh---------h----hc------------cccccccccCHHHHHHHHHHh-cC
Confidence 9999999999999877655443333321 0 00 111122468999999998865 47
Q ss_pred CCCCCC---HHHHhcCCccccccCCC
Q 014750 348 PSLRCT---ALEACAHPFFDELREPN 370 (419)
Q Consensus 348 P~~R~t---~~e~l~hp~f~~~~~~~ 370 (419)
++.|+. ++|+..||||+.++...
T Consensus 913 ad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 913 ADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred hhhhhcccchhhhhcCccccccchHh
Confidence 788874 67899999999987654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.29 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=197.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 46999999999999999999999999999999875321 123469999999999999999998843 345
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++|||+++ +|.+.+.........+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~-~~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEc-CCCCEEECccccce
Confidence 8899999995 6766666544445668999999999999999999999 6999999999999999 57789999999987
Q ss_pred ccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhc
Q 014750 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 229 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 306 (419)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..+.......+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543222 1234678889999998764 4789999999999999999999999654321 11222221111111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.....++..+.++|.+||+.||++|||+.++++.
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0112357889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=313.03 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=209.0
Q ss_pred CCCCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----------ccHHHHHHHHHhcCCCCeeecce
Q 014750 69 KNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKH 137 (419)
Q Consensus 69 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~ 137 (419)
....+...++|.++.+||+|+|+.||+|.+....+.||+|+-.... +..-+|.+|-+.|+||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3455667789999999999999999999999999999999764221 12237999999999999999999
Q ss_pred eeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCcccccccCCceeeCCC-
Q 014750 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPL- 215 (419)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~ivH~Dlkp~NIll~~~- 215 (419)
+|.. +...+|-|+|||+|+- |..|...+.-+++.+++.|+.||+.||.||.+. ..|||-||||.|||+-..
T Consensus 535 yfsl----DtdsFCTVLEYceGND---LDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 535 YFSL----DTDSFCTVLEYCEGND---LDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeee----ccccceeeeeecCCCc---hhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 9853 3334889999999852 233334467899999999999999999999974 369999999999999632
Q ss_pred -CCceEEeecccccccccCCcc--------eeeeeccccccchhhcC---CCCCCCcccEeehhHHHHHHHhCCCCCCCC
Q 014750 216 -THQVKLCDFGSAKVLVKGEAN--------ISYICSRYYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (419)
Q Consensus 216 -~~~vkl~DfG~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (419)
.|.|||+|||+++++.++... ....||.||++||.+.- .+..+.++||||+|||+|.+++|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 367999999999998655432 34678999999998743 345789999999999999999999999866
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.....+-+.-.++ +-.+..||.. ..++.++++||++||++.-++|..+.++-.||||
T Consensus 688 qsQQdILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 688 QSQQDILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hhHHHHHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 4332222111111 1122233321 2479999999999999999999999999999999
Q ss_pred cc
Q 014750 364 DE 365 (419)
Q Consensus 364 ~~ 365 (419)
.-
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 64
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=323.35 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=195.2
Q ss_pred CCCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 71 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
.+....++..+...||+|.||+||+|++.. .||||++..+. ..+..|+.+++.-+|.||+-+.+++.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~---- 458 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM---- 458 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc----
Confidence 334445567888999999999999999743 59999987543 34568999999999999999999883
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
... +.||..+|.| +|+..++. ....|.....+.|++||+.|+.|||. ++|||||||..||++. ++++|||+|
T Consensus 459 -~p~-~AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~-~~~kVkIgD 531 (678)
T KOG0193|consen 459 -NPP-LAIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLH-EDLKVKIGD 531 (678)
T ss_pred -CCc-eeeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEc-cCCcEEEec
Confidence 223 3799999997 66666654 23678889999999999999999999 8999999999999999 578999999
Q ss_pred cccccccccC---CcceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 224 FGSAKVLVKG---EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 224 fG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
||++..-..- .......|...|||||+++.. ..|+..+|||||||++|||+||..||........+.++=++.+.
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence 9998643221 112234567789999999643 24899999999999999999999999955544433333222222
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
|..- ......++++++|+..||.+++++||...+||.
T Consensus 612 pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 612 PDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccch------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 2110 112346789999999999999999999999876
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.31 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+.... ....+|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 3469999999999999999998743 46789999886543 234579999999999999999999843
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhc----------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYS----------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
....++||||+. ++|.+.+.... .....+++..+..++.|++.||.|||+ +|++||||||+||+++
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~- 156 (280)
T cd05049 80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVG- 156 (280)
T ss_pred -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEc-
Confidence 345899999998 46777665432 123457889999999999999999999 6999999999999999
Q ss_pred CCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (419)
.++.+||+|||++........ .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+...
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 678899999999975432221 1233456789999999764 48999999999999999998 999998877666555
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..... ...+..++..+.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4432100 0012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.64 Aligned_cols=255 Identities=27% Similarity=0.473 Sum_probs=200.4
Q ss_pred ceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
+|++.+.||.|+||.||+|++. .+|+.||+|.+.... ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999975 478999999886421 2235689999999 599999999888 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
.+..+|+||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +|++||||||+|||++ .++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEC-CCCCEEEeeC
Confidence 45568999999995 66665543 4568899999999999999999999 6999999999999999 5788999999
Q ss_pred ccccccccCCc--ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 225 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|++........ .....++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.+.....
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 99976543322 2245678899999998643 246789999999999999999999997543322222222211000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~ 368 (419)
...++..++..+.+|+++||..||.+|+ ++++++.||||....+
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0012334688999999999999999997 8999999999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.52 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=201.3
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
|.....||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ ......++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEE
Confidence 444578999999999999999999999999875322 2244689999999999999999988 3445689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+++ +|.+.+. ...+++..++.++.|++.||+|||+ +|++||||+|+||+++ .++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCCEEEcccccceecccc
Confidence 99986 4444332 2468899999999999999999999 6999999999999999 5778999999998655332
Q ss_pred C-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 E-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+..... .
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~------------ 234 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P------------ 234 (292)
T ss_pred cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c------------
Confidence 2 2234567889999998865 4478999999999999999999999988766555444332110 0
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.+. ....++..+.++|.+||..||.+||++.+++.||||.....+.
T Consensus 235 --~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 235 --KLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred --ccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 000 0123688999999999999999999999999999999866433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=308.52 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=194.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 45679999999999999999998642 456899998754321 234688999999999999999987
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccC------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSM------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~ 217 (419)
......++||||++ ++|.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++ .++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~-~~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-EDF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEc-CCC
Confidence 44456899999998 4677666542211 2345778889999999999999999 6999999999999999 678
Q ss_pred ceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014750 218 QVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (419)
Q Consensus 218 ~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 293 (419)
.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 8999999998755332211 112346789999998764 48999999999999999999 789998877665554433
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.. + ++ ..+..++..+.++|.+||+.||++|||+.+++++
T Consensus 236 ~~-~------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-G------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-C------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 0 00 0123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.23 Aligned_cols=248 Identities=22% Similarity=0.292 Sum_probs=193.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc--EEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (419)
++|++.+.||+|+||.||+|.+..++. .+++|.++... ....+|+.+++++ +||||+++++++ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence 369999999999999999999877765 46888775321 2345689999888 799999999987 4445
Q ss_pred eEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~ 215 (419)
.+|++|||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++ .
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~-~ 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVG-E 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEEC-C
Confidence 6899999998 577777754221 12358899999999999999999999 6999999999999999 5
Q ss_pred CCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 014750 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 294 (419)
++.+||+|||++..............+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 778999999998643221111112234569999998654 48999999999999999997 9999988777665554432
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
... ...+..++.++.+||.+||..||.+|||++++++.
T Consensus 234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 01223468899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.73 Aligned_cols=277 Identities=22% Similarity=0.298 Sum_probs=194.7
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|.+.+.+|.| |.||.+++..+++.||+|++.... ....+|+++++.++|+||+++++++ .+....++
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~ 76 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYV 76 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEE
Confidence 3344444444 555666666699999999986441 2345799999999999999999988 44455899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||+++ ++.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEe-cCCceEEecCccceeec
Confidence 9999995 566666543 23458899999999999999999999 6999999999999999 67889999999886543
Q ss_pred cCCc--------ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 232 KGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 232 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
.... .....++..|+|||++.+. ..++.++|+|||||++|+|++|..||........+....+ +.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCL 230 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccc
Confidence 2211 1234567789999998653 3478999999999999999999999987655443322221 111100
Q ss_pred ----HHhccCcCCcc----ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 303 ----EIRCMNPNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 303 ----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.......+... ...+. ............++.++.+||.+||+.||++|||+.++|+||||+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred cccCchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 00000000000 00000 01111112223456789999999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.49 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=202.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..|...+.||+|+||.||+|++..+++.+|+|.+.... ....+|+++++.++|+|++++++++.. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 89 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence 35888899999999999999999999999999885321 123468999999999999999998843 345
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.++||||+.+++.+.+... ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~ 164 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASI 164 (308)
T ss_pred eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEEC-CCCcEEECCccccee
Confidence 8899999998877766532 3568899999999999999999999 6999999999999999 578899999999876
Q ss_pred cccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... .....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 231 (308)
T cd06634 165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------- 231 (308)
T ss_pred ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----------
Confidence 432 234567889999999853 23478899999999999999999999987665554444332100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+. .....++..+.+||++||..+|.+||++++++.|||+...
T Consensus 232 ---------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ---------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 0112468889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=300.10 Aligned_cols=248 Identities=30% Similarity=0.508 Sum_probs=201.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
+|.+.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|+||+++++++. .....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence 4888999999999999999998899999999886554 34567999999999999999999884 33558999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
+||++ ++|.+.+... ...+++..++.++.|++.||.+||+ .|++||||+|+||+++ .++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEc-cCCeEEEeeccccccccc
Confidence 99999 4665555442 2578999999999999999999999 6999999999999999 578899999999977654
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
........++..|++||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... ..+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~------------- 215 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP------------- 215 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCC-------------
Confidence 43334567788999999987644 789999999999999999999999877544444333220 000
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
... ....++..+.++|.+||+.||++|||+.++++|||
T Consensus 216 -----~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 -----GLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----CcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 01123788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=302.54 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=204.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|++.+.||+|+||.||++++..+++.+|+|.+.... ....+|+++++.++|+||+++++++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 4889999999999999999999999999999886432 12346889999999999999999884 345689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.........+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLV-ANDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEe-cCCcEEEeeccchhhh
Confidence 99999975 6777776644445678999999999999999999999 6999999999999999 5778999999999776
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------------- 216 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence 544 33345678899999999764 4788999999999999999999999887765544433221
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.++. .+..++.++.++|.+||..||.+|||+.++++||++
T Consensus 217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0111 122468899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.11 Aligned_cols=249 Identities=24% Similarity=0.450 Sum_probs=199.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC---------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.||++++..++..+++|.++.. .....+|+.+++.++||||+++++++. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 488999999999999999999888777777765421 112346888999999999999999883 344
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..++||||+.+ +|.+.+..+......+++..++.++.|++.||.|||+ .|++|+||||+||+++ + +.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~-~-~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLK-N-NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEee-c-CCEeecccCce
Confidence 58899999985 6766666555556789999999999999999999999 6999999999999998 3 46999999998
Q ss_pred cccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~------- 222 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT------- 222 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence 76543322 234567888999999865 44788999999999999999999999876654444333221 00
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
..++..++.++.++|.+||..||++||++.++++||||
T Consensus 223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01223568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.28 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=192.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcE----EEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|++.+.||+|+||.||+|++..+++. ||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 4699999999999999999998766664 8999876432 2334688999999999999999987431
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..++++||+. |+|.+.+... ...+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~-~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVK-TPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEec-CCCcEEEccccc
Confidence 2568999998 5777766642 3468889999999999999999999 6999999999999999 677899999999
Q ss_pred ccccccCCccee---eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
++.......... ..++..|+|||.+.+. .++.++|||||||++|||++ |..||.+....+.. .+.....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~----- 228 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE----- 228 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCC-----
Confidence 987644332222 2235679999998664 48999999999999999998 99999876654432 2222100
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+ .+..++.++.++|.+||..||.+|||+.+++.+
T Consensus 229 ------------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 229 ------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.08 Aligned_cols=245 Identities=33% Similarity=0.600 Sum_probs=202.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 149 (419)
+|.+.+.||+|+||.||+|.+..+|+.||+|++.+.. ....+|.++++.++ |+||+++++++ .+...
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 6999999999999999999999999999999886421 22346888999998 99999999988 44556
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++||||+. ++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ .++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~-~~~~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLD-KDMHIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEEC-CCCCEEecCCcccc
Confidence 899999995 677776654 3479999999999999999999999 6999999999999999 57789999999987
Q ss_pred ccccCC---------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHH
Q 014750 229 VLVKGE---------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287 (419)
Q Consensus 229 ~~~~~~---------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 287 (419)
...... ......++..|+|||++.+. .++.++|+||||+++++|++|+.||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 653322 11234568889999998654 48899999999999999999999999877554
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCcc
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFF 363 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f 363 (419)
.+..+... ...++..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 44443321 011234568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.01 Aligned_cols=142 Identities=25% Similarity=0.394 Sum_probs=122.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+|.+.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 357999999999999999999999999999999986542 3445788999999999999999887 4445
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
++||||||+.| +|.+.+.. .+.+++..++.++.||+.||.|||. +||+||||||+||||+ .++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~-~~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLIS-NEGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEc-CCCCEEEEeCCCC
Confidence 68999999974 66666653 3568899999999999999999999 6999999999999999 5788999999987
Q ss_pred c
Q 014750 228 K 228 (419)
Q Consensus 228 ~ 228 (419)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=303.13 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=193.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|++.+.||+|+||.||++... .+..+|+|.+.... ....+|+.+++.++|+||+++++++ .....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence 46889999999999999999865 45689999876432 2345799999999999999999988 444558999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||++ |+|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEc-CCCeEEECCCCCccccCC
Confidence 99998 4666655431 2468899999999999999999999 6999999999999999 678899999999876533
Q ss_pred CCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... ...++..|+|||++.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.+....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------- 220 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------- 220 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence 22211 12345679999998654 58999999999999999999 99999888776666655431100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+...+.++.+||.+||..||.+|||++++++
T Consensus 221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012234788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=321.43 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=193.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~ 142 (419)
...++|++.+.||+|+||.||+|.+... +..||+|++..... ...+|+++++.++ ||||+++++++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--- 110 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--- 110 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE---
Confidence 3456799999999999999999987433 34699998864322 2347999999996 99999999998
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhcc---------------------------------------------------
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------------------------------------- 170 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------------------------------------- 170 (419)
.+...+|||||||. |+|.+.+.....
T Consensus 111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 44556899999998 577766654211
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 171 -----------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 171 -----------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~N 267 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARN 267 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHh
Confidence 12357888899999999999999999 699999999999
Q ss_pred eeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCH
Q 014750 210 LLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 285 (419)
||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 268 ill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 268 VLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999 577899999999976533222 1223456789999998764 48999999999999999997 9999987644
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+.+........ .. ..+..++.++.++|.+||+.||++|||+.++.+
T Consensus 346 ~~~~~~~~~~~~-----------------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYNKIKSGY-----------------RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHHHHhcCC-----------------CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333332222100 00 012346889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.87 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=193.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||.||+|++..+|+.||+|++..+. ....+|+++++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 47999999999999999999999999999999986432 1234799999999999999999988 44556
Q ss_pred EEEEeecccc-cHHHHHHhhcc-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
.|+||||++| +|.+.+..... ....++...+..++.||+.||+|||+ +||+||||||+|||++ .++.+||
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEc-CCCCEEE
Confidence 8999999985 66666654211 12345667788999999999999999 6999999999999999 5778999
Q ss_pred eecccccccccCC-------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCC
Q 014750 222 CDFGSAKVLVKGE-------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (419)
Q Consensus 222 ~DfG~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (419)
+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999997652110 01124689999999999765 489999999999999999999999987
Q ss_pred CCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 283 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+....... .....+.. . . -...+++.+.+++.+||..||++|++..+.+.+
T Consensus 234 ~~~~ki~~~--~~i~~P~~--------------~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 234 KKGRKISYR--DVILSPIE--------------V-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cchhhhhhh--hhccChhh--------------c-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 544322211 10000000 0 0 012468899999999999999999887665543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=304.47 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=194.8
Q ss_pred eeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 79 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
|.+.+.||+|+||.||+|.+..+ +..||+|++..+.. ...+|+.+++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999997653 47899998865422 23468999999999999999988754332 2334
Q ss_pred eEEEEeeccc-ccHHHHHHhhc--cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+++|||+. ++|...+.... .....+++..++.++.|++.||.|||+ +||+||||||+||+++ +++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLR-EDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEEC-CCCeEEECCcc
Confidence 5789999998 46666664432 123468999999999999999999999 6999999999999999 67789999999
Q ss_pred cccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR---- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99865433221 11234567999999855 458999999999999999999 9999988776555444332100
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++.++.++|.+||+.||++|||+.+++.+
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=301.11 Aligned_cols=250 Identities=34% Similarity=0.530 Sum_probs=201.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++++.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4788899999999999999999899999999886543 23457999999999999999999884321 25689
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+++||++ ++|.+.+.. ...+++..++.++.|++.||.|||+ +|++|+||+|+||+++ .++.+||+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVD-SDGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEc-CCCCEEEcccccEEec
Confidence 9999996 566666554 2378999999999999999999999 6999999999999999 5788999999999876
Q ss_pred ccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+. ....+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc----------
Confidence 55443 34456788999999986644 89999999999999999999999987662 1111111100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
......++..++.++.+||.+||+.||.+||++.+++.||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111334568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.90 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=196.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||.||+|++..+++.+|+|.+.... ....+|+.+++.++|+||+++++++. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence 46899999999999999999999999999999875321 23346899999999999999999884 3445
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++|||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEECcchhhh
Confidence 8899999985 7777776554455678999999999999999999999 6999999999999999 57789999999987
Q ss_pred ccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~ 305 (419)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... +....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------- 223 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------
Confidence 6543322 2235688899999998664 4789999999999999999999999764321 111111110
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++. .....++.++.+||.+||..||.+|||+.++++
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 ---------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---------CCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0010 011246889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=305.50 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=196.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... ...+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence 45799999999999999999998644 37899998764432 234789999999999999999988 3
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhcc------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
.....++||||+. ++|.+.+..... ....+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~-~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEc-CCCC
Confidence 4456899999997 577777754322 12347888999999999999999999 6999999999999999 6788
Q ss_pred eEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 014750 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 294 (419)
+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999876533221 1233457789999998654 48999999999999999998 9999988776555444331
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. +. ..++..++.++.+||.+||+.||++|||+.++++
T Consensus 237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 G-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00 0122345889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=308.21 Aligned_cols=248 Identities=21% Similarity=0.305 Sum_probs=194.6
Q ss_pred cceeeeceeccCCceEEEEEEEc----CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|++.+.||+|+||+||+|.+. .++..||+|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence 46899999999999999999853 356789999886432 23457999999999999999999883 34
Q ss_pred eeEEEEeecccc-cHHHHHHhhc-------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYS-------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~-------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~ 213 (419)
...|+||||+.+ +|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence 458999999984 6666664221 012357888999999999999999999 6999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHH
Q 014750 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (419)
Q Consensus 214 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (419)
.++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 159 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 -EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred -CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 577899999999976533221 2233456679999998664 48999999999999999998 99999887665544
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+.... . ...+..+++.+.++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4433210 0 00223468899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.40 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=195.9
Q ss_pred ccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++ ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-----VE 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 357999999999999999999863 345679999886432 2345799999999999999999988 34
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhc---------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
...+++||||+. ++|.+.+.... .....+++..++.++.|++.||+|||+ +|++||||||+|||++ ++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~-~~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVG-EN 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc-cC
Confidence 456899999998 57777665432 122358999999999999999999999 6999999999999999 67
Q ss_pred CceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014750 217 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 292 (419)
Q Consensus 217 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i 292 (419)
+.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8899999999976533221 112334678999999865 458999999999999999999 99999887766655554
Q ss_pred HHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...... ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcCCcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 431000 012346889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=302.40 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=195.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++ .+....+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence 3457999999999999999999864 56779999876433 2345799999999999999999887 4445589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+. ++|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVS-ESLMCKIADFGLARVI 153 (261)
T ss_pred EEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEec-CCCcEEECCCccceec
Confidence 9999997 5777666542 24568888999999999999999999 6999999999999999 6788999999999765
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---------- 222 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 432211 122346679999998654 48899999999999999998 9999988776665555433110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+ ....++.++.++|.+||..||++|||++++++
T Consensus 223 --------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 --------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 11246889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=307.06 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=197.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (419)
....+|++.+.||+|+||.||++.+... ...+|+|.+..... ...+|+.+++.+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~--- 85 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC--- 85 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 3445799999999999999999997643 37899998865322 234688999999 899999999988
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhc------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
.....++++|||+. ++|...+.... .....+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus 86 --~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~N 162 (293)
T cd05053 86 --TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARN 162 (293)
T ss_pred --cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceee
Confidence 34445899999998 57777665421 234678999999999999999999999 699999999999
Q ss_pred eeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCH
Q 014750 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 285 (419)
||++ .++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 163 il~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 163 VLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999 6788999999999865433211 11223567999999865 458999999999999999998 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+....+..... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 555544332100 00123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=301.89 Aligned_cols=238 Identities=21% Similarity=0.309 Sum_probs=186.9
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
+.||+|+||.||+|++..+++.+|+|.+.... ....+|+++++.++|+||+++++++ .....+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEeec
Confidence 36999999999999999999999999875432 2345799999999999999999988 3444589999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEc-CCCcEEECccccCccccccccc
Confidence 85 56555543 23468899999999999999999999 6999999999999999 5778999999998754332111
Q ss_pred e---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 237 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 237 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 214 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------------- 214 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence 1 11224569999998664 48999999999999999998 9999977665444333322100
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++..+.+|+.+||+.||++|||+.++++
T Consensus 215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=306.45 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=207.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
....|.+.+.||+|+||.||+|.+..++..|++|.+..... ...+|+++++.++|+||+++++++.. ....|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-----GDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCEEE
Confidence 44569999999999999999999988899999998875432 34579999999999999999998843 35589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+++||+. ++|.+.+.... ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++ .++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLS-KDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEc-CCCCEEECccchhhhh
Confidence 9999999 57777766532 378999999999999999999999 6999999999999999 6778999999998654
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....++..|++||++.+. .++.++|+|||||++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------- 235 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------- 235 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence 33221 2234577889999998664 4899999999999999999999999877665444433221 0000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. .....++.++.+||.+||+.||.+|||+.++++|+||.+..
T Consensus 236 ---------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 236 ---------L-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred ---------C-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 0 01123678999999999999999999999999999998843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=308.52 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=195.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
.+|++.+.||+|+||.||+|.+..+ +..||+|++..... ...+|+.+++.++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 4688999999999999999987543 57899999874432 234688899999999999999988 33
Q ss_pred ceeEEEEeecccc-cHHHHHHhhc------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~ 213 (419)
....++++||+.+ +|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEec
Confidence 4458899999984 5666654211 113458888999999999999999999 6999999999999999
Q ss_pred CCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHH
Q 014750 214 PLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (419)
Q Consensus 214 ~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (419)
+++.+||+|||+++........ ....+++.|+|||.+.+. .++.++|||||||++|||++ |..||.+....+..
T Consensus 159 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 -DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred -CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5778999999998765332221 123446789999998654 48999999999999999998 88999887776666
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+.+.... .++..++.++.+|+.+||+.||.+||++.+++..
T Consensus 237 ~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 555432110 1234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=299.68 Aligned_cols=246 Identities=33% Similarity=0.582 Sum_probs=202.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+|.+.+.||+|++|.||++++..+++.|++|.+..... ...+|+++++.++|+|++++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence 48889999999999999999999999999998865542 2457899999999999999999883 345689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTT-KDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEC-CCCCEEEeccccceec
Confidence 99999986 56555543 3678999999999999999999999 6999999999999999 5788999999999876
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 215 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--D----------- 215 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--C-----------
Confidence 44332 23456788999999986644 889999999999999999999999876654433332210 0
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
...++..++..+.++|.+||..||++|||+.+++.||||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 011234568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=313.13 Aligned_cols=263 Identities=26% Similarity=0.355 Sum_probs=194.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..+++|.-...||+|+||.||+|.. .+|..||||++.... ..+.+|+.++.+++|+|+|+++||+..... .
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~ 146 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H 146 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence 4456788888999999999999995 455899999886533 347789999999999999999999943221 4
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC--CcccccccCCceeeCCCCCceEEeeccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.+||+||+. |+|.+.|...... .++|....+|+.+++.||+|||... .|||||||++|||+| .+++.||+|||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGL 223 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGL 223 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccC
Confidence 889999999 6777777653221 8899999999999999999999853 399999999999999 799999999999
Q ss_pred cccccc-CCcceee-eeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC--HHHHHHHHH-HHhCCCCH
Q 014750 227 AKVLVK-GEANISY-ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEII-KVLGTPTR 301 (419)
Q Consensus 227 a~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~-~~~~~~~~ 301 (419)
|+.... ....... .||..|+|||.+.. ...+.++|||||||+|.||+||+.+..... ....+..+. ..+...
T Consensus 224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-- 300 (361)
T KOG1187|consen 224 AKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-- 300 (361)
T ss_pred cccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc--
Confidence 976544 3332333 89999999999965 458999999999999999999998887543 111122221 111111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCC-CCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.....+++.... ..+.. ..-..+..+..+|+..+|.+||++.|++.
T Consensus 301 ~~~eiiD~~l~~------------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVDPRLKE------------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeCCCccC------------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 011111111110 00110 01223678889999999999999999743
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=301.63 Aligned_cols=244 Identities=19% Similarity=0.271 Sum_probs=193.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|.+.+.||+|+||+||+|.+.. +..+|+|.+..... ...+|+.+++.++||||+++++++ .....++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCCcEEE
Confidence 469999999999999999998653 45699998865432 345799999999999999999988 334458999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+.+ +|.+.+... ...+++..++.++.||+.||.|||+ +|++|+||||+||+++ .++.+||+|||.++....
T Consensus 78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEc-CCCCEEECCCccceecCC
Confidence 999985 566655432 2368999999999999999999999 6999999999999999 678899999999876543
Q ss_pred CCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------- 220 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence 32211 12345679999999654 48999999999999999999 99999877766555554331110
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+...+..+.+++.+||..||.+|||+.+++.+
T Consensus 221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=304.85 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=195.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---- 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 4569999999999999999999987 77899999876432 224568899999999999999998743
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhcc---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC--Cce
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQV 219 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~v 219 (419)
....++||||+. ++|.+.+..... ....+++..+..++.||+.||+|||+ +|++||||||+||+++..+ ..+
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 344789999997 577777655321 12358899999999999999999999 6999999999999998432 369
Q ss_pred EEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 014750 220 KLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 295 (419)
||+|||+++........ .....+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999765322111 112234579999999764 48999999999999999997 99999887766544433221
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.. ..++..++..+.+++.+||+.||++|||+.++++|
T Consensus 238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 01223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=300.32 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=197.2
Q ss_pred ceeccCCceEEEEEEEcCC---CcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|.+... +..|++|.+..... ...+|+++++.++|+||+++++++. +...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence 4699999999999998865 88999998865432 3457899999999999999999884 355689999
Q ss_pred eccc-ccHHHHHHhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 155 EYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
||+. ++|.+.+...... ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~-~~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEEC-CCCcEEEccccccc
Confidence 9996 6777777654221 4779999999999999999999999 6999999999999999 57889999999998
Q ss_pred ccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 229 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~------ 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y------ 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C------
Confidence 765432 12334567889999998764 58999999999999999999 69999988766655544431 0
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
....+..++.++.++|.+||..||.+|||+.++++|
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011233568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=304.49 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=191.9
Q ss_pred eeeeceeccCCceEEEEEEEcCCCc--EEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ....+|+.+++.++|+||++++++++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999999877775 68999875431 223468899999999999999987644322 12235
Q ss_pred EEEEeeccc-ccHHHHHHhhc--cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.+++|||+. |+|.+.+.... .....+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLN-ENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEc-CCCCEEECCCCc
Confidence 789999998 46665553221 123458899999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
++....... .....++..|++||.+.+. .++.++|||||||++|+|++ |..||.+....+....+.+.-.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 987643322 1122346679999998654 58999999999999999999 8999988766554444332100
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. ..+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 -------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -------------L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -------------C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.85 Aligned_cols=238 Identities=34% Similarity=0.578 Sum_probs=196.4
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
||+|+||.||++.+..+++.+|+|.+.+... ...+|+.+++.++|+||+++++.+ .....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6999999999999988999999998865422 345789999999999999999887 5566699999999
Q ss_pred c-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC-Cc
Q 014750 158 P-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EA 235 (419)
Q Consensus 158 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-~~ 235 (419)
. ++|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++ .++.++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEc-CCCcEEEeecCcceecccCCCc
Confidence 5 677666654 3468999999999999999999999 6999999999999999 5778999999998765433 22
Q ss_pred ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcccc
Q 014750 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (419)
Q Consensus 236 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
.....++..|++||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. + .
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~-- 209 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------P-- 209 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------C--
Confidence 3345678889999998664 478899999999999999999999987765444333322 0 0
Q ss_pred CCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH---HHHhcCCcc
Q 014750 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~---~e~l~hp~f 363 (419)
..++..++..+.++|++||..||++||++ +++++||||
T Consensus 210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 01233458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.76 Aligned_cols=248 Identities=31% Similarity=0.492 Sum_probs=197.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+||+++++++. +...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 4699999999999999999999999999999987531 223457999999999999999999984 3455
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++||||+++ +|...+.........+++..++.++.|++.||.|||+ .||+||||||+||+++ .++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~-~~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFIT-ATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEEC-CCCcEEEeccceee
Confidence 8999999984 7777776654455678999999999999999999999 6999999999999999 57789999999987
Q ss_pred ccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 305 (419)
....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------- 223 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence 6543322 2345678899999998764 489999999999999999999999965431 1111111110
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++. .....++.++.++|.+||..||++|||+.++++
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001245789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.40 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=199.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...+|++.+.||.|+||.||+|.+.. +..+|+|.+..... ...+|+.+++.++|+||+++++++ .+....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 34569999999999999999999877 88999998865432 345789999999999999999988 344458
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||.+..
T Consensus 78 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~-~~~~~kl~d~g~~~~ 153 (261)
T cd05148 78 YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVG-EDLVCKVADFGLARL 153 (261)
T ss_pred EEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEc-CCceEEEccccchhh
Confidence 999999985 777777643 24568999999999999999999999 6999999999999999 678899999999976
Q ss_pred cccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+.+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05148 154 IKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--------- 223 (261)
T ss_pred cCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---------
Confidence 533221 1123346679999998654 58999999999999999998 89999887766666655431111
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 224 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=301.25 Aligned_cols=243 Identities=19% Similarity=0.287 Sum_probs=193.3
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+|++.+.||+|+||.||+|.+. ++..+|+|.+.+... ...+|+++++.++|+||+++++++ ......|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5889999999999999999875 567899998864322 345799999999999999999887 4445689999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEEC-CCCcEEECCcccceecccc
Confidence 99975 666666532 2468999999999999999999999 6999999999999999 6788999999998765432
Q ss_pred Ccce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 234 EANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 234 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------- 219 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 2111 11224569999998764 48999999999999999999 8999987766655544432110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++.++.+++.+||..+|++|||+.++++.
T Consensus 220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ---------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.96 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=196.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCC----------------cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVIS 134 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~ 134 (419)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999876544 458999886543 23346899999999999999
Q ss_pred cceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhcc-------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCccccccc
Q 014750 135 LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSS-------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (419)
Q Consensus 135 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlk 206 (419)
+++++. .+...+++|||+. ++|.+.+..... ....+++..++.++.|++.||.|||+ +||+|||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 999883 3455899999998 467777655331 12368999999999999999999999 699999999
Q ss_pred CCceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh--CCCCCC
Q 014750 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 281 (419)
Q Consensus 207 p~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~ 281 (419)
|+||+++ .++.++|+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999 578899999999876533221 1233456789999998664 48999999999999999998 788998
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+.+..+......... ......+..++.++.+||.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 77666555544432111000 0000112345789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.25 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=195.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...+|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+|+.+++.++|+||+++++++ ......|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence 3456999999999999999999964 45789999886543 2345799999999999999999987 3444589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+. ++|.+.+.... ...+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVG-ENNICKVADFGLARVI 153 (261)
T ss_pred eeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEc-CCCCEEECCcceEEEc
Confidence 9999995 67777665422 3568999999999999999999999 6999999999999999 5778999999999876
Q ss_pred ccCCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
....... ....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+....+..+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 223 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------- 223 (261)
T ss_pred cCCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 4322111 11223579999998654 58999999999999999999 99999887766555544331100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++..+.+++.+||+.||.+||++.++++
T Consensus 224 -------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 -------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 012245889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=300.34 Aligned_cols=245 Identities=23% Similarity=0.304 Sum_probs=193.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
++|++.+.||+|+||+||+|++..+ ...||+|.+..... ...+|+.+++.++|+||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence 4699999999999999999998654 45799998764322 234689999999999999999987 3444
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+++|||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~-~~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCCEEECccchh
Confidence 58999999985 66665543 23478999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccCCcc-e--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKGEAN-I--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
......... . ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----- 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----- 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 876422211 1 12335679999998654 48999999999999999998 99999877665554444321100
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+ .+..++..+.+|+.+||+.||++||++.+++++
T Consensus 228 -------------~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 -------------P----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.57 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=192.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|++.+.||+|+||.||+|++..+ ..||+|++..... ...+|+++++.++|+||+++++.+ .+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-----~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-----SE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-----CC-CCcEE
Confidence 45699999999999999999998655 4699998875332 345799999999999999998875 22 23689
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEc-CCCcEEeccCCceeecc
Confidence 9999985 776666542 23457899999999999999999999 6999999999999999 57789999999997654
Q ss_pred cCCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 232 KGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 232 ~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
...... ...++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 222 (262)
T ss_pred ccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------
Confidence 332211 23456679999988654 48999999999999999999 89999877666555443321000
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.....++..+.+||.+||+.||++||++.++++
T Consensus 223 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011246889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=298.51 Aligned_cols=242 Identities=21% Similarity=0.304 Sum_probs=193.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc--cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.+|++.+.||+|+||.||++.. .|..+|+|.+..+.. ...+|+.+++.++|+|+++++++++. +...++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEEE
Confidence 4699999999999999999986 578899998865432 34579999999999999999987643 233478999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +||+||||||+||+++ +++.+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEc-CCCcEEecCCccceecccc
Confidence 99984 777766542 22458899999999999999999999 6999999999999999 6788999999998754322
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2 223445679999998654 58999999999999999998 999998766555444432210
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+..+++.+.++|.+||..||++|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122356899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.13 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=195.0
Q ss_pred cceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|.+.+.||+|+||.||+|++.. ++..+++|.+.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVC-----GDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----ccC
Confidence 469999999999999999998643 45568999876443 2355799999999999999999988 444
Q ss_pred eeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
...++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~- 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG- 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc-
Confidence 55899999998 577776654321 23458899999999999999999999 6999999999999999
Q ss_pred CCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (419)
.++.+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+...
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 678899999999976533221 1234457789999998764 48999999999999999999 999998877665544
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+... . .+ ..+...+..+.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~--~-----------------~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG--R-----------------VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC--C-----------------CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 33221 0 00 012235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=303.07 Aligned_cols=257 Identities=27% Similarity=0.363 Sum_probs=188.7
Q ss_pred ce-eeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 78 SY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 78 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
+| ++.+.||+|+||+||++. ...++..||+|.+.... ....+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence 45 889999999999998865 34578899999886532 223479999999999999999987643 233
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..++++|||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLD-NDRLVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEc-CCCcEEEeeccc
Confidence 458899999995 55555543 458999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCH
Q 014750 227 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~ 301 (419)
++........ ....++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +..+... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~ 230 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV 230 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence 9765433221 122345679999998654 4899999999999999999999998654321 1111110 000000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.. +............+..++.++.+++.+||+.||++|||++++++
T Consensus 231 ~~------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 VR------------LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hh------------hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00000000111123456889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=299.01 Aligned_cols=235 Identities=25% Similarity=0.329 Sum_probs=185.2
Q ss_pred eeccCCceEEEEEEE--cCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 84 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
.||+|+||.||+|.+ ..++..+|+|++..... ...+|+.+++.++|+||+++++++ .++ ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence 589999999999964 45778999998864322 234688999999999999999876 222 3689999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~ 234 (419)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||+ +||+||||||.||+++ .++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEc-CCCeEEECCCccccccCCCC
Confidence 9995 56665543 3568999999999999999999999 6999999999999999 57789999999997654332
Q ss_pred cc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 235 AN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 235 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.. ....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||...+..+....+.+...
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~------------ 216 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER------------ 216 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence 21 11223568999999865 458899999999999999998 9999988776655554432100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..++..+++++.+||.+||+.||++||++++|..
T Consensus 217 ----------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 ----------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0123357899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=304.83 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=194.8
Q ss_pred CccccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeec
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFS 141 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (419)
+...++|.+.+.||+|+||.||+|.+. .++..||+|.+..... ...+|+.+++.+ +|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC-- 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE--
Confidence 345568999999999999999999853 3456899998864422 245699999999 799999999988
Q ss_pred cCCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 142 TTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.....+++||||+. ++|.+.+.... ...+++..+..++.|++.||.|||+ +||+|+||||+|||++ .++.+|
T Consensus 109 ---~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~~ 181 (302)
T cd05055 109 ---TIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLT-HGKIVK 181 (302)
T ss_pred ---ecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEc-CCCeEE
Confidence 33445899999998 56766665321 2348999999999999999999999 6999999999999999 677899
Q ss_pred EeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 014750 221 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 221 l~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 296 (419)
|+|||+++....... .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+.+......
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~- 259 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE- 259 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-
Confidence 999999976533221 11234467899999987654 8999999999999999998 99999877655444333321
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+. ....+...+.++.+|+.+||..||++|||+.++++
T Consensus 260 ~~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 GY--------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CC--------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 00012345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=305.14 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=194.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcC-------CCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFF 140 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (419)
...++|.+.+.||+|+||.||+|++.. ....+|+|.+..... ...+|+.+++.+ +|+||+++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~- 87 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC- 87 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE-
Confidence 445689999999999999999998642 345799998764322 234688999999 699999999988
Q ss_pred ccCCCCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
.+...+|++|||+. ++|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 88 ----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp 162 (314)
T cd05099 88 ----TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAA 162 (314)
T ss_pred ----ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 34455899999998 577777765321 23458889999999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (419)
+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999 577899999999976532211 1112234579999998764 58999999999999999999 89999887
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+....+..... ...+..++.++.+||.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 241 PVEELFKLLREGHR----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 76555554432100 0012346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=306.41 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=193.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcC-------CCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeecc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFST 142 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (419)
.++|.+.+.||+|+||.||+|++.. ++..+|+|.+..... ...+|+++++.+ +|+||+++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 4679999999999999999998643 235799998865421 234688899998 799999999988
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
.....+|+||||++ ++|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 44445899999998 577777765321 12358889999999999999999999 699999999999
Q ss_pred eeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCH
Q 014750 210 LLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 285 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~ 285 (419)
||++ .++.+||+|||++......... ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+...
T Consensus 171 ill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999 5788999999998765332211 112234679999998764 48999999999999999998 8999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+....+.... ....+..++.++.+||.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 54444332210 001223468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.43 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=197.2
Q ss_pred ceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
+|++.+.||+|+||.||++++. .+++.||+|.+.+.. ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4888999999999999999864 467899999886321 2234689999999 599999999888 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
....+|+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||||+||+++ .++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~-~~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLD-SEGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEEC-CCCCEEEEEC
Confidence 44568999999985 55555543 3568899999999999999999999 6999999999999999 5778999999
Q ss_pred ccccccccCCc--ceeeeeccccccchhhcCCC-CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 225 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|++........ .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.......+.+..-.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 99876543322 12346788999999986533 3688999999999999999999999654322111221111000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC---HHHHhcCCccccccCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---~~e~l~hp~f~~~~~~ 369 (419)
. ....+..++.++.++|.+||+.||++||| +.++|+||||+.+.+.
T Consensus 227 ----------~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 ----------S------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------c------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 00122346889999999999999999998 5678999999987663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=300.87 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=191.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|++.+.||+|+||+||+|++..+++ .||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 4579999999999999999999877776 48999876432 223468889999999999999988742
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+++|||++ |++.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ +++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~-~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVK-SPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEc-CCCcEEECCCC
Confidence 12679999998 577666654 23568999999999999999999999 7999999999999998 57789999999
Q ss_pred cccccccCCcce---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+++......... ...++..|+|||.+.+. .++.++|||||||++|||++ |..||......+....+.. ...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~- 231 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERLP- 231 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcCC-
Confidence 998664332221 12335679999998664 48999999999999999998 9999987665443332221 10000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..++.++.++|.+||..||++||++.+++.
T Consensus 232 --------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 --------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred --------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11245889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=302.75 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=190.7
Q ss_pred ceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
+|++.+.||+|+||.||+|++.. ....+++|.+..... ...+|+.+++.++||||+++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence 47889999999999999998753 235688888764432 244699999999999999999987 344
Q ss_pred eeEEEEeeccc-ccHHHHHHhhc--------------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCccccccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlk 206 (419)
...+++|||+. ++|.+.+.... .....+++..+..++.|++.||.|||+ .||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 45889999999 56666655321 112457889999999999999999999 699999999
Q ss_pred CCceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCC
Q 014750 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 282 (419)
Q Consensus 207 p~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~ 282 (419)
|+|||++ +++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999 678899999999975432221 1122346679999998654 48999999999999999998 9999987
Q ss_pred CCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 283 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+....+.+.. ....+..++.++.+||.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76554443322110 00112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=295.43 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=194.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.++||+|+||.||+|.+. +++.||+|.+..... ...+|+.+++.++|+||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence 3457999999999999999999854 678899998875432 3457999999999999999988752 12378
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||+. ++|.+.+... ....+++..+..++.|++.||+|||+ .|++||||||+||+++ +++.++|+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 77 IITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVS-ETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEc-CCCCEEEccCcceeec
Confidence 9999997 5677666532 24568999999999999999999999 6999999999999999 6788999999999765
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 222 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------- 222 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---------
Confidence 422221 123446679999998654 48899999999999999999 99999887766555544321110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++.++.++|.+||+.||++|||++++++
T Consensus 223 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=310.42 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=191.1
Q ss_pred cccceeeeceeccCCceEEEEEEE-----cCCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.++..+ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec--
Confidence 345799999999999999999984 3467899999986432 1234799999999 68999999987742
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc----------------------------------------------------
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS---------------------------------------------------- 170 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------------------------------------------- 170 (419)
....++++||||+ |+|.+.+.....
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 2335789999999 467666653210
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc---c
Q 014750 171 -----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---N 236 (419)
Q Consensus 171 -----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~ 236 (419)
....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhc
Confidence 01346788889999999999999999 6999999999999999 678899999999876532211 1
Q ss_pred eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcccc
Q 014750 237 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315 (419)
Q Consensus 237 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
....++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+...... +. .
T Consensus 239 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--------------~-- 300 (343)
T cd05103 239 GDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT--------------R-- 300 (343)
T ss_pred CCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cC--------------C--
Confidence 112345679999998764 48999999999999999997 99999875433332222210 00 0
Q ss_pred CCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 301 ----------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 ----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00122357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=297.04 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=192.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEE
Confidence 457999999999999999999865 56679999886532 23457999999999999999988762 1 23689
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||+.+ +|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+||+++ +++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVG-DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEe-CCceEEeCCceeeeecc
Confidence 9999985 676666532 23468999999999999999999999 6999999999999999 67889999999997654
Q ss_pred cCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 232 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---------- 222 (260)
T ss_pred CcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 33211 122345679999998654 48999999999999999999 99999887766655554321100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
..+...+..+.+||.+||..||++|||+.+++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=295.79 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=194.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..+|++.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++. +....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEE
Confidence 34689999999999999999987 588999999876544 3457999999999999999999884 3445899
Q ss_pred Eeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||++ ++|.+.+.... ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||.++...
T Consensus 78 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEe-CCCCEEEcccccccccc
Confidence 999998 57777665421 2368999999999999999999999 6999999999999999 67889999999998663
Q ss_pred cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.... ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+.+..
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------------- 216 (256)
T ss_pred cccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 2221 23345679999998654 48899999999999999997 999998776555443332210
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+..+++++.++|.+||..||++|||+.+++.
T Consensus 217 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 --------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=313.37 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=195.5
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~ 142 (419)
...++|.+.+.||+|+||.||+|++. .+++.||+|++..... ...+|+++|..+. |+||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~-- 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT-- 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc--
Confidence 34457889999999999999999864 3456899999875422 2346999999997 999999999883
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhcc---------------------------------------------------
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------------------------------------- 170 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------------------------------------- 170 (419)
....+++|||||. |+|.+.+.....
T Consensus 112 ---~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 112 ---KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred ---cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 3345899999999 577777754211
Q ss_pred -------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 171 -------------------------------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 171 -------------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp 267 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAA 267 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCc
Confidence 11246777889999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (419)
+|||++ .++.+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||...
T Consensus 268 ~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 268 RNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999 578899999999976432221 1234567889999999664 48999999999999999998 89999876
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+.....+.. +. ....+..++.++.+||.+||..||.+||++.++++.
T Consensus 346 ~~~~~~~~~~~~-~~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 346 PMNEQFYNAIKR-GY--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CchHHHHHHHHc-CC--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555544333321 00 001223468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.81 Aligned_cols=205 Identities=27% Similarity=0.403 Sum_probs=171.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccC-CCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT-SKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 150 (419)
.-|...+.||+|+||.||+++++.+|+.||||.+.+.. ..--+|+++|++++|+|||++.++-.... ..-...-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34777889999999999999999999999999886532 22347999999999999999988642211 0002235
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC---CCCceEEeeccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGS 226 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~ 226 (419)
.+|||||.| +|...|.. ......+++.+++.++..++.||.|||+ +||+||||||.||++-. .....||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 699999995 66666654 3446779999999999999999999999 69999999999999842 223589999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 283 (419)
|+...++....+.+||..|.+||++.....|+..+|.|||||++|+++||..||...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 999999998999999999999999975467999999999999999999999999754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=299.01 Aligned_cols=228 Identities=25% Similarity=0.328 Sum_probs=181.7
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccc-cHHHHHH
Q 014750 88 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK 166 (419)
Q Consensus 88 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 166 (419)
|.||.||+|++..+++.||+|.+..... ..+|...+....||||+++++++ .+....++||||+.| +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999876543 33455556666799999999988 444568999999985 6766665
Q ss_pred hhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccc
Q 014750 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246 (419)
Q Consensus 167 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~ 246 (419)
. ...+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.++|+|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEc-CCCCEEEecccchhccccc--cccCCcCcccc
Confidence 4 2458999999999999999999999 6999999999999999 5778999999988655322 22345577799
Q ss_pred cchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchh
Q 014750 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 326 (419)
Q Consensus 247 aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
|||.+.+ ..++.++|+||+||++|+|++|..||...... + . .... .
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~---------------~~~~------------~ 195 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N---------------THTT------------L 195 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c---------------cccc------------c
Confidence 9998855 34789999999999999999999887532210 0 0 0000 0
Q ss_pred hcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCcc
Q 014750 327 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF 363 (419)
Q Consensus 327 ~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f 363 (419)
.++..+++.+.+||.+||+.||++|+++ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1234578899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=299.12 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=186.0
Q ss_pred ceeccCCceEEEEEEEcCCCc--EEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|++..++. .+++|.+.... ....+|+.+++.+ +|+||+++++++ .....+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEE
Confidence 368999999999999988776 46888776422 2334689999999 899999999988 4445589999
Q ss_pred eccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 155 EYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
||+. ++|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++ .++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~-~~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG-ENYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEc-CCCeEEE
Confidence 9998 577777764321 12357899999999999999999999 6999999999999999 6788999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+|||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---- 228 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 228 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence 99999863321111112223566999999865 458999999999999999997 999998776655444432210
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.. ..+..++.++.+|+.+||..||.+|||+.+++.
T Consensus 229 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 --------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------------CC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 012235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=300.99 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=194.0
Q ss_pred ccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|.+.+.||+|+||.||++.+. .++..+|+|.+.... ....+|+++++.++|+||+++++++ .+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVC-----TE 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----ec
Confidence 346888999999999999999753 356789999876432 2345789999999999999999887 33
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
....+++|||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~- 156 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVG- 156 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEc-
Confidence 445899999998 577776654321 11358899999999999999999999 6999999999999999
Q ss_pred CCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (419)
+++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+...
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 678899999999875533221 1123346789999998764 48999999999999999998 999998776665554
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..... ...+..+++.+.+||.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 236 CITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4432100 0012346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=303.13 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=195.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-------CCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (419)
....+|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+|+.+++.+ +|+||+++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~- 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence 44567999999999999999999753 234579999876432 2345789999999 899999999988
Q ss_pred ccCCCCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
......|++|||+. ++|.+.+..... ....+++..+..++.||+.||.|||+ +||+||||||
T Consensus 91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp 165 (304)
T cd05101 91 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAA 165 (304)
T ss_pred ----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 34455899999998 477777765321 12457888899999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (419)
+|||++ .++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 166 ~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999 678899999999976543221 1122345679999998664 48999999999999999998 88999887
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+..+....+..... ...+..++.++.+||.+||..+|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76655544332100 00123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=297.71 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=192.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.+|...+.||+|+||.||+|++..++. .+|+|.+.... .....|+++++.++|+||+++.+++ .+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccCC
Confidence 468889999999999999999876654 79999886442 2234688999999999999999988 4444
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEc-CCCcEEECCCccc
Confidence 58999999995 55555543 23568999999999999999999999 6999999999999999 6778999999998
Q ss_pred cccccCCcce--e--eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGEANI--S--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~~~~--~--~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
.......... . ...+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--- 230 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--- 230 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence 7654322211 1 1124569999998664 47999999999999999998 999998877666555554321111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....++.++.+|+.+||+.||++||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=297.63 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=197.4
Q ss_pred ceeeeceeccCCceEEEEEEEcC-CCcEEEEEEeccCc--------------ccHHHHHHHHH-hcCCCCeeecceeeec
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMR-LMDHPNVISLKHCFFS 141 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~e~~~l~-~l~h~niv~~~~~~~~ 141 (419)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++. .++|+||+++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 38889999999999999999887 68899999875221 11234666665 47999999999988
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.+....+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+.+|++|+||+|+||+++ .++.+|
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-~~~~~~ 154 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVT 154 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-CCCcEE
Confidence 445568999999985 676666554445567999999999999999999999535899999999999999 577899
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+|||++.............++..|++||.+.+. .++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence 9999999876544434456788899999999764 48999999999999999999999998776655444443311110
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.....+++++.++|.+||+.||++||++.|+.++
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112457899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=297.53 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=192.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.+|++.+.||+|+||.||+|++..++. .+|+|.+.... ....+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence 469999999999999999999875544 79999876432 2345689999999999999999988 3444
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..|+||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~-~~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEEC-CCCeEEeCCCCcc
Confidence 58999999985 56655543 23468999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccCCcce----eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
.......... ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||...+..+....+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----- 227 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence 8664332211 11224579999999764 48999999999999999887 9999988776655544432111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+ .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 228 -------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 -------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11245889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=297.89 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=192.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 458999999999999999999887665 59999886432 2344689999999999999999988 4445
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+++||||+.+ +|.+.+.. ..+.+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~-~~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVN-SNLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEc-CCCcEEECCCccc
Confidence 58999999986 55555543 23568999999999999999999999 6999999999999999 5778999999998
Q ss_pred cccccCCcceee---e---eccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 228 KVLVKGEANISY---I---CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 228 ~~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
............ . .+..|+|||.+.+. .++.++|||||||++|||++ |..||...+..+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---- 228 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---- 228 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----
Confidence 765433221111 1 13469999998654 48999999999999999887 999998877665555443210
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+ .+..++..+.+++.+||..||.+||++.+++.
T Consensus 229 --------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 229 --------------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 010 11245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=302.22 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=192.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCC--------------cEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLK 136 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~ 136 (419)
..+|++.+.||+|+||.||+|++..++ ..||+|.+..... ...+|+++++.++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 357999999999999999999875432 3589998865421 244699999999999999999
Q ss_pred eeeeccCCCCceeEEEEeecccc-cHHHHHHhhcc--------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS--------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
+++ ......++||||+.+ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||
T Consensus 84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp 157 (295)
T cd05097 84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT 157 (295)
T ss_pred EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence 988 344458999999985 66666643211 11246888899999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh--CCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 282 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~ 282 (419)
+||+++ .++.+||+|||++......... ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999 5778999999999765333211 122346689999998764 48999999999999999998 6789987
Q ss_pred CCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 283 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..+.+..+......... ..+ ...+..+++.+.+||.+||..||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~------------~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGR------------QIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccc------------ccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7666555544331110000 000 0012235789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=301.43 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=195.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~----- 77 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC----- 77 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE-----
Confidence 34579999999999999999998753 67899999886442 2345699999999999999999987
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhcc------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccc
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSS------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dl 205 (419)
.+...++++|||++ ++|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl 156 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDL 156 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccc
Confidence 34445899999998 477777754221 12347888899999999999999999 69999999
Q ss_pred cCCceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCC
Q 014750 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 281 (419)
Q Consensus 206 kp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~ 281 (419)
||+||+++ .++.+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 157 ~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 157 ATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 678899999999875432221 1122345679999998664 48999999999999999998 888998
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+.+..+....+..... . ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRDGNV-------------------L---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhcCCC-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7776655544432100 0 012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.50 Aligned_cols=244 Identities=24% Similarity=0.312 Sum_probs=193.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|.+.+.||+|+||.||+|.+..+ ..+|+|.+..... ...+|+.+++.++|+||+++++++ .. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-----SE-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-----cC-CCcEE
Confidence 35699999999999999999987654 4699998765432 235799999999999999998876 22 23689
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +||+|+||||+||+++ +++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVG-DNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEc-CCCeEEECCCccceEcc
Confidence 9999985 777777542 23457889999999999999999999 6999999999999999 67889999999997653
Q ss_pred cCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 232 KGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 232 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---------- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 33221 123446679999988654 48999999999999999999 99999887766655544331000
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++..+.++|++||..||.+||+++++++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 ------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=294.19 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=190.4
Q ss_pred ceeccCCceEEEEEEEcC-CCc--EEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|++|.||+|.+.. .++ .||+|.+..... ...+|+.+++.++|+||+++++.+. + ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence 468999999999999865 333 689998876543 3457999999999999999999874 3 5589999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+. ++|.+.+..... ..+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLA-SDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEe-cCCEEEecccccccccccc
Confidence 9997 577777765321 568999999999999999999999 6999999999999999 5788999999999876442
Q ss_pred Ccc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 234 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 234 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------- 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 211 123456789999998654 48999999999999999998 9999988777665555443100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. ...+..++..+.+++.+||+.+|++|||+.++++
T Consensus 219 ----~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----R------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----c------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 0012345789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=302.42 Aligned_cols=255 Identities=18% Similarity=0.205 Sum_probs=185.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCcccHHH---------------HHHHHHhcCCCCeeecce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKNR---------------ELQLMRLMDHPNVISLKH 137 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~---------------e~~~l~~l~h~niv~~~~ 137 (419)
..+|++.+.||+|+||+||+|.+..+ +..+|+|........... +...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999998877 667788754322222111 223345668999999998
Q ss_pred eeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC
Q 014750 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (419)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~ 217 (419)
+..... ....+.+++|+++..++.+.+... ...++..++.++.|++.||.|||+ +||+||||||+|||++ .++
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~-~~~ 163 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVD-GNN 163 (294)
T ss_pred eeeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCC
Confidence 764322 122346789998887766665542 335788899999999999999999 6999999999999999 577
Q ss_pred ceEEeecccccccccCC--------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHH
Q 014750 218 QVKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289 (419)
Q Consensus 218 ~vkl~DfG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 289 (419)
.+||+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 89999999997653221 11234689999999998764 4899999999999999999999999876432222
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+. +.+..+... .......++++.++++.|+..+|.+||+.+++++
T Consensus 243 ~~~~~~------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKC------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHH------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 211110 000000000 0001235789999999999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=333.68 Aligned_cols=257 Identities=30% Similarity=0.440 Sum_probs=193.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------ 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 144 (419)
..+|+..+.||+||||.||+++++-+|+.||||+|.-.. ....+|+.+|.+|+|||||+++..+.....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346889999999999999999999999999999986442 224589999999999999998654220000
Q ss_pred --------------------------------------------------------------------------------
Q 014750 145 -------------------------------------------------------------------------------- 144 (419)
Q Consensus 145 -------------------------------------------------------------------------------- 144 (419)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ---------------------C-------CceeEEEEeecccccHHHHHHhhccCCCCC-CHHHHHHHHHHHHHHHHHhH
Q 014750 145 ---------------------K-------DELFLNLVMEYVPETMYRVLKHYSSMNQRM-PLIYVKLYTYQIFRGLAYIH 195 (419)
Q Consensus 145 ---------------------~-------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l-~~~~~~~i~~qi~~al~~LH 195 (419)
. ....+||-||||+..+++.+.+.. ... .....|++++||++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 014679999999987666665432 222 46779999999999999999
Q ss_pred cCCCcccccccCCceeeCCCCCceEEeecccccccc------------------cC-CcceeeeeccccccchhhcCCC-
Q 014750 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV------------------KG-EANISYICSRYYRAPELIFGAT- 255 (419)
Q Consensus 196 ~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~------------------~~-~~~~~~~~t~~y~aPE~~~~~~- 255 (419)
+ .|||||||||.||+++ .++.|||+|||+|.... .+ ...+..+||..|+|||++.+..
T Consensus 715 ~-~giIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 D-QGIIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred h-CceeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 6999999999999999 56779999999997621 01 1235678999999999997766
Q ss_pred -CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCCh
Q 014750 256 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334 (419)
Q Consensus 256 -~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 334 (419)
.|+.|+|||||||||+||+. ||... ++-...+.. +..+ .+|.- ..|...--+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~-LR~g---------------~iP~~------~~f~~~~~~ 845 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTN-LRKG---------------SIPEP------ADFFDPEHP 845 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHh-cccC---------------CCCCC------cccccccch
Confidence 69999999999999999997 57533 333332222 1111 11110 011122245
Q ss_pred hHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 335 EAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 335 ~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.-..+|++||+.||++||||.|+|++.||-
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 668999999999999999999999999997
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=306.45 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=194.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCC-------CcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeec
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFS 141 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (419)
...+|++.+.||+|+||.||+|++... +..||+|.+.... ....+|+++++.+ +|+||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-- 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE--
Confidence 345799999999999999999986432 2368999876432 2345789999999 899999999988
Q ss_pred cCCCCceeEEEEeecccc-cHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCC
Q 014750 142 TTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~ 208 (419)
.....++++|||+++ +|.+.+..... ....++...+..++.|++.||.|||+ +||+||||||+
T Consensus 88 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~ 163 (334)
T cd05100 88 ---TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAAR 163 (334)
T ss_pred ---ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccc
Confidence 344458999999984 77777764321 23457888899999999999999999 69999999999
Q ss_pred ceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCC
Q 014750 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (419)
Q Consensus 209 NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (419)
|||++ .++.+||+|||+++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 164 Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999 5778999999999765432211 112234679999999764 48999999999999999998 899998877
Q ss_pred HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 285 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+....+..... ...+..++.++.+||.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6665544432100 00123467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=294.94 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=196.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|.+.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++ ......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence 4567999999999999999999975 55789999886543 2345799999999999999999987 3444589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++ .++.+||+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVG-ENLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEc-CCCCEEECccccceec
Confidence 99999985 676666542 23568999999999999999999999 6999999999999999 5788999999998765
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||.+.+....+..+......+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 224 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-------- 224 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 432111 122335679999998754 48999999999999999999 999998887766666554321110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+...+.++.+++.+||+.||.+||+++++++
T Consensus 225 --------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 --------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 12235789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=325.17 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=203.9
Q ss_pred cceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
.+-+..+.||+|+||+||+|+... ....||||.++... .+++||++++..++|||||+++|++. .
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~ 560 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E 560 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence 346677889999999999998643 34679999887543 45679999999999999999999994 4
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccC----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSM----------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~ 215 (419)
..-+|+|+|||. |+|.+.|+..... ...++..+...|+.||+.|+.||-+ ..+|||||-..|+||+ +
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVg-e 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVG-E 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceec-c
Confidence 444999999999 8898888754321 2338899999999999999999999 5999999999999999 7
Q ss_pred CCceEEeecccccccccCCccee---eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014750 216 THQVKLCDFGSAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (419)
+..|||+|||+++.....+.... ..-...||+||.++-. .|++++||||+||+|||+++ |..||.+....+.++.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 88999999999987655443321 2335679999999754 59999999999999999999 9999999999998888
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~ 357 (419)
+.+..- -.-|+.++.++.+|+..||+.+|++||+..||
T Consensus 718 i~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 718 IRAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 765311 11246789999999999999999999999987
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=298.01 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=187.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....|+.+++.++|+||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence 479999999999999999999887776 46777764321 12234666788999999999999762 1
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...++++||+. |+|.+.+.. ....+++..+..++.||+.||.|||+ +|++||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~-~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLK-SDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEc-CCCcEEEcCCcc
Confidence 22678999998 677776654 23568999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
++....... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.........+.+. ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--- 230 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERL--- 230 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC---
Confidence 976543322 1223456789999998764 48999999999999999998 99999877654432222110 000
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. .+...+.++.+++.+||..||.+|||+.++++
T Consensus 231 ------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 11234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.16 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=188.6
Q ss_pred eeeceeccCCceEEEEEEEc----CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 80 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+.+.||.|.||.||+|... ..+..|+||.+.... ....+|++.++.++|+||+++++++.... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----cc
Confidence 45788999999999999987 356789999995432 33457899999999999999999986322 28
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++|||||. |+|.+.+... ....+++..+..++.||+.||.|||+ ++++|+||+++|||++ .++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~-~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLD-SNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEE-TTTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-cccccccccccccccc-ccccccccccccccc
Confidence 89999998 6788888763 24678999999999999999999999 6999999999999999 688999999999976
Q ss_pred cccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 230 LVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 230 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
...... .....+...|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 622211 12234567899999997654 8999999999999999999 7899998877776666633110
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++..+.++|.+||..||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123457889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.76 Aligned_cols=236 Identities=19% Similarity=0.231 Sum_probs=181.2
Q ss_pred ceeccCCceEEEEEEEcCCCcE-------EEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 83 RVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~-------vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+.||+|+||.||+|.+..++.. +|+|.+..... ...+|..+++.++|+||+++++++.. ....+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence 3699999999999998665443 88887754322 23468889999999999999998843 33478
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC-------ceEEee
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKLCD 223 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-------~vkl~D 223 (419)
+||||+++ +|.+.+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++. .+|++|
T Consensus 76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999985 565555432 2468899999999999999999999 69999999999999984332 279999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
||++..... .....++..|+|||++.+...++.++|||||||++|+|++| ..||...+..........
T Consensus 152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-------- 220 (258)
T cd05078 152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-------- 220 (258)
T ss_pred cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------
Confidence 999865432 22356788899999997655689999999999999999998 567765554433221110
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. ..++...+.++.+||.+||+.||++|||++++++.
T Consensus 221 ----------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 01223346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.77 Aligned_cols=236 Identities=23% Similarity=0.281 Sum_probs=184.3
Q ss_pred eeccCCceEEEEEEEc--CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeec
Q 014750 84 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++|+||+++++++. . ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence 3899999999999765 445679999886442 22457899999999999999998762 1 247899999
Q ss_pred ccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc
Q 014750 157 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235 (419)
Q Consensus 157 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~ 235 (419)
+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+|||++ .++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEc-CCCcEEeccCCccccccCCcc
Confidence 985 66555543 23578999999999999999999999 6999999999999999 677899999999975533321
Q ss_pred c----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 236 N----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 236 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
. ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.+.. .
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~----------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R----------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C-----------
Confidence 1 111224679999998654 48999999999999999996 999998877665554443210 0
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..++...++++.++|.+||..||++||++.++++
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122346899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=295.91 Aligned_cols=246 Identities=21% Similarity=0.293 Sum_probs=184.2
Q ss_pred ceeccCCceEEEEEEEcC--CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||+||+|.... ....+++|.+.... ....+|+.+++.++|+||+++++.+ .....+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEEE
Confidence 359999999999997533 34578888765332 1234688999999999999999988 34445899999
Q ss_pred ccc-ccHHHHHHhhccC-CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 156 YVP-ETMYRVLKHYSSM-NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 156 ~~~-~~l~~~l~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|++ |+|.+.+...... ....++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEec-CCCcEEEeccccccccccc
Confidence 998 4777777653321 2345678889999999999999999 6999999999999999 6788999999998654322
Q ss_pred Cc---ceeeeeccccccchhhcC------CCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 234 EA---NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 234 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
.. .....++..|+|||++.. ...++.++|||||||++|+|++ |..||......+.+..+......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI----- 228 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc-----
Confidence 11 112344667999999743 2346889999999999999999 88999887766655554432111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++ ...+...++..+.+++..|+ .||++|||++++++
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 -----------KLP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------cCC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 01123356888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.66 Aligned_cols=265 Identities=27% Similarity=0.397 Sum_probs=216.2
Q ss_pred CCccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
.+...+-|++.+.||.|.+|+||+++++.+++..|+|+...+. ...+.|.++|+.. .|||++.++++|+-......
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3455667999999999999999999999999999999876443 3344577788776 69999999999987766677
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..++||||||+ |+..++++... +.++.|..+..|+++++.||.+||. +.++|||||=.|||++ .++.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT-~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLT-ENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEe-ccCcEEEeeeee
Confidence 78999999999 56667776655 7899999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCC-cceeeeeccccccchhhcCCC----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGE-ANISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+....... ...+.+||++|||||++...+ .|+.++|+||||++..||.-|.+|+-.....-.+-+ +-..|+.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---IpRNPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IPRNPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---CCCCCCc
Confidence 98765433 244678999999999996543 367899999999999999999999976654433322 2222222
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.. .-++..+.++.|+|..||..|-.+||+..++|.|||+++.
T Consensus 247 kL-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 KL-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cc-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 11 0123458899999999999999999999999999999853
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.82 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=194.8
Q ss_pred cceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
.+|++.+.||+|+||.||+|+++. +.+.|++|.+..... ...+|+++++.++|+||+++++++ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 569999999999999999999754 346799998754332 245799999999999999999987 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccC-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSM-----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
....|+||||++ ++|.+.+...... ...+++..+..++.||+.||+|||+ +||+||||||+||+++ .++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~-~~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVS-SQREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEe-CCCcEE
Confidence 556899999998 5777776643311 1268999999999999999999999 6999999999999999 577899
Q ss_pred EeecccccccccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 014750 221 LCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (419)
Q Consensus 221 l~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 297 (419)
|+|||++....... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999986543221 12234567789999998654 47899999999999999999 88999776555444433210
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
... ...+..++..+.++|.+||..||.+|||+.+++.+
T Consensus 235 ---------------~~~----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ---------------KLE----------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------CcC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 01123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.92 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=193.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+++++.++|+||+++++++ ......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence 36899999999999999999875 46789999886442 2356799999999999999999987 444558999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEc-CCCeEEECCCcceeeccc
Confidence 999985 55544432 23468899999999999999999999 6999999999999999 677899999999875533
Q ss_pred CCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------ 219 (256)
T ss_pred CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence 2211 122345679999998754 48999999999999999998 9999987776655554432100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.33 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=191.1
Q ss_pred cceeeeceeccCCceEEEEEEEcC----------------CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeec
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISL 135 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~ 135 (419)
.+|++.+.||+|+||.||++.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986543 34578999886432 234579999999999999999
Q ss_pred ceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhccC-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSM-------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
++++. .....++||||+. ++|.+.+...... ...+++..+..++.|++.||+|||+ +||+||||||
T Consensus 85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 99884 3344899999998 5777766543211 2347788899999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh--CCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 282 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~ 282 (419)
+|||++ .++.+||+|||+++........ ....++..|++||...+. .++.++|+|||||++|||++ |..||..
T Consensus 159 ~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999 5788999999999765332211 112335679999988664 48999999999999999998 7899987
Q ss_pred CCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 283 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..+...........- .....++ .+..++..+.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQ-----------GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhc-----------cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443332211000 0000000 12345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.20 Aligned_cols=236 Identities=26% Similarity=0.360 Sum_probs=186.2
Q ss_pred ceeccCCceEEEEEEEcCCC---cEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|+...++ ..+|+|.+..... ...+|+.+++.++|+||+++++++. . ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----G-EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----C-CceEEEE
Confidence 46999999999999876554 7899998865443 2346899999999999999998762 2 2378999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+. ++|.+.+.. ...+++..+..++.|++.||.|||. +|++||||||+|||++ .++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEc-CCCcEEeccccccceeecC
Confidence 9998 467666654 3468999999999999999999999 6999999999999999 6788999999999766433
Q ss_pred Ccce----eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 234 EANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 234 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER----------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-----------
Confidence 2211 11124569999998654 48999999999999999998 9999987776554444322100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++..+.++|.+||..||.+||++.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.85 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=195.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcC----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34579999999999999999999876 35789999876432 2234689999999999999999976432
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccC----CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSM----NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
....+++++|+. ++|.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++ +++.+|
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~-~~~~~k 157 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVID-EELQVK 157 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEc-CCCcEE
Confidence 334789999998 5777766543222 1568999999999999999999999 6999999999999999 678899
Q ss_pred EeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 014750 221 LCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 296 (419)
|+|||+++.+...... ....++..|+|||++.+. .++.++|||||||++|++++ |+.||...+..+....+....
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 236 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY 236 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence 9999999765333221 123346679999998664 48999999999999999999 999998876655433332210
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++ .+..+++++.+++.+||..||++|||+.++++
T Consensus 237 ------------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 ------------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 11235789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=295.56 Aligned_cols=236 Identities=17% Similarity=0.194 Sum_probs=177.7
Q ss_pred ceeccCCceEEEEEEEcCC------------CcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 83 RVVGTGSFGIVFQAKCLET------------GETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
+.||+|+||.||+|+.... ...+++|.+..... ...+|+.+++.++||||+++++++. +
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 3689999999999985322 23588887654322 2346788999999999999999873 3
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC-------ce
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QV 219 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-------~v 219 (419)
....++||||++++.++.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++ .+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCcee
Confidence 344789999999654443332 123568999999999999999999999 69999999999999973 33 38
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|++|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+... ....
T Consensus 152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--- 224 (262)
T cd05077 152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--- 224 (262)
T ss_pred EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc---
Confidence 99999998654322 23457788999999865566899999999999999998 5889887654333211 1110
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. .. .....+.++.+||.+||+.||.+||++.+++++
T Consensus 225 -----------~---~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 -----------Q---CM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -----------C---cc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 00 011235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=293.06 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=183.1
Q ss_pred ceeccCCceEEEEEEEc--CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.||+|+||.||+|.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++ .+...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEEE
Confidence 36899999999999864 355689999876432 2344689999999999999999987 34445889999
Q ss_pred ccc-ccHHHHHHhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 156 YVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 156 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|++ |+|.+.+..... .....++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEc-CCCcEEECCccccccccCc
Confidence 998 577666654322 22345677888999999999999999 6999999999999999 5788999999998754322
Q ss_pred Cc---ceeeeeccccccchhhcCCC------CCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 234 EA---NISYICSRYYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 234 ~~---~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
.. .....++..|+|||++.+.. .++.++|||||||++|+|++ |..||...+..+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 21 11235677899999985321 25789999999999999996 99999877655543332221000
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++. ..+....+..+.+++.+|+ .||++|||+++++.
T Consensus 229 -----------~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCCC-------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0000 0111235788999999999 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.96 Aligned_cols=260 Identities=27% Similarity=0.358 Sum_probs=189.3
Q ss_pred cceeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.+|++.+.||+|+||.||++. +..+++.||+|.+.... ....+|+++++.++|+||+++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence 469999999999999999997 44578899999986443 2345799999999999999999876442 334
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+++||||++ ++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~-~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVE-SENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEEC-CCCeEEECCCccc
Confidence 5889999997 5777666532 3458999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccCCcce----eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHH
Q 014750 228 KVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPTRE 302 (419)
Q Consensus 228 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~ 302 (419)
.......... ...++..|+|||++.+. .++.++|||||||++|||++|..++...... ....+..... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence 8654332211 11224459999998764 4899999999999999999998776543211 1111000000 00000
Q ss_pred -HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 -EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+... .. ...+..++.++.+||.+||..||++|||+.++++
T Consensus 234 ~~~~~~~~~---~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNN---GR----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcC---Cc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000 00 0112356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=290.92 Aligned_cols=242 Identities=27% Similarity=0.394 Sum_probs=193.8
Q ss_pred eeeceeccCCceEEEEEEEcCCC----cEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 80 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++.+.||.|+||.||++++...+ ..||+|.+..... ....|+.+++.++|+||+++++++. +....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCee
Confidence 56788999999999999998766 8999999865432 3457899999999999999999884 33568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++|||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~-~~~~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEc-cCCeEEEcccCCcee
Confidence 999999985 6666665421 1228999999999999999999999 6999999999999999 577899999999976
Q ss_pred cccCCccee--eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEANIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
......... ..++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 644322211 235678999999854 458999999999999999998 8999988766665555433110
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.+++.+||..||.+|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0012236889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=290.53 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=193.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 3457999999999999999999854 55679999886543 234579999999999999999888732 3478
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|||++ ++|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVS-ASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEc-CCCcEEECCCcceeec
Confidence 9999998 5777776542 24567888899999999999999999 6999999999999999 6788999999998765
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 222 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------- 222 (260)
T ss_pred cCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---------
Confidence 332211 12234567999999865 458999999999999999999 99999887765555444321100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+...+.++.+++.+||+.||++||++.++++
T Consensus 223 -------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 -------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=308.54 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=195.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc---E-EEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
.+-.+.++||+|+||.||+|+.+..+. . ||+|..+.+. ....+|.++|+.++|+|||+++|+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P- 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP- 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-
Confidence 345566899999999999999765432 3 8999876422 233479999999999999999999854443
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
++||||+|.| +|.+.|+.. ...++..+...++.+.+.||+|||+ +++|||||-..|+|++ .++.+||+||
T Consensus 236 ----l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~-~~~~vKISDF 306 (474)
T KOG0194|consen 236 ----LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYS-KKGVVKISDF 306 (474)
T ss_pred ----cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheec-CCCeEEeCcc
Confidence 9999999995 777777653 2369999999999999999999999 6999999999999999 5777899999
Q ss_pred ccccccccCCcceeee-eccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 225 GSAKVLVKGEANISYI-CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 225 G~a~~~~~~~~~~~~~-~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|+++............ -...|+|||.+... .|+.++|||||||++||+++ |..||.+....+...+|...
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------- 378 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------- 378 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc-------
Confidence 9997643111111111 24569999999765 69999999999999999999 89999999999888888541
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++ ...+...+.++..++.+|+..||++|+|+.++.+
T Consensus 379 ----------~~r----------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ----------GYR----------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------Ccc----------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111 1123356889999999999999999999998864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=289.11 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=185.7
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
+.||+|+||.||+|.. .++..+|+|.+..... ...+|+++++.++|+||+++++++. .....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence 3689999999999985 4688999998764432 2446899999999999999999883 344589999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEc-CCCeEEECCCccceeccccccc
Confidence 85 55555543 23457899999999999999999999 6999999999999999 6788999999998754332211
Q ss_pred e--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 237 I--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 237 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
. ...++..|+|||++.+. .++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 212 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---------------- 212 (250)
T ss_pred cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 1 12335669999998654 48999999999999999998 9999987766554443322100
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.+|+.+||..||++||++.++++
T Consensus 213 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 ------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=288.94 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=186.9
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
+.||.|+||.||+|.+.. ++.||+|.+..... ...+|+++++.++|+||+++++++ .+....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence 469999999999999877 99999998764322 345799999999999999999988 3444589999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcc
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~ 236 (419)
.+ +|.+.+.. ....+++..+..++.+++.||.|||+ +|++||||||+||+++ .++.+||+|||++.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEc-CCCcEEEeeccccccccCCcce
Confidence 75 56555543 23467889999999999999999999 6999999999999999 6778999999999765322111
Q ss_pred e---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 237 I---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 237 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
. ...++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+....+
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 1 12235569999998664 58999999999999999999 8999987765544443322100
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.++|.+||+.+|.+|||+.++++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=293.80 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=193.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|++.+.||+|+||+||+|.+..+|+ .+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3579999999999999999999877765 58999876543 233478999999999999999998753
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...++||||+. |+|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~-~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVK-TPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEc-CCCeEEECCCc
Confidence 34789999998 567666654 23458999999999999999999999 6999999999999999 57789999999
Q ss_pred cccccccCCccee---eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEANIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+++.......... ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 229 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER---- 229 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC----
Confidence 9986643322211 122457999999865 448899999999999999998 9999988776555444432100
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+ ..+...+.++.+++.+||..||.+|||+.++++
T Consensus 230 --------------~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 --------------L----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred --------------C----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 012235788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.44 Aligned_cols=235 Identities=20% Similarity=0.232 Sum_probs=178.1
Q ss_pred eeccCCceEEEEEEEcCC------------------------CcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeec
Q 014750 84 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISL 135 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~ 135 (419)
.||+|+||.||+|....+ ...|++|.+..... ...+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999975322 23588887754322 23467889999999999999
Q ss_pred ceeeeccCCCCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 136 KHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
++++. +....++||||++++ |...+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.
T Consensus 82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEE-----eCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence 99884 344588999999965 4333332 24578999999999999999999999 69999999999999973
Q ss_pred C------CCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHH-hCCCCCCCCCHHH
Q 014750 215 L------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287 (419)
Q Consensus 215 ~------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~ 287 (419)
. ...+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|..||......+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 2 224899999988643222 22456778999999876566899999999999999995 6999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
........ .. ++...++++.++|.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~------------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYEKK------------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhc------------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211110 00 112246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=291.96 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=192.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|.+.+.||+|+||.||+|.+... ...||+|...... ....+|+.+++.++|+||+++++++. +
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-----E- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-----C-
Confidence 34689999999999999999987544 3468999876443 13456999999999999999998773 2
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...|+||||+. ++|.+.+... ...+++..++.++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~-~~~~~~l~d~g~ 153 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVS-SPDCVKLGDFGL 153 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEe-cCCCeEEccCce
Confidence 23679999998 4676666542 3458999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCCcce--eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 227 AKVLVKGEANI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 227 a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
++......... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------ 226 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------ 226 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------
Confidence 97654332211 12234579999998654 58999999999999999996 9999988877665554432100
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++.++.++|.+||..||.+|||+.+++..
T Consensus 227 ----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=294.91 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=188.5
Q ss_pred ceeeeceeccCCceEEEEEEE----cCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
-|++.+.||+|+||.||+|+. ..++..||+|.+.... ....+|+.+++.++|+||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 478999999999999999974 4578899999886432 2345799999999999999999887432 234
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..++||||++| +|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVE-SEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEc-CCCCEEECCCccc
Confidence 57899999985 66655543 12458999999999999999999999 7999999999999999 5778999999999
Q ss_pred cccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH-
Q 014750 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 302 (419)
Q Consensus 228 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~- 302 (419)
......... ....++..|+|||++.+. .++.++|||||||++|+|+++..|+..... .. .+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence 765433221 123456679999998764 489999999999999999998766533211 00 1111110000
Q ss_pred ----HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 ----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.....+.. . ....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLEEG---K----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHHcC---c----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 0 001123468999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=294.35 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=187.7
Q ss_pred ceeccCCceEEEEEEEcCCC------cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 83 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+.||+|+||.||+|++.... +.+|+|.+.... ....+|+.+++.++|+||+++++++. +....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence 36899999999999976544 689999875432 23347899999999999999999883 344589
Q ss_pred EEeeccc-ccHHHHHHhhcc---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC-----ceEEe
Q 014750 152 LVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLC 222 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-----~vkl~ 222 (419)
+||||++ ++|.+.+..... ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++ .+||+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 9999998 577777764322 23457889999999999999999999 69999999999999994 44 79999
Q ss_pred ecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 014750 223 DFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 223 DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~ 231 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR 231 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc
Confidence 9999876533221 1123446789999999764 48999999999999999998 99999877766554443211 00
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++..+.+||.+||..+|.+||+++++++
T Consensus 232 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 ---------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0112346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.65 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=191.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+|+.+++.++|+||+++++++.. + ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999864 78899999886442 234579999999999999999988732 1 268999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+. ++|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++ .++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEc-CCCcEEECCCccceecccc
Confidence 9998 5777776542 23458899999999999999999999 6999999999999999 5778999999998754322
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
......+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+.+..
T Consensus 154 --~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------- 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------- 214 (254)
T ss_pred --CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence 1222335679999998654 48999999999999999998 999998877655444332210
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.. ..+..++..+.+||.+||+.+|.+||++++++.
T Consensus 215 --~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 --RM----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --CC----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=290.01 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=183.1
Q ss_pred eeccCCceEEEEEEEcCC--CcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeec
Q 014750 84 VVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
.||+|+||.||++..... ...+++|.+.... ....+|+.+++.++||||+++++.+ .+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC-----VEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEe-----cCCCccEEEEec
Confidence 599999999999975433 2356677665332 2345688889999999999999988 344558999999
Q ss_pred cc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC-
Q 014750 157 VP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE- 234 (419)
Q Consensus 157 ~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~- 234 (419)
+. ++|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEc-CCccEEecccccccccCcchh
Confidence 99 47777776533334456778888999999999999999 6999999999999999 57789999999986432221
Q ss_pred --cceeeeeccccccchhhcCC------CCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 235 --ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 235 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
......++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------ 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence 12235678889999987431 235789999999999999997 578998777766666554321100
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. +...+...+++.+.+++..|| .||.+||+++++++
T Consensus 229 ----------~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----------L-------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------c-------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 011122346788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=296.44 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=190.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|+..+.||+|+||.||+|.+..+|+ .+|+|.+..... ...+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3468899999999999999999887776 468887764432 234688999999999999999987421
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..++++||++ |++.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~-~~~~~kL~Dfg 154 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVK-SPNHVKITDFG 154 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeec-CCCceEEcccc
Confidence 2568999998 567666653 23468899999999999999999999 6999999999999998 57789999999
Q ss_pred cccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+... +......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~--- 229 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGER--- 229 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCC---
Confidence 99865433221 123346789999998654 48999999999999999997 999998765443322 2221000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+ .+...+.++.+++.+||..||++||++.++++.
T Consensus 230 --------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 --------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 112357789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=288.50 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=181.6
Q ss_pred ceeccCCceEEEEEEEcC---CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.++|+||+++++++.. .+...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence 368999999999998654 34579999875322 233468889999999999999986642 233478999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||+. ++|.+.+... ...+++..+..++.|++.||.|||+ +|++||||||+|||++ .++.+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEc-CCCcEEECCccccccccCC
Confidence 9998 5666665432 2346777788999999999999999 6999999999999999 5778999999999754322
Q ss_pred Cc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 234 EA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 234 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.. .....++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+... .+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR-------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 11 1123346689999998654 58999999999999999999 57778776655544433221 00
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. ..+..++..+.+++.+||..||++||++.+++..
T Consensus 221 --------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --------L----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --------C----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0112357889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=289.82 Aligned_cols=233 Identities=19% Similarity=0.197 Sum_probs=180.0
Q ss_pred ceeccCCceEEEEEEEcCCC----------cEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 83 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
+.||+|+||.||+|.+..++ ..+++|.+.... ....+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence 46999999999999998776 358888765443 244578899999999999999998744 23
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC-------ceEE
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-------QVKL 221 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-------~vkl 221 (419)
.++||||+.+ +|.+.+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++. ++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence 6899999995 555555442 2268899999999999999999999 69999999999999984 44 6999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
+|||++..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+........
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~---- 222 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ---- 222 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC----
Confidence 99999976533 2234566779999998765 358999999999999999999 68888766432222111100
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+......+.++|.+||..||.+|||+.++++
T Consensus 223 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 --------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001112478999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=288.63 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=190.7
Q ss_pred eeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCc-e
Q 014750 79 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE-L 148 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~-~ 148 (419)
|.+.+.||+|+||.||+|.+. .+++.||||.+..+.. ...+|+++++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 667889999999999999864 3578999998865422 23478999999999999999998755432222 2
Q ss_pred eEEEEeeccc-ccHHHHHHhhc--cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+++++|+. +++...+.... .....+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~-~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLN-ENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEc-CCCCEEECccc
Confidence 3578899998 45555543211 122357889999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+++....... .....++..|++||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~--- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--N--- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--C---
Confidence 9986543221 1223345679999998654 47899999999999999999 89999877665544433321 0
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
... .+...+..+.+++.+||..+|++|||+.+++.+
T Consensus 233 -----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 -----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 112357899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.53 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=202.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC-----cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
....-.+.+.||+|+||.||.|...... ..||+|.+.+.. ..+.+|..+|+.++|||||+++++.+....
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3456778889999999999999865432 249999886553 334579999999999999999999966333
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhc---cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYS---SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.+|++|||. |+|+..|++-. .....++......++.+|++|++||++ +++|||||...|+||+ ....||
T Consensus 770 -----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~-~~r~VK 842 (1025)
T KOG1095|consen 770 -----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLD-ERRVVK 842 (1025)
T ss_pred -----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeec-ccCcEE
Confidence 789999999 57877777532 124568889999999999999999999 6999999999999999 568899
Q ss_pred EeecccccccccCCcceee---eeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 014750 221 LCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 296 (419)
|+|||+|+.+.+.+..... .-...|||||.+.. ..++.++|||||||++||++| |..||.+.+..+.+..+.+.-
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999965444432221 12346999999976 559999999999999999999 999999999988887666531
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.. ..|..++..+.++|.+||+.+|++||+...+++
T Consensus 922 RL----------------------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 RL----------------------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cc----------------------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11 124568999999999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=295.33 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=202.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.......++++||+|.||.|.++.. ..+..||+|+++.+ +..+.+|+++|.+++|||||.+++++.....
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP---- 609 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP---- 609 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc----
Confidence 3455688899999999999999985 34689999998754 3456689999999999999999999965444
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
+|+++||+. |+|.+.+..... ..+......+|+.||+.|++||.+. ++|||||.+.|+|+| .++++||+|||.+
T Consensus 610 -icmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~-~e~~iKiadfgms 684 (807)
T KOG1094|consen 610 -LCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVD-GEFTIKIADFGMS 684 (807)
T ss_pred -hHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeec-CcccEEecCcccc
Confidence 899999999 677776665321 1134455667999999999999995 999999999999999 7889999999999
Q ss_pred cccccCCcce---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh--CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+.+..++... ..+-...|||+|.++-. .++.++|+|+||+++||+++ ...||....+++...+....+..+...
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 9776555432 23446789999998764 48999999999999999876 789999888887777766655444432
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
.+. ..|.-++..+.+||.+||.+|-.+||+.+++-
T Consensus 764 ~~l---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 764 VVL---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred eec---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 211 12345688999999999999999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=302.44 Aligned_cols=274 Identities=23% Similarity=0.310 Sum_probs=184.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEc----------------CCCcEEEEEEeccCcc------------------cHHH
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR 119 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~ 119 (419)
...++|.+.++||+|+||+||+|... ..++.||||++..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45678999999999999999999752 2456799999854321 1123
Q ss_pred HHHHHHhcCCCCe-----eecceeeeccCC---CCceeEEEEeecccc-cHHHHHHhhcc--------------------
Q 014750 120 ELQLMRLMDHPNV-----ISLKHCFFSTTS---KDELFLNLVMEYVPE-TMYRVLKHYSS-------------------- 170 (419)
Q Consensus 120 e~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------- 170 (419)
|+.++..++|.++ +++++++..... ......+|||||+++ +|.+.+.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666677766654 566666533211 123357899999994 67666653110
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCccee--eeeccccccc
Q 014750 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAP 248 (419)
Q Consensus 171 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~--~~~t~~y~aP 248 (419)
....+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||++........... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234667889999999999999999 6999999999999999 577899999999976543322222 2347899999
Q ss_pred hhhcCCCC-------------------C--CCcccEeehhHHHHHHHhCCC-CCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 249 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 249 E~~~~~~~-------------------~--~~~~DiwslG~il~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
|++..... | ..+.||||+|||+|+|++|.. ||......... .+.. .-....|+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHh
Confidence 99853221 1 234799999999999999875 77543221110 0000 000011111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCC---CCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP---~~R~t~~e~l~hp~f~~ 365 (419)
.... .+.+ ...+..++.++|||.+||..+| .+|+|++|+|+||||..
T Consensus 456 ~~~~--~~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKGQ--KYDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hccc--CCCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1100 0111 1223468999999999999876 68999999999999953
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=287.60 Aligned_cols=283 Identities=29% Similarity=0.489 Sum_probs=215.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcC---CCcEEEEEEeccC--cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
.....|.++.+||+|.|++||++.+.. .++.||+|.+... ......|+++|..+ .+.||+++.+++ ..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccC
Confidence 344569999999999999999999887 7889999988533 34466899999888 589999999998 666
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+.+||||++..-...+. ..++...++.+++.++.||.++|. +|||||||||.|+|.+...+.-.|+|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhH
Confidence 6799999999964333332 236788899999999999999999 799999999999999988888999999998
Q ss_pred cccc-----------------c--CC--------------------------cceeeeeccccccchhhcCCCCCCCccc
Q 014750 228 KVLV-----------------K--GE--------------------------ANISYICSRYYRAPELIFGATEYTTSID 262 (419)
Q Consensus 228 ~~~~-----------------~--~~--------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D 262 (419)
.... . +. ......||+.|+|||++...+.-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6210 0 00 0013568999999999998888899999
Q ss_pred EeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCCHHHHhccC------------------cCCccccCCCCCC--
Q 014750 263 IWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN------------------PNYTDFRFPQIKA-- 321 (419)
Q Consensus 263 iwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~-- 321 (419)
|||.|||+.-+++++.||-. .++.+.+..++.++|...-......- .+|.......+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999854 56667777777777753322111000 0111110011100
Q ss_pred C--CchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 322 H--PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 322 ~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
. .+...+.+..+..+.||+.+||+.||.+|+|++++|.||||.+...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0 1333344456679999999999999999999999999999996544
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=285.66 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=190.0
Q ss_pred cceeeeceeccCCceEEEEEEEc----CCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|++.+.||+|+||.||+|... .++..||+|.+..... ...+|+++++.++|+||+++++++.. .+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence 46888899999999999999864 3478999998875543 34579999999999999999987733 224
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+++|||+. ++|.+.+... ...+++..+..++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~-~~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVE-SEDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEc-CCCCEEEccccc
Confidence 45889999997 4776666542 2358999999999999999999999 6999999999999999 578899999999
Q ss_pred ccccccCCcce----eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-----------HHH
Q 014750 227 AKVLVKGEANI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-----------LVE 291 (419)
Q Consensus 227 a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----------~~~ 291 (419)
+.......... ...++..|++||.+.+. .++.++|||||||++|+|++|..||........ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 98764322211 12335569999998664 489999999999999999999999865432110 111
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+...+.. . ..+ ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~-----------~---~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLKE-----------G---ERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHc-----------C---CcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1110000 0 000 012245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=295.09 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=202.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..+..+.++||.|.||.||.|.++...-.||||.++.+. ..+..|..+|+.++|||+|++++++... .-+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYI 340 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYI 340 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEE
Confidence 345667789999999999999999999999999998775 3455799999999999999999999443 34899
Q ss_pred Eeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|.|||. |+|++.|+.... ..++.-....++.||..|+.||.. +++|||||-..|+||. .++.|||+|||+++.+.
T Consensus 341 iTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVg-EnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhcccc-ccceEEeeccchhhhhc
Confidence 999998 899999987544 446777788999999999999999 7999999999999999 78899999999999885
Q ss_pred cCCcceeeee---ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 232 KGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 232 ~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.+. .+...| ..-|.|||.+.- ..++.++|||+|||+|||+.| |-.||++.+..+.+..+.+..
T Consensus 417 gDT-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy----------- 483 (1157)
T KOG4278|consen 417 GDT-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY----------- 483 (1157)
T ss_pred CCc-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------
Confidence 433 333333 456999998853 348999999999999999999 999999988766665554421
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~ 357 (419)
+.. -+.++++.+.+|++.||+++|.+||+..|+
T Consensus 484 -------RM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 484 -------RMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred -------ccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 111 245789999999999999999999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=307.82 Aligned_cols=251 Identities=31% Similarity=0.442 Sum_probs=193.0
Q ss_pred eeeeceeccCCceE-EEEEEEcCCCcEEEEEEeccCcc-cHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEee
Q 014750 79 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 79 y~~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
|.-.+++|.|+-|+ ||+|.. .|+.||||++..+.. ...+|+..|+.- +|||||++++.- ++..+.||+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 55567899998865 899987 788999998876544 678999999987 599999986654 77888999999
Q ss_pred cccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----CCCceEEeecccccccc
Q 014750 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~DfG~a~~~~ 231 (419)
+|..+|.+++...............+.++.|++.||++||+ .+||||||||.||||+. ...+++|+|||+++...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999987631111111214567788899999999999 49999999999999985 23579999999999876
Q ss_pred cCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.+.. .....||-.|+|||++.+.. -+.++|||||||++|+.++| ..||...- +.-.+|++.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~----------- 728 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTG----------- 728 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcC-----------
Confidence 5543 23457899999999997654 57799999999999999995 99997542 222333321
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
++.-..+. .....++.|||.+||..||..||+|.++|.||||-..
T Consensus 729 ---~~~L~~L~------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 729 ---NYTLVHLE------------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ---ccceeeec------------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11111111 1112289999999999999999999999999999653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=298.45 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=205.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCC---cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
+..+.++||+|.||+|++|.+...+ -.||||.+..+. ..+.+|+.+|..|+|+|++++|++..+. -
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence 4667789999999999999987543 358999887553 3456899999999999999999998542 1
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+.+|||++. |+|++.|++ .....|.......|+.||+.|+.||.+ +++|||||-..|+|+-. ...|||||||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeeccccee
Confidence 569999999 788888876 345678888999999999999999999 79999999999999984 6789999999999
Q ss_pred ccccCCcceeeee----ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKGEANISYIC----SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
.+..++......+ ...|+|||.+... .++.++|+|++||+||||++ |..||.+....+.+.+|-+.-..
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL----- 334 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL----- 334 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC-----
Confidence 8877766554332 3459999999764 48999999999999999999 89999999988888776532110
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.-++.+++++.+++++||..+|++|||...|.+.-+..+
T Consensus 335 -----------------------pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 335 -----------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----------------------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 123568999999999999999999999999876655544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=255.86 Aligned_cols=214 Identities=23% Similarity=0.409 Sum_probs=177.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc-----HHHHHHHH-HhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++..-+..||+|+||.|-+.++..+|...|+|.+...... ..+|+++. +...+|++|.+++.++.. .
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re-----g 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE-----G 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-----c
Confidence 344556677899999999999999999999999998644322 22455543 344799999999988543 3
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++|.||.|+.++..+-++....++.++|..+-+|+..++.||.|||+.-.++|||+||+||||+ ..|+|||||||++.
T Consensus 119 dvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN-YDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc-cCCcEEEcccccce
Confidence 48999999999888777777788999999999999999999999999844899999999999999 78999999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCC---CCCCCcccEeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK 294 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~ 294 (419)
.+.+.-..+...|...|||||.+... ..|+.++||||||+++.||.+++.||.. .+..+++.++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 88766555557788889999998432 3589999999999999999999999975 466777777665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=267.80 Aligned_cols=238 Identities=39% Similarity=0.677 Sum_probs=190.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccc-cHH
Q 014750 89 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMY 162 (419)
Q Consensus 89 ~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 162 (419)
+||.||+|.+..+|+.+|+|++.... ....+|++.++.++|+||+++++++. .....+++|||+++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence 58999999998889999999986442 34568999999999999999999884 33458999999997 777
Q ss_pred HHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcceeeeec
Q 014750 163 RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242 (419)
Q Consensus 163 ~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t 242 (419)
+.+.. ...++...++.++.+++.++.+||+ .|++|+||+|.||+++ .++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCC
Confidence 66654 2238899999999999999999999 6999999999999999 5688999999999876554444556778
Q ss_pred cccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCC
Q 014750 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 322 (419)
Q Consensus 243 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..|++||.+.+ ..++.++|+||||+++|+|++|..||......+........ ... ...
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---~~~-------------~~~----- 207 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---PKP-------------PFP----- 207 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc---cCC-------------CCc-----
Confidence 89999999865 44788999999999999999999999874333333222221 000 000
Q ss_pred CchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 323 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 323 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
.....++.++.+++.+||..||++||++.++++||||
T Consensus 208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0001157899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=297.35 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=206.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCC---cEEEEEEecc-----CcccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQ-----DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
...+.++||.|.||.|++|+.+..| ..||||.++. .+..+..|..||-+++||||+++.++.. ...-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCce
Confidence 3678899999999999999988766 4699999863 3556678999999999999999999983 3334
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+.||.|||+ |+|...|+.. .+.|+..++.-+++.|+.|++||-++ |.|||||-..||||+ .+-..|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVN-snLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVN-SNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchhhhhhhhheeec-cceEEEecccccee
Confidence 889999999 5666666653 46699999999999999999999997 999999999999999 68899999999999
Q ss_pred ccccCC-cceeeee---ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKGE-ANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~~-~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
.+.++. ...+..| ...|.|||.+.- ..++.++||||+||++||.++ |..||-..++.+.+..|.+..+.|+.
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence 876554 2222222 457999999965 458999999999999999887 99999999999999999887666553
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
-+++..+..|+..||++|-.+||...||+.+
T Consensus 857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3578999999999999999999999998864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=288.33 Aligned_cols=240 Identities=30% Similarity=0.427 Sum_probs=193.4
Q ss_pred eeeeceeccCCceEEEEEEEcCC--C--cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 79 YMAERVVGTGSFGIVFQAKCLET--G--ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~--~--~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..+.++||+|-||.||.|..... | -.||||.-+.+. ..+..|..+|+.++|||||+++|++.. .-
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QP 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cc
Confidence 44567899999999999986432 3 358888776542 334578999999999999999999832 22
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+||||+++ |.|.+.|... ...++......++.||+.||.|||+ +..|||||-..|||+. +...|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVs-Sp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVS-SPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeec-Ccceeeecccchhh
Confidence 789999999 7777777653 4678889999999999999999999 7999999999999999 56679999999999
Q ss_pred ccccCCcceeeee--ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEANISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.+.+........| ..-|||||.+.- ..++.++|||-|||.+||++. |..||.+-.+.+.+..+.++-..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl------- 611 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL------- 611 (974)
T ss_pred hccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCC-------
Confidence 9876655444444 445999999854 458999999999999999988 99999998776665554432111
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
..|+++++.+..|+.+||.+||.+||+..++.
T Consensus 612 ---------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 612 ---------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 13567899999999999999999999887654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.36 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=183.0
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.|...+.||+|+||.||+|++..++..||+|++........+|+++++.++|||||++++++.. ....|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEEEEeCC
Confidence 4666778999999999999998999999999987665555678999999999999999999843 34488999999
Q ss_pred cc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH---cCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 158 PE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH---TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 158 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
++ +|.+.++ .+++..+..++.|++.||+||| + .+|+||||||+||+++ .++..++. ||.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEEC-CCCceEEE-ecccccccc-
Confidence 84 6666553 3788899999999999999999 6 5999999999999999 56666665 666543321
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC-CCHHHHhccCcCC
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGT-PTREEIRCMNPNY 311 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~~~ 311 (419)
.....+|..|+|||++.+. .++.++|||||||++|||+||+.||..... ...+..+.+..-. ..... +
T Consensus 835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 904 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM-------W 904 (968)
T ss_pred --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh-------e
Confidence 1234678999999998764 589999999999999999999999954211 1111111111000 00000 0
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+ +.+... . ........++.+++.+||+.||++|||+.|+++.
T Consensus 905 ~~---~~~~~~-~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 ID---PSIRGD-V--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eC---ccccCC-C--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00 000000 0 0001113467899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=278.42 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=173.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH------------HHHHHHHHhcC---CCCeeeccee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRLMD---HPNVISLKHC 138 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~e~~~l~~l~---h~niv~~~~~ 138 (419)
....+|...+.||+|+||.|++|.++.+...|+||.|.+++-.. --|+.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34457999999999999999999999999999999887664322 15999999997 9999999999
Q ss_pred eeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
| +++.++||+||--+.++ .|..+.....++++.+++.|+.|++.|+++||+ .||||||||-||+.++ .+|-
T Consensus 638 F-----Eddd~yyl~te~hg~gI--DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd-~~g~ 708 (772)
T KOG1152|consen 638 F-----EDDDYYYLETEVHGEGI--DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVD-SNGF 708 (772)
T ss_pred e-----ecCCeeEEEecCCCCCc--chhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEe-cCCe
Confidence 9 88888999999887431 233445567899999999999999999999999 6999999999999999 6788
Q ss_pred eEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCC
Q 014750 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (419)
+||+|||.|.....+ ....++||..|.|||++.|..+.+..-|||+||++||.+++...||..
T Consensus 709 ~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999766444 456789999999999998888889999999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=283.08 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=206.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..++|.++..+|.|.||.||+|+++.+++..|+|.++-.. ....+|+-+++..+|+|||.+++.|.... .+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----kl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----Cc
Confidence 4567999999999999999999999999999999987442 34467999999999999999999985433 38
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+||||+|+.++.+.+ ..+.+++.++..++++.+.||+|||+ .|=+|||||-.|||++ +.+.+|++|||.+..+
T Consensus 88 wicMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanillt-d~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLT-DEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeec-ccCceeecccCchhhh
Confidence 89999999765555443 46889999999999999999999999 5999999999999999 6778999999998765
Q ss_pred ccC-Ccceeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKG-EANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... ....++.||++|||||+-. ....|...+|||++|+...|+---++|-........+..+-+..-.
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q--------- 233 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ--------- 233 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC---------
Confidence 332 2345789999999999852 2335899999999999999999888776555444444433332111
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
-|.++. +.+.++-+.+|++.+|..+|++|||++.+|.|||...
T Consensus 234 --------pp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 234 --------PPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred --------CCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111111 1234778889999999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=261.42 Aligned_cols=263 Identities=25% Similarity=0.286 Sum_probs=187.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHH--hcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMR--LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
...++.++||+|.||.||+|.. +++.||||++... ......|.+|.+ .++|+||+++++.--... .+...++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 3467788999999999999986 6699999999644 334455666666 468999999987643322 224568899
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC--------CCcccccccCCceeeCCCCCceEEeec
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--------PGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
++|-+ |+|.+.|+. ..+++....+++..+++||+|||+- ..|+|||||..||||. ++.+..|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeecc
Confidence 99998 899998886 5689999999999999999999962 3699999999999999 6889999999
Q ss_pred ccccccccCCc---ceeeeeccccccchhhcCCCCCC-----CcccEeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHHH
Q 014750 225 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKV 295 (419)
Q Consensus 225 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~ 295 (419)
|+|..+..+.. ....+||..|||||++.|..++. .+.||||+|.+||||++....+. +.-..-++---..+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99988754432 33478999999999998766554 46899999999999999764443 11111111111122
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCC-CChhHHHHHhhhcccCCCCCCCHH
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTAL 355 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dli~~~L~~dP~~R~t~~ 355 (419)
-..|..+++...- .-...+..|...+.+. --..+.+.+..||..|++.|+|+.
T Consensus 441 G~hPt~e~mq~~V-------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELV-------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHH-------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2334443332110 0000011111111111 134688999999999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=275.73 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=192.3
Q ss_pred ceeeeceeccCCceEEEEEEEcC-------CCcEEEEEEeccCcc-----cHHHHHHHHHhcC-CCCeeecceeeeccCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRLMD-HPNVISLKHCFFSTTS 144 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (419)
+..+.+.||+|+||.|++|.-.. ....||||.++.... ....|+++|+.+. |+||+.+++++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence 34566799999999999997431 145799998865433 3457999999885 9999999998843
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhc---cC-------C--CCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCcee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYS---SM-------N--QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIl 211 (419)
...+++|+|||. |+|+..|++.. .. . ..++......++.||+.|++||++ +.+|||||-..|||
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVL 450 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEE
Confidence 555899999999 78888888755 11 1 138899999999999999999999 69999999999999
Q ss_pred eCCCCCceEEeecccccccccCCccee--eee--ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCC-H
Q 014750 212 VDPLTHQVKLCDFGSAKVLVKGEANIS--YIC--SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-A 285 (419)
Q Consensus 212 l~~~~~~vkl~DfG~a~~~~~~~~~~~--~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~-~ 285 (419)
+. .+..+||+|||+|+.......... ..+ ...|||||.+.. ..|+.++||||+||+|||+++ |..||.+-. .
T Consensus 451 i~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 IT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99 678999999999986544433321 111 234999999976 569999999999999999999 999998854 4
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+....+.++.. -.-|..++.++.++++.||..+|.+||+..++.+
T Consensus 529 ~~l~~~l~~G~r----------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNR----------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 444332222100 1123467999999999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.95 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=185.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.+.|.+.+.||+|-||++.+++++.+...+++|.+.... ..+.+|...--.| .|.||+..+++.+.. ..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt----~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT----SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc----CceEE
Confidence 457999999999999999999999999999999886543 3334555443333 589999988876543 33678
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC-CCCCceEEeecccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~DfG~a~~ 229 (419)
++|||++ |+|.+.+.. ..+.+...+.++.|+++||.|||+ +++||||||.+||||- ++..+|||||||+.+.
T Consensus 99 F~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred EeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccc
Confidence 9999999 665554433 568889999999999999999999 7999999999999984 3445899999999865
Q ss_pred cccCCcceeeeeccccccchhhcCCC----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Q 014750 230 LVKGEANISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEI 304 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~ 304 (419)
.. ......-.+..|.+||+..... ...+.+|+|.||+|+|.++||.+||......+. .....+..+.-..
T Consensus 173 ~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--- 247 (378)
T KOG1345|consen 173 VG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--- 247 (378)
T ss_pred cC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---
Confidence 32 1111122355699999864322 246789999999999999999999985432221 2222222221110
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCC---CCHHHHhcCCcccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDE 365 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R---~t~~e~l~hp~f~~ 365 (419)
..|. ....+++.+..+.++-|..++++| .++......-|...
T Consensus 248 ----------~~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 248 ----------ALPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ----------cCch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 1110 113468999999999999999999 45566666667644
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=267.16 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=193.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+..++||.|+||+||+|.+...|+ +||||++... .....+|.-+|.+++|+|+++++++.....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 35566789999999999999877665 5788877533 234457889999999999999999885432
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
+-||++|++ |.|++.++. ....+.......|..||++||.|||. ++++||||-..|+||. .-..+||.|||++
T Consensus 772 -~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVk-sP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVK-SPNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeec-CCCeEEEEecchh
Confidence 569999999 688888776 34678888999999999999999999 6999999999999999 4667999999999
Q ss_pred cccccCCcceeeee---ccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKGEANISYIC---SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
+............+ .+-|||=|.+.. ..|+.++|||||||++||++| |..||.+....+.-..+.+...
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------ 918 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------ 918 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------
Confidence 98766555443332 455999998865 459999999999999999999 9999998876554443332100
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+ .-|...+-++.-++.+||..|+..||+++++.+
T Consensus 919 ------------L----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ------------L----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ------------C----------CCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1 113457889999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=247.69 Aligned_cols=251 Identities=24% Similarity=0.302 Sum_probs=182.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHH--hcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+..+.+.||+|.||.||+|++ .|+.||||+|.... ..-.||.+|++ .|+|+||+.+++.-...+ ..-..++||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEe
Confidence 4688999999999999999988 78999999986433 33346666665 569999999987653333 234568999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCcccccccCCceeeCCCCCceEEeecc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.+|-+ |+|++.|.. ..++.....+++..++.||++||.. ..|.|||||..||||. +++..-|+|+|
T Consensus 288 TdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLG 361 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 361 (513)
T ss_pred eecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeece
Confidence 99999 899999876 5688888999999999999999941 3599999999999999 78899999999
Q ss_pred cccccccCC-----cceeeeeccccccchhhcCCCCC-----CCcccEeehhHHHHHHHhC----------CCCCCCCCH
Q 014750 226 SAKVLVKGE-----ANISYICSRYYRAPELIFGATEY-----TTSIDIWSAGCVLAELLLG----------QPLFPGENA 285 (419)
Q Consensus 226 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~elltg----------~~pf~~~~~ 285 (419)
+|....... .....+||..|||||++...-+. -..+||||||.|+||++.. .+||.+--.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997654432 23457999999999999543221 2368999999999999752 367754311
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCC-----ChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-----PPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
. .|..++++.+ .. ..+++..++... -..+..|++.||..||.-|.|+--+.
T Consensus 442 ~-----------DPs~eeMrkV---VC--------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 S-----------DPSFEEMRKV---VC--------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred C-----------CCCHHHHhcc---ee--------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 1 1111211110 00 001111111111 23567889999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=226.92 Aligned_cols=208 Identities=37% Similarity=0.608 Sum_probs=175.0
Q ss_pred eccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeeccc-
Q 014750 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP- 158 (419)
Q Consensus 85 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~- 158 (419)
||+|.+|.||++.+..+++.+++|++..... ...+|+..++.+.|++|+++++++. .....+++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence 6899999999999988899999999876643 4678999999999999999999883 3356889999999
Q ss_pred ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC-cce
Q 014750 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-ANI 237 (419)
Q Consensus 159 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~-~~~ 237 (419)
++|.+.+.... ..++...++.++.+++.+|++||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 57666665421 468899999999999999999999 6999999999999999426789999999997654332 123
Q ss_pred eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCC
Q 014750 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (419)
Q Consensus 238 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
...+...|++||.+.....++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 355678899999986643578999999999999999
Q ss_pred CCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1457999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.08 Aligned_cols=207 Identities=18% Similarity=0.182 Sum_probs=147.7
Q ss_pred hcCC-CCeeecceeeeccCC--CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 126 LMDH-PNVISLKHCFFSTTS--KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 126 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
.++| .||+++++.|-.... .....++++|||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3445 577777776522211 12234778899999998888763 23569999999999999999999999 79999
Q ss_pred ccccCCceeeCC------------------CCCceEEeecccccccccCC-----------------cceeeeecccccc
Q 014750 203 RDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVKGE-----------------ANISYICSRYYRA 247 (419)
Q Consensus 203 ~Dlkp~NIll~~------------------~~~~vkl~DfG~a~~~~~~~-----------------~~~~~~~t~~y~a 247 (419)
|||||+||||+. .++.+||+|||+++...... .....+||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 24456777777775421100 0112467899999
Q ss_pred chhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhh
Q 014750 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 327 (419)
Q Consensus 248 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
||++.+.. |+.++|||||||+||||++|.+||.... ..+..+.... .+..
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-------------------------- 233 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-------------------------- 233 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence 99997654 8999999999999999999988875321 1122221110 0000
Q ss_pred cCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 328 ~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. ....+...+++.+||+.||.+||++.|+|+||||.+..
T Consensus 234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 00145667999999999999999999999999998743
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=228.55 Aligned_cols=204 Identities=33% Similarity=0.563 Sum_probs=167.3
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
|.+.+.||.|++|.||++.+..+++.+|+|.+... .....+|++.++.++|+|++++++++. .....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence 56778999999999999999888999999998754 234457999999999999999999873 33458899
Q ss_pred eecccc-cHHHHHHhhccCCCC-CCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQR-MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+|++++ +|.+.+... .. +++..++.++.+++.+|.+||+ ++++|+||+|+||+++ .++.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLG-MDGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeeCceeeEec
Confidence 999997 776666542 23 8899999999999999999999 6999999999999999 56889999999998765
Q ss_pred cCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCC-CCHH-HHHHHHH
Q 014750 232 KGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAV-DQLVEII 293 (419)
Q Consensus 232 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~-~~~~~i~ 293 (419)
... ......++..|++||.+.+...++.++|+|+||+++|+|++|+.||.. .+.. .....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 443 334567788899999884344578899999999999999999999977 3443 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=226.65 Aligned_cols=251 Identities=20% Similarity=0.236 Sum_probs=193.4
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcccH-----HHHHHHHHhcCCCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYK-----NRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
....++++..++-+|.||.||.|.+... .+.|.+|.++...... ..|.-++..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-- 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-- 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee--
Confidence 3455788888999999999999976532 2446666665443322 356667777899999999887753
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
+....++++.+++ |+|...|...+. ..+.++..++..++.|++.|++|||++ ||||.||-..|++|| +.-+
T Consensus 359 --~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvId-d~Lq 434 (563)
T KOG1024|consen 359 --DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVID-DQLQ 434 (563)
T ss_pred --ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceeh-hhee
Confidence 3334668888888 777777763322 234567778889999999999999995 999999999999999 6889
Q ss_pred eEEeecccccccccCCcce---eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 014750 219 VKLCDFGSAKVLVKGEANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 294 (419)
|||+|=.+++..-..+... ..-....||++|.+.. ..|+.++|+|||||++|||+| |+.||..-+..++..-+.+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999999998765444321 1122445999999976 459999999999999999999 9999999998888776655
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+. ++. -|-+++.++..++..||..+|++||+.+|+..
T Consensus 514 Gy------------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GY------------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cc------------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 31 111 13468999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=215.05 Aligned_cols=167 Identities=22% Similarity=0.190 Sum_probs=125.2
Q ss_pred ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCccee
Q 014750 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238 (419)
Q Consensus 159 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~ 238 (419)
|+|.+.+... +..+++..++.++.||+.||.|||+ ++ ||+|||++ .++.+|+ ||+++..... .
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~----~ 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLT-WDGLLKL--DGSVAFKTPE----Q 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEc-Cccceee--ccceEeeccc----c
Confidence 4666776542 4569999999999999999999999 57 99999999 6778998 9999765332 2
Q ss_pred eeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhccCcCCccccCC
Q 014750 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317 (419)
Q Consensus 239 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..+........ +
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~ 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------P 126 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------c
Confidence 3688999999999765 4899999999999999999999999765432 22333222111000 0
Q ss_pred CCCCCCchhhcCCCCCh--hHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 318 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~s~--~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.. . .....++. ++.++|.+||..||.+|||+.++++|+|+..
T Consensus 127 ~~-~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 127 RD-R-----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cc-c-----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00 0 00011233 6999999999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=250.96 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=190.6
Q ss_pred eeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--ccc--------HHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRY--------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~--------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
....++|.|++|.|+.+......+.++.|.+... ... ...|+.+-..+.|+|++.....++....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence 4567899999999999988777777777755311 111 1134445567899999887776643222
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.+-+||||+++|+..+.. ...+....+..++.|++.||+|||++ ||.|||||++|+++. .++.+||+|||.+..
T Consensus 396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~-~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVT-ENGILKIIDFGAASV 469 (601)
T ss_pred chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEe-cCCceEEeecCccee
Confidence 333499999977777664 25788889999999999999999995 999999999999999 678999999999876
Q ss_pred cccCC-----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 230 LVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 230 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
..... .....+|+..|+|||++.+..+.....||||.|+|++.|++|+.||......+....-..
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 53332 234578899999999998877666789999999999999999999976544332210000
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
....+.. ...+ ..+...++...+.+|.+||+.||.+|+|+++|++.+||+.+...
T Consensus 540 -----~~~~~~~---~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 540 -----YSDQRNI---FEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred -----ccccccc---ccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 0000000 0000 01112468889999999999999999999999999999987543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=236.59 Aligned_cols=237 Identities=29% Similarity=0.424 Sum_probs=191.6
Q ss_pred eeccCCceEEEEEEE---cCCCcEEEEEEeccC------cccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEEE
Q 014750 84 VVGTGSFGIVFQAKC---LETGETVAIKKVLQD------RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
++|+|+||+|++++. ...|..+|+|..++. ......|..++..++ |+.+|+++.++ +.+..++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 379999999998763 235677899876533 223345888888887 99999999988 445558999
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
+++..|+ .+.........+.+...+.+..+++.++.++|+ .||+|||+|++||+++ .+|.+|+.|||+++.....
T Consensus 76 ld~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld-~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeec-ccCccccCCchhhhHhHhh
Confidence 9999975 222233345678888899999999999999999 5999999999999999 6788999999999887655
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
... |||..|||||++.+ ...++|+||||+++|+|+||..||.+ +.+..|.+..
T Consensus 151 ~~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------- 203 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------- 203 (612)
T ss_pred hhc---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence 443 99999999999962 68899999999999999999999987 5555555411
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccCC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 369 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~ 369 (419)
..+|..++..+.+++..++..+|.+|... .++++|+||..+.|.
T Consensus 204 ------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 ------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 11234568899999999999999999854 799999999998876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=211.60 Aligned_cols=251 Identities=20% Similarity=0.196 Sum_probs=188.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCC-cEEEEEEeccCc----ccHHHHHHHHHhcCC----CCeeecceeeeccCCCCce
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRLMDH----PNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 148 (419)
+|.+.+.||+|+||.||.|.+..++ ..+|+|...... .....|..++..+.. .++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987775 678998765431 145679999988873 57777777652 2455
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC----CceEEeec
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT----HQVKLCDF 224 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~~vkl~Df 224 (419)
+.||||+.++.+|.++..... .+.++...+..++.|++.+|++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 678999999999988776544 6889999999999999999999999 6999999999999998443 56999999
Q ss_pred cccc--ccccCC--------c-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014750 225 GSAK--VLVKGE--------A-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (419)
Q Consensus 225 G~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 293 (419)
|+++ ...... . ...+.||..|.++....+. ..+.+.|+||++.++.+|+.|..||.+........++.
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 2235699999999988765 47999999999999999999999997765433333332
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+...... ... +....+.++.++...+-..+...+|....+...
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2110000 000 111235667777777777888999988777554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=215.94 Aligned_cols=169 Identities=19% Similarity=0.272 Sum_probs=124.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-CCcEEEEEEeccC---------cccHHHHHHHHHhcCCCCeee-cceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVIS-LKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~ 143 (419)
..++|.+.+.||+|+||+||+|++.. +++.+|||++... .....+|+++|+.++|+||+. ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 34579999999999999999999876 6788899986432 123568999999999999985 4321
Q ss_pred CCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccc-cCCceeeCCCCCceEEe
Q 014750 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~ 222 (419)
...|||||||.|+.+..+. . .. ...++.|++.||.|||+ +||+|||| ||+|||++ .++.+||+
T Consensus 91 ----~~~~LVmE~~~G~~L~~~~---~----~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~-~~~~ikLi 154 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLAR---P----HG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMG-PDGEAAVI 154 (365)
T ss_pred ----CCcEEEEEccCCCCHHHhC---c----cc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEc-CCCCEEEE
Confidence 1268999999975333221 0 11 14678899999999999 69999999 99999998 56789999
Q ss_pred ecccccccccCCc---------ceeeeeccccccchhhcCCC-----CCCCcccEe
Q 014750 223 DFGSAKVLVKGEA---------NISYICSRYYRAPELIFGAT-----EYTTSIDIW 264 (419)
Q Consensus 223 DfG~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw 264 (419)
|||+|+....... .....+++.|+|||.+.... ..+...|-|
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999986543221 12446678899999874321 133446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=193.76 Aligned_cols=208 Identities=23% Similarity=0.324 Sum_probs=166.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCC-CCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..+.|+++++||.|+||.+|+|....+|+.||||.-.... .....|..+.+.|++ ..|..+..+. .+..+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence 3456999999999999999999999999999999765443 345679999998865 4555555554 4555667
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeecccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~~ 229 (419)
+||++++.+|.+++.-. ..+++...+..++.|++.-++|+|. +++|||||||+|+|..- ..+.+.|+|||+|+.
T Consensus 88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999999888776543 4678999999999999999999999 69999999999999863 235799999999987
Q ss_pred cccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014750 230 LVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292 (419)
Q Consensus 230 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 292 (419)
+.+... .....||..|.+--...+.. -+.+.|+-|+|.+|.++.-|..||.+.......++.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 754332 24568999999877666543 588899999999999999999999987655444333
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=200.00 Aligned_cols=199 Identities=22% Similarity=0.330 Sum_probs=166.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEec--cCcccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEEEe
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.|+++++||+|+||+++.|++.-+++.||||.-. .+......|....+.|. .++|...+.+. ....+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence 5999999999999999999999999999999643 33445667888888874 67888765443 4555567999
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----CCCceEEeeccccccc
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVL 230 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~DfG~a~~~ 230 (419)
|+++.+|.+++... +.+|+...+..++.|++.-++|+|+ +++|+|||||+|+||.. +.+.|.|+|||+|+.+
T Consensus 104 dLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99999988887653 5789999999999999999999999 69999999999999962 2356999999999987
Q ss_pred ccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 231 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
.+... ..+..||..||+--..+|.. -+.+.|+-|||-+++++|-|..||.+....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 55432 34678999999998888865 689999999999999999999999986443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=204.73 Aligned_cols=259 Identities=35% Similarity=0.500 Sum_probs=194.3
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCC-CeeecceeeeccCCCCceeE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHP-NVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 150 (419)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+|..++..+.|+ +|+++.+++ ......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence 778899999999999999986 7889998864322 345788899999988 799999988 333337
Q ss_pred EEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++++++.++ +.+.+...... ..+....+..++.|++.++.|+|+ .|++|||+||+||+++..+..++++|||.++.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 8999999964 44333321110 368999999999999999999999 69999999999999994333799999999975
Q ss_pred cccCC-------cceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC
Q 014750 230 LVKGE-------ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 297 (419)
Q Consensus 230 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~ 297 (419)
..... ......|+..|++||.+.+. ..++...|+||+|++++++++|..||..... ............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54332 23567889999999999763 4688999999999999999999999887764 333333333222
Q ss_pred CC-CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 298 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 298 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.+ .. .... ..........+.+++.+++..+|..|.+..+...++|.....
T Consensus 232 ~~~~~--------------~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 232 TPSLA--------------SPLS------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred Ccccc--------------cccC------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22 00 0000 000011236789999999999999999999999987776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=234.36 Aligned_cols=225 Identities=28% Similarity=0.480 Sum_probs=168.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
...+|..++.|..|+||.||+++|+.+.+.||+| +.++.....+ ++....+|.+ |
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfv--------------------v- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFV--------------------V- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcce--------------------e-
Confidence 4457999999999999999999999999999995 5444322211 2222222222 2
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~ 234 (419)
|+=...++. -+.++.. ++.+++|||+ .||+|||+||+|.+|. .-|.+|++|||+++......
T Consensus 136 ----gDc~tllk~----~g~lPvd--------mvla~Eylh~-ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVD--------MVLAVEYLHS-YGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhccc----CCCCcch--------hhHHhHhhcc-CCeecCCCCCCcceee-ecccccccchhhhhhhhhhc
Confidence 211122221 2334433 3789999999 6999999999999999 57789999999987542110
Q ss_pred ----------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 235 ----------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 235 ----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
.....+||+.|+|||+++.. .|++.+|||++|+|+||.+.|..||.+.+.++.+.+++....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i- 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI- 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-
Confidence 01235889999999999764 499999999999999999999999999999999988877322
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC---CHHHHhcCCccccccCC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 369 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---t~~e~l~hp~f~~~~~~ 369 (419)
.+++- ...+.++++++|.++|..+|..|. .+-++.+|+||+.++|.
T Consensus 276 ----------------~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 ----------------EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ----------------ccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 22211 124689999999999999999996 46788899999998876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=198.08 Aligned_cols=199 Identities=23% Similarity=0.340 Sum_probs=145.1
Q ss_pred CCCCeeecceeeeccCC----------------------CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHH
Q 014750 128 DHPNVISLKHCFFSTTS----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185 (419)
Q Consensus 128 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ 185 (419)
+|||||++..+|.+... .....+|+||.-.+.+|.+++-. ...+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 59999999988864421 13456899999999888887764 4466677888999
Q ss_pred HHHHHHHHhHcCCCcccccccCCceeeCCC---CCceEEeecccccccccC-------CcceeeeeccccccchhhcCCC
Q 014750 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKVLVKG-------EANISYICSRYYRAPELIFGAT 255 (419)
Q Consensus 186 qi~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~ 255 (419)
|+++|+.|||++ ||.|||||.+||||.-+ -..+.|+|||++-..... ......-|...-||||+....+
T Consensus 349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999995 99999999999998422 235789999998532221 1122345677899999985432
Q ss_pred C-----CCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCC
Q 014750 256 E-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 330 (419)
Q Consensus 256 ~-----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
. .-.++|.|+.|.+.||++....||.+......-. .+|.+-.+|. +++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------RTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------hhhhhhhCCC---------Ccc
Confidence 1 1247899999999999999999998744321100 1122222322 456
Q ss_pred CCChhHHHHHhhhcccCCCCCCCH---HHHhc
Q 014750 331 RMPPEAIDLASRLLQYSPSLRCTA---LEACA 359 (419)
Q Consensus 331 ~~s~~~~dli~~~L~~dP~~R~t~---~e~l~ 359 (419)
.+++.+++|+..+|+.||++|+++ +.+|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 789999999999999999999985 35554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=194.22 Aligned_cols=237 Identities=25% Similarity=0.313 Sum_probs=144.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHH-------hcC----------CCCeeecceeee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-------LMD----------HPNVISLKHCFF 140 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-------~l~----------h~niv~~~~~~~ 140 (419)
.+...+.||.|+++.||.+++..||+.+|+|++........++++-++ .+. |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467788999999999999999999999999988543322222222111 111 111111112111
Q ss_pred cc---------CCCCce---eEEEEeecccccHHHHHHhhccCCC---CCCHHHHHHHHHHHHHHHHHhHcCCCcccccc
Q 014750 141 ST---------TSKDEL---FLNLVMEYVPETMYRVLKHYSSMNQ---RMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (419)
Q Consensus 141 ~~---------~~~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dl 205 (419)
.. ...... ..+++|+-+.++|...+........ .+.......+..|+++.+++||. .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 11 001111 3478899998888777654222222 22333344556899999999999 69999999
Q ss_pred cCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCC-------CCCCCcccEeehhHHHHHHHhCCC
Q 014750 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 278 (419)
Q Consensus 206 kp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~ 278 (419)
||+|++++ .+|.++|+||+....... .......+..|.+||..... ..++.+.|.|+||+++|.|.+|+.
T Consensus 172 ~~~nfll~-~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLD-QDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE--TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEc-CCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999 578899999988765422 22213345779999976432 236889999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCC
Q 014750 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351 (419)
Q Consensus 279 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 351 (419)
||........ .+ ..|..+- ++++.+++||.++|+.||.+|
T Consensus 249 Pf~~~~~~~~-----------------------~~--------~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEAD-----------------------PE--------WDFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGST-----------------------SG--------GGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccc-----------------------cc--------ccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 9976532100 00 0111221 578999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=220.53 Aligned_cols=241 Identities=29% Similarity=0.411 Sum_probs=171.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc--------HHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------KNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
+|...+.||.+.|=+|.+|++. .| .|+||++.+.... ..+|++ ...+++||.+.+..+. ..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 5778899999999999999864 34 4999988654311 123444 5677999999876654 33444
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
-|||-+|+..+|++.+.. ..-+...+.+-|+.||+.||..+|. .||+|||||.|||||++-+ -+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWN-WLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeec-hhhhhcccccCC
Confidence 679999999888887764 3456778888899999999999999 5999999999999999544 589999987653
Q ss_pred cc---cCCc-ceeee----eccccccchhhcCCC----------CCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHH
Q 014750 230 LV---KGEA-NISYI----CSRYYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 290 (419)
Q Consensus 230 ~~---~~~~-~~~~~----~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~ 290 (419)
.. ++.. ...+. ...+|.|||.+.... ..+++.||||+||+++||++ |++||.- .++-
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 31 1111 11122 234699999985421 14678999999999999999 8999941 2222
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+.- .-..+ ..+..--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~~-~~~~e-----------------------~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGN-ADDPE-----------------------QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccC-ccCHH-----------------------HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 211110 00000 00111125688999999999999999999999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=181.89 Aligned_cols=135 Identities=16% Similarity=0.207 Sum_probs=103.0
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------------------------------cHHHHHHHHHhcCCCC
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN 131 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n 131 (419)
...||+|+||.||+|.+. +|+.||+|++..... ...+|..++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 899999999864321 0124888999998877
Q ss_pred eeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCcccccccCCce
Q 014750 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGVCHRDVKPQNL 210 (419)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~ivH~Dlkp~NI 210 (419)
+.....+. ... .+|||||++|+.+.... .....+++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus 81 v~~p~~~~-----~~~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL-----LKS--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE-----ecC--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64433221 111 36999999975322111 1135788999999999999999999 68 6999999999999
Q ss_pred eeCCCCCceEEeeccccccc
Q 014750 211 LVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 211 ll~~~~~~vkl~DfG~a~~~ 230 (419)
|++ ++.++|+|||+|...
T Consensus 150 li~--~~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH--DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEE--CCcEEEEEccccccC
Confidence 998 357999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=179.83 Aligned_cols=171 Identities=13% Similarity=0.129 Sum_probs=125.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----c---------cHHHHHHHHHhcCCCCeeecceeeecc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----R---------YKNRELQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~---------~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (419)
.++|++.++||.|+||.||++.+ ++..+|+|.+.... . ..++|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45799999999999999999765 57789999885321 1 145788899999999999998886543
Q ss_pred CCC---CceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 143 TSK---DELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 143 ~~~---~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
... .....+|+|||++|. |.+. . .+++ ....+++.+|..||+ .|++|||+||+||+++ .++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~-~-------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~-~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDM-P-------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVS-KNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHh-h-------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEe-CCC-
Confidence 211 123478999999984 3332 1 1233 235599999999999 6999999999999999 466
Q ss_pred eEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh
Q 014750 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt 275 (419)
++|+|||............. +++. ..|..++|+||||+++..+..
T Consensus 173 i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHHH
Confidence 99999998865532211111 2333 346789999999999876543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-22 Score=171.86 Aligned_cols=182 Identities=17% Similarity=0.097 Sum_probs=132.8
Q ss_pred eeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc--------cHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeE
Q 014750 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+...|++|+||+||++.. .+..++.+.+..... ...+|+++|+.+. |++|++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 3567899999999998865 778888877765433 3568999999995 47788887742 16
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccc-cCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV-KPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|++|||+.|..+... . +.. ...++.|++.+|.++|+ +||+|||| ||+|||++ .++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~---~------~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~-~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQR---P------PRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQ-EDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhh---h------hhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEc-CCCCEEEEECCCcee
Confidence 899999998533211 1 011 13467899999999999 69999999 79999999 577899999999985
Q ss_pred cccCCcc--------------eeeeeccccccchhhcCCCCCC-CcccEeehhHHHHHHHhCCCCCCCCC
Q 014750 230 LVKGEAN--------------ISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 284 (419)
Q Consensus 230 ~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~ 284 (419)
....... .....++.|+.|+...-....+ ...++++.|+-+|.++|+..++-+.+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 4332210 0112467788887643222223 56799999999999999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=172.96 Aligned_cols=135 Identities=17% Similarity=0.202 Sum_probs=105.0
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------------------------------cHHHHHHHHHhcCCCC
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRLMDHPN 131 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n 131 (419)
.+.||+|+||.||+|++. +|+.||||++..... ...+|.+.+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 899999998864321 0136788889999988
Q ss_pred eeecceeeeccCCCCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCcccccccCCc
Q 014750 132 VISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQN 209 (419)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlkp~N 209 (419)
|.....+... . .||||||++|+ +...... ...++...+..++.|++.+|.+||+ . ||+||||||+|
T Consensus 81 i~~p~~~~~~-----~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N 148 (190)
T cd05145 81 VPVPEPILLK-----K--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN 148 (190)
T ss_pred CCCceEEEec-----C--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence 7544433311 1 37999999975 2222111 2467888899999999999999998 6 99999999999
Q ss_pred eeeCCCCCceEEeecccccccc
Q 014750 210 LLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~~ 231 (419)
||++ ++.++|+|||++....
T Consensus 149 Ill~--~~~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH--DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEE--CCCEEEEEcccceecC
Confidence 9998 5679999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=177.33 Aligned_cols=237 Identities=17% Similarity=0.242 Sum_probs=182.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEecc------CcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+..+..+|.+.-.|..|+|++ .|..+++|++.. ..+.++.|.-.|+.+.||||+.+++.+ ....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence 456677899999999999998 566778887642 245667888999999999999999988 3344588
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccc-cccCCceeeCCCCCceEEe--ecccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR-DVKPQNLLVDPLTHQVKLC--DFGSA 227 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~-Dlkp~NIll~~~~~~vkl~--DfG~a 227 (419)
++..||+ |+|+..|... .+-..+..++.+++.++++|+.|||+...++-| -|....++|| ++.+.+|. |--++
T Consensus 264 ~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfs 340 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFS 340 (448)
T ss_pred EeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceee
Confidence 9999999 7888888753 234567788999999999999999997556554 6889999999 56555553 43333
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCC--CCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.. .......+.||+||.+...+.. -.++|+|||++++|||.|...||......+.-.+|.-
T Consensus 341 fq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------- 403 (448)
T KOG0195|consen 341 FQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------- 403 (448)
T ss_pred ee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----------
Confidence 21 1223457889999999765443 3479999999999999999999998887766555432
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~ 357 (419)
+-++..+|.+++..+..|++-|++.||.+||..+.+
T Consensus 404 ----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 404 ----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 123344677889999999999999999999987765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=196.37 Aligned_cols=194 Identities=23% Similarity=0.374 Sum_probs=149.1
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcC---CCCeeecceeeeccCCCCce
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~ 148 (419)
......|.|.+.||+|+||+||+|.+.+ |+.||+|+-+... ..+.-=.+++.+|+ -+.|+.+..++...+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~---- 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA---- 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence 4455679999999999999999999876 9999999654332 11111223444444 2345555555433222
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC------CCCCceEE
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD------PLTHQVKL 221 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~------~~~~~vkl 221 (419)
-+||+||.+ |+|++++. ..+.+++..+..+..|++..++.||.+ +||||||||+|+||. ++...++|
T Consensus 769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEE
Confidence 569999999 78888776 467899999999999999999999995 999999999999994 22345999
Q ss_pred eecccccccc---cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCC
Q 014750 222 CDFGSAKVLV---KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278 (419)
Q Consensus 222 ~DfG~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 278 (419)
+|||.+-.+. ++......++|-.+-++|+..|+. ++..+|.|.|+.+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 9999986553 333344567788999999998765 9999999999999999999973
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=163.09 Aligned_cols=135 Identities=17% Similarity=0.226 Sum_probs=101.3
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhc-----CCCCeeecceeeeccCCCCcee-E
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLM-----DHPNVISLKHCFFSTTSKDELF-L 150 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~ 150 (419)
-.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ +||||+++++++.+.. +... +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence 356899999999995 6667666 69987643 33456899999999 6799999999985432 2233 3
Q ss_pred EEEeeccc---ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHH-HHhHcCCCcccccccCCceeeCC---CCCceEEee
Q 014750 151 NLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL-AYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCD 223 (419)
Q Consensus 151 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~D 223 (419)
.+||||++ ++|.+.+.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. .+..++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 47899955 577777754 235555 35677888888 99999 69999999999999973 234799999
Q ss_pred ccccc
Q 014750 224 FGSAK 228 (419)
Q Consensus 224 fG~a~ 228 (419)
|+.+.
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=167.35 Aligned_cols=140 Identities=16% Similarity=0.133 Sum_probs=105.3
Q ss_pred ceeeeceeccCCceEEEEEE-EcCCCcEEEEEEeccCcc----------------------------cHHHHHHHHHhcC
Q 014750 78 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRLMD 128 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~----------------------------~~~~e~~~l~~l~ 128 (419)
.|.+.+.||+|+||.||+|. +..+|+.||+|++..... ...+|..+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 677999999998864311 1246888898887
Q ss_pred CCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-cccccccC
Q 014750 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-VCHRDVKP 207 (419)
Q Consensus 129 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-ivH~Dlkp 207 (419)
+. ++.+..++.. . ..++||||++|..+.... .....+....+..++.||+.+|++||+ .| |+||||||
T Consensus 109 ~~-~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW---R---RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe---c---CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 3333333311 1 147999999985322211 123445666778999999999999999 59 99999999
Q ss_pred CceeeCCCCCceEEeeccccccc
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhcc
Confidence 999998 567999999998643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-21 Score=180.89 Aligned_cols=178 Identities=30% Similarity=0.448 Sum_probs=131.1
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.++||.|++|.. +|.+-+. ........+......++.|+..|+.| +|.+|+|+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccc-cchhhhhhhhhh
Confidence 468999999995 4444443 33445567778889999999999999 4999999999999998 577899999999
Q ss_pred ccccccCC-------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 014750 227 AKVLVKGE-------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 227 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
........ ..+..+||.+||+||.+.+. .|+.++||||||+|||||++ -...|.... .+..+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r----- 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIR----- 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhh-----
Confidence 87665554 44567899999999999875 49999999999999999998 222221110 011110
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
+-.+| ..+... .++-.+|+.+||...|.+||++.+.-.|.|.
T Consensus 474 --------------~g~ip--------~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 --------------DGIIP--------PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred --------------cCCCC--------hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 00111 001111 3456799999999999999988888778775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.4e-19 Score=169.71 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=172.1
Q ss_pred HHhcCCCCeeecceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCc-c
Q 014750 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-C 201 (419)
Q Consensus 124 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-v 201 (419)
|+.+.|.|+.++++..+.. ...++|.+||. |+|.+.+.. ....+++.....++++|+.||.|||.. .| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence 4578999999999998655 44889999999 788887765 356688888889999999999999994 55 9
Q ss_pred cccccCCceeeCCCCCceEEeecccccccccC---CcceeeeeccccccchhhcCCCC------CCCcccEeehhHHHHH
Q 014750 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATE------YTTSIDIWSAGCVLAE 272 (419)
Q Consensus 202 H~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~e 272 (419)
|+.|+..|+++| ..+.+||+|||+....... .......-...|.|||.+.+... .+.+.|+||+|++++|
T Consensus 72 hg~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 72 HGALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999 7899999999998765321 11111223445999999976321 3677999999999999
Q ss_pred HHhCCCCCCCCC----HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCC
Q 014750 273 LLLGQPLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348 (419)
Q Consensus 273 lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP 348 (419)
+++...||.... ..+.+..+.+ .+... .-|.+.. . ....+++..++.+||..+|
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~--------------~rP~i~~------~-~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP--------------FRPSIEL------L-NELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHh-cCCCC--------------cCcchhh------h-hhcchHHHHHHHHhcccCh
Confidence 999999998632 2223333222 11110 0011100 0 0245689999999999999
Q ss_pred CCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCC---------------ch---HHhhcCCHHHHhhhcHHHHHhhcC
Q 014750 349 SLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN---------------FK---QELAGASPELINRLIPEHVRRQTG 410 (419)
Q Consensus 349 ~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~---------------~~---~~~~~~~~~~~~~~~~~~~~~~~~ 410 (419)
.+||+++++-.- +..+..... ..+..+..+++ .. .+....+..++.+++|..++++++
T Consensus 209 ~~rPs~~~i~~~--~~~~~~~~~--~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk 284 (484)
T KOG1023|consen 209 EKRPSIEQIRSK--LLTINKGGS--SKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLK 284 (484)
T ss_pred hhCccHHHHHhh--hhhhccccc--ccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhh
Confidence 999999987531 111111000 00011111110 11 112235778899999999999988
Q ss_pred CCC
Q 014750 411 LSM 413 (419)
Q Consensus 411 ~~~ 413 (419)
.+.
T Consensus 285 ~G~ 287 (484)
T KOG1023|consen 285 LGK 287 (484)
T ss_pred cCC
Confidence 765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-20 Score=187.32 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=190.7
Q ss_pred cceeeeceeccCCceEEEEEEEcC-CCcEEEEEEeccCc---cc---HHHHHHHHHhcC-CCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RY---KNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~---~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (419)
..|.+.+.||+|+|+.|-++.... +...+|.|.+.... .. ...|..+-+.+. |.|++.+++.. .+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence 358888889999999999887643 34456777654332 11 124666766776 99999999887 5555
Q ss_pred eEEEEeeccccc-HHHHHHhhccCCC-CCCHHHHHHHHHHHHHHHHHhH-cCCCcccccccCCceeeCCCCC-ceEEeec
Q 014750 149 FLNLVMEYVPET-MYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLAYIH-TVPGVCHRDVKPQNLLVDPLTH-QVKLCDF 224 (419)
Q Consensus 149 ~~~lv~e~~~~~-l~~~l~~~~~~~~-~l~~~~~~~i~~qi~~al~~LH-~~~~ivH~Dlkp~NIll~~~~~-~vkl~Df 224 (419)
+.+++++|..|+ +.+.+. .... ..+...+..++.|+..++.|+| . .++.|+||||+|.+++ ..+ .+|++||
T Consensus 95 ~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~-~s~~~l~~~df 169 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLD-ESGSALKIADF 169 (601)
T ss_pred ccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhc-cCCCcccCCCc
Confidence 688999997764 333221 2222 5677778899999999999999 8 7999999999999999 455 8999999
Q ss_pred cccccccc-CCc---ceeeee-ccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 225 GSAKVLVK-GEA---NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 225 G~a~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
|+|..... ... ....+| ++.|+|||...+.....+..|+||+|+++..+++|..|+......+..
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---------- 239 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---------- 239 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----------
Confidence 99987655 222 234678 999999999987666789999999999999999999999765433210
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
| +.+.... ..+.......++....+++.++|..+|..|.+.+++..+||+..
T Consensus 240 -----------~--~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 -----------Y--SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------c--eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 0011000 11112233567899999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=149.77 Aligned_cols=132 Identities=18% Similarity=0.156 Sum_probs=99.4
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------------------------ccHHHHHHHHHhcCCCC
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRLMDHPN 131 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~e~~~l~~l~h~n 131 (419)
.|.+.+.||+|+||.||++... +|+.||||++.... ....+|..++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999864 79999999865321 01346788888887774
Q ss_pred e--eecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 132 V--ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 132 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
+ ...++. ...++||||++|..+..+.. ......++.+++.++.++|+ .||+||||||+|
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 3 322221 12579999999753322211 03356788899999999999 699999999999
Q ss_pred eeeCCCCCceEEeeccccccc
Q 014750 210 LLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~~ 230 (419)
|+++ .++.++|+|||.+...
T Consensus 156 ill~-~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVD-DDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEc-CCCcEEEEECCccccC
Confidence 9999 5788999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-18 Score=149.54 Aligned_cols=129 Identities=20% Similarity=0.314 Sum_probs=101.1
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+.||+|++|.||+|.+ .|..+++|+..... ....+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999987 77889999764321 1234688899999999887766655332 236
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++|||++| +|.+.+... .. ....++.+++.+|.+||+ .|++|||++|.|||++ ++.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 799999986 555554321 11 678899999999999999 6999999999999998 56799999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=144.59 Aligned_cols=125 Identities=21% Similarity=0.315 Sum_probs=93.8
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.||+|+||.||+|.. +|..+++|...... ....+|+++++.+.|+++.....++.. ....+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCCCE
Confidence 489999999999985 67889999754321 112368999999988876544433322 22257
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+||||++| ++.+.+.. .. ..++.+++.+|.+||+ .|++|||++|+||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~----~~-------~~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----GN-------DELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhh----cH-------HHHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999986 44444332 11 0678899999999999 6999999999999998 56799999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=164.52 Aligned_cols=132 Identities=20% Similarity=0.270 Sum_probs=99.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEec-cCc-----------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..|...+.||+|+||+||++... +..+++|+.. +.. ....+|+++++.++|++|+....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 34567889999999999999864 3445554322 110 1234799999999999988766554322
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
...++||||++| +|.+.+. ....++.+++.+|.+||+ .||+||||||+|||++ ++.++|+|
T Consensus 409 ---~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~liD 470 (535)
T PRK09605 409 ---EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLID 470 (535)
T ss_pred ---CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEEe
Confidence 236799999986 5544443 246788899999999999 6999999999999995 56799999
Q ss_pred ccccccc
Q 014750 224 FGSAKVL 230 (419)
Q Consensus 224 fG~a~~~ 230 (419)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=139.18 Aligned_cols=130 Identities=25% Similarity=0.213 Sum_probs=90.3
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH----------------------------HHHHHHHHhcCCCC--
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRLMDHPN-- 131 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~e~~~l~~l~h~n-- 131 (419)
.+.||+|+||+||+|.+. +|+.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 89999999876432111 12333444443322
Q ss_pred eeecceeeeccCCCCceeEEEEeecccccH-H-HHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCcccccccCC
Q 014750 132 VISLKHCFFSTTSKDELFLNLVMEYVPETM-Y-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQ 208 (419)
Q Consensus 132 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlkp~ 208 (419)
+.+.+.+ ...++||||++++. . ..+.... . ...++.++.+++.++.++|. . ||+||||||+
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~ 144 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREA-GLVHGDLSEY 144 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhcc-CcCcCCCChh
Confidence 2222211 12579999999721 1 1222211 0 15578899999999999998 6 9999999999
Q ss_pred ceeeCCCCCceEEeeccccccc
Q 014750 209 NLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 209 NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||+++ ++.++|+|||.+...
T Consensus 145 Nili~--~~~~~liDfg~a~~~ 164 (187)
T cd05119 145 NILVD--DGKVYIIDVPQAVEI 164 (187)
T ss_pred hEEEE--CCcEEEEECcccccc
Confidence 99999 667999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=154.42 Aligned_cols=252 Identities=24% Similarity=0.250 Sum_probs=191.1
Q ss_pred ccccceeeeceecc--CCceEEEEEEE--cCCCcEEEEEEec------cCcccHHHHHHHHHhc-CCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRLM-DHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (419)
.....+.+.+.+|. |.+|.||.+.+ ..++..+|+|.-+ .......+|+..-+.+ .|+|.++.+..+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--- 187 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--- 187 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc---
Confidence 34456788889999 99999999999 8899999999632 2233344666666666 489999866666
Q ss_pred CCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHH----HHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 143 TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR----GLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
.+...+++-+|+|+.++...... ....++...++.++.+... ||.++|. ++|+|-|+||+||+...+...
T Consensus 188 --e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 188 --EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred --ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccce
Confidence 55666899999999776655443 3455888899999999999 9999999 799999999999999954377
Q ss_pred eEEeecccccccccCCccee-e-----eeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC--CHHHHHH
Q 014750 219 VKLCDFGSAKVLVKGEANIS-Y-----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLV 290 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~~~~-~-----~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~~~~~~ 290 (419)
.+++|||+...+.++..... . .+...|++||.+.+ -++...|++++|.++.+..+|..++... +...++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 99999999988766653322 1 45667999999865 3799999999999999999988766543 2221111
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.+ .+...+-...+.++...+.+|+..||..|+++..+++|++....
T Consensus 340 ~~------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 340 QG------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred cc------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 11 01111223446677779999999999999999999999998753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=138.06 Aligned_cols=134 Identities=17% Similarity=0.203 Sum_probs=96.3
Q ss_pred ceec-cCCceEEEEEEEcCCCcEEEEEEeccCc-----------------ccHHHHHHHHHhcCCCCe--eecceeeecc
Q 014750 83 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNV--ISLKHCFFST 142 (419)
Q Consensus 83 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 142 (419)
..|| .|+.|+||.+.. .+..+++|.+.... ....+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 888899999886 47889999774211 123469999999998885 4555543221
Q ss_pred CCCCceeEEEEeecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 143 TSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
. ......++|||+++| +|.+.+.. ..+++.. +.+|+.+|.+||+ +||+||||||+|||++ .++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~-~~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLD-PDGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEc-CCCCEE
Confidence 1 111123599999996 55555432 3455543 4689999999999 6999999999999999 466899
Q ss_pred Eeeccccccc
Q 014750 221 LCDFGSAKVL 230 (419)
Q Consensus 221 l~DfG~a~~~ 230 (419)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-17 Score=163.23 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=194.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..+.+.+.+-+-+|+++.++.+.-..+|...++|...... .....+-.++-...+|.++...--+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 3456788889999999999999887788777777543222 1222333344344566666543332 223
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+|+|+|+++ ++...|+. .+..+..-++.++..+..++++||. ..+.|+|++|.|+|+. .++..+++|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~-~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIA-YDGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhc-ccCCcccCcccc
Confidence 347899999975 55555543 3456777788888899999999999 4799999999999999 678899999984
Q ss_pred cccccc------C--------------------------CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHH
Q 014750 227 AKVLVK------G--------------------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL 274 (419)
Q Consensus 227 a~~~~~------~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 274 (419)
.....- . .......+|+.|.+||.+++.. ....+|+|++|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 322100 0 0012346799999999998865 788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH
Q 014750 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (419)
Q Consensus 275 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~ 354 (419)
+|.+||........+..|.+.. ..++. -+...+.++++++..+|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~-----------------~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD-----------------IPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC-----------------CCCCC---------CccccChhhhhhhhhhhccCchhccCc
Confidence 9999999888877776655421 11111 123468899999999999999999998
Q ss_pred H---HHhcCCccccccCCCCCCCCCCCCC
Q 014750 355 L---EACAHPFFDELREPNARLPNGRPFP 380 (419)
Q Consensus 355 ~---e~l~hp~f~~~~~~~~~~~~~~~~~ 380 (419)
. ++-.|+||+...|.+.........|
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCC
Confidence 7 8999999999988876654444433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=127.35 Aligned_cols=131 Identities=19% Similarity=0.233 Sum_probs=102.9
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc--cHHHHHHHHHhcCC--CCeeecceeeeccCCCCceeEEEEeec
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
+.+.||+|.++.||++.+. +..+++|.+..... ...+|..+++.+++ .++.+++.++ ......+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence 3567999999999999974 47899998865543 56789999999977 4788877665 223457899999
Q ss_pred ccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC--CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 157 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+.|.....+ +......++.+++.+|.+||.. .+++|+||+|+||+++ .++.++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence 987522211 4455677888999999999984 2699999999999999 467899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.9e-14 Score=126.82 Aligned_cols=210 Identities=17% Similarity=0.190 Sum_probs=146.8
Q ss_pred HHHhcCCCCeeecceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCc
Q 014750 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGV 200 (419)
Q Consensus 123 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~i 200 (419)
-|-.+.|.|||+++.++.+....+.....++.||+. |++...|+........+.....++|+.||++||.|||+. .-|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344567999999999876665556667889999998 788888887777778899999999999999999999984 359
Q ss_pred ccccccCCceeeCCCCCceEEeeccccccccc-----CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh
Q 014750 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-----GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL 275 (419)
Q Consensus 201 vH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt 275 (419)
+|+++..+.|++. .++-|||.--.-...... ........+-+.|.+||.=. ..+.+.++|||+||....+|..
T Consensus 200 ihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHH
Confidence 9999999999999 577677653221111000 00011223456788998532 2335678999999999999998
Q ss_pred CCCC-CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH
Q 014750 276 GQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (419)
Q Consensus 276 g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~ 354 (419)
|..- -.+....+.-..+.+. +-.--...-.++|.+||+-.|..||++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~--------------------------------i~~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANV--------------------------------IIGLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred heeccCCCcceeehhhhhhhh--------------------------------eeeccCccccCcCcccccCCCCCCcch
Confidence 8643 2222211111111111 000012334689999999999999999
Q ss_pred HHHhcCCccccc
Q 014750 355 LEACAHPFFDEL 366 (419)
Q Consensus 355 ~e~l~hp~f~~~ 366 (419)
.+++.||.+-++
T Consensus 326 r~llfHpllfeV 337 (458)
T KOG1266|consen 326 RLLLFHPLLFEV 337 (458)
T ss_pred hhhhcCceeeec
Confidence 999999998664
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.1e-14 Score=138.61 Aligned_cols=140 Identities=20% Similarity=0.268 Sum_probs=87.3
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc--------------------------------------HHH
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------KNR 119 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~~~ 119 (419)
.|.. +.||.|++|.||+|+.+.+|+.||||+....... ..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 7899999999999998888999999988543100 012
Q ss_pred HHHHHHh------c----CCCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCC---CCCCHHHHHHHHHH
Q 014750 120 ELQLMRL------M----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTYQ 186 (419)
Q Consensus 120 e~~~l~~------l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~---~~l~~~~~~~i~~q 186 (419)
|+++.+. + .+.+.+.+-.+|... ....+|||||+.|.-...+......+ ..+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2222222 1 233333333333211 11256999999974322222111111 13445555556666
Q ss_pred HHHHHHHhHcCCCcccccccCCceeeCCCCC----ceEEeecccccccc
Q 014750 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLV 231 (419)
Q Consensus 187 i~~al~~LH~~~~ivH~Dlkp~NIll~~~~~----~vkl~DfG~a~~~~ 231 (419)
++ . .|++|+|+||.||+++. ++ +++++|||++....
T Consensus 276 if-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECC
Confidence 54 4 49999999999999984 55 89999999997664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.3e-13 Score=114.85 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=92.3
Q ss_pred eceeccCCceEEEEEEEcC------CCcEEEEEEecc--------------Ccc----------------cHHHHHHHHH
Q 014750 82 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRR----------------YKNRELQLMR 125 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~--------------~~~----------------~~~~e~~~l~ 125 (419)
...||.|--+.||.|.... .+..+|||+.+. +.+ ..++|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998643 357999997631 100 0126888888
Q ss_pred hcCCC--CeeecceeeeccCCCCceeEEEEeeccccc-HH-HHHHhhccCCCCCCHHHHHHHHHHHHHHHHHh-HcCCCc
Q 014750 126 LMDHP--NVISLKHCFFSTTSKDELFLNLVMEYVPET-MY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI-HTVPGV 200 (419)
Q Consensus 126 ~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~i 200 (419)
++... ++...+++. . -+|||||++++ +. ..++. ..++...+..+..+++.+|..| |+ .||
T Consensus 82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 77432 333443321 1 46999999863 21 12222 2345566777889999999999 89 599
Q ss_pred ccccccCCceeeCCCCCceEEeeccccccc
Q 014750 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 201 vH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|||||++.|||++ ++.+.|+|||.+...
T Consensus 147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence 9999999999997 356999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.1e-13 Score=129.56 Aligned_cols=137 Identities=20% Similarity=0.238 Sum_probs=86.8
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-cH-------------------------------------------
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK------------------------------------------- 117 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~------------------------------------------- 117 (419)
.+.||.|++|.||+|+. .+|+.||||+...... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999985 4799999998753310 01
Q ss_pred HHHHHHHHhc----CCCCeeecceeeeccCCCCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHH-HH
Q 014750 118 NRELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFR-GL 191 (419)
Q Consensus 118 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~-al 191 (419)
.+|...+..+ ++.+-+.+-.++.... ...+|||||++|. +.+.... .. .... ...++.+++. .+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence 1233222222 2333333333332111 1257999999974 3333221 11 1122 2345555555 46
Q ss_pred HHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 192 ~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
..+|. .|++|+|+||.||+++ .++.++|+|||++....
T Consensus 271 ~ql~~-~g~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR-DGFFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh-CCceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 78899 5999999999999998 57889999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-12 Score=126.21 Aligned_cols=166 Identities=24% Similarity=0.304 Sum_probs=120.9
Q ss_pred EEEEcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhcc
Q 014750 95 QAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 170 (419)
Q Consensus 95 ~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~ 170 (419)
.|..+.++.+|.|...+.... ...+.++-|+.++||||+++++.+ +.+..+|||+|-+.. |...++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~--- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE--- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH---
Confidence 355577888888887754433 245778899999999999999988 555569999999873 3334544
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc-ceeeeeccccccch
Q 014750 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYICSRYYRAPE 249 (419)
Q Consensus 171 ~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~-~~~~~~t~~y~aPE 249 (419)
+....+..-+.||+.||.|||..++++|++|.-.-|+|+ ..|..||++|-++........ .....---.|..|+
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 235667778889999999998547999999999999999 688899999998754422221 11111122366776
Q ss_pred hhcCCCCCCCcccEeehhHHHHHHHhCC
Q 014750 250 LIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (419)
Q Consensus 250 ~~~~~~~~~~~~DiwslG~il~elltg~ 277 (419)
.+.. -.-..|.|-|||++++++.|.
T Consensus 176 ~~~~---s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 EIDP---SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcCc---cccchhhhhHHHHHHHHhCcc
Confidence 5522 124579999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=112.50 Aligned_cols=125 Identities=15% Similarity=0.157 Sum_probs=90.3
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeee-cceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVIS-LKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.+.|+.|.++.||+++. .+..|++|...... ....+|..+++.+.+.+++. ++.+. .+ ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~--~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PE--TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CC--CCeEEEEec
Confidence 35689999999999986 47889999875443 34568999999887655543 33322 11 136999999
Q ss_pred cccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCc-----ccccccCCceeeCCCCCceEEeecccccc
Q 014750 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV-----CHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 158 ~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~i-----vH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|...... ......++.+++.+|..||+ .++ +|||++|.||+++ ++.++++|||.+..
T Consensus 74 ~G~~l~~~-----------~~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE-----------DFSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc-----------cccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 98522110 01123456799999999999 475 9999999999998 45699999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.4e-13 Score=130.35 Aligned_cols=247 Identities=20% Similarity=0.177 Sum_probs=171.5
Q ss_pred ccceeeeceeccCCceEEEEEEEc-CCCcEEEEEEeccCcccH------HHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|..+..||.|.|+.|+.+... .++..|++|.+.+..... ..|+.+...+ .|.+++.....+ ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----ccc
Confidence 457889999999999999987754 578889999776543322 2455555444 588888876655 233
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
...||-.|||.+...++-. .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++...++.-++.|||++
T Consensus 339 r~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence 3366999999864333322 223457778889999999999999999 699999999999999844477899999998
Q ss_pred cccccCCcceeeeeccccc-cchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKGEANISYICSRYYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..+. -........-++. ..|++.....+..+.|++|||..+.+.++|...=..... ...+...
T Consensus 415 t~~~--~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~----------- 478 (524)
T KOG0601|consen 415 TRLA--FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG----------- 478 (524)
T ss_pred cccc--eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc-----------
Confidence 6421 1112223333444 366666666688999999999999999998743221111 0000000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..+. . .....++..+.+.++..|+..|+.+.++..|.-|..
T Consensus 479 --------~~p~---------~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 479 --------DTPN---------L-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --------cccC---------C-CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0000 1 123467889999999999999999999998877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.1e-11 Score=113.82 Aligned_cols=214 Identities=19% Similarity=0.257 Sum_probs=154.1
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccc--cHHH
Q 014750 90 FGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE--TMYR 163 (419)
Q Consensus 90 ~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~ 163 (419)
-.+.|++....+|..|++|++..++. ....-++.++++.|.|+|.+.++|.+.. -++..+++|++|.++ +|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 46889999999999999999954432 2235688999999999999999987433 567779999999984 6666
Q ss_pred HHHhh-----------ccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 164 VLKHY-----------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 164 ~l~~~-----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
.-... ...+...++..+|.++.||..||.++|+ .|+.-+-|.+.+||++ .+.+|+|...|+......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~-G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVT-GKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEee-CcceEEEecccceeeecC
Confidence 54321 1234567899999999999999999999 6999999999999999 455899998888765543
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC-CCCCCHHHH-HHHHHHHhCCCCHHHHhccCcC
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQ-LVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
+. . |.+.+ -.+-|.=.||.+++.|.||..- +........ +..|
T Consensus 446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------ 490 (655)
T KOG3741|consen 446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------ 490 (655)
T ss_pred CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence 32 0 11211 2345788899999999999632 111111111 1111
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...++.++.++|.-+...++++ -++.+++.|
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1235778888888888888775 566666643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-11 Score=101.25 Aligned_cols=139 Identities=19% Similarity=0.234 Sum_probs=96.5
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEe-ccC-----------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
....|-+|+-+.|+++.. .|+.+.||.= .+. +....+|.++|.++.--.|.--.-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 456789999999999987 8888888842 221 1223468888877653333322223322222
Q ss_pred eEEEEeecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce--EEeec
Q 014750 149 FLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV--KLCDF 224 (419)
Q Consensus 149 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v--kl~Df 224 (419)
-+|+|||++| .+.+.+.... ...........++.+|-+.+.-||. ++||||||..+||++.++++.+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4599999998 5555554432 2223333347788899999999999 7999999999999998766655 89999
Q ss_pred ccccc
Q 014750 225 GSAKV 229 (419)
Q Consensus 225 G~a~~ 229 (419)
|++..
T Consensus 161 gls~~ 165 (229)
T KOG3087|consen 161 GLSSV 165 (229)
T ss_pred cchhc
Confidence 99864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.8e-12 Score=124.90 Aligned_cols=155 Identities=20% Similarity=0.318 Sum_probs=113.4
Q ss_pred HHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc--------cee--eeeccccccchhhcCCC
Q 014750 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA--------NIS--YICSRYYRAPELIFGAT 255 (419)
Q Consensus 186 qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~--------~~~--~~~t~~y~aPE~~~~~~ 255 (419)
++..|+.|+|.+.++||++|.|++|.++ .++..||+.|+++........ ... ..-...|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 3448999999877999999999999999 688899999998865433111 111 122456999999977 4
Q ss_pred CCCCcccEeehhHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCCh
Q 014750 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334 (419)
Q Consensus 256 ~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 334 (419)
..+.++|++|+||++|.+. .|+..|...+.......-....+.. ...+...++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~ 239 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPS 239 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcH
Confidence 5789999999999999999 5666665543322221111110000 0112356899
Q ss_pred hHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 335 EAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 335 ~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
++++=|.++|..|...||++.+++.-|||.+..
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 999999999999999999999999999998743
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.5e-11 Score=98.99 Aligned_cols=127 Identities=17% Similarity=0.283 Sum_probs=83.6
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEE-eccCc-----------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKK-VLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~-~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+++|+-+.+|.+.. -|..+.+|. +.+.- ....+|..++..+.--.|..-.-+.++. + ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~---~--~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP---D--NG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC---C--CC
Confidence 3578999999999965 455566763 22211 1123688888776533332222222221 1 24
Q ss_pred EEEeecccccHHH-HHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.|+|||++|.++. .+.. . ...++..+-.-+.-||. .||+|+||.++||++. ++.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~----~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~--~~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE----A-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILS--GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh----c-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEe--CCcEEEEECCcccc
Confidence 5999999996444 3332 1 13456677778888999 6999999999999998 33499999999974
Q ss_pred c
Q 014750 230 L 230 (419)
Q Consensus 230 ~ 230 (419)
.
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.7e-10 Score=97.66 Aligned_cols=121 Identities=26% Similarity=0.307 Sum_probs=76.0
Q ss_pred EEEEEEEcCCCcEEEEEEeccC--------------cc----------------cHHHHHHHHHhcCCCC--eeecceee
Q 014750 92 IVFQAKCLETGETVAIKKVLQD--------------RR----------------YKNRELQLMRLMDHPN--VISLKHCF 139 (419)
Q Consensus 92 ~V~~~~~~~~~~~vaiK~~~~~--------------~~----------------~~~~e~~~l~~l~h~n--iv~~~~~~ 139 (419)
.||.|.. ..|+.+|+|+.... .+ ...+|.+.|..+..-+ +.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888885 56789999976321 00 1136899999987653 44554432
Q ss_pred eccCCCCceeEEEEeeccc--ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHH-hHcCCCcccccccCCceeeCCCC
Q 014750 140 FSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY-IHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 140 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
. -+|||||++ |.....+.... ++......++.+++..+.. +|+ .||+||||.+.|||++ .+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~-~~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVD-DG 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEE-TT
T ss_pred -----C----CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEee-cc
Confidence 1 359999999 64333343311 1133456677788885555 579 5999999999999999 34
Q ss_pred CceEEeeccccccc
Q 014750 217 HQVKLCDFGSAKVL 230 (419)
Q Consensus 217 ~~vkl~DfG~a~~~ 230 (419)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 7999999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=97.70 Aligned_cols=140 Identities=19% Similarity=0.197 Sum_probs=94.0
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCC--eeecceeeeccCCCCceeEEEEee
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
+.|+.|.++.||++... +|+.+++|..... .....+|.++++.+.+.+ +.+++.+.... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999864 3688999987543 245678999999987643 45554443111 11124579999
Q ss_pred cccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------------------
Q 014750 156 YVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------- 197 (419)
Q Consensus 156 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------------------------------------- 197 (419)
|++|....... . ...++......++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99975221110 0 02355555666666666666666631
Q ss_pred -----------------CCcccccccCCceeeCCC-CCceEEeecccccc
Q 014750 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV 229 (419)
Q Consensus 198 -----------------~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~ 229 (419)
..++|+|+++.||+++.+ ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246999999999999943 45688999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.7e-09 Score=96.53 Aligned_cols=257 Identities=16% Similarity=0.152 Sum_probs=156.1
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-cHHHHHHHHHh-cCCCCeeecceee---eccCCCCceeEEEEee
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRL-MDHPNVISLKHCF---FSTTSKDELFLNLVME 155 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~-l~h~niv~~~~~~---~~~~~~~~~~~~lv~e 155 (419)
..+.||+|+-+.+|-.-. -+ ..+.|+...... ...+.+..|.. -.||-+-.-+.+- .... .....+.+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecch--hh-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEecc
Confidence 356799999999986542 22 245576654322 22223333332 2455332211110 1111 11222668888
Q ss_pred cccc--cHHHHHH--hhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 156 YVPE--TMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 156 ~~~~--~l~~~l~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
.++| ....+.. ..........+..+.+.++.|+.+...||.+ |-+-||++++|+|++ +++.|.|+|=..-....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVs-d~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVS-DDSKVVLVDSDSFQINA 168 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeee-cCceEEEEcccceeecc
Confidence 8885 3322221 2223345577899999999999999999995 999999999999999 68889999765544445
Q ss_pred cCCcceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHH----HHHH-HHHHHhCCCCH
Q 014750 232 KGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAV----DQLV-EIIKVLGTPTR 301 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~----~~~~-~i~~~~~~~~~ 301 (419)
++......+|...|.+||.-.- .-.-+...|.|.||+++|+++.| +.||.+.-.. .-.+ .|....-.-.
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya- 247 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA- 247 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec-
Confidence 5666667788999999997531 11246789999999999999996 9999864210 0000 1111000000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhccc--CCCCCCCHHH
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY--SPSLRCTALE 356 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~--dP~~R~t~~e 356 (419)
+.-..-..+.-...+| .-+++++..|..+|++. ++.-|||++.
T Consensus 248 -------~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 248 -------SDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred -------hhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0000001112222333 23688999999999976 3568999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.2e-09 Score=97.31 Aligned_cols=134 Identities=10% Similarity=0.090 Sum_probs=89.7
Q ss_pred eEEEEEEEcCCCcEEEEEEeccCc---------------ccHHHHHHHHHhcCCCCeeec--ceeeeccCCCCceeEEEE
Q 014750 91 GIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISL--KHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 91 g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv 153 (419)
..|+++.. .|+.|.||...... ....+|...+..+...+|... +.+...........-+||
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555543 66788888653221 125688888877754444333 223221111112335799
Q ss_pred eecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC------CCCceEEeecc
Q 014750 154 MEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------LTHQVKLCDFG 225 (419)
Q Consensus 154 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~------~~~~vkl~DfG 225 (419)
||++++ ++.+.+.... ....+......++.+++..+.-||. .||+|+||++.|||++. .+..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999997 4666654332 2345667788999999999999999 69999999999999973 24679999999
Q ss_pred cccc
Q 014750 226 SAKV 229 (419)
Q Consensus 226 ~a~~ 229 (419)
.+..
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-08 Score=91.27 Aligned_cols=131 Identities=21% Similarity=0.184 Sum_probs=91.3
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--------------------------cccHHHHHHHHHhcCCC--
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRLMDHP-- 130 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~e~~~l~~l~h~-- 130 (419)
+.+...||.|--|.||.|.+ ..|..+|||.-... +...++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 56778899999999999995 47899999953211 11234788999888654
Q ss_pred CeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCce
Q 014750 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (419)
Q Consensus 131 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NI 210 (419)
.+.+-+++ +.-.+||||++|-. |.. -++.......++..|+.-+..+-. .||||||+++-||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI 233 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI 233 (304)
T ss_pred CCCCcccc---------ccceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence 45544332 22569999999842 221 111233345555566666655556 5999999999999
Q ss_pred eeCCCCCceEEeecccccc
Q 014750 211 LVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 211 ll~~~~~~vkl~DfG~a~~ 229 (419)
+++ .++.+.++||--+..
T Consensus 234 lV~-~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 234 LVT-EDGDIVVIDWPQAVP 251 (304)
T ss_pred EEe-cCCCEEEEeCccccc
Confidence 999 577799999987754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.6e-09 Score=104.75 Aligned_cols=245 Identities=20% Similarity=0.189 Sum_probs=168.9
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCC-eeecceeeeccCCCCceeEEEEeec
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPN-VISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
-|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ +.+.+..++|++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 3666778999999999999876555444 6665444 34456899999999999 44433333 566778899999
Q ss_pred cccc--HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC
Q 014750 157 VPET--MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (419)
Q Consensus 157 ~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~ 234 (419)
++++ .... .......+.+-+...+++.-++++++||+. .=+|+| ||+.. .+..|..||+....+....
T Consensus 316 ~s~~rs~~~~---~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALE---MTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGS--EEEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCcccccc---CChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccc--ccccccccccCCcccCccc
Confidence 9854 1111 111223445556677778888999999994 568999 88887 3568999999987775555
Q ss_pred cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccc
Q 014750 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (419)
Q Consensus 235 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 314 (419)
...+..+++.++|||+..... +....|.|++|+-..+|.-|-+|-...-.. . ...|. ..
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~----~~~g~--------------~p 444 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--L----PMIGN--------------GP 444 (829)
T ss_pred ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCccc--c----CCCCC--------------CC
Confidence 566788999999999886544 888999999999888888888776441100 0 00000 00
Q ss_pred cCCCCCC-CCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 315 RFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 315 ~~~~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..+.+.. ..|...++. ++...|+..-|..|+...+++.|.+|+...
T Consensus 445 ~s~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 445 NSPMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CccccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 0111111 233333222 678899999999999999999999998743
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.8e-07 Score=82.85 Aligned_cols=108 Identities=19% Similarity=0.268 Sum_probs=74.5
Q ss_pred HHHHHHHHHhcCCCCee--ecceeeeccCCCCceeEEEEeecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHH
Q 014750 117 KNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (419)
Q Consensus 117 ~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~ 192 (419)
..+|...+..+....|. +.+.+...... .....+||+|++++ +|.+.+... ...+......++.++...+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 45687777766433332 22233222111 12345799999996 455555542 22566678889999999999
Q ss_pred HhHcCCCcccccccCCceeeCCCC--CceEEeeccccccc
Q 014750 193 YIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVL 230 (419)
Q Consensus 193 ~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~~~ 230 (419)
-||. .||+|+|+++.|||++..+ ..+.++||+-++..
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 6999999999999999433 27899999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.8e-07 Score=78.25 Aligned_cols=137 Identities=15% Similarity=0.226 Sum_probs=84.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH-------------HHHHHHHHhcCCCCeeecceeee--
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMRLMDHPNVISLKHCFF-- 140 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~e~~~l~~l~h~niv~~~~~~~-- 140 (419)
..+|.+.+++-......|.+..- +|..+.+|......... .+++..+..+....+..+-+.++
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34688888888888888877764 77889999765432221 23333333332222222211111
Q ss_pred -ccCCCCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc
Q 014750 141 -STTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 218 (419)
Q Consensus 141 -~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~ 218 (419)
-.........+++|||++|- +.+. ..+++ .+...+..++.-||++ |++|+|..|.|++++ ++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~--------~~i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~-~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDI--------EDIDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVS-NN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccc--------hhcCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEE-CC-c
Confidence 11112223356899999984 2111 11222 2335677889999995 999999999999998 34 4
Q ss_pred eEEeecccccc
Q 014750 219 VKLCDFGSAKV 229 (419)
Q Consensus 219 vkl~DfG~a~~ 229 (419)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-06 Score=75.86 Aligned_cols=138 Identities=12% Similarity=0.078 Sum_probs=94.6
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEecc----------CcccHHHHHHHHHhcCCCCee--ecceeeeccCCCCceeEEEE
Q 014750 86 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 86 g~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv 153 (419)
|+||-+-|++... .|..+-+|.-.. ....+.+|+..++.+..-+|. +.. ++-.........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688888888765 445688886431 223456899988888644433 332 1111111223446799
Q ss_pred eecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc--eEEeecccccc
Q 014750 154 MEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKV 229 (419)
Q Consensus 154 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~--vkl~DfG~a~~ 229 (419)
+|-++| +|.+.+... .-.+.+......++.+++.++.-||+ .|+.|+|+.+.||+++. ++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 998884 665555432 12345777788999999999999999 59999999999999983 344 99999988764
Q ss_pred c
Q 014750 230 L 230 (419)
Q Consensus 230 ~ 230 (419)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.9e-07 Score=79.50 Aligned_cols=133 Identities=18% Similarity=0.162 Sum_probs=86.8
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCccc----------------------------HHHHHHHHHhcCCC--Ce
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY----------------------------KNRELQLMRLMDHP--NV 132 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~e~~~l~~l~h~--ni 132 (419)
..|..|--+.||+|.. .++..+|+|++...... ..+|+.-|+++..- .+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3688899999999984 56889999987532111 12455555555322 22
Q ss_pred eecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
.+-+.++ .-.|||||++... ...-.-..-.+....+..+..++++.+.-|-...|+||+||+.-|||+
T Consensus 133 P~Pi~~~---------~nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 133 PEPIAFR---------NNVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCceeec---------CCeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 2222322 1459999998430 000000122333336777788888888877762499999999999999
Q ss_pred CCCCCceEEeeccccccc
Q 014750 213 DPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 213 ~~~~~~vkl~DfG~a~~~ 230 (419)
. ++.+.|+|||-|...
T Consensus 201 ~--~~~p~iID~~QaV~~ 216 (268)
T COG1718 201 H--DGEPYIIDVSQAVTI 216 (268)
T ss_pred E--CCeEEEEECcccccc
Confidence 8 566999999998654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-07 Score=92.62 Aligned_cols=136 Identities=24% Similarity=0.301 Sum_probs=80.2
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCccc--------------------------------------------HH
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------KN 118 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~ 118 (419)
..|+.++-|.||+|+.. +|+.||||+...+... ..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999954 5999999976432110 01
Q ss_pred HHHHHHHhc----CCCCeeecceeeeccCCCCceeEEEEeeccccc-HHHH--HHhhccCCCCCCHHHHHHHHHHHHHHH
Q 014750 119 RELQLMRLM----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPET-MYRV--LKHYSSMNQRMPLIYVKLYTYQIFRGL 191 (419)
Q Consensus 119 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~--l~~~~~~~~~l~~~~~~~i~~qi~~al 191 (419)
+|..-+..+ ++..-+.+-.+|.... ..-.|+|||+.|- +.+. ++........+...-+..++.|++.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--
Confidence 233323222 2222233334442211 1246999999983 3333 2221111112223333333333332
Q ss_pred HHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 192 ~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
.|++|.|..|.||+++ .++++.+.|||+......
T Consensus 284 ------dgffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 ------DGFFHADPHPGNILVR-SDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ------cCccccCCCccceEEe-cCCcEEEEcCcceecCCH
Confidence 4999999999999999 578899999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-06 Score=78.73 Aligned_cols=143 Identities=20% Similarity=0.231 Sum_probs=77.1
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCC--eeecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++.... ........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEEEEEe
Confidence 4678999999999999744 58999987554 234557888888775443 334443221 112233478999999
Q ss_pred ccc-HHH----------------HHHhhccC---CCCCCHHH------HHHH---------------HHHHHH-HHHHhH
Q 014750 158 PET-MYR----------------VLKHYSSM---NQRMPLIY------VKLY---------------TYQIFR-GLAYIH 195 (419)
Q Consensus 158 ~~~-l~~----------------~l~~~~~~---~~~l~~~~------~~~i---------------~~qi~~-al~~LH 195 (419)
+|. +.. .+...... ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 974 333 11111111 11111000 0000 011111 233333
Q ss_pred c------CCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 196 T------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 196 ~------~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+ ...++|+|+.+.|||+++.++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 13699999999999999556667899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=6.4e-07 Score=93.96 Aligned_cols=202 Identities=22% Similarity=0.305 Sum_probs=136.7
Q ss_pred HHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 014750 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196 (419)
Q Consensus 118 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 196 (419)
+.|+..+..+.|+|++.++.+-+.....+ ..+.+..++|.. ++...+.+ -+.++...++.+..+++.||.|+|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 45777888899999999877654332211 122344566664 44444443 4678889999999999999999999
Q ss_pred CCCcccccccCC---ceeeCCCCCceEEe--ecccccccccCCcceeeeeccccccchhhcCCCCCCC--cccEeehhHH
Q 014750 197 VPGVCHRDVKPQ---NLLVDPLTHQVKLC--DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT--SIDIWSAGCV 269 (419)
Q Consensus 197 ~~~ivH~Dlkp~---NIll~~~~~~vkl~--DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~~DiwslG~i 269 (419)
+ ...|.-|... +--++ ..+.+.++ ||+.++................+.++|...... +.. ..|+|.+|..
T Consensus 305 ~-~l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 L-SLEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL 381 (1351)
T ss_pred h-ccceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence 4 6666655555 33344 34456666 999888776665555566677788998875432 333 3699999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCC
Q 014750 270 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349 (419)
Q Consensus 270 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~ 349 (419)
+..+..|..+-.. ...+... ..........+++.+|+.-|++
T Consensus 382 ~~~~~~~~~i~~~------~~~~~~~--------------------------------l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 382 LLQLSQGEDISEK------SAVPVSL--------------------------------LDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred HhhhhhcCccccc------ccchhhh--------------------------------hccccchhhhhhhhhhcchhhh
Confidence 9999987643211 0111110 0001112678999999999999
Q ss_pred CCCCHHHHhcCCcccc
Q 014750 350 LRCTALEACAHPFFDE 365 (419)
Q Consensus 350 ~R~t~~e~l~hp~f~~ 365 (419)
+|+++.+++.|+|.+.
T Consensus 424 ~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRF 439 (1351)
T ss_pred hccchhhhhhchhccc
Confidence 9999999999999875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.2e-06 Score=75.13 Aligned_cols=69 Identities=16% Similarity=0.087 Sum_probs=45.7
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCe--eecceeeeccCCCCceeEEEEeeccc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVMEYVP 158 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (419)
..||+|..+.||+. .|..+++|...... ....+|.++++.+..-.+ .+.+++. .+.....+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999974 25568889765432 235679999988764333 3333333 22333678999999
Q ss_pred cc
Q 014750 159 ET 160 (419)
Q Consensus 159 ~~ 160 (419)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 84
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.5e-06 Score=83.64 Aligned_cols=136 Identities=20% Similarity=0.256 Sum_probs=80.4
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH-----------------------------------------HHHH
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----------------------------------------NREL 121 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~e~ 121 (419)
+.||..+.|.|++|+.+. |+.||||+-+...+.. .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999654 9999999643221110 0122
Q ss_pred H----HHHhcCCCC---eeecceeeeccCCCCceeEEEEeeccccc---HHHHHHhhccCCCCCCHHHHHHHHHHHHHHH
Q 014750 122 Q----LMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEYVPET---MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191 (419)
Q Consensus 122 ~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al 191 (419)
+ +.+.+.|-+ -|.+-.+|.... ..-.|+||||+|. -.+.++. ..++...+...+.+...-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHHH
Confidence 1 222234444 122333332211 1256999999973 2233332 3344444433333322211
Q ss_pred HHhHcCCCcccccccCCceeeCC---CCCceEEeecccccccc
Q 014750 192 AYIHTVPGVCHRDVKPQNLLVDP---LTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 192 ~~LH~~~~ivH~Dlkp~NIll~~---~~~~vkl~DfG~a~~~~ 231 (419)
|=. .|++|+|=.|.||++++ .+..+.+-|||+.....
T Consensus 317 --If~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 --IFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --HHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 112 48999999999999994 36789999999987653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=68.19 Aligned_cols=126 Identities=25% Similarity=0.362 Sum_probs=87.0
Q ss_pred cceeeeceeccCCc-eEEEEEEEcCCCcEEEEEEecc----C----------cc-----------cHHHHHH---HHHhc
Q 014750 77 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ----D----------RR-----------YKNRELQ---LMRLM 127 (419)
Q Consensus 77 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~----~----------~~-----------~~~~e~~---~l~~l 127 (419)
.+++.++.||.|.- |.||+++. .|+.||+|.+.. . .. -+..|.+ .|+.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46888999999999 99999987 788999998321 0 00 0123444 44555
Q ss_pred CCCCe--eecceeeeccCC-------------CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHH
Q 014750 128 DHPNV--ISLKHCFFSTTS-------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (419)
Q Consensus 128 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~ 192 (419)
.+.++ |+.++++..... .......||.||+...- .+....+ .+|++-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~----~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDI----PQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHH----HHHHHHHH
Confidence 66677 888888754421 11223468888877541 2333333 37788889
Q ss_pred HhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 193 ~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|+ .||+-+|+++.|.. ++ ||+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~G--~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----GG--KLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----CC--EEEecccC
Confidence 9999 59999999999985 33 79999975
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.8e-05 Score=83.24 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=50.3
Q ss_pred eceeccCCceEEEEEEEcCCC--cEEEEEEeccC-----cccHHHHHHHHHhcC-CCCe--eecceeeeccCCCCceeEE
Q 014750 82 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRLMD-HPNV--ISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~ 151 (419)
.+.|+.|.+..+|+......+ ..+++|+.... .....+|.++|+.+. |.++ .+++.++.. .......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d--~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD--ASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC--CCcCCCce
Confidence 466899999999998764332 46778765322 234678999999996 6664 444443311 11123467
Q ss_pred EEeeccccc
Q 014750 152 LVMEYVPET 160 (419)
Q Consensus 152 lv~e~~~~~ 160 (419)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999974
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.7e-05 Score=69.96 Aligned_cols=69 Identities=17% Similarity=0.114 Sum_probs=42.8
Q ss_pred eccCCc-eEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcCC-CCeeecceeeeccCCCCceeEEEEeeccccc
Q 014750 85 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET 160 (419)
Q Consensus 85 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 160 (419)
|-.|.. +.||++.. .+..+.+|+.... .....+|+++++.+.. --+.+++++. ......++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYG-----SDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEE-----ecCCccEEEEEeeCCc
Confidence 444444 88999975 3467888876432 1345689999888742 2233444443 1122367999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.3e-05 Score=64.87 Aligned_cols=127 Identities=20% Similarity=0.325 Sum_probs=83.3
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeec
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
-++.+.||+|.+|.||++.. .|..+|+|+=..+ +.....|.++|..+.-.++-.=+-.+ . + .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence 45567899999999999987 6679999966544 34556899999988766654422111 1 1 2366999
Q ss_pred ccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCccccccc-CC-ceeeCCCCCceEEeecccccc
Q 014750 157 VPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK-PQ-NLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 157 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlk-p~-NIll~~~~~~vkl~DfG~a~~ 229 (419)
+.| .|.+.... .+..++ ..+++.---|-. .||-|+.|. |. ||+++ ++.+.|+||..|..
T Consensus 94 i~G~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-------GDRKHL----LRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-------ccHHHH----HHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchhh
Confidence 998 43322211 122233 355555555656 499999886 33 56665 34799999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4e-05 Score=71.63 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=93.5
Q ss_pred eeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------c------------------------ccHHHHHHHHHhcCC
Q 014750 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------------------------RYKNRELQLMRLMDH 129 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------------------------~~~~~e~~~l~~l~h 129 (419)
.+..+|..|--+.||.|. ..+|..+|||+++.. + ...++|+.-|++++.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 455678899999999998 567888999976421 1 012356777777765
Q ss_pred CCeeecceeeeccCCCCceeEEEEeeccccc--HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPET--MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 130 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
..|..-.-++. ..-.|||+|++.. -.-.|+ .-.++...++.+-.|++.-+.-|-+.+++||.||.-
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 54432211111 1135999999842 111222 355677778888888888887776557999999999
Q ss_pred CceeeCCCCCceEEeeccccccc
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
-|+|+. +|.+.|+|.+-+...
T Consensus 294 fN~Lyh--dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 294 FNLLYH--DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhheEE--CCEEEEEEccccccC
Confidence 999997 567999999988643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=5e-06 Score=89.41 Aligned_cols=213 Identities=16% Similarity=0.019 Sum_probs=141.4
Q ss_pred HHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 014750 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198 (419)
Q Consensus 120 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 198 (419)
|.+.++...|+++.....-... ......|+.++||. |.+...+.+-......+....+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445556688888765443322 23334678999998 5777777665555555555555555555577777777643
Q ss_pred C----cccccccCCceeeCCCCCceEEeecccccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHH
Q 014750 199 G----VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAEL 273 (419)
Q Consensus 199 ~----ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 273 (419)
| .+|++||+.|.+|. .+..+|++++|+.+..... ......+|++.|+.+++... -.++.++|+|..|+.+|.+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence 3 48999999999999 5778999999999843222 22345678999999998754 4578889999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC
Q 014750 274 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (419)
Q Consensus 274 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 353 (419)
..|..+|. ..++.+.+. .-.+-..+.++. ..+.++-.+...+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~------------l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEK------------LKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHcC-----------cccccccccccc------------cCCCcccHHHHHHHHHHhhhcch
Confidence 99988773 222222221 111112222221 12445555666666666788999
Q ss_pred HHHHhcCCcccc
Q 014750 354 ALEACAHPFFDE 365 (419)
Q Consensus 354 ~~e~l~hp~f~~ 365 (419)
-...+.-+.|..
T Consensus 1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred hhhhcccccccc
Confidence 999888888754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00029 Score=63.67 Aligned_cols=69 Identities=17% Similarity=0.292 Sum_probs=44.5
Q ss_pred eceeccCCceEEEEEEEcC-CCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEEEeec
Q 014750 82 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
++.|..|-...+|++.... .++.|++|+..... ....+|..+++.+...+++ +++..+ . -.++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEEEEe
Confidence 3567888889999997533 35688899765332 2335789999988644443 332221 1 1379999
Q ss_pred ccc
Q 014750 157 VPE 159 (419)
Q Consensus 157 ~~~ 159 (419)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00016 Score=66.26 Aligned_cols=133 Identities=19% Similarity=0.214 Sum_probs=74.3
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEEEeeccc
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYVP 158 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (419)
.+..|-.+.+|+... +++.+++|...... ....+|..+++.+....++ +++... . -++||||++
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~ 71 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLE 71 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEecc
Confidence 356688889998873 56788898754332 2346799999988654443 222211 1 258999998
Q ss_pred ccHHH---------------HHHhhccC---CCCCCH-HHHHHHHHHH---------HHHHHHhHc-------CCCcccc
Q 014750 159 ETMYR---------------VLKHYSSM---NQRMPL-IYVKLYTYQI---------FRGLAYIHT-------VPGVCHR 203 (419)
Q Consensus 159 ~~l~~---------------~l~~~~~~---~~~l~~-~~~~~i~~qi---------~~al~~LH~-------~~~ivH~ 203 (419)
|.... .+.+.... ...+.. ..+..+..++ ...+..+-. ...++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 73211 11111111 111221 1122222111 111221211 0258999
Q ss_pred cccCCceeeCCCCCceEEeecccccc
Q 014750 204 DVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 204 Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+.|.||+++. ++ +.|+||..|..
T Consensus 152 Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeC-CC-CEEEeccccCc
Confidence 99999999984 44 88999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00024 Score=64.32 Aligned_cols=31 Identities=39% Similarity=0.511 Sum_probs=25.2
Q ss_pred CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.+++|+|+.+.|||++ .+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~-~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQ-DGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEE-CCCEEEEEeCcccCc
Confidence 3589999999999998 455456999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=61.53 Aligned_cols=127 Identities=19% Similarity=0.274 Sum_probs=83.0
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------------------ccHHHHHHHHHhcC------CCCeeecc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRLMD------HPNVISLK 136 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~e~~~l~~l~------h~niv~~~ 136 (419)
..||+|+.=.||.-- ......||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 569999999998654 34457788776554 34456777666665 78899999
Q ss_pred eeeeccCCCCceeEEEEeeccc---ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC
Q 014750 137 HCFFSTTSKDELFLNLVMEYVP---ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~ 213 (419)
|+..+.. -..+|+|.+. |.....|..+.. .+.++. .++.. +-.-..||-+ .+|+.+||+|.||++.
T Consensus 84 G~veT~~-----G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNL-----GLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCC-----ceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 9884433 3678888764 443344444432 244655 33333 3344567777 5999999999999996
Q ss_pred CCC--C-ceEEee
Q 014750 214 PLT--H-QVKLCD 223 (419)
Q Consensus 214 ~~~--~-~vkl~D 223 (419)
..+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 322 2 566776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0011 Score=62.16 Aligned_cols=75 Identities=4% Similarity=-0.037 Sum_probs=49.3
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCC---CeeecceeeeccCCCCceeEEEEeec
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHP---NVISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
.+.||.|..+.||+... .+..+.+|..+.. ......|...|+.+... .+.++++++... .....-+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEec
Confidence 45699999999999874 2335777765432 24667899999888542 455555544221 112336899999
Q ss_pred cccc
Q 014750 157 VPET 160 (419)
Q Consensus 157 ~~~~ 160 (419)
++|.
T Consensus 95 i~G~ 98 (297)
T PRK10593 95 LRGV 98 (297)
T ss_pred cCCE
Confidence 9863
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00014 Score=70.77 Aligned_cols=172 Identities=20% Similarity=0.242 Sum_probs=111.9
Q ss_pred HHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc
Q 014750 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196 (419)
Q Consensus 117 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 196 (419)
......+++.+.|+|....+++--.. .....+|||++..++.+.+.... +... +++ .
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~ 85 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A 85 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c
Confidence 34567788999999999887765221 22277999999999888876521 1111 111 2
Q ss_pred CCCcccccccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC
Q 014750 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 276 (419)
Q Consensus 197 ~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 276 (419)
+|+.|- +.++++| .++. . | |-. ..+++||||+|.|+.++..|
T Consensus 86 -~~~~~~-------------~~~~~td-~~~t---~------------~--~~~------~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 86 -HGVLHL-------------NIIYITD-HFLT---K------------Y--PSP------IGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -ccccee-------------hhhhccc-cccc---c------------C--CCC------CCcchhhhhHHHHHHHHHHh
Confidence 233331 1234444 1110 0 0 111 12499999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHH
Q 014750 277 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356 (419)
Q Consensus 277 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e 356 (419)
...+......+.+..+.+....+.....-.+. ..+.-.++....++..+|+-..|..||...+
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-----------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAME-----------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-----------------HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 99998888888888777754443322111100 0111235777889999999999999999999
Q ss_pred HhcCCccccc
Q 014750 357 ACAHPFFDEL 366 (419)
Q Consensus 357 ~l~hp~f~~~ 366 (419)
+..|+-|.+.
T Consensus 191 ~~k~~i~~ev 200 (725)
T KOG1093|consen 191 LSKRCSFTEV 200 (725)
T ss_pred HhcCccHHHH
Confidence 9999999876
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0012 Score=64.04 Aligned_cols=71 Identities=23% Similarity=0.333 Sum_probs=46.0
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEecc------C-----cccHHHHHHHHHhcC---CCCeeecceeeeccCCCCc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------D-----RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 147 (419)
.+.||.|.+..||++.+...++.+.||.-.. + ......|.+.|+.+. -.++.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~-- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E-- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence 3569999999999999754446899997431 1 112345777777653 23455555542 2
Q ss_pred eeEEEEeecccc
Q 014750 148 LFLNLVMEYVPE 159 (419)
Q Consensus 148 ~~~~lv~e~~~~ 159 (419)
...++||||+++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 225699999985
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=63.20 Aligned_cols=30 Identities=30% Similarity=0.300 Sum_probs=25.4
Q ss_pred CCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.|+||+|+.+.|||++ .+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~-~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFE-GDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence 4899999999999998 45445799999885
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=8.3e-05 Score=68.44 Aligned_cols=131 Identities=18% Similarity=0.177 Sum_probs=86.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEec----------cCc----------------ccHHHHHHHHHhcCC-C
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----------QDR----------------RYKNRELQLMRLMDH-P 130 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~----------------~~~~~e~~~l~~l~h-~ 130 (419)
-|.++..||-|--+.||.+-+ ..|+++++|.-. ..+ ....+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367788999999999999985 468889998431 111 112367778877742 2
Q ss_pred C-eeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCc
Q 014750 131 N-VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQN 209 (419)
Q Consensus 131 n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~N 209 (419)
. +.+.+ +...-++|||++.|--+..+++. ..+..+...+..-+--|-. .|+||||..-=|
T Consensus 172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRHV---------EDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFN 232 (465)
T ss_pred CCCCCcc---------cccceeeHHHhhcccceeeeeec---------CChHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence 2 22222 22336799999987311112211 1133445555666667778 599999999999
Q ss_pred eeeCCCCCceEEeecccccc
Q 014750 210 LLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 210 Ill~~~~~~vkl~DfG~a~~ 229 (419)
|+|+ ++..++++||--...
T Consensus 233 imv~-dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 233 IMVK-DDDKIVVIDFPQMVS 251 (465)
T ss_pred eEEe-cCCCEEEeechHhhc
Confidence 9999 577799999976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00098 Score=62.90 Aligned_cols=144 Identities=16% Similarity=0.059 Sum_probs=76.2
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCC--eeecceeeecc-CCCCceeEEEEeec
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEY 156 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~ 156 (419)
.+.++.|....+|++.. ++..+++|+.... ......|.+++..|.... +.+++...-.. ........+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 55678888889999874 3346888976543 233446777777774333 22322211000 00123346899999
Q ss_pred ccccH-----H-------HHHHhhcc--CC--C------CCCH-HH--HH----------HHHHHHHHHHHHhHc-----
Q 014750 157 VPETM-----Y-------RVLKHYSS--MN--Q------RMPL-IY--VK----------LYTYQIFRGLAYIHT----- 196 (419)
Q Consensus 157 ~~~~l-----~-------~~l~~~~~--~~--~------~l~~-~~--~~----------~i~~qi~~al~~LH~----- 196 (419)
++|.. . ..+..... .+ . .+.. .. .. .....+...++++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 88621 0 11111000 00 0 0000 00 00 001122334444432
Q ss_pred -CCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 197 -~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFD-GDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEE-CCceEEEeeccccc
Confidence 15899999999999998 45556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=62.11 Aligned_cols=144 Identities=15% Similarity=0.005 Sum_probs=77.2
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEecc-CcccHHHHHHHHHhcCCCC--eeecceeeecc-CCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRLMDHPN--VISLKHCFFST-TSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 157 (419)
.+.|..|....+|++.. .+..+++|+... .......|+.+++.+.+.+ +.+++...-.. ........++|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 45677888889999864 445789998763 2233456888888875433 33332210000 001123457999999
Q ss_pred cccHH------------HHH---HhhccC-CC-----CC-CHHHH--H--------HHHHHHHHHHHHhHc------CCC
Q 014750 158 PETMY------------RVL---KHYSSM-NQ-----RM-PLIYV--K--------LYTYQIFRGLAYIHT------VPG 199 (419)
Q Consensus 158 ~~~l~------------~~l---~~~~~~-~~-----~l-~~~~~--~--------~i~~qi~~al~~LH~------~~~ 199 (419)
+|... +.+ +..... .. .. .+... . .....+..++.++.+ ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 86321 111 111000 00 00 00000 0 011112233344332 137
Q ss_pred cccccccCCceeeCCCCCceEEeeccccc
Q 014750 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 200 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
++|+|+.|.|||++ .+..+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~-~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFD-GDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEe-CCceEEEeehhhhc
Confidence 99999999999999 45556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00052 Score=59.63 Aligned_cols=99 Identities=23% Similarity=0.219 Sum_probs=74.9
Q ss_pred HHHHHHHHhcCC-CCeeecceeeeccCCCCceeEEEEeecccc-cHHHH---HHhhccCCCCCCHHHHHHHHHHHHHHHH
Q 014750 118 NRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRV---LKHYSSMNQRMPLIYVKLYTYQIFRGLA 192 (419)
Q Consensus 118 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~---l~~~~~~~~~l~~~~~~~i~~qi~~al~ 192 (419)
..|.-+++.+.+ +++.+++|.+ . -.+|.||.+. .+... +.+ -...++..+..|+.++++.+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~ 73 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLE 73 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHH
Confidence 358888888876 6899999887 2 3578999984 33211 111 134678899999999999999
Q ss_pred HhHcC--CCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 193 YIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 193 ~LH~~--~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|+.. ..+.-.|++++|+-++ +++++|++|...+...
T Consensus 74 ~l~~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 74 ELDHGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHhcCCCCcEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 99972 1366789999999999 6788999999887544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0054 Score=57.68 Aligned_cols=68 Identities=18% Similarity=0.260 Sum_probs=42.5
Q ss_pred ceeccCCceEEEEEEEcC------CCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEE
Q 014750 83 RVVGTGSFGIVFQAKCLE------TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~l 152 (419)
+.|..|-...||++.... +++.+++|+..... ....+|..+++.+....+. +++.++ .+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~----~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF-----PN----GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe-----CC----Cc
Confidence 456667777888887532 25789999875432 3456788888888644443 333322 11 25
Q ss_pred Eeecccc
Q 014750 153 VMEYVPE 159 (419)
Q Consensus 153 v~e~~~~ 159 (419)
|+||++|
T Consensus 75 v~e~i~G 81 (302)
T cd05156 75 IEEFIPS 81 (302)
T ss_pred hhheeCC
Confidence 7888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0048 Score=59.17 Aligned_cols=138 Identities=17% Similarity=0.231 Sum_probs=76.2
Q ss_pred eceeccCCceEEEEEEEcC----CCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEEE
Q 014750 82 ERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv 153 (419)
...|-.|-...+|++.... .++.|++|+..... ....+|..+++.+..-++. ++++.+ .+ ..|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~----g~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN----GRV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-----CC----ceE
Confidence 3456668889999987432 24689999775432 1235788888888654443 333433 11 146
Q ss_pred eecccccHH---------------HHHHhhccCC---C--CCCHHHHHHHHHHH-----------------HHHHHH---
Q 014750 154 MEYVPETMY---------------RVLKHYSSMN---Q--RMPLIYVKLYTYQI-----------------FRGLAY--- 193 (419)
Q Consensus 154 ~e~~~~~l~---------------~~l~~~~~~~---~--~l~~~~~~~i~~qi-----------------~~al~~--- 193 (419)
.+|+.+... ..+.+..... . ......+..+..++ ...+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 777764211 1111111111 0 11122333333221 111111
Q ss_pred -hH----cCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 194 -IH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 194 -LH----~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+. . ..++|+|+++.|||++..++.+.|+||..|..
T Consensus 192 ~~~~~~~~-~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQE-IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCC-ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 2 25899999999999985456799999998864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0079 Score=56.77 Aligned_cols=29 Identities=31% Similarity=0.618 Sum_probs=25.0
Q ss_pred CCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 47899999999999983 458999999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.016 Score=55.24 Aligned_cols=69 Identities=23% Similarity=0.224 Sum_probs=42.4
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccC-----------cccHHHHHHHHHhcC--CC-CeeecceeeeccCCCCcee
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~ 149 (419)
.||.|....||++.+...++.|+||.-... ......|...|+... -| .+.+++.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 479999999999997543468999954211 112235777776653 23 34444332 1222
Q ss_pred EEEEeecccc
Q 014750 150 LNLVMEYVPE 159 (419)
Q Consensus 150 ~~lv~e~~~~ 159 (419)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4599999864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0064 Score=56.35 Aligned_cols=31 Identities=32% Similarity=0.500 Sum_probs=24.8
Q ss_pred CcccccccCCceeeCCCCCceEEeecccccc
Q 014750 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 199 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.++|+|+++.|||++..+...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999994233356999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.014 Score=55.56 Aligned_cols=30 Identities=20% Similarity=0.334 Sum_probs=26.1
Q ss_pred cccccccCCceeeCCCCCceEEeecccccc
Q 014750 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 200 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++|+||.+.|||++++++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975567899999998854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.022 Score=53.49 Aligned_cols=30 Identities=30% Similarity=0.495 Sum_probs=25.9
Q ss_pred cccccccCCceeeCCCCCceEEeeccccccc
Q 014750 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 200 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++|+|+.+.||+|++.+. +=|.||+++..-
T Consensus 200 lvHGD~~~gNlii~~~~~-~gVlDwe~~~lG 229 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRP-TGVLDWELATLG 229 (321)
T ss_pred eeeCCcccCCEEEeCCCe-eEEEeccccccC
Confidence 899999999999995444 889999999754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=56.90 Aligned_cols=71 Identities=20% Similarity=0.244 Sum_probs=44.6
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC----------cccHHHHHHHHHhcC--CC-CeeecceeeeccCCCCce
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRLMD--HP-NVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~ 148 (419)
.+.||.|.-..||++.+...++.|+||.-..- ......|.+.|+... .| ++.+++.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcH
Confidence 56789999999999997444678999954211 112235777777653 23 34445432 122
Q ss_pred eEEEEeecccc
Q 014750 149 FLNLVMEYVPE 159 (419)
Q Consensus 149 ~~~lv~e~~~~ 159 (419)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 24589999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.024 Score=55.06 Aligned_cols=69 Identities=19% Similarity=0.246 Sum_probs=44.4
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEecc-----------CcccHHHHHHHHHhcC---CCCeeecceeeeccCCCCc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 147 (419)
.+.||.|....||++.+ .+..++||.-.. .......|...|+.+. -.++.+++.+. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 56789999999999986 345689996431 1122234666666553 23566665544 222
Q ss_pred eeEEEEeecccc
Q 014750 148 LFLNLVMEYVPE 159 (419)
Q Consensus 148 ~~~~lv~e~~~~ 159 (419)
-+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 4588999976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.02 Score=54.01 Aligned_cols=31 Identities=19% Similarity=0.223 Sum_probs=26.7
Q ss_pred CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.++||+|+.+.|+|++ .++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYD-ETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
Confidence 3799999999999998 466789999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.015 Score=56.98 Aligned_cols=30 Identities=20% Similarity=0.274 Sum_probs=23.2
Q ss_pred cccccccCCceeeCCCCC----ceEEeecccccc
Q 014750 200 VCHRDVKPQNLLVDPLTH----QVKLCDFGSAKV 229 (419)
Q Consensus 200 ivH~Dlkp~NIll~~~~~----~vkl~DfG~a~~ 229 (419)
++||||..+|||++.++. -..|+||-++..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 699999999999996443 345788877654
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.062 Score=49.99 Aligned_cols=71 Identities=13% Similarity=0.078 Sum_probs=42.1
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcC---CCCeeecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD---HPNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.+.|+.|....+|+.. .+++.+.+|.-... ......|.+-|+.|. --.+.+.+.+..... .-+|||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DAFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CCEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----CceEEEEee
Confidence 4568889999999987 57888999976533 344678888888884 233555555542221 137999998
Q ss_pred cc
Q 014750 158 PE 159 (419)
Q Consensus 158 ~~ 159 (419)
+.
T Consensus 95 ~~ 96 (288)
T PF03881_consen 95 EM 96 (288)
T ss_dssp --
T ss_pred cC
Confidence 73
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.048 Score=51.52 Aligned_cols=76 Identities=17% Similarity=0.202 Sum_probs=56.7
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
.+..+.|++|++-++.+.. + .....+++..++.+.+..+.-+...-..-||||...||||+ .|+|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 3456788999987765321 1 23456778888888887777776533578999999999999 567999999
Q ss_pred cccccc
Q 014750 225 GSAKVL 230 (419)
Q Consensus 225 G~a~~~ 230 (419)
-+++..
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999854
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.27 Score=46.76 Aligned_cols=28 Identities=25% Similarity=0.271 Sum_probs=24.0
Q ss_pred CCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCC
Confidence 4789999999999996 3 37899999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.39 Score=46.65 Aligned_cols=28 Identities=29% Similarity=0.346 Sum_probs=23.7
Q ss_pred CcccccccCCceeeCCCCCceEEeeccccc
Q 014750 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 199 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..+|.||-+.|||.+ +..++++||-.|.
T Consensus 228 VfCHNDL~~gNIL~~--~~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDF--NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEec--CCCEEEEEecccc
Confidence 579999999999986 3459999998874
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.06 Score=51.66 Aligned_cols=60 Identities=27% Similarity=0.313 Sum_probs=38.7
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
..++-+|..| ++...++. ...+++..+.++.-..+|+--+--..+++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3456667766 55555543 334555566666555666554443358999999999999963
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.034 Score=51.62 Aligned_cols=132 Identities=21% Similarity=0.220 Sum_probs=85.3
Q ss_pred eeeceeccCCceEEEEEEEcC----------CCcEEEEEEeccCc--------------cc----------------HHH
Q 014750 80 MAERVVGTGSFGIVFQAKCLE----------TGETVAIKKVLQDR--------------RY----------------KNR 119 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~----------~~~~vaiK~~~~~~--------------~~----------------~~~ 119 (419)
.+...|..|--++|+-|+--. .-..+|||+++... +. .++
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 345678889999999885210 12458999764210 00 012
Q ss_pred HHHHHHhc-----CCCCeeecceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHh
Q 014750 120 ELQLMRLM-----DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194 (419)
Q Consensus 120 e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~L 194 (419)
|.--|.++ .+|-+|.+... .|||-|++.. .+..-.-.+-.++..+.+..-.|+..++.-|
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~l 399 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRL 399 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHH
Confidence 33333332 46777766443 4999999842 1111122345588888888888888888766
Q ss_pred HcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 195 H~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
-.-.-+||-||.--|+|+.+ +.+.++|..-+.
T Consensus 400 Y~Ec~LVHADlSEyN~Lw~~--gKvw~IDVsQsv 431 (531)
T KOG2269|consen 400 YKECLLVHADLSEYNLLWTP--GKVWVIDVSQSV 431 (531)
T ss_pred HHhhheeecchhhhhheecC--CceEEEechhcc
Confidence 43258999999999999983 479999988764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.27 Score=44.80 Aligned_cols=67 Identities=15% Similarity=0.130 Sum_probs=46.9
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHH---HHHHhcCCCCeeecceeeeccCCCCceeEEEEeeccc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL---QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP 158 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 158 (419)
..+..|..+.|+.++ ..+|...++|+...... ...|. ..|+..+-...|++++.- ...-.+++|.+.
T Consensus 8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~-~~~E~~g~~~L~~w~G~GaVrll~~d-------~~~~AlLLErl~ 77 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHAE-AEHEARGEAALRWWNGRGAVRLLAAD-------PERGALLLERLD 77 (253)
T ss_pred CCCCCCcceEEEEEE-cCCCCeEEEEecCCccc-chhhhhHHhHhheeCCCCceeeeccc-------cccchhhhhhcc
Confidence 446778999999998 56899999997654332 22343 568888888889987743 112448888883
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.095 Score=49.14 Aligned_cols=63 Identities=21% Similarity=0.246 Sum_probs=36.2
Q ss_pred EEEeecccccHHHHHH-hhccCCCCCCHHHHHHHHHHHHHHHHHh---HcCCCcccccccCCceeeC
Q 014750 151 NLVMEYVPETMYRVLK-HYSSMNQRMPLIYVKLYTYQIFRGLAYI---HTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~~ivH~Dlkp~NIll~ 213 (419)
.||+++..++....-. ...+.+-..-...++.++.||+.-.--+ -...+.+|-||||+||||-
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 313 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF 313 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence 3888887654322211 1112222223455777888875533112 1114789999999999985
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.055 Score=46.64 Aligned_cols=28 Identities=29% Similarity=0.328 Sum_probs=24.4
Q ss_pred cccccccCCceeeCCCCCceEEeecccccc
Q 014750 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 200 ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.+|+|+.|.||+++ +++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~-~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHS-ASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEE-CCC-EEEEeCCcccC
Confidence 59999999999998 455 99999999864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 419 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-142 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-142 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-142 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-142 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-142 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-141 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-141 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-141 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-141 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-140 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-140 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-140 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-139 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-138 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-138 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-138 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-138 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-137 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-137 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-137 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-135 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-132 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-91 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-83 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-46 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-45 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-44 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-44 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-44 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-44 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-44 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-44 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-44 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-44 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-44 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-43 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-43 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-43 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-42 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-42 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-42 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-42 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-42 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-42 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-42 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-42 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-42 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-42 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-42 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-42 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-42 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-42 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-42 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-42 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-42 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-42 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-42 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-42 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-42 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-41 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-40 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-39 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-39 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-39 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-39 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-38 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-38 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-38 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-38 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-35 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-35 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-34 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-34 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-34 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-34 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-34 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-34 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-34 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-34 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-34 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-34 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-34 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-34 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-34 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-34 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-34 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-34 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-34 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-33 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-33 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-33 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-33 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-33 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-33 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-33 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-33 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-33 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-33 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-33 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-33 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-33 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-32 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-32 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-32 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-32 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-32 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-32 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-32 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-31 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-31 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-31 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-31 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-31 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-31 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-31 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-30 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-30 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-30 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-29 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-28 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-28 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-26 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-26 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-26 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-26 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-26 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-25 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-25 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-20 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-19 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-16 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-16 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-16 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-15 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-11 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 627 bits (1618), Expect = 0.0
Identities = 221/368 (60%), Positives = 284/368 (77%), Gaps = 4/368 (1%)
Query: 42 SDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 101
S+ ++ + D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVES 64
Query: 102 GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPET 160
E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K DE+FLNLV+EYVPET
Sbjct: 65 DE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220
+YR +HY+ + Q MP++ +KLY YQ+ R LAYIH++ G+CHRD+KPQNLL+DP + +K
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLK 182
Query: 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 280
L DFGSAK+L+ GE N+SYICSRYYRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLF
Sbjct: 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
Query: 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 340
PGE+ +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL
Sbjct: 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLI 302
Query: 341 SRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRL 400
SRLL+Y+PS R TA+EA HPFFDELR AR+PNGR PPLFN+ +E P+LI+RL
Sbjct: 303 SRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRL 362
Query: 401 IPEHVRRQ 408
+P+H +
Sbjct: 363 VPQHAEAE 370
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 627 bits (1620), Expect = 0.0
Identities = 234/364 (64%), Positives = 290/364 (79%), Gaps = 4/364 (1%)
Query: 59 GHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+
Sbjct: 34 GSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 93
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSK-DELFLNLVMEYVPETMYRVLKHYSSMNQRM 175
KNRELQ+MR +DH N++ L++ F+S+ K DE++LNLV++YVPET+YRV +HYS Q +
Sbjct: 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P+IYVKLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
N+SYICSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKV
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
LGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T L
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 415
EACAH FFDELR+PN +LPNGR P LFNF + ++P L LIP H R Q S P
Sbjct: 333 EACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPT 392
Query: 416 SAGT 419
+A
Sbjct: 393 NATA 396
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 596 bits (1538), Expect = 0.0
Identities = 155/358 (43%), Positives = 221/358 (61%), Gaps = 13/358 (3%)
Query: 59 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 117 KNRELQLMRLM---DHPNVISLKHCFFSTTSK--DELFLNLVMEYVPETMYRVLKHYSSM 171
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP+T++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
E N++YICSRYYRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 347
EI++VLG P+RE +R +NP++TD K PW VF + EA DL S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 348 PSLRCTALEACAHPFFDELREPNARLPNGRPFPP-LFNF-KQELAGASPELINRLIPE 403
P R EA HP+FDEL +P +LPN + P LF F E+ S +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 573 bits (1478), Expect = 0.0
Identities = 166/381 (43%), Positives = 240/381 (62%), Gaps = 44/381 (11%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP 130
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+++DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 131 NVISLKHCFFSTTSK---------------------------------DELFLNLVMEYV 157
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 158 PETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217
P+T+++VLK + + +P+ + +Y YQ+FR + +IH++ G+CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+KLCDFGSAK L+ E +++YICSR+YRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 278 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 337
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ + P AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 338 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPFPPLFNF-KQ 387
DL ++L+Y P LR EA AHPFFD LR N+ P+G + P LFNF
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 388 ELAGASPELINRLIPEHVRRQ 408
EL+ ++NR++P++
Sbjct: 360 ELSIIPGNVLNRILPKNFSPN 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 99/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
F L+LV EY T+ L + +P VK T+Q + + + H
Sbjct: 71 FRRKRR-----LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
HRDVKP+N+L+ +KLCDFG A++L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 315
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 316 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374
P + P F + A+ L L P+ R T + HP+F+ +RE L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 375 NGRPFPPLFNFKQ 387
P + Q
Sbjct: 299 KEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 7e-98
Identities = 97/295 (32%), Positives = 152/295 (51%), Gaps = 21/295 (7%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
LV E+V T+ L+ + V+ Y +QI G+ + H+
Sbjct: 93 CKKKKR-----WYLVFEFVDHTILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELIFGATEY 257
+ HRD+KP+N+LV + VKLCDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 315
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 316 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
P+IK P + + ++ IDLA + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 8e-97
Identities = 86/313 (27%), Positives = 155/313 (49%), Gaps = 30/313 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRLMDHPNV 132
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 133 ISLKHCFFSTTSKDELFLN---------LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLY 183
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----Y 239
YQ+ RGL YIH+ V HRD+KP NL ++ +K+ DFG A+++ ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 300 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
E+ + + + P ++ + EA+D ++L +SP R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 358 CAHPFFDELREPN 370
+HP+ P
Sbjct: 304 LSHPYMSIYSFPM 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 4e-96
Identities = 102/346 (29%), Positives = 182/346 (52%), Gaps = 34/346 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I++ + + ++ + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----------YI 240
+H V HRD+KP NLL++ +K+CDFG A+++ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 301 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+ +P ++ P A P K+F + + P+ IDL R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 357 ACAHPFFDELREPNARLPNGRPFPPL-FNFKQELAGASPELINRLI 401
A HP+ +PN P G P PP F F + + + +LI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 9e-96
Identities = 93/303 (30%), Positives = 152/303 (50%), Gaps = 23/303 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-LMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 257 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 310
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 311 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ D + W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 367 REP 369
+
Sbjct: 327 VKD 329
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-95
Identities = 102/327 (31%), Positives = 168/327 (51%), Gaps = 35/327 (10%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMD 128
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQI 187
H N+++L + S L LV EY + + LK Y + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEY----LDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRY 244
RGLAY H V HRD+KPQNLL++ ++KL DFG A+ K +Y + + +
Sbjct: 110 LRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARA--KSIPTKTYDNEVVTLW 165
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 302
YR P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 303 -EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
I + + +P+ +A R+ + DL ++LLQ+ R +A +A HP
Sbjct: 226 PGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283
Query: 362 FFDELREPNARLPNGRPFPPLFNFKQE 388
FF L E +LP+ L + +
Sbjct: 284 FFLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 2e-94
Identities = 95/332 (28%), Positives = 158/332 (47%), Gaps = 33/332 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 123
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVK 181
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
+ Y I GL +H GV HRD+ P N+L+ + + +CDF A+ Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 302 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
E++ +P +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 358 CAHPFFDELREPNARLPNGRPFPPLFNFKQEL 389
HP+F+ L +P L G F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 1e-92
Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIF 252
+ HRD+KP NLL+D +KL DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 309
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+Y F P H +F + +DL L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 370 NARLPNGRPFPP 381
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 107/337 (31%), Positives = 178/337 (52%), Gaps = 28/337 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----YICSRYYRA 247
YIH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 308 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
N ++ P PW+++F +A+DL ++L ++P R +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 365 ELREPNARLPNGRPFPPLFNFKQELAGASPELINRLI 401
+ +P+ P F F EL E + LI
Sbjct: 319 QYYDPS-DEP---IAEAPFKFDMELDDLPKEKLKELI 351
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 8e-92
Identities = 106/335 (31%), Positives = 169/335 (50%), Gaps = 29/335 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ GV HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARHA--DAEMTGYVVTRWYRAPE 193
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ PQ + ++F R P+A DL ++L+ R TA +A HPFF+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 367 REPNARLPNGRPFPPLFNFKQELAGASPELINRLI 401
R+P F+ E + + + I
Sbjct: 313 RDPE----EETEAQQPFDDSLEHEKLTVDEWKQHI 343
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 4e-91
Identities = 103/318 (32%), Positives = 169/318 (53%), Gaps = 25/318 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F + D+ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPE 195
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
++ P+++ + + P A++L ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 367 REPNARLPNGRPFPPLFN 384
+ P + + F+
Sbjct: 315 HDTEDE-PQVQKYDDSFD 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 6e-91
Identities = 95/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
L+L+ EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 IHHNHR-----LHLIFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 199 GVCHRDVKPQNLLVDPLTH----QVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
HRD+KPQNLL+ +K+ DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 308
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P++ FP+ + +V + E +DL + +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 369 PNARLPNGRPFPP 381
F P
Sbjct: 326 ---------DFDP 329
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 275 bits (707), Expect = 9e-91
Identities = 101/294 (34%), Positives = 163/294 (55%), Gaps = 27/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
+ HRD+KPQNLL++ +KL DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F + PW + E IDL S +L + P+ R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 1e-90
Identities = 94/294 (31%), Positives = 159/294 (54%), Gaps = 28/294 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++K+ DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 312
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 3e-89
Identities = 105/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 131 NVISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
NVI L F S +E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL YIH+ + HRD+KP NL V+ ++K+ DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARHT--ADEMTGYVATRWYRAPE 199
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 308
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 309 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ ++ Q+ + VF P A+DL ++L R TA +A AH +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 367 REPNARLPNGRPFPPLFNFKQELAGASPELINRLI 401
+P+ P ++ E + L
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 5e-89
Identities = 98/331 (29%), Positives = 160/331 (48%), Gaps = 38/331 (11%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPL--IYVKLYTYQI 187
N+I L + F S +E + +VME + + +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRA 247
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 308 NPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTA 354
P + P+ + + K+F + +A DL S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 355 LEACAHPFFDELREPNARLPNGRPFPPLFNF 385
EA HP+ + +P+ P P
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQL 343
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 6e-89
Identities = 95/320 (29%), Positives = 158/320 (49%), Gaps = 41/320 (12%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVISL 135
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAY 193
+ L LV E++ + + + + + + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPEL 250
H + HRD+KPQNLL++ Q+KL DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 311 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
T Q +V + +D LLQ +P +R +A +A HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 362 FFDELREPNARLPNGRPFPP 381
+F E A + R
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKHC 138
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELIFGAT 255
V HRD+KPQNLL++ ++KL +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 256 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 311
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+ V ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 2e-87
Identities = 93/360 (25%), Positives = 169/360 (46%), Gaps = 61/360 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRLM-DH 129
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+++L + + +D + LV +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS----------- 238
+ Y+H+ G+ HRD+KP N+L++ VK+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 288 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 333
QL II V+ P+ E++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 334 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEL 389
EA+DL +LLQ++P+ R +A +A HPF PN N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 3e-87
Identities = 99/345 (28%), Positives = 171/345 (49%), Gaps = 36/345 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRLMDHP 130
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 131 NVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N+ISL + F + +E + LVME + + +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
G+ ++H+ G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 310 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 356
++ P+ + K+F +K +A DL S++L P+ R + +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 357 ACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLI 401
A HP+ + +P P P +++ + + + E LI
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 394
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-86
Identities = 101/381 (26%), Positives = 159/381 (41%), Gaps = 79/381 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRLMDHP 130
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVG 168
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+ Y+H+ G+ HRD+KP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 239 ----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 275
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 276 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 310
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 311 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ FP+ + + F +AI L R+L ++P+ R T E AHPFF E+R
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 369 PNARLPNGRPFPPLFNFKQEL 389
FN +
Sbjct: 406 AEVETNATEKVRLPFNDWMNM 426
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 8e-86
Identities = 84/302 (27%), Positives = 141/302 (46%), Gaps = 35/302 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRLMDHPNV 132
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRG 190
+ L ++ + E+ + LV E+ + + L+ Y + +P +K Q RG
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRA 247
L ++H + HRD+KP+N+LV VKL DFG A++ ++ + + +YRA
Sbjct: 133 LDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIY---SYQMALTPVVVTLWYRA 187
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW--- 243
Query: 308 NPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
P FP P V M L +L ++P R +A A H +
Sbjct: 244 -PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
Query: 365 EL 366
+
Sbjct: 302 KD 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 2e-85
Identities = 96/316 (30%), Positives = 155/316 (49%), Gaps = 37/316 (11%)
Query: 85 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRLMDHPNVI 133
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--SSMNQRMPLIYVKLYTYQIFRGL 191
L + + E L LV E+ + + L Y +P +K +Q+ RGL
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAP 248
++H+ V HRD+KPQN+LV + Q+KL DFG A++ ++ + + +YRAP
Sbjct: 134 DFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 188
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+
Sbjct: 189 EVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 243
Query: 309 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
P F A P K + DL + L ++P+ R +A A +HP+F +
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 366 LREPNARLPNGRPFPP 381
L L + PP
Sbjct: 303 LERCKENLDS--HLPP 316
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-85
Identities = 87/320 (27%), Positives = 142/320 (44%), Gaps = 36/320 (11%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMDHPNVIS 134
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++L+ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 135 LK---HCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRG 190
L S ++ + + LV ++ L S++ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV--LVKGEANISY---ICSRYY 245
L YIH + HRD+K N+L+ +KL DFG A+ L K Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 302
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ Y + + P A+DL +LL P+ R + +A H
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 362 FFDELREPNARLPNGRPFPP 381
FF +P G
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 5e-85
Identities = 96/373 (25%), Positives = 159/373 (42%), Gaps = 71/373 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRLMDHP 130
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L L +V+E + ++ K + ++K Y + G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLG 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS------------ 238
+IH G+ HRD+KP N L++ VK+CDFG A+ + +
Sbjct: 142 ENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 239 -----------YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ---------- 277
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 278 -PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF--RF 316
PLFPG ++ DQL I ++GTPT ++++ + P + F
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376
P K + + + + I+L +L+++P+ R T +A HP+ ++R+ +
Sbjct: 320 PHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFST 378
Query: 377 RPFPPLFNFKQEL 389
+ F+ L
Sbjct: 379 KKIILPFDDWMVL 391
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-77
Identities = 92/333 (27%), Positives = 152/333 (45%), Gaps = 40/333 (12%)
Query: 85 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 141 STTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKLYTYQIFRGLAYIH 195
S + + L+ +Y ++ ++K + + ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 196 TVPGVCHRDVKPQNLLVDPLTH---QVKLCDFGSAKVLVKGEANISYICSR----YYRAP 248
V HRD+KP N+LV +VK+ D G A++ ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 299
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 300 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
+ E + ++ + + + + +A L +LL P
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 351 RCTALEACAHPFFDELREP--NARLPNGRPFPP 381
R T+ +A P+F E P + P+P
Sbjct: 325 RITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK 357
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 94/342 (27%), Positives = 155/342 (45%), Gaps = 60/342 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
NVI + F F N + E + +Y ++K Q L V+ + +
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208
Query: 187 IFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
I + L +H + H D+KP+N LL +K+ DFGS+ + +YI SR+Y
Sbjct: 209 ILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
RAPE+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 306 -----------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA--- 336
P Y R +++ P + + +
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 337 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 377
+D + L++ P++R T +A HP+ R + P G
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-62
Identities = 85/339 (25%), Positives = 145/339 (42%), Gaps = 42/339 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 131 NVISLKHC-----FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + H F+ + + + +V E + E + ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYI 240
Q+ GL Y+H G+ H D+KP+N+L++ + +K+ D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 294
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 295 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 341
+LG +R N ++K P V ++ E D S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 342 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 380
+LQ P R A HP+ + R
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-62
Identities = 93/336 (27%), Positives = 147/336 (43%), Gaps = 62/336 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM------DH 129
Y + ++G GSFG V +A E VAIK + + + N E++L+ LM
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++ LK F F N LV E + +Y +L++ + + + L + + Q
Sbjct: 116 YYIVHLKRHFM--------FRNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQ 165
Query: 187 IFRGLAYIHTV-PGVCHRDVKPQN-LLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ L ++ T + H D+KP+N LL +P +K+ DFGS+ G+ YI SR+
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRF 223
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YR+PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 224 YRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282
Query: 305 R-----------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA--------- 336
+ + + K P + H + P
Sbjct: 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342
Query: 337 -------IDLASRLLQYSPSLRCTALEACAHPFFDE 365
DL R+L Y P R A H FF +
Sbjct: 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-60
Identities = 79/337 (23%), Positives = 136/337 (40%), Gaps = 60/337 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F +V E + + Y +K L +++ Y
Sbjct: 76 TFRCVQMLEWFE--------HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAY 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVD-----------------PLTHQVKLCDFGSA 227
QI + + ++H+ + H D+KP+N L V + +K+ DFGSA
Sbjct: 126 QICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YRAPE+I ++ D+WS GC+L E LG +FP ++ +
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
Query: 288 QLVEIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP----------- 334
L + ++LG + I+ Y R + + + P
Sbjct: 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 335 --EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-59
Identities = 75/338 (22%), Positives = 137/338 (40%), Gaps = 66/338 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM-----DHP 130
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 131 NVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N++ F ++ + L+ E + ++Y ++ + + +KLY +I
Sbjct: 97 NIVKYHGKF--------MYYDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEI 146
Query: 188 FRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------------QVKLCD 223
+ L Y+ + + H D+KP+N LL DP +KL D
Sbjct: 147 LKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 283
FG A K + + S I +R YRAPE+I + S D+WS GCVLAEL G LF
Sbjct: 206 FGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 284 NAVDQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPP 334
++ L + ++ + + +N + +P+ + K+ P
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322
Query: 335 EA--------IDLASRLLQYSPSLRCTALEACAHPFFD 364
D +LQ P+LR + E H F +
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-59
Identities = 83/434 (19%), Positives = 141/434 (32%), Gaps = 85/434 (19%)
Query: 5 PLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIST 64
G P+ + A ++ H D+ L D S ++G
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI--------- 57
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------ 118
Y + +G+G VFQ E + AIK V +
Sbjct: 58 --------------YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR 102
Query: 119 RELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
E+ + + + +I L + ++ +VME + LK + +
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSID 153
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
K Y + + IH G+ H D+KP N L+ +KL DFG A + +
Sbjct: 154 PWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 210
Query: 237 I---SYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG- 282
+ S + + Y PE I ++ + D+WS GC+L + G+ F
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
N + +L II +PN+ FP I + D+
Sbjct: 271 INQISKLHAII--------------DPNHE-IEFPDI------------PEKDLQDVLKC 303
Query: 343 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIP 402
L+ P R + E AHP+ P ++ G + Q + SP I +
Sbjct: 304 CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAK 363
Query: 403 EHVRRQTGLSMPHS 416
+G +S
Sbjct: 364 TLYEHYSGGESHNS 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-58
Identities = 77/346 (22%), Positives = 129/346 (37%), Gaps = 60/346 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRLM------D 128
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 129 HPNVISLKHCFFSTTSKDELFLN---LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + F F + E + + + LK + Q PL +V+ Y
Sbjct: 81 KFLCVLMSDWF--------NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAY 130
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQN-LLVDPLTH-----------------QVKLCDFGSA 227
Q+ L ++H + H D+KP+N L V+ +++ DFGSA
Sbjct: 131 QLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
E + + + +R+YR PE+I + D+WS GC+L E G LF +
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 288 QLVEIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA-- 336
LV + K+LG I + + K M ++
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 337 ----IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378
DL R+L++ P+ R T EA HPFF L R
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V ++ + E+ + + +
Sbjct: 30 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 89 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 248 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 296
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+PN+ FP I + D+ L+ P R + E
Sbjct: 254 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 357 ACAHPFFDELREPNARLPNG 376
AHP+ P ++ G
Sbjct: 290 LLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-57
Identities = 74/360 (20%), Positives = 125/360 (34%), Gaps = 62/360 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPN- 131
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 132 -VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRA 247
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 248 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 296
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
+PN+ FP I + D+ L+ P R + E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 357 ACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPHS 416
AHP+ P ++ G + Q + SP I + +G +S
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-57
Identities = 73/344 (21%), Positives = 120/344 (34%), Gaps = 52/344 (15%)
Query: 33 LKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGI 92
L S ++ + + + S E S+ +G GS+G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 93 VFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRLMDHPNVISLKHCFFSTTSK 145
VF+ + E G A+K+ + +DR K E+ ++ HP + L+ + +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----E 127
Query: 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205
+ L L E ++ + + + +P V Y LA++H+ G+ H DV
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDV 183
Query: 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWS 265
KP N+ + P + KL DFG L A Y APEL+ Y T+ D++S
Sbjct: 184 KPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYGTAADVFS 240
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
G + E+ L G QL +
Sbjct: 241 LGLTILEVACNMELPHGGEGWQQLRQGYL------------------------------P 270
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
F + E + +L+ P LR TA A P R+P
Sbjct: 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-57
Identities = 68/324 (20%), Positives = 108/324 (33%), Gaps = 53/324 (16%)
Query: 70 NGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRE 120
+ Y+ + +G G F V + L G A+K++L QDR RE
Sbjct: 17 LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76
Query: 121 LQLMRLMDHPNVISLKHCFF-STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLI 178
+ RL +HPN++ L +K E + L++ + T++ ++ +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG----- 233
+ I RGL IH G HRD+KP N+L+ Q L D GS
Sbjct: 135 QILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSR 192
Query: 234 -----EANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ + C+ YRAPEL D+WS GCVL ++ G+ +
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
V + V PQ R L + ++
Sbjct: 253 GDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTV 286
Query: 347 SPSLRCTALEACAHPFFDELREPN 370
P R + + P
Sbjct: 287 DPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 51/301 (16%)
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LMDHPNVIS 134
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R +HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMY-RVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
KD F + +E T+ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 194 IHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVLVKGEANISY---IC-SRYY 245
+H++ + HRD+KP N+L+ + + DFG K L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 246 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302
APE++ + T ++DI+SAGCV ++ G F +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ + P K A +L +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 363 F 363
F
Sbjct: 287 F 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ +F +I R E ++ +R+L R + E +P E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 186 bits (472), Expect = 4e-55
Identities = 47/333 (14%), Positives = 91/333 (27%), Gaps = 57/333 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRLMDHP 130
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 131 NVISLKHCFFSTTSKDELFLN---------------------LVMEYVP---ETMYRVLK 166
+ + D + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 167 HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226
++ + + T Q+ R A + + G+ H P NL + P ++ L D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 227 AKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 345
+ L P + +P L R L
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338
Query: 346 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 377
+ R LEA P F +L+ E ++ L G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-54
Identities = 70/312 (22%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 136 KHCF--------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ T K + L + MEY T+Y ++ S N Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLFRQ 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
I L+YIH+ G+ HRD+KP N+ +D + VK+ DFG AK + + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 244 ------------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y A E++ G Y ID++S G + E++ P G V
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
I+K L + FP P F + L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 352 CTALEACAHPFF 363
A +
Sbjct: 276 PGARTLLNSGWL 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 53/302 (17%), Positives = 113/302 (37%), Gaps = 23/302 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L +ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ P + + + + +L+ + A
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 362 FF 363
Sbjct: 305 SD 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-54
Identities = 80/323 (24%), Positives = 130/323 (40%), Gaps = 60/323 (18%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-LM 127
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKH--YSSMNQRMPLIYVKLYT 184
DHPNVI +C + FL + +E V +
Sbjct: 67 DHPNVIRY-YCSE----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVD------------PLTHQVKLCDFGSAKVLVK 232
QI G+A++H++ + HRD+KPQN+LV ++ + DFG K L
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 233 GEANISY----IC-SRYYRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 280
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 340
+ + II+ F ++K + EA DL
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 341 SRLLQYSPSLRCTALEACAHPFF 363
S+++ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-53
Identities = 63/309 (20%), Positives = 115/309 (37%), Gaps = 51/309 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHC 138
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 139 F-----------FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+ +++ L + ME+ + T+ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
I +G+ YIH+ + +RD+KP N+ + T QVK+ DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DE 365
+ + L +LL P R E +
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274
Query: 366 LREPNARLP 374
E N R
Sbjct: 275 SPEKNERHT 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 83/322 (25%), Positives = 138/322 (42%), Gaps = 53/322 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQI 187
++ L F +D+ + LV E E ++ +S + Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+H + HRD+KP+NLL++ + +++ DFG + + I + YY
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ G Y D+WS G +L LL G P F G N + +I+ +++
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVE 240
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ W KV A DL ++L Y PS+R +A +A H +
Sbjct: 241 KGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 366 LREPNARLPNGRPFPPLFNFKQ 387
+ + + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-52
Identities = 79/341 (23%), Positives = 136/341 (39%), Gaps = 55/341 (16%)
Query: 62 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 113
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 114 RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYS 169
E+ +++L+DHPN++ L F +D+ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSA 227
+ + Q+ G+ Y+H + HRD+KP+NLL++ +K+ DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
V + + + YY APE++ +Y D+WS G +L LL G P F G+ D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
Q EI+ ++ + W V A DL ++LQ+
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279
Query: 348 PSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF-NFKQ 387
R +A +A HP+ E+ N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +D +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+H + HRD+KP+N+L++ +K+ DFG + + I + YY
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ F W + +A DL ++L + PSLR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 367 REPNARLPNGRPFPPLF-NFKQ 387
+ + N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-52
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 44/294 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
VI F ++ LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV-KGEANISYICSRYYRAPE 249
L ++H+ V HRD+KP N+ + T VKL D G + K A S + + YY +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 308
I Y DIWS GC+L E+ Q F G+ + L + I +C
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+P + + E L + + P R
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-51
Identities = 71/318 (22%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 60 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 112
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSM 171
+R RE+ ++ M HPN++ + F ++ L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQK-- 118
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ + QI L ++H + HRD+K QN+ + V+L DFG A+VL
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 232 KGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
+ YY +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
I ++ +Y + L S+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 351 RCTALEACAHPFFDELRE 368
R + F + E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 85/308 (27%), Positives = 128/308 (41%), Gaps = 54/308 (17%)
Query: 71 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 124
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
+ +DHPN+I L F +D + LVME E RV+ +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANIS 238
+ +AY H + V HRD+KP+N L + +KL DFG A G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 239 YIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
+ YY +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
F FP W V P+A L RLL SP R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 358 CAHPFFDE 365
H +F++
Sbjct: 260 LEHEWFEK 267
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-51
Identities = 60/355 (16%), Positives = 130/355 (36%), Gaps = 32/355 (9%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L TT++ L +ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTR-HKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
++ G+ HR++KP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 249 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
+ P + + + + +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299
Query: 362 FFDELREP-NARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSMPH 415
FF E + + + + + K + + E V +QT + +
Sbjct: 300 FFAETSDILHRMVIHVFSLQQMTAHKIYI---HSYNTATIFHELVYKQTKIISSN 351
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-51
Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRLMDHPNVISLKHC 138
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 139 FFSTTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ + + F+ + ME VP + R + + I YT QI GL Y+
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK-GEANISYICSRYYRAPELIFG 253
H + HRD+K N+L++ + +K+ DFG++K L ++ + Y APE+I
Sbjct: 139 HD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 254 ATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y + DIWS GC + E+ G+P F +L E +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235
Query: 313 DFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
F+ K HP +P EA + + P R A + F +
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
Query: 369 PNARLP 374
P
Sbjct: 288 KKKTQP 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-51
Identities = 76/324 (23%), Positives = 133/324 (41%), Gaps = 60/324 (18%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 112
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 113 DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL----- 165
E+++++ +DHPN+I + F +D + +VME E + R++
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 166 -KHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLC 222
K S YV Q+ LAY H+ V H+D+KP+N+L + +K+
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 223 DFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281
DFG A++ E + + + Y APE+ + T DIWSAG V+ LL G F
Sbjct: 170 DFGLAELFKSDE-HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFT 226
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
G + + + + + + P+A+DL
Sbjct: 227 GTSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLK 260
Query: 342 RLLQYSPSLRCTALEACAHPFFDE 365
++L P R +A + H +F +
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 8e-51
Identities = 76/332 (22%), Positives = 130/332 (39%), Gaps = 63/332 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 121
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPL 177
L++ +DHPN+I L F +D+ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEA 235
QI G+ Y+H + HRD+KP+N+L++ +K+ DFG + K
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 236 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
+ + YY APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 355
+++ + + W + EA +L +L Y + RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 356 EACAHPFFDELREPNARLPNGRPFPPLFNFKQ 387
EA + + + L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 60/318 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 134 SLKHCFF-------STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+ + S +++L + M+ E + + ++ +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
QI + ++H+ G+ HRD+KP N+ VK+ DFG + + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 244 -----------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
++ + +FP + + P + +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 353 TALEACAHPFFDELREPN 370
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 77/380 (20%), Positives = 141/380 (37%), Gaps = 45/380 (11%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
A G P P ++ + + +S+ +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYK 117
+ K+ Y +GTG+FG+V + TG A K V D+
Sbjct: 144 YPQPVEIKHDHVLDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+E+Q M ++ HP +++L F +D+ + ++ E++ E +V ++ M++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGE 234
+ Y++ Q+ +GL ++H H D+KP+N++ ++++KL DFG L +
Sbjct: 257 AVEYMR----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE+ G D+WS G + LL G F GEN +
Sbjct: 312 SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------- 363
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
T ++ + N D F I + D +LL P+ R T
Sbjct: 364 -----TLRNVKSCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTI 405
Query: 355 LEACAHPFFDELREPNARLP 374
+A HP+ P
Sbjct: 406 HQALEHPWLTPGNAPGRDSQ 425
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-50
Identities = 83/348 (23%), Positives = 132/348 (37%), Gaps = 84/348 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRLMDH 129
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKL----- 182
PN+ L + +DE ++ LVME + ++ + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 183 ------------------------------YTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212
QIF L Y+H G+CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 213 D-PLTHQVKLCDFGSAKVLVKGEANISYIC-----SRYYRAPELIFGATE-YTTSIDIWS 265
+ ++KL DFG +K K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 266 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325
AG +L LL+G FPG N D + +++ F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
+ P A DL S LL + R A+ A HP+ + + ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-50
Identities = 67/313 (21%), Positives = 118/313 (37%), Gaps = 48/313 (15%)
Query: 59 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 116
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRM 175
+ EL + P ++ L ++ ++N+ ME + ++ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMG----CL 147
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
P Y Q GL Y+HT + H DVK N+L+ + LCDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 236 NISYICSR------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 289
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 349
++I P +I P L+ P
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299
Query: 350 LRCTALEACAHPF 362
R +A+E
Sbjct: 300 HRASAMELRRKVG 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-50
Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 56/306 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYT 184
++HP +I +K+ F D +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC- 241
YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 242 SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
+ F W +V +A+DL +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 360 HPFFDE 365
HP+ +
Sbjct: 400 HPWLQD 405
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 70/358 (19%), Positives = 137/358 (38%), Gaps = 53/358 (14%)
Query: 54 NDAVTGHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK---- 108
D ++ + + E + I+ Y R + G F + + + + A+K
Sbjct: 7 KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEK 64
Query: 109 -KVLQDRRYKN----------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151
+ + R + ELQ++ + + ++ + T+ DE+++
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII---TNYDEVYI- 120
Query: 152 LVMEYVP-----ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVK 206
+ EY+ + + +P+ +K + +YIH +CHRDVK
Sbjct: 121 -IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGATEY-TTSIDIW 264
P N+L+D +VKL DFG ++ +V + S + + PE + Y +DIW
Sbjct: 180 PSNILMDK-NGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVDIW 236
Query: 265 SAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 324
S G L + F + ++ +L I+ + I P + F +
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIR------TKNIEY--PLDRN-HFLYPLTNKK 287
Query: 325 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-----DELREPNARLPNGR 377
+ + E ID L+ +P+ R T+ +A H + ++LRE + L R
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 78/333 (23%), Positives = 132/333 (39%), Gaps = 60/333 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRL 126
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKL 182
++HP +I +K+ F D +V+E + E +V+ + L
Sbjct: 72 LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYI 240
Y YQ+ + Y+H G+ HRD+KP+N+L+ +K+ DFG +K+L + + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 241 C-SRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
C + Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
+ F W +V +A+DL +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 358 CAHPFFDELREPNARLPNGRPFPPLFNFKQELA 390
HP+ + Q LA
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-49
Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 52/326 (15%)
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 124
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLY 183
R + H +V+ F D +F +V+E ++ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEARYY 120
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYIC- 241
QI G Y+H V HRD+K NL ++ +VK+ DFG + KV GE +C
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGER-KKVLCG 177
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 178 TPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 230
Query: 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
++ P + P A L ++LQ P+ R T E
Sbjct: 231 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 267
Query: 362 FFDELREPNARLPNGRPFPPLFNFKQ 387
FF P PP F+
Sbjct: 268 FFTSGYIPARLPITCLTIPPRFSIAP 293
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F D + L++EY P T+YR L+ + Y ++ L+Y
Sbjct: 75 YGYF-----HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H+ V HRD+KP+NLL+ ++K+ DFG + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+ +D+WS G + E L+G+P F + I +V +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
F FP + + A DL SRLL+++PS R E HP+ +
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 374 PN 375
N
Sbjct: 272 QN 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-49
Identities = 81/321 (25%), Positives = 135/321 (42%), Gaps = 56/321 (17%)
Query: 60 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 113
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 114 RRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--H 167
+ RE++L++ +DHPN++ L +D +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 168 YSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG 225
+S Q+F G+ Y+H + HRD+KP+N+L++ +K+ DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 226 SAKVLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 284
+ + + + YY APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNT-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344
D L + + F W + +A DL ++L
Sbjct: 227 EYDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKML 261
Query: 345 QYSPSLRCTALEACAHPFFDE 365
+ PSLR TA + HP+ +
Sbjct: 262 TFHPSLRITATQCLEHPWIQK 282
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 76/317 (23%), Positives = 124/317 (39%), Gaps = 44/317 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L F +D+ + L++E++ E R+ M++ V Y Q GL
Sbjct: 113 LHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 193 YIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
++H + H D+KP+N++ VK+ DFG A L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 370
D+ F + V PEA D LLQ P R T +A HP+ +
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
Query: 371 ARLPNGRPFPPLFNFKQ 387
+R+P+ R K+
Sbjct: 317 SRIPSSRYNKIRQKIKE 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISLKH 137
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ ST + + LV E + T+ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 197 -VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
P + HRD+K N+ + T VK+ D G A + A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+Y S+D+++ G + E+ + + Q+ + T
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
PE ++ ++ + R + + H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 77/366 (21%), Positives = 139/366 (37%), Gaps = 33/366 (9%)
Query: 67 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 119
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLN-LVMEYVP--ETMYRVLKH--YSSMNQR 174
E+Q+M+ ++HPNV+S + L L MEY + + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVK 232
+ I L Y+H + HRD+KP+N+++ P + K+ D G AK L +
Sbjct: 122 PIRTLLS----DISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
GE ++ + Y APEL+ +YT ++D WS G + E + G F Q
Sbjct: 177 GELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI---DLASRLLQYSPS 349
++ + E I + +F + P + A +L +
Sbjct: 236 VR---EKSNEHIVVYDDLTGAVKFSSVLPTP-----NHLSGILAGKLERWLQCMLMWHQR 287
Query: 350 LRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQT 409
R T + F L + + + + + + + +++ T
Sbjct: 288 QRGTDPQNPNVGCFQALDSILSLKL--LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDT 345
Query: 410 GLSMPH 415
G+
Sbjct: 346 GIPEEE 351
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-48
Identities = 79/347 (22%), Positives = 124/347 (35%), Gaps = 67/347 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR-LMDHPNVI 133
RV+ G F V++A+ + +G A+K++L + R +E+ M+ L HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 134 SLKHCFF-----STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
S T + E L+ E + LK S + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTC 146
Query: 189 RGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG-------------E 234
R + ++H P + HRD+K +NLL+ +KLCDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 235 ANISYICSRYYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
I+ + YR PE+I + DIW+ GC+L L Q F +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
R +N Y P H L +LQ +P R
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 353 TALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINR 399
+ E E+ N P P+ ++ G ++R
Sbjct: 295 SIAEVVHQLQ--EIAAA----RNVNPKSPITELLEQNGGYGSATLSR 335
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 82/388 (21%), Positives = 136/388 (35%), Gaps = 78/388 (20%)
Query: 10 PQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGK 69
P P P +A P P KE+ ++
Sbjct: 2 PAPADPGKAGVPGVAAP--------GAPAAAPPAKEIPEVLV------------------ 35
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+P+ Y+ R +G G F F+ +T E A K +L + E+
Sbjct: 36 --DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 93
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ R + H +V+ F D +F +V+E ++ + K + + +
Sbjct: 94 IHRSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKR----RKALTEPEAR 144
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC 241
Y QI G Y+H V HRD+K NL ++ +VK+ DFG A + +C
Sbjct: 145 YYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLC 202
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 203 GTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----- 256
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
++ P + P A L ++LQ P+ R T E
Sbjct: 257 ------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLND 292
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQE 388
FF P PP F+
Sbjct: 293 EFFTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-48
Identities = 71/304 (23%), Positives = 132/304 (43%), Gaps = 52/304 (17%)
Query: 71 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 122
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVK 181
+ + HP+++ L + F + ++ LV+E M R LK+ + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNR---VKPFSENEAR 115
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYI 240
+ +QI G+ Y+H+ G+ HRD+ NLL+ +K+ DFG + ++ + E +
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEK-HYTL 172
Query: 241 C-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
C + Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 173 CGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA---- 227
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
D+ P + + EA DL +LL+ +P+ R +
Sbjct: 228 -------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLD 262
Query: 360 HPFF 363
HPF
Sbjct: 263 HPFM 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-48
Identities = 72/331 (21%), Positives = 132/331 (39%), Gaps = 47/331 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F + L ++ E++ + R+ +N+R + Y +Q+ L +
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 194 IHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
+H+ + H D++P+N++ + +K+ +FG A+ L G+ N + + Y APE +
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPE-V 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+T+ D+WS G ++ LL G F E +Q +II E I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-- 369
+ F +I EA+D RLL R TA EA HP+ + E
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
Query: 370 NARLPNGRPFPPLFNFKQELAGASPELINRL 400
+ + + R+
Sbjct: 270 TKVIRTLKHRRYYHTLIK-KDLNMVVSAARI 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 9e-48
Identities = 49/323 (15%), Positives = 93/323 (28%), Gaps = 80/323 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQ----LMRLMDHPN 131
+ +G+G FG VF+ G AIK+ L + L+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V+ + ++ + + EY ++ + + +K Q+ RG
Sbjct: 73 VVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDP------------------LTHQVKLCDFGSAKVLVK 232
L YIH+ + H D+KP N+ + K+ D G +
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
+ + A E++ + DI++ + +PL
Sbjct: 187 PQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 345
WH++ R+P E +L ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 346 YSPSLRCTALEACAHPFFDELRE 368
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 70/327 (21%), Positives = 124/327 (37%), Gaps = 59/327 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPNVI+L + +++ + L++E V E + + + +
Sbjct: 73 HPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H++ + H D+KP+N+++ + ++K+ DFG A + G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
NY +F + A D RLL P R T ++ H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQ 387
P+ ++ L + FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 5e-47
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 52/296 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRLMDHPNVISL 135
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFG 253
H V HRD+KP+NLL+ ++K+ DFG + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+ +D+W AG + E L+G P F + + I+ V D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+FP P+ + + DL S+LL+Y P R HP+
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-47
Identities = 71/306 (23%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRLMDHPNVIS 134
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRG 190
L+ + + LVM+ V E R+L+ Y+ ++ + ++ Q+
Sbjct: 71 LEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRA 247
+ Y+H G+ HRD+KP+NLL ++ + DFG +K+ G +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVA 175
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
+ F + W + A D LL+ P+ R T +A +HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 368 EPNARL 373
+ +
Sbjct: 270 ALHRDI 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRLMDHPNV 132
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L ++E F LV + V E ++ YS + QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+AY H+ G+ HR++KP+NLL+ VKL DFG A + EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ +P + W V PEA L +L +P R TA +A P+
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 72/312 (23%), Positives = 119/312 (38%), Gaps = 58/312 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L F +++ + L++E V E + + + +
Sbjct: 67 HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+H+ + H D+KP+N+++ + ++KL DFG A + G I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
++ F + A D RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 361 PFFDELREPNAR 372
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 80/379 (21%), Positives = 142/379 (37%), Gaps = 68/379 (17%)
Query: 8 PQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIG 67
P P +LL + D+ + + + + +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 68 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRR 115
+ + Y + V+G G +V + TG A+K ++ + R
Sbjct: 90 KEFYQ-----KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 116 YKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSS 170
RE ++R + HP++I+L + + F+ LV + + E + + S
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSE 199
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
R + ++++H + HRD+KP+N+L+D Q++L DFG + L
Sbjct: 200 KETR-------SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHL 250
Query: 231 VKGEANISYIC-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGEN 284
GE + +C + Y APE++ + + Y +D+W+ G +L LL G P F
Sbjct: 251 EPGEK-LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
Query: 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 344
+ L I++ ++F + W DL SRLL
Sbjct: 310 QILMLRMIMEG-----------------QYQFS---SPEWDDR-----SSTVKDLISRLL 344
Query: 345 QYSPSLRCTALEACAHPFF 363
Q P R TA +A HPFF
Sbjct: 345 QVDPEARLTAEQALQHPFF 363
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 85/396 (21%), Positives = 153/396 (38%), Gaps = 49/396 (12%)
Query: 3 SMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHII 62
++ + + N L P A I A H I
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRI 77
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN 118
+ K G + ++G G FG V + + TG +A K + ++D+
Sbjct: 78 ---VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
E+ +M +DH N+I L F + + + LVMEYV E R++ ++ +
Sbjct: 135 NEISVMNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTHQVKLCDFGSAKVLVKGEA 235
++++K QI G+ ++H + + H D+KP+N+L V+ Q+K+ DFG A+ E
Sbjct: 190 ILFMK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ + + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 244 KLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+ D + + EA + S+LL S R +A
Sbjct: 303 C--------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISA 337
Query: 355 LEACAHPFFDELREPNARLPNGRPFPPLFNFKQELA 390
EA HP+ + + ++RL + + + +
Sbjct: 338 SEALKHPWLSD-HKLHSRLSAQKKKNRGSDAQDFVT 372
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 60/335 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRLMDH 129
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLY 183
P+++ L + + L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 184 TYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYI 240
QI L Y H + HRDVKP +L+ + + VKL FG A L +
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 241 C-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
++ W + A DL R+L P+ R T EA
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286
Query: 360 HPFFDELREPNARLPNGRPFPPL--FNFKQELAGA 392
HP+ E ++ L FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-46
Identities = 68/355 (19%), Positives = 113/355 (31%), Gaps = 83/355 (23%)
Query: 63 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 111
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 112 QDRRYKNR---------------------ELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150
Q + R L++ +I ++ FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210
M+ +T VL +SS ++ + T Q+ R LA +H G+ H ++P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 211 LVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----------FGATEYTTS 260
++D V L F V+ A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 261 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 320
D W+ G V+ + + A+ E I FR
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329
Query: 321 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 374
K +P L L+Y R L+A P +++LR +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 73/330 (22%), Positives = 118/330 (35%), Gaps = 59/330 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
H NVI+L + ++ + L++E V E + + S +
Sbjct: 74 HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ F + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELA 390
P+ + + L NF+++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRKQYV 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-46
Identities = 76/311 (24%), Positives = 123/311 (39%), Gaps = 64/311 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 124
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYV 180
++ HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + +H + + HRD+KP+N+L+D +KL DFG + L GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 241 C-SRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+++F + W DL SR L P R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278
Query: 355 LEACAHPFFDE 365
EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 86/347 (24%), Positives = 136/347 (39%), Gaps = 60/347 (17%)
Query: 60 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 108
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 109 --KVLQDRRYKN--RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMY 162
K L R ++ RE ++ R + HPN++ L ++E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 163 RVLK--HYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQ 218
++ YS + QI +AY H+ G+ HR++KP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278
VKL DFG A + EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 338
F E+ +I + +P + W V PEA
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263
Query: 339 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385
L +L +P R TA +A P+ + + L F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 75/300 (25%), Positives = 119/300 (39%), Gaps = 52/300 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+F +V + + G+ A + + RE ++ RL+ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIF 188
+ L +E L+ + V E ++ +YS QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + H + GV HR++KP+NLL L VKL DFG A + + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ FP + W V PEA DL +++L +PS R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 49/317 (15%)
Query: 57 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 116
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 117 KNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSM 171
E++++ R HPN+I+LK + D ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAK 228
+ I + + Y+H GV HRD+KP N+L +++CDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 229 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
L + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 288 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
+ ++ G F W+ V A DL S++L
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264
Query: 347 SPSLRCTALEACAHPFF 363
P R TA HP+
Sbjct: 265 DPHQRLTAALVLRHPWI 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 74/330 (22%), Positives = 120/330 (36%), Gaps = 59/330 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRLMD 128
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYT 184
HPN+I+L + ++ + L++E V E + + S +
Sbjct: 74 HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLVKGEANISYIC 241
QI G+ Y+HT + H D+KP+N+++ + +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 242 -SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+ F + + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELA 390
P+ + + L NFK++
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKKQYV 302
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 93/370 (25%), Positives = 132/370 (35%), Gaps = 63/370 (17%)
Query: 2 ASMPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHI 61
P P P P PPPQ P P P + V G I
Sbjct: 7 GQSPPVPFPAPAPPPQPPTPALPHPP-------AQPPPPPPQQFPQFHVKSGLQIKKNAI 59
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
I + +V+G G G V Q T E A+K +LQD RE+
Sbjct: 60 IDDY-------------KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREV 105
Query: 122 QLM-RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLI 178
+L R P+++ + + L +VME + E R+ R
Sbjct: 106 ELHWRASQCPHIVRI-VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQA 157
Query: 179 Y----VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVLV 231
+ I + Y+H++ + HRDVKP+NLL P +KL DFG AK
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT 215
Query: 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
+ + + YY APE + G +Y S D+WS G ++ LL G P F + +
Sbjct: 216 SHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+ R Y +F P W +V E L LL+ P+ R
Sbjct: 275 MKT----------RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQR 313
Query: 352 CTALEACAHP 361
T E HP
Sbjct: 314 MTITEFMNHP 323
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 74/316 (23%), Positives = 122/316 (38%), Gaps = 39/316 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 141 STTSKDELFLNLVMEYVP--ETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ L ++ME + E R + + +R I + ++H+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----AAEIMRDIGTAIQFLHSH 147
Query: 198 PGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGA 254
+ HRDVKP+NLL +KL DFG AK + + C + YY APE + G
Sbjct: 148 -NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGP 203
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
+Y S D+WS G ++ LL G P F + + R Y F
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY-GF 252
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARL 373
P W +V +A L LL+ P+ R T + HP+ + P L
Sbjct: 253 PNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302
Query: 374 PNGRPFPPLFNFKQEL 389
R + E+
Sbjct: 303 HTARVLQEDKDHWDEV 318
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 50/303 (16%)
Query: 70 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 125
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVK 181
+ HPN+I LK F + ++LV+E V E R+++ +YS +R VK
Sbjct: 104 RLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVK 155
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISY 239
QI +AY+H G+ HRD+KP+NLL P +K+ DFG +K++ +
Sbjct: 156 ----QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 240 IC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
C ++ F + W +V A DL +L+ P R T +A
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 359 AHP 361
HP
Sbjct: 305 QHP 307
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 43/297 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMD-HPNVISL 135
+ ++ +G GSF I + ++ + A+ K++ R N +E+ ++L + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGL 191
F D+L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 192 AYIHTVPGVCHRDVKPQNLL-VDPLTH-QVKLCDFGSAKVLVKGEANISYIC-SRYYRAP 248
+++H V GV HRD+KP+NLL D + ++K+ DFG A++ + C + +Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E + Y S D+WS G +L +L GQ F + ++++ ++I+
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
DF F W V EA DL LL P+ R + + +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 80/323 (24%), Positives = 131/323 (40%), Gaps = 51/323 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRLMDHP 130
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
NVI L ++ + + +VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDG 121
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRA 247
L Y+H+ G+ H+D+KP NLL+ +K+ G A+ L A+ S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 248 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ P P DL +L+Y P+ R + + H +F +
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 367 REPNARLPNGRPFPPLFNFKQEL 389
P P PP + K
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-43
Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 50/308 (16%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-NRELQLMRLMDH-PNV 132
+ + +G G F +V Q TG+ A K + QD R + E+ ++ L P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVL-KHYSSMNQRMPLIYVKLYTYQIFR 189
I+L + ++ + L++EY E L + +++ V QI
Sbjct: 92 INLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND----VIRLIKQILE 142
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAKVLVKGEANISYIC-SRYYR 246
G+ Y+H + H D+KPQN+L+ + +K+ DFG ++ + + I + Y
Sbjct: 143 GVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 201 APE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----------- 248
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ + + V A D LL +P R TA +H + +
Sbjct: 249 ------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
Query: 367 REPNARLP 374
N P
Sbjct: 295 DFENLFHP 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 72/311 (23%), Positives = 115/311 (36%), Gaps = 58/311 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RLMDHPNVISLK 136
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 137 HCFFSTTSKDELFLNLVMEYVP--ETMYRVLK--HYSSMNQRMPLIYVKLYTYQIFRGLA 192
F ++E LV E + + + K H++ + + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSR---- 243
++H G+ HRD+KP+N+L H VK+CDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 244 ----YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295
Y APE++ A+ Y D+WS G +L LL G P F G D + +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 296 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
E I+ + FP W + A DL S+LL R
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288
Query: 353 TALEACAHPFF 363
+A + HP+
Sbjct: 289 SAAQVLQHPWV 299
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 74/311 (23%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 63 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 116
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 117 KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQR 174
RE+ R + HPN++ K + L ++MEY E R+ R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGELYERICNA-----GR 112
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKG 233
+ + Q+ G++Y H++ +CHRD+K +N L+D ++K+CDFG +K V
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 234 EANISYICSRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
T + I + + P R+ PE L SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 353 TALEACAHPFF 363
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-42
Identities = 76/330 (23%), Positives = 132/330 (40%), Gaps = 34/330 (10%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 119
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLI 178
ELQ++ + P ++ F+S +++ ME++ ++ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLK----KAGRIPEQ 131
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
+ + + +GL Y+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 343
E + + P +F E D ++
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 344 LQYSPSLRCTALEACAHPFFDELREPNARL 373
L +P+ R + H F
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 70/332 (21%), Positives = 123/332 (37%), Gaps = 73/332 (21%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 118
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 119 ----------------------RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEY 156
+E+ +++ +DHPNV+ L ++D L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 157 VP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214
V M + + + Y + +G+ Y+H + HRD+KP NLLV
Sbjct: 120 VNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 215 LTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIFGAT-EYT-TSIDIWSAGCVLA 271
+K+ DFG + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 272 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 331
+ GQ F E + L IK FP
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264
Query: 332 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ + DL +R+L +P R E HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 70/289 (24%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
F + + ME + ++ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG---A 254
V HRDVKP N+L++ QVK+CDFG + LV A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PQ+ A + E +D S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 66/297 (22%), Positives = 122/297 (41%), Gaps = 52/297 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 306
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
PW K + + L ++L +PS R T + ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 80/330 (24%), Positives = 135/330 (40%), Gaps = 53/330 (16%)
Query: 65 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 118
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 119 RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMP 176
RE+++M++++HPN++ L ++ L+ L+MEY E + Y + RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
+ QI + Y H + HRD+K +NLL+D +K+ DFG + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 237 ISYIC-SRYYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354
+R P + M + +L R L +P R T
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259
Query: 355 LEACAHPFFDELREPNARLPNGRPFPPLFN 384
+ + + E + P P + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-41
Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 52/307 (16%)
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ + QI + Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 167
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR-- 224
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
F P + + L +LQ P R T +
Sbjct: 225 --------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258
Query: 357 ACAHPFF 363
H +F
Sbjct: 259 IREHEWF 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 56/354 (15%), Positives = 103/354 (29%), Gaps = 78/354 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 125
V+G +A ETGE+ + R + ++ M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 126 ---------------LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSS 170
+I ++ FL M+ +T VL +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
++ + T Q+ R LA +H G+ H ++P ++++D V L F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRD 261
Query: 231 VKGEANISYICSRY----YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPG 282
G + +S I + A ++ T T + D W+ G + +
Sbjct: 262 --GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 283 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342
+ A+ W K +P L
Sbjct: 320 DAALGGS---------------------------------EWIFRSCKNIPQPVRALLEG 346
Query: 343 LLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPFPPLFNFKQELAGASPE 395
L+Y R L+A P +++LR +A LP + + +
Sbjct: 347 FLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQ 400
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 72/295 (24%), Positives = 107/295 (36%), Gaps = 68/295 (23%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKH 137
+ +V+G G G V Q T E A+ K+LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 138 CFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIY----VKLYTYQIFRGL 191
+ L +VME + E R+ R + I +
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQD-------RGDQAFTEREASEIMKSIGEAI 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSAKVLVKGEANISYICSRYYR 246
Y+H++ + HRDVKP+NLL T + +KL DFG
Sbjct: 131 QYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFG--------------------F 166
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
A E +Y S D+WS G ++ LL G P F + + + R
Sbjct: 167 AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RI 214
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 215 RMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 50/313 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ + L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQY--LFLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN--ISYIC-SRYYRAP 248
Y+H + G+ HRD+KP+NLL+D +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 249 ELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
PW K + + L ++L +PS R T + ++++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 368 EPNARLPNGRPFP 380
+ A+ P
Sbjct: 270 KKGAKRPRVTSGG 282
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 51/297 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG VF + TG+ A K L +R K R E +++ + ++S
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + F +K +L L VM + + Y + + N YT QI GL
Sbjct: 250 LAYAF---ETKTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
++H + +RD+KP+N+L+D + V++ D G A L G+ + + APEL+
Sbjct: 304 HLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G EY S+D ++ G L E++ + F +E+
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL------- 401
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
++ + + P + D LLQ P R + HP F
Sbjct: 402 ----KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-40
Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 72/308 (23%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D+ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS---------YICSRY 244
+H G+ HRD+KP+N+L++ H +++ DFG+AKVL Y+
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+PEL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEAC 358
++ FP ++ P+A DL +LL + R
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 359 AHPFFDEL 366
AHPFF+ +
Sbjct: 288 AHPFFESV 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-40
Identities = 44/387 (11%), Positives = 110/387 (28%), Gaps = 73/387 (18%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
PQ A P +D+ L+ + + + + T
Sbjct: 2 SPQMSSLGTVDAPNFIVGNP-WDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEF 60
Query: 67 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYK 117
+ ++G G+F V++A + + +K +
Sbjct: 61 QLGSKL------VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 118 NRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
+ ++ ++ + ++ L V E + + + ++ + M
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVM 169
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ----------VKLCDFG 225
P V + ++ + +H + H D+KP N ++ + + L D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 226 SA---KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-P 281
+ K+ KG + + ++ E++ + ID + + +L G +
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 341
E + + + R P + W++ FH
Sbjct: 288 NEGGECKPEGLFR--------------------RLPHL--DMWNEFFHV----------- 314
Query: 342 RLLQYSPSLRCTALEACAHPFFDELRE 368
+L +L+ ++
Sbjct: 315 -MLNIPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 69/318 (21%), Positives = 113/318 (35%), Gaps = 61/318 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 129 H--PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F D L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + + H GV HRD+K +N+L+D ++KL DFGS +L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
PE I Y S +WS G +L +++ G F + EII+
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364
F +R+ E L L PS R T E HP+
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 365 ELREPNARLP-NGRPFPP 381
++ P + P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 49/293 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRLMDHPN 131
Y+ +G GSFG V A +T + VA+K + + + RE+ ++L+ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I L T+ ++ +V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIV--MVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
Y H + HRD+KP+NLL+D VK+ DFG + ++ G + C S Y APE+
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEV 178
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN---------------- 221
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+ P + + P A L R++ P R T E P+F
Sbjct: 222 SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 81/374 (21%), Positives = 145/374 (38%), Gaps = 59/374 (15%)
Query: 7 GPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTI 66
Q ++ ++ + G+ + +
Sbjct: 77 CLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV 136
Query: 67 GGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ 119
+ + T++ + +++G G+FG V K TG A+K +L+ +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHT 195
Query: 120 --ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRM 175
E ++++ HP + +LK+ F + D L VMEY E + + S +
Sbjct: 196 LTENRVLQNSRHPFLTALKYSF---QTHDRLCF--VMEYANGGELFFHL-----SRERVF 245
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ Y +I L Y+H+ V +RD+K +NL++D H +K+ DFG K +K A
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGA 304
Query: 236 NISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294
+ C + Y APE++ +Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL 362
Query: 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--- 351
+ RFP + + PEA L S LL+ P R
Sbjct: 363 ----------------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGG 394
Query: 352 --CTALEACAHPFF 363
A E H FF
Sbjct: 395 GSEDAKEIMQHRFF 408
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 89/342 (26%), Positives = 142/342 (41%), Gaps = 68/342 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
RV+G G FG V + TG+ A K L+ +R K R E Q++ ++ V+S
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L + + +KD L L V+ + + + + Y P Y +I GL
Sbjct: 249 LAYAY---ETKDALCL--VLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLE 300
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
+H + +RD+KP+N+L+D H +++ D G A + +G+ + + Y APE++
Sbjct: 301 DLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
YT S D W+ GC+L E++ GQ F REE+
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV-------- 397
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 367
+K P + + +R P+A L S+LL P+ R +A E HP F +L
Sbjct: 398 ---ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL- 451
Query: 368 EPN-ARLPNGRPFPP------------LFNFKQELAGASPEL 396
N RL G PP + + +Q EL
Sbjct: 452 --NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-39
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 39/300 (13%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKH-YSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + ME + + + K+ YS ++ +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP N+L+D + +KLCDFG + LV A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 257 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 373
PQ+ + F P I+ + L S R E HPF E +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 58/302 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRLMDHPN 131
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ + + F + D+L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPE 249
GL ++H V +RD+KP N+L+D H V++ D G A K + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 364
PE L LLQ + R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
Query: 365 EL 366
L
Sbjct: 455 SL 456
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 75/320 (23%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRLMD 128
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 129 ----HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
HP VI L +F T ++ L V+E L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SR 243
Q+ + + H+ GV HRD+K +N+L+D KL DFGS +L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 244 YYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
Y PE I +Y +WS G +L +++ G F + EI++
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 363 FDELREPNARLPNGRPFPPL 382
E P+ PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 68/298 (22%), Positives = 128/298 (42%), Gaps = 54/298 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +DE + +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYSF-----QDEEDMFMVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF- 252
+ + HRD+KP N+L+D H V + DF A +L + + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 253 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 309
Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 366
T +P E + L +LL+ +P R + L P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 48/302 (15%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRLMDHPNVISLKH 137
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 138 CFFSTTSKDELFLNLVMEYVPETMYR-VLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F + T + + ME M K M +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMEL----MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI----F 252
GV HRDVKP N+L+D Q+KLCDFG + LV +A Y APE I
Sbjct: 143 KHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNY 311
+Y D+WS G L EL GQ + + L ++++ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------ 247
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
P + H + L R + H F
Sbjct: 248 -----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
Query: 372 RL 373
+
Sbjct: 296 DV 297
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-38
Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 59/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRLMDHPNVIS 134
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
LK+ F + D L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF---QTHDRLCF--VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
Y+H+ V +RD+K +NL++D H +K+ DFG K + A + C Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
+ RFP + + PEA L + LL+ P R A E H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 63/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 134 SLKH----------------------------------------------------CFFS 141
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 142 TTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGV 200
S +++L + M+ E + + S+ R + + ++ QI + ++H+ G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-------------VKGEANISYICSRYYRA 247
HRD+KP N+ VK+ DFG + + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE I G Y+ +DI+S G +L ELL E ++++ ++R
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
+ +FP + + P+ + +L SP+ R A + + F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 80/330 (24%), Positives = 123/330 (37%), Gaps = 79/330 (23%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRLMDHPNVISL 135
+V+G G+F V K +TG+ A+K + + K E+ ++ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +DE +L LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
+H + G HRD+KP N+L+D H ++L DFGS L S Y+
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 246 RAPELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+PE++ G Y D W+ G E+ GQ F ++ + I
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALE 356
++ P + +P EA D RLL P R A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 357 ACAHPFF-----DELREPNARLPNGRPFPP 381
HPFF D LR+ PF P
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP------PFTP 348
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 77/322 (23%), Positives = 125/322 (38%), Gaps = 65/322 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-ICSRY-YRAPELI 251
+H + HRD+KP N+L+D H ++L DFGS L++ S Y +PE++
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 252 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
G Y D WS G + E+L G+ F E+ + + I M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFF- 363
N F+FP + A DL RL+ S R + HPFF
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFS 343
Query: 364 ----DELREPNARLPNGRPFPP 381
D +R A P+ P
Sbjct: 344 GIDWDNIRNCEA------PYIP 359
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 86/307 (28%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 68 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 119
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 120 ELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPL 177
E+Q ++L HP++I L ++ ++F +VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIF--MVMEYVSGGE-----LFDYICKNGRLDE 115
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI 237
+ QI G+ Y H V HRD+KP+N+L+D K+ DFG + ++ GE +
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE-FL 172
Query: 238 SYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
C S Y APE+I G +DIWS+G +L LL G F ++ V L + I
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-- 229
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
F P + + P I L +LQ P R T +
Sbjct: 230 --------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKD 263
Query: 357 ACAHPFF 363
H +F
Sbjct: 264 IREHEWF 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 9e-37
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 60/299 (20%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRL 126
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++H N+I + F ++ LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ + Y+ + HRD+K +N+++ +KL DFGSA L +G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 246 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
P + E + L S LLQ P R T + P+
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 56/294 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHPNVI 133
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ F +K+ LF VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF---QTKENLFF--VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
++H+ G+ +RD+K N+L+D H +K+ DFG K + G+A + C Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 363
+ +P + + EA DL +L P R HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-36
Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 61/300 (20%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRLMDHPN 131
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++ L + F + +L+L ++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF---QTGGKLYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAP 248
L ++H G+ +RD+KP+N++++ H VKL DFG K + C Y AP
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ + + ++D WS G ++ ++L G P F GEN + ++ I + ++
Sbjct: 191 EILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL---- 238
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
P + EA DL +LL+ + + R A E AHPFF
Sbjct: 239 ------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-36
Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 59/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRLMDHPNVI 133
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L F + D+L+ V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF---QTADKLYF--VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPEL 250
Y+H++ + +RD+KP+N+L+D H + L DFG K ++ + S C Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 363
+ + A L LLQ + R +E +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-36
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----- 65
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--T 196
+ + L VMEY ++Y VL H + + + Q +G+AY+H
Sbjct: 66 LYGACLNPVCL--VMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ HRD+KP NLL+ +K+CDFG+A + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 291
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 59/298 (19%)
Query: 83 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRLMDHPNVI 133
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
L + F ++ +L+L +++++ + R+ S VK Y ++ L
Sbjct: 90 KLHYAF---QTEGKLYL--ILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALAL 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPEL 250
++H++ G+ +RD+KP+N+L+D H +KL DFG +K + E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
PQ + PEA L L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 9e-36
Identities = 78/364 (21%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRLM-----DHP 130
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 131 N---VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
N V+ L F + + + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLV----------------------------------- 212
+GL Y+HT + H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 213 -------------DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
+ +VK+ D G+A + + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 260 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 306
DIWS C+ EL G LF + D + II++LG R+ I
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 360
++K +V ++ D +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 361 PFFD 364
P+ +
Sbjct: 393 PWLN 396
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 59/298 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++H G+ +RD+K N+L+D H KL DFG K + + C Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 363
+ +P + +A + + +P++R HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 77/307 (25%), Positives = 124/307 (40%), Gaps = 68/307 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F +D+ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--------YICSRYY 245
IH++ G HRDVKP N+L+D H +KL DFG+ + K YI
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 246 RAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302
+PE++ G Y D WS G L E+L+G F ++ V T
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYS 283
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACA 359
+I MN FP + EA +L L +R E
Sbjct: 284 KI--MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329
Query: 360 HPFFDEL 366
H FF
Sbjct: 330 HLFFKND 336
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 76/297 (25%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF + D L+ VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-YRAPELI 251
++ + G+ +RD+K N+++D H +K+ DFG K + C Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 363
+P K M EA+ + L+ P R + H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 52/306 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRLMDHP 130
Y + V+G+G+ +V A C E VAIK++ + + +E+Q M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
N++S F KDEL+ LVM+ V + + ++ + + +
Sbjct: 74 NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR- 243
++ GL Y+H G HRDVK N+L+ V++ DFG SA + G+ + R
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRK 184
Query: 244 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--- 241
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
N P ++ K K+ + S LQ P R TA E
Sbjct: 242 ----------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285
Query: 358 CAHPFF 363
H FF
Sbjct: 286 LRHKFF 291
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 48/219 (21%), Positives = 86/219 (39%), Gaps = 30/219 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRLMDHP 130
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIAL 133
Query: 190 GLAYIHTV-PGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
G+ Y+ P + HRD++ N+ + K+ DFG ++ + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 245 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-35
Identities = 80/303 (26%), Positives = 125/303 (41%), Gaps = 68/303 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F +D + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN-----ISYICSRYYRAP 248
+H+ + +RD+KP+N+L+D H +K+ DFG AK V YI AP
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKY-VPDVTYTLCGTPDYI------AP 172
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y SID WS G ++ E+L G F N + E I
Sbjct: 173 EVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL-------------- 216
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFF 363
+ RFP + DL SRL+ S R L + HP+F
Sbjct: 217 --NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
Query: 364 DEL 366
E+
Sbjct: 263 KEV 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 60/299 (20%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ F KD L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEY 156
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H++ + +RD+KP+NLL+D + +++ DFG AK + + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAK---RVKGRTWTLCGTPEALAPEIIL 211
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 366
RFP + DL LLQ + R L + H +F
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 363
F I + + +A + L P R + HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-34
Identities = 81/381 (21%), Positives = 134/381 (35%), Gaps = 68/381 (17%)
Query: 9 QPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGG 68
+ + P S+ + +
Sbjct: 263 GISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKT 322
Query: 69 KNGEPKQTISYMAER----------VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN 118
N K + +R V+G GSFG V ++ T E A+K + +D ++
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 382
Query: 119 RELQ--------LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHY 168
+++ L P + L CF + D L+ VMEYV + MY + +
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCF---QTMDRLYF--VMEYVNGGDLMYHIQQV- 436
Query: 169 SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228
R + Y +I GL ++ + G+ +RD+K N+++D H +K+ DFG K
Sbjct: 437 ----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCK 490
Query: 229 VLVKGEANISYIC-SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 287
+ C + Y APE+I Y S+D W+ G +L E+L GQ F GE+ D
Sbjct: 491 ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-ED 548
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
+L + I + +P K M EA+ + L+
Sbjct: 549 ELFQSI------MEHNV----------AYP------------KSMSKEAVAICKGLMTKH 580
Query: 348 PSLR-----CTALEACAHPFF 363
P R + H FF
Sbjct: 581 PGKRLGCGPEGERDIKEHAFF 601
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 57/311 (18%), Positives = 108/311 (34%), Gaps = 42/311 (13%)
Query: 86 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
G V A+ TGE V ++++ + EL + +L +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 140 FSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
+ +EL+ +V ++ + ++ + M + + + + L YIH +
Sbjct: 96 I---ADNELW--VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSA--------KVLVKGEANISYICSRYYRAPEL 250
G HR VK ++L+ + +V L S + V + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 251 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--------------- 294
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 295 --VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
+ ++ + T +H+ P + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 353 TALEACAHPFF 363
+A H FF
Sbjct: 327 SASTLLNHSFF 337
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 59/303 (19%)
Query: 83 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRLMDHP 130
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++L + F ++ +L L +++Y+ E + S +R V++Y +I
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIV 169
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY-IC-SRYYR 246
L ++H + G+ +RD+K +N+L+D H V L DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 247 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
AP+++ G + ++D WS G ++ ELL G F + + EI I
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAH 360
++ +PQ M A DL RLL P R A E H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 361 PFF 363
FF
Sbjct: 323 LFF 325
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 68/298 (22%), Positives = 126/298 (42%), Gaps = 50/298 (16%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHPNVIS 134
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
L CF ++ LF V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSCF---QTESRLF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELI 251
Y+H G+ +RD+K N+L+D H +KL D+G K ++ S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 363
F I + + +A + L P R C HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 82/371 (22%), Positives = 141/371 (38%), Gaps = 73/371 (19%)
Query: 4 MPLGPQPQPPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIIS 63
M + + R D +++ + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD--------- 51
Query: 64 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----- 118
P++ + R +G GSFG V+ A+ + E VAIKK+ + N
Sbjct: 52 ---------PEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 119 --RELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMP 176
+E++ ++ + HPN I + C+ + + LVMEY + +L+ + + +
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQ 152
Query: 177 LIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGE 234
+ + T+ +GLAY+H+ + HRDVK N+L L+ VKL DFGSA ++
Sbjct: 153 EVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIMAPAN 208
Query: 235 ANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292
S++ + Y+ APE+I E Y +D+WS G EL +P NA+ L I
Sbjct: 209 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265
Query: 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352
+ P +++ W + F + LQ P R
Sbjct: 266 AQ------------NES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRP 298
Query: 353 TALEACAHPFF 363
T+ H F
Sbjct: 299 TSEVLLKHRFV 309
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
+ T L + V EY+ ++YR+L H S +++ Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 195 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIF 252
H P + HR++K NLLVD + VK+CDFG +++ + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRLMDHPNVI 133
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 134 SLK-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+L+ C + L L VME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGVC----LKEPNLCL--VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 192 AYIH--TVPGVCHRDVKPQNLLVD-------PLTHQVKLCDFGSAKVLVKGEANISYICS 242
Y+H + + HRD+K N+L+ +K+ DFG A+ + S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGA 177
Query: 243 RYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 59/306 (19%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTY 185
+PN+++ + DEL+ +VMEY+ + + M++ +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVTETCMDEG----QIAAVCR 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR-- 243
+ + L ++H+ V HRD+K N+L+ + VKL DFG A I+ S+
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFC-------AQITPEQSKRS 174
Query: 244 ------YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
Y+ APE++ Y +DIWS G + E++ G+P + EN + L I G
Sbjct: 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G 232
Query: 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357
TP + +F D +R L+ R +A E
Sbjct: 233 TPELQN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKEL 267
Query: 358 CAHPFF 363
H F
Sbjct: 268 LQHQFL 273
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 58/315 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-LMDHPNVIS 134
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 135 LKHCFF---STTSKDELFLNLVMEYVP----ETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
F D+L+ LVME+ + + K + ++ +I
Sbjct: 86 YYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSR 243
RGL+++H V HRD+K QN+L LT +VKL DFG + L G N ++I +
Sbjct: 139 LRGLSHLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTP 193
Query: 244 YYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
Y+ APE+I Y D+WS G E+ G P + + L I +
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 248
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
NP P++K+ W K F L + S R +
Sbjct: 249 --------NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMK 286
Query: 360 HPFFDELREPNARLP 374
HPF +
Sbjct: 287 HPFIRDQPNERQVRI 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 48/302 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ +L+ ++MEY+ L +++ + +I +GL Y
Sbjct: 84 KYYGSYL---KDTKLW--IIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDY 134
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV--KGEANISYICSRYYRAPELI 251
+H+ HRD+K N+L+ +VKL DFG A L + + N +++ + ++ APE+I
Sbjct: 135 LHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEVI 191
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
+ Y + DIWS G EL G+P + + L I K PT E
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG-------- 241
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ K + L PS R TA E H F + +
Sbjct: 242 -----------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282
Query: 372 RL 373
L
Sbjct: 283 YL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G +G V+ K GE VA+K + RE + LM H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
T S +L+L + +Y ++Y LK + + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
T P + HRD+K +N+LV + D G A + + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
S S +L+L + Y ++Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV Q + D G A + + + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 244 YYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 274
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)
Query: 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNV 132
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 133 IS-LKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFR 189
+ + T+ +L+L + + + ++ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 190 GLAYIHT---------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
GLAY+H P + HRD+K +N+L+ + DFG A EA S
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKF---EAGKSAG 188
Query: 241 CSRY------YRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
+ Y APE++ GA + ID+++ G VL EL G L
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
++ P+ E+++ + P ++ + W K M + +
Sbjct: 249 FEEEIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEA 302
Query: 351 RCTALE 356
R +A
Sbjct: 303 RLSAGC 308
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 70 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 125
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYT 184
H NV+ + + +EL++ +ME++ + ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG-SAKVLVKGEANISYICSR 243
+ + LAY+H GV HRD+K ++L+ L +VKL DFG A++ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303
Y+ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+H V D R+L P R TA E HPF
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 137 HCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+F +L+ +VMEY V + + N+ + + +GL
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDII-------RLRNKTLTEDEIATILQSTLKGL 138
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLV--KGEANISYICSRYYRA 247
Y+H + HRD+K N+L L KL DFG A L + N + I + ++ A
Sbjct: 139 EYLHFM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMA 193
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE+I Y DIWS G E+ G+P + + + + I PT +
Sbjct: 194 PEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK---- 247
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
W F D + L SP R TA + HPF
Sbjct: 248 -------------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMDHPNVISLKH 137
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
F KD+ LN + EY+ T+ ++K SM+ + P + I G+AY+H+
Sbjct: 72 -FIGVLYKDKR-LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------------- 243
+ + HRD+ N LV V + DFG A+++V + + S
Sbjct: 127 M-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 244 --YYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 36/211 (17%), Positives = 77/211 (36%), Gaps = 22/211 (10%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISL 135
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
S L+ ++P ++Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 195 HTV-PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
HT+ P + + +++++D ++ + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 254 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 282
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 136 KHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F ++ +L + V ++ ++Y L + + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + + VK+ DFG A + + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 64/304 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ +G G+FG V++AK ETG A K + L+D E++++ DHP
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCDHPY 77
Query: 132 VISLKHCFFSTTSKDELFLNLVMEY-----VPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
++ L ++ +L+ +++E+ V M +++ + +++ Q
Sbjct: 78 IVKLLGAYY---HDGKLW--IMIEFCPGGAVDAIM-------LELDRGLTEPQIQVVCRQ 125
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG-SAKVLVKGEANISYICSR 243
+ L ++H+ + HRD+K N+L +T ++L DFG SAK L + S+I +
Sbjct: 126 MLEALNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 244 YYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
Y+ APE++ T Y DIWS G L E+ +P N + L++I K P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPP 240
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
T W F D L +P R +A +
Sbjct: 241 TLLT-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLE 275
Query: 360 HPFF 363
HPF
Sbjct: 276 HPFV 279
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRLMDHPNVIS-LKH 137
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ +L+L V +Y +++ L Y+ ++ + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 196 TV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS-----R 243
P + HRD+K +N+LV + D G A I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 244 YYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 274
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 39/241 (16%)
Query: 60 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 113
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 114 ---RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYS 169
+R++ RE+ + H N++S+ +D+ + LVMEY+ T L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPT----LSEYI 102
Query: 170 SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229
+ + + +T QI G+ + H + + HRD+KPQN+L+D +K+ DFG AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160
Query: 230 LVKGEANISY----ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
L E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE A
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETA 217
Query: 286 V 286
V
Sbjct: 218 V 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 50/247 (20%), Positives = 96/247 (38%), Gaps = 45/247 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 136 K-HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
C S L + + T+Y V++ + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY--------Y 245
+H G+ H+D+K +N+ D +V + DFG + G + +
Sbjct: 146 LHA-KGILHKDLKSKNVFYD--NGKVVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200
Query: 246 RAPELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297
APE+I + ++ D+++ G + EL + F + A II +G
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMG 256
Query: 298 TPTREEI 304
T + +
Sbjct: 257 TGMKPNL 263
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDH 129
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 130 PNVISLKHCFFSTTSKDELFLN---LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTY 185
P ++++ + T + +VMEYV T L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIA 123
Query: 186 QIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY----IC 241
+ L + H G+ HRDVKP N+++ T+ VK+ DFG A+ + +++ I
Sbjct: 124 DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286
+ Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 182 TAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 50/307 (16%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRL--MDHPNVISLKHC 138
++G G +G V++ VA+K +R+ E + R+ M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYS-SMNQRMPLIYVKLYTYQIFRGLAYIHT 196
T+ + LVMEY P ++ + L ++ L + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129
Query: 197 --------VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---------ANISY 239
P + HRD+ +N+LV + DFG + L A IS
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 240 ICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVE 291
+ + Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 292 IIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
+V PT E+++ R P+ W + + +
Sbjct: 249 QTEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDA 300
Query: 349 SLRCTAL 355
R TA
Sbjct: 301 EARLTAQ 307
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 28/220 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRLMDHP 130
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
+V+ + D L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYY 245
L H G HRDVKP+N+LV L DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 285
APE + T DI++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 32/252 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRLMDHP 130
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 131 NVISLKHCFFSTTSKDELFLN-LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+++ + F T + + +VMEYV +++ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
L+Y+H++ G+ + D+KP+N+++ Q+KL D G+ + + ++AP
Sbjct: 193 PALSYLHSI-GLVYNDLKPENIMLTE--EQLKLIDLGAVSRI--NSFG-YLYGTPGFQAP 246
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-EEI--R 305
E++ T + DI++ G LA L L P G VD L E VL T + R
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 306 CMNPNYTDFRFP 317
++P+ RF
Sbjct: 304 AIDPDPRQ-RFT 314
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I K C L LVMEYVP L+ Y + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+H + HRD+ +N+L+D VK+ DFG AK + +G YYR
Sbjct: 149 YLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 292
APE + + + D+WS G L ELL +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 46/231 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 133 ISLKH-CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIF 188
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYY 245
G+ Y+ + + HRD+ +N ++ V + DFG ++ + G+ YY
Sbjct: 148 CGMEYLSSRNFI----HRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YY 193
Query: 246 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
R A E L YT D+W+ G + E++ GQ + G
Sbjct: 194 RQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ K S L L+MEY+P Y L+ Y +R+ I + YT QI +G+
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + +++
Sbjct: 128 EYLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 47/230 (20%), Positives = 87/230 (37%), Gaps = 45/230 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKL--YTYQIFR 189
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 190 GLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
G+ Y+ + + HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 159 GMEYLSNRNFL----HRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYR 204
Query: 247 ------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 38/214 (17%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRLMDHPNVI 133
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ T + HRD+ +N+LV+ ++VK+ DFG KVL + + YY+
Sbjct: 160 YLGTKRYI-HRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKE--------YYKVKEPGE 209
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++++ + D+WS G VL EL
Sbjct: 210 SPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 82 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMN-QRMPLIYVKLYTYQIFRGL 191
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ HQVK+ DFG K + + YY
Sbjct: 140 DYLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKE--------YYTVKDDR 189
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + + + + D+WS G L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 52/238 (21%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV----HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 59/252 (23%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPL 177
N+++L T ++ EY + + + L
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 178 IYVKLYT--YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDS- 199
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y APE IF YT D+WS G L EL LG +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 283 ENAVDQLVEIIK 294
+ ++IK
Sbjct: 251 MPVDSKFYKMIK 262
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 82 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ + + + L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + V HRD+ +N+LV+ VK+ DFG AK+L + YY
Sbjct: 141 EYLGSRRCV-HRDLAARNILVES-EAHVKIADFGLAKLLPLDKD--------YYVVREPG 190
Query: 247 -------APELIFGATEYTTSIDIWSAGCVLAELL 274
APE + ++ D+WS G VL EL
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 3e-18
Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)
Query: 85 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 123
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 124 MRLMDHPNVISLKHCFF---------------------------STTSKDELFLNLVMEY 156
I L D+LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 157 VPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216
+ ++ SS+ K +Q+ LA HRD+ N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 276
KL + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 277 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 327
+ LF G+ D +I +++ +P +Y + + +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
K++ + + +L +S +A +
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 57/225 (25%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRLMDHPNVISL- 135
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSM--NQRMPLIYVKLYTYQIF 188
C ++E+ L + +Y+ +Y SM QR+ +I
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EIC 145
Query: 189 ----RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
RGL Y+HT + HRDVK N+L+D K+ DFG +K + + +++ +
Sbjct: 146 IGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQ--THLSTVV 201
Query: 245 -----YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 278
Y P EY T D++S G VL E+L +
Sbjct: 202 KGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
HR++ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ ++ D+W+ G +L E+ G +PG
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRLMDHPN 131
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ + + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADEN--------YYKAQTHG 180
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 37/313 (11%), Positives = 68/313 (21%), Gaps = 76/313 (24%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNR---ELQLMRLMDHPN 131
Y G +QA VA+ V + +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
V + L +V E++ ++ V + +
Sbjct: 93 VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPEL 250
H GV P + V V L
Sbjct: 142 ADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
DI G L LL+ + P L + E ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+P + +A+R +Q +R + + +++
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264
Query: 371 ARLPNGRPFPPLF 383
A P+
Sbjct: 265 AVADRTEVLGPID 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 33/213 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCF 139
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHTV 197
+++ L +V EY+ L Y R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE-L 250
HRD+ +N+LV + K+ DFG K + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+++T D+WS G +L E+ G+ +P
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 41/221 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-YTYQIFRGLAYIH 195
++ + +VME V + + L G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--------- 246
+ + HRD+ +N LV + +K+ DFG ++ G Y
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGV---------YAASGGLRQVPV 279
Query: 247 ---APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L +G Y++ D+WS G +L E LG +P
Sbjct: 280 KWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 53/239 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 124
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL-- 182
R ++HPNV++L E ++++ Y+ + L + + + L
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQF-IRSPQRNPTVKDLIS 128
Query: 183 YTYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ Q+ RG+ Y+ V HRD+ +N ++D + VK+ DFG A+ ++ E
Sbjct: 129 FGLQVARGMEYLAEQKFV----HRDLAARNCMLDE-SFTVKVADFGLARDILDRE----- 178
Query: 240 ICSRYYR--------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ----YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 141
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N ++D VK+ DFG A+ + E YY
Sbjct: 142 KYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKT 190
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 191 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APE- 249
HRD+ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
L + +++ D+W+ G +L E+ G +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ S++ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------APEL 250
+ HRD++ N+LV K+ DFG A+++ E Y + + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+T D+WS G +L EL G+ +PG
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 83 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHPN 131
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYSSMNQRMPLI 178
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 179 YVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP---- 202
Query: 239 YICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 285
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 286 VDQLVEIIK 294
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
L + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ V HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 131 NYLEDRRLV-HRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEK--------EYHAEGGK 180
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 49/250 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 117
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 118 N---RELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPET 160
EL+ + + + I + T K + +VME
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER---- 133
Query: 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQV 219
+ L+ S N V ++ L YIH H D+K NLL+ QV
Sbjct: 134 LGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192
Query: 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSAG 267
L D+G + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 268 CVLAELLLGQ 277
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/258 (23%), Positives = 99/258 (38%), Gaps = 63/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+V+G+G+FG V A VA+K + +R EL++M +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP------------------ETMYRVLKHYSSMN 172
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L + L + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 276
+ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 44/234 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRLMDHPNV 132
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGL 191
+ L L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ G+ HR++ +N+L+ QV++ DFG A +L +
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDK--------QLLYSEAK 178
Query: 247 ------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 291
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 179 TPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G GSFG++F+ L + VAIK + E + + L + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ ++ L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 56/246 (22%)
Query: 83 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY--------SSMNQRMPLIYVKL-- 182
+ L S+ + L ++ME + LK Y ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMT---RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 183 YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICS 242
+I G+AY++ V HRD+ +N +V VK+ DFG + + + +
Sbjct: 143 MAGEIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD-------- 192
Query: 243 RYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
YYR +PE L G +TT D+WS G VL E+ L + + G + +Q
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQ 248
Query: 289 LVEIIK 294
++ +
Sbjct: 249 VLRFVM 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
++ +++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV T K+ DFG A+++ E Y
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +G +T D+WS G +L E++ G+ +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGLAYIHT 196
+ +K+ ++ ++ E++ L + ++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---------- 246
HRD++ N+LV + K+ DFG A+V+ E Y
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351
Query: 247 -APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + FG +T D+WS G +L E++ G+ +PG
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 60/252 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A G+ VA+K + ++ EL++M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY------------SSMNQRMPLI 178
N+++L T + ++ EY Y L ++ +
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCC---YGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 179 YVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN 236
L ++ Q+ +G+A++ + HRDV +N+L+ H K+ DFG A+ ++
Sbjct: 163 TRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDS-- 218
Query: 237 ISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 219 -------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPG 269
Query: 283 ENAVDQLVEIIK 294
+ +++K
Sbjct: 270 ILVNSKFYKLVK 281
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 62/296 (20%), Positives = 111/296 (37%), Gaps = 49/296 (16%)
Query: 12 PPPPPQAQAPPSQQPHFDNDLLKRHRPDMDSDKEMSAAVIQGNDAVTGHIISTTIGGKNG 71
P P P + ++D + S + + + + + K
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL 330
Query: 72 EPKQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLM 124
K+ +A+ +G G+FG V Q + VAIK + Q + E Q+M
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 390
Query: 125 RLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLY 183
+D+P ++ L + L LVME L + + +P+ V
Sbjct: 391 HQLDNPYIVRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAEL 441
Query: 184 TYQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+Q+ G+ Y+ + V HR++ +N+L+ H K+ DFG +K L ++
Sbjct: 442 LHQVSMGMKYLEEKNFV----HRNLAARNVLLVN-RHYAKISDFGLSKALGADDS----- 491
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY APE + F ++++ D+WS G + E L GQ +
Sbjct: 492 ---YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-16
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 80 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRLMDHPNV 132
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
+ L + L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ HRD+ +N+L+ H K+ DFG +K L ++ YY
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 247 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 44/223 (19%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMR-LMDHPNVISL 135
+ + +G G+FG + K L T E VAIK + + E + + L + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +V+E + ++ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 196 TVPGVCHRDVKPQNLLV----DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YR 246
+ + +RDVKP+N L+ + + + DF AK YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 247 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKL--YTYQIFRGL 191
SL S+ +V+ Y+ + L+++ N+ L + Q+ +G+
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF-IRNETHNPTVKDLIGFGLQVAKGM 205
Query: 192 AY---IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR-- 246
+ V HRD+ +N ++D VK+ DFG A+ + E + +
Sbjct: 206 KFLASKKFV----HRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFD------SVHNKT 254
Query: 247 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 255 GAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 52/231 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRLMDHP 130
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 131 NVISLKH-CFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIF 188
+++ C DE L V E+V + L Y + +++ Q+
Sbjct: 73 HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 189 RGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ-------VKLCDFGSAKVLVKGEANIS 238
+ ++ + H +V +N+L+ + +KL D G + ++ +
Sbjct: 124 AAMHFLEENTLI----HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175
Query: 239 YICSRYYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+ PE I + D WS G L E+ G
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 64/258 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-------------------ETMYRVLKHYSSMN 172
VI L + L L++EY +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 173 QRMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
L L + +QI +G+ Y+ + + HRD+ +N+LV ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 231 VKGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 276
+ + Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 277 QPLFPGENAVDQLVEIIK 294
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + V HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 554
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 59/259 (22%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 123
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMN 172
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 173 QRMPLIYVKLY--TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ L ++ QI G+ Y+ + HRD+ +N LV VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 231 VKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 276
+ YYR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 277 -QPLFPGENAVDQLVEIIK 294
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ + ++ME P Y L HY + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 193 YI---HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR--- 246
Y+ + V HRD+ +N+LV VKL DFG ++ + + YY+
Sbjct: 128 YLESINCV----HRDIAVRNILVAS-PECVKLGDFGLSRYIEDED---------YYKASV 173
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 174 TRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRGLA 192
L +++ ++ ++ME L+ + + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + HRD+ +N+LV VKL DFG ++ + YY+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L +K + + +V EY+ L + + + +I + I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+L++ K+ DFG +VL Y
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDP-------EAAYTTRGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 213 PIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVI 133
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLA 192
L ++ L + +V EY+ L + + + + ++ + + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR------ 246
Y+ + G HRD+ +N+LVD K+ DFG ++VL E + Y
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSRVL---EDDPDA----AYTTTGGKI 216
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 217 PIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
Y R +G+GSFG ++ + GE VAIK ++ E ++ + + + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ C + + +VME + ++ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSR-----YYRAP 248
+ HRDVKP N L+ + V + DFG AK Y +R YR
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y SI D+ S G VL LG
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ SK+ +V EY+ L +Y S + + + Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LVD VK+ DFG + ++ + Y
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKWS 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 173 APEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 45/218 (20%), Positives = 86/218 (39%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ + LV E++ + L+ + L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
V HRD+ +N LV +K+ DFG + ++ + Y
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKWA 172
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
+PE F Y++ D+WS G ++ E+ G+ +
Sbjct: 173 SPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 53/239 (22%), Positives = 84/239 (35%), Gaps = 57/239 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
+G FG V++ VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYV 180
V+ L +KD+ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 181 KL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS 238
QI G+ Y+ + V H+D+ +N+LV VK+ D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 239 YICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 282
YY+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L T L+ +++EY + + + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 257
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 283 ENAVDQLVEIIK 294
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 56/249 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRLMDHPNV 132
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
Q+ G+ Y+ + HRD+ +N LV VK+ DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 285
YYR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 286 VDQLVEIIK 294
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 50/237 (21%), Positives = 86/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + +++E + LK + +Q L + L
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 185 YQIFRGLAY---IHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 188 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----- 238
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 239 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 51/237 (21%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-----SSMNQRMPLIYVKL--YT 184
++ + + ++ME + LK + +Q L + L
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMA---GGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 185 YQIFRGLAYI---HTVPGVCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISY 239
I G Y+ H + HRD+ +N L+ K+ DFG A+ + +
Sbjct: 147 RDIACGCQYLEENHFI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----- 197
Query: 240 ICSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YYR PE + G +T+ D WS G +L E+ LG +P
Sbjct: 198 ----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 56/240 (23%)
Query: 82 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RLMD 128
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPE-----------TMYRVLKHYSSMNQRMPL 177
H N+I+L ++D +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 178 IYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
+ L TYQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDINNID- 211
Query: 236 NISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 82 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ-RMPLIYVKLYTYQIFRG 190
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR---- 246
+ Y+ + HRD+ +NLL+ VK+ DFG + L + + +Y
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQND--------DHYVMQEH 183
Query: 247 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE L ++ + D W G L E+ GQ + G
Sbjct: 184 RKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 49/223 (21%), Positives = 90/223 (40%), Gaps = 40/223 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRLMDHPNV 132
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHY-SSMNQRMPLIYVKLYTYQIFRGL 191
I L SK + + ++ EY+ L + + ++ + I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----- 246
Y+ + HRD+ +N+LV+ K+ DFG ++VL Y
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAT------YTTSGGKI 212
Query: 247 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 213 PIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 68/268 (25%)
Query: 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 122
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 123 LMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYV-------------PETMYRVLKHYS 169
LM D+PN++ L + + L+ EY+ P T+ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 170 SMNQRMPLIYVKLYT--------YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221
S R+ + Q+ G+AY+ HRD+ +N LV VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 222 CDFGSAKVLVKGEANISYICSRYYR------------APE-LIFGATEYTTSIDIWSAGC 268
DFG ++ + + YY+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 269 VLAELL-LG-QPLFPGENAVDQLVEIIK 294
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 42/252 (16%), Positives = 80/252 (31%), Gaps = 50/252 (19%)
Query: 58 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 109
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 110 VLQDRRYKNRELQLMRLMDHPNVISLK-----------HCFFSTTSKDELFLNLVMEYVP 158
+D R N + R V K C +D+ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 159 ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-H 217
++ L + V ++ L ++H H +V +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPEDQS 198
Query: 218 QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWS 265
QV L +G A +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 266 AGCVLAELLLGQ 277
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 69/296 (23%), Positives = 117/296 (39%), Gaps = 70/296 (23%)
Query: 84 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRLMDHPNVIS 134
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 135 LK-HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL-------IYVKLYTYQ 186
L + D+L L V Y+P +L S ++ PL I
Sbjct: 95 LLGFS----SDGDDLCL--VYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR--- 243
G+ ++H HRD+K N+L+D K+ DFG A+ K + + SR
Sbjct: 142 AANGINFLHENH-HIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQ--TVMTSRIVG 197
Query: 244 -Y-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 295
Y APE + G E T DI+S G VL E++ G P AVD+ L++I +
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249
Query: 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+ + ++ D ++ +AS+ L + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 46/220 (20%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRLMDHPNVISLK 136
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 137 HCFFSTTSKDELFLNLVMEYVP-----ETMYRVLKHYSSMN--QRMPLIYVKLYTYQIF- 188
T + L LV Y+ + + ++ +R +I
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ----------RIAL 138
Query: 189 ---RGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR 243
RGLAY+H P + HRDVK N+L+D + + DFG AK++ + +++ +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTA 194
Query: 244 Y-----YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 277
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 195 VRGTIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR-LMDHPNVISL 135
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + + LVM+ + ++ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 196 TVPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ HRD+KP N L+ +QV + DFG AK Y + YR
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170
Query: 249 ELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 277
+ + G Y S+ D+ S G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV 197
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR----------- 246
HRD+ +N LV+ VK+ DFG ++ ++ E Y
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRWS 188
Query: 247 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
PE L++ ++++ DIW+ G ++ E+ LG+ +
Sbjct: 189 PPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 56/236 (23%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-----------ETMYRVLKHYSSMNQRMPLIYVKL 182
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 183 --YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSRG----------- 191
Query: 241 CSRYYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 282
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 44/251 (17%), Positives = 78/251 (31%), Gaps = 50/251 (19%)
Query: 59 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 113
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 114 RRYKNRELQLMRLMDHPNVISLK--------------HCFFSTTSKDELFLNLVMEYVPE 159
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT-HQ 218
+ ++ + + +R V + +I L YIH H D+K NLL++ Q
Sbjct: 137 DLQKIYE---ANAKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQ 192
Query: 219 VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSI------------DIWSA 266
V L D+G A + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 267 GCVLAELLLGQ 277
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 116 YKNRELQLMRLMDHPNVI--SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQ 173
YK + + + D+ I LK S TS + +E + +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-DLY 186
Query: 174 RMPLIYVKL--YTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ L L Y++Q+ +G+ ++ + + HRD+ +N+L+ + VK+CDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 232 KGEANISYICSRYYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 278
K Y APE IF YT D+WS G +L E+ LG
Sbjct: 245 KDP---------DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGAS 294
Query: 279 LFPGENAVDQLVEIIK 294
+PG ++ +K
Sbjct: 295 PYPGVKIDEEFCRRLK 310
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 5e-08
Identities = 61/438 (13%), Positives = 116/438 (26%), Gaps = 129/438 (29%)
Query: 23 SQQPHFDNDLLKRHRPDMDSD------KEMSAAVIQGNDAVTGHIISTTIGGKNGEPKQT 76
+ + D+L + ++M +++ + HII + +
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL--SKEEIDHII------MSKDAVSG 63
Query: 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLK 136
+ F L + + ++K +++ N + + + S+
Sbjct: 64 TLRL---------FW------TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ +D L+ N + + R L+ Y + Q L + + + I
Sbjct: 109 TRMYIEQ-RDRLY-NDNQVFAKYNVSR-LQPYLKLRQ-------ALLELRPAKNVL-IDG 157
Query: 197 VPG---------VCHRDVKPQNLLVDP---------------LTHQVKLCDF--GSAKVL 230
V G VC K Q + L KL +
Sbjct: 158 VLGSGKTWVALDVC-LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 231 VKGEANISYICSRYYRAPELIFGATEYTTSI----DIWSAGCVLAELLLGQPLFPGENAV 286
+NI + + Y + ++ +A NA
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--------------NAF 262
Query: 287 DQLVEII--KVLGTPTREEIRCMNPNYTDFRFPQIKAHP----WHKVFHKRMPPEAIDLA 340
+ + K+L T TR TDF H P E L
Sbjct: 263 N-----LSCKILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLL 307
Query: 341 SRLLQYSPS-LRCTALEACA-HPFF-----DELREPNARLPNGRPFPPLFNFKQ----EL 389
+ L P L E +P + +R+ A N+K +L
Sbjct: 308 LKYLDCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWD---------NWKHVNCDKL 355
Query: 390 AGASPELINRLIPEHVRR 407
+N L P R+
Sbjct: 356 TTIIESSLNVLEPAEYRK 373
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.22 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.89 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-65 Score=494.85 Aligned_cols=320 Identities=33% Similarity=0.603 Sum_probs=260.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||++++++..... .+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 479999999999999999999999999999999965432 23479999999999999999998754321 24456
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|||||||+|+|.+.+.. .+.+++..++.++.||+.||.|||+ +|||||||||+|||++ .++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVN-ENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccC-CCCCEEEeecceeee
Confidence 899999999998887764 5689999999999999999999999 6999999999999999 678899999999986
Q ss_pred cccC-----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 230 LVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 230 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
.... ....+.+||++|||||++.+..+|+.++||||+|||+|||++|++||.+.+..+++..|.+..|.|+...+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 23346799999999999988777899999999999999999999999999999999999999999987766
Q ss_pred hccCcCCcc---ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCC
Q 014750 305 RCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPP 381 (419)
Q Consensus 305 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~ 381 (419)
......... ..++.....+|...++ .++++++|||.+||++||.+|+|++|+|+||||+++.++..... ..+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~----~~~ 362 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD----CAP 362 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC----CSS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC----CCC
Confidence 543221111 1234444455655554 57999999999999999999999999999999999876654422 223
Q ss_pred CCCchHHhhcCCHHHHhhhcHHHHHh
Q 014750 382 LFNFKQELAGASPELINRLIPEHVRR 407 (419)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (419)
.+++..+....+.+.+++++.+++.+
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~~ 388 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIED 388 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHHH
Confidence 45566566667788888888776554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-65 Score=477.93 Aligned_cols=253 Identities=30% Similarity=0.540 Sum_probs=220.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.++|||||+++++| ++...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4699999999999999999999999999999998642 23356899999999999999999999 55667
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|||||||.| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~-~~g~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLN-EDMHIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEc-CCCCEEEEEcCCce
Confidence 9999999985 88887765 3679999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.+|.+.
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------- 249 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------- 249 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 764332 34467999999999999875 4899999999999999999999999999988888888762
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHH------HhcCCccccccCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPN 370 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~ 370 (419)
.+. +++.++++++|||++||++||++|+|++| +++||||++++|..
T Consensus 250 -------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 250 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp -------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred -------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 111 33467999999999999999999999987 68999999988764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-65 Score=468.90 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=204.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence 357999999999999999999999999999999986432 2345899999999999999999998 4555
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|||||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~-~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLD-EHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEEC-TTCCEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEEC-CCCCEEEeecCCCe
Confidence 6999999999999888875 4679999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.........+.+||+.|||||++.+..+++.++|||||||++|+|+||+.||.+.+..+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------ 228 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 77666666678999999999999887766789999999999999999999999988877777765521
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+. ++..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 229 -----~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -----YT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11 23457999999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-64 Score=474.21 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=217.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|. +...+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence 35699999999999999999999999999999998532 334568999999999999999999994 444599
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||||+| +|.+.+.+ ..+++..++.|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|+..
T Consensus 148 ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEC-CCCCEEEecCcCceec
Confidence 99999995 67766654 569999999999999999999999 6999999999999999 6788999999999876
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ....+.+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+..+.+..+......
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------- 288 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------- 288 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-----------
T ss_pred CCCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----------
Confidence 543 345568999999999999764 5899999999999999999999999999888888777652110
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.++ .+..+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus 289 -----~~~----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 289 -----RLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp -----CCS----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred -----CCC----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 000 11347999999999999999999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-64 Score=485.38 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=217.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.. ...+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEE
Confidence 35699999999999999999999999999999998633 3345689999999999999999999944 44599
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||||+| +|.+.+.. ..+++..++.|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|+..
T Consensus 225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~-~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEc-CCCCEEEecCccceEC
Confidence 99999995 67766653 569999999999999999999999 6999999999999999 6788999999999876
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ....+.+||++|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...... .
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~--------- 366 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-R--------- 366 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-C---------
T ss_pred CCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-C---------
Confidence 443 345578999999999999764 5899999999999999999999999999888888777652110 0
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
+ .....+|+++++||.+||+.||++|+|++|+|+||||++...
T Consensus 367 ------~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 367 ------L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp ------C----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred ------C----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 0 012357999999999999999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-64 Score=473.91 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=212.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence 4568999999999999999999999999999999986542 2345799999999999999999999 4455
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|||||||+ |+|.+.+... ....+++..++.|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGla 172 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLT-KDGTVQLGDFGIA 172 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEEC-TTCCEEECSTTEE
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEEC-CCCCEEEcccccc
Confidence 6999999998 5888887642 24568999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+...... .....+||+.|||||++.+. .|+.++||||||||+|||+||+.||.+.+..+.+.++.+..-
T Consensus 173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 242 (350)
T 4b9d_A 173 RVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--------- 242 (350)
T ss_dssp SCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------
T ss_pred eeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------
Confidence 8764332 23456899999999999775 489999999999999999999999999998888888776311
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+ .++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 243 ----------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 ----------P---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ----------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ----------C---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 1 022457999999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=476.50 Aligned_cols=332 Identities=68% Similarity=1.192 Sum_probs=296.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCC-CCceeEEE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNL 152 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 152 (419)
....+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+++|+.++|+||++++++++.... .+..++++
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 34557999999999999999999999999999999998777777789999999999999999998865432 45667889
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.+++.+||+|||+++....
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999999998888777777889999999999999999999999 69999999999999996567899999999987766
Q ss_pred CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 233 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
.......+||++|+|||++.+...|+.++||||||||+|||++|+.||.+.+..+++.++++.+|.|..+.+..+++++.
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66666788999999999998766799999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcC
Q 014750 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGA 392 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (419)
.+.++.+...+|...++..+++++.+||++||++||.+|||+.|+++||||+++.++...++.....+..++|.......
T Consensus 290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (420)
T 1j1b_A 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS 369 (420)
T ss_dssp CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence 99999999999999999999999999999999999999999999999999999988877777777778888888666555
Q ss_pred CHHHHhhhcHHHHH
Q 014750 393 SPELINRLIPEHVR 406 (419)
Q Consensus 393 ~~~~~~~~~~~~~~ 406 (419)
.+.+...++|.+.+
T Consensus 370 ~~~~~~~~~~~~~~ 383 (420)
T 1j1b_A 370 NPPLATILIPPHAR 383 (420)
T ss_dssp CGGGHHHHSCTTTT
T ss_pred ChhHHHhhCCHhhh
Confidence 66666666655543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-62 Score=451.37 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=208.5
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+++|+.++|||||+++++|.... .....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 23457999999999999999999885432 34566899
Q ss_pred Eeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecccccc
Q 014750 153 VMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|||||+ |+|.+.+.. ...+++..++.|+.||+.||+|||+ +| ||||||||+||||+..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999998 578777765 3679999999999999999999999 58 999999999999985578899999999986
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
. ......+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+....+...+.. +..+
T Consensus 182 ~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~--------- 248 (290)
T 3fpq_A 182 K-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------- 248 (290)
T ss_dssp C-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------
T ss_pred C-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCC---------
Confidence 4 3344567799999999999864 4899999999999999999999999876655444333321 0000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..++..+++++++||.+||+.||++|||++|+|+||||++
T Consensus 249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123456899999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-63 Score=460.94 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=211.3
Q ss_pred cceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
++|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+++|+.++|||||++++++ .++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence 57999999999999999999974 46889999998643 23456799999999999999999999 445
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~-~~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLD-EEGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-TTSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEc-CCCCEEeccccc
Confidence 56999999998 578777765 3679999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 227 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+.++.+..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 9865433 334567899999999999765 48999999999999999999999999999888888877521
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
+. ++..+|+++++||++||+.||++|+| ++|+++||||+++++.
T Consensus 243 --------~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 243 --------LG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------CC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 11 23457999999999999999999998 5899999999988654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=470.63 Aligned_cols=335 Identities=49% Similarity=0.937 Sum_probs=286.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCC----------
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS---------- 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---------- 144 (419)
...+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 4467999999999999999999999999999999998887777899999999999999999999865433
Q ss_pred -----------------------CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcc
Q 014750 145 -----------------------KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVC 201 (419)
Q Consensus 145 -----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~iv 201 (419)
.+..++++||||++++|.+.+..+...+..+++..++.++.||+.||.|||+ +||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCc
Confidence 3455689999999999999998877778899999999999999999999999 6999
Q ss_pred cccccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCC
Q 014750 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (419)
Q Consensus 202 H~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 281 (419)
||||||+|||++..++.+||+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999866789999999999887666666778899999999999876679999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
+.+..+++..+++.+|.|..+.+..+++++..+.++.+....|...++..+++++.+||.+||++||.+|||+.|+|+||
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-------CCCCCCCC--CCCCCCCCchHHh-hcCCHHHHhhhcHHHHHhhcC
Q 014750 362 FFDELRE-------PNARLPNG--RPFPPLFNFKQEL-AGASPELINRLIPEHVRRQTG 410 (419)
Q Consensus 362 ~f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 410 (419)
||+++.. .....+.. ...+.+++|.... ....++...+++|+.++..++
T Consensus 324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 382 (383)
T 3eb0_A 324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382 (383)
T ss_dssp GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC-------
T ss_pred HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhccccc
Confidence 9998765 23334444 5677889998644 445899999999988776653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=469.16 Aligned_cols=330 Identities=65% Similarity=1.162 Sum_probs=301.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCC-CCceeEEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLV 153 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv 153 (419)
...+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+++++.++|+||+++++++..... .+..++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 45679999999999999999999877766 9999888777777799999999999999999999876554 556678999
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|||+++++.+.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+..++.+||+|||+++.....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999999988888777777889999999999999999999999 699999999999999866789999999999887666
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
.......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+..+++++..
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 66677889999999999987767999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcCC
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGAS 393 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (419)
..++.+...++...++..+++++.+||.+||++||.+|||+.|+++||||+++++.....+.....+++++|..+.....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVR 355 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHTC
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhcC
Confidence 99999999999999999999999999999999999999999999999999999998888888888899999998888888
Q ss_pred HHHHhhhcHHHHH
Q 014750 394 PELINRLIPEHVR 406 (419)
Q Consensus 394 ~~~~~~~~~~~~~ 406 (419)
++++.+++|.+..
T Consensus 356 ~~~~~~~~~~~~~ 368 (394)
T 4e7w_A 356 PDLISRLVPQHAE 368 (394)
T ss_dssp GGGHHHHSCGGGC
T ss_pred HHHHHhhccHhhh
Confidence 8999999998773
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-62 Score=459.97 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=214.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
....|++.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+|+.++|||||++++++ .+...+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEEEE
Confidence 34569999999999999999999999999999999976543 35799999999999999999998 4445699999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|||+ |+|.+.++. .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+.++..+||+|||+|+.....
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9998 588888765 3579999999999999999999999 699999999999999954447999999999876443
Q ss_pred Cc------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 234 EA------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 234 ~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.. ....+||+.|||||++.+. .|+.++|||||||++|||+||++||.+.+..+.+.++... .++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 21 1235799999999999875 4899999999999999999999999987766666666541 110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH-------------hcCCccccccCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREP 369 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~-------------l~hp~f~~~~~~ 369 (419)
...++..+++++.+||.+||+.||.+|||+.|+ |+|||+.+..++
T Consensus 275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 011345689999999999999999999999997 579999887654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=456.72 Aligned_cols=281 Identities=28% Similarity=0.472 Sum_probs=217.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCcc--cHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||+||+|+++ .+++.||+|++.+... ...+|+++|+.+ +|||||+++++| .+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCF-----RKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----EET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEE-----EEC
Confidence 34467999999999999999999875 4678999998865432 345799999988 699999999999 445
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.++|||||||+ |+|.+.+ +.+++.+++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 56999999998 4666655 248999999999999999999999 69999999999999996558999999999
Q ss_pred ccccccCC-----------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCC
Q 014750 227 AKVLVKGE-----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 277 (419)
Q Consensus 227 a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 277 (419)
|+...... ...+.+||++|+|||++.+...|+.++||||+|||+|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 97543221 1234579999999999988777999999999999999999999
Q ss_pred CCCC-CCCHHHHHHHHHHHhCCCCHHHHhccCcC--C-------------------ccccCCCCC----CCCchhhcCCC
Q 014750 278 PLFP-GENAVDQLVEIIKVLGTPTREEIRCMNPN--Y-------------------TDFRFPQIK----AHPWHKVFHKR 331 (419)
Q Consensus 278 ~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~~~----~~~~~~~~~~~ 331 (419)
.||. +.+..+++..|.+.+|++....+...... . .+...|... ...........
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9984 56788999999999987654433211000 0 000011100 00011112345
Q ss_pred CChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 332 MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 332 ~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
+|++++|||++||++||++|+|++|+|+||||++++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 799999999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-59 Score=434.56 Aligned_cols=260 Identities=23% Similarity=0.435 Sum_probs=193.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC-------
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------- 144 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 144 (419)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999986432 234579999999999999999999865432
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
....++|||||||. |+|.+.+..... .....+..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~-~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEEC-CCCcEEEcc
Confidence 23456899999998 477777764221 2234567789999999999999999 6999999999999999 578899999
Q ss_pred cccccccccCCc-------------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHH
Q 014750 224 FGSAKVLVKGEA-------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (419)
Q Consensus 224 fG~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (419)
||+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||.+. .+...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence 999987643321 2345899999999999775 58999999999999999996 77543 23333
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.+....... +|. .....++.+.+||++||+.||.+|||+.|+|+||||++++++.
T Consensus 236 ~~~~~~~~~----------------~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 236 TLTDVRNLK----------------FPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHTTC----------------CCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHhcCC----------------CCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 333221111 110 0012367889999999999999999999999999999887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=467.32 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=213.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHH---HHHHHhcCCCCeeecceeeecc
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRE---LQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e---~~~l~~l~h~niv~~~~~~~~~ 142 (419)
+...++|++.++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 456678999999999999999999999999999999986432 112233 5566677999999999999
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
.+...+|||||||. |+|.+.+.. .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+ .++.+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld-~~G~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEEC-TTSCEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEe-CCCCEEe
Confidence 55666999999998 578777765 3679999999999999999999999 6999999999999999 6788999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 298 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~ 298 (419)
+|||+|+..... ...+.+||+.|||||++.+...|+.++||||||||+|||++|.+||.+.+. .+....+...
T Consensus 334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--- 409 (689)
T 3v5w_A 334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 409 (689)
T ss_dssp CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence 999999876443 345679999999999997655699999999999999999999999976432 2222222220
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCCC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 370 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~~ 370 (419)
. ..++..+|+++++||.+||+.||.+|++ ++|+++||||++++|..
T Consensus 410 --------------~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 410 --------------A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp --------------C------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred --------------C------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 0 1134568999999999999999999998 79999999999987653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=460.75 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=224.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+|+.+|+.++|||||+++++| .+...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 468999999999999999999999999999999986543 2345799999999999999999999 5566799
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC-CCceEEeecccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~ 229 (419)
||||||+| +|.+.+.. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999985 77766643 34679999999999999999999999 699999999999999843 37899999999998
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..........+||+.|||||++.+. .|+.++||||||||+|+|++|.+||.+.+..+.+..+.+......
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 376 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------- 376 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence 8777667778999999999999875 489999999999999999999999999999888888765322111
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
......+|++++|||++||++||.+|||++|+|+||||+...++.
T Consensus 377 ----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 377 ----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 112245799999999999999999999999999999999876553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=421.34 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=209.8
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|.+.+.||+|+||+||+|++. .++..||||++.... ..+.+|+++|+.++|||||++++++.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----- 85 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----- 85 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----
Confidence 3457999999999999999999875 357899999986542 33568999999999999999999984
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhc---------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYS---------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~ 215 (419)
+...+|||||||+ |+|.+.|.... .....+++..+..++.||+.||.|||+ ++||||||||+||||+ .
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~-~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVG-E 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-G
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEEC-C
Confidence 4445899999998 68888887532 234579999999999999999999999 6999999999999999 6
Q ss_pred CCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014750 216 THQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (419)
++.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 788999999999865443322 235689999999999765 49999999999999999999 9999999988887777
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
+.+.... ..+..+++++.+||.+||+.||++|||++++ |+|++++.
T Consensus 243 i~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 243 ITQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 7652110 1234679999999999999999999999999 56887654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=436.52 Aligned_cols=324 Identities=31% Similarity=0.519 Sum_probs=244.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++|+||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999999999999999986532 23457999999999999999999986655455567
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+|+.
T Consensus 132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~-~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVN-QDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEEC-CCCCEeecccccchh
Confidence 899999999998887764 4679999999999999999999999 6999999999999999 678899999999986
Q ss_pred cccCC----------------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh------
Q 014750 230 LVKGE----------------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL------ 275 (419)
Q Consensus 230 ~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt------ 275 (419)
..... .....+||++|+|||++.+...|+.++||||||||+|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 53221 22346789999999988666679999999999999999999
Q ss_pred -----CCCCCCCCC--------------------HHHHHHHHHHHhCCCCHHHHhccCcCCc---cccCCCCCCCCchhh
Q 014750 276 -----GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYT---DFRFPQIKAHPWHKV 327 (419)
Q Consensus 276 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 327 (419)
|+++|.+.+ ..+++..+.+.+|.|..+.+........ ...++......+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 788887754 3688999999999999988765432110 011233333334444
Q ss_pred cCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcCCHHHHhhhcHHHHHh
Q 014750 328 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 407 (419)
Q Consensus 328 ~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (419)
++ .+++++.+||++||++||.+|||++|+|+||||+++.+.........+.. +.|. +....+...++..+.+++..
T Consensus 366 ~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~e~~~ 441 (458)
T 3rp9_A 366 FP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR--LPFN-DWMNMDEPQLRYAFVKEIQR 441 (458)
T ss_dssp ST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--CSSC-TTSCCCHHHHHHHHHHHHTT
T ss_pred CC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--CCcc-ccccCCHHHHHHHHHHHHHH
Confidence 43 46999999999999999999999999999999999887654432222221 2222 23456788888888888875
Q ss_pred hc
Q 014750 408 QT 409 (419)
Q Consensus 408 ~~ 409 (419)
..
T Consensus 442 ~~ 443 (458)
T 3rp9_A 442 YH 443 (458)
T ss_dssp TC
T ss_pred hC
Confidence 44
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=418.14 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=201.3
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|.+.+.||+|+||+||+|++. .+++.||||++.... ..+.+|+++|+.++|||||++++++ .
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~ 113 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-----T 113 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 3457999999999999999999865 368899999986542 3356899999999999999999998 4
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSS-----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD 213 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~ 213 (419)
+...+|||||||+ |+|.+.+..... ....+++..+..|+.||+.||.|||+ ++||||||||+||||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEEC
Confidence 4445899999999 688888765422 23569999999999999999999999 6999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHH
Q 014750 214 PLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 289 (419)
Q Consensus 214 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 289 (419)
.++.+||+|||+|+....... ....+||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 688999999999986643322 2346789999999999764 58999999999999999999 99999999888877
Q ss_pred HHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 290 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 290 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+.+... ...+..+++++.+||.+||+.||++|||++|++++
T Consensus 271 ~~i~~g~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQGRE----------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCC----------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 77665211 01234679999999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=436.95 Aligned_cols=319 Identities=30% Similarity=0.525 Sum_probs=241.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999999999999999986532 233479999999999999999999854432 2335
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+||||||+++++.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~-~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEe-CCCCEEEEEEEeee
Confidence 689999999999877664 348999999999999999999999 6999999999999999 67789999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
...........+||++|+|||++.+. .|+.++||||||||+|+|++|+.||.+.+..+++.++++.+|.|..+.+....
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 77665556678999999999999875 58999999999999999999999999999999999999999999988776554
Q ss_pred cCCccc--cCCCCCCCCchhhcCCC-----------CChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 014750 309 PNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (419)
Q Consensus 309 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 375 (419)
.....+ ..+......+...++.. .++++.+||++||++||.+|||++|+|+||||+.+..+.....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~- 370 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA- 370 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC-
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC-
Confidence 222111 11111222222333222 1567999999999999999999999999999998765433211
Q ss_pred CCCCCCCCCchHHhhcCCHHHHhhhcHHHHH
Q 014750 376 GRPFPPLFNFKQELAGASPELINRLIPEHVR 406 (419)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (419)
+.+..+.+..+....+.+.+++.+.+++.
T Consensus 371 --~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 399 (464)
T 3ttj_A 371 --PPPQIYDKQLDEREHTIEEWKELIYKEVM 399 (464)
T ss_dssp --CC-----------CCCHHHHHHHHHHHHH
T ss_pred --CCCccCCcchhhccCCHHHHHHHHHHHHH
Confidence 11122333333344566667777766654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-55 Score=423.74 Aligned_cols=321 Identities=29% Similarity=0.563 Sum_probs=240.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (419)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. |+||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 357999999999999999999999999999999885432 22347999999997 99999999998542 334
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+|||||+++|...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLN-AECHVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEc-CCCCEEecCCcccc
Confidence 5899999999998888765 478999999999999999999999 6999999999999999 67889999999997
Q ss_pred cccc----------------------CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 229 VLVK----------------------GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 229 ~~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
.... .......+||++|+|||++.+...++.++||||||||+|+|++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6532 111234689999999999987667999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcCCccccC------CCCCCCCchhh------------cCCCCChhHHHHHhhhcccCC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKV------------FHKRMPPEAIDLASRLLQYSP 348 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------------~~~~~s~~~~dli~~~L~~dP 348 (419)
+++..+...++.|..+.+......+....+ .......+... ....+++++.+||++||++||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 999999999999998877654332211000 00000001111 112578999999999999999
Q ss_pred CCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcCCHHHHhhhcHHHHHhhc
Q 014750 349 SLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQT 409 (419)
Q Consensus 349 ~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (419)
.+|||++|+|+||||+.+..+.........+... |. .....+.+.+++++.+++.+..
T Consensus 318 ~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~ 375 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIFHNPNEEPNCDHIITIP--IN-DNVKHSIDDYRNLVYSEISRRK 375 (388)
T ss_dssp GGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---------CCHHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCC--cc-ccccCCHHHHHHHHHHHHHHhh
Confidence 9999999999999999887766544333333222 22 1223467778888877766543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=410.21 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=197.4
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+++++.+.||+|+||+||+|++. ..||||+++... ..+.+|+.+|+.++|||||++++++. +
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~- 103 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-----K- 103 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----C-
Confidence 34467899999999999999999853 359999886332 23457999999999999999999762 1
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|||||||+ |+|.+.|.. ....+++..+..|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~-~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLH-EGLTVKIGDFGL 178 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEE-TTEEEEECCCSS
T ss_pred CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEEC-CCCcEEEeeccC
Confidence 23789999999 577777754 24679999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCC---cceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+...... .....+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+..+.+..++.....
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~--- 255 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA--- 255 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC---
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC---
Confidence 98654322 23456899999999999653 24899999999999999999999999987766665555442111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.|.. ..++..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 --------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 256 --------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp --------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred --------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111 11234578999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=413.25 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=206.1
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
...++++.+.||+|+||+||+|+.. .+++.||||++.... ..+.+|+.+|+.++|||||++++++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~---- 99 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT---- 99 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE----
Confidence 3456888999999999999999853 467899999986432 34568999999999999999999983
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCcee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIl 211 (419)
+...+|||||||+ |+|.+.|..... ....+++..+..++.||+.||.|||+ ++||||||||+|||
T Consensus 100 -~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 -KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVL 177 (308)
T ss_dssp -SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred -ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceE
Confidence 4445899999998 688888865321 13568999999999999999999999 69999999999999
Q ss_pred eCCCCCceEEeecccccccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHH
Q 014750 212 VDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 287 (419)
Q Consensus 212 l~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 287 (419)
|+ +++.+||+|||+|+...... .....+||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+
T Consensus 178 l~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 178 VY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred EC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 67889999999998764332 22346789999999999765 59999999999999999998 899999998887
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+..+.+.... ..++.+++++.+||.+||+.||++|||+.||+++
T Consensus 256 ~~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 256 VVEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77666542111 1234679999999999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=423.79 Aligned_cols=325 Identities=29% Similarity=0.496 Sum_probs=253.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+|+.++|+||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457999999999999999999999999999999986532 23458999999999999999999986543333356
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~-~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLN-QDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEEC-CCCCEEEccCCCccc
Confidence 899999999998888764 4679999999999999999999999 6999999999999999 678899999999987
Q ss_pred cccCC-----------------------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-----------
Q 014750 230 LVKGE-----------------------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL----------- 275 (419)
Q Consensus 230 ~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt----------- 275 (419)
..... .....+||++|+|||++.+...|+.++||||||||+|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 64332 12567899999999998666779999999999999999998
Q ss_pred CCCCCCCCC-----------------HHHHHHHHHHHhCCCCHHHHhccCcCCc-c--ccCCCCCCCCchhhcCCCCChh
Q 014750 276 GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPPE 335 (419)
Q Consensus 276 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~ 335 (419)
|.++|.+.+ ..+++..+.+.+|.|..+.+........ . ..++......+...++ .++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~ 337 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP-SISDD 337 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST-TSCHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC-CCCHH
Confidence 556666554 4788999999999999988765432110 0 0122222333333333 47999
Q ss_pred HHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcCCHHHHhhhcHHHHHhhcC
Q 014750 336 AIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTG 410 (419)
Q Consensus 336 ~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (419)
+.+||++||++||.+|||++|+|+||||+++++..........+ ...|+ +....+.+.++.++.+++.....
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~e~~~~~~ 409 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI--ILPFD-DWMVLSETQLRYIFLKEVQSFHP 409 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCC--CCSSC-TTCCCCHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCC--CCChh-hcccCCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999988765443222222 22232 22457888999999998876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=414.92 Aligned_cols=305 Identities=46% Similarity=0.870 Sum_probs=251.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc---HHHHHHHHHhcCCCCeeecceeeeccCC--CCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRLMDHPNVISLKHCFFSTTS--KDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~~ 149 (419)
..++|++.+.||+|+||.||+|++..+|+.||||++..+... ..+++..++.++||||+++++++..... ....+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 345799999999999999999999999999999988655433 3356667788899999999999865433 34556
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH--cCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
+++||||+++++...+..+......+++..++.++.|++.||.||| + +||+||||||+|||++..++.+||+|||++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 8899999999998888877677788999999999999999999999 8 699999999999999954789999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 88766666666788999999999977666899999999999999999999999999999999999999999999999888
Q ss_pred CcCCccccCCCCCCCCchhhcCC---CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFP 380 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~ 380 (419)
++....+.+......+|...++. ..++++.+||.+||+.||.+|||+.|+|+||||+++..+....+.....+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~ 335 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP 335 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence 87776666666666666666554 35789999999999999999999999999999999888776655544444
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=400.82 Aligned_cols=281 Identities=34% Similarity=0.570 Sum_probs=229.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence 47999999999999999999999999999999986432 23347999999999999999999984 34458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLIN-RNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEeecccceec
Confidence 99999999988877764 34679999999999999999999999 6999999999999999 6788999999999866
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+....|....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 433 2334567899999999998766689999999999999999987666 77788888999999999998877665443
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.......++..............+++++.+||++||+.||++|||++|+|+||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 21111112211111112223345799999999999999999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=410.05 Aligned_cols=318 Identities=32% Similarity=0.559 Sum_probs=245.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
..+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++..... .+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357999999999999999999999999999999985432 223579999999999999999999854322 1224
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEc-CCCCEEEEeeeccc
Confidence 5789999998888887764 568999999999999999999999 6999999999999999 57889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... .....++|++|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..|.++.+.+..+.
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 6532 34457889999999999876679999999999999999999999999999999999999999999988776543
Q ss_pred cCCcc---ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
..... ..++......+...+ ..+++++.+||.+||+.||.+|||++|+|+||||+.+.+....... . .+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-~----~~~~ 328 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-Q----KYDD 328 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-C----CCCC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC-C----CCCC
Confidence 21100 022333334444433 3579999999999999999999999999999999998766543211 1 2333
Q ss_pred hHHhhcCCHHHHhhhcHHHHHhh
Q 014750 386 KQELAGASPELINRLIPEHVRRQ 408 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~ 408 (419)
..+....+.+.+++++.+++...
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~ 351 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVLSF 351 (367)
T ss_dssp C-----CCHHHHHHHHHHHHHTC
T ss_pred ChhhhcCCHHHHHHHHHHHHHHh
Confidence 33344567788888888877653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-54 Score=404.79 Aligned_cols=282 Identities=35% Similarity=0.657 Sum_probs=231.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+|+++++.++||||+++++++ .+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 4467999999999999999999985 58999999986432 2345799999999999999999998 4555
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLIN-SDGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEEC-CCCCEEEccCcCce
Confidence 6899999999998887765 24569999999999999999999999 6999999999999999 57789999999998
Q ss_pred ccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....|...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 76433 22344678999999999987667899999999999999999999999999999999999999999887766543
Q ss_pred Cc--CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 308 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. .+....+......++... ...+++++.+||++||+.||.+|||++|+|+||||++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSI-IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHH-STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hccchhhhcccccccCCcHHHh-CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 21 111112222333344333 3457899999999999999999999999999999998754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=412.49 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCc-----ccHHHHHHHHHhcCC-CCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRLMDH-PNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h-~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||+||+|++..+ ++.||||.+.... ....+|+++|+.++| ||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-- 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence 456899999999999999999997654 3689999986543 234579999999976 899999998743
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCce
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NI 210 (419)
....+|||||||+ |+|.+.|+.... ....+++..+..++.||+.||+|||+ ++||||||||+||
T Consensus 140 --~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 216 (353)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred --cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence 2334889999999 688888875432 13568999999999999999999999 6999999999999
Q ss_pred eeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHH
Q 014750 211 LVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (419)
Q Consensus 211 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 286 (419)
|++ .++.+||+|||+|+....... ....+||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..
T Consensus 217 Ll~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999 678899999999987644432 2246789999999999875 59999999999999999998 99999987654
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+.+..++.....+ ..++.+++++.+||.+||+.||++|||+.|+++|
T Consensus 295 ~~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4444443321110 1234579999999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=408.83 Aligned_cols=323 Identities=33% Similarity=0.609 Sum_probs=259.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++|+||+++++++..........+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999999999999999986432 233479999999999999999999865544445568
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEEC-CCCCEEEEeCcceEec
Confidence 99999999998888864 569999999999999999999999 6999999999999999 6778999999999866
Q ss_pred ccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 231 VKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 231 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..... ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43322 23458899999999987766689999999999999999999999999999999999999999999887765
Q ss_pred cCcCC---ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCC
Q 014750 307 MNPNY---TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLF 383 (419)
Q Consensus 307 ~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~ 383 (419)
..... ....++.....+|...+ ..+++++.+||.+||+.||.+|||++|+|+||||++...+...... ...+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~----~~~~ 333 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPF 333 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCC----CCcC
Confidence 42110 00122223333444333 3579999999999999999999999999999999987654433222 2235
Q ss_pred CchHHhhcCCHHHHhhhcHHHHHhhcC
Q 014750 384 NFKQELAGASPELINRLIPEHVRRQTG 410 (419)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (419)
.++.+....+.+.+++++.++..+..+
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~e~~~~~~ 360 (364)
T 3qyz_A 334 KFDMELDDLPKEKLKELIFEETARFQP 360 (364)
T ss_dssp CCC-----CCHHHHHHHHHHHTGGGCC
T ss_pred CcccccccCCHHHHHHHHHHHHHHhhh
Confidence 556667778889999999988776554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=402.31 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=221.0
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++++.++||||+++++++ ...
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence 456689999999999999999999999999999999865422 234799999999999999999998 445
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||++ ++|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEc-CCCCEEEeeccC
Confidence 56899999997 577777765 3569999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------- 230 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------- 230 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9877666556677899999999999887655689999999999999999999999998887777766521
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
+. ++..+++++.+||++||+.||.+|||++|+++||||+......
T Consensus 231 -------~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~ 275 (328)
T 3fe3_A 231 -------YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275 (328)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred -------CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence 11 2234689999999999999999999999999999998765443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=407.18 Aligned_cols=291 Identities=33% Similarity=0.615 Sum_probs=234.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+.+++.++|+||+++++++. +...++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence 479999999999999999999999999999998864322 2336999999999999999999984 444589
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
+||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...
T Consensus 77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLIN-ERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEEC-TTCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEEC-CCCCEEEccCccccccc
Confidence 99999999988887753 4568999999999999999999999 6999999999999999 57789999999997654
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC--
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 308 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 308 (419)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....|+...
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 322 23345789999999999876678999999999999999999999999999999999999999999877665432
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCC
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 378 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~ 378 (419)
..+..+.++......+... ...+++++.+||.+||+.||.+|||++|+|+||||.++.......+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~ 300 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSH-APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTS 300 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHH-CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSC
T ss_pred hhhcccccccccchhhhhh-cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCc
Confidence 1122233333333333222 34579999999999999999999999999999999998876655544443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=409.37 Aligned_cols=320 Identities=32% Similarity=0.521 Sum_probs=242.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++..... .+...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 57999999999999999999999999999999986432 233479999999999999999999854321 12245
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEEC-CCCCEEEeecccccc
Confidence 789999998887776653 579999999999999999999999 6999999999999999 678899999999986
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .....+||++|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+..+..
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 532 244578999999999998766789999999999999999999999999999999999999999999887765432
Q ss_pred CCcc---ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCch
Q 014750 310 NYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (419)
Q Consensus 310 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 386 (419)
.... ..++......+...++ .+++++.+||++||+.||.+|||++|+|+||||+.+..+..... ...+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~-----~~~~~~~ 333 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV-----ADPYDQS 333 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTT-TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCC-----CCCCCGG
T ss_pred HHHHHHHhccCCCCCCCHHHHCC-CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCC-----CCCCCcc
Confidence 1100 0123333334444443 57999999999999999999999999999999999877654321 1224444
Q ss_pred HHhhcCCHHHHhhhcHHHHHhhcCC
Q 014750 387 QELAGASPELINRLIPEHVRRQTGL 411 (419)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (419)
.+......+.+++++.+++......
T Consensus 334 ~~~~~~~~~~~~~~~~~e~~~~~~~ 358 (367)
T 2fst_X 334 LESRDLLIDEWKSLTYDEVISFVPP 358 (367)
T ss_dssp GSSCCCCHHHHHHHHHHHHHHCCCC
T ss_pred hhhccCCHHHHHHHHHHHHHHhccC
Confidence 4445678889999999998876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=399.08 Aligned_cols=288 Identities=32% Similarity=0.566 Sum_probs=221.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence 357999999999999999999999999999999986432 2345899999999999999999998 455568
Q ss_pred EEEeecccccHHHHHHhhcc--CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
|+||||++++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLIN-KRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCSSCE
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEc-CCCCEEECcCccce
Confidence 99999999999888875432 23468999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.+....|...
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 65432 22345678999999999977666899999999999999999999999999999999999999998887665543
Q ss_pred Cc--CCccccCCCCCCCCc----hhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCC
Q 014750 308 NP--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371 (419)
Q Consensus 308 ~~--~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 371 (419)
.. .+. ..+.......+ .......++.++.+||.+||+.||.+|||++|+|+||||++...+..
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 237 TKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp GGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred hhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 21 110 01111111111 12233467899999999999999999999999999999999776543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=397.41 Aligned_cols=284 Identities=30% Similarity=0.531 Sum_probs=232.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcC---CCCeeecceeeeccC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMD---HPNVISLKHCFFSTT 143 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~---h~niv~~~~~~~~~~ 143 (419)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 457999999999999999999999999999999886322 23457887777664 999999999987665
Q ss_pred CCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
......+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~-~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVT-SGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEEC-TTSCEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEc-CCCCEEEee
Confidence 55566789999999999988887532 2449999999999999999999999 6999999999999999 678899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776555556678999999999997654 89999999999999999999999999999999999999999888766
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
|..... .....++.....++.. +...+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 243 WPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 543211 1112233222233333 234579999999999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=393.86 Aligned_cols=278 Identities=33% Similarity=0.628 Sum_probs=224.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||+|+||+||+|++ .+|+.||+|++.... ....+|+.+++.++||||+++++++. +...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence 4799999999999999999998 679999999985432 23458999999999999999999984 34458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEEeECcccccc
Confidence 999999999988877642 3678999999999999999999999 6999999999999999 6788999999999765
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+....|.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 322 2234457899999999997766689999999999999999999999999999999999999998887665543221
Q ss_pred CC-ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 310 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 310 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.. .+..+......+|.. +...+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 001111222222322 334689999999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=402.55 Aligned_cols=285 Identities=32% Similarity=0.564 Sum_probs=232.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++. +.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence 35568999999999999999999999999999999986432 22347999999999999999999984 44
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----CCCceEEee
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCD 223 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~D 223 (419)
..+|+||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ..+.+||+|
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 45899999999998888765 3569999999999999999999999 69999999999999952 345699999
Q ss_pred cccccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 224 FGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 224 fG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9999765432 223456789999999999876668999999999999999999999999999999999999999988876
Q ss_pred HHhccCcC-CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 303 EIRCMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 303 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+...... .....++......+...+...+++++.+||.+||+.||.+|||++|+|+||||++..+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 65433210 1112344455555666666668999999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=404.02 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=212.0
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34568999999999999999999999999999999986432 2344788899887 799999999998 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|+|||||.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~-~~g~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLD-HEGHCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEEC-CCCCEEEccc
Confidence 45569999999985 77777654 3569999999999999999999999 6999999999999999 6788999999
Q ss_pred cccccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 225 GSAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 225 G~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
|+|+.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 99986432 3334567899999999999764 4899999999999999999999999999988888887652
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH------HHHhcCCccccccCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 369 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~------~e~l~hp~f~~~~~~ 369 (419)
... ++..+++++.+||++||+.||.+|+++ +++++||||++++|.
T Consensus 240 ---------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 240 ---------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 111 234579999999999999999999998 999999999988654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=405.19 Aligned_cols=321 Identities=30% Similarity=0.509 Sum_probs=237.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++..... .+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 457999999999999999999999999999999986532 223479999999999999999999854331 2234
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||++++|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence 689999999999887775 358999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+..+.
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 76554445567899999999999764 58999999999999999999999999999999999999999999887765443
Q ss_pred cCCccc--cCCCCCCCCchhhcCC-----------CCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCC
Q 014750 309 PNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 375 (419)
Q Consensus 309 ~~~~~~--~~~~~~~~~~~~~~~~-----------~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 375 (419)
+....+ ..+......+...++. ..+.++++||++||+.||.+|||++|+|+||||+.+.++.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~- 333 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA- 333 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC-
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC-
Confidence 211100 0111111111111111 12568999999999999999999999999999987655432211
Q ss_pred CCCCCCCCCchHHhhcCCHHHHhhhcHHHHHhh
Q 014750 376 GRPFPPLFNFKQELAGASPELINRLIPEHVRRQ 408 (419)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (419)
+.+.......+....+.+.+++++++++...
T Consensus 334 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (371)
T 2xrw_A 334 --PPPKIPDKQLDEREHTIEEWKELIYKEVMDL 364 (371)
T ss_dssp --CCCCCCTTTTCCCCCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCChhhccccCcHHHHHHHHHHHHHHH
Confidence 1111222222334557788899988887654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=401.06 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=218.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|.+.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----- 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----- 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence 4467999999999999999999999999999999986542 2346899999999999999999998
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC---ceE
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVK 220 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vk 220 (419)
.+...+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence 44556999999997 577776643 4679999999999999999999999 69999999999999984432 799
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+|||++............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~ 238 (361)
T 2yab_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238 (361)
T ss_dssp ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 9999999887665555677899999999999764 589999999999999999999999999988888777765322222
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.. +...+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 11 2235799999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=394.98 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=216.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+.+++.++||||+++++++ .+..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence 46799999999999999999999999999999998643 12345799999999999999999998 4455
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEEC-CCCCEEEeeccch
Confidence 69999999985 77666654 3578999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 8643 23344567899999999999764 5899999999999999999999999988877777666541
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
... ++..+++++.+||.+||+.||.+|+ +++++++||||+.+++.
T Consensus 221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 111 2345799999999999999999999 99999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=393.61 Aligned_cols=323 Identities=30% Similarity=0.587 Sum_probs=251.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+++.++|+||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 34579999999999999999999999999999999864322 2347999999999999999999875443334466
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.|+||||+.++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLIN-SNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEc-CCCcEEEEecccccc
Confidence 899999999998888765 569999999999999999999999 6999999999999999 577899999999986
Q ss_pred cccCCc-----------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 230 LVKGEA-----------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 230 ~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
...... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 123578999999999876667899999999999999999999999999999999999988888
Q ss_pred CCHHHHh-ccCcC-Ccc--ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCC
Q 014750 299 PTREEIR-CMNPN-YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 374 (419)
Q Consensus 299 ~~~~~~~-~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 374 (419)
+...... +.... ... ..++......+.. ....+++++.+||.+||+.||.+|||++++++||||+.+..+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 320 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence 7632111 00000 000 0111111222222 22457999999999999999999999999999999999887765433
Q ss_pred CCCCCCCCCCchHHhhcCCHHHHhhhcHHHH
Q 014750 375 NGRPFPPLFNFKQELAGASPELINRLIPEHV 405 (419)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (419)
.....+..+++.......+.+.+++++.+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (353)
T 2b9h_A 321 GEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351 (353)
T ss_dssp CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred cCCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence 3222234456666666678888888888775
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-52 Score=396.64 Aligned_cols=285 Identities=34% Similarity=0.590 Sum_probs=230.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence 3457999999999999999999999999999999886321 2345799999999999999999998 4
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
+...+++||||+++++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg 157 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLD-ENGVLKLADFG 157 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCCG
T ss_pred eCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEc-CCCCEEEEecc
Confidence 4455899999999988777754 23568899999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 99876433 23345678999999999977666899999999999999999999999999999999999999999887766
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
...........+......++... ...++.++.+||.+||+.||.+|||++|+|+||||++...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred hhhccCcccccccccCCCChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence 54432211122222222333332 245789999999999999999999999999999998765443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=396.86 Aligned_cols=319 Identities=33% Similarity=0.577 Sum_probs=249.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCC-Cce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 148 (419)
..+|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357999999999999999999999999999999986532 2334799999999999999999998543321 112
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||+.++|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 121 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVN-EDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEEC-CCCCEEEEecCccc
Confidence 348999999998766552 459999999999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+...+
T Consensus 193 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 653 233456789999999999875678999999999999999999999999999999999999999999887765543
Q ss_pred cCCccc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
...... .++......+... ...+++++.+||.+||+.||.+|||++|+|+||||+.+..+.......+++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~--- 346 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDS--- 346 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCT---
T ss_pred hhhhhhhhhccCCCcchhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcc---
Confidence 211100 1122222222222 345799999999999999999999999999999999887766554433333322
Q ss_pred hHHhhcCCHHHHhhhcHHHHHhhc
Q 014750 386 KQELAGASPELINRLIPEHVRRQT 409 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~ 409 (419)
.+....+.+.+++.+.+++....
T Consensus 347 -~~~~~~~~~~~~~~~~~~~~~~~ 369 (371)
T 4exu_A 347 -LEHEKLTVDEWKQHIYKEIVNFS 369 (371)
T ss_dssp -TSSCCCCHHHHHHHHHHHHHHCC
T ss_pred -hhhcccchHHHHHHHHHHHHhcc
Confidence 23345677888888888876644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=394.07 Aligned_cols=321 Identities=29% Similarity=0.549 Sum_probs=245.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------------ccHHHHHHHHHhcCCCCeeecceeee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRLMDHPNVISLKHCFF 140 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~~~~~~ 140 (419)
.++|++.+.||+|+||.||+|.+.. |+.||||++.... ....+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3579999999999999999999754 9999999885321 23458999999999999999999987
Q ss_pred ccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 141 STTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.........+|+||||++|++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEc-CCCCEE
Confidence 766566667899999999998888764 34579999999999999999999999 6999999999999999 678899
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998665555556678899999999998756689999999999999999999999999999999999999999998
Q ss_pred HHHHhccCcC----CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCC
Q 014750 301 REEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376 (419)
Q Consensus 301 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 376 (419)
...+...... +............|.. ....+++.+.+||.+||+.||.+|||+.|+|+||||+.+..+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~-- 331 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTE-- 331 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTT--
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccc--
Confidence 7765432210 0111112222223332 33457899999999999999999999999999999998866543321
Q ss_pred CCCCCCCCchHHhhcCCHHHHhhhcHHHHHhh
Q 014750 377 RPFPPLFNFKQELAGASPELINRLIPEHVRRQ 408 (419)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (419)
.....+.+.. ...+...+.+.+..++.+.
T Consensus 332 -~~~~~~~~~~--~~~~~~~~~~~~~~e~~~~ 360 (362)
T 3pg1_A 332 -GLSERFHFDE--SVTDVYDMHKIFTAEVERF 360 (362)
T ss_dssp -TCCCCCCCCT--TCCCHHHHHHHHHHHHHHH
T ss_pred -ccccccChhh--hhhhHHHHHHHHHHHHHHh
Confidence 1222333332 4456777788887776653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=407.91 Aligned_cols=261 Identities=26% Similarity=0.365 Sum_probs=200.5
Q ss_pred cccceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHH-HhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..++|.+. +.||+|+||+||+|++..+|+.||||++... ....+|+.++ +..+|+||+++++++.... .+..++||
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 44568776 7899999999999999999999999998644 3456788876 5568999999999874322 24567899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~ 229 (419)
|||||.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999985 787777642 23469999999999999999999999 699999999999999842 67899999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHh
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 305 (419)
..........+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+... ....+...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~---------- 282 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------- 282 (400)
T ss_dssp CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----------
T ss_pred cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----------
Confidence 655555566789999999999965 458999999999999999999999998764322 12222211
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.+.++.. ....++.++.+||++||+.||.+|||+.++++||||...
T Consensus 283 -------~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 283 -------QYEFPNP--------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------CCCCCTT--------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------cccCCCc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1111110 113478999999999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=400.64 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=210.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||+||+|+++.+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence 45568999999999999999999999999999999986542 2245788888876 899999999998 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|+|||||.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~-~~g~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEC-CCCCEEEeec
Confidence 45569999999985 77666654 3579999999999999999999999 6999999999999999 6788999999
Q ss_pred cccccc-ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---------HHHHHHHHH
Q 014750 225 GSAKVL-VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIK 294 (419)
Q Consensus 225 G~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~ 294 (419)
|+|+.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ......+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 999863 334445668899999999999764 589999999999999999999999964321 112222222
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH------HHHhcCCccccccC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~------~e~l~hp~f~~~~~ 368 (419)
. . ..++..+++++.+||++||+.||.+|+++ +|+++||||+.++|
T Consensus 277 ~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 277 K-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp C-----------------C------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred c-----------------c------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 0 0 11345679999999999999999999985 89999999999876
Q ss_pred C
Q 014750 369 P 369 (419)
Q Consensus 369 ~ 369 (419)
.
T Consensus 328 ~ 328 (396)
T 4dc2_A 328 D 328 (396)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=385.12 Aligned_cols=284 Identities=33% Similarity=0.604 Sum_probs=223.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+|+.+++.++|+||+++++++. +....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence 479999999999999999999999999999998865432 2347999999999999999999984 34458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||||++++++..+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILIT-KHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEc-CCCCEEEeeCCCchhc
Confidence 99999999875554443 34679999999999999999999999 6999999999999999 6788999999999876
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc--
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 307 (419)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+.++..........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 4322 2345678999999999987667899999999999999999999999999999999999988888776544322
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
+..+.....+..............++.++.+||++||+.||.+|||++|+++||||+++.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 112222223322221111222245799999999999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=401.58 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=218.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEecc-------CcccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||+||+|++..+++.||+|++.+ ......+|+.+++.++||||+++++++ .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 45689999999999999999999999999999999854 233456899999999999999999998 455
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||+ |+|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~-~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLD-KSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeEC-CCCCEEEeccce
Confidence 66999999997 577777654 468999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc--ceeeeeccccccchhhcCCCC---CCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGEA--NISYICSRYYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+....... ....+||+.|+|||++.+... |+.++|||||||++|+|++|..||.+.+..+...++.+....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 291 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--- 291 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence 987644332 235789999999999976432 788999999999999999999999999988888877653110
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 370 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~ 370 (419)
+.+|. ...+++++++||++||+.+|.+ |++++|+++||||++++|..
T Consensus 292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 11111 1247999999999999999988 99999999999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=387.67 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=216.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+|++.+.||+|+||+||+|++..+|+.||+|++.+. .....+|+.+++.++||||+++++++ .+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence 346799999999999999999999999999999998643 22345799999999999999999998 445
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~Dfg~ 152 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLD-KNGHIKITDFGF 152 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEEC-TTSCEEECCCSS
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEc-CCCCEEEeecCc
Confidence 569999999985 77777764 4579999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
++.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 153 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 218 (318)
T 1fot_A 153 AKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------- 218 (318)
T ss_dssp CEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------
T ss_pred ceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 986532 34457899999999999764 4899999999999999999999999998888777777652
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
... ++..+++++.+||++||+.||.+|+ +++++++||||+++.+.
T Consensus 219 ------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 219 ------ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 011 2345789999999999999999999 99999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=401.37 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=212.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|.+.+.||+|+||+||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++. .
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence 3456899999999999999999999999999999988532 224568999999999999999999984 4
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+++||||++|+|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kl~DFG~ 154 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLD-DNLNVKIADFGL 154 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEEC-TTCCEEECCSSC
T ss_pred CCEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEc-CCCCEEEEEecc
Confidence 4458999999999988887653 569999999999999999999999 6999999999999999 677899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+............+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+...
T Consensus 155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---------------- 218 (336)
T 3h4j_B 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---------------- 218 (336)
T ss_dssp TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------
T ss_pred ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence 9887666666677899999999999876645889999999999999999999997643211100
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.+.. ....++..+++++.+||++||+.||.+|||++|+++||||+.
T Consensus 219 -----------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 219 -----------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -----------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -----------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 0000 011234567999999999999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=397.50 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=211.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHH-HHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||+||+|+++.+++.||+|++.+... ...+|..+ ++.++||||+++++++ .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 34579999999999999999999999999999999865432 12234444 4678999999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~ikL~DFG 184 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLD-SQGHIVLTDFG 184 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEC-CCCCEEEeeCc
Confidence 5569999999985 77777664 3568999999999999999999999 6999999999999999 67889999999
Q ss_pred ccccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 254 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------- 254 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS---------
T ss_pred cccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------
Confidence 9986432 3344567899999999999764 5899999999999999999999999998888877777652
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH----HHHhcCCccccccCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREPN 370 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~----~e~l~hp~f~~~~~~~ 370 (419)
.. .++..++.++.+||++||+.||.+|+++ .++++||||+.++|..
T Consensus 255 --------~~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 255 --------PL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp --------CC------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred --------cc------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 00 1234579999999999999999999986 6999999999887643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=402.84 Aligned_cols=280 Identities=31% Similarity=0.554 Sum_probs=229.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhc------CCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLM------DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 145 (419)
...+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.+ +|+||+++++++.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----- 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----- 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence 3457999999999999999999999999999999997653 2344688888877 5779999999884
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc--eEEee
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ--VKLCD 223 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~--vkl~D 223 (419)
....+|+||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++. +||+|
T Consensus 170 ~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~-~~~~~~vkL~D 245 (429)
T 3kvw_A 170 FRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLK-QQGRSGIKVID 245 (429)
T ss_dssp ETTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEES-STTSCCEEECC
T ss_pred cCCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEc-cCCCcceEEee
Confidence 344589999999999998887632 2458999999999999999999999 6999999999999999 4554 99999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||++.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.+.+|.|....
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99997543 3344578899999999998754 89999999999999999999999999999999999999999999887
Q ss_pred HhccCcC--------Cccc----------------------cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC
Q 014750 304 IRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 353 (419)
Q Consensus 304 ~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 353 (419)
+...... +..+ .........|...+....++++.+||++||++||.+|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 6543210 0000 000112334555566667899999999999999999999
Q ss_pred HHHHhcCCccccc
Q 014750 354 ALEACAHPFFDEL 366 (419)
Q Consensus 354 ~~e~l~hp~f~~~ 366 (419)
++|+|+||||++.
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=402.41 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=220.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.++||+|+||+||+|++..+++.||+|++.+. .....+|+.++..++|+||+++++++ .+.
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence 346899999999999999999999999999999998542 23467899999999999999999998 455
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~-~~g~vkL~DFGl 221 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMD-MNGHIRLADFGS 221 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEc-CCCCEEEcchhh
Confidence 56999999997 577777764 24679999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcc--eeeeeccccccchhhc----CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 227 AKVLVKGEAN--ISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 227 a~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+........ ...+||+.|+|||++. +...|+.++|||||||++|||++|+.||.+.+..+...++.....
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--- 298 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--- 298 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc---
Confidence 9766443332 3368999999999996 234589999999999999999999999999998888887764211
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCC--CCCHHHHhcCCccccccCCCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNA 371 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~--R~t~~e~l~hp~f~~~~~~~~ 371 (419)
.+.+|. ....+++++++||++||+.+|++ |++++|+++||||++++|..-
T Consensus 299 ------------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 ------------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp ------------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred ------------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 011111 11247999999999999999988 999999999999999887654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=389.32 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=219.2
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++. +...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEEE
Confidence 457999999999999999999999999999999886443 23457999999999999999999984 3445899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC-CCceEEeeccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~ 230 (419)
|||||.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999985 77766643 23579999999999999999999999 699999999999999842 678999999999887
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence 666666677899999999999764 479999999999999999999999999988888887776433322221
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
...++.++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 134689999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=391.22 Aligned_cols=289 Identities=28% Similarity=0.477 Sum_probs=228.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC---C
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 145 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4568999999999999999999999999999999885432 134589999999999999999998855321 1
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
....+|+||||+++++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLIT-RDGVLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEc-CCCCEEEccch
Confidence 24568999999999988877653 3569999999999999999999999 6999999999999999 67789999999
Q ss_pred cccccccC-----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99765422 1223467899999999998766689999999999999999999999999999999999999998887
Q ss_pred HHHHhccCc--CCccccCCCCCCCCchhhcC-CCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 301 REEIRCMNP--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 301 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
...++.... .+............+...+. ...++++.+||.+||+.||.+|||++|+|+||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 665543321 11111111111111111110 113778999999999999999999999999999986443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=389.19 Aligned_cols=253 Identities=19% Similarity=0.233 Sum_probs=187.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-c--HHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-Y--KNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~--~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|.+.+.||+|+||+||+|++ +|+.||||++..... . .+.|+..+..++|||||++++++.... .....+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 4689999999999999999987 689999999865432 1 234555566889999999999986432 123458999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CcccccccCCceeeCCCCCceEEeec
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
||||+ |+|.+.++. ..+++..+..++.|++.||.|||+ + +||||||||+||||+ .++++||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeC
Confidence 99998 688887764 468999999999999999999997 5 899999999999999 6889999999
Q ss_pred ccccccccCCcc-----eeeeeccccccchhhcCCC-----CCCCcccEeehhHHHHHHHhCCCCCCCCCH---------
Q 014750 225 GSAKVLVKGEAN-----ISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA--------- 285 (419)
Q Consensus 225 G~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~--------- 285 (419)
|+|+........ ...+||+.|||||++.+.. .|+.++|||||||++|||+||.+||.....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999876544322 2357999999999997542 257799999999999999999887753321
Q ss_pred -----HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 286 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 286 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+.+...... .. .+..+|.. ......+..+.+||.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~-------------~~-~rp~~p~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCE-------------QK-LRPNIPNR-------WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTT-------------SC-CCCCCCGG-------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhc-------------cc-CCCCCCcc-------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111100 00 00001100 0001123578899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=393.44 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=215.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (419)
..++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|..+++.+ +||||+++++++ .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 4467999999999999999999999999999999986431 2334688888876 999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+|||||. |+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLD-KDGHIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEEC-CCCCEEEeECh
Confidence 556999999997 577777764 3569999999999999999999999 6999999999999999 57789999999
Q ss_pred ccccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~------ 234 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N------ 234 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C------
Confidence 9986432 2334567899999999999764 4899999999999999999999999998887777776541 0
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH-HHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~-e~l~hp~f~~~~~~ 369 (419)
. .++..+++++.+||.+||+.||.+|+++. ++++||||+++++.
T Consensus 235 ---------~------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 235 ---------P------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ---------C------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ---------C------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 0 12345799999999999999999999998 99999999988754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=400.28 Aligned_cols=290 Identities=31% Similarity=0.519 Sum_probs=214.7
Q ss_pred cceee-eceeccCCceEEEEEEEc--CCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
+.|.+ .++||+|+||+||+|++. .+++.||+|++.... ....+|+.+|+.++||||+++++++.. .....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence 45777 458999999999999966 578999999987543 345689999999999999999999864 2344689
Q ss_pred EEeecccccHHHHHHhhcc-----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC---CCCCceEEee
Q 014750 152 LVMEYVPETMYRVLKHYSS-----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCD 223 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~~vkl~D 223 (419)
+||||+.++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||||. ..++.+||+|
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999999888865432 12359999999999999999999999 6999999999999993 2567899999
Q ss_pred cccccccccC----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---------HHHHH
Q 014750 224 FGSAKVLVKG----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLV 290 (419)
Q Consensus 224 fG~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~ 290 (419)
||+++..... ......+||+.|+|||++.+...++.++||||||||+|+|++|..||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999876432 2233568899999999998766689999999999999999999999987654 47899
Q ss_pred HHHHHhCCCCHHHHhccCcCC---------ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 291 EIIKVLGTPTREEIRCMNPNY---------TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
.+.+.+|.|....|......- ....+.......+........++++.+||.+||++||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999877665432110 00001100000111111223478999999999999999999999999999
Q ss_pred ccccccCCC
Q 014750 362 FFDELREPN 370 (419)
Q Consensus 362 ~f~~~~~~~ 370 (419)
||.+...+.
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 998865543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=388.34 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=209.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||.||+|++..+++.||+|++.+... ...+|..+++.+ +||||+++++++ .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence 345689999999999999999999999999999999875421 234688899887 899999999998 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLD-SEGHIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEC-CCCCEEEEec
Confidence 45569999999985 77777654 3569999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC---------HHHHHHHHHH
Q 014750 225 GSAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEIIK 294 (419)
Q Consensus 225 G~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---------~~~~~~~i~~ 294 (419)
|+++... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 9998643 23344567899999999999764 58999999999999999999999997521 1122222222
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH------HHHhcCCccccccC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~------~e~l~hp~f~~~~~ 368 (419)
. .. .++..++.++.+||++||+.||.+|+++ +++++||||++++|
T Consensus 234 ~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 234 K-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp C-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred C-----------------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 0 00 1334579999999999999999999995 89999999998775
Q ss_pred C
Q 014750 369 P 369 (419)
Q Consensus 369 ~ 369 (419)
.
T Consensus 285 ~ 285 (345)
T 3a8x_A 285 D 285 (345)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=397.27 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=213.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 44568999999999999999999999999999999985432 2345799999999999999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+.| +|...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLD-EHGHVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEC-CCCCEEEeccc
Confidence 5568999999975 66666653 4679999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~~ 300 (419)
+++...........+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||...+. .+....+...
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----- 235 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----- 235 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence 99887666666778999999999999642 3489999999999999999999999975432 2222222221
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-HHHHhcCCccccccCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP 369 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-~~e~l~hp~f~~~~~~ 369 (419)
. ..++..++.++.+||.+||+.||.+|++ ++++++||||+++++.
T Consensus 236 ------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 ------------V------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp ------------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred ------------c------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 0 1123457999999999999999999998 8999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=386.15 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=216.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 83 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----- 83 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 4457999999999999999999999999999999986432 2356899999999999999999998
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC----ce
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH----QV 219 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~----~v 219 (419)
.+...+++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~~ 157 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPRI 157 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCCE
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCCE
Confidence 44556899999997 577776653 4679999999999999999999999 69999999999999984 44 79
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
||+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 99999999877555555567899999999999654 58999999999999999999999999988887777766532221
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.. .....++.++.+||++||+.||.+|||+.++|+||||+..
T Consensus 237 ~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 237 ED-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CH-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred Cc-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11 1223568999999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=380.84 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=212.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...+|++.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCEE
Confidence 3457999999999999999999999999999999885332 234579999999999999999999844 3448
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||. ++|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEC-CCCCEEEeeCCCcee
Confidence 99999997 577776654 468999999999999999999999 6999999999999999 577899999999976
Q ss_pred cccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...... .
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~-------- 235 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-E-------- 235 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-C--------
T ss_pred cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C--------
Confidence 64433 23456899999999999765 4899999999999999999999999988877766665542111 0
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...+..++..+.+||.+||+.||.+|||++|+++||||+..
T Consensus 236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 -----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 00123578999999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=386.57 Aligned_cols=282 Identities=33% Similarity=0.612 Sum_probs=229.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc------HHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++...... ..+|+.+++.++|+||+++++++. +.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence 3556899999999999999999999999999999988644322 347999999999999999999984 44
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|+||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVS-QSGVVKLCDFGFA 171 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEc-CCCcEEEEeCCCc
Confidence 55899999999876665543 34679999999999999999999999 6999999999999999 5778999999999
Q ss_pred cccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.........
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 765432 2234567899999999998765689999999999999999999999999999999999999888877665443
Q ss_pred c--CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 M--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
. ++.+.....+.+............+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2 3333444455444333333344568999999999999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=390.50 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=213.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC---------cccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
..++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 96 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS----- 96 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 346799999999999999999999999999999988532 233568999999999999999999984
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEe
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLC 222 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~ 222 (419)
+...+|+|||||. ++|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.. ...+||+
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEe
Confidence 3455899999998 57877777655556679999999999999999999999 699999999999999842 2349999
Q ss_pred ecccccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 223 DFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 223 DfG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|||++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+.+.......
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~ 253 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP 253 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence 9999987654332 3456899999999999764 48999999999999999999999998753 3444444442111111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.. ...+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 254 ~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 254 RQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 11 134689999999999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=394.63 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=218.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|..++..++|+||+++++++ .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 456899999999999999999999999999999998642 23456899999999999999999998 455
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||. |+|.+.+... +..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld-~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLD-RCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeec-CCCCEEEeechh
Confidence 66999999996 6888777653 3479999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCc--ceeeeeccccccchhhcC------CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 227 AKVLVKGEA--NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 227 a~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
++....... ....+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.+.+..+...++......
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 987644332 234689999999999973 245899999999999999999999999999888887777642100
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCC---CCHHHHhcCCccccccCCCC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNA 371 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R---~t~~e~l~hp~f~~~~~~~~ 371 (419)
..+|. +...+++++++||++||+ ||.+| ++++|+++||||++++|..-
T Consensus 289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 01111 123579999999999999 99998 59999999999999987754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=388.36 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=217.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 45578999999999999999999999999999999985432 2345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+. |+|.+.+... +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~g~~kL~DFg 186 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLID-QQGYIQVTDFG 186 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEEC-CCCCEEEcccc
Confidence 556999999997 5787777653 569999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+++.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 187 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 187 FAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------- 254 (350)
T ss_dssp TCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 9986533 23467899999999999764 48999999999999999999999999988887777776520
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
.. ++..+++++.+||.+||+.||.+|++ ++++++||||+.+++.
T Consensus 255 --------~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 255 --------VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp --------CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred --------CC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 11 23457999999999999999999998 9999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=390.88 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=215.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||+||+|++..+|+.||+|++.+.. ....+|..++..+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 4567999999999999999999999999999999986432 2234688888877 899999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+.| +|.+.+... +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~-~~g~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLD-SEGHIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEc-CCCcEEEEeCC
Confidence 5569999999985 777777642 569999999999999999999999 6999999999999999 67789999999
Q ss_pred cccccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++... ........+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+...
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 236 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 236 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 998643 23344567899999999999764 4899999999999999999999999998888887777652
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
... ++..+++++.+||++||+.||.+|++ ++++++||||+.++|.
T Consensus 237 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred --------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 111 23457999999999999999999994 6999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=392.48 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=215.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence 3457999999999999999999999999999999986543 2345799999999999999999998 4555
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG 225 (419)
..|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 68999999985 77666653 4678999999999999999999999 699999999999999843 3469999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 252 (362)
T 2bdw_A 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--- 252 (362)
T ss_dssp TCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred cceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence 99877655555567899999999999764 58999999999999999999999999988877777766532111100
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
....+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 253 ----------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 253 ----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ----------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ----------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 112468999999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=386.21 Aligned_cols=317 Identities=33% Similarity=0.583 Sum_probs=246.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCC-Ccee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK-DELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 149 (419)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999999999999999986532 2234799999999999999999998543221 1123
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+||||+.++|.+.+ ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVN-EDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-TTCCEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeEC-CCCcEEEeecccccC
Confidence 5899999998765443 2459999999999999999999999 6999999999999999 677899999999976
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..|.+..+.+...+.
T Consensus 176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 532 234567899999999997756689999999999999999999999999999999999999999998877655432
Q ss_pred CCccc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCch
Q 014750 310 NYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK 386 (419)
Q Consensus 310 ~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 386 (419)
..... .++......+.. +...+++++.+||.+||+.||.+|||++++++||||+.+..+........+ ++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~----~~~~ 328 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP----FDDS 328 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC----CCCT
T ss_pred HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC----Cccc
Confidence 21100 111111122222 223579999999999999999999999999999999988766544332222 2333
Q ss_pred HHhhcCCHHHHhhhcHHHHHhh
Q 014750 387 QELAGASPELINRLIPEHVRRQ 408 (419)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~ 408 (419)
.+....+.+.+++.+.+++...
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~ 350 (353)
T 3coi_A 329 LEHEKLTVDEWKQHIYKEIVNF 350 (353)
T ss_dssp TTTCCCCHHHHHHHHHHHHHTC
T ss_pred hhhccCCHHHHHHHHHHHHHhh
Confidence 3445678888899988887653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=400.19 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=214.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence 3467999999999999999999999999999999986543 2345899999999999999999998 4556
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG 225 (419)
.+|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 68999999985 77777664 4679999999999999999999999 69999999999999984 25679999999
Q ss_pred cccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
++........ .....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+....+.......+..
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 235 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP-- 235 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc--
Confidence 9977644332 3456899999999999764 58999999999999999999999999998888887776632211100
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
....+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 236 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 236 -----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 113468999999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=387.35 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=212.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+......+|++++..+ +||||+++++++ .+...+|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence 34579999999999999999999999999999999988777778899998887 799999999998 455669999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC---CceEEeecccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLCDFGSAKV 229 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~DfG~a~~ 229 (419)
||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+...+ +.+||+|||+++.
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999984 77776654 4679999999999999999999999 6999999999999985333 3599999999986
Q ss_pred cccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHHHHh
Q 014750 230 LVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 230 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---------- 238 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG---------- 238 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC----------
T ss_pred CcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC----------
Confidence 6443 234456889999999999764 3889999999999999999999999863 344444444331
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.+.++ ......+++++.+||++||..||.+|||+.++++||||.++.
T Consensus 239 -------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 239 -------KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp -------CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred -------CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 01111 112245799999999999999999999999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=385.89 Aligned_cols=280 Identities=25% Similarity=0.435 Sum_probs=224.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcC-----CCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----HPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~ 145 (419)
...++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.+. |+||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~---- 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY---- 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE----
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE----
Confidence 34568999999999999999999999999999999986432 23456899999986 9999999999844
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-----------
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----------- 214 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----------- 214 (419)
...+|+||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 108 -~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 108 -YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp -TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred -CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchh
Confidence 34589999999889988887532 2458999999999999999999999 69999999999999973
Q ss_pred -------------CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCC
Q 014750 215 -------------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 281 (419)
Q Consensus 215 -------------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 281 (419)
.++.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCC
Confidence 267899999999976432 33457889999999999765 48999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCcCC-cc--------ccCCCCCCCC--------chhhcCCCCChhHHHHHhhhc
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNY-TD--------FRFPQIKAHP--------WHKVFHKRMPPEAIDLASRLL 344 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~--------~~~~~~~~~s~~~~dli~~~L 344 (419)
+.+..+.+..+....+..+...+....... .. ..++...... ....+....++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 999999999999988888876554322110 00 0111100000 000111123578889999999
Q ss_pred ccCCCCCCCHHHHhcCCccc
Q 014750 345 QYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 345 ~~dP~~R~t~~e~l~hp~f~ 364 (419)
+.||.+|||++|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=376.46 Aligned_cols=290 Identities=33% Similarity=0.568 Sum_probs=235.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-CCCcEEEEEEeccC------cccHHHHHHHHHhc---CCCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQD------RRYKNRELQLMRLM---DHPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~ 143 (419)
....+|++.+.||+|+||.||+|++. .+|+.||+|++... .....+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 44568999999999999999999995 67899999988532 22455788887766 8999999999886443
Q ss_pred CCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 144 SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
......+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~-~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEc-CCCCEEEec
Confidence 34567789999999999988887532 3458999999999999999999999 6999999999999999 577899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||++.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999876544445567889999999999764 489999999999999999999999999999999999999999888766
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
|...... ....+......++ ..+...++.++.+||.+||+.||.+|||+.++++||||+++....
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 243 WPRDVAL-PRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp SCTTCSS-CGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred Ccccccc-chhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 5432110 0111111111122 223456899999999999999999999999999999999876654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=391.65 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=196.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. +...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence 3457999999999999999999999999999999987543 33558999999999999999999984 445589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC--ceEEeeccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAK 228 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~a~ 228 (419)
+|||||. ++|.+.+.. .+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .+||+|||+++
T Consensus 93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC-
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCccc
Confidence 9999997 577777754 3569999999999999999999999 69999999999999983 43 49999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
...........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------- 236 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------- 236 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----------
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----------
Confidence 6544445556789999999999987664455599999999999999999999875443322222221100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..+.++. ...+++++.+||++||+.||.+|||+.|+++||||.+.
T Consensus 237 ---~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 237 ---VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ---TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ---CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0011111 12468999999999999999999999999999999654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=389.90 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=216.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+...++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence 457999999999999999999999999999999986542 2345799999999999999999998 4455689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-CCCceEEeecccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~ 229 (419)
+|||||.| +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999985 66665543 23579999999999999999999999 69999999999999974 346799999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 268 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----------- 268 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 7655555667899999999999764 4899999999999999999999999998887777776552111
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
++ ......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 269 ------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 269 ------FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ------CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11 011235799999999999999999999999999999998643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=385.10 Aligned_cols=283 Identities=30% Similarity=0.524 Sum_probs=221.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++ |+||+++++++.. ......++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEE
Confidence 446799999999999999999999999999999998643 344568999999997 9999999998854 22445889
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+.+ +|.+.+. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++..+||+|||+++...
T Consensus 111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999996 4444332 38899999999999999999999 6999999999999999555589999999998776
Q ss_pred cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHHhc-cCc
Q 014750 232 KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRC-MNP 309 (419)
Q Consensus 232 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~-~~~ 309 (419)
.........+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+.+.++.+....+.. ...
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 65555667889999999999776678999999999999999999999984 4567777777777776544322211 110
Q ss_pred CCcc---ccCCCCCCCCchhhc----CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTD---FRFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~---~~~~~~~~~~~~~~~----~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.... ..........|...+ ...+++++.+||.+||+.||.+|||++|+|+||||+++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0000 000011111222211 2237899999999999999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=373.21 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=209.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|.+.+.||+|+||.||+|++..++..+|+|++.... ....+|+++++.++||||+++++++ .+...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence 3457999999999999999999999999999999986543 3346899999999999999999998 44556
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeeccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~ 226 (419)
+|+||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 8999999985 8888887665556789999999999999999999999 69999999999999953 346799999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 243 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-------- 243 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------
T ss_pred ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc--------
Confidence 987665555566788999999999853 4899999999999999999999999988776655544331100
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+. .....+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 244 ---------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 244 ---------YA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ---------CC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ---------cc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 001236899999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=378.85 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=206.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------------------------ccHHHHHHH
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQL 123 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~~~ 123 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34568999999999999999999999999999999986432 234579999
Q ss_pred HHhcCCCCeeecceeeeccCCCCceeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 124 MRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 124 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
++.++||||+++++++.. .....+|+||||++++ |.+. .....+++..++.++.||+.||.|||+ +||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH 160 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIH 160 (298)
T ss_dssp HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeec
Confidence 999999999999998854 2245689999999864 3321 124579999999999999999999999 69999
Q ss_pred ccccCCceeeCCCCCceEEeecccccccccCCc-ceeeeeccccccchhhcCCCC--CCCcccEeehhHHHHHHHhCCCC
Q 014750 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPL 279 (419)
Q Consensus 203 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~p 279 (419)
|||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+... ++.++|||||||++|+|++|..|
T Consensus 161 ~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 161 RDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999 577899999999987644322 334678999999999976442 47789999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
|.+.+.......+.... ..++. ...+++++.+||.+||+.||.+|||+.|+++
T Consensus 240 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99887666555544310 01111 1347899999999999999999999999999
Q ss_pred CCcccc
Q 014750 360 HPFFDE 365 (419)
Q Consensus 360 hp~f~~ 365 (419)
||||++
T Consensus 293 hp~~~~ 298 (298)
T 2zv2_A 293 HPWVTR 298 (298)
T ss_dssp CHHHHC
T ss_pred CccccC
Confidence 999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=381.42 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=207.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence 457999999999999999999999999999999885432 4456899999999999999999998 445568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+|||||.+ +|.+.+ .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~-~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEe-CCCCEEEEEeeccce
Confidence 999999986 544433 345679999999999999999999999 6999999999999999 677899999999976
Q ss_pred cccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...+..............
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------- 226 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------- 226 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------
Confidence 53322 2235678999999999987665688999999999999999999999876543222221111000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.. . ....++.++.+||.+||+.||.+|||++|+++||||++..
T Consensus 227 --------~~-----~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 227 --------YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp --------TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------cC-----C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 00 0 0124689999999999999999999999999999998743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=381.06 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=208.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhcCCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (419)
....+|++.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-- 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--
Confidence 34568999999999999999999985 689999999986532 23457999999999999999999984
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
....+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 92 ---~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~-~~~~~kl 162 (327)
T 3a62_A 92 ---TGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLN-HQGHVKL 162 (327)
T ss_dssp ---CSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEEC-TTSCEEE
T ss_pred ---cCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEEC-CCCcEEE
Confidence 4445899999998 577777664 3568999999999999999999999 6999999999999999 5788999
Q ss_pred eecccccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 222 CDFGSAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 222 ~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+|||+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---- 237 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---- 237 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 999999754322 223456789999999999764 48999999999999999999999999988887777776521
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
.. ++..++.++.+||.+||..||.+|| ++.++++||||+.+.+.
T Consensus 238 -------------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 238 -------------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp -------------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred -------------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 01 2345789999999999999999999 89999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=400.90 Aligned_cols=253 Identities=30% Similarity=0.437 Sum_probs=216.5
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|.+.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++. .
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence 34568999999999999999999999999999999986431 23468999999999999999999983 4
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+|||||. ++|.+.+. ..+.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~-~~~~vkL~DFG 161 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLD-AHMNAKIADFG 161 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEC-TTCCEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEe-cCCCeEEEecc
Confidence 455899999997 46666554 35679999999999999999999999 6999999999999999 57789999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+++...........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+...++.....
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------- 233 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-------- 233 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------
Confidence 998876665566778999999999998766558899999999999999999999998887776666654210
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. .+..+++++.+||++||+.||.+|||+.++++||||+..
T Consensus 234 ---------~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 ---------Y------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ---------C------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ---------C------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 123478999999999999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=376.78 Aligned_cols=287 Identities=29% Similarity=0.519 Sum_probs=222.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccC--------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT-------- 143 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 143 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 457999999999999999999999999999999886443 23457999999999999999999874321
Q ss_pred -CCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 144 -SKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 -~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
..+...+|+||||++++|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccCCCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 123456899999999998877753 578999999999999999999999 6999999999999998567789999
Q ss_pred ecccccccccCC----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 223 DFGSAKVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 223 DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|||+++...... ......+|..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998653221 1233567899999999877567899999999999999999999999999999999988888777
Q ss_pred CCHHHHhccCcCCccc---cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 299 PTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.....+.........+ ... ....++ ..+...++.++.+||++||+.||.+|||++++|+||||+....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred CchhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 6665544321111000 000 001111 122345799999999999999999999999999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=374.90 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=217.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 84 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY----- 84 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----
Confidence 3457999999999999999999999999999999986432 2256899999999999999999998
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC---ceE
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVK 220 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vk 220 (419)
.+...+++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence 44556899999997 577777654 4678999999999999999999999 69999999999999984332 799
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 9999999877655555567899999999999764 489999999999999999999999999888777776654322111
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
..+...++..+.+||.+||..||.+|||++++++||||+...+
T Consensus 239 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 239 -------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred -------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 1122357899999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=401.18 Aligned_cols=257 Identities=27% Similarity=0.414 Sum_probs=214.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++.+. .....+|+.+|+.++||||+++++++ .+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence 4567899999999999999999999999999999998543 12345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+. |+|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld-~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLD-DHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEe-CCCCeEEEecc
Confidence 556999999997 5777766542 23459999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~~~ 301 (419)
+++...........+||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+. .+....+...
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------ 404 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------ 404 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence 99887665555667899999999999764 489999999999999999999999987642 2222222210
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
...++..+++++.+||++||+.||.+|+ +++|+++||||+++++.
T Consensus 405 -----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 405 -----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp -----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred -----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 0112345799999999999999999999 89999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=377.07 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=199.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccH------HHHHHHH-HhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++....... ..|+..+ +..+|+||+++++++ .+..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~ 130 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGG 130 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCC
Confidence 367999999999999999999999999999999886543222 2333333 344999999999998 3445
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLG-PRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-GGGCEEECCCTTCE
T ss_pred EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEC-CCCCEEEccceeee
Confidence 58999999999988887653 4579999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..+.. +.
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~---------- 268 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GY---------- 268 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TC----------
T ss_pred ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cC----------
Confidence 7755555556679999999999875 4899999999999999999997776543322 11111 00
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
....++..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 269 ---------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 269 ---------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011233457999999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=372.35 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=199.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc------HHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++...... ..++...++.++||||+++++++.. ..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence 456899999999999999999999999999999998654221 1234445778899999999999843 44
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..++||||+++++.+.+.........+++..++.++.||+.||.|||+ + ||+||||||+|||++ .++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLIN-ALGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEEC-TTCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEEC-CCCCEEEeecCCc
Confidence 489999999999988888776677889999999999999999999999 7 999999999999999 5778999999999
Q ss_pred cccccCCcceeeeeccccccchhh---cCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKGEANISYICSRYYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~ 303 (419)
.............||+.|+|||++ .....++.++|||||||++|+|++|..||... .....+........ +
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-P---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC-C----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC-C----
Confidence 876555555556899999999997 23455899999999999999999999999863 34444444333100 0
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 233 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 233 ----------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 00113468999999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=367.77 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=218.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence 3467999999999999999999999999999999986543 2345799999999999999999998 4455
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG 225 (419)
..++||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.+ ++.+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 68999999985 77666654 2568999999999999999999999 699999999999999732 2349999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP----- 227 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-----
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC-----
Confidence 99877655555567899999999999764 489999999999999999999999999888777776655321111
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 372 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 372 (419)
. .....+++++.+||.+||+.||.+|||++|+++||||++..+....
T Consensus 228 ------------~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 228 ------------S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp ------------T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred ------------c--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 0 0113468999999999999999999999999999999886655444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=388.18 Aligned_cols=287 Identities=21% Similarity=0.334 Sum_probs=209.6
Q ss_pred ccccceeeeceeccC--CceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...++|++.+.||+| +||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 97 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---- 97 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence 355689999999999 99999999999999999999986543 233469999999999999999999843
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
...+|+|||||. ++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~df 172 (389)
T 3gni_B 98 -DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILIS-VDGKVYLSGL 172 (389)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCG
T ss_pred -CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEc-CCCCEEEccc
Confidence 445899999998 5777777653 23569999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCC--------cceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 225 GSAKVLVKGE--------ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 225 G~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
|++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 9986543221 11234788999999999763 45899999999999999999999999887665555443321
Q ss_pred hCC--------CCHHHHhccC-----cCCccc-----cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH
Q 014750 296 LGT--------PTREEIRCMN-----PNYTDF-----RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 357 (419)
Q Consensus 296 ~~~--------~~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~ 357 (419)
.-. +......... ....+. ..+. ........++..+++++.+||++||+.||.+|||++|+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 110 0000000000 000000 0000 00001112345679999999999999999999999999
Q ss_pred hcCCccccccCCC
Q 014750 358 CAHPFFDELREPN 370 (419)
Q Consensus 358 l~hp~f~~~~~~~ 370 (419)
|+||||+.+.+..
T Consensus 332 l~hp~f~~~~~~~ 344 (389)
T 3gni_B 332 LNHSFFKQIKRRA 344 (389)
T ss_dssp TTSGGGGGC---C
T ss_pred hcCHHHHHHhhcc
Confidence 9999999877543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=380.39 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=197.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++ .+...++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeEE
Confidence 3456799999999999999999999999999999998754 23455799999999999999999998 3445589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeeccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAK 228 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~ 228 (419)
+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||+++
T Consensus 125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 9999998 477666653 4568999999999999999999999 69999999999999972 36789999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 307 (419)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||......+ .+..+.....
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---------- 268 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------- 268 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC----------
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC----------
Confidence 76554445567899999999999764 48999999999999999999999998766544 3333332100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.++ ..+...++.++.+||++||+.||++|||+.|+|+||||....
T Consensus 269 -------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 269 -------YFI--------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp -------CCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred -------ccC--------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 000 011235789999999999999999999999999999998644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=397.46 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=208.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++. +.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----TH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eC
Confidence 4568999999999999999999999999999999986431 23346888999999999999999984 34
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHc-CCCcccccccCCceeeCCCCCceEEeecc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+|+|||||++ +|.+.+.. ...+++..++.++.||+.||.|||+ . ||+||||||+||||+ .++.+||+|||
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~-~~~~~kl~DFG 294 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLD-KDGHIKITDFG 294 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEEC-SSSCEEECCCC
T ss_pred CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEEC-CCCCEEEccCC
Confidence 458999999985 67666654 3579999999999999999999996 5 999999999999999 57889999999
Q ss_pred ccccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 364 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------- 364 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------
Confidence 9976432 2334457899999999999764 5899999999999999999999999998887777766542
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
... ++..+++++.+||.+||+.||.+|| |++|+++||||+++.+.
T Consensus 365 --------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 365 --------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 111 2345799999999999999999999 99999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=399.20 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=215.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|.+.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence 34568999999999999999999999999999999985432 2345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+. |+|...+.........+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~-~~g~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLD-DDGNVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEe-CCCCEEEeecc
Confidence 556999999998 57777776654445679999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~~ 300 (419)
+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+ ..+....+...
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----- 408 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----- 408 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence 9987654433 3346899999999999764 58999999999999999999999998753 23333333321
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
. ..++..+++++.+||++||+.||.+||+ ++++++||||+.+.+.
T Consensus 409 ------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 409 ------------A------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp ------------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred ------------c------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 0 0123467999999999999999999995 5899999999987653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=398.11 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=215.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||+||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCC
Confidence 345799999999999999999999999999999998532 23456899999999999999999998 4455
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG 225 (419)
.+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 68999999984 777776552 569999999999999999999999 69999999999999963 34579999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 243 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---- 243 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----
Confidence 9987765555566789999999999975 4899999999999999999999999999888888777653211111
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
+ ....+++++++||++||+.||.+|||+.++|+||||+....
T Consensus 244 -----------~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 -----------P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -----------G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -----------c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 1 11246899999999999999999999999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=366.03 Aligned_cols=254 Identities=30% Similarity=0.443 Sum_probs=217.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||+|+||.||+|++..++..+|+|++... .....+|+++++.++||||+++++++ .+....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence 45799999999999999999999999999999998643 23456799999999999999999998 4455689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee---CCCCCceEEeecccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA 227 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a 227 (419)
+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +||+||||||+|||+ + .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSS-TTCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCC-CCCcEEEEecccc
Confidence 99999985 77776654 3568999999999999999999999 699999999999999 5 5678999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.......+...+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--- 231 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence 87766666667789999999999865 3899999999999999999999999998888877777664333322211
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 24689999999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=396.96 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=216.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----------------ccHHHHHHHHHhcCCCCeeecce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRLMDHPNVISLKH 137 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~~ 137 (419)
...+|.+++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4467999999999999999999999999999999986432 22457999999999999999999
Q ss_pred eeeccCCCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC
Q 014750 138 CFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
++ .+...+|+|||||.| +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKN 183 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTT
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCC
Confidence 98 455669999999985 77777764 2569999999999999999999999 6999999999999998433
Q ss_pred --CceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 014750 217 --HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 217 --~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 294 (419)
..+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.+
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2699999999988766655667789999999999864 489999999999999999999999999998888887776
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
......... ...+++++++||++||+.||.+|||++|+|+||||++...
T Consensus 262 ~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 262 GKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 322222211 1347999999999999999999999999999999987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=399.25 Aligned_cols=257 Identities=32% Similarity=0.535 Sum_probs=218.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 4457999999999999999999999999999999985432 2345899999999999999999998 455
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeec
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDF 224 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~Df 224 (419)
..+|+|||||. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 66999999998 477666654 4679999999999999999999999 69999999999999952 4678999999
Q ss_pred ccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 225 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
|+++...........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.+......
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 247 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---- 247 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred eeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 99987766555566789999999999976 489999999999999999999999999998888887766321111
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+ ....+++++++||++||+.||.+|||+.|+|+||||+....
T Consensus 248 -----------~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 248 -----------LP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp -----------SG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred -----------Cc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 01 11246899999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=385.69 Aligned_cols=253 Identities=27% Similarity=0.379 Sum_probs=207.5
Q ss_pred eeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEee
Q 014750 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVME 155 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 155 (419)
...+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ .+...++||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEEEEe
Confidence 33678999999999999999999999999987542 3445899999999999999999998 44456899999
Q ss_pred cccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC-CCCCceEEeecccccccccC
Q 014750 156 YVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 156 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~~vkl~DfG~a~~~~~~ 233 (419)
|+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||+++.....
T Consensus 167 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 167 YVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp CCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 9984 777766542 3468999999999999999999999 6999999999999993 24678999999999877655
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCcc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 313 (419)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------ 309 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------------ 309 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS------------
T ss_pred cccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh------------
Confidence 555567899999999999654 5899999999999999999999999999988888877763221110
Q ss_pred ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 01134689999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.25 Aligned_cols=283 Identities=31% Similarity=0.535 Sum_probs=220.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcC-CC-----CeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMD-HP-----NVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~ 145 (419)
..++|++.+.||+|+||+||+|++..+++.||||++..... ...+|+.+++.++ |+ +|+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~---- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF---- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence 45689999999999999999999999999999999875532 3346888888775 44 48888888843
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-CCcccccccCCceeeCC-CCCceEEee
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-PGVCHRDVKPQNLLVDP-LTHQVKLCD 223 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~ivH~Dlkp~NIll~~-~~~~vkl~D 223 (419)
...+|+||||++++|.+.+.... ...+++..++.++.||+.||.|||++ .||+||||||+||||+. .++.+||+|
T Consensus 128 -~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 -RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred -CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 34589999999999999887632 24589999999999999999999942 59999999999999952 467899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++...
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999986632 33457889999999999775 489999999999999999999999999999999999999999988776
Q ss_pred HhccCcC---Cc---c--c----------cCCCCCCCCchhhcCCC-----------------CChhHHHHHhhhcccCC
Q 014750 304 IRCMNPN---YT---D--F----------RFPQIKAHPWHKVFHKR-----------------MPPEAIDLASRLLQYSP 348 (419)
Q Consensus 304 ~~~~~~~---~~---~--~----------~~~~~~~~~~~~~~~~~-----------------~s~~~~dli~~~L~~dP 348 (419)
+...... +. + + .+.......+...+... .++++.+||.+||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 5432100 00 0 0 00000001111111000 01478999999999999
Q ss_pred CCCCCHHHHhcCCcccccc
Q 014750 349 SLRCTALEACAHPFFDELR 367 (419)
Q Consensus 349 ~~R~t~~e~l~hp~f~~~~ 367 (419)
++|||++|+|+||||++..
T Consensus 362 ~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTSCCHHHHTTSGGGCC--
T ss_pred hhCCCHHHHhcCcccccCC
Confidence 9999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=409.15 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=217.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhc-CCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||+||+|++..+++.||||++.+. ......|..++..+ +|+||+++++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 456899999999999999999999999999999998643 12334688888877 799999999988 55
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+||||||+. |+|...+... +.+++..++.|+.||+.||.|||+ +||+||||||+||||+ .++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~-~~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLD-SEGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEEC-SSSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEc-CCCcEEEeecc
Confidence 566999999998 4777777653 569999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccc-cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLV-KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+|+... ........+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..|...
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------- 557 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 557 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 998643 33345567899999999999764 5899999999999999999999999999888888777642
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH-----HHHhcCCccccccCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 370 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~-----~e~l~hp~f~~~~~~~ 370 (419)
.. .++..+++++.+||++||+.||.+|+++ +|+++||||+.++|..
T Consensus 558 --------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 558 --------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp --------CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred --------CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 11 1334679999999999999999999997 9999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=376.57 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=211.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
...|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.. ..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence 356999999999999999999999999999999986432 224579999999999999999999843 34
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
..++||||+.|++.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 128 ~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 128 TAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSAS 202 (348)
T ss_dssp EEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEE-TTTEEEECCCTTCB
T ss_pred eEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEC-CCCCEEEeeccCce
Confidence 58999999999988877642 3679999999999999999999999 6999999999999999 67899999999997
Q ss_pred ccccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 229 VLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
.... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+.+..+..... +
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~------- 271 (348)
T 1u5q_A 203 IMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------- 271 (348)
T ss_dssp SSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------
T ss_pred ecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C-------
Confidence 6532 335689999999999853 34589999999999999999999999998887776666554210 0
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. .....+++.+.+||.+||+.||.+|||++++++||||...
T Consensus 272 -----------~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 272 -----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -----------C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0 0123468899999999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=383.40 Aligned_cols=283 Identities=27% Similarity=0.402 Sum_probs=222.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcC--------CCCeeecceeeeccCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD--------HPNVISLKHCFFSTTS 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~~ 144 (419)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 468999999999999999999999999999999987543 23457999999885 788999999885322
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCC-------
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLT------- 216 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~------- 216 (419)
.+...+|+||||+++++++.+... ....+++..++.++.||+.||.|||+ + ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhh
Confidence 245678999999999988887653 23569999999999999999999999 7 999999999999998432
Q ss_pred -----------------------------------------CceEEeecccccccccCCcceeeeeccccccchhhcCCC
Q 014750 217 -----------------------------------------HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255 (419)
Q Consensus 217 -----------------------------------------~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 255 (419)
..+||+|||++...... ....+||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 27999999999866432 34568899999999998754
Q ss_pred CCCCcccEeehhHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHhccCcCCccc-------cCCCCCCC
Q 014750 256 EYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAH 322 (419)
Q Consensus 256 ~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 322 (419)
++.++|||||||++|+|++|+.||.+.+ ..+.+..+.+.+|.++...+.........+ .+......
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 8999999999999999999999998755 567888889999998877654322110000 00010000
Q ss_pred Cchh------hcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 323 PWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 323 ~~~~------~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.... .++...+.++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 011223567899999999999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=396.01 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=213.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..+|++.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 457999999999999999999999999999999986432 2345899999999999999999998 44556
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeeccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~ 226 (419)
+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 8999999985 777766542 568999999999999999999999 699999999999999742 34599999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+..........
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---- 259 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP---- 259 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence 988766665667789999999999853 48999999999999999999999999999888887776632221111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
....+++++++||++||+.||.+|||+.++|+||||++..
T Consensus 260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 1134789999999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=379.12 Aligned_cols=263 Identities=30% Similarity=0.476 Sum_probs=210.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++ .+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence 457999999999999999999999999999999885331 2345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccC------------------------------------CCCCCHHHHHHHHHHHHH
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSM------------------------------------NQRMPLIYVKLYTYQIFR 189 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~ 189 (419)
...+++|||||. ++|.+.+..+... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 556899999997 5777666422111 223467889999999999
Q ss_pred HHHHhHcCCCcccccccCCceeeCCCC-CceEEeecccccccccCC-----cceeeeeccccccchhhcCC-CCCCCccc
Q 014750 190 GLAYIHTVPGVCHRDVKPQNLLVDPLT-HQVKLCDFGSAKVLVKGE-----ANISYICSRYYRAPELIFGA-TEYTTSID 262 (419)
Q Consensus 190 al~~LH~~~~ivH~Dlkp~NIll~~~~-~~vkl~DfG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~D 262 (419)
||.|||+ +||+||||||+|||++.++ ..+||+|||++....... ......||+.|+|||++.+. ..++.++|
T Consensus 180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999 6999999999999998422 279999999998653322 12456789999999999652 45899999
Q ss_pred EeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhh
Q 014750 263 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 342 (419)
Q Consensus 263 iwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 342 (419)
||||||++|+|++|..||.+.+..+....+......... .....+++++.+||.+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence 999999999999999999999888887777653211110 0112368999999999
Q ss_pred hcccCCCCCCCHHHHhcCCccccccCC
Q 014750 343 LLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 343 ~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
||+.||.+|||+.++|+||||+++.+.
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=376.69 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=207.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 457999999999999999999999999999999986542 2334799999999999999999998
Q ss_pred CCCceeEEEEeeccc-c-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 144 SKDELFLNLVMEYVP-E-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
.+...+++||||+. | +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIA-EDFTIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEc-CCCcEEE
Confidence 45556899999986 4 66666654 4679999999999999999999999 6999999999999999 5788999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------- 238 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------- 238 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence 99999988766666667789999999999987665588999999999999999999999652210 00
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.. ...+..+++++.+||.+||+.||.+|||++++++||||++
T Consensus 239 ----------~~------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 ----------AA------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------TC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------hc------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00 0112347899999999999999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=375.01 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=187.3
Q ss_pred cceeee---ceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.+|.+. +.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.+. ||||+++++++ .+....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence 356664 78999999999999999999999999986543 44568999999997 99999999998 4555689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC--CceEEeeccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVKLCDFGSAK 228 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vkl~DfG~a~ 228 (419)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999985 77777765 4679999999999999999999999 6999999999999998432 279999999998
Q ss_pred ccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCC
Q 014750 229 VLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------VDQLVEIIKVLGTPT 300 (419)
Q Consensus 229 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~ 300 (419)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-- 234 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-- 234 (325)
T ss_dssp ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--
Confidence 654332 23456789999999999764 489999999999999999999999987543 2222222221000
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+ .......+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 235 ---------------~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 235 ---------------F--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------C--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------C--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 0 001113479999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=375.47 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=213.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 57999999999999999999999999999999886442 1234789999998 899999999988
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
......|+||||+.| +|.+.+.. ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+||+
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~-~~~~ikl~ 242 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLD-DNMQIRLS 242 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEEC
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEC-CCCCEEEE
Confidence 344558999999985 77777764 3568999999999999999999999 6999999999999999 67889999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCC-----CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 297 (419)
|||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999877665555667899999999998632 2478899999999999999999999998887777776665322
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
...... ...++.++.+||.+||+.||.+|||++++|+||||++
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 222111 1246889999999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=386.02 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=197.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 457999999999999999999999999999999986432 23568999999999999999999872
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceE
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVK 220 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vk 220 (419)
.. .+|+||||+.+ +|.+.+ .....+++..++.++.||+.||.|||+ +||+||||||+|||++.. +..+|
T Consensus 211 --~~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AE-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SS-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cC-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 22 26899999985 544333 345779999999999999999999999 699999999999999732 34599
Q ss_pred EeecccccccccCCcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|+|||+++...........+||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987765555566789999999999853 345788999999999999999999999875443322222221000
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
. +.......+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0 0011123478999999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.90 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=210.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++ .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence 4567899999999999999999999999999999988532 22345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
....++||||++ ++|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~-~~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLG-SAGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEEC-TTSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEc-CCCCEEEEecc
Confidence 456899999998 4777777653 568999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 224 (279)
T 3fdn_A 155 WSVHAPS-SRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-------- 224 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred ccccCCc-ccccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence 9865432 233456789999999999764 589999999999999999999999998887777766654211
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 123446899999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=367.70 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=208.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 119 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWV 119 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 35888889999999999999999999999999986433 234579999999999999999999854 334899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||+.+ +|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++....
T Consensus 120 v~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 120 LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEC-CCCcEEEeeeeeeeecc
Confidence 9999985 6655554 2569999999999999999999999 6999999999999999 67889999999997664
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+......
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------------ 259 (321)
T 2c30_A 193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP------------ 259 (321)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC------------
T ss_pred cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 432 23456899999999999664 5899999999999999999999999988877666655442100
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.. .....+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 260 -------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 260 -------KL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -------CC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -------Cc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 00 01124688999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=363.33 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=211.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence 57999999999999999999999999999999886432 23468999999999999999999984 4
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC---CceEEe
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT---HQVKLC 222 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~~vkl~ 222 (419)
....++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..+ ..+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 455899999997 577777754 3568999999999999999999999 6999999999999998432 179999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|||++.............|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-- 231 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--
Confidence 99999876555545566789999999999654 489999999999999999999999999887776666544221111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
......++..+.+||.+||..||.+|||+.++++||||+.+....
T Consensus 232 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 -----------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -----------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -----------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 112235689999999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=370.50 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=199.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS------ 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 144 (419)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999999999999999986432 234579999999999999999998754321
Q ss_pred ----------------------------------------------CCceeEEEEeecccc-cHHHHHHhhccCCCCCCH
Q 014750 145 ----------------------------------------------KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPL 177 (419)
Q Consensus 145 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~ 177 (419)
....++++|||||.+ +|.+.+.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 123358999999985 7777666432 2334566
Q ss_pred HHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC-------------cceeeeeccc
Q 014750 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE-------------ANISYICSRY 244 (419)
Q Consensus 178 ~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~~t~~ 244 (419)
..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++...... ......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7789999999999999999 6999999999999999 67889999999998765432 1234578999
Q ss_pred cccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCc
Q 014750 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 324 (419)
Q Consensus 245 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
|+|||++.+. .++.++|||||||++|+|++|..|+. +....+..........
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~---------------------- 293 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL---------------------- 293 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH----------------------
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc----------------------
Confidence 9999999765 48999999999999999999876652 1111111111110000
Q ss_pred hhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 325 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 325 ~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.....++++.+||.+||+.||.+|||++|+++||||+++
T Consensus 294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 011246788999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=361.93 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=204.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ .+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----ST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ec
Confidence 45568999999999999999999999999999999985331 2345799999999999999999998 34
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLD-AHMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEEC-TTSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEEC-CCCCEEEeecc
Confidence 456899999997 5887777652 568999999999999999999999 6999999999999999 57789999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++.............+++.|+|||++.+....+.++||||||+++|+|++|..||...+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 228 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-------- 228 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------
Confidence 998765554455667899999999997765457899999999999999999999998877666655543100
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.++..++.++.+||.+||+.||.+|||+.++++||||++
T Consensus 229 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 229 ---------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 023356899999999999999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=370.15 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=211.0
Q ss_pred cccceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcC-CCCeeecceeeeccCCCC
Q 014750 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 146 (419)
..++|.+. +.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+. |+||+++++++ .+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~ 100 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----EN 100 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ee
Confidence 34568887 89999999999999999999999999886432 23457899999884 69999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEee
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCD 223 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~D 223 (419)
...+|+||||+.+ +|.+.+.. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 5568999999986 55444422 224679999999999999999999999 69999999999999984 257899999
Q ss_pred cccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 224 FGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 224 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 254 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-- 254 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred CccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence 9999877555555567899999999999764 4899999999999999999999999998888777776653222111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.....+++.+.+||.+||+.||.+|||++++|+||||+++.+..
T Consensus 255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 11234689999999999999999999999999999999877654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=364.99 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=213.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 357999999999999999999999999999999986431 334579999999999999999998753 233
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|+||||+.+++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~-~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLT-TGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEc-CCCcEEeeccccc
Confidence 4589999999998877776532 4679999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccC---CcceeeeeccccccchhhcCCC-CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKG---EANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
...... .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~------- 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS------- 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence 765422 2223456899999999987533 24779999999999999999999999888776666554410
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
+ .++..+++++.+||.+||..||.+|||++++++||||++.....
T Consensus 230 ----------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 230 ----------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ----------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ----------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 12345689999999999999999999999999999998865543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=363.24 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=213.5
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----ED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----cc
Confidence 34568999999999999999999999999999999886442 2235799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg 160 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLN-EDLEVKIGDFG 160 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCT
T ss_pred CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEc-CCCCEEEEecc
Confidence 556899999998 566666554 3578999999999999999999999 6999999999999999 67789999999
Q ss_pred cccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------- 230 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--------- 230 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------
T ss_pred CceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc---------
Confidence 99865432 233446789999999999764 4899999999999999999999999988776655544321
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 370 (419)
.. .++..+++.+.+||.+||+.||.+|||++++++||||.....+.
T Consensus 231 --------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 231 --------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp --------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred --------cC------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 00 12345789999999999999999999999999999998765444
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=371.24 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=213.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+|.+.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence 4467999999999999999999999999999999986442 2345799999999999999999998 445
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~ 187 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLN-EDLEVKIGDFGL 187 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTT
T ss_pred CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEc-CCCCEEEeeccC
Confidence 56899999998 477666654 3578999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 227 AKVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 227 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 256 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 256 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------
T ss_pred ceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------
Confidence 9866432 233456789999999999764 4899999999999999999999999988777666555431
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.+. ++..+++++.+||.+||+.||.+|||++|+++||||.....+
T Consensus 257 -------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 257 -------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred -------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 011 234568999999999999999999999999999999875543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=371.36 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=200.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCC--CCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDH--PNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+|+.+++.++| +||+++++++ .+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----ee
Confidence 345799999999999999999997 568999999986442 223579999999987 9999999998 44
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~ 153 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 153 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeeccc
Confidence 556899999888898888875 4679999999999999999999999 6999999999999997 46799999999
Q ss_pred ccccccCCc---ceeeeeccccccchhhcC----------CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 014750 227 AKVLVKGEA---NISYICSRYYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI 292 (419)
Q Consensus 227 a~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i 292 (419)
++....... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 233 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH
Confidence 987643322 235679999999999864 245889999999999999999999999865332 222222
Q ss_pred HHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. .. ....++...+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 234 ~~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 234 ID---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp HC---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred hc---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 21 00 011123445789999999999999999999999999999986443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=357.67 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=208.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
...|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++.... .+...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCce
Confidence 345999999999999999999999999999999886432 22357999999999999999999875433 34567
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeeccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
+++||||+++ +|.+.+... ..+++..++.++.||+.||.|||+ +| |+||||||+|||++..++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 8999999975 777777653 568999999999999999999999 68 999999999999985677899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+.... ........||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................
T Consensus 179 ~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (290)
T 1t4h_A 179 ATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------- 247 (290)
T ss_dssp GGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred ccccc-ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence 97543 233445678999999998864 4899999999999999999999999886554444332221000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
...++...++++.+||.+||+.||.+|||++++++||||++
T Consensus 248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01123456789999999999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=361.09 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=215.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------------ccHHHHHHHHHhcC-CCCeeecceeee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRLMD-HPNVISLKHCFF 140 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~~ 140 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 3457999999999999999999999999999999986432 22347899999995 99999999998
Q ss_pred ccCCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce
Q 014750 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v 219 (419)
.+....++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~ 163 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLD-DDMNI 163 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEc-CCCcE
Confidence 44556899999998 578777764 3568999999999999999999999 6999999999999999 67789
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhc-----CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 294 (419)
||+|||++.............+++.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999999998776555556678899999999985 234578999999999999999999999998887777666655
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
....... + ....++.++.+||.+||+.||.+|||++++++||||++...
T Consensus 244 ~~~~~~~---------------~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 244 GNYQFGS---------------P----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp TCCCCCT---------------T----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CCcccCc---------------c----------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 2111100 0 01246889999999999999999999999999999987554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=359.69 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=213.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+++++.++|+||+++++++ .+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HD 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----Ec
Confidence 3456899999999999999999999999999999988532 13356799999999999999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMG-YKGELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEEC-TTCCEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEc-CCCCEEEeccc
Confidence 4568999999984 887777653 468999999999999999999999 6999999999999999 57789999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
++..... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 227 (284)
T 2vgo_A 160 WSVHAPS-LRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227 (284)
T ss_dssp TCEECSS-SCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccccCcc-cccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence 9876533 223456789999999999764 4899999999999999999999999988777666555431
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. .++..++.++.+||.+||..||.+|||++++++||||+....
T Consensus 228 -------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 -------DL------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------cc------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 123457899999999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=366.31 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=197.7
Q ss_pred cccceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHh-cCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRL-MDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+.|++. +.||+|+||.||+|++..+++.||||++.... ....+|+.+++. ++||||+++++++. +..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence 34579885 78999999999999999999999999986543 234579999988 57999999999984 344
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC--ceEEeecc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG 225 (419)
.+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 5899999998 5887777652 568999999999999999999999 69999999999999984332 39999999
Q ss_pred cccccccCC--------cceeeeeccccccchhhcCC----CCCCCcccEeehhHHHHHHHhCCCCCCCCCH--------
Q 014750 226 SAKVLVKGE--------ANISYICSRYYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-------- 285 (419)
Q Consensus 226 ~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~-------- 285 (419)
++....... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987653221 12235689999999998641 2378999999999999999999999987542
Q ss_pred -------HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 286 -------VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 286 -------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
......+..... .++ ......++.++.+||++||+.||.+|||++|++
T Consensus 240 ~~~~~~~~~~~~~i~~~~~-----------------~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGKY-----------------EFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCCC-----------------CCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccCc-----------------ccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 112222222110 111 001124689999999999999999999999999
Q ss_pred cCCccccccC
Q 014750 359 AHPFFDELRE 368 (419)
Q Consensus 359 ~hp~f~~~~~ 368 (419)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=376.34 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=200.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcC--CCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~ 147 (419)
..+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+|+.++ |+||+++++++. ..
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~ 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cC
Confidence 3469999999999999999999764 8999999986443 23457999999996 599999999884 34
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..+|||||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a 201 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 201 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSS
T ss_pred CEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCcc
Confidence 45899999877888888775 3578999999999999999999999 6999999999999997 467999999999
Q ss_pred cccccCCc---ceeeeeccccccchhhcCC----------CCCCCcccEeehhHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q 014750 228 KVLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEII 293 (419)
Q Consensus 228 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~ 293 (419)
+....... ....+||+.|+|||++.+. ..++.++||||||||+|+|++|..||..... ...+..+.
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 87643322 2356799999999998652 3588999999999999999999999987543 23333322
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. . .. ..++...+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 282 ~~--------------~-~~------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 282 DP--------------N-HE------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp CT--------------T-SC------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred Cc--------------c-cc------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 10 0 00 1122345789999999999999999999999999999986443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=373.73 Aligned_cols=290 Identities=29% Similarity=0.492 Sum_probs=224.1
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcC-----------CCCeeeccee
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKHC 138 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~ 138 (419)
+....+|++.+.||+|+||.||+|++..+++.||||++..+. ....+|+.+++.++ |+||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345568999999999999999999999999999999987543 23457888888876 8999999999
Q ss_pred eeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCC---
Q 014750 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDP--- 214 (419)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~--- 214 (419)
+.... .+...+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ + ||+||||||+||||+.
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCC
Confidence 85432 2345789999999889988887643 3558999999999999999999999 7 9999999999999952
Q ss_pred --CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC------HH
Q 014750 215 --LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AV 286 (419)
Q Consensus 215 --~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~ 286 (419)
..+.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 344799999999976543 234567899999999998754 8999999999999999999999998654 56
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcC-------CccccCCCCCCCCchhh------cCCCCChhHHHHHhhhcccCCCCCCC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQYSPSLRCT 353 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~s~~~~dli~~~L~~dP~~R~t 353 (419)
+.+..+...+|.++...+...... -....+......++... ++..++.++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 778888888998887655432110 00000111111111111 22334678999999999999999999
Q ss_pred HHHHhcCCccccccCC
Q 014750 354 ALEACAHPFFDELREP 369 (419)
Q Consensus 354 ~~e~l~hp~f~~~~~~ 369 (419)
++|+|+||||++....
T Consensus 328 ~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHTCGGGTTCTTC
T ss_pred HHHHhhChhhhcccCc
Confidence 9999999999985443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=366.31 Aligned_cols=283 Identities=27% Similarity=0.482 Sum_probs=222.4
Q ss_pred cccceeeeceeccCCceEEEEEEE-cCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCC------CeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRLMDHP------NVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ....+|+.+++.++|+ +|+++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 345799999999999999999998 5688999999986543 2345788899888665 4899999883
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC---------
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--------- 215 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--------- 215 (419)
....+|+||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++..
T Consensus 88 -~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 88 -HHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp -ETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCc
Confidence 344689999999989988887532 2468999999999999999999999 699999999999999842
Q ss_pred ---------CCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 216 ---------THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 216 ---------~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
++.+||+|||++.... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 4579999999997643 233456889999999999764 4899999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcC-Cc---cccCCCCC---------CCCchh--hcCCCCChhHHHHHhhhcccCCCCC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPN-YT---DFRFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLR 351 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~---------~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R 351 (419)
+.+..+.+..+..+...+...... +. ...+.... ..++.. ......++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 999999999988887665543211 00 00000000 000000 0011235679999999999999999
Q ss_pred CCHHHHhcCCccccccC
Q 014750 352 CTALEACAHPFFDELRE 368 (419)
Q Consensus 352 ~t~~e~l~hp~f~~~~~ 368 (419)
||++|+++||||+.++.
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 99999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=362.35 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=211.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+...+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence 457999999999999999999999999999999986542 2345899999999999999999988 4455689
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee---CCCCCceEEeecccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSA 227 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a 227 (419)
+||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPE-ENSKIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCC-CCCCEEEccCCcc
Confidence 9999997 577777754 2568999999999999999999999 699999999999999 5 5778999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.+....
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------- 225 (304)
T 2jam_A 157 KMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--------- 225 (304)
T ss_dssp CCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred eecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 75432 233445789999999999764 4899999999999999999999999988887777666552111
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+ ...+...+++++.+||.+||..||.+|||++++++||||+..
T Consensus 226 --------~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 --------F--------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp --------C--------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred --------C--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0 011224578999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=372.77 Aligned_cols=276 Identities=21% Similarity=0.317 Sum_probs=208.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 457999999999999999999999999999999986432 2345899999999999999999987542 33358
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee----CCCCCceEEeecc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFG 225 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~DfG 225 (419)
|+||||+. ++|.+.+.... ....+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTT-SCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCC-CCceEEEccCC
Confidence 89999998 57777776533 23449999999999999999999999 699999999999998 5 56779999999
Q ss_pred cccccccCCcceeeeeccccccchhhcC-------CCCCCCcccEeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 294 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~ 294 (419)
+++............||+.|+|||++.. ...++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9988766665566789999999999852 2458999999999999999999999997533 2334444443
Q ss_pred HhCCCCHHHHhccCc-CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 295 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
. .|. ..+..... ....+.+. ...+....+...++..+.+||++||+.||++|||++|+|+||-
T Consensus 242 ~--~p~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 G--KPS-GAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp H--CCT-TCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred C--CCc-ccchhhhcccCCccccC--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2 111 11111000 00000000 0000111122345678999999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=378.02 Aligned_cols=266 Identities=14% Similarity=0.118 Sum_probs=189.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhc--CCCCeeecceee-------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLM--DHPNVISLKHCF------- 139 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l--~h~niv~~~~~~------- 139 (419)
...|.+.+.||+|+||.||+|++..+|+.||+|++..... ...+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999976432 223564444444 699988855333
Q ss_pred eccCC--------C----CceeEEEEeecccccHHHHHHhhccCCCCCCHHHH------HHHHHHHHHHHHHhHcCCCcc
Q 014750 140 FSTTS--------K----DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV------KLYTYQIFRGLAYIHTVPGVC 201 (419)
Q Consensus 140 ~~~~~--------~----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~iv 201 (419)
..... . ....+|||||||+++|.+.+..... .+.+..+ ..++.||+.||.|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 21111 0 1145899999999999999886422 2334444 5677999999999999 6999
Q ss_pred cccccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCC
Q 014750 202 HRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 280 (419)
Q Consensus 202 H~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf 280 (419)
||||||+||||+ .++.+||+|||+++... .......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus 217 HrDikp~NIll~-~~~~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIM-PDGRLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEEC-TTSCEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEEC-CCCCEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999 67889999999998653 222255677999999999651 35899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 281 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 281 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+..... ...+............+.......+++++.+||.+||+.||++|||+.++|+|
T Consensus 294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8764210 00111111111111111111224679999999999999999999999999999
Q ss_pred CccccccC
Q 014750 361 PFFDELRE 368 (419)
Q Consensus 361 p~f~~~~~ 368 (419)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=362.08 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=204.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+..+..+ +||||+++++++. +.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence 4568999999999999999999999999999999987532 2234688888888 9999999999984 34
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC------------
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------ 214 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~------------ 214 (419)
..+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 458999999975 8888887765555779999999999999999999999 69999999999999983
Q ss_pred ------CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH
Q 014750 215 ------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 288 (419)
Q Consensus 215 ------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 288 (419)
....+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++...+.
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 2346999999999865432 2346899999999998765677899999999999999999987755432
Q ss_pred HHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 289 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...+... .. ..++..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 237 ~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2222110 00 11234579999999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=360.17 Aligned_cols=251 Identities=28% Similarity=0.488 Sum_probs=185.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 457999999999999999999999999999999985432 3345799999999999999999998 4455
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~-~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLT-RNMNIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEEC-TTCCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEc-CCCCEEEEeecce
Confidence 68999999975 77666654 23578999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------ 226 (278)
T ss_dssp EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence 765432 223346789999999998764 479999999999999999999999987654322221100
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
.++ .++..++.++.+||.+||..||.+|||++++++||||...
T Consensus 227 -----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 -----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 000 1234578999999999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=387.50 Aligned_cols=256 Identities=20% Similarity=0.228 Sum_probs=195.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHH---HHHHhcCCCCeeecce-------
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL---QLMRLMDHPNVISLKH------- 137 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~---~~l~~l~h~niv~~~~------- 137 (419)
...+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+ ++++.++|||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467999999999999999999999999999999986321 2345788 4555568999999984
Q ss_pred eeeccC---------CCCc---eeEEEEeecccccHHHHHHhhccCC---CCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 138 CFFSTT---------SKDE---LFLNLVMEYVPETMYRVLKHYSSMN---QRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 138 ~~~~~~---------~~~~---~~~~lv~e~~~~~l~~~l~~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
++.... ..+. ...|+||||++|+|.+.+....... ..+++..++.++.||+.||.|||+ +||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence 332211 0111 1378999999999999887643211 234458888899999999999999 69999
Q ss_pred ccccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCC----------CCCCCcccEeehhHHHHH
Q 014750 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAE 272 (419)
Q Consensus 203 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~e 272 (419)
|||||+||||+ .++.+||+|||+++.. .......+| +.|+|||++.+. ..++.++|||||||++|+
T Consensus 230 rDikp~NIll~-~~~~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 230 TYLRPVDIVLD-QRGGVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp SCCCGGGEEEC-TTCCEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEc-CCCCEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999 5788999999999853 233445677 999999999765 258999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC
Q 014750 273 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 352 (419)
Q Consensus 273 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 352 (419)
|++|+.||.+.+..+....+. .....+++++.+||.+||+.||.+||
T Consensus 306 lltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCC
Confidence 999999997654321111000 01135799999999999999999999
Q ss_pred CHHHHhcCCccccccC
Q 014750 353 TALEACAHPFFDELRE 368 (419)
Q Consensus 353 t~~e~l~hp~f~~~~~ 368 (419)
|+.++++||||+++..
T Consensus 353 t~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 353 LPLQAMETPEYEQLRT 368 (377)
T ss_dssp CHHHHHTSHHHHHHHH
T ss_pred CHHHHhhChHHHHHHH
Confidence 9999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=357.35 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=205.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++. +....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence 357999999999999999999999999999999986432 23457999999999999999999884 34458
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+++ +|.+.+ .....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEc-cCCCEEEeeCCCccc
Confidence 999999986 554433 345679999999999999999999999 6999999999999999 577899999999976
Q ss_pred cccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHh
Q 014750 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIR 305 (419)
Q Consensus 230 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 305 (419)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||........ ...+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------- 226 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT------- 226 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT-------
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc-------
Confidence 54322 233467899999999997765457899999999999999999999987654322 2222110 00
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..+ ....++.++.+||.+||+.||.+|||++|+++||||++..
T Consensus 227 ---------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 227 ---------YLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ---------TST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---------ccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 000 0124689999999999999999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=366.53 Aligned_cols=255 Identities=28% Similarity=0.469 Sum_probs=204.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 86 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 86 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence 357999999999999999999999999999999886432 235689999999999999999998732
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC--CceE
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT--HQVK 220 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~--~~vk 220 (419)
.. +|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+ ..+|
T Consensus 87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence 22 7899999985 76666543 4679999999999999999999999 6999999999999998432 2499
Q ss_pred EeecccccccccCCcceeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhC
Q 014750 221 LCDFGSAKVLVKGEANISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV-EIIKVLG 297 (419)
Q Consensus 221 l~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~i~~~~~ 297 (419)
|+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||........+. .+.....
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 237 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence 99999998765443344567899999999974 34458999999999999999999999998654332222 2222110
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
... ......++.++.+||.+||..||.+|||++++++||||++.
T Consensus 238 ~~~-------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 238 NFI-------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred ccC-------------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 000 11123468999999999999999999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=369.11 Aligned_cols=284 Identities=25% Similarity=0.427 Sum_probs=222.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC-cEEEEEEeccCc---ccHHHHHHHHHhcCCCC------eeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRLMDHPN------VISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||+||+|++..++ +.||+|++.... ....+|+.+++.++|++ ++.+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~----- 91 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF----- 91 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence 3468999999999999999999998777 689999986542 23457899999887665 88888877
Q ss_pred CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----------
Q 014750 145 KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP---------- 214 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~---------- 214 (419)
.....+|+||||+++++.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 92 NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccc
Confidence 3344689999999999888876532 2569999999999999999999999 69999999999999931
Q ss_pred --------CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 215 --------LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 215 --------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
.++.+||+|||+++... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 46789999999997643 233456889999999999764 4899999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcCCcc----ccCCCCC---------CCCchhh--cCCCCChhHHHHHhhhcccCCCCC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPNYTD----FRFPQIK---------AHPWHKV--FHKRMPPEAIDLASRLLQYSPSLR 351 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R 351 (419)
+.+..+.+..+..+...+......... ..++... ..++... .....+.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 999999999998887765443211000 0000000 0000000 001124588999999999999999
Q ss_pred CCHHHHhcCCccccccCC
Q 014750 352 CTALEACAHPFFDELREP 369 (419)
Q Consensus 352 ~t~~e~l~hp~f~~~~~~ 369 (419)
||+.|+|+||||+++.+.
T Consensus 326 pt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CCHHHHTTSGGGGGCCHH
T ss_pred cCHHHHhcChhhcCCChh
Confidence 999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=374.45 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=206.0
Q ss_pred CccccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccC--------cccHHHHHHHHHhc-CCCCeeecceeee
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRLM-DHPNVISLKHCFF 140 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (419)
.....+|++.+.||+|+||.||+|++. .+++.||||++.+. .....+|+.+++.+ +|+||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345578999999999999999999984 58999999988532 12344699999999 6999999999884
Q ss_pred ccCCCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce
Q 014750 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v 219 (419)
....+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+
T Consensus 130 -----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~ 198 (355)
T 1vzo_A 130 -----TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHV 198 (355)
T ss_dssp -----ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCE
T ss_pred -----eCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCcE
Confidence 34458999999985 777777652 568999999999999999999999 6999999999999999 67889
Q ss_pred EEeecccccccccCC--cceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 014750 220 KLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 220 kl~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 296 (419)
||+|||+++...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+.+..
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 999999997653322 23346789999999999753 347899999999999999999999997543222112221110
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
.. . ...++..++..+.+||.+||..||.+|| |++++++||||+++.+.
T Consensus 279 ~~--------~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 279 LK--------S-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp HH--------C-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred hc--------c-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 00 0 0012345789999999999999999999 99999999999987543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=357.26 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=212.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++||||+++++++ .+...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCe
Confidence 347999999999999999999999999999999985432 2345799999999999999999998 34456
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeeccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~ 226 (419)
+++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+||+++.. +..+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 899999997 5777766542 468999999999999999999999 699999999999999743 34799999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 242 (287)
T 2wei_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------ 242 (287)
T ss_dssp GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 987655544455678999999999865 389999999999999999999999999887776666554211100
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+ ....+++++.+||.+||..||.+|||+.++++||||++...
T Consensus 243 ---------~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ---------LP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ---------SG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ---------ch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 00 11346899999999999999999999999999999987643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=363.80 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=208.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+|+.+++.++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 34579999999999999999999999999999999865422 2347888899999999999999875433 223
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...|+||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEc-CCCCEEEeeccC
Confidence 45689999997 577777764 3569999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+..
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 240 (311)
T ss_dssp C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-
T ss_pred cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-
Confidence 976543321 2335689999999999765 4899999999999999999999999998887776666553222111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.....++.++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 241 ------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 ------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 122357999999999999999999999999999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=353.63 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=214.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 79 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TN 79 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GG
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CC
Confidence 34568999999999999999999999999999999986432 2245799999999999999999987542 23
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----cccccccCCceeeCCCCCceEE
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl 221 (419)
..+++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~-~~~~~kl 157 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLD-GKQNVKL 157 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEEC-SSSCEEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEc-CCCCEEE
Confidence 458999999985 8888887765556679999999999999999999999 58 99999999999999 6788999
Q ss_pred eecccccccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 222 CDFGSAKVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 222 ~DfG~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--- 233 (279)
T 2w5a_A 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--- 233 (279)
T ss_dssp CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred ecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---
Confidence 99999976543322 2345789999999999765 489999999999999999999999998887666665554210
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..++..++.++.+||.+||+.||.+|||+.++++|+|+.+-
T Consensus 234 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01233578999999999999999999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=358.01 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=207.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC---cccHHHHHHHHHhc-CCCCeeecceeeeccCCC-Cce
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK-DEL 148 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~ 148 (419)
...++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.+ +|+||+++++++...... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4566899999999999999999999999999999998643 23456899999998 899999999998653321 145
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~-~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLT-ENAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTCCEEECCCTTT
T ss_pred eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEc-CCCCEEEeeCcCc
Confidence 68999999985 8888776532 3568999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCC-cceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
....... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 251 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----- 251 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----
Confidence 7654322 2334678999999999863 24488999999999999999999999988877666554433100
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
+ ......++..+.+||.+||..||.+|||++++++||||++.
T Consensus 252 --------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 --------------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --------------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --------------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0 01123568999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=371.57 Aligned_cols=282 Identities=25% Similarity=0.406 Sum_probs=209.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCE
Confidence 4567999999999999999999999999999999986542 234579999999999999999999843 445
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCCCceEEeecccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
+|+||||+.+ +|.+.+... ..+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVN-SRGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEEC-TTCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEEC-CCCCEEEEECCCC
Confidence 8999999985 887777653 568999999999999999999998 5 899999999999999 5778999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCCHHHHhc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 306 (419)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +.........
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 755322 23456889999999999764 58999999999999999999999999877665433322111 1111000000
Q ss_pred cC--cCCccccCCC------------CCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 307 MN--PNYTDFRFPQ------------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~--~~~~~~~~~~------------~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.. ..+..+.... +............++.++.+||++||+.||.+|||++|+|+||||+.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 00 0000000000 000000011123468899999999999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=362.07 Aligned_cols=269 Identities=26% Similarity=0.399 Sum_probs=192.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++.. ..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence 3456799999999999999999999999999999987533 2234578889999999999999999844 33
Q ss_pred eEEEEeeccc-ccHHHHHHhhcc----CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSS----MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
..++||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLG-EDGSVQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTCCEEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEc-CCCCEEEEe
Confidence 4899999997 578777765322 24568999999999999999999999 6999999999999999 578899999
Q ss_pred cccccccccCC------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 014750 224 FGSAKVLVKGE------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 297 (419)
Q Consensus 224 fG~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 297 (419)
||++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||......+........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 242 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-- 242 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS--
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc--
Confidence 99987653321 1234578999999999865445899999999999999999999999887665544433221
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+. ..............++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 243 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 243 DPP-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp SCC-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred CCC-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 100 000000011123457899999999999999999999999999999987554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=355.37 Aligned_cols=258 Identities=25% Similarity=0.417 Sum_probs=206.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
....+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCe
Confidence 34567999999999999999999999999999999886432 234579999999999999999999843 345
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMT-LEGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEC-TTSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEC-CCCCEEEEECCCCc
Confidence 8999999985 56555543 24569999999999999999999999 6999999999999999 57789999999975
Q ss_pred ccccC-Ccceeeeeccccccchhhc----CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 229 VLVKG-EANISYICSRYYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 229 ~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
..... .......||+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---- 241 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence 43211 1223467899999999984 33458899999999999999999999999888777666555421100
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
...+..++.++.+||.+||..||.+|||+.++++||||+.+.
T Consensus 242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 011234688999999999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=362.85 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=198.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhc----CCCCeeecceeeec
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLM----DHPNVISLKHCFFS 141 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l----~h~niv~~~~~~~~ 141 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+ +|+||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-- 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-- 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE--
Confidence 346999999999999999999999999999999986432 2234699999998 899999999988
Q ss_pred cCCCCceeEEEEeec-cc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce
Q 014750 142 TTSKDELFLNLVMEY-VP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v 219 (419)
.+....++|||+ +. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++..++.+
T Consensus 108 ---~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 108 ---ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEE
T ss_pred ---ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeE
Confidence 344458899998 55 688777765 3568999999999999999999999 6999999999999998557889
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
||+|||++...... ......||..|+|||++.+...++.++|||||||++|+|++|+.||..... +...
T Consensus 180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~---- 248 (312)
T 2iwi_A 180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA---- 248 (312)
T ss_dssp EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT----
T ss_pred EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh----
Confidence 99999999876433 334567899999999997655456689999999999999999999965321 1110
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
. ..++..++.++.+||.+||+.||.+|||++|+++||||+...+
T Consensus 249 -------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 249 -------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp -------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred -------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 0 0123457899999999999999999999999999999987544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=354.35 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=206.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence 456999999999999999999999999999999986543 345689999999999999999999843 3458999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ .||+||||||+||+++ .++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEEC-CCCCEEEeecccchhhhh
Confidence 999985 77776653 24679999999999999999999999 6999999999999999 577899999999976543
Q ss_pred CC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCC
Q 014750 233 GE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 311 (419)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... .+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------ 243 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP------------ 243 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC------------
T ss_pred hccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc------------
Confidence 32 23346789999999999764 48999999999999999999999999877665554433210 00
Q ss_pred ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. + ..+..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 244 -~--~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 -T--F----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -C--C----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -c--c----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0 0 01234688999999999999999999999999999998743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=363.24 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=186.1
Q ss_pred ccccceeeec-eeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 74 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 74 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
...++|.+.+ .||+|+||+||+|++..+|+.||+|++........+....++.++|+||+++++++.... .+...+++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence 3456799955 699999999999999999999999999776555555555678889999999999885422 33566899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~ 229 (419)
|||||.| +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 104 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999985 887777653 23579999999999999999999999 699999999999999842 45699999999976
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...........+......
T Consensus 181 ~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 247 (336)
T 3fhr_A 181 TTQ-NALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL----------- 247 (336)
T ss_dssp C-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred ccc-cccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-----------
Confidence 543 233456789999999998654 4889999999999999999999999776543322211111000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..+.++ ......+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 248 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 --GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred --cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000111 01113579999999999999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=353.46 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=209.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence 346999999999999999999999999999999986432 334679999999999999999998843 3458
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|+||||+++ +|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEEC-CCCCEEEeeccccee
Confidence 999999985 6666554 2579999999999999999999999 6999999999999999 677899999999977
Q ss_pred cccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.+. .+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 236 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP--------- 236 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC---------
T ss_pred cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC---------
Confidence 64433 23356789999999999764 4899999999999999999999999988776655544331 00
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..++..++..+.+||.+||..||.+|||+.++++||||...
T Consensus 237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01234578999999999999999999999999999999763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.63 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=204.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 4567999999999999999999999999999999885432 2345799999999999999999998 455
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||++| +|.+.+... +.+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILID-SNKTLKIFDFGI 157 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCSS
T ss_pred CeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEC-CCCCEEEEeCCC
Confidence 568999999985 777777652 569999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 227 AKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 227 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+......... .+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~----- 230 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP----- 230 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC-----
T ss_pred ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC-----
Confidence 986643322 2345789999999999775 48999999999999999999999999888766554443210 00
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
.....+...+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus 231 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 ------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111223346799999999999999999999777777777765443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.72 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=197.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
...+|++.+.||+|+||+||+|++ +|+.||+|++..... ...+|+++++.++||||+++++++ .+..
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 107 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP 107 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 456899999999999999999987 688999999865432 234799999999999999999998 4444
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.+++||||+.+ +|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD-KKYTVKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEEC-TTCCEEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEe-CCCcEEECCCC
Confidence 58999999985 7777776421 11248999999999999999999999 69 99999999999999 67889999999
Q ss_pred cccccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 226 SAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 226 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------ 257 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------ 257 (309)
T ss_dssp -----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------
T ss_pred CCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------
Confidence 997653332 23456789999999999765 4899999999999999999999999988877666554331111
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc--CCcccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 365 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~--hp~f~~ 365 (419)
..++..+++++.+||.+||+.||.+|||++++++ +++++.
T Consensus 258 ---------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 ---------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1133467999999999999999999999999987 455543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.48 Aligned_cols=258 Identities=25% Similarity=0.432 Sum_probs=201.7
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
+|.....||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. +...+++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence 3444558999999999999999999999999886543 23457999999999999999999984 34458999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+. ++|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 99997 5777776642 223456789999999999999999999 69999999999999985478899999999976543
Q ss_pred CC-cceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 233 GE-ANISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 233 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+..............
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 243 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------ 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence 22 23346789999999998653 23789999999999999999999999765433222111111110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
...++..++.++.+||.+||+.||.+|||++++++||||+....
T Consensus 244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 01123457899999999999999999999999999999986543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=359.00 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=187.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc-----HHHHHH-HHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQ-LMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+|+. +++.++||||+++++++. +.
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~ 93 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE 93 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence 3456899999999999999999999999999999998654321 223444 667789999999999984 34
Q ss_pred eeEEEEeecccccHHHHHHhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCCCceEEeecc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...++||||+.++|.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+|||
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~-~~~~~kl~Dfg 171 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLD-RSGNIKLCDFG 171 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEE-TTTEEEECCCS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEc-CCCCEEEccCC
Confidence 45899999999998887764322 35779999999999999999999999 8 999999999999999 67899999999
Q ss_pred cccccccCCcceeeeeccccccchhhc---CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 301 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~ 301 (419)
+++............||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.. +.+..+.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 243 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------- 243 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC--------
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh--------
Confidence 998765544444567899999999983 2344899999999999999999999999865321 1110000
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
....+ .+.......+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 244 -----------~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 244 -----------KGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp -----------CSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred -----------cCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 00000 0111122357899999999999999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.06 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=191.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc------HHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
....+|++.+.||+|+||.||+|++..+|+.||||++...... ..++..+++.++|+||+++++++. +.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TN 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cC
Confidence 3456899999999999999999999999999999998654321 123445678889999999999984 34
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC-CcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP-GVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+++.+...... ....+++..++.++.||+.||.|||+ + ||+||||||+|||++ .++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLD-ERGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEEC-CCCCEEEEECCC
Confidence 46899999996655544432 24678999999999999999999998 5 999999999999999 677899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~ 301 (419)
+.............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||... ...+.+..+.... +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~- 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP- 248 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC-
Confidence 977655554556678999999999852 345789999999999999999999999874 4444455444311 00
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.++ ....+++++.+||.+||+.||.+|||++++++||||++...
T Consensus 249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 000 01246899999999999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=358.71 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=206.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcC--CCCeeecceeeec
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFS 141 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~ 141 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++ |+||+++++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~-- 117 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF-- 117 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE--
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE--
Confidence 34567999999999999999999999999999999986432 23457999999996 59999999998
Q ss_pred cCCCCceeEEEEeeccc--ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCce
Q 014750 142 TTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 219 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~v 219 (419)
.....+++|||++. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++..++.+
T Consensus 118 ---~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 118 ---ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ---ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred ---ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence 34455899999997 678777765 3568999999999999999999999 6999999999999998557889
Q ss_pred EEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 220 KLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
||+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+. +.. +.
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~- 259 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ- 259 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC-
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc-
Confidence 99999999876432 334567899999999997766557889999999999999999999965321 111 00
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..++..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus 260 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 --------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 012345799999999999999999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=360.70 Aligned_cols=274 Identities=21% Similarity=0.336 Sum_probs=208.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------------------ccHHHHHHHHHhcCCCCe
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRLMDHPNV 132 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~e~~~l~~l~h~ni 132 (419)
...++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3456899999999999999999998 99999999885321 445689999999999999
Q ss_pred eecceeeeccCCCCceeEEEEeecccc-cHHHHHHhh--ccC--CCCCCHHHHHHHHHHHHHHHHHhHc-CCCccccccc
Q 014750 133 ISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY--SSM--NQRMPLIYVKLYTYQIFRGLAYIHT-VPGVCHRDVK 206 (419)
Q Consensus 133 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~l~~~~~~~i~~qi~~al~~LH~-~~~ivH~Dlk 206 (419)
+++++++. +...+|+||||+.+ +|.+.+... ... ...+++..++.++.||+.||.|||+ . ||+|||||
T Consensus 106 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~ 179 (348)
T 2pml_X 106 LTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVK 179 (348)
T ss_dssp CCCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCC
T ss_pred ceEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCC
Confidence 99999984 34568999999986 554441110 122 5779999999999999999999997 6 99999999
Q ss_pred CCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCC-cccEeehhHHHHHHHhCCCCCCCCCH
Q 014750 207 PQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA 285 (419)
Q Consensus 207 p~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~ 285 (419)
|+|||++ .++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||...+.
T Consensus 180 p~Nil~~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 180 PSNILMD-KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GGGEEEC-TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hHhEEEc-CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999 6778999999999865433 3445678999999999977544655 99999999999999999999988766
Q ss_pred -HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 286 -VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 286 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
.+....+.......+. ....+..+ ... .........++.++.+||.+||+.||.+|||++|+++||||+
T Consensus 258 ~~~~~~~i~~~~~~~~~--------~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPL--------DRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp SHHHHHHHTSCCCCCCC--------SSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHhccCcCCcc--------chhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 4444444321100000 00000000 000 000112245799999999999999999999999999999998
Q ss_pred ccc
Q 014750 365 ELR 367 (419)
Q Consensus 365 ~~~ 367 (419)
+..
T Consensus 328 ~~~ 330 (348)
T 2pml_X 328 DTN 330 (348)
T ss_dssp TCC
T ss_pred CCC
Confidence 743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.88 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=203.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-------CCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFF 140 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (419)
...++|++.+.||+|+||.||+|++. .++..||+|++..... ...+|+.+++.+ +||||+++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-
Confidence 45578999999999999999999975 3456799999865432 345799999999 899999999998
Q ss_pred ccCCCCceeEEEEeecccc-cHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
.+...+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 157 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp 231 (370)
T 2psq_A 157 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 231 (370)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCG
T ss_pred ----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccch
Confidence 444558999999985 88888876431 13468999999999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (419)
+||||+ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.
T Consensus 232 ~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 232 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999 678899999999986543322 2234567889999999764 48999999999999999999 99999988
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+..+....+..... ...+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 310 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CGGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 76665554433100 01234578999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=349.08 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=198.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccC--------C
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTT--------S 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------~ 144 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 357999999999999999999999999999999986432 23457999999999999999999875432 1
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.....+|+||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~-~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFID-ESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEc-CCCCEEEee
Confidence 34567899999997 488887764 23467889999999999999999999 6999999999999999 677899999
Q ss_pred cccccccccC---------------CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH-HH
Q 014750 224 FGSAKVLVKG---------------EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VD 287 (419)
Q Consensus 224 fG~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~ 287 (419)
||++...... .......||+.|+|||++.+...++.++|||||||++|+|++ ||..... .+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765321 122345789999999999776568999999999999999998 5543322 22
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
....+... ...+ ...+....+..+.+||++||+.||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~-----------------~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSV-----------------SIEF--------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHST-----------------TCCC--------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhcccc-----------------cccc--------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 22222210 0011 11133456788999999999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=360.91 Aligned_cols=257 Identities=18% Similarity=0.202 Sum_probs=207.5
Q ss_pred ccccceeeeceeccCCceEEEEEE-----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
....+|++.+.||+|+||+||+|+ +..+++.||||++.... ....+|+.+++.++|+||+++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~---- 143 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS---- 143 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence 345689999999999999999999 45578899999986432 2345799999999999999999998
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CC
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--TH 217 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~ 217 (419)
.+....++|||||. |+|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+||||+.. +.
T Consensus 144 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 144 -LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred -ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCc
Confidence 34445789999997 588888876432 23568999999999999999999999 699999999999999832 23
Q ss_pred ceEEeecccccccccC---CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014750 218 QVKLCDFGSAKVLVKG---EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 293 (419)
Q Consensus 218 ~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~ 293 (419)
.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5999999999754322 223345678999999999764 48999999999999999998 999999988877766655
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..... ..+..++.++.+||.+||+.||.+|||+.++++|.|+..
T Consensus 301 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 42110 012357899999999999999999999999999988753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=353.61 Aligned_cols=248 Identities=19% Similarity=0.220 Sum_probs=200.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +|+||+++++++.. ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence 35799999999999999999999999999999988643 34567899999999 99999999998843 445899
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc-----eEEeecccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGSA 227 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~-----vkl~DfG~a 227 (419)
||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++. +||+|||++
T Consensus 83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIG-RPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-CGGGTCTTSEEECCCTTC
T ss_pred EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeec-cCCCCCCceEEEEEcccc
Confidence 9999988888888753 4679999999999999999999999 6999999999999999 4555 999999999
Q ss_pred cccccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHHHh
Q 014750 228 KVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVL 296 (419)
Q Consensus 228 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~ 296 (419)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ ..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 87544322 2456889999999999764 48999999999999999999999998743 333344433221
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+.. .+...++ ++.+||.+||..||.+||+++++++
T Consensus 237 ~~~~~~------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIE------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHH------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHH------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111110 0112234 9999999999999999999998875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=349.41 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=202.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+++++.++||||+++++++.. ....
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCee
Confidence 3468999999999999999999999999999999885432 234579999999999999999999843 4458
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+.+ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEEC-CCCCEEEeeccccee
Confidence 999999985 77777764 24679999999999999999999999 6999999999999999 678899999999986
Q ss_pred cccCCcc---------------eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 014750 230 LVKGEAN---------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 230 ~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 294 (419)
....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~------ 230 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------ 230 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT------
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH------
Confidence 5433221 145789999999999764 589999999999999999999999875321100
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.+............+..+++++.+||.+||+.||.+|||+.++++ |+..+..
T Consensus 231 --------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 231 --------------------DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp --------------------TSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred --------------------HHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 000000000112234567899999999999999999999999987 6766543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.23 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=201.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||.||+|++..+++ .||||++.... ....+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 345689999999999999999999986655 49999986542 2345799999999999999999998 4
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Df 195 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVD-SNLVCKVSDF 195 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEC-CCCCEEECCC
Confidence 45558999999975 77777754 24579999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 225 G~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 999876443221 123457789999999764 48999999999999999999 999999988877776665421111
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..+++++.+||.+||..||.+|||+.++++
T Consensus 275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22357899999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.37 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=197.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcC--CCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMD--HPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||.||+|++. +++.||+|++.... ....+|+.+++.++ |+||+++++++. +
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----C
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----c
Confidence 3457999999999999999999975 58999999986432 22357999999997 599999999883 4
Q ss_pred ceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 147 ELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 147 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
...+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccc
Confidence 456899999888898888875 3578999999999999999999999 6999999999999997 47899999999
Q ss_pred ccccccCCc---ceeeeeccccccchhhcCC----------CCCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 014750 227 AKVLVKGEA---NISYICSRYYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI 292 (419)
Q Consensus 227 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i 292 (419)
+........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 986543322 2345789999999998651 35788999999999999999999999865432 222222
Q ss_pred HHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
... . . ...++...+.++.+||.+||..||.+|||+.++++||||+....
T Consensus 253 ~~~--------------~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 253 IDP--------------N-H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp HCT--------------T-S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred Hhc--------------c-c------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 210 0 0 01123345889999999999999999999999999999986443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=342.83 Aligned_cols=250 Identities=18% Similarity=0.226 Sum_probs=204.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.+ +|+||+++++++ .+....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCceeE
Confidence 345799999999999999999999999999999988643 34567899999999 799999999987 3445589
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc-----eEEeeccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ-----VKLCDFGS 226 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~-----vkl~DfG~ 226 (419)
+||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++. +||+|||+
T Consensus 83 lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred EEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence 99999988888888753 3569999999999999999999999 69999999999999983 443 99999999
Q ss_pred ccccccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHHH
Q 014750 227 AKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKV 295 (419)
Q Consensus 227 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~ 295 (419)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. ...+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 987644322 2356789999999999764 4899999999999999999999999874 344444444332
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+... .+...+++++.+||.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1111111 122357899999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=355.60 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=202.4
Q ss_pred cccceeeeceeccCCceEEEEEE-----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~-- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec--
Confidence 45679999999999999999999 55677899999986543 2345799999999 78999999998843
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccC---------------------------------------------------
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------------------------------------- 171 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------------------------------------- 171 (419)
....+++|||||.+ +|.+.+......
T Consensus 98 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 98 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred --CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 23347899999985 888887654321
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCc---ce
Q 014750 172 -----------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NI 237 (419)
Q Consensus 172 -----------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~ 237 (419)
...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++....... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhcc
Confidence 1228999999999999999999999 6999999999999999 678899999999986543322 23
Q ss_pred eeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccC
Q 014750 238 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316 (419)
Q Consensus 238 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
...||+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+
T Consensus 254 ~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 315 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------- 315 (359)
T ss_dssp -CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------
T ss_pred ccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-----------------
Confidence 45678999999999764 48999999999999999998 999998876555444444321110
Q ss_pred CCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 316 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1234578999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=339.04 Aligned_cols=246 Identities=18% Similarity=0.301 Sum_probs=203.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...+|++.+.||+|+||.||+|++. +++.||+|++.... ....+|+++++.++||||+++++++ .+...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence 4467999999999999999999976 57789999987543 3356899999999999999999998 4445589
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-GGGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEc-CCCCEEeccccccccc
Confidence 99999985 67776654 23568999999999999999999999 6999999999999998 5778999999999765
Q ss_pred ccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 3321 12234567789999999764 48999999999999999999 9999999888777666544211
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01223468999999999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=344.51 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=209.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccC-----------
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTT----------- 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----------- 143 (419)
...+|++.+.||+|+||.||+|++..+++.||+|++........+|+++++.++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 345799999999999999999999999999999999877777889999999999999999999874311
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
......+++||||+++ +|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~ 164 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLV-DTKQVKIG 164 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEEC
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEc-CCCCEEEC
Confidence 1224568999999995 8888876532 3578999999999999999999999 6999999999999999 67889999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||... ......+..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~-------- 233 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD-------- 233 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--------
T ss_pred cchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--------
Confidence 99999877655555567789999999999764 4899999999999999999999887421 111111110
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..++..++.++.+||.+||..||.+|||+.++++|.|.-.
T Consensus 234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0122346889999999999999999999999999988643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.64 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=192.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.+|.+.+.||+|+||+|+. ....+|+.||||++... .....+|+.+|+.+ +|||||++++++ .+...+||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEEEEE
Confidence 4699999999999999764 34568999999998654 34567899999999 799999999988 4455689999
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----CCCceEEeeccccccc
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKVL 230 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~DfG~a~~~ 230 (419)
|||+|+|.+.+... ...+.+..++.++.||+.||.|||+ +||+||||||+||||+. ....+||+|||+++..
T Consensus 98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999998888753 2334555677899999999999999 69999999999999952 2235889999999876
Q ss_pred ccCC----cceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 231 VKGE----ANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 231 ~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
.... .....+||+.|+|||++.+ ...++.++|||||||++|+|++ |..||........ ..+. +...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~--- 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACS--- 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCC---
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCC---
Confidence 4332 2334678999999999964 2446889999999999999999 9999976543322 1111 1100
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
..... .....+..+.+||.+||+.||.+|||++++++||||..+.
T Consensus 247 ------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 247 ------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp ------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000 0012356789999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=349.43 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=189.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
...++|++.+.||+|+||.||+|++..+++ .||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345679999999999999999999887765 89999886432 234579999999999999999999855432
Q ss_pred CC-ceeEEEEeecccc-cHHHHHHhhcc--CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceE
Q 014750 145 KD-ELFLNLVMEYVPE-TMYRVLKHYSS--MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 145 ~~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vk 220 (419)
.+ ....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~-~~~~~k 177 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLA-EDMTVC 177 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEc-CCCCEE
Confidence 11 1234899999985 78777764332 22368999999999999999999999 6999999999999999 678899
Q ss_pred EeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 014750 221 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 221 l~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 296 (419)
|+|||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 999999986644322 2234567789999999764 48999999999999999999 999999887776666554321
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-------HHHHhcCCccccc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDEL 366 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-------~~e~l~hp~f~~~ 366 (419)
. ...+..+++++.+||.+||+.||.+||| +++++.|||+...
T Consensus 257 ~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 257 R----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp C----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred C----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0 0122357899999999999999999999 7788899999764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=364.74 Aligned_cols=258 Identities=29% Similarity=0.400 Sum_probs=190.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++ .+...+||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence 457778999999999998754 5689999999886543 3346799999876 899999999988 4556689999
Q ss_pred ecccccHHHHHHhhccCCCC---CCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC------------CCCce
Q 014750 155 EYVPETMYRVLKHYSSMNQR---MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP------------LTHQV 219 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~------------~~~~v 219 (419)
|||+|+|.+.+......... .++..++.++.||+.||.|||+ +||+||||||+|||++. .+..+
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99999999888754322111 1333467899999999999999 69999999999999973 23579
Q ss_pred EEeecccccccccCCc-----ceeeeeccccccchhhcC------CCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHH
Q 014750 220 KLCDFGSAKVLVKGEA-----NISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 287 (419)
Q Consensus 220 kl~DfG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~ 287 (419)
||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999987644322 224578999999999965 2458999999999999999999 999997654433
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
..+..... ..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 --~~i~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 --SNIIRGIF-----------------SLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp --HHHHHTCC-----------------CCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred --HHHhcCCC-----------------Cccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 22222110 111100 0001124678999999999999999999999999999964
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=352.04 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=205.4
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC-------CcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeee
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFF 140 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (419)
...++|.+.+.||+|+||.||+|++..+ +..||+|++.... ....+|+++++.+ +||||+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~- 144 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC- 144 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-
Confidence 4557899999999999999999997543 3579999986543 2245799999999 999999999998
Q ss_pred ccCCCCceeEEEEeecccc-cHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccC
Q 014750 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKP 207 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp 207 (419)
.+...+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 145 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 219 (382)
T 3tt0_A 145 ----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAA 219 (382)
T ss_dssp ----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred ----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCc
Confidence 444458999999985 88888876432 12469999999999999999999999 6999999999
Q ss_pred CceeeCCCCCceEEeecccccccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCC
Q 014750 208 QNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 283 (419)
Q Consensus 208 ~NIll~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 283 (419)
+||||+ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 67889999999998664332 22334668899999999764 48999999999999999999 99999988
Q ss_pred CHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 284 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 284 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+..+....+..... ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87766655543210 01234578999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=335.36 Aligned_cols=246 Identities=19% Similarity=0.276 Sum_probs=203.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||.||+|++. ++..||+|++.... ....+|+.+++.++||||+++++++ .+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4568999999999999999999875 56789999987543 3345899999999999999999998 4555589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||++ ++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEEC-TTCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEEC-CCCCEEEccCccceec
Confidence 9999997 5687777653 3458999999999999999999999 6999999999999999 6788999999999866
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
...... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------- 224 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence 443321 223456789999999764 48999999999999999999 99999988877766655432100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123468899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=352.46 Aligned_cols=267 Identities=22% Similarity=0.247 Sum_probs=198.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...+|++.+.||+|+||+||+|++ .++.||||++..... ...+|+.+++.++||||+++++++..... ....++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEE
Confidence 446899999999999999999987 489999999864432 23458888999999999999999865332 245579
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC----------CcccccccCCceeeCCCCCceE
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP----------GVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~----------~ivH~Dlkp~NIll~~~~~~vk 220 (419)
+|||||.+ +|.+.+.. ..+++..++.++.||+.||.|||+ . ||+||||||+|||++ .++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~-~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLK-NNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEEC-TTCCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEEC-CCCeEE
Confidence 99999985 88887764 459999999999999999999999 8 999999999999999 678899
Q ss_pred EeecccccccccCCc---ceeeeeccccccchhhcCCC----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014750 221 LCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 293 (419)
Q Consensus 221 l~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 293 (419)
|+|||+++....... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999976644332 23357899999999997632 35568899999999999999999998754322222222
Q ss_pred HHhCCCCHHHHhcc-CcCCccccCCCCCCCCchhhc-CCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 294 KVLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 294 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+.+....+... ..... .+. +...+ ....++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKK---RPV-----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCC---CCC-----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhcccC---CCC-----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22223333222211 00000 000 00000 0112456999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=355.09 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=203.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.....+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+++++.++||||+++++++ .+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 184 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQK 184 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecC
Confidence 345578999999999999999999999999999999886442 2345799999999999999999998 344
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||++ |+|.+.+... ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~-~~~~~kl~DfG~ 259 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVT-EKNVLKISDFGM 259 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCGGG
T ss_pred CCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEc-CCCcEEECcCCC
Confidence 45899999998 5888777642 3458999999999999999999999 6999999999999999 678899999999
Q ss_pred ccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
++........ ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+....
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---- 334 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---- 334 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC----
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9764332111 122357789999999764 48999999999999999998 99999988876655544331100
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+++++.+||.+||+.||.+|||++++++
T Consensus 335 ------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 123457899999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=350.22 Aligned_cols=250 Identities=25% Similarity=0.300 Sum_probs=203.7
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC----- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----
Confidence 4567999999999999999999987 355899999987542 2345799999999999999999998
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccc
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSM--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~ 203 (419)
.+...+|+||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 444558999999985 888888764221 2679999999999999999999999 699999
Q ss_pred cccCCceeeCCCCCceEEeecccccccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCC
Q 014750 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 279 (419)
Q Consensus 204 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p 279 (419)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 199 Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999 67789999999997653322 22345678899999999764 48999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
|.+.+..+....+..... ..++..++.++.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 998887766655543100 0123457899999999999999999999999986
Q ss_pred C
Q 014750 360 H 360 (419)
Q Consensus 360 h 360 (419)
+
T Consensus 329 ~ 329 (343)
T 1luf_A 329 I 329 (343)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.50 Aligned_cols=245 Identities=22% Similarity=0.343 Sum_probs=197.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----------ccHHHHHHHHHhcCCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--- 92 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--- 92 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence 34568999999999999999999999999999999885322 2345799999999999999999987
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCc-
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQ- 218 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~- 218 (419)
.+.. ++||||+. ++|.+.+.. ....+++..++.++.|++.||.|||+ +| |+||||||+|||++. ++.
T Consensus 93 --~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~ 163 (287)
T 4f0f_A 93 --HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDEN 163 (287)
T ss_dssp --TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTT
T ss_pred --cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCC
Confidence 2222 59999998 677776654 34579999999999999999999999 69 999999999999983 444
Q ss_pred ----eEEeecccccccccCCcceeeeeccccccchhhcC-CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH--HHH
Q 014750 219 ----VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVE 291 (419)
Q Consensus 219 ----vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~ 291 (419)
+||+|||+++... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..+. ...
T Consensus 164 ~~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CSCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CceeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 9999999997543 23445788999999999843 23468899999999999999999999987643332 222
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+.. .+ +...++..+++++.+||.+||+.||.+|||++++++
T Consensus 242 ~~~-~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IRE-EG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHH-SC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hhc-cC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222 11 011133467899999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=336.91 Aligned_cols=244 Identities=27% Similarity=0.428 Sum_probs=190.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+|+++++.++||||+++++++ .+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 77 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LK 77 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ec
Confidence 345799999999999999999997 58899999885432 2345799999999999999999998 44
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC---cccccccCCceeeCC-------C
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG---VCHRDVKPQNLLVDP-------L 215 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~---ivH~Dlkp~NIll~~-------~ 215 (419)
....++||||+.+ +|.+.+. ...+++..++.++.|++.||.|||+ +| |+||||||+|||++. .
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~ 151 (271)
T 3dtc_A 78 EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLS 151 (271)
T ss_dssp C--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred CCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEeccccccccc
Confidence 5558999999985 5555543 3579999999999999999999999 68 899999999999984 2
Q ss_pred CCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
++.+||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 152 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 152 NKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp SCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred CcceEEccCCcccccccc-cccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 667999999999765433 23356789999999999764 4899999999999999999999999988776655544321
Q ss_pred hCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 296 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. +...++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 230 ~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 K---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 0011234578999999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=348.06 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=186.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcC-CCCeeecceeeeccCC---CCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMD-HPNVISLKHCFFSTTS---KDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~~ 147 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+. |+||+++++++..... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 347999999999999999999999999999999885443 23457899999996 9999999998854322 455
Q ss_pred eeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecc
Q 014750 148 LFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 148 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+++||||+.|+|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+||||+ .++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLS-NQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEEC-TTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEEC-CCCCEEEecCc
Confidence 6789999999999998887643 34579999999999999999999999 69 99999999999999 57789999999
Q ss_pred cccccccCCcc-------------eeeeeccccccchhhc--CCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHH
Q 014750 226 SAKVLVKGEAN-------------ISYICSRYYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (419)
Q Consensus 226 ~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (419)
++......... ....||+.|+|||++. ....++.++|||||||++|+|++|..||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 99876433221 1456899999999983 23457889999999999999999999997654322111
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.. +.. ......+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 264 ~~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 GK---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred Cc---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 10 000 012345778999999999999999999999998844
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.91 Aligned_cols=273 Identities=22% Similarity=0.338 Sum_probs=203.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++... +....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence 457999999999999999999999999999999986432 2345899999999999999999987542 23357
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee----CCCCCceEEeecc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV----DPLTHQVKLCDFG 225 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~~vkl~DfG 225 (419)
|+|||||. ++|.+.+.... ....+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 89999998 47777665432 23449999999999999999999999 699999999999998 5 56679999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCC-------CCCCCcccEeehhHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLVEIIK 294 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~i~~ 294 (419)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99877655555567899999999998641 34678999999999999999999999753 23344444433
Q ss_pred HhCCCCHHHHhccCc-CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 295 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+.|. ..+..... ....+.+. ...+....+...++..+.+||++||+.||++|+|++++++
T Consensus 242 --~~p~-~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKPS-GAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCCT-TCCEEEECSTTCCEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCCc-ccchhheeccCCCcccC--ccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222 11111000 00000000 0000011122334678899999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=337.72 Aligned_cols=247 Identities=18% Similarity=0.249 Sum_probs=201.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
....+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+++++.++|+||+++++++ .+...+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence 44568999999999999999999875 67789999987543 3345899999999999999999998 445558
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~-~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVN-DQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEEC-TTSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEc-CCCCEEEcccccccc
Confidence 99999997 5777777642 3569999999999999999999999 6999999999999999 677899999999976
Q ss_pred cccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 533211 1234457789999999765 48999999999999999998 99999988887776666542111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123468899999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=347.65 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=204.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+|+++++.++|+||+++++++. ....
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSSC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCCc
Confidence 445799999999999999999984 468999999986432 23568999999999999999999984 4445
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC---CcccccccCCceeeCCCCCceEEeecc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---GVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLD-EEFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEEC-TTCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEEC-CCCCEEeccCc
Confidence 7899999985 8888887765556679999999999999999999999 8 999999999999999 67889999999
Q ss_pred cccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCC
Q 014750 226 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 299 (419)
Q Consensus 226 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~ 299 (419)
++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9987643322 23356899999999997654 8999999999999999999999995211 0000111110
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
..........+....+...+....+.++.+||.+||+.||.+|||+.++++|-+-..+
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 0000111111111111122223345789999999999999999999999998664443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=343.84 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=203.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
....+|.+.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 44568999999999999999999973 456899999986543 2345799999999999999999998
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc--------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS--------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
.+...+++||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+|
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH 173 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVH 173 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence 44455899999998 688888876432 12348999999999999999999999 69999
Q ss_pred ccccCCceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCC
Q 014750 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 278 (419)
Q Consensus 203 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~ 278 (419)
|||||+|||++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus 174 ~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 678899999999986643322 1234567889999999764 48999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 279 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
||.+.+..+....+..... ...+..+++++.+||.+||+.||.+|||+.+++
T Consensus 252 p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~ 303 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9988776555544332100 012345789999999999999999999999998
Q ss_pred cC
Q 014750 359 AH 360 (419)
Q Consensus 359 ~h 360 (419)
++
T Consensus 304 ~~ 305 (314)
T 2ivs_A 304 KD 305 (314)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=338.81 Aligned_cols=252 Identities=23% Similarity=0.254 Sum_probs=201.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++|++++..+..+.. .....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEE
Confidence 345799999999999999999999999999999988643 3346689999999999988777665532 3345789
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC--CCCCceEEeeccccccc
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~--~~~~~vkl~DfG~a~~~ 230 (419)
||||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ..++.+||+|||++...
T Consensus 83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999988888887642 3579999999999999999999999 6999999999999994 25678999999999876
Q ss_pred ccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Q 014750 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTP 299 (419)
Q Consensus 231 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~~ 299 (419)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 54322 2456789999999999765 489999999999999999999999986432 22333332211111
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+. ..+...+++++.+||.+||+.||.+|||++++++
T Consensus 238 ~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ch------------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 10 1122457899999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.02 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=192.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CC
Confidence 346999999999999999999999999999999986421 223579999999999999999999843 34
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+++||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~-~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFIT-ATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCC---
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEc-CCCCEEEEeccce
Confidence 58999999985 8888887766667789999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHHH
Q 014750 228 KVLVKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 228 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 304 (419)
........ .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+....+.. ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------- 254 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CD------- 254 (310)
T ss_dssp ---------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TC-------
T ss_pred eeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-cc-------
Confidence 76543322 2345789999999999764 589999999999999999999999976432 222222211 00
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
++. .....+++++.+||.+||..||.+|||+.++++ .++++.
T Consensus 255 -----------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l~ 296 (310)
T 2wqm_A 255 -----------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRMH 296 (310)
T ss_dssp -----------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred -----------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHHH
Confidence 110 011346899999999999999999999999986 344443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.29 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=203.2
Q ss_pred cccceeeeceeccCCceEEEEEEE-----cCCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|++ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 456899999999999999999985 4577899999987543 2345799999999 999999999998
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCC
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS--------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~ 208 (419)
.+....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~ 174 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence 344458999999985 88888775421 12358999999999999999999999 69999999999
Q ss_pred ceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCC
Q 014750 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (419)
Q Consensus 209 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (419)
|||++ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 175 Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999 678899999999987644432 2234568889999998764 48999999999999999999 999998876
Q ss_pred HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 285 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.......+...... ...+..++.++.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555444432111 01123568999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.86 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=211.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeecc
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFST 142 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (419)
....++|++.+.||+|+||.||+|++. .+++.||+|.+..... ...+|+.+++.++|+||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--- 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--- 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE---
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE---
Confidence 345678999999999999999999876 3678899999865432 234799999999999999999998
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhcc------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSS------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~ 215 (419)
.+....++||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .
T Consensus 98 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~-~ 173 (322)
T 1p4o_A 98 --SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-E 173 (322)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEEC-T
T ss_pred --ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEc-C
Confidence 44445899999998 588888765432 12457899999999999999999999 6999999999999999 6
Q ss_pred CCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014750 216 THQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (419)
++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 78899999999976543321 2234668899999999764 48999999999999999999 8999998887766655
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC------Ccccc
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDE 365 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h------p~f~~ 365 (419)
+..... ...+..++.++.+||.+||+.||.+|||+.++++| +||++
T Consensus 253 ~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 253 VMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp HHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 543100 00123578999999999999999999999999976 77776
Q ss_pred ccCCC
Q 014750 366 LREPN 370 (419)
Q Consensus 366 ~~~~~ 370 (419)
+....
T Consensus 305 ~~~~~ 309 (322)
T 1p4o_A 305 VSFYY 309 (322)
T ss_dssp HCSTT
T ss_pred ccccc
Confidence 55443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=340.88 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=195.4
Q ss_pred ccccceeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||+||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 345689999999999999999998 56789999999986543 2345799999999999999999987542
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~-~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVE-NENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEc-CCCeEEEccC
Confidence 2234789999997 5888877653 2458999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|++........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||...... . .+..+...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~ 232 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDK 232 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTC
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCcc
Confidence 99987643321 2234567789999999765 4899999999999999999999998643221 1 11111111
Q ss_pred HHH------HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REE------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
... ....... .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CTHHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0000000 001123467899999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.20 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=206.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.....+|++.+.||+|+||.||+|.+..++..||+|++..+. ....+|+.+++.++|+||+++++++ .+...
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCC
Confidence 345678999999999999999999999999999999987554 2345799999999999999999998 44555
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+++||||+. ++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++ .++.+||+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEEC-GGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEc-CCCCEEEccCccce
Confidence 899999998 5888877653 23568999999999999999999999 6999999999999999 57789999999998
Q ss_pred ccccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------- 230 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------- 230 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------
T ss_pred eccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------
Confidence 76443322 234567889999999764 48999999999999999999 9999988776655544432100
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..+++++.+||.+||..||.+|||++++++
T Consensus 231 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 --------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1123457899999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=345.89 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=197.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcE----EEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|++.+.||+|+||+||+|++..+++. ||+|.+... .....+|+.+++.++|+||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 456799999999999999999999888876 677766432 233457999999999999999999872
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
....++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~-~~~~~kl~Df 159 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLK-SPSQVQVADF 159 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEES-SSSCEEECSC
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEEC-CCCeEEECCC
Confidence 223789999998 5777777542 3568899999999999999999999 6999999999999999 5778999999
Q ss_pred ccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 235 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--- 235 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence 99987644332 2345667899999999764 48999999999999999999 9999998776555544432100
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++.++.+||.+||..||.+|||+.++++|
T Consensus 236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123457889999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.52 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=202.5
Q ss_pred ccccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeecc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFST 142 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (419)
....+|.+.+.||+|+||.||+|++. .++..||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 34568999999999999999999973 466789999986432 2345899999999 8999999999983
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccC-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCccc
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSM-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCH 202 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH 202 (419)
....+++||||++ |+|.+.+...... ...+++..++.++.||+.||.|||+ +||+|
T Consensus 120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH 195 (344)
T 1rjb_A 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVH 195 (344)
T ss_dssp ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccc
Confidence 3445899999997 5888888653211 1348999999999999999999999 69999
Q ss_pred ccccCCceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCC
Q 014750 203 RDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP 278 (419)
Q Consensus 203 ~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~ 278 (419)
|||||+|||++ .++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..
T Consensus 196 ~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 196 RDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999 6789999999999866443322 235668899999999764 48999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 279 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 279 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
||.+......+..+...... ...+..+++++.+||.+||..||.+|||+.+++
T Consensus 274 p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp SSTTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99887655554444431100 012234689999999999999999999999999
Q ss_pred cCCc
Q 014750 359 AHPF 362 (419)
Q Consensus 359 ~hp~ 362 (419)
+|-.
T Consensus 327 ~~l~ 330 (344)
T 1rjb_A 327 SFLG 330 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.59 Aligned_cols=259 Identities=16% Similarity=0.151 Sum_probs=196.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC-----CcEEEEEEeccCcccHHHHHH---------------HHHhcCCCCeeec
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRELQ---------------LMRLMDHPNVISL 135 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~e~~---------------~l~~l~h~niv~~ 135 (419)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++........+|++ .++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 44799999999999999999998764 588999998766544444444 4455679999999
Q ss_pred ceeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-
Q 014750 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP- 214 (419)
Q Consensus 136 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~- 214 (419)
++++.... .+..+.|||||||+++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESS
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecC
Confidence 99886532 23467899999997788887765 24679999999999999999999999 69999999999999972
Q ss_pred CCCceEEeecccccccccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 286 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 286 (419)
.++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 357899999999976543221 1335599999999999765 4899999999999999999999999864322
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhc-CCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
............+....+. ...+ ...++.++.+||..||..||.+||++.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLM-------------------DKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHH-------------------HHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHH-------------------HHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2222222111000100000 0001 1356899999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=347.90 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=202.9
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEE--EEEEeccC-----cccHHHHHHHHHhc-CCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (419)
...++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~----- 96 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE----- 96 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----
Confidence 34468999999999999999999999888865 99988642 23356799999999 8999999999983
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhc------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYS------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
+...+|+||||++ ++|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 175 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence 3445899999997 58888876532 234579999999999999999999999 699999999999999
Q ss_pred CCCCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014750 213 DPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 291 (419)
Q Consensus 213 ~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~ 291 (419)
+ .++.+||+|||+++............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 G-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp C-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred c-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 9 5778999999999754333333445668889999999764 47999999999999999998 9999998877665554
Q ss_pred HHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 292 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+.... ....+..+++++.+||.+||..||.+|||++++++|
T Consensus 254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43210 001223568999999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=337.19 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=198.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|++++..+..+.. .....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence 45799999999999999999999999999999976533 4456789999999999988887776643 33457899
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee---CCCCCceEEeeccccccc
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV---DPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~~vkl~DfG~a~~~ 230 (419)
|||++++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||+ + .++.+||+|||+++..
T Consensus 84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEEC
T ss_pred EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccC-CCCeEEEecCccceec
Confidence 999988888887642 3569999999999999999999999 699999999999999 5 5778999999999876
Q ss_pred ccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Q 014750 231 VKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGTP 299 (419)
Q Consensus 231 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~ 299 (419)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. ..+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 44322 2346789999999999765 4899999999999999999999999874332 2222222211000
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+ ...+...+++++.+||.+||+.||.+|||++++++
T Consensus 238 ~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 P------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp C------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred h------------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 01122456899999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=350.70 Aligned_cols=268 Identities=22% Similarity=0.235 Sum_probs=200.9
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
....++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+|+.+++.++||||+++++++ .+..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 108 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERN 108 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTT
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCC
Confidence 34566899999999999999999995 478999999886543 2345799999999999999999998 4445
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+++||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLD-ENFVPKITDFGIS 186 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEEC-TTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEEC-CCCCEEEeecccc
Confidence 58999999985 6665554433333468999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 228 KVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 228 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+... ...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~- 259 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VES- 259 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHH-
T ss_pred cccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhc-
Confidence 7643222 22345689999999999765 4899999999999999999999999765432211110000 000
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
..+ ..+...........+....+..+.+||.+||+.||++|||+.++++|-
T Consensus 260 -~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 260 -HNN-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp -HTT-----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -ccc-----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 011111111111222233467899999999999999999999999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.42 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=203.3
Q ss_pred CCccccceeeeceeccCCceEEEEEEEc-------CCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeeccee
Q 014750 72 EPKQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHC 138 (419)
Q Consensus 72 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~ 138 (419)
.....++|++.+.||+|+||.||+|++. .++..||+|++..... ...+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3445678999999999999999999975 4577899999865432 245799999999 89999999999
Q ss_pred eeccCCCCceeEEEEeecccc-cHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccc
Q 014750 139 FFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDV 205 (419)
Q Consensus 139 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dl 205 (419)
+ .+...+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||
T Consensus 110 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dl 183 (334)
T 2pvf_A 110 C-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDL 183 (334)
T ss_dssp E-----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred E-----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCC
Confidence 8 444558999999985 88888775432 12358999999999999999999999 69999999
Q ss_pred cCCceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCC
Q 014750 206 KPQNLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 281 (419)
Q Consensus 206 kp~NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~ 281 (419)
||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 184 kp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 184 AARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp SGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999 678899999999986644322 2234567889999999764 48999999999999999999 999999
Q ss_pred CCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 282 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 282 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+.+..+....+...... ..+..++.++.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 88877666555442100 1223578999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=338.70 Aligned_cols=243 Identities=17% Similarity=0.199 Sum_probs=195.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC-------cEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--- 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC---
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE---
Confidence 4568999999999999999999998877 469999885433 23457999999999999999999984
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCc----
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ---- 218 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~---- 218 (419)
+....++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~-~~~~~~~~ 155 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLI-REEDRKTG 155 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-ECCBGGGT
T ss_pred --eCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEe-cCCccccc
Confidence 3445789999998 5888877652 2348999999999999999999999 6999999999999998 4544
Q ss_pred ----eEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 014750 219 ----VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEII 293 (419)
Q Consensus 219 ----vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~ 293 (419)
+||+|||++..... .....+|..|+|||++.+...++.++|||||||++|+|++| .+||...+.........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 99999999865422 23456788999999998756689999999999999999995 55565555443332221
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.. ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus 233 ~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 233 DR------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TT------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cc------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 10 01223457889999999999999999999999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.52 Aligned_cols=256 Identities=14% Similarity=0.132 Sum_probs=192.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcC---CCcEEEEEEeccCccc---------------HHHHHHHHHhcCCCCeeecce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRLMDHPNVISLKH 137 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~e~~~l~~l~h~niv~~~~ 137 (419)
.++|++.+.||+|+||.||+|++.. ++..+|+|++...... ..+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 7889999988754322 225667778889999999999
Q ss_pred eeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC
Q 014750 138 CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH 217 (419)
Q Consensus 138 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~ 217 (419)
++.... .+...+|+||||++++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~ 188 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KN 188 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SS
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CC
Confidence 886533 33567899999997787776654 2379999999999999999999999 69999999999999983 44
Q ss_pred --ceEEeecccccccccCC--------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC--CH
Q 014750 218 --QVKLCDFGSAKVLVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NA 285 (419)
Q Consensus 218 --~vkl~DfG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--~~ 285 (419)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. +.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 89999999997653321 11345789999999999765 5899999999999999999999999652 32
Q ss_pred HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 286 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 286 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..............+....... -...+++++.+||.+||..||.+|||++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2222222222111111111000 01157899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=338.04 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=195.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcC---CCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
....+|.+.+.||+|+||.||+|++.. +++.||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 455689999999999999999998765 55689999986442 224579999999999999999999865544
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhc--cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYS--SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
......++||||+.+ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~-~~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLR-DDMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEEC-TTSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCcEEE
Confidence 334457999999984 7777775332 234679999999999999999999999 6999999999999999 5778999
Q ss_pred eecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Q 014750 222 CDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 297 (419)
Q Consensus 222 ~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 297 (419)
+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999976543321 2234567889999999764 58999999999999999999 9999998877666555443110
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..+++++.+||.+||..||.+|||+.++++|
T Consensus 268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234578999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=335.28 Aligned_cols=248 Identities=27% Similarity=0.342 Sum_probs=191.2
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
....++|++.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----
Confidence 34567899999999999999999998654 4579999876432 23457999999999999999999872
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
+ ...|+||||+.+ +|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 87 -~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~D 159 (281)
T 1mp8_A 87 -E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGD 159 (281)
T ss_dssp -S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECC
T ss_pred -c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEEC-CCCCEEECc
Confidence 1 237899999985 777777542 3568999999999999999999999 6999999999999999 578899999
Q ss_pred cccccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 224 FGSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 224 fG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
||+++....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--- 235 (281)
T 1mp8_A 160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--- 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---
Confidence 999987644332 2234557889999999754 48999999999999999997 9999998877666655543110
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..++..+++++.+||.+||..||.+|||+.+++++
T Consensus 236 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01234578999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.62 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=193.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHh--cCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||+||+|++ +++.||||++.... ....+|.+++.. ++||||+++++++.... .....++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence 456799999999999999999987 78999999986543 233457777776 79999999999865432 3456689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCcccccccCCceeeCCCCCceEEe
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
+||||+.+ +|.+.+. ...+++..++.++.||+.||.||| + +||+||||||+|||++ .++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~-~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVK-KNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEEC-TTSCEEEC
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEc-CCCCEEEe
Confidence 99999985 7777774 357999999999999999999999 8 6999999999999999 67889999
Q ss_pred ecccccccccCCcc-----eeeeeccccccchhhcCCCC-----CCCcccEeehhHHHHHHHhC----------CCCCCC
Q 014750 223 DFGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPG 282 (419)
Q Consensus 223 DfG~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~ 282 (419)
|||+++........ ....||+.|+|||++.+... ++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999765443322 23478999999999976532 34689999999999999999 888865
Q ss_pred CC----HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 283 EN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 283 ~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
.. ....+.......+.. ..++ ...+...+++++.+||.+||+.||.+|||+.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQR--------------PNIP-------NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCC--------------CCCC-------GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCC--------------CCCC-------hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 32 122222222110000 0000 0111223467899999999999999999999997
Q ss_pred c
Q 014750 359 A 359 (419)
Q Consensus 359 ~ 359 (419)
+
T Consensus 295 ~ 295 (301)
T 3q4u_A 295 K 295 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=338.03 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=190.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3467999999999999999999999999999999986442 234579999999999999999999843 4
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVS-ADDFAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEc-CCCCEEEecCcc
Confidence 458999999985 777777652 568999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 227 AKVLVKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 227 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
+....... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+... +........ +
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~-~----- 252 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAI-P----- 252 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCC-C-----
T ss_pred CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCC-C-----
Confidence 97654332 12345789999999999764 58999999999999999999999998765542 222222100 0
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-CHHHHhc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 359 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-t~~e~l~ 359 (419)
....++..++.++.+||.+||+.||.+|| |++++++
T Consensus 253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01122346789999999999999999999 7777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.16 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=202.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCc-----EEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
...+|.+.+.||+|+||.||+|.+..+++ .||+|.+.... ....+|+.+++.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~---- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC---- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 45679999999999999999999977665 79999886542 2345799999999 899999999998
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhcc----------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSS----------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
.+...+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLL 197 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEE
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEE
Confidence 344458999999985 88888765432 14568999999999999999999999 699999999999999
Q ss_pred CCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHH
Q 014750 213 DPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 288 (419)
Q Consensus 213 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~ 288 (419)
+ .++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......
T Consensus 198 ~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 198 T-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp E-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred C-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9 678899999999986544332 2234568889999999764 48999999999999999999 9999988765555
Q ss_pred HHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 289 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+..+......+ ..+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 54444321110 1123468899999999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=360.61 Aligned_cols=254 Identities=20% Similarity=0.191 Sum_probs=192.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCC-CCeeecce---------e
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDH-PNVISLKH---------C 138 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h-~niv~~~~---------~ 138 (419)
...|...+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.+.| .|+..+.. .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346899999999999999999999999999999886322 234578888888877 32211111 1
Q ss_pred ------------eeccCCCCceeEEEEeecccccHHHHHHhh---ccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccc
Q 014750 139 ------------FFSTTSKDELFLNLVMEYVPETMYRVLKHY---SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (419)
Q Consensus 139 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~ 203 (419)
+..........++++|+++.++|.+++... ......+++..+..++.||+.||.|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 111001112347899999999988887533 2234557888899999999999999999 699999
Q ss_pred cccCCceeeCCCCCceEEeecccccccccCCcceeeeeccccccchhhc---------CCCCCCCcccEeehhHHHHHHH
Q 014750 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 274 (419)
Q Consensus 204 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~ell 274 (419)
||||+||||+ .++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~-~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLD-QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEEC-TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEe-cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999 5778999999998765322 445677 9999999983 3334788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCH
Q 014750 275 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 354 (419)
Q Consensus 275 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~ 354 (419)
+|+.||...+..+.... .+. ....+++++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~-----------------------~~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEW-----------------------IFR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGG-----------------------GGS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHH-----------------------HHh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999976543211110 000 012468999999999999999999999
Q ss_pred HHHhcCCcccccc
Q 014750 355 LEACAHPFFDELR 367 (419)
Q Consensus 355 ~e~l~hp~f~~~~ 367 (419)
.++++||||+.+.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=337.96 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=200.8
Q ss_pred cccceeeeceeccCCceEEEEEEE-----cCCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|++ ..+++.||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec--
Confidence 446799999999999999999985 45778999999875432 244799999999 78999999998743
Q ss_pred CCCceeEEEEeecccc-cHHHHHHhhccC------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCce
Q 014750 144 SKDELFLNLVMEYVPE-TMYRVLKHYSSM------------NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNL 210 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NI 210 (419)
....+++||||+.+ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 103 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI 179 (316)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred --CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceE
Confidence 23347899999984 888877653221 2238999999999999999999999 6999999999999
Q ss_pred eeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHH
Q 014750 211 LVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 286 (419)
Q Consensus 211 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~ 286 (419)
|++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus 180 l~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 180 LLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 999 577899999999986643332 2235678899999999764 48999999999999999998 99999887644
Q ss_pred HHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 287 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+.+......... ...+..+++++.+||.+||..||.+|||+.++++|
T Consensus 258 ~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 258 EEFCRRLKEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444333321110 01223468999999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=359.98 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=204.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
....+|++.+.||+|+||.||+|++..++..||||++..+. ....+|+.+|+.++||||+++++++ .+...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCcE
Confidence 34567999999999999999999999899999999987553 3345799999999999999999998 344458
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|||||||. |+|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++.
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVG-ENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-GGGCEEECCTTCEEC
T ss_pred EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEEC-CCCcEEEeeccccee
Confidence 99999998 68888876532 3568999999999999999999999 6999999999999999 678899999999987
Q ss_pred cccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
....... ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+...
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 437 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 437 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 6433221 123456789999999764 48999999999999999999 9999998876655544432100
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 438 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0123457899999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.35 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=193.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEE----EEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|++.+.||+|+||+||+|++..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 4567999999999999999999998887765 77766432 23345799999999999999999988531
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
..++|+||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 90 ---~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~-~~~~~kl~Df 161 (327)
T 3poz_A 90 ---TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDF 161 (327)
T ss_dssp ---SEEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCT
T ss_pred ---CeEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEEC-CCCCEEEccC
Confidence 1678888888 577777765 24679999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+++........ ....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence 999876443322 234557889999999764 48999999999999999999 99999887765554443321100
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 --------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0123468899999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=347.85 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=190.1
Q ss_pred cccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...+|.+.+.||+|+||.||+|++. .++..||||++.... ....+|+.+++.++||||+++++++ .+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 4467999999999999999999976 467789999986432 2345799999999999999999998 44
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
...+++||||++ ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~-~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILIN-SNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEc-CCCCEEECcCc
Confidence 455899999997 588777764 24579999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+++........ ....++..|+|||++.+. .++.++|||||||++|||++ |+.||...+..+....+......+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~- 270 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99876433211 122346789999999764 48999999999999999998 999999888776665554321110
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 271 ---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 ---------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 12346889999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=340.95 Aligned_cols=256 Identities=18% Similarity=0.209 Sum_probs=201.7
Q ss_pred cccceeeeceeccCCceEEEEEE-----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
...+|++.+.||+|+||.||+|+ +..+++.||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---- 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence 45679999999999999999999 55678899999985432 23457999999999999999999983
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhcc---CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCc
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSS---MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQ 218 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~ 218 (419)
+....|+||||+. ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+..
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 4445789999996 688888876432 12458999999999999999999999 69999999999999983 2346
Q ss_pred eEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 014750 219 VKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 294 (419)
Q Consensus 219 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~ 294 (419)
+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 99999999975533221 2234678899999999764 48999999999999999998 9999998877666655543
Q ss_pred HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 295 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
... ...+..++..+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 110 0122357899999999999999999999999999998753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=342.82 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=199.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 457999999999999999999999999999999885432 33457999999999999999999885322 2455689
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEc-CCCCEEEEecCcchhc
Confidence 99999985 8888888766667889999999999999999999999 6999999999999999 5778999999998754
Q ss_pred ccCCc----------ceeeeeccccccchhhcCCC--CCCCcccEeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Q 014750 231 VKGEA----------NISYICSRYYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLG 297 (419)
Q Consensus 231 ~~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~ 297 (419)
..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 22111 12245689999999986543 2688999999999999999999999531100 001111110
Q ss_pred CCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 298 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...++ ....++.++.+||.+||+.||.+|||+.++++|
T Consensus 263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00011 113468999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.32 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=199.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
....+|++.+.||+|+||.||+|.+ .|+.||||++.... ....+|+.+|+.++||||+++++++... ...+|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence 4456899999999999999999987 57899999997553 3356899999999999999999987532 23489
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+|||||. |+|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEC-CCCCEEEeeCCCcccc
Confidence 9999998 58888887532 2347899999999999999999999 6999999999999999 6788999999999854
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.+...
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------ 404 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------ 404 (450)
T ss_dssp C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred ccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 322 2234668889999999764 48999999999999999998 9999998776665555433110
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..+++++.+||.+||..||.+|||+.++++
T Consensus 405 ----------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ----------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123467999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=328.54 Aligned_cols=246 Identities=18% Similarity=0.301 Sum_probs=202.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...+|++.+.||+|+||.||+|++. +++.||+|++.... ....+|+.+++.++||||+++++++. +...++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence 3467999999999999999999986 67889999987543 33468999999999999999999983 444589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||++ ++|.+.+... ...+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFV 154 (267)
T ss_dssp EEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEEC-GGGCEEECCTTGGGGB
T ss_pred EEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEC-CCCCEEEccccccccc
Confidence 9999998 5777777642 3568999999999999999999999 6999999999999999 5778999999999765
Q ss_pred ccCC--cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGE--ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------- 223 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 223 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred ccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------
Confidence 3221 11234567889999999754 48999999999999999999 8999998887776665543210
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123468899999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.18 Aligned_cols=254 Identities=13% Similarity=0.133 Sum_probs=196.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC--------CcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecc-----------
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLK----------- 136 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~----------- 136 (419)
.++|++.+.||+|+||.||+|++..+ ++.||+|++... ....+|+++++.++|+||++++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 35799999999999999999999874 889999998755 4567899999999999999843
Q ss_pred ----eeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceee
Q 014750 137 ----HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLV 212 (419)
Q Consensus 137 ----~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll 212 (419)
+++. .+...+|+||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 120 ~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 120 PTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV 192 (352)
T ss_dssp CCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred cchhhccc----cCCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence 3332 1245689999999889888887532 3579999999999999999999999 699999999999999
Q ss_pred CCCCC--ceEEeecccccccccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCC
Q 014750 213 DPLTH--QVKLCDFGSAKVLVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 282 (419)
Q Consensus 213 ~~~~~--~vkl~DfG~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 282 (419)
+ .++ .+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 193 ~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 193 D-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp E-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred c-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9 465 899999999976543221 1334789999999999764 589999999999999999999999987
Q ss_pred CC-HHHHHHHHHH-HhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 283 EN-AVDQLVEIIK-VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 283 ~~-~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.. ..+.+..... ....+. .+.. . ......+++++.+||.+||..||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~---------~~~~---~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPG---------PFVG---P--------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCC---------CEEC---T--------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChh---------hhhh---h--------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 63 3333332222 111110 0000 0 0001246899999999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.33 Aligned_cols=245 Identities=16% Similarity=0.224 Sum_probs=199.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||.||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP 82 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence 456799999999999999999998 58899999986542 2345788899999999999999988442 224
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
.+++||||+. ++|.+.+... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++ .++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~-~~~~~~l~~~~ 158 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMID-EDMTARISMAD 158 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEEC-TTSCEEEEGGG
T ss_pred CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEc-CCcceeEEecc
Confidence 5889999998 4888877642 22358999999999999999999999 69 99999999999999 67789999998
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCC--CCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
++.... .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 159 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 229 (271)
T 3kmu_A 159 VKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR----- 229 (271)
T ss_dssp SCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----
T ss_pred ceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----
Confidence 875432 234578999999999976432 233799999999999999999999988877766655442111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..++..+++++.+||.+||+.||.+|||++++++
T Consensus 230 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 ----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123457999999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=331.83 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=187.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|++. ..||+|++.... ....+|+.+++.++|+||++++++.. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence 45567999999999999999999853 359999886443 22457999999999999999998641 2
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~-~~~~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLH-EDNTVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-TTTEEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEEC-CCCCEEEcccee
Confidence 23789999998 566666643 34668999999999999999999999 6999999999999999 578899999999
Q ss_pred ccccccC---CcceeeeeccccccchhhcC--CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKG---EANISYICSRYYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+...... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+..+........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 245 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP- 245 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-
Confidence 9765322 12234578999999999862 34478899999999999999999999998776666555544211110
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. ...+...+++++.+||.+||..||.+|||+.++++
T Consensus 246 ----------------~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 ----------------D------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----------------C------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------c------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 01122357899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.92 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=202.4
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.....+|++.+.||+|+||.||+|.+. ++..||||++.... ....+|+.+|+.++||||+++++++. ...
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 345568999999999999999999975 46789999987543 33458999999999999999999873 223
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+|||||. |+|.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVS-ASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEEC-TTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEC-CCCcEEEeeCCCce
Confidence 789999998 58888876432 2357889999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
....... .....++..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+....+
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------ 405 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------ 405 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------
T ss_pred EcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 6533211 1223457789999999754 48999999999999999999 999999988877777665421111
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.+..+++++.+||.+||..||.+|||++++++
T Consensus 406 ----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12357899999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=374.85 Aligned_cols=285 Identities=25% Similarity=0.322 Sum_probs=206.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 357999999999999999999999999999999886542 234579999999999999999988643111 22455
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC--ceEEeeccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGS 226 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--~vkl~DfG~ 226 (419)
.|+|||||. ++|.+.+.... ....+++..++.++.||+.||.|||+ +||+||||||+|||++..+. .+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 789999997 57777776532 23468999999999999999999999 69999999999999984322 489999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......... ...........
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCS
T ss_pred ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhh
Confidence 9887666656667899999999999764 5899999999999999999999999876543221110 00000000000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.........+.. ..+....+...+++.+.+||.+||.+||.+|||+.++++||||+.+..
T Consensus 247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000001111111 111112233346789999999999999999999999999999988643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=351.05 Aligned_cols=262 Identities=21% Similarity=0.238 Sum_probs=205.5
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...++|++.+.||+|+||.||+|++..+++.||||++... .....+|+++++.+.|.+++..+..+. ......+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence 3456799999999999999999999999999999987533 345678999999998866555554443 2334578
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeC--CCCCceEEeecccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD--PLTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~--~~~~~vkl~DfG~a~~ 229 (419)
|||||++++|.+++... ...+++..++.++.||+.||.|||+ +||+||||||+||||+ ..++.+||+|||+++.
T Consensus 80 lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99999988988888642 4579999999999999999999999 6999999999999993 2577899999999987
Q ss_pred cccCCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Q 014750 230 LVKGEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 298 (419)
Q Consensus 230 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~ 298 (419)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... .+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 654332 1256789999999999765 489999999999999999999999987543 3333333321111
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc----------CCccccccC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA----------HPFFDELRE 368 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~ 368 (419)
.. ...+...++.++.+||.+||..||.+||+++++++ ++|+..++|
T Consensus 235 ~~------------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW 290 (483)
T 3sv0_A 235 TS------------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW 290 (483)
T ss_dssp SC------------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred cc------------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence 11 01122457899999999999999999999998763 666655443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=330.57 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=197.6
Q ss_pred ccccceeeeceeccCCceEEEEEEEcC---CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...++|.+.+.||+|+||.||+|++.. ++..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----- 83 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----- 83 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----
Confidence 455689999999999999999998654 34569999986542 23457999999999999999999873
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+. ..|+||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~kl~Df 157 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVA-SPECVKLGDF 157 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEE-ETTEEEECCC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEC-CCCcEEeCcc
Confidence 22 2579999998 5777777642 3568999999999999999999999 6999999999999999 5788999999
Q ss_pred ccccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 225 GSAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 225 G~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--- 233 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--- 233 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---
T ss_pred CCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---
Confidence 99986543322 2234567889999999754 48999999999999999998 99999877766655554432110
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0123468999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=339.09 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=200.7
Q ss_pred ccccceeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||.||+|+ +..+++.||+|++..... ...+|+++++.++|+||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 455689999999999999999999 567899999999865432 24689999999999999999998754 3
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|+||||++ ++|.+.+.... ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~-~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVE-SEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEEC-CCCCEEEccc
Confidence 4456889999996 57877776532 358999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|++........ .....+|..|+|||++.+. .++.++|||||||++|+|++|..||.......... .......+.
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccccccccc
Confidence 99987643332 2234578889999999764 47999999999999999999999997543321110 000000000
Q ss_pred HHH-HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 301 REE-IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 301 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
... ....... .....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 250 LSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0000000 0011234578999999999999999999999999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.08 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=195.3
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCC----cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
....+|.+.+.||+|+||.||+|++..++ ..||+|++.... ....+|+.+++.++||||+++++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 115 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI----- 115 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 34567999999999999999999987654 359999986542 2244799999999999999999998
Q ss_pred CCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.+...+++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kl~D 190 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVN-SNLVCKVSD 190 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEEC-CCCcEEECC
Confidence 444558999999985 77777654 24679999999999999999999999 6999999999999999 678899999
Q ss_pred cccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 014750 224 FGSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 224 fG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
||+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence 999987643321 1123457789999999764 48999999999999999999 99999988877666655432111
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+ .+..++.++.+||.+||+.||.+||++.+++++
T Consensus 270 ~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 P----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp C----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred C----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 123468899999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.53 Aligned_cols=244 Identities=28% Similarity=0.414 Sum_probs=187.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
...+|++.+.||+|+||.||+|++ .++.||+|++.... ....+|+.+++.++||||+++++++. +. .++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence 345799999999999999999987 57899999986543 33457999999999999999999873 22 689
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC--CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV--PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
||||+.+ +|.+.+.... ....+++..+..++.|++.||.|||+. +||+||||||+|||++.++..+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999984 7777776421 123478899999999999999999992 28999999999999985444589999999975
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 307 (419)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+.. +..
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~-------- 222 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR-------- 222 (307)
T ss_dssp -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC--------
T ss_pred cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC--------
Confidence 5322 2345789999999999764 58999999999999999999999998643222 1111111 100
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+...++..+.+||.+||+.||.+|||++++++
T Consensus 223 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 223 ------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122457899999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=330.58 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=189.1
Q ss_pred cccceeee-ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHH-HhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 75 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 75 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
..++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++|+||+++++++.... .+...+++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEE
Confidence 44568887 7899999999999999999999999998654 3456788887 6779999999999884321 23567899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeecccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~ 229 (419)
||||+.+ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999985 888887753 23569999999999999999999999 699999999999999943 67899999999864
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.. ...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------- 212 (299)
T 3m2w_A 170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------- 212 (299)
T ss_dssp CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence 32 12378899999999999999999999976544321110000
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
..... ...+.......+++++.+||.+||+.||.+|||++|+++||||.+...
T Consensus 213 ---~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 ---RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ---SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ---HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000 000111112457999999999999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.43 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=196.3
Q ss_pred cccceeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++|+||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED--- 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---
Confidence 34569999999999999999999 57789999999986432 3346899999999999999999998542
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Df 170 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVE-SEHQVKIGDF 170 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEc-CCCCEEECcc
Confidence 22458899999985 887777542 3569999999999999999999999 6999999999999999 5788999999
Q ss_pred ccccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|++........ .....+|..|+|||++.+. .++.++|||||||++|+|++|..||.... .......+...
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~ 244 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTH 244 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCC
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcc
Confidence 99987654432 2234578889999999764 47899999999999999999998864321 11111111111
Q ss_pred HHHH-hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.... ........ .......+..+++++.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 245 GQMTVTRLVNTLK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGGHHHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1000 00000000 00001123467899999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.49 Aligned_cols=248 Identities=14% Similarity=0.189 Sum_probs=192.7
Q ss_pred cccceeeeceeccCCceEEEEE-----EEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcC---CCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRLMD---HPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~ 145 (419)
...+|.+.+.||+|+||+||+| .+..+++.||+|++.... ....+|+.+++.++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~---- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF---- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC----
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec----
Confidence 4467999999999999999999 467789999999986543 34557888888887 8999999999843
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhcc-CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--------
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSS-MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-------- 215 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~-------- 215 (419)
....|||||||. |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+||||+..
T Consensus 139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC----
T ss_pred -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccc
Confidence 344899999998 688888876443 35679999999999999999999999 699999999999999831
Q ss_pred --CCceEEeecccccccc---cCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHH
Q 014750 216 --THQVKLCDFGSAKVLV---KGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 290 (419)
Q Consensus 216 --~~~vkl~DfG~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 290 (419)
++.+||+|||+|+... ........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~---- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG---- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC----
Confidence 6789999999997543 222334567999999999997754 899999999999999999999999643220
Q ss_pred HHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 291 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
.+..... + ..+ ..++.+.+++..||+.+|.+|++..+.+.+.+
T Consensus 292 ----------------------~~~~~~~----~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 ----------------------ECKPEGL----F-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ----------------------EEEECSC----C-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ----------------------ceeechh----c-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 0000000 0 000 13678999999999999999977655555433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=338.56 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=191.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEE----EEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|++.+.||+|+||.||+|++..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 3457999999999999999999998888766 56655322 22345799999999999999999998532
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
. .++||+|+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 90 --~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~-~~~~~kL~Df 161 (327)
T 3lzb_A 90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDF 161 (327)
T ss_dssp --S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCT
T ss_pred --C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEc-CCCCEEEccC
Confidence 1 678888887 5777777652 4579999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 999876433222 234557789999999764 48999999999999999999 99999988766655444331100
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++.++.+||.+||..||.+|||+.++++
T Consensus 239 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 --------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012346889999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=329.99 Aligned_cols=248 Identities=25% Similarity=0.284 Sum_probs=200.2
Q ss_pred cccceeeec-eeccCCceEEEEEEEc--CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... ....+|+++++.++||||+++++++. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~---- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A---- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C----
Confidence 445687776 9999999999999854 467889999987542 23457999999999999999999872 1
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~Dfg 155 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLV-NRHYAKISDFG 155 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-ETTEEEECCCT
T ss_pred -CCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEc-CCCCEEECccc
Confidence 127899999985 67666643 34569999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~--- 231 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--- 231 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---
Confidence 99876433221 223457889999999754 48999999999999999998 9999998877666555443100
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCc
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~ 362 (419)
..++..+++++.+||.+||..||.+|||+.++++|.+
T Consensus 232 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 -------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0123457999999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.53 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=193.8
Q ss_pred CccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 73 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 73 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
....++|++.+.||+|+||.||+|++ +|+.||+|++.... ....+|+.+++.++|+||+++++++.. ....+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence 34567899999999999999999987 58899999987543 234579999999999999999998642 23357
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+++ +|.+.+..... ..+++..++.++.|++.||.|||+ +||+||||||+||+++ .++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEe-CCCcEEEeecccccc
Confidence 899999985 88888765321 237889999999999999999999 6999999999999999 677899999999975
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.+..
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------ 231 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------ 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence 5322 2334678899999999764 48999999999999999998 999998876655444432210
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....+..+++++.+||.+||..||.+|||+.++++
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01123457899999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=329.46 Aligned_cols=244 Identities=23% Similarity=0.266 Sum_probs=196.7
Q ss_pred cccceeeec-eeccCCceEEEEEE--EcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 75 QTISYMAER-VVGTGSFGIVFQAK--CLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 75 ~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
...+|.+.+ .||+|+||.||+|. +..+++.||+|++.... ....+|+.+++.++||||+++++++. .
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~--- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A--- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S---
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-C---
Confidence 456799988 99999999999995 45678899999986542 23457999999999999999999872 1
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
..+++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~-~~~~~kl~Df 161 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDF 161 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCC
T ss_pred --CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEe-CCCcEEEccC
Confidence 23789999998 577777764 3569999999999999999999999 6999999999999999 5788999999
Q ss_pred ccccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 225 G~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
|++......... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-- 238 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-- 238 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence 999876443322 123456889999999764 47899999999999999999 9999998887665554433100
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 239 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123457899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=338.91 Aligned_cols=277 Identities=22% Similarity=0.284 Sum_probs=194.0
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-cHHHHHHH--HHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...++|++.+.||+|+||.||+|++ +++.||||++..... ....|.++ +..++|+||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3456899999999999999999987 789999999864432 22234444 445899999999987655444566678
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC---------CcccccccCCceeeCCCCCceE
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP---------GVCHRDVKPQNLLVDPLTHQVK 220 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------~ivH~Dlkp~NIll~~~~~~vk 220 (419)
++|||||+ |+|.+.+.. ...++..++.++.||+.||.|||+ + ||+||||||+||||+ .++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~-~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVK-NDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEEC-TTSCEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEc-CCCcEE
Confidence 99999997 588887764 345888999999999999999999 8 999999999999999 678899
Q ss_pred EeecccccccccCC---------cceeeeeccccccchhhcCC------CCCCCcccEeehhHHHHHHHhCCCCCCCC-C
Q 014750 221 LCDFGSAKVLVKGE---------ANISYICSRYYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPGE-N 284 (419)
Q Consensus 221 l~DfG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~-~ 284 (419)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||... .
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 12245789999999999763 23567899999999999999997665432 2
Q ss_pred HHHHHHHHH-HHhCCCCHHHHhcc-CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh----
Q 014750 285 AVDQLVEII-KVLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 358 (419)
Q Consensus 285 ~~~~~~~i~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l---- 358 (419)
..+....+. .....+....+... ........++.... . ...+++++.+||.+||+.||++|||+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK----E--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC----C--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc----c--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 111111111 11112222221110 00000001111000 0 011345799999999999999999999995
Q ss_pred --cCCcccc
Q 014750 359 --AHPFFDE 365 (419)
Q Consensus 359 --~hp~f~~ 365 (419)
.++|-++
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 4666655
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=329.11 Aligned_cols=247 Identities=22% Similarity=0.332 Sum_probs=195.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC---cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
...+|++.+.||+|+||.||+|++..++ ..+|+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----S 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----S
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----C
Confidence 3457999999999999999999975443 358999886432 234579999999999999999998642 3
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
+...++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLD-EKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEC-CCCCEEECccc
Confidence 3457899999986 77777754 24568999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCC-----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 226 SAKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 226 ~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-- 250 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-- 250 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--
Confidence 997653322 12345667889999999764 48999999999999999999 6778877766555554433110
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 251 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123456889999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=349.46 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=200.1
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
....+|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+.+|+.++||||+++++++. + ..+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cce
Confidence 455689999999999999999999864 4679999987543 33568999999999999999999873 2 237
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
||||||+. |+|.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEC-CCCCEEECCCcccee
Confidence 89999998 58888876432 2468999999999999999999999 6999999999999999 677899999999987
Q ss_pred cccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
...... .....++..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+.+....
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 400 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 400 (452)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred cCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 643322 1234567889999999764 48999999999999999999 99999998887776665432111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc--CCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~--hp~f~~ 365 (419)
..+..+++++.+||.+||..||.+|||++++++ ..+|..
T Consensus 401 --------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 122457899999999999999999999999986 344443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=326.63 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=199.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...++|++.+.||+|+||.||+|++. ++..||+|.+.... ....+|+++++.++|+||+++++++. + ...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----Q-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----C-CCc
Confidence 44568999999999999999999964 56789999987543 33457999999999999999999873 1 237
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++||||+. ++|.+.+.... ...+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVS-DTLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEc-CCCCEEECCCccccc
Confidence 89999997 57777665321 1368999999999999999999999 6999999999999999 678899999999987
Q ss_pred cccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
....... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 228 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------- 228 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred ccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------
Confidence 6433221 224567789999999754 48999999999999999999 9999998887766655543110
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.+||.+||..||.+|||++++++
T Consensus 229 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 -------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1123457899999999999999999999999886
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=325.80 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=195.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
.....|.+.+.||+|+||.||+|++..+++ .||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 94 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP--- 94 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---
Confidence 344568889999999999999999766554 79999886433 2334799999999999999999998432
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...++||||+. ++|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 95 -~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~-~~~~~kl~Df 168 (298)
T 3pls_A 95 -EGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLD-ESFTVKVADF 168 (298)
T ss_dssp -SSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECCT
T ss_pred -CCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEc-CCCcEEeCcC
Confidence 223489999997 677777754 34678999999999999999999999 6999999999999999 6778999999
Q ss_pred ccccccccCC-----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 014750 225 GSAKVLVKGE-----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 225 G~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
|+++...... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence 9997553321 22345678899999999764 48999999999999999999 55666665555544444331100
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112356899999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=361.46 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=191.1
Q ss_pred ceeccCCceEEEEEEE--cCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||.||+|.+ ..+++.||||+++... ....+|+++|+.++|+|||++++++. ++ .+++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~-~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----AE-SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SS-SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC-CEEEEE
Confidence 4799999999999954 4567899999986532 23457999999999999999999873 11 278999
Q ss_pred eccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|||. |+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++.....
T Consensus 449 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 449 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-
T ss_pred EccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEe-CCCCEEEEEcCCccccccC
Confidence 9998 477777754 4679999999999999999999999 6999999999999999 6788999999999876443
Q ss_pred Cc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 234 EA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 234 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.. .....+|..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+....
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---------- 591 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---------- 591 (635)
T ss_dssp ------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred ccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22 2233457889999999764 48999999999999999998 99999998887766665542110
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..+++++.+||.+||..||++|||++++++
T Consensus 592 ------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 123457899999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=359.35 Aligned_cols=247 Identities=25% Similarity=0.295 Sum_probs=195.3
Q ss_pred cceeeec-eeccCCceEEEEEEEc--CCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++.+.+ .||+|+||.||+|.+. .++..||||++.... ....+|+++|+.++|||||++++++.. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~ 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------C
Confidence 4555555 8999999999999875 356679999986532 334689999999999999999998742 1
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++||||||.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~-~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLV-NRHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEc-CCCcEEEeeccCc
Confidence 28899999985 67666643 24669999999999999999999999 6999999999999999 6789999999999
Q ss_pred cccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+........ ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+...
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----- 557 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----- 557 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 876433221 123346789999999764 58999999999999999998 9999999887776666543210
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh---cCCcc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 363 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l---~hp~f 363 (419)
..++..+++++.+||.+||..||.+|||+.+++ ++.|+
T Consensus 558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 012345789999999999999999999999875 44444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.12 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=188.5
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC---cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
....|.+.+.||+|+||.||+|++..++ ..||+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~ 162 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----S 162 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----C
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----C
Confidence 4456899999999999999999975433 468999886432 234578999999999999999998642 2
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
+...++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~-~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLD-EKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEEC-CCCCEEEeecc
Confidence 3347899999985 78777754 24568899999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 226 SAKVLVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 226 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-- 314 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-- 314 (373)
T ss_dssp --------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC--
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC--
Confidence 9986533321 1234567889999999764 48999999999999999999 7888987665554444332100
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234578999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=334.58 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=195.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.|...+.||+|+||.||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----ecCCc
Confidence 366678999999999999986 68899999886431 2345799999999999999999998 34445
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.++||||+. ++|.+.+... .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~-~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLD-EAFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEc-CCCcEEEeeccccc
Confidence 899999997 5777777643 234679999999999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+.+...........
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6543322 223578999999999865 37899999999999999999999998765433333332211111000000
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..... ++ ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~-----~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDKK-----MN---------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCSS-----CS---------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hcccc-----cc---------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 00 0111235679999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=336.35 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=188.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-cHHHHHHHHHhc--CCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRLM--DHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|++.+.||+|+||.||+|++ +++.||+|++..... ...+|.+++..+ +|+||+++++++..... ....+|+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceEE
Confidence 45799999999999999999998 489999999864432 233455565544 99999999998854321 2256899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CcccccccCCceeeCCCCCceEEee
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP--------GVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++ .++.+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~-~~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEEC-CCCCEEEEe
Confidence 9999985 88888764 469999999999999999999998 7 999999999999999 677899999
Q ss_pred cccccccccCCcc-----eeeeeccccccchhhcCCCCCCCc------ccEeehhHHHHHHHhC----------CCCCCC
Q 014750 224 FGSAKVLVKGEAN-----ISYICSRYYRAPELIFGATEYTTS------IDIWSAGCVLAELLLG----------QPLFPG 282 (419)
Q Consensus 224 fG~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~------~DiwslG~il~elltg----------~~pf~~ 282 (419)
||+++........ ....||+.|+|||++.+.. ++.. +|||||||++|+|++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999765433222 2457899999999997654 4443 9999999999999999 667754
Q ss_pred CC----HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 283 EN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 283 ~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
.. ..+.........+. ...++. ......+++++.+||.+||+.||.+|||+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKL--------------RPSFPN-------RWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCC--------------CCCCCG-------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcCCCCchhhhHHHHhhhcc--------------Cccccc-------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 32 11122221110000 000000 001123467899999999999999999999999
Q ss_pred cC
Q 014750 359 AH 360 (419)
Q Consensus 359 ~h 360 (419)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=354.06 Aligned_cols=245 Identities=25% Similarity=0.315 Sum_probs=200.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...+|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+++|+.++|+||+++++++. + ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-ccce
Confidence 34679999999999999999999864 4679999987543 34568999999999999999999873 2 2378
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||||. |+|.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEc-CCCcEEEcccccceec
Confidence 9999998 48888876432 2458999999999999999999999 6999999999999999 6778999999999865
Q ss_pred ccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .....++..|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+.+....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------- 483 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------- 483 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred CCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 32211 1223457789999999764 48999999999999999999 99999998887776665432110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+..++.++.+||.+||..||++|||++++++
T Consensus 484 -------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 484 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122457899999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=332.25 Aligned_cols=252 Identities=27% Similarity=0.362 Sum_probs=191.6
Q ss_pred eeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 79 YMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
|++++.||+|+||+||++. +..+++.||+|++.... ....+|+++++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 4999999999999998775 44578999999987543 2345799999999999999999998542 2345
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+++||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLD-NDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEc-CCCCEEECCccccc
Confidence 8899999985 77766653 358999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH-
Q 014750 229 VLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE- 303 (419)
Q Consensus 229 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~- 303 (419)
....... .....+|..|+|||++.+. .++.++|||||||++|+|++|..||....... ....+......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~ 256 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMT 256 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchh
Confidence 7654432 2234578889999999764 47899999999999999999999997532211 00001100000
Q ss_pred ----HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 304 ----IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 304 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
....... .....+..++.++.+||++||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELLERG-------------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcc-------------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000000 001123457899999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=327.34 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=190.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-CCc--EEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
...+|++.+.||+|+||.||+|++.. +++ .||+|++.... ....+|+.+++.++|+||+++++++..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 92 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--- 92 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc---
Confidence 34579999999999999999998643 333 68999876431 233579999999999999999998843
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
.. .++||||+. ++|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|
T Consensus 93 --~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~-~~~~~kl~D 164 (291)
T 1u46_A 93 --PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLA-TRDLVKIGD 164 (291)
T ss_dssp --SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECC
T ss_pred --CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEc-CCCCEEEcc
Confidence 22 689999998 5888777653 2468999999999999999999999 6999999999999999 578899999
Q ss_pred cccccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q 014750 224 FGSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 224 fG~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
||++......... ....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC
Confidence 9999876443321 234567789999999764 47899999999999999999 99999988877666655431100
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
. ..+..++.++.+||.+||..||.+|||+.++++
T Consensus 244 -----------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 244 -----------------L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------C----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 012357899999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=348.30 Aligned_cols=247 Identities=19% Similarity=0.187 Sum_probs=183.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcC---------CCCeee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMD---------HPNVIS 134 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~---------h~niv~ 134 (419)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999998 78999999987542 33568999998886 555555
Q ss_pred ccee-----------------eeccC--------CCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHH
Q 014750 135 LKHC-----------------FFSTT--------SKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188 (419)
Q Consensus 135 ~~~~-----------------~~~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~ 188 (419)
+.++ |.... ..+...+|||||||.+ ++++.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 5544 32210 0124568999999975 4444442 25689999999999999
Q ss_pred HHHHHhH-cCCCcccccccCCceeeCCCCC--------------------ceEEeecccccccccCCcceeeeecccccc
Q 014750 189 RGLAYIH-TVPGVCHRDVKPQNLLVDPLTH--------------------QVKLCDFGSAKVLVKGEANISYICSRYYRA 247 (419)
Q Consensus 189 ~al~~LH-~~~~ivH~Dlkp~NIll~~~~~--------------------~vkl~DfG~a~~~~~~~~~~~~~~t~~y~a 247 (419)
.||.||| + +||+||||||+||||+. ++ .+||+|||+|+..... ..+||+.|+|
T Consensus 172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 9999999 8 69999999999999994 44 8999999999876432 4589999999
Q ss_pred chhhcCCCCCCCcccEeehhHH-HHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCch
Q 014750 248 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 325 (419)
Q Consensus 248 PE~~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
||++.+.. +.++||||||++ .+++++|..||..... ......+..... +... . .
T Consensus 246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~---~-~ 301 (336)
T 2vuw_A 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------FKTK---C-N 301 (336)
T ss_dssp SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------CSSC---C-C
T ss_pred hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------cCcc---c-c
Confidence 99997643 889999998777 7888899999953211 111222221100 0000 0 0
Q ss_pred hhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh-cCCccc
Q 014750 326 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD 364 (419)
Q Consensus 326 ~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l-~hp~f~ 364 (419)
......+++++.+||++||++| |++|+| +||||+
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0112246889999999999987 999999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=328.55 Aligned_cols=259 Identities=25% Similarity=0.389 Sum_probs=196.9
Q ss_pred ccccceeeeceeccCCceEEEEEE----EcCCCcEEEEEEeccCcc----cHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRR----YKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||.||+|+ +..+|+.||+|++..... ...+|+.+++.++|+||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--- 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence 455679999999999999999998 467899999999865432 345799999999999999999987432
Q ss_pred CceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~-~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVE-NENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEc-CCCcEEEecC
Confidence 23357899999984 888777652 3568999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 225 GSAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 225 G~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
|++......... ....++..|+|||++.+. .++.++|||||||++|+|++|..||..... . ..+..+...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~ 263 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDK 263 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTC
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhcccc
Confidence 999876443321 223567789999999764 478999999999999999999999864311 1 111111111
Q ss_pred HHHH------hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 301 REEI------RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 301 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+ ..+... . ....+..++.++.+||.+||..||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTHHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhhhHHHHHHHhhcC-C------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 000000 0 00123457899999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.42 Aligned_cols=252 Identities=19% Similarity=0.261 Sum_probs=195.7
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...++|++.+.||+|+||.||+|++.. .+|+|++... .....+|+.+++.++|+||+++++++.. .
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 345679999999999999999999743 4999988633 2334579999999999999999999843 3
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCC
Confidence 44899999998 466666543 23468999999999999999999999 6999999999999998 45799999999
Q ss_pred ccccccC------CcceeeeeccccccchhhcC--------CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014750 227 AKVLVKG------EANISYICSRYYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 292 (419)
Q Consensus 227 a~~~~~~------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 292 (419)
+...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 8654211 12234568999999999864 234788999999999999999999999988877666554
Q ss_pred HHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
...... . .....++.++.+||.+||..||.+|||+.++++ .|+.+..
T Consensus 256 ~~~~~~-------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKP-------------------N--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK 302 (319)
T ss_dssp HTTCCC-------------------C--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred ccCCCC-------------------C--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence 431100 0 011246889999999999999999999999986 3444443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=328.03 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=192.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHh--cCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRL--MDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
++|.+.+.||+|+||.||+|++ +|+.||+|++.... ....+|.++++. ++||||+++++++..... ....+|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccceeEEE
Confidence 5799999999999999999998 68999999986443 334578888887 799999999998854331 12358999
Q ss_pred eecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCcccccccCCceeeCCCCCceEEeec
Q 014750 154 MEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH--------TVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 154 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
|||+.+ +|.+.+.. ..+++..++.++.||+.||.||| + +||+||||||+||||+ .++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~-~~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVK-KNGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEEC-TTSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEEC-CCCCEEEEEC
Confidence 999985 88888764 46899999999999999999999 8 6999999999999999 5778999999
Q ss_pred ccccccccCCc-----ceeeeeccccccchhhcCCCC-----CCCcccEeehhHHHHHHHhC----------CCCCCCCC
Q 014750 225 GSAKVLVKGEA-----NISYICSRYYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 284 (419)
Q Consensus 225 G~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~elltg----------~~pf~~~~ 284 (419)
|++........ .....||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99977654432 234578999999999976432 23689999999999999999 78886542
Q ss_pred H----HHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 285 A----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 285 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. .+.+........ ....++. ......++..+.+||.+||+.||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--------------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQK--------------LRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSC--------------CCCCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHH--------------hCCCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 122221111000 0000000 00011234679999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.77 Aligned_cols=246 Identities=27% Similarity=0.346 Sum_probs=199.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCC---CcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
....+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.++||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 4557899999999999999999998654 4579999876432 23457999999999999999999872
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+ ..+|+||||+. |+|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+||
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~-~~~~vkL~DF 535 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGDF 535 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECCC
T ss_pred c-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEe-CCCCEEEEec
Confidence 1 23789999998 577777764 23568999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 225 GSAKVLVKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 225 G~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--- 611 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 999876433222 234557889999999764 58999999999999999997 99999998888777766542111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
.++..+++++.+||.+||..||.+|||+.++++
T Consensus 612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123457899999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=360.26 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=194.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||.||+|++.. +|+.||||++.... ....+|+.+++.++||||+++++++......+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34689999999999999999999976 78999999886432 2235799999999999999999998765544445
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..||||||++| +|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. + .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~-~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE-E-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-S-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC-C-cEEEEecccc
Confidence 57999999986 4433322 379999999999999999999999 69999999999999994 4 7999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... +
T Consensus 229 ~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~---------- 283 (681)
T 2pzi_A 229 SRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------G---------- 283 (681)
T ss_dssp EETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------S----------
T ss_pred hhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------c----------
Confidence 865432 456799999999999653 588999999999999999999988642110 0
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
++. ..+. ...++.+.+||.+||+.||.+||+..+.+.|+|+.-+
T Consensus 284 --------~~~--~~~~-----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------LPE--DDPV-----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------CCT--TCHH-----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------ccc--cccc-----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 0000 1136789999999999999999999999999998643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=306.61 Aligned_cols=221 Identities=15% Similarity=0.059 Sum_probs=173.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++. +..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence 356999999999999999999999999999999986542 23457899999999999999999984 344
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
..|+||||+.| +|.+.+.. + .....+..++.||+.||.|||+ +||+||||||+|||++ .++.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~-~~g~~kl~~~~-- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVS-IDGDVVLAYPA-- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEE-TTSCEEECSCC--
T ss_pred cEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEc-CCCCEEEEecc--
Confidence 58999999985 77766632 2 3556788899999999999999 6999999999999999 67789998544
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+..
T Consensus 175 -----------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------------- 213 (286)
T 3uqc_A 175 -----------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------------- 213 (286)
T ss_dssp -----------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------------
T ss_pred -----------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------------
Confidence 332 268999999999999999999999987643211000
Q ss_pred CcCCccccCCCC-CCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 308 NPNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 308 ~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..... ........+...+++++.+||.+||+.||.+| |+.++++.
T Consensus 214 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 214 -------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp -------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred -------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00000 00011122335689999999999999999999 99999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-34 Score=290.64 Aligned_cols=179 Identities=19% Similarity=0.104 Sum_probs=125.4
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccCc--------------ccHHHHHHHHHhc-CCCCeeecceeeeccCCCCce
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++.|++|.+..++....|+.||+|.+.++. ....+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4677888888888888899999999986542 2245799999999 799999999999 6677
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|||||||+| +|.+.+.. .+.+++. .|+.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~-~dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVD-ARQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEEC-TTSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEEC-CCCCEEEeecccC
Confidence 79999999996 77777764 4566654 478899999999999 6999999999999999 6788999999999
Q ss_pred cccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCC
Q 014750 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 278 (419)
Q Consensus 228 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 278 (419)
+..... ....+.+||+.|||||++.+ .+..++|+||+|+++|+|.+|..
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence 876433 33456789999999999976 36788999999999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-28 Score=245.71 Aligned_cols=179 Identities=17% Similarity=0.211 Sum_probs=133.7
Q ss_pred eeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 80 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 80 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
...+.||+|+||.||+|.. .++.+++|+..... ....+|+++++.++|+||+++..+.....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---- 412 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT----
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC----
Confidence 4466899999999999954 67889999764321 11358999999999999996555543222
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..|||||||+ ++|.+.+.. +..++.||+.||.|||+ +||+||||||+|||++. .+||+|||+
T Consensus 413 -~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 413 -NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp -TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred -ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 2589999998 576666543 55789999999999999 69999999999999993 899999999
Q ss_pred ccccccCCc--------ceeeeeccccccchhhcCC-CCCCCcccEeehhHHHHHHHhCCCCCC
Q 014750 227 AKVLVKGEA--------NISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 281 (419)
Q Consensus 227 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 281 (419)
++....... ....+||+.|||||++.+. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987644322 1356899999999999641 237888999999998888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-25 Score=202.58 Aligned_cols=138 Identities=17% Similarity=0.206 Sum_probs=109.0
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------------------ccHHHHHHHHHhcCCCCeeecc
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK 136 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~ 136 (419)
|.+.+.||+|+||.||+|.+ .+|+.||+|++.... ....+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 889999999985322 12458999999999 5 7777
Q ss_pred eeeeccCCCCceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC
Q 014750 137 HCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL 215 (419)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~ 215 (419)
+++.. ...|+||||++| +|.+ +. ......++.||+.||.|||+ +||+||||||+|||++
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-- 227 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-- 227 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--
T ss_pred eEEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--
Confidence 75521 336899999986 5443 21 12355789999999999999 6999999999999999
Q ss_pred CCceEEeecccccccccCCcceeeeeccccccchhhc
Q 014750 216 THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252 (419)
Q Consensus 216 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~ 252 (419)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 ~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 67899999999963 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.4e-22 Score=180.14 Aligned_cols=135 Identities=19% Similarity=0.240 Sum_probs=102.8
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcE--EEEEEeccCc----------------------------ccHHHHHHHHHhc
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRLM 127 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~e~~~l~~l 127 (419)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998788999 9999864321 1245799999999
Q ss_pred CCCCeeecceeeeccCCCCceeEEEEeecccc------cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhH-cCCCc
Q 014750 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE------TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH-TVPGV 200 (419)
Q Consensus 128 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~i 200 (419)
.|++|....-+.. ...+|||||+++ .|.+.... .++..+..++.||+.||.||| + .||
T Consensus 128 ~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 8876522211111 125799999953 44433221 234557889999999999999 8 699
Q ss_pred ccccccCCceeeCCCCCceEEeeccccccc
Q 014750 201 CHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 201 vH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999993 7999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.6e-19 Score=167.23 Aligned_cols=140 Identities=14% Similarity=0.121 Sum_probs=91.6
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---------------cH---HHHHHHHHhcCCCCeeecceeee
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---------------YK---NRELQLMRLMDHPNVISLKHCFF 140 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~---~~e~~~l~~l~h~niv~~~~~~~ 140 (419)
|.+.+.||+|+||.||+|.+ .+|+.||||+++.... .. ..+.++.....|+|++++++...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999997 4799999998743210 00 11222222233444444433221
Q ss_pred ccCC-CCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC--
Q 014750 141 STTS-KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-- 217 (419)
Q Consensus 141 ~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-- 217 (419)
.... -+....+|||||++|.. +.... .......++.||+.+|.+||+ .|||||||||.|||++. ++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~---L~~l~------~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~-dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALP---MRQVS------SVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIRE-EKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEE---GGGCC------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEE-EECS
T ss_pred CCCeeeeccCceEEEEecCCcc---Hhhhc------ccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeC-CCCc
Confidence 1000 00011369999999752 22211 112356788999999999999 69999999999999983 33
Q ss_pred --------ceEEeeccccccc
Q 014750 218 --------QVKLCDFGSAKVL 230 (419)
Q Consensus 218 --------~vkl~DfG~a~~~ 230 (419)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3889999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-12 Score=117.36 Aligned_cols=135 Identities=15% Similarity=0.080 Sum_probs=100.6
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEecc----CcccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.|.+...++.|+++.||++.. .++.+++|+... ......+|..+++.+. +..+.+++++.. +....|+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence 588888999999999999975 468999998753 3345778999999885 556677777663 3345789
Q ss_pred Eeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------
Q 014750 153 VMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------- 197 (419)
Q Consensus 153 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------- 197 (419)
||||++|. +.+.+ .+......++.++..+|..||+.
T Consensus 88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999984 33221 01122346777899999999981
Q ss_pred ------------------------CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 198 ------------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 198 ------------------------~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
..++|+|+++.|||++ .+..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhccc
Confidence 2489999999999998 455567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=5.7e-11 Score=107.76 Aligned_cols=134 Identities=16% Similarity=0.084 Sum_probs=91.2
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcCCCCe--eecceeeeccCCCCceeEEEEe
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDHPNV--ISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~ 154 (419)
.|.+....+.|..+.||++. ..+|+.+++|..... .....+|..+++.+.+.++ .+++.+.. +....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence 35555444567779999996 456788999987543 2456789999998865443 44666552 223478999
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCC------------------------------------
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------ 198 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------ 198 (419)
||++|.... . .... ...++.++...|..||+..
T Consensus 95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999984222 1 0111 2245567777777777631
Q ss_pred ---------------------CcccccccCCceeeCCCCCceEEeecccccc
Q 014750 199 ---------------------GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 199 ---------------------~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+++|+|++|.|||++ .+..+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhccc
Confidence 299999999999998 455567999999853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.6e-10 Score=108.82 Aligned_cols=140 Identities=16% Similarity=0.144 Sum_probs=98.6
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEec--cC-----cccHHHHHHHHHhcCC--CCeeecceeeeccCCCCceeEEE
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRLMDH--PNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.+.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.+.. ..+.+++.++... ......|+
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeEE
Confidence 56789999999999985 34678888765 22 3456789999999974 3456666654221 11134679
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-----------------------------------
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------- 197 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------- 197 (419)
||||++|... .. .....++......++.+++..|..||+.
T Consensus 119 vme~v~G~~l---~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVL---WD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCC---CC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeec---CC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999998521 11 1123467788888999999999999962
Q ss_pred ----------------------CCcccccccCCceeeCCCCC-ceEEeeccccccc
Q 014750 198 ----------------------PGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVL 230 (419)
Q Consensus 198 ----------------------~~ivH~Dlkp~NIll~~~~~-~vkl~DfG~a~~~ 230 (419)
.+++|||+++.|||++.++. .+.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999985443 3689999998653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-10 Score=108.83 Aligned_cols=186 Identities=15% Similarity=0.197 Sum_probs=109.6
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcC-CCCeeecceeeeccC-CCCceeEEEEeeccc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMD-HPNVISLKHCFFSTT-SKDELFLNLVMEYVP 158 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~ 158 (419)
+.++.|....||++. ..+++|+.... .....+|..+|+.+. +..+ .+-..+.... .......|+||++++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v-~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL-PIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS-CCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC-CCCceEeecCCCCCCCcceEEEcccC
Confidence 458999999999864 46899976433 234568999998874 3332 2222221111 111123478999999
Q ss_pred cc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 014750 159 ET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------------- 197 (419)
Q Consensus 159 ~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------- 197 (419)
|. +..... ..++..+...++.++...|..||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 74 222111 2355666666777777777777741
Q ss_pred -----------------CCcccccccCCceeeCCC-CCceEEeecccccccccCCcceeeeeccccccchhhc---C-CC
Q 014750 198 -----------------PGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF---G-AT 255 (419)
Q Consensus 198 -----------------~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~---~-~~ 255 (419)
..++|+|+++.||+++.+ +..+.|+||+.+.................-..|+... . ..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 147999999999999943 4567899999986532211100000000001222110 0 00
Q ss_pred C---------CCCcccEeehhHHHHHHHhCCCCC
Q 014750 256 E---------YTTSIDIWSAGCVLAELLLGQPLF 280 (419)
Q Consensus 256 ~---------~~~~~DiwslG~il~elltg~~pf 280 (419)
. .....+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 112258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4.7e-07 Score=84.14 Aligned_cols=70 Identities=11% Similarity=-0.033 Sum_probs=45.6
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCC---eeecceeeeccCCCCceeEEEEeec
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPN---VISLKHCFFSTTSKDELFLNLVMEY 156 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~ 156 (419)
.+.++.|....||++ |..+++|+-... .....+|..+|+.+.+.. +.+.+.+.. ......++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence 345788998999988 567889975322 234568999999997532 233333321 122346799999
Q ss_pred cccc
Q 014750 157 VPET 160 (419)
Q Consensus 157 ~~~~ 160 (419)
++|.
T Consensus 95 i~G~ 98 (306)
T 3tdw_A 95 VQGQ 98 (306)
T ss_dssp CCSE
T ss_pred cCCe
Confidence 9973
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.1e-06 Score=77.94 Aligned_cols=131 Identities=15% Similarity=0.148 Sum_probs=82.1
Q ss_pred eccCCce-EEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcCC-CCeeecceeeeccCCCCceeEEEEeeccccc-
Q 014750 85 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLVMEYVPET- 160 (419)
Q Consensus 85 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~- 160 (419)
+..|..| .||+......+..+++|+-.... ....+|..+|+.+.. --+.+++.+. .+....++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEEeeCCcc
Confidence 3444444 79998877778889999764332 234678999988752 1234444444 2233478999999974
Q ss_pred HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-------------------------------------------
Q 014750 161 MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 197 (419)
Q Consensus 161 l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------------- 197 (419)
+.+.... .......+..++...|..||+.
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 3332221 0111233445555555556542
Q ss_pred --------------CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 198 --------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 198 --------------~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
..++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence 0178999999999998 455567999998853
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=2e-06 Score=80.86 Aligned_cols=75 Identities=15% Similarity=0.217 Sum_probs=39.6
Q ss_pred ceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCC--Ceeecceeeecc-CCCCceeEEEEeecccc
Q 014750 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHP--NVISLKHCFFST-TSKDELFLNLVMEYVPE 159 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~-~~~~~~~~~lv~e~~~~ 159 (419)
+.|+.|..+.||++.. .+..+++|+..........|..+++.+... .+.+++...... ........+++|+|++|
T Consensus 38 ~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT--DSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EECC----CEEEEEEE--TTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeccccccCcEEEEEe--CCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 4567778899999985 334599998876443344566666655321 223333210000 00112346899999987
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.1e-06 Score=78.19 Aligned_cols=77 Identities=13% Similarity=0.091 Sum_probs=49.1
Q ss_pred eecee-ccCCceEEEEEEEc--C----CCcEEEEEEeccCc-------ccHHHHHHHHHhcCC---CCeeecceeeeccC
Q 014750 81 AERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRLMDH---PNVISLKHCFFSTT 143 (419)
Q Consensus 81 ~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~~~~~~ 143 (419)
..+.| +.|....+|++... . +++.+++|+..... ....+|..+++.+.. -.+.+++.+....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~- 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG- 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence 34667 88999999998753 0 16689999765432 356789999888743 2345555543211
Q ss_pred CCCceeEEEEeecccc
Q 014750 144 SKDELFLNLVMEYVPE 159 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~~ 159 (419)
......++||||++|
T Consensus 103 -~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 -DVLGTPFFLMDYVEG 117 (357)
T ss_dssp -TTTSSCEEEEECCCC
T ss_pred -CccCCceEEEEecCC
Confidence 111235799999986
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=8.2e-06 Score=78.56 Aligned_cols=71 Identities=17% Similarity=0.177 Sum_probs=44.1
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----------ccHHHHHHHHHhcCC--CCe-eecceeeeccCCCCc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRLMDH--PNV-ISLKHCFFSTTSKDE 147 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~~ 147 (419)
.+.||.|.++.||++....+++.+++|...... .....|.++++.+.. +.. .+++.+ . .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 457999999999999765567899999754221 123568888887743 333 333322 1 111
Q ss_pred eeEEEEeecccc
Q 014750 148 LFLNLVMEYVPE 159 (419)
Q Consensus 148 ~~~~lv~e~~~~ 159 (419)
.++|||+++|
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 4699999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=66.07 Aligned_cols=65 Identities=15% Similarity=0.098 Sum_probs=41.5
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.+.|+.|....+|++ +.+++|+..... ....+|..+++.+...++. +++... .+. -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence 567889999999998 468888765331 2345788888877533333 333322 211 24899999
Q ss_pred -cc
Q 014750 158 -PE 159 (419)
Q Consensus 158 -~~ 159 (419)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 64
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00065 Score=62.06 Aligned_cols=74 Identities=16% Similarity=0.110 Sum_probs=48.6
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
..-++.+|.|..+.||+++ ..+|+.|.+|+-.... ....+|...|+.|....-|.+-.++... . -++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence 4456789999999999998 4578999999764332 2356899999988532212222222111 1 35899
Q ss_pred ecccc
Q 014750 155 EYVPE 159 (419)
Q Consensus 155 e~~~~ 159 (419)
||+.+
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 99873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0003 Score=68.08 Aligned_cols=79 Identities=11% Similarity=-0.048 Sum_probs=46.3
Q ss_pred HcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcceeeee--ccccccchhhcCCCC--CCCcccEeehhHHH
Q 014750 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATE--YTTSIDIWSAGCVL 270 (419)
Q Consensus 195 H~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwslG~il 270 (419)
+. ..++|||+++.|||++. ++ ++|+||+.+.............. ...|.+|+....... -....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 58999999999999983 44 99999999875422211111111 234666665421110 01123444677777
Q ss_pred HHHHhC
Q 014750 271 AELLLG 276 (419)
Q Consensus 271 ~elltg 276 (419)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00078 Score=62.48 Aligned_cols=144 Identities=13% Similarity=0.031 Sum_probs=74.5
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEecc--CcccHHHHHHHHHhcCCCCe--eecceeeeccCC--CCceeEEEEee
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRLMDHPNV--ISLKHCFFSTTS--KDELFLNLVME 155 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~--~~~~~~~lv~e 155 (419)
.+.|+.|....+|++... +..+++|.... .......|..+++.+...++ .+++... .... ......+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEEE
Confidence 456788988999999853 33688998765 33445678888877743222 2222110 0000 01123579999
Q ss_pred cccccH------------HHH---HHhhccC-CCC----CCHHHHHH---------------HHHHHHHHHHHhHc----
Q 014750 156 YVPETM------------YRV---LKHYSSM-NQR----MPLIYVKL---------------YTYQIFRGLAYIHT---- 196 (419)
Q Consensus 156 ~~~~~l------------~~~---l~~~~~~-~~~----l~~~~~~~---------------i~~qi~~al~~LH~---- 196 (419)
|++|.. .+. ++..... ... .....-.. +...+...+..+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998631 111 1111000 000 11000000 00113334444442
Q ss_pred --CCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 197 --VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 197 --~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
..+++|+|+.+.|||++ .+..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~-~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFL-GDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEe-CCceEEEecchhccC
Confidence 13799999999999998 454457999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00039 Score=64.36 Aligned_cols=72 Identities=15% Similarity=0.098 Sum_probs=50.3
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC-cccHHHHHHHHHhcCC---CCeeecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRLMDH---PNVISLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.+.|+.|....+|++.. ++..+++|+.... .....+|...|+.|.. ..+.+++.+. ......++||||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~-----~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIG-----NSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEE-----ECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEe-----ecCCceEEEEEec
Confidence 45689999999999985 5678899976543 2345678888887742 4455565544 2223478999999
Q ss_pred ccc
Q 014750 158 PET 160 (419)
Q Consensus 158 ~~~ 160 (419)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=61.98 Aligned_cols=33 Identities=39% Similarity=0.406 Sum_probs=27.1
Q ss_pred CCcccccccCCceeeCCC---CCceEEeeccccccc
Q 014750 198 PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKVL 230 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~~~ 230 (419)
..++|||+.+.|||++.+ .+.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999842 157899999998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0031 Score=61.55 Aligned_cols=69 Identities=13% Similarity=0.220 Sum_probs=45.7
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEEEEeecc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLNLVMEYV 157 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 157 (419)
.+.|+.|-...+|++.....+..+++|+..... ....+|..+++.+...++. ++++++ .+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEee
Confidence 457888999999999875445789999764322 2236899999999765553 454443 21 2599998
Q ss_pred cc
Q 014750 158 PE 159 (419)
Q Consensus 158 ~~ 159 (419)
+|
T Consensus 184 ~G 185 (458)
T 2qg7_A 184 DG 185 (458)
T ss_dssp CS
T ss_pred CC
Confidence 85
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0012 Score=63.94 Aligned_cols=69 Identities=16% Similarity=0.254 Sum_probs=46.2
Q ss_pred eceeccCCceEEEEEEEcC-------CCcEEEEEEecc-Cc-ccHHHHHHHHHhcCCCCe-eecceeeeccCCCCceeEE
Q 014750 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 151 (419)
.+.|+.|....||++.... .++.+++|+... .. ....+|..+++.+...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4568889999999998642 257899998744 22 334468888888754444 4454443 22 2
Q ss_pred EEeecccc
Q 014750 152 LVMEYVPE 159 (419)
Q Consensus 152 lv~e~~~~ 159 (419)
+||||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 88999885
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0018 Score=55.84 Aligned_cols=99 Identities=18% Similarity=0.071 Sum_probs=62.2
Q ss_pred cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCCcceee
Q 014750 160 TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239 (419)
Q Consensus 160 ~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~~~~ 239 (419)
+|.++|..+ +.++++.++|.++.|.+.+|.-+-..+.-..+=+.|..|+|. .+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW-RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe-cCCceeccc-cccc-----------
Confidence 577888764 689999999999999999987762101112233456888888 566665553 1110
Q ss_pred eeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC
Q 014750 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 276 (419)
Q Consensus 240 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 276 (419)
.....+.+||... ...+.+.=|||||+++|..+--
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhc
Confidence 1122366888763 2357788999999999998873
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0017 Score=60.35 Aligned_cols=72 Identities=14% Similarity=0.028 Sum_probs=43.0
Q ss_pred eeccCCceEEEEEEEcCCCcEEEEEEeccC---cccHHHHHHHHHhcCCCC--eeecceeeeccCC--CCceeEEEEeec
Q 014750 84 VVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRLMDHPN--VISLKHCFFSTTS--KDELFLNLVMEY 156 (419)
Q Consensus 84 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~ 156 (419)
.|+ |....||++.. .+|+.+++|..... ......|..+++.+.... +.+++.. .... ......+++|++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 456 77889998863 35668999988632 234456888887774322 3333322 1100 012345789999
Q ss_pred ccc
Q 014750 157 VPE 159 (419)
Q Consensus 157 ~~~ 159 (419)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0024 Score=60.65 Aligned_cols=138 Identities=15% Similarity=0.221 Sum_probs=76.4
Q ss_pred ceeccCCceEEEEEEEcC-------CCcEEEEEEeccC---cccHHHHHHHHHhcCCCCe-eecceeeeccCCCCceeEE
Q 014750 83 RVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 151 (419)
+.|..|....+|++.... +++.+.+|+.-.. .....+|..+++.+...++ .++++++ .+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence 467778889999998632 3578999975332 2233478888887753333 3444443 22 2
Q ss_pred EEeecccccH---------------HHHHHhhccC----CCCC--CHHHHHHHHHHHHH-------------------HH
Q 014750 152 LVMEYVPETM---------------YRVLKHYSSM----NQRM--PLIYVKLYTYQIFR-------------------GL 191 (419)
Q Consensus 152 lv~e~~~~~l---------------~~~l~~~~~~----~~~l--~~~~~~~i~~qi~~-------------------al 191 (419)
+||||++|.. .+.|...... .... -+.++..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998621 1112211111 1111 23455555544422 12
Q ss_pred HHhH----cC---CCcccccccCCceeeCCC---CCceEEeecccccc
Q 014750 192 AYIH----TV---PGVCHRDVKPQNLLVDPL---THQVKLCDFGSAKV 229 (419)
Q Consensus 192 ~~LH----~~---~~ivH~Dlkp~NIll~~~---~~~vkl~DfG~a~~ 229 (419)
..|. .. ..++|+|+.+.|||++.+ .+.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 11 258999999999999843 25799999998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0019 Score=61.24 Aligned_cols=69 Identities=13% Similarity=0.130 Sum_probs=41.4
Q ss_pred eceeccCCceEEEEEEEcC--------CCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCe-eecceeeeccCCCCcee
Q 014750 82 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELF 149 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 149 (419)
.+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .++++.+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 3467888889999998643 136888997643322 24678888888754443 3444332 1
Q ss_pred EEEEeecccc
Q 014750 150 LNLVMEYVPE 159 (419)
Q Consensus 150 ~~lv~e~~~~ 159 (419)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 2489999986
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0029 Score=59.20 Aligned_cols=30 Identities=23% Similarity=0.513 Sum_probs=25.9
Q ss_pred CcccccccCCceeeCCCCCceEEeecccccc
Q 014750 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 199 ~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
.++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCee
Confidence 689999999999998 456799999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.079 Score=50.96 Aligned_cols=69 Identities=12% Similarity=0.158 Sum_probs=45.2
Q ss_pred eceeccCCceEEEEEEEcCC-------CcEEEEEEeccCc---ccHHHHHHHHHhcCCCCe-eecceeeeccCCCCceeE
Q 014750 82 ERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR---RYKNRELQLMRLMDHPNV-ISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~ 150 (419)
++.|..|....+|++..... ++.+++|+..... ....+|..+++.+...++ .++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence 45677788899999986421 5789999764322 234689999888753333 3343322 1 2
Q ss_pred EEEeecccc
Q 014750 151 NLVMEYVPE 159 (419)
Q Consensus 151 ~lv~e~~~~ 159 (419)
++||||++|
T Consensus 146 ~~I~efI~G 154 (424)
T 3mes_A 146 GRIEEFIDG 154 (424)
T ss_dssp EEEEECCCS
T ss_pred CEEEEEeCC
Confidence 588999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.89 E-value=0.63 Score=44.23 Aligned_cols=30 Identities=27% Similarity=0.487 Sum_probs=24.9
Q ss_pred cccccccCCceeeC-----CCCCceEEeecccccc
Q 014750 200 VCHRDVKPQNLLVD-----PLTHQVKLCDFGSAKV 229 (419)
Q Consensus 200 ivH~Dlkp~NIll~-----~~~~~vkl~DfG~a~~ 229 (419)
++|+|+.+.|||+. ..+..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 2456799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 419 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-123 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-65 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-64 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-61 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-59 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-58 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-58 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 360 bits (924), Expect = e-123
Identities = 230/346 (66%), Positives = 281/346 (81%), Gaps = 3/346 (0%)
Query: 62 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 121
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 122 QLMRLMDHPNVISLKHCFFST-TSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYV 180
Q+MR +DH N++ L++ F+S+ KDE++LNLV++YVPET+YRV +HYS Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
KLY YQ+FR LAYIH+ G+CHRD+KPQNLL+DP T +KLCDFGSAK LV+GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
CSRYYRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
RE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 361 PFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVR 406
FFDELR+PN +LPNGR P LFNF + ++P L LIP H R
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 3e-75
Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRLMDHPNVI 133
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRAPE 249
IH+ V HRD+KP NLL++ T +K+CDFG A+V + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 307
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 308 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
P PW+++F +A+DL ++L ++P R +A AHP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 367 REPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 407
+P+ F F EL E + LI E R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-71
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 31/305 (10%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
F+ + +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFY-----SDGEISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
+ + HRDVKP N+LV+ ++KLCDFG + L+ AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 312
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 313 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
+ I P K+ E D ++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 359 AHPFF 363
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 7e-69
Identities = 96/304 (31%), Positives = 148/304 (48%), Gaps = 23/304 (7%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRLMDHPNVI 133
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L F + ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAF-----GHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPELIF 252
+H + HRD+KP NLL+D +KL DFG AK ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 370
F P H +F + +DL L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 371 ARLP 374
+LP
Sbjct: 293 CQLP 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 213 bits (544), Expect = 7e-67
Identities = 94/300 (31%), Positives = 149/300 (49%), Gaps = 21/300 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RLMDHPNVISLK 136
Y R +G G + VF+A + E V +K + ++ K RE++++ L PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
S+ LV E+V T ++ + Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSR---TPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 197 VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATE 256
+ G+ HRDVKP N+++D +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 257 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 316 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
F I W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 6e-66
Identities = 104/339 (30%), Positives = 174/339 (51%), Gaps = 25/339 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 133 ISLKHCFFSTTSKDELF-LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I L F + D+ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
YIH G+ HRD+KP NL V+ ++K+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 312 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
P+++ + + P A++L ++L R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 369 PNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRR 407
P + + F+ + + R+ + V
Sbjct: 310 TE-DEPQVQKYDDSFDDVDR----TLDEWKRVTYKEVLS 343
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 9e-66
Identities = 100/307 (32%), Positives = 166/307 (54%), Gaps = 21/307 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L E L LV E++ + + + + S +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ +KL DFG A+ V + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 310
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
FP+ + KV + + L S++L Y P+ R +A A AHPFF ++ +P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 371 ARLPNGR 377
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-65
Identities = 83/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++L+ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 133 ISLKHCFFSTTS---KDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
++L + S + + + LV ++ + S++ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-----SYICSRY 244
GL YIH + HRD+K N+L+ +KL DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 305 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361
++ + +K ++ P A+DL +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 362 FFDELREPN 370
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 101/336 (30%), Positives = 163/336 (48%), Gaps = 23/336 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNV 132
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L F S +E ++ ++ + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIF 252
YIH+ + HRD+KP NL V+ K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 253 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 313 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
Q+ + VF P A+DL ++L R TA +A AH +F + +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 370 NARLPNGRPFPPLFNFKQELAGASPELINRLIPEHV 405
+ P ++ E + L + V
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEV 341
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-64
Identities = 96/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 79 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRLM---D 128
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
RGL ++H+ V HRD+KPQN+LV + Q+KL DFG A++ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (529), Expect = 3e-64
Identities = 67/309 (21%), Positives = 124/309 (40%), Gaps = 41/309 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRLMDHPNVIS 134
Y +GTG+FG+V + TG A K V+ D+ +E+Q M ++ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + ++ E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF-----EDDNEMVMIYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 195 HTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H H D+KP+N++ ++++KL DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 371
+ + D +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 372 RLPNGRPFP 380
++P+ R
Sbjct: 294 QIPSSRYTK 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (518), Expect = 2e-63
Identities = 100/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
+ H+ V HRD+KPQNLL++ ++KL +FG A+ + + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+P A ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (514), Expect = 5e-63
Identities = 92/295 (31%), Positives = 156/295 (52%), Gaps = 20/295 (6%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNV 132
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIA 114
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL-VKGEANISYICSRYYRAPELI 251
Y H V HRD+KPQNLL++ ++K+ DFG A+ + I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 310
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
D F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-61
Identities = 73/328 (22%), Positives = 130/328 (39%), Gaps = 32/328 (9%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RLMDHPNVISLKHCFF 140
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 141 STTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 200 VCHRDVKPQNLLVDPLTHQ--VKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEY 257
+ HRDVKP+NLL +KL DFG AK + + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317
S D+WS G ++ LL G P F + + + + IR + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 376
++ E L LL+ P+ R T E HP+ + P L
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 377 RPFPPLFNFKQELAGASPELINRLIPEH 404
R +++ + + ++
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 199 bits (508), Expect = 4e-61
Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 40/318 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F +D+ + L++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF-----EDKYEMVLILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 195 HTVPGVCHRDVKPQNLLVD-PLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H + H D+KP+N++ + VK+ DFG A L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNAR 372
+ PEA D LLQ P R T +A HP+ + +R
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 373 LPNGRPFPPLFNFKQELA 390
+P+ R K++ A
Sbjct: 297 IPSSRYNKIRQKIKEKYA 314
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-61
Identities = 67/301 (22%), Positives = 116/301 (38%), Gaps = 44/301 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPEL 250
+H G+ HRD+KP+NLL+D +K+ DFG A V + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 251 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+PW K+ + L ++L +PS R T + ++++ +
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
Query: 371 A 371
A
Sbjct: 271 A 271
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-60
Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 44/294 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRLMDHPNVIS 134
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L F E L +++E+ + + + +++ Q L Y+
Sbjct: 74 LLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYRAPELIFG 253
H + HRD+K N+L +KL DFG + + S+I + Y+ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 254 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
T Y D+WS G L E+ +P N + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
K+ P R D + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 61/289 (21%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVISL 135
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 196 T-VPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 254
T P + HRD+K N+ + T VK+ D G A L + + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 255 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314
+Y S+D+++ G + E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
F K PE ++ ++ + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 6e-60
Identities = 76/305 (24%), Positives = 120/305 (39%), Gaps = 49/305 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
I + C+ E LVMEY + + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
AY+H+ + HRDVK N+L+ VKL DFGSA ++ S++ + Y+ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 183
Query: 252 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
+ + + LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 370 NARLP 374
+
Sbjct: 277 TVIMD 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-60
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 45/296 (15%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRLMDHPNV 132
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 192 AYIH----TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI-SYICSRYYR 246
H V HRD+KP N+ +D VKL DFG A++L + +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
+F +I E ++ +R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++ L F D + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYF-----HDATRVYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+Y H+ V HRD+KP+NLL+ ++K+ DFG + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-59
Identities = 99/359 (27%), Positives = 177/359 (49%), Gaps = 34/359 (9%)
Query: 69 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 120
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 121 LQLMRLMDHPNVISLKHCFFSTTSKDEL-FLNLVMEYVPETMYRVLKHYSSMNQRMPLIY 179
L LM+ ++H N+ISL + F + +E + LVME + + +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 180 VKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY 239
+ YQ+ G+ ++H+ + HRD+KP N++V +K+ DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 240 ICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
+ +RYYRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 300 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 346
E ++ + P ++ P+ + K+F +K +A DL S++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 347 SPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASPELINRLIPEHV 405
P+ R + +A HP+ + +P P P +++ + + + E LI + V
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELIYKEV 353
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-59
Identities = 69/342 (20%), Positives = 128/342 (37%), Gaps = 42/342 (12%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVISL 135
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
F + L ++ E++ ++ + + + + Y +Q+ L ++
Sbjct: 67 HESF-----ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 195 HTVPGVCHRDVKPQNLLVDPLTH-QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFG 253
H+ + H D++P+N++ +K+ +FG A+ L G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 254 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 313
+T+ D+WS G ++ LL G F E + I+ T E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 314 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE--LREPNA 371
K + EA+D RLL R TA EA HP+ + R
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 372 RLPNGRPFPPLFNFKQELAGASPELINRLIPEHVRRQTGLSM 413
+ + ++ +R Q G+S+
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 193 bits (490), Expect = 2e-58
Identities = 97/357 (27%), Positives = 159/357 (44%), Gaps = 49/357 (13%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLM 127
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 128 DHPNVISLKH----------CFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPL 177
+ + F+ + + + +V E + E + ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 178 IYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH-----QVKLCDFGSAKVLVK 232
IYVK + Q+ GL Y+H G+ H D+KP+N+L++ + Q+K+ D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 233 GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 286
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 333
D + +II++LG +R T F ++K P V F K
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 334 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPFPPLF 383
E D S +LQ P R A HP+ +E+R P+ L +G P F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-58
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 45/309 (14%)
Query: 71 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRL 126
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 127 MDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
+PN+++ + L +VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSYL-----VGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYY 245
+ L ++H+ V HRD+K N+L+ VKL DFG + ++ S + + Y+
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 246 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305
APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365
+ + P +++ D +R L R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 366 LREPNARLP 374
+ ++ P
Sbjct: 276 AKPLSSLTP 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 188 bits (479), Expect = 9e-58
Identities = 76/306 (24%), Positives = 120/306 (39%), Gaps = 54/306 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 125
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 126 -LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYT 184
+ HPN+I LK + + F LV + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY 244
+ + +H + HRD+KP+N+L+D + +KL DFG + L GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 245 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 299
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359
M+ NY F P+ DL SR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 360 HPFFDE 365
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 1e-56
Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 42/303 (13%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+L + + L L+M+ V L +Q+ + Y
Sbjct: 71 ALDDIY-----ESGGHLYLIMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTH--QVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
+H + + HRD+KP+NLL L ++ + DFG +K+ G + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 371
+ + A D L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 372 RLP 374
+
Sbjct: 276 NIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-55
Identities = 83/320 (25%), Positives = 130/320 (40%), Gaps = 59/320 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRLMDHPN 131
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+ L F +D+ L + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF-----QDDEKLYFGLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAP 248
Y+H G+ HRD+KP+N+L++ +++ DFG+AKVL S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
EL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 362
++ FP+ + P+A DL +LL + R E AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 363 FDELREPNARLPNGRPFPPL 382
F+ + L P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-53
Identities = 63/305 (20%), Positives = 119/305 (39%), Gaps = 50/305 (16%)
Query: 74 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 121
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 122 QLMRLMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVK 181
+++ + HPNVI+L + +++ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 182 LYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVD---PLTHQVKLCDFGSAKVLVKGEANIS 238
+ QI G+ Y+H+ + H D+KP+N+++ ++K+ DFG A + G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 239 YICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358
E + A D RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 359 AHPFF 363
HP+
Sbjct: 270 QHPWI 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-52
Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRLMDHP 130
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+ + F + + L VMEY+ L ++ + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC-SRYYRAPE 249
L ++H+ G+ +RD+K N+L+D H K+ DFG K + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 250 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
++ G +Y S+D WS G +L E+L+GQ F G++ + IR NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 368
Y + + EA DL +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
Query: 369 PNARLPNGR---PFPP-------LFNFKQELAGASPEL 396
L PF P NF +E P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-52
Identities = 66/303 (21%), Positives = 111/303 (36%), Gaps = 56/303 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRLMD 128
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 129 --HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQ 186
VI L F L++E + L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE-----RPDSFVLILERPE--PVQDLFDFITERGALQEELARSFFWQ 118
Query: 187 IFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYR 246
+ + + H GV HRD+K +N+L+D ++KL DFGS L+K + +R Y
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 367 REP 369
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (442), Expect = 2e-51
Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 52/303 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD 128
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
P ++ + + F L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAF-----HTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
GL ++H V +RD+KP N+L+D H V++ D G A K + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
E++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 363
PE L LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 364 DEL 366
L
Sbjct: 269 RSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 172 bits (437), Expect = 4e-51
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPN 131
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
+I + F +D + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGE---LFSLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELI 251
Y+H+ + +RD+KP+N+L+D H +K+ DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 252 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 311
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 312 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 366
+ RFP + DL SRL+ S R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 5e-49
Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 51/299 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 136 KHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L +V ++ ++Y L + + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISY---ICSRYYRAPELI 251
H + HRD+K N+ + VK+ DFG A V + + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 252 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ P + P L + L+ R + A + L
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 2e-48
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPN 131
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGL 191
++++ + + +VMEYV L+ M + L
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 192 AYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI----SYICSRYYRA 247
+ H G+ HRDVKP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 248 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
H+ + + + + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-47
Identities = 68/311 (21%), Positives = 119/311 (38%), Gaps = 53/311 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRLMDHPNVISL 135
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAF-----QTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
+ V +RD+K +NL++D +K+ DFG K + A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+Y ++D W G V+ E++ G+ F ++ I+ + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 370
FP + + PEA L + LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 371 ARLPNGRPFPP 381
+ + PP
Sbjct: 270 QDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-45
Identities = 51/282 (18%), Positives = 102/282 (36%), Gaps = 45/282 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLKHCFF 140
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 141 STTSKDELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+++ L +V EY+ + ++ L+ S + + ++ + + Y+
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTT 259
HRD+ +N+LV + K+ DFG K + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 260 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 318
D+WS G +L E+ G+ +P D + + K ++
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220
Query: 319 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
PP ++ ++R + L+
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 9e-45
Identities = 48/267 (17%), Positives = 95/267 (35%), Gaps = 24/267 (8%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G GSFG++F+ L + VAIK + E + +L+ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ F + L LV++ + ++ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQ----EGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 197 VPGVCHRDVKPQNLLVD----PLTHQVKLCDFGSAKVLVKGEANI--------SYICSRY 244
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKR 331
R + + + F + + + F
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 1e-44
Identities = 57/302 (18%), Positives = 103/302 (34%), Gaps = 45/302 (14%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRLMDHPNVISLK 136
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHT 196
+ + + +VME + ++ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGA----EGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 197 VPGVCHRDVKPQNLLV--DPLTHQVKLCDFGSAKVLVKGEANI--------SYICSRYYR 246
HRDVKP N L+ + V + DFG AK + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 247 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 363
+ Y P E + + + + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 364 DE 365
+
Sbjct: 279 RQ 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 73/322 (22%), Positives = 125/322 (38%), Gaps = 55/322 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRLM 127
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQI 187
+ H F + E L+L+++Y L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAF----QTETKLHLILDY---INGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 188 FRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC---SRY 244
L ++H G+ +RD+K +N+L+D V L DFG +K V E +Y Y
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 359
P + + M A DL RLL P R A E
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 360 HPFFDELREPNARLPNGRPFPP 381
H FF ++ L + P
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP 311
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-41
Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRLMDHPNVIS 134
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 135 LKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + L LV +Y +++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 194 IHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS-----YIC 241
+H P + HRD+K +N+LV + D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 242 SRYYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296
++ Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
P+ EE+R + +++ + ++ + + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 6e-41
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 54/295 (18%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRLMDHPNVISL 135
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGAT 255
++ + +RD+KP+NLL+D +++ DFG AK + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 256 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDE 365
F + DL LLQ +L+ + H +F
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-40
Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 47/293 (16%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISL 135
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 136 KHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIH 195
+++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 196 TVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFG 253
HRD++ N+LV K+ DFG A+++ E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 254 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 312
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 313 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 363
+ V P E L + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-40
Identities = 47/291 (16%), Positives = 100/291 (34%), Gaps = 45/291 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
++ + LV E++ + + + + + G+AY+
Sbjct: 70 L-----EQAPICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAPELIFGATEY 257
V HRD+ +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 258 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 317
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 318 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368
+ + + + + P R E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 57/288 (19%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 83 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRLMDHPNV 132
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLA 192
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 193 YIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANI---SYICSRYYRAPE 249
Y+ + HRD+ +NLL+ VK+ DFG + L + + + + +
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
R P+ + P + ++ + + P R T +
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 59/303 (19%), Positives = 108/303 (35%), Gaps = 56/303 (18%)
Query: 82 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRLMDHPNVI 133
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE----ANISYICSRYYRAPE 249
+ HRD+ +N+L+ H K+ DFG +K L E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 250 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225
Query: 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 365
R P E DL + Y R + ++D
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 366 LRE 368
+ E
Sbjct: 272 VNE 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 64/296 (21%), Positives = 105/296 (35%), Gaps = 47/296 (15%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
S++ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD++ N+LV K+ DFG A+++ E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 257 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 315
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 316 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 369
P DL + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 3e-39
Identities = 55/294 (18%), Positives = 112/294 (38%), Gaps = 43/294 (14%)
Query: 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHC 138
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 139 FFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVP 198
E ++ E++ Q + + + QI + Y+
Sbjct: 82 CT-----REPPFYIITEFMTYGNLLDY-LRECNRQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 199 GVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE--ANISYICSRYYRAPELIFGATE 256
HRD+ +N LV H VK+ DFG ++++ A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 257 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
++ D+W+ G +L E+ + Q+ E+++ D+R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 370
+ P + +L Q++PS R + E H F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 3e-39
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDH 129
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 130 PNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFR 189
PNVI L+ + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 190 GLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR------ 243
G+ Y+ HRD+ +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 244 YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 302
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248
Query: 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 362
D+R P P L Q + R +
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 363 FDELREPNA 371
+R PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-39
Identities = 59/314 (18%), Positives = 108/314 (34%), Gaps = 70/314 (22%)
Query: 82 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RLMDHP 130
+V+G+G+FG V A +T VA+K + + EL++M +L H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLK-------------------HYSS 170
N+++L + L+ EY + L+
Sbjct: 102 NIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 171 MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230
+ + + YQ+ +G+ ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 231 VKGEANISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 286
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 287 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 346
++I+ F+ E + +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306
Query: 347 SPSLRCTALEACAH 360
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-39
Identities = 69/315 (21%), Positives = 118/315 (37%), Gaps = 56/315 (17%)
Query: 83 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRLMDHPNVI 133
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR---YYRAPEL 250
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369
R P + + + R E F R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 370 NARL---PNGRPFPP 381
L + R P
Sbjct: 275 QRYLVIQGDERMHLP 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 48/284 (16%), Positives = 101/284 (35%), Gaps = 45/284 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRLMDHPNVISLKHCF 139
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 140 FSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG 199
+ + ++ EY+ +L + M R + + + Y+ +
Sbjct: 69 T-----KQRPIFIITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 200 VCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANIS--YICSRYYRAPELIFGATEY 257
HRD+ +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 258 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 316
++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222
Query: 317 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
P + + + R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-38
Identities = 63/303 (20%), Positives = 107/303 (35%), Gaps = 54/303 (17%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRLMDHPNVIS 134
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 135 LKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYI 194
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 195 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSR----YYRAPEL 250
HRD+ +N+L+ H K+ DFG +K L ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 251 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 366
PPE L S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 367 REP 369
+
Sbjct: 275 SKV 277
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-37
Identities = 60/304 (19%), Positives = 111/304 (36%), Gaps = 57/304 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRLMDHPNVI 133
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAY 193
SL + E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 194 IHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRY-----YRAP 248
+ + HRD+ +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E + ++TT D+WS G +L EL+ G P +P N D V +++ R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHP 361
P Y P ++ + +R + + A
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 362 FFDE 365
F E
Sbjct: 295 FIGE 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-36
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 56/300 (18%)
Query: 82 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RLMDHPNVI 133
+ V+G G+FG V +A+ + G AIK++ D R EL+++ +L HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 134 SLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLK------------HYSSMNQRMPLIYV 180
+L +L L +EY P + L+ +S + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 181 KLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYI 240
+ + RG+ Y+ HRD+ +N+LV + K+ DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 241 CSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
+R E DL + + P R + +
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 65/305 (21%)
Query: 82 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RLMDHP 130
+ +G G+FG V +A + TVA+K + L +R EL+++ L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVP-ETMYRVLKHY--------------SSMNQRM 175
N+++L ++ EY + L+ +
Sbjct: 88 NIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 176 PLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEA 235
L + ++YQ+ +G+A++ + HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 236 NISYICSR---YYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 291
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 292 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 351
+IK + + + P E D+ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 352 CTALE 356
T +
Sbjct: 293 PTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-36
Identities = 68/293 (23%), Positives = 100/293 (34%), Gaps = 50/293 (17%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRLMDHP 130
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 131 NVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRG 190
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 191 LAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--SRYYRAP 248
LAY+ + HRD+ +N+LV VKL DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 249 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360
PP L ++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 55/292 (18%), Positives = 96/292 (32%), Gaps = 50/292 (17%)
Query: 78 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRLMD 128
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC----SRY 244
G+ Y+ HRD+ +N+LV+ K+ DFG ++VL
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 245 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 356
FR P P L + Q + R +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-35
Identities = 67/321 (20%), Positives = 114/321 (35%), Gaps = 64/321 (19%)
Query: 79 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRLM 127
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 128 DHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMNQR 174
H NV++L L +++E+ + L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 175 MPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234
+ L ++ Y++Q+ +G+ ++ + HRD+ +N+L+ + VK+CDFG A+ + K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 235 ANI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 290
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 291 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 350
+K T R P PE PS
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 351 RCTALEACAHPFFDELREPNA 371
R T E H L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 8e-34
Identities = 65/321 (20%), Positives = 106/321 (33%), Gaps = 73/321 (22%)
Query: 83 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRLMDHPNV 132
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 133 ISLKHCFFSTTSKDELFLNLVMEYVP---------------------ETMYRVLKHYSSM 171
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 172 NQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231
+ Q+ G+AY+ HRD+ +N LV VK+ DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 232 KGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 287
+ A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 347
+ + I A P + P E +L
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 348 PSLRCTALEACAHPFFDELRE 368
P+ R + H + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 7e-33
Identities = 59/309 (19%), Positives = 112/309 (36%), Gaps = 66/309 (21%)
Query: 79 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 125
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 126 LMDHPNVISLKHCFFSTTSKDELFLNLVMEYVPE-TMYRVLKHY------------SSMN 172
+ H N+I+L + L +++EY + + L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 173 QRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232
+++ + YQ+ RG+ Y+ + HRD+ +N+LV + +K+ DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 233 GEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 288
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 289 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 348
L +++K R E + P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278
Query: 349 SLRCTALEA 357
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-30
Identities = 59/312 (18%), Positives = 108/312 (34%), Gaps = 63/312 (20%)
Query: 82 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRLMDHPN 131
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 132 VISLKHCFFSTTSKDELFLNLVMEYVPE-------TMYRVLKHYSSMNQRMPLIYVKLYT 184
V+ L ++ME + R + + L +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 185 YQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYIC--- 241
+I G+AY++ HRD+ +N +V VK+ DFG + + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 242 SRYYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 300
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 354
P +L QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 355 LEACAHPFFDEL 366
++ P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 6e-20
Identities = 32/204 (15%), Positives = 55/204 (26%), Gaps = 32/204 (15%)
Query: 83 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------------RELQLMRLMD 128
+++G G VF E +K +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 129 HPNVISLKHCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIF 188
+ L+ ++ME + R+ + I
Sbjct: 65 FRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEVLDMIL 113
Query: 189 RGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRYYRAP 248
+A + G+ H D+ N+LV + + DF + + GE I R R
Sbjct: 114 EEVAKFYH-RGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV--GEEGWREILERDVRNI 168
Query: 249 ELIFGATEYTTSIDIWSAGCVLAE 272
F Y T DI SA + +
Sbjct: 169 ITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.91 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.06 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-66 Score=491.35 Aligned_cols=327 Identities=69% Similarity=1.197 Sum_probs=291.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHHhcCCCCeeecceeeeccCC-CCceeEEEEe
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELFLNLVM 154 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~ 154 (419)
..+|+..++||+|+||+||+|++..+|+.||||++.++.....+|+++|+.++|+||++++++|..... .+..++||||
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 346999999999999999999999999999999998887777899999999999999999999866443 4566789999
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccCC
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE 234 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~ 234 (419)
|||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+++......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 999999888888777777889999999999999999999999 6999999999999999655689999999998877666
Q ss_pred cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccc
Q 014750 235 ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 314 (419)
Q Consensus 235 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 314 (419)
...+.+||+.|+|||++.+...|+.++|||||||++|||++|+.||...+..+++..+.+.+|.+..+.+......+...
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 67778999999999999877779999999999999999999999999999999999999999999999999999999898
Q ss_pred cCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCchHHhhcCCH
Q 014750 315 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELAGASP 394 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (419)
.++.....++.......+++++.|||.+||++||++|||+.|+|+||||+++.++...++..+..+..++|..+.....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 337 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP 337 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCG
T ss_pred cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCc
Confidence 99998888888888888999999999999999999999999999999999999888888888888888888876666677
Q ss_pred HHHhhhcHH
Q 014750 395 ELINRLIPE 403 (419)
Q Consensus 395 ~~~~~~~~~ 403 (419)
++...++|.
T Consensus 338 ~~~~~~~p~ 346 (350)
T d1q5ka_ 338 PLATILIPP 346 (350)
T ss_dssp GGHHHHSCT
T ss_pred cccccCCCc
Confidence 666666653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-61 Score=449.39 Aligned_cols=278 Identities=35% Similarity=0.606 Sum_probs=231.4
Q ss_pred eeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 81 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 81 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.+++||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++|||||++++++ .+...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 3578999999999999999999999999985432 2345899999999999999999999 4455689
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
||||||.+++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEec-CCCccccccCccccccC
Confidence 9999999886655543 45679999999999999999999999 6999999999999999 67889999999998764
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... .....+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++.++.+.+|.|..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 432 3345689999999999987777899999999999999999999999999999999999999999988776554333
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.....+......++...++ .+++++.|||++||+.||++|||++|+|+||||++...+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCT-TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred chhhhhccCCCCChHHhcc-cCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 3333333333444444433 579999999999999999999999999999999875543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=441.19 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=214.9
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+++++.++|||||++++++ .+.
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~ 78 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA 78 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EEC
Confidence 356899999999999999999999999999999998532 22345799999999999999999999 455
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|||||||+ |+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~-~~~~~kl~DFG~ 152 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLG-SAGELKIADFGW 152 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEECCCCS
T ss_pred CEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceec-CCCCEeecccce
Confidence 56999999998 577777764 3569999999999999999999999 6999999999999999 577899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
|+..... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 153 a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------- 219 (263)
T d2j4za1 153 SVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 219 (263)
T ss_dssp CSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred eeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 9865433 34567899999999999875 4899999999999999999999999998887777766542
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.+. +++.+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 220 ------~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 ------EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 23457999999999999999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-62 Score=445.70 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=208.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.++|++.+.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.++|||||++++++. +...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCcee
Confidence 45799999999999999999999999999999998643 234568999999999999999999994 44568
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|||||||.| +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~-~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLD-ERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEEC-CCCCEEEccchhhee
Confidence 999999985 555444 345689999999999999999999999 6999999999999999 577899999999987
Q ss_pred cccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
..... .....+||+.|||||++.+...++.++|||||||++|+|++|+.||...................
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------- 225 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------- 225 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence 64332 23457899999999999876656788999999999999999999998765443333322210000
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
. .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 226 --------------~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------------L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------C-----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 011346899999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=443.24 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=212.9
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++|||||++++++.. ...+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence 46999999999999999999999999999999986432 234689999999999999999999943 445899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|||||+| +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEEC-CCCcEeeccchhheeec
Confidence 9999995 66555443 569999999999999999999999 6999999999999999 57889999999998764
Q ss_pred cCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 232 KGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.... .+.
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~---------- 235 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE---------- 235 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC----------
T ss_pred cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC----------
Confidence 433 34567899999999999764 58999999999999999999999999988888777766531 110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
+ ..+..+++++++||.+||+.||.+|||++|+|+||||+.
T Consensus 236 -----~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 -----L----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----C----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----C----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 122457999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=442.28 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=214.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.++|||||++++++ .++..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 5799999999999999999999999999999998532 12356899999999999999999998 45566
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|+|||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~-~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLN-EDMHIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccC-CCceEEecccccce
Confidence 9999999995 77676654 3679999999999999999999999 6999999999999999 67789999999998
Q ss_pred ccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 229 VLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 229 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
...... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 225 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 225 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence 764332 23456899999999999775 4899999999999999999999999998888877776542
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHH------HhcCCccccccCCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPN 370 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e------~l~hp~f~~~~~~~ 370 (419)
.+. ++..+++++++||++||+.||.+|||++| +++||||+++++..
T Consensus 226 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 226 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp -------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred -------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 111 33467999999999999999999999987 68999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-60 Score=440.20 Aligned_cols=283 Identities=34% Similarity=0.639 Sum_probs=234.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++|+.++|||||++++++. +...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence 5799999999999999999999999999999998543 223457999999999999999999994 44559
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
|+|||||.+++...+... ....+++..++.++.||+.||+|||+ +|||||||||+|||++ .++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeec-ccCcceeccCCcceec
Confidence 999999999877766542 34679999999999999999999999 6999999999999999 5778999999999876
Q ss_pred ccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 433 3344568999999999988777779999999999999999999999999999999999999999888765543321
Q ss_pred CC-ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 310 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.. ....++......+.... ..++++++|||++||+.||++|||++|+|+||||+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 10 11122333333333333 3578999999999999999999999999999999987665
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-60 Score=436.50 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=205.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
.++|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+|+++|+.++|||||++++++.. ..+..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence 3579999999999999999999999999999999865432 24579999999999999999998854 23345
Q ss_pred EEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----cccccccCCceeeCCCCCceEEee
Q 014750 150 LNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG-----VCHRDVKPQNLLVDPLTHQVKLCD 223 (419)
Q Consensus 150 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~~vkl~D 223 (419)
+|||||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +| |+||||||+||||+ .++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~-~~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLD-GKQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEEC-TTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcC-CCCcEEEee
Confidence 899999998 58888887766667889999999999999999999998 46 99999999999999 578899999
Q ss_pred cccccccccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 224 FGSAKVLVKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 224 fG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
||+|+...... .....+||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..+...++.+..
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------ 230 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------ 230 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------
Confidence 99998765433 23457899999999999764 58999999999999999999999999988887777765520
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 363 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f 363 (419)
++ .++..+|+++.+||++||+.||.+|||++|+|+|||+
T Consensus 231 -------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 -------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 00 1234579999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-60 Score=442.32 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=202.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 456999999999999999999999999999999986432 2334799999999999999999998 455669
Q ss_pred EEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeecccc
Q 014750 151 NLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSA 227 (419)
Q Consensus 151 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a 227 (419)
|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||+.. .++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence 99999998 578777764 4679999999999999999999999 69999999999999952 4678999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+.........+.+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+.+......
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 229 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------- 229 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence 877666666678899999999999765 589999999999999999999999999888877777665211111
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
......+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus 230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1123457999999999999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-60 Score=448.87 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=222.0
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||++++++ .+...+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 357999999999999999999999999999999986543 2345799999999999999999998 4455699
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-CCCceEEeecccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKV 229 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~ 229 (419)
||||||+| +|.+.+.. ..+.+++..++.++.||+.||+|||+ +|||||||||+|||++. .++.+||+|||+|+.
T Consensus 100 ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999984 77666643 34679999999999999999999999 69999999999999963 357899999999998
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
...........||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 246 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------- 246 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------
T ss_pred cccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence 7766667778999999999999875 4899999999999999999999999999988888888764222111
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
.....+++++++||.+||+.||++|||++|+|+||||+....+
T Consensus 247 -----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 247 -----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp -----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred -----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1123479999999999999999999999999999999986654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=436.16 Aligned_cols=287 Identities=33% Similarity=0.565 Sum_probs=236.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCC-CcEEEEEEeccC------cccHHHHHHHHHhc---CCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRLM---DHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~ 145 (419)
.++|++++.||+|+||+||+|++..+ ++.||||++... .....+|+.+|+.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999765 677999988532 23445788887766 799999999998765556
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
....++++||||.++++..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..+.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~-~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEc-CCCCeeecchh
Confidence 6778999999999886665543 235679999999999999999999999 6999999999999999 67789999999
Q ss_pred cccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 226 SAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 226 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
+++............||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.++.+.++.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99877666666778999999999999765 48999999999999999999999999999999999999999999877665
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
...... ...+......++ ..+...++++++|||++||++||++|||++|+|+||||+++...
T Consensus 241 ~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 241 RDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp TTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 322111 111111112222 22345689999999999999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=442.44 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=218.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++||||+++++++ .+.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 77 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccc
Confidence 346799999999999999999999999999999998643 23345799999999999999999999 556
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||.| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~-~~g~vkl~DFG~ 151 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLD-KDGHIKITDFGL 151 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTT
T ss_pred cccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEec-CCCCEEEeeccc
Confidence 679999999995 66666554 4679999999999999999999999 6999999999999999 578899999999
Q ss_pred cccccc-CCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Q 014750 227 AKVLVK-GEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 305 (419)
Q Consensus 227 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 305 (419)
|+.... .......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~---------- 220 (337)
T d1o6la_ 152 CKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------- 220 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred ccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC----------
Confidence 987543 3344568999999999999775 4899999999999999999999999999988777766552
Q ss_pred ccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccC
Q 014750 306 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~ 368 (419)
.+. ++..+|+++++||++||++||.+|++ ++|+++||||+++++
T Consensus 221 -------~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 221 -------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp -------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -------CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 111 34568999999999999999999994 999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-59 Score=428.52 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=207.1
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+++|+.++|||||++++++.... .+...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 478889999999999999999999999999886432 23457999999999999999999885433 34566899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCC--cccccccCCceeeCCCCCceEEeecccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPG--VCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +| |+||||||+||||+..++.+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999985 77777765 3579999999999999999999999 68 999999999999975578899999999976
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.. .......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+.+.+.. +..+
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~--------- 231 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------- 231 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------
T ss_pred cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC---------
Confidence 43 334456789999999999865 4899999999999999999999999876555444332221 1100
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
..++..+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112345689999999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-60 Score=436.71 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=212.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
+.|++.+.||+|+||+||+|++..+|+.||+|++... .....+|+++|+.++|||||++++++. +...+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence 4699999999999999999999999999999998643 234568999999999999999999984 3445899
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
|||||+| +|.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+...
T Consensus 87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeEC-CCCCEEEEechhhhccC
Confidence 9999985 666655432 4579999999999999999999999 6999999999999999 57889999999997653
Q ss_pred cCC-cceeeeeccccccchhhcC----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 232 KGE-ANISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 232 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
... .....+||+.|+|||++.+ ...|+.++|||||||++|+|++|+.||.+.+..+.+.++.+... +
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--~------ 233 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--P------ 233 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--C------
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--C------
Confidence 322 2335789999999999853 33478999999999999999999999999888887777765210 0
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
. ...+..+++++.+||++||+.||.+|||++|+|+||||+.
T Consensus 234 -----------~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 -----------T-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp -----------C-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred -----------C-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 0012357999999999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-59 Score=445.28 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=219.1
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++|||||+++++| .+...+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence 46999999999999999999999999999999986543 2345799999999999999999999 45566999
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC-CCCceEEeeccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP-LTHQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~~vkl~DfG~a~~~ 230 (419)
|||||+| +|.+.+. .....+++..++.++.||+.||+|||+ +||+||||||+||||+. .++.+||+|||+|+..
T Consensus 104 vmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceec
Confidence 9999995 6555443 234579999999999999999999999 69999999999999973 3578999999999988
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+..+.+....++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------- 248 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------- 248 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred CCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 776667778999999999999764 589999999999999999999999999998888888776322211
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
......+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 249 ---------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 ---------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11224579999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=433.16 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=218.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcCCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 457999999999999999999999999999999986431 2245899999999999999999999 5
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC---ceEE
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH---QVKL 221 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---~vkl 221 (419)
+...+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++..+. .+||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence 5566999999998 577777765 3579999999999999999999999 69999999999999984332 5999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
+|||+|+............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+......
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE- 236 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 999999887666666678899999999999764 589999999999999999999999999998888877765322211
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCC
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 369 (419)
..++..+|+++++||++||+.||.+|||++|+|+||||+...+.
T Consensus 237 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred ------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 12234579999999999999999999999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-58 Score=439.23 Aligned_cols=318 Identities=32% Similarity=0.551 Sum_probs=246.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
..+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4579999999999999999999999999999999864322 23579999999999999999999865432 2344
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+|+|||||++++...++. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVN-EDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcc-ccccccccccccee
Confidence 5799999998777776653 579999999999999999999999 6999999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... .......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.++.+.+....
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 653 334567899999999999887778999999999999999999999999999999999999999999988776543
Q ss_pred cCCc---cccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
.... ...++......+...+ ..+++++.|||++||+.||.+|||++|+|+||||+++.+...... . ..++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~-~----~~~~~ 321 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-V----QKYDD 321 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-C----CCCCC
T ss_pred chhhhhhhccCCcccccchHHhc-cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc-C----CCCCC
Confidence 2111 1123333344444333 457999999999999999999999999999999998875543321 1 11222
Q ss_pred hHHhhcCCHHHHhhhcHHHHHhh
Q 014750 386 KQELAGASPELINRLIPEHVRRQ 408 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~ 408 (419)
..+....+.+.+++++.+++...
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~~~ 344 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVLSF 344 (346)
T ss_dssp C-----CCHHHHHHHHHHHHHTC
T ss_pred chhhhhcCHHHHHHHHHHHhhcC
Confidence 22333457788888888877643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-59 Score=435.82 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=211.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..|+..+.||+|+||+||+|++..+|+.||||++..... ...+|+++|+.++|||||++++++.. ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence 359999999999999999999999999999999865432 24579999999999999999999843 445
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|||||||.++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|+.
T Consensus 90 ~~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEE-TTTEEEECCCTTCBS
T ss_pred EEEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEC-CCCCEEEeecccccc
Confidence 899999999876554432 24679999999999999999999999 6999999999999999 688999999999986
Q ss_pred cccCCcceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... ....+||+.|||||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--------- 232 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 232 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 532 3457899999999999653 34899999999999999999999999998888777776652110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
. ..+..+|+++.+||.+||+.||.+|||++|+|+||||..
T Consensus 233 ----------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 233 ----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ----------C--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------C--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 0 012346899999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-59 Score=437.84 Aligned_cols=251 Identities=29% Similarity=0.490 Sum_probs=215.9
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC-------cccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||++++++ .+..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCC
Confidence 35799999999999999999999999999999998532 22345799999999999999999999 4556
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|+|||||.| ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~-~~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLD-KNGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEEC-TTSCEEECCCSSC
T ss_pred eeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEc-CCCCEEEecCccc
Confidence 69999999996 44444433 5678999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 228 KVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 228 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
+.... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++.+.-
T Consensus 152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----------- 217 (316)
T d1fota_ 152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 217 (316)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------
Confidence 87643 34567899999999999764 48999999999999999999999999999888888776521
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
.. ++..+++++.+||.+||+.||.+|+ |++++++||||+++.+.
T Consensus 218 ------~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 218 ------LR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp ------CC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------CC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 11 2345799999999999999999996 99999999999997654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=443.48 Aligned_cols=282 Identities=26% Similarity=0.417 Sum_probs=208.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCcee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELF 149 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 149 (419)
..++|++++.||+|+||+||+|++..+|+.||+|++..+. ....+|+.+|+.++|||||+++++| .+...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 3567999999999999999999999999999999986442 2345799999999999999999999 44556
Q ss_pred EEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 150 LNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 150 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
+|||||||.| +|.+.+.. .+.+++..++.++.||+.||.|||+.+||+||||||+||||+ .++.+||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC-CCCCEEEeeCCCcc
Confidence 9999999995 77777764 357999999999999999999999613899999999999999 67889999999998
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHhcc
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 307 (419)
..... ...+.+||++|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+. ...+....+.+........
T Consensus 154 ~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 154 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 66432 33467999999999999875 499999999999999999999999987654332 2222233332221111000
Q ss_pred CcC--Cccc---cCCCC---------CCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 308 NPN--YTDF---RFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 308 ~~~--~~~~---~~~~~---------~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
... .... ..+.. ............+|.+++|||.+||++||.+|||++|+|+||||++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 000 0000 00000 0000000111236889999999999999999999999999999987543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=434.22 Aligned_cols=322 Identities=33% Similarity=0.606 Sum_probs=251.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
.+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++||||+++++++..........+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 469999999999999999999999999999999864432 234799999999999999999998665544555678
Q ss_pred EEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccc
Q 014750 152 LVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLV 231 (419)
Q Consensus 152 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~ 231 (419)
++|++++|+|.+.+.. ..+++..++.++.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEEC-CCCCEEEcccCceeecc
Confidence 8888888899888864 469999999999999999999999 6999999999999999 67889999999997654
Q ss_pred cCC----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 232 KGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 232 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
... .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+....+...++.+........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 332 2345678999999999877667899999999999999999999999999999999999998888887655332
Q ss_pred CcC---CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCC
Q 014750 308 NPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFN 384 (419)
Q Consensus 308 ~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~ 384 (419)
... ......+.....++...++ .+++++++||.+||++||.+|||++|+|+||||+......... .....++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~~ 315 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPFK 315 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCT-TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC-
T ss_pred hhhhhhcccccCCccCCCCHHHhCC-CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCccC
Confidence 110 0111233334444544443 5799999999999999999999999999999999766554321 1223456
Q ss_pred chHHhhcCCHHHHhhhcHHHHHhhcC
Q 014750 385 FKQELAGASPELINRLIPEHVRRQTG 410 (419)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (419)
++.+....+.+.+++++.++..+...
T Consensus 316 ~~~~~~~~~~~~l~~l~~~e~~~~~~ 341 (345)
T d1pmea_ 316 FDMELDDLPKEKLKELIFEETARFQP 341 (345)
T ss_dssp -------CCHHHHHHHHHHHSGGGST
T ss_pred CChhhhhCCHHHHHHHHHHHHHhcCC
Confidence 66777778888999988887766543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-58 Score=423.12 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=217.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------------cHHHHHHHHHhcC-CCCeeecceeeecc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------YKNRELQLMRLMD-HPNVISLKHCFFST 142 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~e~~~l~~l~-h~niv~~~~~~~~~ 142 (419)
++|++.+.||+|+||+||+|++..+|+.||||++.+... ...+|+.+++.++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 579999999999999999999999999999999865421 2347999999997 99999999999
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
.++..+|||||||+ |+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~-~~~~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLD-DDMNIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTCCEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEc-CCCCeEE
Confidence 55667999999998 588888765 3579999999999999999999999 6999999999999999 6888999
Q ss_pred eecccccccccCCcceeeeeccccccchhhcC-----CCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 014750 222 CDFGSAKVLVKGEANISYICSRYYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 296 (419)
Q Consensus 222 ~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 296 (419)
+|||+++...........+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+.+..
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999998766666667889999999999863 3347889999999999999999999999999888877776631
Q ss_pred CCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 297 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
-.+. ......+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1110 0012357999999999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-58 Score=436.14 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=217.0
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++ .+.
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~ 113 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence 4578999999999999999999999999999999985321 2345899999999999999999998 455
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++||||+.| ++...+.. .+.+++..++.++.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~-~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLID-QQGYIQVTDFGF 187 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred cccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccC-CCCCEEeeecee
Confidence 568999999985 66666654 3579999999999999999999999 6999999999999999 578899999999
Q ss_pred ccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 227 AKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 227 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
|+.... ......||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+....+.++.....
T Consensus 188 a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--------- 255 (350)
T d1rdqe_ 188 AKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--------- 255 (350)
T ss_dssp CEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred eeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------
Confidence 987643 34467899999999999875 489999999999999999999999999988888777765211
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccCC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 369 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~ 369 (419)
.++..+++++.+||++||+.||.+|+ |++++++||||+++++.
T Consensus 256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 12345799999999999999999995 99999999999987653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.7e-58 Score=424.92 Aligned_cols=277 Identities=34% Similarity=0.625 Sum_probs=226.3
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+|+.+|+.++|||||++++++. +....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCce
Confidence 47999999999999999999985 78999999986432 23458999999999999999999994 44458
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+++|||+.++++..+.. ..+.+++..++.++.||+.||+|||+ .||+||||||+|||++ .++.+||+|||+|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEc-CCCCEEecccccceec
Confidence 99999999987766654 35789999999999999999999999 6999999999999999 5788999999999876
Q ss_pred ccCCc-ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEA-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..... .....+++.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+++.++.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 43322 34557899999999998777789999999999999999999999999999999999999999988776654321
Q ss_pred CC-ccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 310 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 310 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.. ....+......++ ..+...+++++.|||++||++||++|||++|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11 1111222222222 2334568999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=432.41 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=219.7
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+|+++|+.++|||||+++++| .+...+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence 3579999999999999999999999999999999975532 345899999999999999999999 44556999
Q ss_pred Eeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC-CCceEEeeccccccc
Q 014750 153 VMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL-THQVKLCDFGSAKVL 230 (419)
Q Consensus 153 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~~vkl~DfG~a~~~ 230 (419)
|||||+| +|.+.+.. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.+ ...+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999995 77776653 23579999999999999999999999 699999999999999843 357999999999887
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
..........+|+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+..+.+..+.+.....+...
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------
Confidence 666666678899999999999764 489999999999999999999999999999888888877433322221
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
...+|+++++||++||+.||.+|||++|+|+||||++
T Consensus 227 ------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 2347999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-58 Score=440.73 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=209.6
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHH---HHHHHHhcCCCCeeecceeeeccCCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRLMDHPNVISLKHCFFSTTSK 145 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+ ++.+++.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 457999999999999999999999999999999985321 11223 45667777899999999998 4
Q ss_pred CceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeec
Q 014750 146 DELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDF 224 (419)
Q Consensus 146 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~Df 224 (419)
+...+|||||||. |+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~-~~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLD-EHGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-SSSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEc-CCCcEEEeee
Confidence 4556999999998 577777765 3678999999999999999999999 6999999999999999 6788999999
Q ss_pred ccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 225 GSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 225 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
|+|+..... .....+||+.|+|||++.+...|+.++|||||||++|+|+||+.||.+.+..+...........
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 999876443 3445789999999999976666899999999999999999999999876543333222221110
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCC-----HHHHhcCCccccccCC
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t-----~~e~l~hp~f~~~~~~ 369 (419)
...++..+++++.+||.+||+.||.+||| ++|+++||||+++++.
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 01134568999999999999999999999 7999999999987643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=426.58 Aligned_cols=317 Identities=32% Similarity=0.545 Sum_probs=249.4
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc------cHHHHHHHHHhcCCCCeeecceeeeccCC-CCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRLMDHPNVISLKHCFFSTTS-KDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 148 (419)
.++|++++.||+|+||+||+|++..+|+.||||++.+... ...+|+++|+.++|+|||++++++..... .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3579999999999999999999999999999999865432 23579999999999999999999865443 2334
Q ss_pred eEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 149 FLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 149 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.+++++++++|+|.+.+.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~-~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVN-EDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCcccccc-ccccccccccchhc
Confidence 4556666666788776643 579999999999999999999999 6999999999999999 67889999999997
Q ss_pred ccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 229 VLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 229 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.. ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus 170 ~~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CC--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred cc--CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 54 3334567899999999998887778999999999999999999999999999999999999999998877665432
Q ss_pred cCCcc---ccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCCCCCCCCCCc
Q 014750 309 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNF 385 (419)
Q Consensus 309 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 385 (419)
..... ..++......+...+ ..++++++|||++||+.||.+|||++|+|+||||+++..+... +....+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~-----~~~~~~~~ 321 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQ 321 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC-----CCCCCCCC
T ss_pred chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC-----CCCCCCCC
Confidence 11110 112233333444333 3579999999999999999999999999999999987654433 22333445
Q ss_pred hHHhhcCCHHHHhhhcHHHHHh
Q 014750 386 KQELAGASPELINRLIPEHVRR 407 (419)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~ 407 (419)
..+......+.+++++-+++.+
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~~ 343 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVIS 343 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHHT
T ss_pred cccchhcCHHHHHHHHHHHhhc
Confidence 5555677888888888777654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=426.75 Aligned_cols=251 Identities=29% Similarity=0.505 Sum_probs=212.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-------ccHHHHHHHH-HhcCCCCeeecceeeeccCCCCce
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
++|++.+.||+|+||+||+|+++.+|+.||||++.++. ....+|..++ +.++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 57999999999999999999999999999999986431 1233555555 478999999999999 5556
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|||||||.| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++
T Consensus 77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~-~~~~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLD-KDGHIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEEC-TTSCEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeec-CCCceeccccchh
Confidence 69999999985 77777654 3568999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccC-CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 228 KVLVKG-EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 228 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
+..... .......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 865433 334457899999999999875 4899999999999999999999999999888877776541 11
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH-HHhcCCccccccC
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE 368 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~-e~l~hp~f~~~~~ 368 (419)
.++..+|+++.+||++||+.||.+|||+. ++++||||+++++
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 13345799999999999999999999995 8999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=428.31 Aligned_cols=317 Identities=31% Similarity=0.531 Sum_probs=234.5
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC-CCcee
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS-KDELF 149 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 149 (419)
.+|++++.||+|+||+||+|++..+|+.||||++.+.. ....+|+.+++.++|||||+++++|..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999999999999999996542 224589999999999999999999865432 34567
Q ss_pred EEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 150 LNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 150 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
+|+|||||.+++++.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~-~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVK-SDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccc-cccceeeechhhhhc
Confidence 99999999998777653 468999999999999999999999 6999999999999999 577799999999987
Q ss_pred cccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 230 LVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 230 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
..........++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+...+..++...++.+..+.+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7666666778899999999999875 589999999999999999999999999999999999999999998887765443
Q ss_pred CCcccc--CCCCCCCCchhhc-----------CCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccCCCCCCCCC
Q 014750 310 NYTDFR--FPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 376 (419)
Q Consensus 310 ~~~~~~--~~~~~~~~~~~~~-----------~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~ 376 (419)
.+..+. .+......+...+ ....++++.|||++||+.||++|||++|+|+||||+...++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~--- 324 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE--- 324 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT---
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc---
Confidence 221110 0011111111111 112467899999999999999999999999999999865433221
Q ss_pred CCCCCCCCchHHhhcCCHHHHhhhcHHHH
Q 014750 377 RPFPPLFNFKQELAGASPELINRLIPEHV 405 (419)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (419)
.+.+..++...+....+.+.++++|-.++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T d2b1pa1 325 APPPQIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_dssp CCCC-------CCCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcchhhhhcCHHHHHHHHHHHh
Confidence 11122344444444567777877776554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=417.84 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=206.0
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------ccHHHHHHHHHhcC--CCCeeecceeeeccCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRLMD--HPNVISLKHCFFSTTS 144 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 144 (419)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+.+|+.++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----- 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----- 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-----
Confidence 47999999999999999999999999999999986432 22358999999987 89999999998
Q ss_pred CCceeEEEEeecccc--cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEe
Q 014750 145 KDELFLNLVMEYVPE--TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 222 (419)
Q Consensus 145 ~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~ 222 (419)
.+...+|+||||+.+ ++.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence 445568999999974 55555554 3679999999999999999999999 6999999999999998666789999
Q ss_pred ecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 223 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 223 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|||+|+... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+ .+.+.
T Consensus 154 DFG~a~~~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------- 219 (273)
T d1xwsa_ 154 DFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------- 219 (273)
T ss_dssp CCTTCEECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred ccccceecc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence 999997653 3344567899999999999876666788999999999999999999997532 12220
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccccc
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 367 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~ 367 (419)
. ..++..+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus 220 ----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0 013346899999999999999999999999999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-56 Score=424.27 Aligned_cols=283 Identities=30% Similarity=0.511 Sum_probs=226.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcC-CCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMD-HPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++ ||||++++++|.. .....+++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEE
Confidence 457999999999999999999999999999999987543 44568999999995 9999999998854 234458999
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
||||.++.+ .. ..+.+++..++.++.||+.||+|||+ +||+||||||+||||+.+++.+||+|||+|+.....
T Consensus 111 ~e~~~~~~L---~~---~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDF---KQ---LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBG---GG---TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EeecCCCcH---HH---HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999997532 22 23579999999999999999999999 699999999999999966677999999999887666
Q ss_pred CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCHHHHhccCcCCc
Q 014750 234 EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNYT 312 (419)
Q Consensus 234 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 312 (419)
......++|+.|+|||++.+...++.++||||+||++|+|++|+.||... +..++...+.+.+|.+....+........
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 66677889999999999988777899999999999999999999999754 56677778888887665544432111100
Q ss_pred cc----cCCCCCCCCchhh----cCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 313 DF----RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 313 ~~----~~~~~~~~~~~~~----~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
.. .........+... ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 00 0111111122211 12347899999999999999999999999999999998765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-56 Score=412.36 Aligned_cols=282 Identities=34% Similarity=0.566 Sum_probs=229.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
++|++++.||+|+||+||+|++..+|+.||||+++... ....+|+.+|+.++|+||+++++++ .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 47999999999999999999999999999999986442 2335899999999999999999998 445558
Q ss_pred EEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 151 NLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 151 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
++||+++.++.+..+.. ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLIN-RNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred eEEeeeccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccc-cCCceeeeecchhhcc
Confidence 99999999875555443 45788999999999999999999999 6999999999999999 5778999999999876
Q ss_pred ccCC-cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGE-ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
.... ......+++.|+|||++.+...++.++|||||||++|+|++|+.| |.+.+..+.+.++....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 5433 333456788999999998777789999999999999999999887 56677888889999988888776554432
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccccC
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 368 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 368 (419)
........+..............+++++.|||++||+.||.+|||++|+|+||||+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 221111222222222223344567999999999999999999999999999999987653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=419.47 Aligned_cols=286 Identities=28% Similarity=0.482 Sum_probs=224.2
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCC---C
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTS---K 145 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 145 (419)
..++|++++.||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++|+||+++++++..... .
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3578999999999999999999999999999999885332 224589999999999999999998854321 2
Q ss_pred CceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 146 DELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 146 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
....+|+|||||.+++..... .....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~-~~~~~kl~dfg 162 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLIT-RDGVLKLADFG 162 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEC-TTSCEEECCCT
T ss_pred cCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeec-CCCcEEeeecc
Confidence 245689999999988666543 345679999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccC-----CcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKG-----EANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+++..... ......+||++|+|||++.+...|+.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99765422 1233467899999999998777799999999999999999999999999999999999999999888
Q ss_pred HHHHhccCcCC--ccccCCCCCCCCchhhcC-CCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 301 REEIRCMNPNY--TDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 301 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
.+.+......- ..+.............+. ...++++.|||.+||++||++|+|++|+|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 66544332111 111111111111111111 124788999999999999999999999999999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=427.14 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=209.6
Q ss_pred ccceeeec-eeccCCceEEEEEEEcCCCcEEEEEEeccCcccHHHHHHHHH-hcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 76 TISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-LMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 76 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.++|.+.. .||+|+||+||+|++..+|+.||||++.+. ....+|+.++. ..+|||||+++++|.+.. ..+.++|||
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence 45798875 699999999999999999999999998654 44668998865 558999999999884322 345678999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCC--CCceEEeeccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPL--THQVKLCDFGSAKVL 230 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~~vkl~DfG~a~~~ 230 (419)
||||+ |+|.+.+... ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+..
T Consensus 88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence 99998 5888887642 23579999999999999999999999 699999999999999842 457999999999887
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCcC
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 310 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 310 (419)
.........+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+....+.....
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------------- 230 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------------- 230 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-------------
T ss_pred cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh-------------
Confidence 766666778999999999999764 489999999999999999999999987665444333322110
Q ss_pred CccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCcccc
Q 014750 311 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 365 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~ 365 (419)
...+.++. .....+|+++.+||++||+.||++|||+.|+|+||||.+
T Consensus 231 ~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 MGQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp SCSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred cCCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 01111111 011247999999999999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-54 Score=399.56 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=204.3
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||+||+|++..+|+.||||++..+.. ...+|+++|+.++|||||++++++ .+...+|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCeeE
Confidence 44579999999999999999999999999999999875543 345899999999999999999998 4444589
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||||+ |++.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+|+..
T Consensus 90 iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVG-ENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEEC-CCCcEEEccccceeec
Confidence 9999999 5777776542 34678999999999999999999999 6999999999999999 6788999999999876
Q ss_pred ccCCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 231 VKGEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 231 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
...... ....|++.|+|||++.+. .|+.++|||||||++|||++|..||........+..++....
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~----------- 233 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------- 233 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred CCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-----------
Confidence 443322 234578999999999765 489999999999999999997655544433333333332100
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~~~ 366 (419)
...++..+++++.+||.+||+.||.+|||++|+++ +|+.+
T Consensus 234 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 ----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ----------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 01133567999999999999999999999999965 55543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-54 Score=398.47 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=202.8
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc-------cHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
.++|++.+.||+|+||+||+|++..+|+.||||++.+... ...+|+++++.++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4579999999999999999999999999999999864321 2457999999999999999999986543 2345
Q ss_pred eEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.+|||||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~-~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-TTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccC-ccccceeehhhhh
Confidence 68999999995 56555544 3679999999999999999999999 6999999999999999 5778999999998
Q ss_pred cccccCC----cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Q 014750 228 KVLVKGE----ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 228 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 303 (419)
....... .....+||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+.+.++.+....++
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 234 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 234 (277)
T ss_dssp EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence 7553322 23456899999999999764 589999999999999999999999999988887777665321111
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCCccc
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 364 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp~f~ 364 (419)
......+|+++.+||.+||+.||.+||+..+.+.|+|.+
T Consensus 235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112345799999999999999999999544455577764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-54 Score=394.48 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=197.6
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCce
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDEL 148 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (419)
..++|++.+.||+|+||+||+|+. +..||||++.... ....+|+.+|+.++|||||+++++.. + .
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-----~-~ 76 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A-P 76 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-S
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-----c-c
Confidence 456799999999999999999985 3469999986432 23457999999999999999998752 1 2
Q ss_pred eEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccc
Q 014750 149 FLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSA 227 (419)
Q Consensus 149 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a 227 (419)
.++||||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ +|||||||||+||||+ .++.+||+|||+|
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~-~~~~~Kl~DFGla 151 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLH-EDLTVKIGDFGLA 151 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-TTSSEEECCCCCS
T ss_pred EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEc-CCCCEEEccccce
Confidence 3789999999 577777754 24579999999999999999999999 6999999999999999 6788999999999
Q ss_pred cccccCC---cceeeeeccccccchhhcCC--CCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 228 KVLVKGE---ANISYICSRYYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 228 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+...... ......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+..+.+..+......++
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-- 229 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-- 229 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC--
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--
Confidence 8764332 22346789999999999643 2478999999999999999999999998776666655544211111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
. ...++..+++++.+||.+||..||.+|||++|+++|
T Consensus 230 ---------------~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ---------------D------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---------------C------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------c------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 111334578999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=390.81 Aligned_cols=244 Identities=18% Similarity=0.301 Sum_probs=193.6
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|++.+.||+|+||+||+|++. +++.||||++..+. ....+|+++++.++|||||++++++. +...+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence 46999999999999999999975 56789999987543 33458999999999999999999984 34458999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
||||. |+|.+.+.. ....+++..+..++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEEC-GGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeec-CCCCeEecccchheeccC
Confidence 99998 567666654 34668999999999999999999999 6999999999999999 678899999999987644
Q ss_pred CCcc--eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEAN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.... ....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+.....
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------ 220 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------ 220 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 3322 235789999999999765 48999999999999999999 5777777777776666654211
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+..+++++.+||.+||+.||++|||++|+++|
T Consensus 221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 11234568999999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=403.14 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=203.7
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCc-----EEEEEEeccCc-----ccHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||+||+|++..+++ .||+|.+.... ....+|+.+++.+ +|||||++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~---- 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC---- 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE----
Confidence 34689999999999999999999876654 69999885432 2345799999888 899999999998
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhcc-------------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccc
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYSS-------------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~ 203 (419)
.+...+|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +|||||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHR 188 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHR 188 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEET
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeec
Confidence 44455899999998 588888765321 12458999999999999999999999 699999
Q ss_pred cccCCceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCC
Q 014750 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 279 (419)
Q Consensus 204 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~p 279 (419)
||||+|||++ .++.+||+|||+|+........ ....||+.|||||++.+. .|+.++|||||||++|||+| |..|
T Consensus 189 DlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999 6789999999999876554432 245679999999999764 58999999999999999998 8999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
|.+.+..+.+.++++.... ...+..+++++.+||.+||+.||++|||++||++
T Consensus 267 f~~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp STTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9987766666666542111 0123457999999999999999999999999997
Q ss_pred C
Q 014750 360 H 360 (419)
Q Consensus 360 h 360 (419)
|
T Consensus 320 ~ 320 (325)
T d1rjba_ 320 F 320 (325)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-53 Score=396.16 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=191.3
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCc---EEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..+|++.+.||+|+||+||+|+++.+++ .||||.+.... ....+|+++|+.++|||||++++++. +.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence 4579999999999999999999987765 58899875432 23458999999999999999999983 34
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+|+|||||++ +|.+.+.. ..+.+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVN-SNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEEC-CCCcEEECCccc
Confidence 458999999995 56555543 24579999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcc------eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q 014750 227 AKVLVKGEAN------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 299 (419)
Q Consensus 227 a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 299 (419)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9876443221 124568899999999764 58999999999999999998 899999988877776665421111
Q ss_pred CHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 300 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 223578999999999999999999999998865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=391.86 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=203.8
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCcc---cHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
..++|++.+.||+|+||+||+|++. +++.||||++..... ...+|+++++.++|||||++++++. + ..+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~-~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----Q-EPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-----c-CCeE
Confidence 4468999999999999999999975 678899999875432 3568999999999999999999762 1 1268
Q ss_pred EEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
||||||++ +|.+.+.... ...+++..+..++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+|+..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVS-DTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeee-cccceeeccccceEEc
Confidence 99999994 6665544322 2458999999999999999999999 6999999999999999 6888999999999876
Q ss_pred ccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhcc
Q 014750 231 VKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCM 307 (419)
Q Consensus 231 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 307 (419)
..... .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.+...
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---------- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 54432 2345688999999999764 489999999999999999994 666666676666665543110
Q ss_pred CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc--CCcccc
Q 014750 308 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 365 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~--hp~f~~ 365 (419)
...+..+++++.+||.+||+.||++|||++++++ |+||..
T Consensus 229 ------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1123467999999999999999999999999998 888863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=385.91 Aligned_cols=244 Identities=18% Similarity=0.260 Sum_probs=204.8
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
++|++.+.||+|+||+||+|+++ +++.||||+++++. ....+|+.+++.++||||+++++++ .+...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCCceEEE
Confidence 46999999999999999999974 78899999987643 3445899999999999999999998 444558999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccccc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~ 232 (419)
|||+. |++.+.+.. ....+++..++.++.||++||.|||+ +||+||||||+|||++ .++.+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEc-CCCcEEECcchhheeccC
Confidence 99998 555655443 24568899999999999999999999 6999999999999999 678899999999986644
Q ss_pred CCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 233 GEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 233 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
... .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+...++.+....
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~----------- 220 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------- 220 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 333 2235689999999999765 48999999999999999998 89999999888777766542111
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..+..+++++.+||++||+.||++|||++++++|
T Consensus 221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1234568999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-53 Score=390.11 Aligned_cols=250 Identities=25% Similarity=0.305 Sum_probs=203.0
Q ss_pred ccceeeece-eccCCceEEEEEEEcC--CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.++|.+.+. ||+|+||+||+|.++. ++..||||++.... ....+|+++|+.++|||||++++++.. +
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~ 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C
Confidence 456888885 9999999999998754 45579999986442 234579999999999999999998732 1
Q ss_pred eeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
.+|||||||++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~-~~~~~Kl~DFGl 155 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLV-NRHYAKISDFGL 155 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEE-ETTEEEECCCTT
T ss_pred -eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeec-cCCceeeccchh
Confidence 27899999995 66665543 34679999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+...
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---- 230 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 230 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 9876543322 234678999999999765 48999999999999999998 9999998887776666543210
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH---hcCCcccc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE 365 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~---l~hp~f~~ 365 (419)
..++..+++++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 231 ------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01335679999999999999999999999877 67888853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=400.44 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=208.7
Q ss_pred cccceeeeceeccCCceEEEEEEEc---CCCcEEEEEEeccCc--------ccHHHHHHHHHhcCC-CCeeecceeeecc
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRLMDH-PNVISLKHCFFST 142 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h-~niv~~~~~~~~~ 142 (419)
..++|++++.||+|+||+||+|++. .+|+.||||++.+.. ....+|++++++++| |||+++++++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~--- 98 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF--- 98 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE---
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee---
Confidence 4578999999999999999999974 478999999885321 234479999999977 7999999998
Q ss_pred CCCCceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEE
Q 014750 143 TSKDELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKL 221 (419)
Q Consensus 143 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl 221 (419)
.+...++++|||+. |+|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||
T Consensus 99 --~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~-~~~~vkL 170 (322)
T d1vzoa_ 99 --QTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLD-SNGHVVL 170 (322)
T ss_dssp --EETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEC-TTSCEEE
T ss_pred --ccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeec-CCCCEEE
Confidence 44456999999999 477766654 3567899999999999999999999 6999999999999999 5788999
Q ss_pred eecccccccccCC--cceeeeeccccccchhhcCCC-CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 014750 222 CDFGSAKVLVKGE--ANISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 298 (419)
Q Consensus 222 ~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 298 (419)
+|||+|+...... ......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+....
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 9999998654332 234567899999999997643 4688999999999999999999999887655555444432110
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCC-----CHHHHhcCCccccccC
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 368 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~ 368 (419)
. ...++..+++++.+||++||++||.+|+ |++|+++||||+++++
T Consensus 251 ~-------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 251 S-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp C-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred C-------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 0 0012345799999999999999999999 5899999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=387.93 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=195.2
Q ss_pred ceeccCCceEEEEEEEc--CCCcEEEEEEeccCc------ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 83 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 83 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
+.||+|+||+||+|.+. .+++.||||++.... ....+|+++|+.++|||||++++++.. + ..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----S-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----C-CEEEEE
Confidence 47999999999999864 456789999986432 234579999999999999999998732 1 268999
Q ss_pred ecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccccccC
Q 014750 155 EYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKG 233 (419)
Q Consensus 155 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~ 233 (419)
|||++ +|.+.+.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhccc-ccCcccccchhhhhhcccc
Confidence 99985 67666654 4679999999999999999999999 6999999999999999 6889999999999876443
Q ss_pred Ccc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccC
Q 014750 234 EAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 308 (419)
Q Consensus 234 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 308 (419)
... ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------- 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------- 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 322 234678999999999764 48999999999999999998 8999999887766665543110
Q ss_pred cCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHH---hcCCcccc
Q 014750 309 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~---l~hp~f~~ 365 (419)
..++..+++++.+||.+||+.||++|||++++ |+|+|++-
T Consensus 229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 11234679999999999999999999999998 46766653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=383.23 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=200.0
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
...++|++.+.||+|+||+||+|++..+ +.||||++.... ....+|+.+++.++|+|||++++++. ++ .+
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~-~~ 86 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EE-PI 86 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-SC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cC-Ce
Confidence 3456899999999999999999998655 579999986543 33558999999999999999999872 22 26
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++|||||.+ ++...+... ....+++.+++.++.||+.||+|||+ +||+||||||+||||+ .++++||+|||+|+.
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~-~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVG-ENLVCKVADFGLARL 162 (285)
T ss_dssp EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-GGGCEEECCCCTTC-
T ss_pred EEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEEC-CCCcEEEcccchhhh
Confidence 899999995 555555432 23569999999999999999999999 6999999999999999 678899999999987
Q ss_pred cccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhc
Q 014750 230 LVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 306 (419)
Q Consensus 230 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 306 (419)
...... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+....+.+..+.+....
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------- 233 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 233 (285)
T ss_dssp -------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------
T ss_pred ccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence 643332 2345689999999999764 589999999999999999995 5666666666666655432111
Q ss_pred cCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc--CCcccccc
Q 014750 307 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELR 367 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 367 (419)
.++..+++++++||.+||+.||++|||++++++ |+||+...
T Consensus 234 --------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 234 --------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 123457999999999999999999999999987 88997643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=381.59 Aligned_cols=246 Identities=27% Similarity=0.347 Sum_probs=191.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC---cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
..++|++.+.||+|+||+||+|++..++ ..||||.+.... ....+|+.+|+.++|||||++++++. +
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----~ 79 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----E 79 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence 3468999999999999999999986543 468899875432 23457999999999999999999872 1
Q ss_pred ceeEEEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
..+|+|||||.+ ++.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~-~~~~~Kl~DfG 153 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVS-SNDCVKLGDFG 153 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEE-ETTEEEECC--
T ss_pred -CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeec-CCCcEEEccch
Confidence 247899999995 55554443 34679999999999999999999999 6999999999999999 67889999999
Q ss_pred cccccccCCc--ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 226 SAKVLVKGEA--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 226 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
+|+....... .....||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+..+.+..+.+...
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~----- 227 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER----- 227 (273)
T ss_dssp -----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-----
T ss_pred hheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 9987643322 2345678999999999764 48999999999999999998 8999999888777766654210
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
..++..+++++.+||.+||+.||.+|||++|+++|
T Consensus 228 -----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 -----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234679999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=377.85 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=188.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCC----cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
..|++.++||+|+||+||+|.+..++ ..||||++.... ....+|+++++.++|||||++++++. +.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence 35999999999999999999987655 469999986432 23457999999999999999999984 34
Q ss_pred eeEEEEeeccccc-HHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVPET-MYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
..+++|||||.++ +.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+||||+ .++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~-~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVN-SNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEC-TTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEEC-CCCeEEEcccch
Confidence 4489999999964 4444433 34679999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCc----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCH
Q 014750 227 AKVLVKGEA----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTR 301 (419)
Q Consensus 227 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~ 301 (419)
|+....... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||...+..+.+..+.....
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---- 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC----
Confidence 987644322 2234678999999999764 589999999999999999995 555555555555544433111
Q ss_pred HHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 302 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
...+..++.++.+||.+||+.||++|||+.|+++
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1123457899999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=386.44 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=196.2
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCc----EEEEEEeccC-----cccHHHHHHHHHhcCCCCeeecceeeeccCCCCc
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (419)
.+|++++.||+|+||+||+|++..+|+ .||+|.+... .+...+|+++++.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 469999999999999999999988876 5788877532 22356899999999999999999998432
Q ss_pred eeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccc
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGS 226 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~ 226 (419)
. .+++|||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||||+ .++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~-~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVK-TPQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEE-ETTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeC-CCCCeEeecccc
Confidence 2 557777776 677776654 35679999999999999999999999 6999999999999999 688999999999
Q ss_pred ccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHH
Q 014750 227 AKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 302 (419)
Q Consensus 227 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 302 (419)
|+........ ....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+....+.+....
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---- 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9876443322 234679999999999775 48999999999999999998 89999988776665555442111
Q ss_pred HHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcCC
Q 014750 303 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 361 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~hp 361 (419)
..+..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 12345789999999999999999999999999883
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=381.53 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=190.5
Q ss_pred ccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeeccCC
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTTS 144 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (419)
.++|++.+.||+|+||+||+|++.. +++.||||++..... ...+|..++.++ +|+||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--- 88 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 88 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence 4679999999999999999999754 457899999864322 223455666555 78999999887643
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCcee
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLL 211 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIl 211 (419)
+...+++|||||+ |+|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NIL 166 (299)
T d1ywna1 89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 166 (299)
T ss_dssp -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCcccee
Confidence 3345889999998 688888765432 23468999999999999999999999 69999999999999
Q ss_pred eCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHH
Q 014750 212 VDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD 287 (419)
Q Consensus 212 l~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~ 287 (419)
|+ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+.+..+
T Consensus 167 l~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 167 LS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99 678899999999986543322 2346789999999999764 589999999999999999996 57888776555
Q ss_pred HHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
.+..++.....+ .+++.+++++.+||.+||+.||.+|||++|+++|
T Consensus 245 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555544321111 1234579999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=373.67 Aligned_cols=246 Identities=20% Similarity=0.305 Sum_probs=196.2
Q ss_pred ccccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEE
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 151 (419)
...++|++.+.||+|+||.||+|++ +|..||||+++++. ....+|+++++.++||||+++++++.. +...+|
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 3456799999999999999999998 57899999997553 345689999999999999999998743 233478
Q ss_pred EEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeeccccccc
Q 014750 152 LVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVL 230 (419)
Q Consensus 152 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~~ 230 (419)
+||||++ |+|.+.+.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 78 lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTSCEEECCCCC----
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheec-CCCCEeecccccceec
Confidence 9999998 57888776532 2358999999999999999999999 6999999999999999 6788999999999865
Q ss_pred ccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHHhccCc
Q 014750 231 VKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 309 (419)
Q Consensus 231 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 309 (419)
.. ......+|..|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+..
T Consensus 154 ~~--~~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~------------- 217 (262)
T d1byga_ 154 SS--TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 217 (262)
T ss_dssp ----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------
T ss_pred CC--CCccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 32 23345678999999999765 58999999999999999998 799998877766665553210
Q ss_pred CCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 310 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...++..+++++.+||++||..||.+|||+.+++++
T Consensus 218 ---------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ---------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111344578999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=382.04 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=203.1
Q ss_pred ccceeeeceeccCCceEEEEEEEcCCCcE--EEEEEeccC-----cccHHHHHHHHHhc-CCCCeeecceeeeccCCCCc
Q 014750 76 TISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRLM-DHPNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 76 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (419)
-++|++.+.||+|+||+||+|+++.+|.. ||||++... .....+|+++|+.+ +|||||++++++.. .
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~ 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----C
Confidence 35799999999999999999999888874 677776432 23456899999998 79999999999843 4
Q ss_pred eeEEEEeeccc-ccHHHHHHhh------------ccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC
Q 014750 148 LFLNLVMEYVP-ETMYRVLKHY------------SSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP 214 (419)
Q Consensus 148 ~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~ 214 (419)
..+++|||||+ |+|.+.+... ......+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~- 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG- 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc-
Confidence 45899999999 6888877643 1235779999999999999999999999 6999999999999999
Q ss_pred CCCceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCC-CCCCCCCHHHHHHHHH
Q 014750 215 LTHQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEII 293 (419)
Q Consensus 215 ~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~i~ 293 (419)
.++.+||+|||+|+............||..|+|||.+.+. .|+.++|||||||++|||++|. +||.+.+..+....+.
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 6778999999999876554444556789999999999765 4899999999999999999964 6788887776665543
Q ss_pred HHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 294 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
+.. ...++..+++++.+||.+||+.||++|||++|+++|
T Consensus 241 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 310 011234578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=373.26 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=190.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCC-C--cEEEEEEeccCc-------ccHHHHHHHHHhcCCCCeeecceeeeccCCCC
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDR-------RYKNRELQLMRLMDHPNVISLKHCFFSTTSKD 146 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (419)
.+|++.+.||+|+||.||+|+...+ + ..||||++.++. ....+|+.+|+.++|||||++++++..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 4699999999999999999986533 3 368999875431 234589999999999999999998832
Q ss_pred ceeEEEEeeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecc
Q 014750 147 ELFLNLVMEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 147 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
. .+++|||||. |++.+.+... ...+++..++.++.||+.||.|||+ +||+||||||+|||++ .++.+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~-~~~~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLA-TRDLVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEE-ETTEEEECCCT
T ss_pred c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccc-cccceeeccch
Confidence 2 3689999998 5666665542 3569999999999999999999999 6999999999999999 57899999999
Q ss_pred cccccccCCcc----eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q 014750 226 SAKVLVKGEAN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 300 (419)
Q Consensus 226 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 300 (419)
+++........ ....|+..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+.++.+....
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-- 233 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-- 233 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence 99876444322 234567889999999764 58999999999999999998 89999999988887776542111
Q ss_pred HHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHh
Q 014750 301 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 358 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l 358 (419)
...+..+++++.+||.+||..||++|||+++++
T Consensus 234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 112346789999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-50 Score=376.63 Aligned_cols=249 Identities=24% Similarity=0.282 Sum_probs=202.4
Q ss_pred cccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTS 144 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (419)
..++|++.+.||+|+||+||+|+.+. +++.||||++.... ....+|+++|+.++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---- 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA---- 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec----
Confidence 35679999999999999999999753 56789999986542 23468999999999999999999984
Q ss_pred CCceeEEEEeeccc-ccHHHHHHhhc--------------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccc
Q 014750 145 KDELFLNLVMEYVP-ETMYRVLKHYS--------------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHR 203 (419)
Q Consensus 145 ~~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~ 203 (419)
....++++|||+. |+|.+.+.... .....+++..+..++.||+.||+|||+ +|||||
T Consensus 87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHr 164 (301)
T d1lufa_ 87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 164 (301)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred -cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEee
Confidence 3444889999998 67888775422 123458899999999999999999999 699999
Q ss_pred cccCCceeeCCCCCceEEeecccccccccCC---cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCC-CC
Q 014750 204 DVKPQNLLVDPLTHQVKLCDFGSAKVLVKGE---ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PL 279 (419)
Q Consensus 204 Dlkp~NIll~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~p 279 (419)
||||+||||+ .++.+||+|||+|+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|. +|
T Consensus 165 DlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 165 DLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCC
Confidence 9999999999 67889999999998654332 22346788999999999764 4899999999999999999985 78
Q ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 280 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 280 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
|.+.+..+.+..+.+... ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 988888887776654210 0123467899999999999999999999999954
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=372.88 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=197.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCC-------cEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeec
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFS 141 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (419)
..++|++.+.||+|+||.||+|++..++ ..||||++.++.. ...+|...+..+ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~-- 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc--
Confidence 4568999999999999999999976654 4799999865542 223577777777 899999999999
Q ss_pred cCCCCceeEEEEeeccc-ccHHHHHHhhcc------------CCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCC
Q 014750 142 TTSKDELFLNLVMEYVP-ETMYRVLKHYSS------------MNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (419)
Q Consensus 142 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~ 208 (419)
.++..+++|||||. |++.+.+..... ....+++..++.++.||+.||+|||+ +|||||||||+
T Consensus 89 ---~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~ 164 (299)
T d1fgka_ 89 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 164 (299)
T ss_dssp ---CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred ---ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeeccc
Confidence 44456899999998 578777765321 23568999999999999999999999 69999999999
Q ss_pred ceeeCCCCCceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCC
Q 014750 209 NLLVDPLTHQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (419)
Q Consensus 209 NIll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (419)
|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+
T Consensus 165 NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 165 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999 678899999999987654432 2336789999999999764 59999999999999999998 799998888
Q ss_pred HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 285 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+....+.+.. . ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~i~~~~-~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGH-R---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTC-C---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC-C---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 766555443310 0 0123457999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-50 Score=374.97 Aligned_cols=259 Identities=22% Similarity=0.268 Sum_probs=200.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeEEEEe
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFLNLVM 154 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 154 (419)
++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|+|++..+..+. .+....++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEEEEE
Confidence 4699999999999999999999999999999987643 345678999999998887666655443 2334578999
Q ss_pred ecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC--CCCceEEeeccccccccc
Q 014750 155 EYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP--LTHQVKLCDFGSAKVLVK 232 (419)
Q Consensus 155 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~~vkl~DfG~a~~~~~ 232 (419)
||+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+....
T Consensus 83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999987776654 35679999999999999999999999 69999999999999763 345799999999987654
Q ss_pred CCc--------ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Q 014750 233 GEA--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 304 (419)
Q Consensus 233 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 304 (419)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||......+....+.+......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---- 233 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 233 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH----
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC----
Confidence 322 23467999999999997754 89999999999999999999999988765554443332110000
Q ss_pred hccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHH---HHhcCCcccc
Q 014750 305 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE 365 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~---e~l~hp~f~~ 365 (419)
. .+ ...+...+++++.+||.+||+.||.+||+++ ++|+|+|.+.
T Consensus 234 ----------~------~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 ----------S------TP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ----------H------SC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------C------CC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0 00 0112345799999999999999999999987 5577877654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=370.88 Aligned_cols=257 Identities=23% Similarity=0.280 Sum_probs=208.8
Q ss_pred ccccceeeeceeccCCceEEEEEEEcC-----CCcEEEEEEeccCcc-----cHHHHHHHHHhcCCCCeeecceeeeccC
Q 014750 74 KQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRLMDHPNVISLKHCFFSTT 143 (419)
Q Consensus 74 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (419)
...++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+|+++++.++|||||++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~---- 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---- 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence 345789999999999999999998753 357899999865432 235899999999999999999998
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhc------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYS------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
.....+++|||||. |+|.+.+.... .....+++..+..++.|++.||.|||+ ++|+||||||+||||+ .+
T Consensus 93 -~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld-~~ 169 (308)
T d1p4oa_ 93 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVA-ED 169 (308)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEEC-TT
T ss_pred -ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeec-CC
Confidence 33445899999998 57777665422 122457889999999999999999999 6999999999999999 68
Q ss_pred CceEEeecccccccccCCc---ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 014750 217 HQVKLCDFGSAKVLVKGEA---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEI 292 (419)
Q Consensus 217 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i 292 (419)
+++||+|||+|+....... .....||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8999999999986644332 2334789999999999765 489999999999999999998 5889888888777766
Q ss_pred HHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc------CCccccc
Q 014750 293 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL 366 (419)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~------hp~f~~~ 366 (419)
.+... ...+..+++.+.+||.+||+.||.+|||++++++ +|+|+++
T Consensus 249 ~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 249 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 54211 0123457899999999999999999999999997 7777653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=368.58 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.3
Q ss_pred cccceeeeceeccCCceEEEEEEEc-----CCCcEEEEEEeccCcc-----cHHHHHHHHHhc-CCCCeeecceeeeccC
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRLM-DHPNVISLKHCFFSTT 143 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (419)
..++|++.+.||+|+||.||+|++. .+++.||||++..... ...+|+.+++.+ +|||||++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---- 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 4568999999999999999999863 4677999999875432 234788999988 699999999998
Q ss_pred CCCceeEEEEeeccc-ccHHHHHHhhc--------------cCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCC
Q 014750 144 SKDELFLNLVMEYVP-ETMYRVLKHYS--------------SMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQ 208 (419)
Q Consensus 144 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~ 208 (419)
.+...+|+|||||+ |++.+.+.... .....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR 174 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccccc
Confidence 44445899999998 57777776432 123468999999999999999999999 69999999999
Q ss_pred ceeeCCCCCceEEeecccccccccCCcc---eeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHh-CCCCCCCCC
Q 014750 209 NLLVDPLTHQVKLCDFGSAKVLVKGEAN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 284 (419)
Q Consensus 209 NIll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~ 284 (419)
|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+
T Consensus 175 NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999 5788999999999876544322 235789999999999764 58999999999999999999 777787777
Q ss_pred HHHHHHHHHHHhCCCCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 285 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 285 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
..+.+.++.+.... ...+..+++++.+||.+||+.||.+|||++++++
T Consensus 253 ~~~~~~~~i~~~~~---------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhcCCC---------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66666666543111 1123456899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-49 Score=379.92 Aligned_cols=287 Identities=29% Similarity=0.466 Sum_probs=213.1
Q ss_pred cccceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcC-----------CCCeeecceeee
Q 014750 75 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMD-----------HPNVISLKHCFF 140 (419)
Q Consensus 75 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~~ 140 (419)
..++|+++++||+|+||+||+|+++.+|+.||||++.++. ....+|+++++.++ |+||+++++++.
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 3456999999999999999999999999999999997653 23457888888775 578999998874
Q ss_pred ccCCCCceeEEEEeeccc--ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCC-
Q 014750 141 STTSKDELFLNLVMEYVP--ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTH- 217 (419)
Q Consensus 141 ~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~- 217 (419)
... ....+++|+++. ++...... ......+++..++.++.||+.||.|||+..||+||||||+||||+..+.
T Consensus 91 ~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 91 HKG---PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEE---TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred ecc---ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 422 223445555554 44333333 3345778999999999999999999997349999999999999984322
Q ss_pred ----ceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCC------HHH
Q 014750 218 ----QVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVD 287 (419)
Q Consensus 218 ----~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~ 287 (419)
.+||+|||.+.... ......+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+ ..+
T Consensus 166 ~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeecccccccc--cccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 49999999997653 334567899999999999865 48999999999999999999999997543 456
Q ss_pred HHHHHHHHhCCCCHHHHhccCcC-------CccccCCCCCCCCchhhc------CCCCChhHHHHHhhhcccCCCCCCCH
Q 014750 288 QLVEIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHKVF------HKRMPPEAIDLASRLLQYSPSLRCTA 354 (419)
Q Consensus 288 ~~~~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~s~~~~dli~~~L~~dP~~R~t~ 354 (419)
.+......+|.++...+...... .....+......++.... ....+++++|||.+||++||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 77888889999887766432211 001111222222222211 12346789999999999999999999
Q ss_pred HHHhcCCccccccCC
Q 014750 355 LEACAHPFFDELREP 369 (419)
Q Consensus 355 ~e~l~hp~f~~~~~~ 369 (419)
+|+|+||||++....
T Consensus 323 ~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 323 GGLVNHPWLKDTLGM 337 (362)
T ss_dssp HHHHTCGGGTTCTTC
T ss_pred HHHhcCcccCCCCCc
Confidence 999999999976443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=363.15 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=188.9
Q ss_pred eeeeceeccCCceEEEEEEEcCCC---cEEEEEEeccCc-----ccHHHHHHHHHhcCCCCeeecceeeeccCCCCceeE
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRLMDHPNVISLKHCFFSTTSKDELFL 150 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 150 (419)
+...++||+|+||+||+|++..++ ..||||++.+.. ....+|+++|++++|||||++++++.. .+..+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCce
Confidence 344678999999999999986643 368999986421 234689999999999999999998743 23358
Q ss_pred EEEeecccc-cHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 151 NLVMEYVPE-TMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 151 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
++|||||++ +|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+||||+ +++.+||+|||+++.
T Consensus 105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLD-EKFTVKVADFGLARD 179 (311)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC-TTCCEEECSSGGGCC
T ss_pred EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeEC-CCCCEEEecccchhh
Confidence 899999995 55555443 34567888899999999999999999 6999999999999999 678899999999987
Q ss_pred cccCCc-----ceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Q 014750 230 LVKGEA-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE 303 (419)
Q Consensus 230 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 303 (419)
...... .....||+.|+|||.+.+. .++.++|||||||++|||+||..||..... .+....+.+. .
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~----- 251 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R----- 251 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C-----
T ss_pred ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence 643322 2235689999999998764 489999999999999999997777765432 2223332221 0
Q ss_pred HhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 304 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
....+..+++++.+||.+||..||++|||+.|+++|
T Consensus 252 ---------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 ---------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011234578999999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-47 Score=356.37 Aligned_cols=249 Identities=18% Similarity=0.230 Sum_probs=200.4
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC--cccHHHHHHHHHhcCC-CCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
++|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.+.| +||+.+++++ ......++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccEEE
Confidence 4799999999999999999999999999999987543 3456789999999976 8999998887 344558999
Q ss_pred eecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCC----CCCceEEeecccccc
Q 014750 154 MEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDP----LTHQVKLCDFGSAKV 229 (419)
Q Consensus 154 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~~vkl~DfG~a~~ 229 (419)
|||++++|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .++.+||+|||+|+.
T Consensus 80 me~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 80 IDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99999998887764 34579999999999999999999999 69999999999999973 246799999999987
Q ss_pred cccCC--------cceeeeeccccccchhhcCCCCCCCcccEeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Q 014750 230 LVKGE--------ANISYICSRYYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 298 (419)
Q Consensus 230 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~ 298 (419)
..... .....+||+.|||||++.+. .++.++|||||||++|||++|..||.+... .+....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 64321 23346799999999999764 589999999999999999999999986533 3333333321111
Q ss_pred CCHHHHhccCcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhc
Q 014750 299 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 359 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~ 359 (419)
+.. ..+...+++++.+++..|+..+|++||+.+.+.+
T Consensus 235 ~~~------------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPL------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCH------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCh------------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111 1122457899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=359.94 Aligned_cols=267 Identities=21% Similarity=0.223 Sum_probs=187.7
Q ss_pred cceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCccc-HHHH--HHHHHhcCCCCeeecceeeeccCCCCceeEEEE
Q 014750 77 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRE--LQLMRLMDHPNVISLKHCFFSTTSKDELFLNLV 153 (419)
Q Consensus 77 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~e--~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 153 (419)
.+|.+.+.||+|+||.||+|+. +|+.||||++..+... ..+| +..+..++|||||++++++.... .....+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence 4699999999999999999986 7899999998644322 2234 44455789999999999986543 334468999
Q ss_pred eeccc-ccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCcccccccCCceeeCCCCCceEEeecc
Q 014750 154 MEYVP-ETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV-------PGVCHRDVKPQNLLVDPLTHQVKLCDFG 225 (419)
Q Consensus 154 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~ivH~Dlkp~NIll~~~~~~vkl~DfG 225 (419)
||||. |+|.+.++. ..+++..+..++.|++.||.|||+. +||+||||||+||||+ .++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecC
Confidence 99998 588888765 4689999999999999999999962 4999999999999999 67899999999
Q ss_pred cccccccCCc-----ceeeeeccccccchhhcCCC-----CCCCcccEeehhHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 014750 226 SAKVLVKGEA-----NISYICSRYYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 295 (419)
Q Consensus 226 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 295 (419)
+++....... .....||+.|+|||++.+.. .++.++|||||||++|||+||..||........... ...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-hcc
Confidence 9987654432 23467899999999986532 156789999999999999999988754221100000 000
Q ss_pred hCCCCHHHHhcc-CcCCccccCCCCCCCCchhhcCCCCChhHHHHHhhhcccCCCCCCCHHHHhcC
Q 014750 296 LGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 360 (419)
Q Consensus 296 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t~~e~l~h 360 (419)
...+........ ..... -|.+. ...........+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~---~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKL---RPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCC---CCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccc---CCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000000000 00000 00000 000011123468999999999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=6.1e-26 Score=195.99 Aligned_cols=165 Identities=16% Similarity=0.098 Sum_probs=115.6
Q ss_pred eeeeceeccCCceEEEEEEEcCCCcEEEEEEeccCc----------------------ccHHHHHHHHHhcCCCCeeecc
Q 014750 79 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRLMDHPNVISLK 136 (419)
Q Consensus 79 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~ 136 (419)
|.+.+.||+|+||+||+|++. +|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 567899999999999999974 78999999764211 0112477888899999998876
Q ss_pred eeeeccCCCCceeEEEEeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcCCCcccccccCCceeeCCCC
Q 014750 137 HCFFSTTSKDELFLNLVMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLT 216 (419)
Q Consensus 137 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~ivH~Dlkp~NIll~~~~ 216 (419)
++. . .+++|||+++... ..++...+..++.|++.+|.|||+ +||+||||||+|||++ ++
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~-~~ 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EE 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TT
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeee-CC
Confidence 543 1 3699999997521 124445577899999999999999 6999999999999998 34
Q ss_pred CceEEeecccccccccCCcceeeeeccccccchhhcCCCCCCCcccEeehhHH
Q 014750 217 HQVKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 269 (419)
Q Consensus 217 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 269 (419)
.++|+|||+|.......... +...-...-.+.+. ..|+.++|+||+.--
T Consensus 140 -~~~liDFG~a~~~~~~~~~~-~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWRE-ILERDVRNIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp -EEEECCCTTCEETTSTTHHH-HHHHHHHHHHHHHH--HHHCCCCCHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcHH-HHHHHHHHHHHHHc--CCCCCcccHHHHHHH
Confidence 49999999997653222111 10000000012221 347899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=9.2e-07 Score=77.79 Aligned_cols=136 Identities=15% Similarity=0.093 Sum_probs=83.1
Q ss_pred ceeeeceeccCCceEEEEEEEcCCCcEEEEEEeccC----cccHHHHHHHHHhcCC-CCeeecceeeeccCCCCceeEEE
Q 014750 78 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRLMDH-PNVISLKHCFFSTTSKDELFLNL 152 (419)
Q Consensus 78 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~l 152 (419)
.|++++..+.++.+.||++.. .++.+.+|+.... .....+|...++.+.- --+.+++.+. .+....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence 477777666666689998863 6667888877533 2345688888887742 2234444443 23345789
Q ss_pred EeecccccHHHHHHhhccCCCCCCHHHHHHHHHHHHHHHHHhHcC-----------------------------------
Q 014750 153 VMEYVPETMYRVLKHYSSMNQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------- 197 (419)
Q Consensus 153 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------- 197 (419)
||++++|........ +......++.++...+..||+.
T Consensus 88 v~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 999999742221100 0001122333444444444431
Q ss_pred -----------------------CCcccccccCCceeeCCCCCceEEeecccccc
Q 014750 198 -----------------------PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKV 229 (419)
Q Consensus 198 -----------------------~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~~ 229 (419)
..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec-CCceEEEeechhccc
Confidence 0278999999999998 455456999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=1.1e-05 Score=70.19 Aligned_cols=69 Identities=13% Similarity=0.097 Sum_probs=44.2
Q ss_pred eccCC-ceEEEEEEEcCCCcEEEEEEeccCc-ccHHHHHHHHHhcCCCC--eeecceeeeccCCCCceeEEEEeecccc
Q 014750 85 VGTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRLMDHPN--VISLKHCFFSTTSKDELFLNLVMEYVPE 159 (419)
Q Consensus 85 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 159 (419)
+..|. -+.||++.. ..+..+.+|...... ....+|...++.+.... +.+++.+. .+....++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEEEeeec
Confidence 33444 468999874 467778899765443 34567888888775433 33444443 223347899999986
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=8.6e-05 Score=68.97 Aligned_cols=71 Identities=18% Similarity=0.142 Sum_probs=42.6
Q ss_pred eceeccCCceEEEEEEEcCCCcEEEEEEeccC-----------cccHHHHHHHHHhcC-C--CCeeecceeeeccCCCCc
Q 014750 82 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRLMD-H--PNVISLKHCFFSTTSKDE 147 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 147 (419)
.+.||.|....||++.+..+++.+++|.-... .....+|.+.|+.+. + ..+.+++.+ + .+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence 34689999999999998777889999964311 112345888887663 2 234444332 1 111
Q ss_pred eeEEEEeecccc
Q 014750 148 LFLNLVMEYVPE 159 (419)
Q Consensus 148 ~~~~lv~e~~~~ 159 (419)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 4589999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.91 E-value=0.002 Score=59.47 Aligned_cols=69 Identities=16% Similarity=0.231 Sum_probs=45.4
Q ss_pred eceeccCCceEEEEEEEcC-------CCcEEEEEEeccCc--ccHHHHHHHHHhcCCCCee-ecceeeeccCCCCceeEE
Q 014750 82 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR--RYKNRELQLMRLMDHPNVI-SLKHCFFSTTSKDELFLN 151 (419)
Q Consensus 82 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~ 151 (419)
++.|+.|-.-.+|++.... ..+.|.+++.-... ....+|..+++.+.-.++. ++++++ .+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 3578889999999998643 34567777654222 2245788888887544444 555554 22 4
Q ss_pred EEeecccc
Q 014750 152 LVMEYVPE 159 (419)
Q Consensus 152 lv~e~~~~ 159 (419)
+||||+.|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78999886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.002 Score=57.69 Aligned_cols=69 Identities=17% Similarity=0.060 Sum_probs=39.1
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCc---ccHHHHHHHHHhcCCCCeeecceeeeccC--CCCceeEEEEeecccc
Q 014750 90 FGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRLMDHPNVISLKHCFFSTT--SKDELFLNLVMEYVPE 159 (419)
Q Consensus 90 ~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~ 159 (419)
--.||++.. .+|+.|++|+..... .....|...+..|....|.-..-...... .......+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999984 578899999876543 33456888887764332211100000000 0123346788888875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.06 E-value=0.04 Score=48.36 Aligned_cols=30 Identities=30% Similarity=0.245 Sum_probs=25.6
Q ss_pred CCcccccccCCceeeCCCCCceEEeeccccc
Q 014750 198 PGVCHRDVKPQNLLVDPLTHQVKLCDFGSAK 228 (419)
Q Consensus 198 ~~ivH~Dlkp~NIll~~~~~~vkl~DfG~a~ 228 (419)
.|+||+|+.++||+++ .+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~-~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL-GDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcc-cccceeEecccccc
Confidence 4799999999999999 45556799999884
|